data_2ife_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ife _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 . . . . . 0 CA--C 1.481 -1.676 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.412 HG23 ' HD3' ' A' ' 123' ' ' LYS . 70.2 t -102.04 114.32 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.665 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 161.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -108.94 -179.83 3.97 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 156.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -143.82 158.42 43.69 Favored 'General case' 0 N--CA 1.433 -1.309 0 O-C-N 123.462 0.476 . . . . 0.0 110.544 -169.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.9 tp -135.35 162.23 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 166.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -120.91 157.26 30.25 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 118.863 0.756 . . . . 0.0 111.396 165.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.489 ' CE2' HG23 ' A' ' 148' ' ' VAL . 39.8 m-85 -136.92 100.32 4.27 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 173.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 . . . . . 0 N--CA 1.434 -1.274 0 C-N-CA 124.124 0.97 . . . . 0.0 109.086 178.862 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.0 t70 . . . . . 0 N--CA 1.424 -1.757 0 CA-C-O 122.758 1.266 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.501 ' HH ' HG21 ' A' ' 148' ' ' VAL . 1.2 t80 -73.95 -71.17 0.34 Allowed 'General case' 0 CA--C 1.474 -1.977 0 CA-C-N 111.572 -2.558 . . . . 0.0 113.082 -161.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.33 0.0 OUTLIER -60.63 -14.11 18.47 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 119.639 3.2 . . . . 0.0 119.639 175.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 87.5 t -60.65 -47.82 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.18 0.99 . . . . 0.0 109.444 161.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -91.94 7.66 41.09 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.08 -32.78 24.6 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 162.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.46 ' HA ' HG12 ' A' ' 115' ' ' ILE . 58.3 ttt-85 -61.87 -42.79 99.48 Favored 'General case' 0 C--N 1.363 1.189 0 CA-C-O 118.739 -0.648 . . . . 0.0 110.677 168.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.6 t -61.56 -41.31 97.19 Favored 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.512 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.434 HD13 HD22 ' A' ' 174' ' ' LEU . 65.0 tp -70.08 -29.29 66.24 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-O 117.088 -1.434 . . . . 0.0 113.541 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.46 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.269 10.0 mm -55.47 -53.08 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.957 0 CA-C-N 120.293 1.406 . . . . 0.0 107.569 170.014 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -47.29 -48.9 24.71 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 128.649 2.78 . . . . 0.0 111.776 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -56.81 -55.71 30.83 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.94 -36.17 64.99 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -89.1 -14.9 35.21 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 128.929 2.892 . . . . 0.0 110.341 -166.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -67.57 -24.94 65.57 Favored 'General case' 0 C--N 1.36 1.023 0 C-N-CA 122.981 0.512 . . . . 0.0 109.706 161.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 93.42 57.52 1.35 Allowed Glycine 0 CA--C 1.472 -2.655 0 N-CA-C 104.542 -3.423 . . . . 0.0 104.542 -174.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -126.53 167.73 15.23 Favored 'General case' 0 CA--C 1.462 -2.408 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.412 ' HD3' HG23 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -101.54 115.61 30.91 Favored 'General case' 0 N--CA 1.407 -2.597 1 N-CA-C 99.762 -4.162 . . . . 0.0 99.762 176.689 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.77 115.7 31.11 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.065 -1.425 . . . . 0.0 107.751 -168.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -97.44 121.58 39.51 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -171.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.1 mm -84.04 134.22 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.527 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 25.7 m -119.62 124.06 45.4 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 173.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.507 HD23 ' CE1' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -88.02 155.84 19.61 Favored 'General case' 0 CA--C 1.467 -2.236 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 167.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -152.07 91.52 1.62 Allowed 'General case' 0 N--CA 1.397 -3.115 1 N-CA-C 99.221 -4.363 . . . . 0.0 99.221 -174.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.507 ' CE1' HD23 ' A' ' 128' ' ' LEU . 92.0 m-85 . . . . . 0 N--CA 1.422 -1.854 0 CA-C-N 112.437 -2.165 . . . . 0.0 108.755 -173.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 82.1 mt . . . . . 0 CA--C 1.468 -2.188 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.59 -60.95 2.38 Favored Glycine 0 N--CA 1.41 -3.099 0 C-N-CA 118.867 -1.635 . . . . 0.0 111.926 -170.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 72.4 mtm -89.51 0.08 57.14 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -161.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -67.77 -50.37 57.47 Favored 'General case' 0 CA--C 1.457 -2.614 0 C-N-CA 116.096 -2.242 . . . . 0.0 113.295 151.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.81 -69.22 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.443 -3.168 0 O-C-N 125.946 2.028 . . . . 0.0 108.15 -166.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.403 ' HG ' HD13 ' A' ' 128' ' ' LEU . 27.8 mt -42.22 -53.31 4.12 Favored 'General case' 0 CA--C 1.476 -1.887 0 C-N-CA 128.929 2.891 . . . . 0.0 115.119 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -62.9 -36.16 82.43 Favored 'General case' 0 CA--C 1.46 -2.508 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -81.76 -14.15 56.82 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.603 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.501 HG21 ' HH ' ' A' ' 107' ' ' TYR . 1.6 t -77.68 -46.2 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.768 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -51.93 -50.62 60.79 Favored 'General case' 0 CA--C 1.463 -2.401 0 C-N-CA 125.583 1.553 . . . . 0.0 111.003 171.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.64 -36.62 70.76 Favored 'General case' 0 N--CA 1.411 -2.404 0 C-N-CA 124.447 1.099 . . . . 0.0 110.187 -169.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -72.69 -40.09 66.5 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 116.305 -2.158 . . . . 0.0 115.299 170.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.289 0.2 OUTLIER -80.2 -19.97 45.78 Favored 'General case' 0 CA--C 1.464 -2.352 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -177.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -26.38 -27.04 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.443 1 C-N-CA 134.457 5.103 . . . . 0.0 118.901 173.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -55.28 -59.04 5.35 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 127.045 2.138 . . . . 0.0 112.902 169.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.42 -52.1 3.19 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 125.842 1.657 . . . . 0.0 107.805 -167.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.431 ' HB3' ' CD1' ' A' ' 174' ' ' LEU 0.281 . . -100.28 141.44 33.12 Favored 'General case' 0 CA--C 1.459 -2.546 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.882 -178.217 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.5 m -123.93 164.25 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.421 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 139.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.5 t -84.08 153.46 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.104 0 CA-C-N 110.021 -3.263 . . . . 0.0 108.478 -172.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -82.32 -41.25 20.32 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.3 t -152.45 151.17 30.44 Favored 'General case' 0 CA--C 1.468 -2.174 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 N--CA 1.424 -1.768 0 N-CA-C 101.199 -3.63 . . . . 0.0 101.199 164.771 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.3 38.0 mt-30 . . . . . 0 CA--C 1.504 -0.79 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 51.8 ttp -134.93 118.73 17.2 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 119.155 0.889 . . . . 0.0 111.671 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.527 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 22.0 mm -82.49 123.94 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 O-C-N 121.31 -0.869 . . . . 0.0 108.666 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.9 ttt -101.07 130.29 47.07 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 159.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.16 134.87 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -173.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 1.1 tp -129.19 143.73 50.96 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 -174.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.32 . . -131.98 178.36 1.79 Allowed Pre-proline 0 CA--C 1.488 -1.424 0 C-N-CA 123.813 0.845 . . . . 0.0 110.065 -174.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -62.73 148.23 93.66 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 122.932 2.421 . . . . 0.0 109.059 160.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt . . . . . 0 CA--C 1.492 -1.273 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 174.54 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 . . . . . 0 CA--C 1.481 -1.706 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 82.0 t -103.03 124.77 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -108.38 171.74 7.24 Favored 'General case' 0 CA--C 1.479 -1.784 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 154.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -144.43 146.65 32.6 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.415 HG23 HD23 ' A' ' 114' ' ' LEU . 4.8 tp -124.97 160.07 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.085 0 N-CA-C 103.169 -2.9 . . . . 0.0 103.169 173.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -119.22 154.12 33.89 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 119.414 -0.915 . . . . 0.0 110.447 162.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.464 ' CE2' HG23 ' A' ' 148' ' ' VAL . 34.1 m-85 -134.03 110.83 9.91 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 . . . . . 0 N--CA 1.429 -1.486 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.187 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.4 t70 . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.436 ' HH ' ' HG2' ' A' ' 147' ' ' ARG . 0.9 OUTLIER -66.91 -73.71 0.13 Allowed 'General case' 0 CA--C 1.477 -1.86 0 C-N-CA 127.209 2.203 . . . . 0.0 110.371 -173.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.275 0.0 OUTLIER -65.49 -9.02 22.32 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 119.394 3.109 . . . . 0.0 119.394 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.84 -42.79 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 122.169 0.985 . . . . 0.0 110.793 161.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -91.67 -1.53 57.4 Favored 'General case' 0 CA--C 1.477 -1.831 0 O-C-N 120.352 -1.468 . . . . 0.0 114.686 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 tt -76.79 -31.98 57.36 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 161.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.487 ' HA ' HG12 ' A' ' 115' ' ' ILE . 31.4 ttt180 -62.47 -45.03 94.88 Favored 'General case' 0 C--N 1.363 1.19 0 C-N-CA 123.812 0.845 . . . . 0.0 111.482 170.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.1 m -61.77 -42.31 98.83 Favored 'General case' 0 C--N 1.377 1.796 0 C-N-CA 118.666 -1.214 . . . . 0.0 113.761 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.415 HD23 HG23 ' A' ' 96' ' ' ILE 0.323 52.4 tp -68.0 -27.92 66.98 Favored 'General case' 0 N--CA 1.406 -2.644 0 C-N-CA 126.73 2.012 . . . . 0.0 113.67 177.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.487 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.289 9.4 mm -57.33 -52.87 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.901 0 CA-C-N 121.036 1.744 . . . . 0.0 108.217 170.534 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -53.78 -42.64 68.5 Favored 'General case' 0 CA--C 1.492 -1.262 0 O-C-N 125.816 1.947 . . . . 0.0 110.402 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -58.21 -54.11 50.66 Favored 'General case' 0 CA--C 1.481 -1.701 0 C-N-CA 125.343 1.457 . . . . 0.0 112.639 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -33.07 72.84 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -73.58 -31.56 63.66 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 129.116 2.966 . . . . 0.0 109.798 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -64.67 -19.75 65.9 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 124.213 1.005 . . . . 0.0 111.679 171.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.53 54.79 2.72 Favored Glycine 0 CA--C 1.469 -2.825 0 N-CA-C 103.995 -3.642 . . . . 0.0 103.995 -174.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -120.42 163.52 17.77 Favored 'General case' 0 CA--C 1.447 -2.984 1 N-CA-C 99.82 -4.141 . . . . 0.0 99.82 170.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.04 116.13 32.12 Favored 'General case' 0 N--CA 1.393 -3.285 1 N-CA-C 98.644 -4.576 . . . . 0.0 98.644 171.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.52 156.71 25.12 Favored 'General case' 0 N--CA 1.407 -2.585 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 173.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.314 27.4 mtpp -131.44 138.76 49.19 Favored 'General case' 0 CA--C 1.487 -1.458 0 O-C-N 118.688 -2.507 . . . . 0.0 104.248 163.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.9 mm -85.43 136.77 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.527 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 27.5 m -117.51 130.11 56.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 169.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.483 HD21 ' CE1' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -92.19 160.09 15.34 Favored 'General case' 0 CA--C 1.468 -2.189 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 167.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -152.48 96.26 2.13 Favored 'General case' 0 N--CA 1.402 -2.843 1 N-CA-C 99.036 -4.431 . . . . 0.0 99.036 -174.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.483 ' CE1' HD21 ' A' ' 128' ' ' LEU . 96.8 m-85 . . . . . 0 CA--C 1.485 -1.551 0 CA-C-N 113.068 -1.878 . . . . 0.0 106.438 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 89.5 mt . . . . . 0 CA--C 1.477 -1.843 0 CA-C-O 119.997 -0.049 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -78.94 -57.85 3.14 Favored Glycine 0 N--CA 1.407 -3.245 0 C-N-CA 119.355 -1.403 . . . . 0.0 112.505 -167.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 58.4 mtm -93.92 18.24 10.84 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -170.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.86 -61.25 1.96 Allowed 'General case' 0 CA--C 1.456 -2.657 0 C-N-CA 115.138 -2.625 . . . . 0.0 114.573 133.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 23.7 t -64.07 -66.14 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.444 -3.111 0 O-C-N 126.213 2.196 . . . . 0.0 109.064 -160.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.1 mt -43.58 -55.81 4.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 127.811 2.444 . . . . 0.0 114.003 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -53.62 -43.12 68.41 Favored 'General case' 0 CA--C 1.485 -1.522 0 C-N-CA 126.791 2.036 . . . . 0.0 114.159 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.436 ' HG2' ' HH ' ' A' ' 107' ' ' TYR . 17.0 ttp180 -82.48 -14.26 55.33 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.464 HG23 ' CE2' ' A' ' 98' ' ' PHE . 2.5 t -72.93 -44.57 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.597 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.22 -53.94 51.74 Favored 'General case' 0 CA--C 1.45 -2.888 0 O-C-N 125.126 1.516 . . . . 0.0 112.722 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.88 -38.68 82.91 Favored 'General case' 0 N--CA 1.403 -2.791 0 C-N-CA 127.686 2.394 . . . . 0.0 109.241 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.01 -40.48 71.79 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 116.065 -2.254 . . . . 0.0 116.901 168.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.277 0.2 OUTLIER -80.2 -22.89 41.39 Favored 'General case' 0 CA--C 1.463 -2.384 0 N-CA-C 117.263 2.319 . . . . 0.0 117.263 -175.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -27.51 -27.96 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.44 1 C-N-CA 135.376 5.47 . . . . 0.0 118.483 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -50.77 -53.52 31.06 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 127.353 2.261 . . . . 0.0 112.842 168.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -53.56 2.99 Favored 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 126.102 1.761 . . . . 0.0 110.309 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.299 . . -110.32 136.54 49.34 Favored 'General case' 0 CA--C 1.452 -2.821 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -163.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.1 m -126.16 -179.57 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.407 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 161.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 160' ' ' SER . 0.0 OUTLIER -85.71 163.41 2.67 Favored 'Isoleucine or valine' 1 N--CA 1.377 -4.091 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.54 -166.312 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -84.5 -41.72 16.25 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 156.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.417 ' H ' HG13 ' A' ' 158' ' ' VAL 0.269 0.4 OUTLIER -169.85 150.87 4.0 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.921 -169.106 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.426 -1.649 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 167.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.267 32.3 mt-30 . . . . . 0 CA--C 1.51 -0.562 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 56.1 ttp -141.29 116.29 9.86 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-O 122.079 0.942 . . . . 0.0 112.063 -173.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.527 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 8.7 mm -80.35 135.95 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.841 0 O-C-N 120.944 -1.098 . . . . 0.0 109.005 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -108.53 131.42 54.85 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 151.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.47 135.81 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.82 81.98 1.85 Allowed 'General case' 0 C--N 1.356 0.884 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -170.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -87.03 179.01 1.92 Allowed Pre-proline 0 CA--C 1.509 -0.599 0 O-C-N 118.407 -2.683 . . . . 0.0 117.128 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -64.35 137.69 56.97 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 122.702 2.268 . . . . 0.0 111.966 169.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt . . . . . 0 CA--C 1.487 -1.455 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 168.778 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 . . . . . 0 CA--C 1.481 -1.697 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.44 117.48 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.744 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -112.24 173.99 6.1 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 153.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -139.5 159.25 42.59 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 123.34 0.4 . . . . 0.0 109.951 -165.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 tp -137.03 162.8 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 165.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -121.35 153.27 37.98 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.675 0.75 . . . . 0.0 112.225 164.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.477 ' CE2' HG23 ' A' ' 148' ' ' VAL . 43.7 m-85 -130.27 135.04 47.68 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 170.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.429 ' HD3' HH21 ' A' ' 129' ' ' ARG . 22.1 mtm-85 . . . . . 0 N--CA 1.434 -1.249 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 -176.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 47.1 t0 . . . . . 0 N--CA 1.427 -1.589 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.7 -73.29 0.45 Allowed 'General case' 0 CA--C 1.475 -1.904 0 CA-C-N 112.316 -2.22 . . . . 0.0 110.868 -156.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.331 0.0 OUTLIER -58.13 -15.85 11.11 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 119.038 2.977 . . . . 0.0 119.038 174.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.67 -48.94 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-O 122.488 1.137 . . . . 0.0 110.233 162.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -91.72 8.07 38.73 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.7 tt -84.29 -32.23 24.49 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 161.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.437 ' HA ' HG12 ' A' ' 115' ' ' ILE . 57.4 ttt180 -62.84 -44.2 96.77 Favored 'General case' 0 C--N 1.363 1.157 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.636 168.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 69.3 m -60.08 -40.38 89.34 Favored 'General case' 0 C--N 1.378 1.824 0 C-N-CA 118.464 -1.295 . . . . 0.0 113.532 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 mt -61.02 -33.68 73.65 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.437 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.3 mm -58.52 -48.86 84.24 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.648 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -49.82 -51.26 41.16 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 125.814 1.946 . . . . 0.0 112.255 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -54.75 -50.38 68.56 Favored 'General case' 0 CA--C 1.476 -1.874 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -43.24 99.23 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.3 -12.63 56.46 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 125.723 1.609 . . . . 0.0 112.358 -171.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.18 -12.7 60.97 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 124.112 0.965 . . . . 0.0 109.759 166.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.82 60.73 1.57 Allowed Glycine 0 CA--C 1.467 -2.908 0 N-CA-C 106.45 -2.66 . . . . 0.0 106.45 175.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -135.93 175.49 9.55 Favored 'General case' 0 CA--C 1.462 -2.42 0 N-CA-C 102.301 -3.222 . . . . 0.0 102.301 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.299 21.0 mtpt -89.21 148.05 23.82 Favored 'General case' 0 N--CA 1.405 -2.682 1 N-CA-C 100.046 -4.057 . . . . 0.0 100.046 165.35 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.26 115.41 25.23 Favored 'General case' 0 N--CA 1.407 -2.585 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 173.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -100.63 116.56 32.84 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.9 mm -85.73 132.23 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 28.1 m -119.65 127.92 53.36 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . 0.26 0.2 OUTLIER -79.91 154.88 28.03 Favored 'General case' 0 CA--C 1.469 -2.148 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 167.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.429 HH21 ' HD3' ' A' ' 99' ' ' ARG . 47.0 ttp180 -145.18 91.19 2.11 Favored 'General case' 0 N--CA 1.404 -2.759 1 N-CA-C 100.154 -4.017 . . . . 0.0 100.154 178.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 . . . . . 0 N--CA 1.429 -1.502 0 CA-C-N 111.84 -2.437 . . . . 0.0 110.301 -170.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.424 -1.762 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.38 -69.37 1.4 Allowed Glycine 0 N--CA 1.412 -2.918 0 O-C-N 124.094 0.871 . . . . 0.0 111.747 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 55.0 mtm -96.56 23.57 6.76 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -163.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -72.92 -55.86 6.0 Favored 'General case' 0 CA--C 1.452 -2.824 0 C-N-CA 116.355 -2.138 . . . . 0.0 113.072 135.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 38.9 t -64.69 -67.28 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.445 -3.063 0 O-C-N 126.512 2.382 . . . . 0.0 108.526 -163.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.0 mt -42.02 -54.98 3.34 Favored 'General case' 0 CA--C 1.475 -1.942 0 C-N-CA 127.662 2.385 . . . . 0.0 113.768 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -54.48 -44.76 72.92 Favored 'General case' 0 CA--C 1.484 -1.559 0 C-N-CA 126.619 1.967 . . . . 0.0 114.031 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -83.26 -12.29 56.9 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 118.386 0.539 . . . . 0.0 112.102 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.477 HG23 ' CE2' ' A' ' 98' ' ' PHE . 2.3 t -73.87 -44.46 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.419 ' HZ3' ' HB2' ' A' ' 174' ' ' LEU . 0.8 OUTLIER -61.12 -53.76 53.01 Favored 'General case' 0 CA--C 1.451 -2.859 0 O-C-N 125.366 1.666 . . . . 0.0 112.341 179.598 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -61.9 -36.75 82.25 Favored 'General case' 0 N--CA 1.403 -2.784 0 C-N-CA 126.807 2.043 . . . . 0.0 109.716 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.87 -34.1 66.5 Favored 'General case' 0 C--N 1.358 0.948 0 C-N-CA 115.955 -2.298 . . . . 0.0 116.469 169.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.31 0.2 OUTLIER -81.31 -27.91 34.83 Favored 'General case' 0 CA--C 1.464 -2.331 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -176.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -28.42 -25.78 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.531 1 C-N-CA 136.116 5.766 . . . . 0.0 118.885 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -48.71 -50.44 33.47 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 127.65 2.38 . . . . 0.0 113.234 166.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 tt -114.66 -48.57 2.85 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 126.282 1.833 . . . . 0.0 108.895 -170.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.5 ' HB3' ' CD1' ' A' ' 174' ' ' LEU 0.284 . . -110.82 131.02 55.41 Favored 'General case' 0 CA--C 1.463 -2.398 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -170.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.2 m -128.12 175.33 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.029 0 N-CA-C 119.929 3.307 . . . . 0.0 119.929 162.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.48 HG13 ' H ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -83.14 162.49 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.388 0 C-N-CA 126.309 1.844 . . . . 0.0 111.054 -159.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.61 -44.19 12.83 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 159.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.48 ' H ' HG13 ' A' ' 158' ' ' VAL 0.265 0.9 OUTLIER -167.92 145.81 4.43 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.621 -171.51 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.478 -1.817 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 172.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.281 20.2 mt-30 . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 118.585 -0.721 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 32.5 ttp -118.43 117.54 29.31 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 119.743 1.156 . . . . 0.0 113.841 -169.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.7 mm -84.37 127.16 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.356 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.51 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -105.53 130.3 53.62 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 101.339 -3.578 . . . . 0.0 101.339 150.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.3 t -91.93 136.32 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.5 ' CD1' ' HB3' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -122.25 147.64 45.97 Favored 'General case' 0 N--CA 1.439 -0.988 1 N-CA-C 99.177 -4.379 . . . . 0.0 99.177 -176.997 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.351 . . -137.19 179.87 1.24 Allowed Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 125.61 1.564 . . . . 0.0 109.426 -173.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -63.75 138.16 62.4 Favored 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 122.681 2.254 . . . . 0.0 110.176 167.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt . . . . . 0 CA--C 1.488 -1.424 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 165.32 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 . . . . . 0 CA--C 1.48 -1.73 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.0 t -88.49 114.26 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.793 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -109.9 179.84 4.0 Favored 'General case' 0 CA--C 1.472 -2.057 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 160.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -146.68 158.01 43.82 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.585 -168.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 tp -135.59 163.25 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 169.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -116.46 154.2 30.76 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-O 121.522 0.677 . . . . 0.0 111.496 162.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.476 ' CE2' HG23 ' A' ' 148' ' ' VAL . 40.9 m-85 -130.52 131.4 45.06 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 102.866 -3.012 . . . . 0.0 102.866 166.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 . . . . . 0 N--CA 1.431 -1.376 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -179.452 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . 0.328 52.6 m-20 . . . . . 0 N--CA 1.404 -2.726 0 CA-C-O 122.204 1.002 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.424 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.8 OUTLIER -72.83 -72.58 0.24 Allowed 'General case' 0 CA--C 1.479 -1.775 0 CA-C-N 112.579 -2.101 . . . . 0.0 111.138 -163.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.34 0.0 OUTLIER -58.5 -14.67 8.5 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 119.548 3.166 . . . . 0.0 119.548 176.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.08 -45.86 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 C-N-CA 124.092 0.957 . . . . 0.0 110.183 163.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -91.8 4.95 51.67 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.1 tt -82.97 -32.52 27.03 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 162.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.44 ' HA ' HG12 ' A' ' 115' ' ' ILE . 57.5 ttt180 -63.05 -42.74 99.79 Favored 'General case' 0 C--N 1.362 1.122 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.73 168.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.8 m -59.71 -40.93 89.6 Favored 'General case' 0 C--N 1.377 1.799 0 C-N-CA 118.509 -1.276 . . . . 0.0 113.36 173.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.6 mt -62.6 -32.84 73.91 Favored 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.0 mm -59.21 -46.67 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.533 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 174.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.57 -47.88 66.54 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 126.04 1.736 . . . . 0.0 113.079 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -54.93 -49.7 70.67 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.7 -37.28 81.13 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -80.09 -20.82 44.23 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 128.26 2.624 . . . . 0.0 112.46 -173.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -71.97 -15.83 62.07 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 168.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.42 69.58 1.33 Allowed Glycine 0 CA--C 1.463 -3.174 0 N-CA-C 104.182 -3.567 . . . . 0.0 104.182 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -143.62 177.77 8.25 Favored 'General case' 0 CA--C 1.459 -2.529 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 171.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -116.94 114.08 23.33 Favored 'General case' 0 N--CA 1.393 -3.3 1 N-CA-C 96.929 -5.212 . . . . 0.0 96.929 -170.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -103.42 111.54 24.02 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.361 -1.335 . . . . 0.0 108.237 -162.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -97.6 122.85 41.16 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -164.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.3 mm -85.49 133.46 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.2 m -119.57 123.13 43.17 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . 0.266 0.2 OUTLIER -80.05 150.91 30.18 Favored 'General case' 0 CA--C 1.471 -2.065 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 166.058 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -145.75 95.39 2.64 Favored 'General case' 0 N--CA 1.403 -2.798 1 N-CA-C 98.712 -4.551 . . . . 0.0 98.712 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 . . . . . 0 N--CA 1.426 -1.665 0 CA-C-N 112.01 -2.359 . . . . 0.0 110.476 -172.107 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.8 mt . . . . . 0 N--CA 1.424 -1.759 0 N-CA-C 111.448 0.166 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.46 -58.83 4.06 Favored Glycine 0 N--CA 1.415 -2.729 0 O-C-N 123.695 0.622 . . . . 0.0 112.07 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 22.4 mtm -92.85 2.96 56.49 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 113.502 0.926 . . . . 0.0 113.502 -160.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.252 1.2 tm-20 -54.74 -71.65 0.08 Allowed 'General case' 0 CA--C 1.449 -2.913 0 C-N-CA 115.083 -2.647 . . . . 0.0 114.767 138.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' A' ' 98' ' ' PHE . 39.2 t -56.51 -67.6 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.441 -3.216 0 O-C-N 127.411 2.944 . . . . 0.0 108.973 -161.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.2 mt -39.09 -53.78 1.79 Allowed 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 128.399 2.68 . . . . 0.0 115.213 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.406 ' HA ' ' CE2' ' A' ' 161' ' ' PHE . 1.7 t-20 -62.82 -36.71 84.09 Favored 'General case' 0 CA--C 1.46 -2.5 0 N-CA-C 117.591 2.441 . . . . 0.0 117.591 175.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -81.09 -14.46 57.73 Favored 'General case' 0 N--CA 1.417 -2.097 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.233 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.476 HG23 ' CE2' ' A' ' 98' ' ' PHE . 1.5 t -77.58 -43.11 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.42 ' HE2' ' HB ' ' A' ' 158' ' ' VAL . 30.5 ttmt -52.93 -51.09 62.55 Favored 'General case' 0 CA--C 1.464 -2.364 0 CA-C-O 117.024 -1.465 . . . . 0.0 110.8 169.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.75 -38.2 73.48 Favored 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 124.27 1.028 . . . . 0.0 110.071 -168.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -75.65 -28.78 58.88 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 116.673 -2.011 . . . . 0.0 115.414 171.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.286 0.1 OUTLIER -76.39 -33.02 58.88 Favored 'General case' 0 CA--C 1.475 -1.931 0 CA-C-O 116.827 -1.559 . . . . 0.0 113.084 178.107 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -28.26 -26.94 0.0 OUTLIER 'General case' 0 CA--C 1.483 -1.623 1 C-N-CA 135.468 5.507 . . . . 0.0 119.525 -172.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -57.63 -59.0 5.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.155 2.182 . . . . 0.0 112.246 171.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.08 -52.18 3.48 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.39 -1.732 . . . . 0.0 108.186 -167.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.449 ' CB ' HD12 ' A' ' 174' ' ' LEU 0.284 . . -98.85 147.53 24.84 Favored 'General case' 0 CA--C 1.459 -2.533 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.773 -178.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.43 171.41 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.765 0 C-N-CA 114.794 -2.762 . . . . 0.0 116.405 134.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.7 t -82.37 155.88 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.979 0 C-N-CA 128.948 2.899 . . . . 0.0 109.798 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -82.16 -42.93 18.39 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 113.7 -1.591 . . . . 0.0 106.885 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.7 t -152.87 144.97 23.81 Favored 'General case' 0 CA--C 1.464 -2.328 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.406 ' CE2' ' HA ' ' A' ' 146' ' ' ASN . 2.7 t80 . . . . . 0 N--CA 1.421 -1.918 0 N-CA-C 101.087 -3.671 . . . . 0.0 101.087 163.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.251 20.4 mt-30 . . . . . 0 CA--C 1.506 -0.718 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.7 ttp -113.6 113.59 25.28 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 118.742 0.701 . . . . 0.0 110.326 -172.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.1 mm -82.17 124.98 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 O-C-N 121.227 -0.921 . . . . 0.0 108.756 170.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.2 ttp -106.92 135.44 48.47 Favored 'General case' 0 CA--C 1.471 -2.081 0 N-CA-C 101.783 -3.414 . . . . 0.0 101.783 156.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 t -98.1 132.94 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 C-N-CA 116.486 -2.085 . . . . 0.0 106.894 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 0.3 OUTLIER -116.47 148.33 40.86 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 100.255 -3.98 . . . . 0.0 100.255 -177.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -142.06 -173.96 0.39 Allowed Pre-proline 0 N--CA 1.431 -1.401 0 CA-C-O 117.009 -1.472 . . . . 0.0 110.242 -172.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -68.88 153.67 72.34 Favored 'Trans proline' 0 N--CA 1.437 -1.823 0 C-N-CA 122.564 2.176 . . . . 0.0 108.817 165.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt . . . . . 0 CA--C 1.488 -1.427 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 169.706 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 . . . . . 0 CA--C 1.484 -1.582 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.3 t -103.22 120.67 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.627 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 172.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -104.34 171.81 7.14 Favored 'General case' 0 CA--C 1.482 -1.661 0 C-N-CA 117.863 -1.535 . . . . 0.0 107.203 152.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -144.46 154.73 43.23 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.52 165.23 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 171.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -111.32 153.71 25.57 Favored 'General case' 0 CA--C 1.487 -1.456 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.113 166.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -140.24 98.9 3.53 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 172.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 . . . . . 0 N--CA 1.435 -1.193 0 C-N-CA 125.376 1.471 . . . . 0.0 110.013 -173.703 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . 0.263 0.9 OUTLIER . . . . . 0 N--CA 1.404 -2.728 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.401 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.8 OUTLIER -87.14 -72.18 0.52 Allowed 'General case' 0 CA--C 1.477 -1.833 0 CA-C-N 113.953 -1.476 . . . . 0.0 109.787 -158.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.35 0.0 OUTLIER -55.61 -15.36 2.85 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 120.018 3.34 . . . . 0.0 120.018 173.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.4 t -61.54 -46.82 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 123.397 1.57 . . . . 0.0 110.373 163.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -89.25 -18.5 26.91 Favored 'General case' 0 CA--C 1.468 -2.207 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 tt -56.23 -38.26 70.83 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.094 154.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.476 ' HA ' HG12 ' A' ' 115' ' ' ILE . 42.3 ttt-85 -60.02 -42.93 95.42 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-N 119.193 0.906 . . . . 0.0 111.756 169.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.0 t -56.78 -45.87 81.87 Favored 'General case' 0 C--N 1.376 1.756 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.272 72.2 mt -67.7 -24.83 65.44 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.284 7.2 mm -60.74 -51.09 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.437 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 172.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.37 -43.72 68.03 Favored 'General case' 0 N--CA 1.426 -1.63 0 O-C-N 126.196 2.185 . . . . 0.0 109.898 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -60.51 -53.8 53.2 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.49 -21.01 63.72 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 126.926 2.091 . . . . 0.0 114.649 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -73.26 -37.1 66.42 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 127.188 2.195 . . . . 0.0 108.625 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -66.51 -26.98 67.42 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 123.14 0.576 . . . . 0.0 110.669 170.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.45 65.05 1.47 Allowed Glycine 0 CA--C 1.471 -2.662 0 N-CA-C 104.717 -3.353 . . . . 0.0 104.717 -171.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -119.97 166.41 13.38 Favored 'General case' 0 CA--C 1.451 -2.848 1 N-CA-C 97.775 -4.898 . . . . 0.0 97.775 169.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.63 116.97 32.85 Favored 'General case' 0 N--CA 1.395 -3.202 1 N-CA-C 97.365 -5.05 . . . . 0.0 97.365 171.018 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.27 159.09 21.02 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.258 44.8 mtmt -128.08 133.54 49.06 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 163.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.9 mm -86.3 129.96 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.3 m -100.38 126.16 46.72 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 168.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . 0.278 0.3 OUTLIER -80.28 152.1 29.2 Favored 'General case' 0 CA--C 1.462 -2.412 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 164.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -149.42 96.42 2.5 Favored 'General case' 0 N--CA 1.395 -3.216 1 N-CA-C 96.853 -5.24 . . . . 0.0 96.853 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 . . . . . 0 N--CA 1.427 -1.578 0 CA-C-N 112.227 -2.26 . . . . 0.0 111.542 -172.943 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 67.5 mt . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.47 -61.4 3.9 Favored Glycine 0 N--CA 1.417 -2.627 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 8.4 ptm -87.51 -3.2 59.0 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -156.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -53.37 57.46 Favored 'General case' 0 CA--C 1.452 -2.813 0 C-N-CA 115.391 -2.524 . . . . 0.0 114.095 152.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.1 t -69.62 -64.33 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.445 -3.071 0 O-C-N 126.308 2.255 . . . . 0.0 107.859 -162.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 90.2 mt -47.13 -52.98 13.99 Favored 'General case' 0 CA--C 1.477 -1.831 0 C-N-CA 128.274 2.63 . . . . 0.0 114.789 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.258 1.5 t30 -62.9 -30.86 71.86 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 174.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -82.83 -14.31 54.58 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.385 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.401 HG21 ' HH ' ' A' ' 107' ' ' TYR . 2.1 t -76.23 -46.67 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.628 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 177.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.265 25.2 ttmt -49.51 -53.68 22.06 Favored 'General case' 0 CA--C 1.458 -2.56 0 C-N-CA 125.895 1.678 . . . . 0.0 111.539 173.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -37.2 63.69 Favored 'General case' 0 N--CA 1.408 -2.56 0 C-N-CA 126.469 1.907 . . . . 0.0 109.985 -167.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.79 -31.62 66.79 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 116.339 -2.144 . . . . 0.0 114.678 171.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.296 0.2 OUTLIER -83.51 -27.48 29.34 Favored 'General case' 0 CA--C 1.46 -2.51 0 CA-C-O 115.702 -2.094 . . . . 0.0 115.326 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -28.07 -22.31 0.0 OUTLIER 'General case' 0 CA--C 1.483 -1.624 1 C-N-CA 136.163 5.785 . . . . 0.0 119.786 -174.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -50.16 -49.58 51.72 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 126.342 1.857 . . . . 0.0 115.042 162.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.409 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 2.6 tm? -121.6 -52.77 2.01 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 128.06 2.544 . . . . 0.0 107.23 -157.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.362 . . -112.1 148.16 34.54 Favored 'General case' 0 CA--C 1.452 -2.791 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -176.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -119.93 -178.27 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.459 -2.528 0 C-N-CA 116.128 -2.229 . . . . 0.0 115.672 147.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.569 HG11 ' H ' ' A' ' 160' ' ' SER . 6.0 t -86.64 148.63 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 165.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -82.39 -39.54 22.56 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.569 ' H ' HG11 ' A' ' 158' ' ' VAL . 0.9 OUTLIER -150.61 131.0 13.74 Favored 'General case' 0 CA--C 1.465 -2.316 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -174.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.0 t80 . . . . . 0 N--CA 1.424 -1.755 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 172.001 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.317 25.6 mt-30 . . . . . 0 N--CA 1.443 -0.781 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.635 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 38.1 ttp -123.0 117.27 25.09 Favored 'General case' 0 C--N 1.364 1.214 0 CA-C-N 118.802 0.728 . . . . 0.0 112.633 -172.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.7 mm -82.19 123.84 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 O-C-N 120.555 -1.341 . . . . 0.0 109.058 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -100.47 128.57 46.49 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 157.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.22 122.94 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.404 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.2 69.12 0.84 Allowed 'General case' 0 C--N 1.354 0.765 0 C-N-CA 127.654 2.382 . . . . 0.0 117.281 -170.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.335 . . -91.48 172.59 6.37 Favored Pre-proline 0 C--N 1.359 0.99 0 N-CA-C 119.604 3.187 . . . . 0.0 119.604 -171.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -68.85 140.08 45.24 Favored 'Trans proline' 0 CA--C 1.491 -1.661 0 CA-C-N 120.912 1.362 . . . . 0.0 110.922 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp . . . . . 0 CA--C 1.483 -1.597 0 O-C-N 125.0 1.438 . . . . 0.0 107.263 176.772 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 . . . . . 0 CA--C 1.479 -1.755 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 75.3 t -90.2 120.62 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.801 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 161.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -112.09 166.54 11.15 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 150.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -133.94 155.72 49.42 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.002 -164.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 tp -135.72 162.82 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 101.881 -3.377 . . . . 0.0 101.881 166.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -111.15 157.78 19.65 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 119.413 1.006 . . . . 0.0 109.612 163.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.454 ' CE2' HG23 ' A' ' 148' ' ' VAL . 17.1 m-85 -125.74 135.15 51.73 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 166.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.461 ' HE ' ' H ' ' A' ' 99' ' ' ARG . 1.3 mpm_? . . . . . 0 N--CA 1.424 -1.735 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.359 -167.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 N--CA 1.425 -1.677 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.489 ' HH ' HG21 ' A' ' 148' ' ' VAL . 1.0 OUTLIER -73.9 -71.78 0.31 Allowed 'General case' 0 CA--C 1.481 -1.693 0 C-N-CA 126.265 1.826 . . . . 0.0 109.475 -170.214 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.325 0.0 OUTLIER -59.32 -15.48 16.36 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 119.487 3.144 . . . . 0.0 119.487 173.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.66 -43.56 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 121.556 0.693 . . . . 0.0 109.937 162.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -92.39 7.38 43.21 Favored 'General case' 0 CA--C 1.485 -1.556 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.2 tt -85.13 -31.5 23.26 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 104.038 -2.579 . . . . 0.0 104.038 161.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.453 ' HA ' HG12 ' A' ' 115' ' ' ILE . 31.7 ttt180 -62.97 -43.2 99.45 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 122.88 0.472 . . . . 0.0 110.969 168.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.2 t -56.51 -45.26 81.15 Favored 'General case' 0 C--N 1.376 1.732 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.66 -30.23 71.37 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.8 mm -58.54 -48.49 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.521 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 173.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.1 tpt85 -52.37 -50.29 62.7 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 125.466 1.729 . . . . 0.0 112.391 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -57.58 -44.97 85.75 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -35.39 80.7 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 176.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -77.69 -20.87 52.92 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 127.821 2.448 . . . . 0.0 112.417 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -67.87 -19.91 65.07 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 123.658 0.783 . . . . 0.0 109.422 169.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.45 61.59 1.7 Allowed Glycine 0 CA--C 1.46 -3.357 0 N-CA-C 103.561 -3.816 . . . . 0.0 103.561 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -134.19 175.45 9.49 Favored 'General case' 0 CA--C 1.446 -3.043 1 N-CA-C 99.003 -4.443 . . . . 0.0 99.003 173.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.263 17.8 mtpt -89.12 140.19 29.71 Favored 'General case' 0 N--CA 1.396 -3.167 1 N-CA-C 97.55 -4.981 . . . . 0.0 97.55 163.622 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.49 160.34 20.56 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 155.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -142.33 125.87 16.79 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 102.673 -3.084 . . . . 0.0 102.673 167.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.0 mm -86.14 122.72 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.9 m -92.66 123.0 35.63 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 163.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.432 HD12 ' CZ ' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -84.11 152.05 24.55 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 165.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -152.56 91.5 1.58 Allowed 'General case' 0 N--CA 1.393 -3.281 1 N-CA-C 98.752 -4.536 . . . . 0.0 98.752 -172.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.432 ' CZ ' HD12 ' A' ' 128' ' ' LEU . 93.9 m-85 . . . . . 0 N--CA 1.417 -2.075 0 CA-C-N 112.638 -2.074 . . . . 0.0 107.128 -175.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 66.8 mt . . . . . 0 N--CA 1.421 -1.9 0 CA-C-O 119.822 -0.132 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.57 -59.82 3.17 Favored Glycine 0 CA--C 1.466 -2.982 0 C-N-CA 119.059 -1.543 . . . . 0.0 113.122 -172.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 60.5 mtm -88.02 -0.07 56.58 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -166.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -68.16 -47.7 67.31 Favored 'General case' 0 CA--C 1.457 -2.632 0 C-N-CA 114.73 -2.788 . . . . 0.0 113.33 151.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 98' ' ' PHE . 31.9 t -70.1 -68.98 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.436 -3.426 0 O-C-N 125.67 1.856 . . . . 0.0 107.343 -163.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 mp -48.79 -50.54 33.69 Favored 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 129.217 3.007 . . . . 0.0 113.259 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -61.03 -37.01 81.07 Favored 'General case' 0 CA--C 1.471 -2.061 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -81.02 -14.22 58.11 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.512 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.489 HG21 ' HH ' ' A' ' 107' ' ' TYR . 1.7 t -76.14 -49.1 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.645 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.281 11.9 ttmt -51.95 -45.84 64.53 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 126.394 1.878 . . . . 0.0 113.096 171.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.57 -36.48 63.07 Favored 'General case' 0 N--CA 1.409 -2.492 0 C-N-CA 124.347 1.059 . . . . 0.0 110.024 -171.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -72.94 -39.72 66.0 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 116.473 -2.091 . . . . 0.0 115.178 169.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.306 0.2 OUTLIER -79.61 -20.24 47.32 Favored 'General case' 0 CA--C 1.46 -2.514 0 CA-C-O 116.357 -1.782 . . . . 0.0 115.759 -177.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -26.24 -23.79 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.493 1 C-N-CA 135.042 5.337 . . . . 0.0 119.55 175.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -51.69 -56.54 13.1 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 126.993 2.117 . . . . 0.0 113.21 165.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.3 tt -116.38 -47.42 2.74 Favored 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 126.455 1.902 . . . . 0.0 109.291 -162.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.352 . . -110.14 143.45 40.21 Favored 'General case' 0 CA--C 1.448 -2.954 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.043 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.8 m -120.46 171.98 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.483 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 140.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.456 HG11 ' H ' ' A' ' 160' ' ' SER . 4.0 t -81.46 151.54 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.931 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 172.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -80.92 -38.35 28.02 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 125.581 1.552 . . . . 0.0 107.005 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.456 ' H ' HG11 ' A' ' 158' ' ' VAL . 5.4 t -118.44 -176.32 3.05 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 10.7 t80 . . . . . 0 N--CA 1.42 -1.959 0 N-CA-C 101.111 -3.663 . . . . 0.0 101.111 139.181 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.291 36.4 mt-30 . . . . . 0 CA--C 1.495 -1.165 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 60.7 ttp -146.47 120.85 9.63 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 118.933 0.788 . . . . 0.0 110.765 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.4 mm -79.64 126.89 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 O-C-N 120.786 -1.196 . . . . 0.0 108.627 173.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.7 ttp -105.5 135.24 47.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 160.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.58 126.39 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 118.299 -1.36 . . . . 0.0 109.68 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.78 80.32 1.29 Allowed 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 -168.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.279 . . -85.82 174.91 5.0 Favored Pre-proline 0 CA--C 1.498 -1.032 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -169.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -64.15 141.48 76.34 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 C-N-CA 123.243 2.629 . . . . 0.0 108.263 160.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? . . . . . 0 N--CA 1.431 -1.395 0 O-C-N 124.216 0.947 . . . . 0.0 110.856 -177.857 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 . . . . . 0 N--CA 1.431 -1.411 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.9 t -96.67 115.7 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.792 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 160.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -107.35 175.45 5.49 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 152.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -135.17 155.34 50.85 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 tp -134.66 162.79 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 102.573 -3.121 . . . . 0.0 102.573 164.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -112.31 159.96 18.14 Favored 'General case' 0 CA--C 1.487 -1.465 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.195 161.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.484 ' CE2' HG23 ' A' ' 148' ' ' VAL . 10.8 m-85 -129.31 149.23 51.19 Favored 'General case' 0 CA--C 1.475 -1.924 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 166.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.417 -2.109 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.845 -171.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 N--CA 1.423 -1.818 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -74.92 -72.73 0.28 Allowed 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 125.902 1.681 . . . . 0.0 108.677 -171.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.328 0.0 OUTLIER -58.57 -12.42 4.04 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 120.417 3.488 . . . . 0.0 120.417 178.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.56 -41.82 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 C-N-CA 124.197 0.999 . . . . 0.0 110.184 161.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -92.58 -0.09 57.36 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.6 tt -77.52 -35.1 53.75 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 162.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.415 ' HA ' HG12 ' A' ' 115' ' ' ILE . 9.3 ttp180 -60.87 -44.74 96.64 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 125.093 1.357 . . . . 0.0 110.67 171.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.4 m -59.64 -42.18 92.16 Favored 'General case' 0 C--N 1.378 1.831 0 C-N-CA 118.755 -1.178 . . . . 0.0 113.396 174.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.5 mt -62.2 -33.58 74.82 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.2 mm -55.43 -50.52 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 O-C-N 124.433 1.083 . . . . 0.0 108.37 173.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.9 tpt85 -51.71 -45.73 63.67 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 126.207 1.803 . . . . 0.0 112.783 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -58.08 -51.72 68.54 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.21 -19.61 61.7 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -73.45 -34.51 65.44 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 125.257 1.423 . . . . 0.0 110.294 173.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -67.89 -27.84 67.0 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 169.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.56 61.73 1.68 Allowed Glycine 0 CA--C 1.471 -2.678 0 N-CA-C 105.73 -2.948 . . . . 0.0 105.73 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -122.44 170.55 9.85 Favored 'General case' 0 CA--C 1.461 -2.467 1 N-CA-C 98.541 -4.614 . . . . 0.0 98.541 171.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -105.58 122.94 47.06 Favored 'General case' 0 N--CA 1.401 -2.879 1 N-CA-C 97.079 -5.156 . . . . 0.0 97.079 171.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.03 155.32 22.78 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 114.897 -2.721 . . . . 0.0 103.807 167.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -115.71 127.35 55.07 Favored 'General case' 0 CA--C 1.476 -1.899 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 165.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.401 HD13 HD23 ' A' ' 174' ' ' LEU . 3.2 mm -86.65 116.03 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 176.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.3 m -98.13 119.01 36.03 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 172.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.528 HD12 ' CZ ' ' A' ' 130' ' ' PHE 0.287 0.3 OUTLIER -79.95 145.49 32.57 Favored 'General case' 0 CA--C 1.466 -2.263 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 167.844 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -150.46 89.17 1.54 Allowed 'General case' 0 N--CA 1.401 -2.895 1 N-CA-C 96.192 -5.484 . . . . 0.0 96.192 -172.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.528 ' CZ ' HD12 ' A' ' 128' ' ' LEU . 56.0 m-85 . . . . . 0 N--CA 1.417 -2.097 0 N-CA-C 101.37 -3.567 . . . . 0.0 101.37 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.293 89.2 mt . . . . . 0 N--CA 1.407 -2.608 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -80.85 -58.61 2.62 Favored Glycine 0 N--CA 1.417 -2.61 0 CA-C-N 114.438 -1.255 . . . . 0.0 113.986 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.4 mtm -89.25 1.4 55.76 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -163.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -55.53 -67.71 0.26 Allowed 'General case' 0 CA--C 1.445 -3.063 0 C-N-CA 115.391 -2.524 . . . . 0.0 114.284 140.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.69 -66.63 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.438 -3.346 0 O-C-N 127.269 2.856 . . . . 0.0 108.336 -158.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 22.6 mt -45.99 -55.2 7.15 Favored 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 129.0 2.92 . . . . 0.0 115.299 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -62.21 -31.64 72.21 Favored 'General case' 0 CA--C 1.462 -2.429 0 N-CA-C 117.94 2.57 . . . . 0.0 117.94 173.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -82.26 -16.6 48.92 Favored 'General case' 0 N--CA 1.419 -1.991 0 C-N-CA 117.592 -1.643 . . . . 0.0 109.253 173.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.484 HG23 ' CE2' ' A' ' 98' ' ' PHE . 1.5 t -72.89 -45.82 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.856 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.416 ' HE2' ' HB ' ' A' ' 158' ' ' VAL . 35.7 ttmt -50.59 -51.67 46.24 Favored 'General case' 0 CA--C 1.464 -2.359 0 C-N-CA 125.775 1.63 . . . . 0.0 111.863 172.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -70.1 -41.13 74.43 Favored 'General case' 0 N--CA 1.406 -2.66 0 C-N-CA 125.936 1.695 . . . . 0.0 109.275 -168.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -74.18 -32.79 63.22 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 116.701 -2.0 . . . . 0.0 115.527 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.348 0.3 OUTLIER -81.93 -26.2 34.25 Favored 'General case' 0 CA--C 1.461 -2.464 0 CA-C-O 116.409 -1.758 . . . . 0.0 115.128 -178.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -25.43 -29.94 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.489 1 C-N-CA 135.02 5.328 . . . . 0.0 119.202 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -49.24 -50.38 38.86 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 128.413 2.685 . . . . 0.0 113.993 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 tt -118.26 -50.62 2.45 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 126.339 1.855 . . . . 0.0 109.881 -164.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.346 . . -106.58 147.22 29.72 Favored 'General case' 0 CA--C 1.443 -3.17 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 -177.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.5 m -118.34 -174.54 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.529 0 C-N-CA 114.841 -2.744 . . . . 0.0 114.321 141.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.417 HG11 ' H ' ' A' ' 160' ' ' SER . 2.8 t -88.08 151.02 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.233 0 CA-C-N 111.762 -2.472 . . . . 0.0 105.717 168.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -81.89 -39.59 23.61 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.417 ' H ' HG11 ' A' ' 158' ' ' VAL . 1.1 t -160.69 142.0 12.04 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -171.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.426 -1.632 0 N-CA-C 101.751 -3.426 . . . . 0.0 101.751 169.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 . . . . . 0 N--CA 1.443 -0.777 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 10.7 ttm -121.53 162.6 20.28 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.6 mt -122.02 152.11 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 158.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.1 ttt -122.22 129.33 52.16 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 103.313 -2.847 . . . . 0.0 103.313 162.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 25.7 t -88.5 138.06 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.401 HD23 HD13 ' A' ' 126' ' ' ILE . 6.0 tp -118.87 90.15 3.27 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 131.104 3.762 . . . . 0.0 121.1 -177.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.391 . . -104.9 165.41 13.29 Favored Pre-proline 0 CA--C 1.5 -0.975 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -71.97 141.01 35.9 Favored 'Trans proline' 0 CA--C 1.492 -1.614 0 C-N-CA 121.762 1.641 . . . . 0.0 108.412 -171.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.9 tmmt? . . . . . 0 CA--C 1.488 -1.432 0 O-C-N 125.097 1.498 . . . . 0.0 107.593 -173.136 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 . . . . . 0 CA--C 1.481 -1.7 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.2 t -101.07 115.73 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 161.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -99.62 172.52 7.23 Favored 'General case' 0 CA--C 1.476 -1.892 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 157.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -148.08 148.2 30.38 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -172.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.8 tp -131.43 161.06 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 103.733 -2.691 . . . . 0.0 103.733 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -121.88 154.25 37.34 Favored 'General case' 0 CA--C 1.487 -1.48 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.606 163.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.469 ' CE2' HG23 ' A' ' 148' ' ' VAL . 46.4 m-85 -129.62 143.5 50.85 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 170.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 . . . . . 0 N--CA 1.428 -1.543 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 174.273 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 N--CA 1.427 -1.616 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.483 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -69.91 -75.95 0.11 Allowed 'General case' 0 CA--C 1.478 -1.798 0 C-N-CA 126.784 2.034 . . . . 0.0 109.976 -171.713 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.331 0.0 OUTLIER -59.49 -12.7 6.73 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 119.967 3.321 . . . . 0.0 119.967 176.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.24 -43.74 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 122.126 0.965 . . . . 0.0 110.259 162.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -91.7 -1.09 57.56 Favored 'General case' 0 CA--C 1.475 -1.938 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.3 tt -79.05 -31.15 44.41 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 161.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.469 ' HA ' HG12 ' A' ' 115' ' ' ILE . 19.1 ttt85 -62.69 -43.0 99.92 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 118.599 -0.715 . . . . 0.0 111.276 169.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.4 m -61.69 -40.97 96.87 Favored 'General case' 0 C--N 1.378 1.819 0 C-N-CA 118.899 -1.12 . . . . 0.0 113.51 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.408 HD12 HD22 ' A' ' 174' ' ' LEU 0.282 55.8 tp -69.09 -26.97 65.2 Favored 'General case' 0 N--CA 1.402 -2.863 0 C-N-CA 126.259 1.823 . . . . 0.0 113.952 178.073 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.469 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.268 5.6 mm -60.96 -49.37 84.98 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.873 0 CA-C-N 121.061 1.755 . . . . 0.0 109.232 170.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -52.39 -48.36 65.69 Favored 'General case' 0 CA--C 1.494 -1.203 0 C-N-CA 126.662 1.985 . . . . 0.0 108.899 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -56.5 -53.85 52.67 Favored 'General case' 0 CA--C 1.483 -1.622 0 C-N-CA 125.992 1.717 . . . . 0.0 111.647 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.4 -39.83 80.76 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.23 -14.06 44.99 Favored 'General case' 0 C--N 1.364 1.212 0 C-N-CA 125.767 1.627 . . . . 0.0 111.746 -170.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -65.79 -25.06 67.08 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 123.073 0.549 . . . . 0.0 109.839 161.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.2 59.47 1.3 Allowed Glycine 0 CA--C 1.468 -2.865 0 N-CA-C 103.917 -3.673 . . . . 0.0 103.917 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -125.32 164.5 20.24 Favored 'General case' 0 CA--C 1.461 -2.475 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 171.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.02 121.54 42.36 Favored 'General case' 0 N--CA 1.407 -2.601 1 N-CA-C 99.869 -4.122 . . . . 0.0 99.869 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.91 115.91 29.76 Favored 'General case' 0 N--CA 1.415 -2.191 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.597 -166.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -98.3 119.68 37.39 Favored 'General case' 0 CA--C 1.491 -1.315 0 O-C-N 121.683 -0.636 . . . . 0.0 110.717 -167.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.9 mm -83.82 134.8 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.51 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 18.6 m -116.64 115.38 25.58 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 165.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.463 HD22 ' CZ ' ' A' ' 130' ' ' PHE . 18.4 tp -82.4 148.49 28.19 Favored 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 167.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -150.58 103.82 3.15 Favored 'General case' 0 N--CA 1.405 -2.708 1 N-CA-C 98.44 -4.652 . . . . 0.0 98.44 -174.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.463 ' CZ ' HD22 ' A' ' 128' ' ' LEU 0.294 77.6 m-85 . . . . . 0 CA--C 1.491 -1.321 0 C-N-CA 127.345 2.258 . . . . 0.0 109.227 -175.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 91.3 mt . . . . . 0 CA--C 1.478 -1.8 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.402 ' HA2' ' CD2' ' A' ' 128' ' ' LEU . . . -77.0 -57.99 3.56 Favored Glycine 0 CA--C 1.458 -3.515 0 C-N-CA 119.07 -1.538 . . . . 0.0 113.733 -171.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 53.0 mtm -84.54 -0.04 51.62 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 118.123 -0.942 . . . . 0.0 113.09 -166.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.303 2.8 tp10 -64.34 -69.73 0.27 Allowed 'General case' 0 CA--C 1.454 -2.741 0 C-N-CA 115.051 -2.659 . . . . 0.0 115.012 143.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 39.7 t -59.98 -66.9 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.455 -2.707 0 O-C-N 126.261 2.226 . . . . 0.0 110.884 -161.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 73.4 mt -46.07 -55.06 7.45 Favored 'General case' 0 CA--C 1.483 -1.631 0 C-N-CA 128.421 2.688 . . . . 0.0 114.278 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -60.7 -30.01 69.68 Favored 'General case' 0 CA--C 1.469 -2.151 0 N-CA-C 118.609 2.818 . . . . 0.0 118.609 172.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -82.24 -15.35 53.37 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 119.41 -0.329 . . . . 0.0 110.486 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.483 HG21 ' HH ' ' A' ' 107' ' ' TYR . 1.9 t -77.37 -42.47 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.666 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 175.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.43 ' HE2' ' HB ' ' A' ' 158' ' ' VAL 0.254 31.8 ttmt -53.91 -52.04 61.83 Favored 'General case' 0 CA--C 1.462 -2.409 0 C-N-CA 124.943 1.297 . . . . 0.0 111.014 171.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -71.88 -38.75 69.95 Favored 'General case' 0 N--CA 1.407 -2.608 0 C-N-CA 125.674 1.59 . . . . 0.0 109.18 -169.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -74.53 -24.84 59.03 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 116.802 -1.959 . . . . 0.0 114.647 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.267 0.1 OUTLIER -78.92 -37.06 40.78 Favored 'General case' 0 CA--C 1.477 -1.833 0 CA-C-O 116.26 -1.829 . . . . 0.0 111.958 177.259 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -27.63 -29.89 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.488 1 C-N-CA 135.8 5.64 . . . . 0.0 119.642 -167.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -51.51 -47.69 63.19 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 128.789 2.836 . . . . 0.0 114.202 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.43 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 2.0 tm? -120.24 -51.88 2.19 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 128.167 2.587 . . . . 0.0 105.47 -159.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.448 ' HB3' HD13 ' A' ' 174' ' ' LEU 0.302 . . -107.43 144.62 34.09 Favored 'General case' 0 CA--C 1.452 -2.806 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.303 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.3 m -122.71 164.72 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.762 0 C-N-CA 115.286 -2.565 . . . . 0.0 117.604 141.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 5.8 t -81.82 149.37 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.257 0 CA-C-N 110.067 -3.242 . . . . 0.0 105.968 -174.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.76 -38.9 27.81 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -173.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -162.65 144.82 10.64 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -173.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.424 -1.74 0 N-CA-C 100.64 -3.837 . . . . 0.0 100.64 165.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.444 -0.74 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 39.4 ttm -118.49 123.89 46.25 Favored 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 124.008 0.923 . . . . 0.0 108.815 -174.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.51 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 15.5 mm -83.72 130.05 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 O-C-N 120.968 -1.082 . . . . 0.0 108.282 168.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 3.2 ttp -110.87 124.31 51.81 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 160.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 43.5 t -88.46 136.51 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 0.5 OUTLIER -124.77 150.31 46.41 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 101.673 -3.455 . . . . 0.0 101.673 -178.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.337 . . -142.26 -179.32 0.94 Allowed Pre-proline 0 CA--C 1.488 -1.42 0 CA-C-O 117.824 -1.084 . . . . 0.0 109.458 -173.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -64.93 143.4 79.23 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 122.82 2.347 . . . . 0.0 110.111 165.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp . . . . . 0 N--CA 1.434 -1.226 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 165.855 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 . . . . . 0 CA--C 1.478 -1.807 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.62 113.61 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.813 0 C-N-CA 118.641 -1.224 . . . . 0.0 108.028 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -107.76 177.42 4.83 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 155.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -139.14 155.8 47.6 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.482 -172.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 tp -133.85 161.37 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 102.936 -2.987 . . . . 0.0 102.936 166.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -118.16 159.36 23.42 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 118.845 0.748 . . . . 0.0 110.175 165.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.41 ' CE2' HG23 ' A' ' 148' ' ' VAL . 25.8 m-85 -138.51 114.01 9.68 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 167.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.433 -1.286 0 C-N-CA 124.586 1.154 . . . . 0.0 107.911 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 N--CA 1.425 -1.686 0 CA-C-O 122.648 1.214 . . . . 0.0 107.857 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.491 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -86.78 -71.08 0.57 Allowed 'General case' 0 CA--C 1.469 -2.154 0 CA-C-N 112.351 -2.204 . . . . 0.0 111.235 -157.345 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.431 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.323 0.0 OUTLIER -58.94 -14.97 10.7 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 118.844 2.905 . . . . 0.0 118.844 174.057 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.03 -45.71 98.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 C-N-CA 124.711 1.205 . . . . 0.0 110.328 161.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -92.84 5.15 52.29 Favored 'General case' 0 CA--C 1.485 -1.541 0 O-C-N 120.137 -1.602 . . . . 0.0 115.269 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -83.45 -32.42 26.05 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 163.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.425 ' HA ' HG12 ' A' ' 115' ' ' ILE . 14.9 ttp180 -60.33 -45.62 92.77 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 125.158 1.383 . . . . 0.0 110.122 169.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.5 t -62.0 -40.38 95.45 Favored 'General case' 0 C--N 1.374 1.66 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.5 tp -67.42 -33.4 75.08 Favored 'General case' 0 N--CA 1.401 -2.88 0 C-N-CA 125.069 1.348 . . . . 0.0 113.844 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.425 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.255 8.5 mm -54.16 -50.75 53.12 Favored 'Isoleucine or valine' 0 C--N 1.373 1.626 0 CA-C-N 119.155 0.889 . . . . 0.0 108.865 170.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -50.01 -45.22 51.64 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 128.172 2.589 . . . . 0.0 112.464 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -55.94 -54.23 47.23 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 172.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.51 -22.35 64.53 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -76.27 -31.4 58.26 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 126.188 1.795 . . . . 0.0 111.175 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.1 -23.93 63.13 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 168.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.28 72.89 1.24 Allowed Glycine 0 CA--C 1.466 -2.977 0 N-CA-C 104.778 -3.329 . . . . 0.0 104.778 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -129.14 170.91 12.95 Favored 'General case' 0 CA--C 1.449 -2.941 1 N-CA-C 97.749 -4.908 . . . . 0.0 97.749 169.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -104.72 113.48 27.1 Favored 'General case' 0 N--CA 1.393 -3.314 1 N-CA-C 96.395 -5.409 . . . . 0.0 96.395 171.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.99 154.34 25.75 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.279 78.9 mttt -118.68 137.53 53.25 Favored 'General case' 0 CA--C 1.469 -2.145 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 164.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.5 mm -83.18 128.92 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.37 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.8 m -110.78 122.84 48.84 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 169.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.487 HD23 ' CE1' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -87.01 155.37 20.19 Favored 'General case' 0 CA--C 1.469 -2.163 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 170.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -151.57 89.69 1.51 Allowed 'General case' 0 N--CA 1.405 -2.694 0 N-CA-C 101.042 -3.688 . . . . 0.0 101.042 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.487 ' CE1' HD23 ' A' ' 128' ' ' LEU . 95.8 m-85 . . . . . 0 N--CA 1.425 -1.707 0 CA-C-N 112.237 -2.256 . . . . 0.0 109.394 -171.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.2 mt . . . . . 1 N--CA 1.376 -4.163 1 N-CA-C 95.296 -5.816 . . . . 0.0 95.296 . . . . . . . . . 2 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.88 -71.01 0.33 Allowed Glycine 1 N--CA 1.381 -4.999 2 C-N-CA 134.887 5.994 . . . . 0.0 108.273 165.293 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.4 mtm -94.86 20.07 9.32 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -169.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -50.68 25.45 Favored 'General case' 0 CA--C 1.454 -2.726 0 C-N-CA 116.4 -2.12 . . . . 0.0 113.939 137.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.0 t -68.14 -67.72 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.429 -3.696 0 O-C-N 126.469 2.356 . . . . 0.0 106.669 -159.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.13 -55.93 3.05 Favored 'General case' 0 CA--C 1.459 -2.546 0 C-N-CA 129.336 3.055 . . . . 0.0 111.843 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.51 -37.96 73.83 Favored 'General case' 0 CA--C 1.469 -2.157 0 C-N-CA 125.924 1.689 . . . . 0.0 114.509 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -81.82 -14.83 55.8 Favored 'General case' 0 N--CA 1.421 -1.925 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.747 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.491 HG21 ' HH ' ' A' ' 107' ' ' TYR . 1.4 t -75.25 -47.77 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.764 0 CA-C-O 116.082 -1.913 . . . . 0.0 106.55 176.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.414 ' HB2' HG23 ' A' ' 158' ' ' VAL . 3.5 ttmt -53.06 -51.87 60.37 Favored 'General case' 0 CA--C 1.46 -2.482 0 CA-C-O 117.248 -1.358 . . . . 0.0 110.02 171.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.41 -36.53 81.46 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 119.01 0.823 . . . . 0.0 110.268 -168.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.29 -43.97 66.09 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 116.519 -2.072 . . . . 0.0 116.414 168.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.275 0.2 OUTLIER -82.74 -18.17 41.68 Favored 'General case' 0 CA--C 1.468 -2.176 0 N-CA-C 118.064 2.616 . . . . 0.0 118.064 -172.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -25.64 -31.52 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.154 1 C-N-CA 133.571 4.748 . . . . 0.0 118.321 170.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -53.11 -50.32 64.7 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 127.998 2.519 . . . . 0.0 114.459 173.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 tt -112.4 -51.76 2.82 Favored 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 125.97 1.708 . . . . 0.0 110.633 -169.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.308 . . -104.46 144.46 31.63 Favored 'General case' 0 CA--C 1.452 -2.821 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.572 -174.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.5 m -128.84 159.78 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.484 0 N-CA-C 120.196 3.406 . . . . 0.0 120.196 148.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 149' ' ' LYS . 2.4 t -83.2 150.07 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.257 0 CA-C-N 110.108 -3.224 . . . . 0.0 105.841 -173.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -81.54 -39.75 24.18 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 -174.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.4 t -159.78 157.74 29.89 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -169.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.408 ' CE1' ' SD ' ' A' ' 172' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.423 -1.819 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.322 28.5 mt-30 . . . . . 0 CA--C 1.504 -0.817 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 41.9 ttm -129.98 121.11 25.9 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 121.275 0.559 . . . . 0.0 110.519 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.7 mm -83.02 128.99 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 O-C-N 120.895 -1.128 . . . . 0.0 109.205 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.408 ' SD ' ' CE1' ' A' ' 161' ' ' PHE . 1.2 ttp -108.48 140.61 41.56 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 156.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.1 t -106.17 135.79 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 C-N-CA 119.171 -1.011 . . . . 0.0 109.299 -173.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.1 tp -118.81 96.66 5.35 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 121.626 3.935 . . . . 0.0 121.626 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.271 . . -98.84 168.43 9.75 Favored Pre-proline 0 CA--C 1.499 -0.987 0 N-CA-C 115.899 1.815 . . . . 0.0 115.899 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -75.7 135.6 18.02 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 N-CA-C 105.039 -2.716 . . . . 0.0 105.039 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.2 pttt . . . . . 0 CA--C 1.49 -1.349 0 C-N-CA 118.365 -1.334 . . . . 0.0 113.905 -175.487 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 . . . . . 0 CA--C 1.482 -1.667 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.8 t -97.84 120.34 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -102.5 168.5 9.25 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 152.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -136.12 153.27 51.35 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 tp -135.57 160.93 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 167.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -117.27 155.73 28.99 Favored 'General case' 0 CA--C 1.484 -1.564 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.831 165.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -139.44 139.29 37.03 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 . . . . . 0 N--CA 1.434 -1.253 0 CA-C-O 118.804 -0.617 . . . . 0.0 109.403 -172.01 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 N--CA 1.423 -1.811 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -82.51 -64.02 1.26 Allowed 'General case' 0 CA--C 1.483 -1.609 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.138 -163.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.336 0.0 OUTLIER -61.44 -12.02 12.88 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 119.649 3.203 . . . . 0.0 119.649 176.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.84 -44.69 99.73 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-O 122.649 1.214 . . . . 0.0 110.06 161.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -91.46 0.55 57.49 Favored 'General case' 0 CA--C 1.477 -1.842 0 O-C-N 120.454 -1.404 . . . . 0.0 114.568 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.66 -28.76 33.43 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 162.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.464 ' HA ' HG12 ' A' ' 115' ' ' ILE . 40.7 ttt180 -62.08 -42.78 99.56 Favored 'General case' 0 C--N 1.361 1.096 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.874 166.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.4 m -58.88 -43.6 90.96 Favored 'General case' 0 C--N 1.38 1.9 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 173.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.261 83.5 mt -64.75 -29.2 70.17 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 116.585 2.069 . . . . 0.0 116.585 175.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.254 10.1 mm -58.32 -51.44 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.899 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.085 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -50.08 -46.88 53.78 Favored 'General case' 0 CA--C 1.49 -1.329 0 O-C-N 126.025 2.078 . . . . 0.0 109.713 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -59.76 -56.05 26.65 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.221 1.008 . . . . 0.0 112.848 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.71 -27.66 65.18 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 125.737 1.615 . . . . 0.0 115.321 -177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -82.8 -17.34 44.43 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 124.113 0.965 . . . . 0.0 111.81 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -71.44 -29.64 65.12 Favored 'General case' 0 C--N 1.362 1.137 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 162.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.02 65.27 1.13 Allowed Glycine 0 CA--C 1.474 -2.483 0 N-CA-C 105.558 -3.017 . . . . 0.0 105.558 -172.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -125.82 173.34 9.15 Favored 'General case' 0 CA--C 1.456 -2.654 1 N-CA-C 98.069 -4.789 . . . . 0.0 98.069 169.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.12 122.49 47.39 Favored 'General case' 0 N--CA 1.4 -2.974 1 N-CA-C 96.983 -5.191 . . . . 0.0 96.983 170.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.98 160.11 21.1 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 115.453 -2.499 . . . . 0.0 105.708 169.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -133.26 119.3 19.62 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 171.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.8 mm -85.23 134.65 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.704 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.1 m -122.89 127.97 49.7 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . 0.377 0.3 OUTLIER -80.47 153.35 28.24 Favored 'General case' 0 CA--C 1.454 -2.739 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 169.365 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 33.4 ttt-85 -148.34 91.77 1.95 Allowed 'General case' 0 N--CA 1.399 -3.024 1 N-CA-C 98.556 -4.609 . . . . 0.0 98.556 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 . . . . . 0 N--CA 1.423 -1.82 0 CA-C-N 110.598 -3.001 . . . . 0.0 109.139 -172.882 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.416 -2.125 0 N-CA-C 110.753 -0.091 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.85 -63.55 2.82 Favored Glycine 0 N--CA 1.414 -2.809 0 O-C-N 123.814 0.696 . . . . 0.0 112.404 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 71.5 mtm -96.84 24.75 5.83 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -163.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -62.3 1.49 Allowed 'General case' 0 CA--C 1.453 -2.756 0 C-N-CA 116.171 -2.212 . . . . 0.0 115.545 129.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.7 t -61.94 -64.03 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.45 -2.899 0 O-C-N 126.435 2.335 . . . . 0.0 109.183 -161.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 72.9 mt -43.45 -55.53 4.12 Favored 'General case' 0 CA--C 1.48 -1.725 0 C-N-CA 127.686 2.395 . . . . 0.0 114.086 176.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -57.62 -37.6 73.56 Favored 'General case' 0 CA--C 1.476 -1.879 0 C-N-CA 126.484 1.914 . . . . 0.0 114.298 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -80.2 -15.29 57.36 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 118.845 0.748 . . . . 0.0 111.38 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.8 t -74.2 -47.07 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.724 0 CA-C-O 116.459 -1.734 . . . . 0.0 106.732 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.439 ' HB2' HG23 ' A' ' 158' ' ' VAL . 10.7 ttmt -55.41 -50.78 68.87 Favored 'General case' 0 CA--C 1.461 -2.452 0 CA-C-O 116.776 -1.583 . . . . 0.0 110.011 172.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -66.84 -36.45 82.36 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 119.733 1.151 . . . . 0.0 110.105 -168.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.09 -48.44 57.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 116.662 -2.015 . . . . 0.0 115.843 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.283 0.2 OUTLIER -82.62 -14.38 54.86 Favored 'General case' 0 CA--C 1.468 -2.198 0 N-CA-C 118.147 2.647 . . . . 0.0 118.147 -172.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -25.4 -30.23 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.263 1 C-N-CA 133.815 4.846 . . . . 0.0 118.358 168.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.36 -54.37 27.09 Favored 'General case' 0 CA--C 1.488 -1.428 0 C-N-CA 127.478 2.311 . . . . 0.0 113.828 170.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.3 tt -113.52 -53.7 2.67 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.38 -1.736 . . . . 0.0 110.491 -168.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.301 . . -92.65 148.22 22.24 Favored 'General case' 0 CA--C 1.455 -2.698 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.2 m -118.58 -164.04 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.452 -2.821 0 C-N-CA 114.305 -2.958 . . . . 0.0 111.155 141.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.545 HG13 ' H ' ' A' ' 160' ' ' SER 0.277 2.9 t -111.93 163.01 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.394 0 C-N-CA 129.649 3.18 . . . . 0.0 107.364 -177.319 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -84.09 -43.97 14.53 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 172.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.545 ' H ' HG13 ' A' ' 158' ' ' VAL . 0.9 OUTLIER -157.29 147.62 21.01 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.557 -167.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.416 -2.15 0 N-CA-C 103.136 -2.912 . . . . 0.0 103.136 165.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.508 -0.671 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 31.2 ttm -123.36 121.86 36.85 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -170.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.4 mt -87.69 142.69 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 C-N-CA 117.755 -1.578 . . . . 0.0 110.758 173.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.403 ' SD ' HG11 ' A' ' 158' ' ' VAL . 3.3 tmm? -111.72 126.84 55.47 Favored 'General case' 0 CA--C 1.476 -1.894 0 N-CA-C 101.421 -3.548 . . . . 0.0 101.421 153.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.2 t -91.72 124.93 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 118.052 -1.459 . . . . 0.0 108.45 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.422 HD11 HG21 ' A' ' 158' ' ' VAL . 14.5 tp -104.45 84.43 2.19 Favored 'General case' 0 C--N 1.349 0.556 0 N-CA-C 121.324 3.824 . . . . 0.0 121.324 -174.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.438 . . -108.08 155.66 39.7 Favored Pre-proline 0 C--N 1.359 0.993 0 N-CA-C 119.279 3.066 . . . . 0.0 119.279 -173.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.25 139.39 45.84 Favored 'Trans proline' 0 CA--C 1.491 -1.653 0 C-N-CA 123.398 2.732 . . . . 0.0 111.545 -160.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp . . . . . 0 CA--C 1.49 -1.343 0 O-C-N 125.053 1.471 . . . . 0.0 107.614 -178.777 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 . . . . . 0 CA--C 1.484 -1.571 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.496 HG21 ' HZ3' ' A' ' 123' ' ' LYS . 72.3 t -90.18 112.43 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -104.58 177.08 4.95 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 157.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -140.01 156.29 46.69 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 117.778 0.263 . . . . 0.0 111.265 -170.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 tp -139.51 168.64 18.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 164.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -118.23 155.61 30.24 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 118.833 0.742 . . . . 0.0 111.178 162.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.415 ' CE2' HG22 ' A' ' 148' ' ' VAL . 19.2 m-85 -124.55 153.49 42.04 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 168.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 . . . . . 0 N--CA 1.437 -1.101 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.828 -170.501 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 N--CA 1.424 -1.731 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.502 ' HH ' HG23 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -73.23 -71.69 0.29 Allowed 'General case' 0 CA--C 1.479 -1.76 0 C-N-CA 126.556 1.942 . . . . 0.0 109.112 -171.731 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.427 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.368 0.0 OUTLIER -57.49 -15.42 6.97 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 119.8 3.259 . . . . 0.0 119.8 175.11 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.97 -43.89 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-O 122.014 0.911 . . . . 0.0 110.699 163.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -91.96 2.78 56.33 Favored 'General case' 0 CA--C 1.477 -1.858 0 O-C-N 120.495 -1.378 . . . . 0.0 114.367 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 tt -81.82 -31.96 31.47 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 163.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.434 ' HA ' HG12 ' A' ' 115' ' ' ILE . 50.4 ttt180 -62.64 -42.36 99.55 Favored 'General case' 0 C--N 1.361 1.095 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.696 168.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.7 m -60.18 -38.0 81.91 Favored 'General case' 0 C--N 1.377 1.798 0 C-N-CA 118.632 -1.227 . . . . 0.0 113.728 172.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 72.2 mt -65.24 -33.74 76.71 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 175.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 112' ' ' ARG . 4.7 mm -58.62 -46.11 90.34 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.391 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -49.64 -48.78 49.02 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 128.14 2.576 . . . . 0.0 111.835 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -58.97 -50.05 75.56 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.56 -21.77 62.66 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 124.853 1.261 . . . . 0.0 114.119 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -71.29 -37.7 71.84 Favored 'General case' 0 CA--C 1.491 -1.327 0 C-N-CA 126.75 2.02 . . . . 0.0 109.694 173.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -66.82 -28.22 68.19 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-O 120.732 0.301 . . . . 0.0 110.61 170.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.53 71.47 1.29 Allowed Glycine 0 CA--C 1.473 -2.579 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 -175.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -134.79 174.45 10.56 Favored 'General case' 0 N--CA 1.414 -2.229 1 N-CA-C 99.97 -4.085 . . . . 0.0 99.97 170.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.496 ' HZ3' HG21 ' A' ' 93' ' ' VAL 0.333 13.9 mtmt -88.5 147.47 24.63 Favored 'General case' 0 CA--C 1.459 -2.554 0 N-CA-C 100.918 -3.734 . . . . 0.0 100.918 159.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.18 123.2 47.21 Favored 'General case' 0 CA--C 1.457 -2.623 0 C-N-CA 115.331 -2.548 . . . . 0.0 106.091 160.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -99.75 117.67 34.59 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -168.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.6 mm -85.29 125.92 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -178.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.3 m -97.79 117.22 31.61 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 159.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.46 148.5 37.2 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 166.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -151.14 92.61 1.82 Allowed 'General case' 0 N--CA 1.402 -2.837 1 N-CA-C 97.009 -5.182 . . . . 0.0 97.009 -167.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 N--CA 1.418 -2.031 0 N-CA-C 101.423 -3.547 . . . . 0.0 101.423 174.656 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 16.6 mt . . . . . 1 N--CA 1.367 -4.623 1 N-CA-C 94.153 -6.24 . . . . 0.0 94.153 . . . . . . . . . 2 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 157.7 -89.67 0.11 Allowed Glycine 0 N--CA 1.412 -2.943 1 CA-C-N 107.883 -4.235 . . . . 0.0 108.857 -174.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.528 ' HG2' ' CE1' ' A' ' 161' ' ' PHE 0.254 75.0 mtp -90.09 5.16 47.96 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 128.779 2.832 . . . . 0.0 113.876 -168.394 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.251 2.3 tp10 -75.48 -45.67 37.06 Favored 'General case' 0 CA--C 1.433 -3.529 0 C-N-CA 116.111 -2.236 . . . . 0.0 111.823 151.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.51 -74.9 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.444 -3.113 0 O-C-N 126.693 2.495 . . . . 0.0 107.539 -161.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.46 -47.4 63.12 Favored 'General case' 0 CA--C 1.481 -1.675 0 C-N-CA 129.908 3.283 . . . . 0.0 112.102 -177.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.253 1.5 t30 -64.98 -32.31 73.97 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -81.39 -15.58 54.78 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.363 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.502 HG23 ' HH ' ' A' ' 107' ' ' TYR . 1.7 t -74.78 -46.42 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.885 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.444 ' HE2' ' HB ' ' A' ' 158' ' ' VAL 0.303 19.7 ttmt -51.27 -48.48 62.19 Favored 'General case' 0 CA--C 1.472 -2.051 0 C-N-CA 126.781 2.032 . . . . 0.0 113.424 172.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.89 -39.65 61.36 Favored 'General case' 0 N--CA 1.408 -2.554 0 C-N-CA 127.238 2.215 . . . . 0.0 109.577 -171.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -75.24 -25.06 57.8 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 116.623 -2.031 . . . . 0.0 115.0 170.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.307 0.2 OUTLIER -79.44 -31.55 42.56 Favored 'General case' 0 CA--C 1.466 -2.252 0 CA-C-O 116.152 -1.88 . . . . 0.0 112.223 178.192 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -30.57 -17.88 0.0 OUTLIER 'General case' 0 C--N 1.371 1.526 1 C-N-CA 135.237 5.415 . . . . 0.0 120.336 -175.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -53.58 -58.41 7.28 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 126.379 1.872 . . . . 0.0 111.378 163.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.58 -54.09 2.73 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 126.002 1.721 . . . . 0.0 109.286 -172.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.307 . . -110.67 140.16 45.28 Favored 'General case' 0 CA--C 1.459 -2.557 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.652 -164.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.8 m -126.73 166.87 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.527 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 144.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 174' ' ' LEU 0.305 70.2 t -74.54 146.83 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.874 0 CA-C-N 111.121 -2.763 . . . . 0.0 107.349 176.137 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.46 -41.42 16.62 Favored 'General case' 0 CA--C 1.473 -2.016 0 CA-C-N 110.895 -2.866 . . . . 0.0 105.695 -170.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -160.18 140.15 11.41 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 -169.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.528 ' CE1' ' HG2' ' A' ' 142' ' ' MET . 1.8 t80 . . . . . 0 N--CA 1.425 -1.689 0 N-CA-C 100.373 -3.936 . . . . 0.0 100.373 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.264 18.3 mt-30 . . . . . 0 CA--C 1.506 -0.749 0 CA-C-O 119.78 -0.152 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 46.6 ttm -124.41 119.12 28.29 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.0 mm -81.9 136.57 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 O-C-N 120.624 -1.297 . . . . 0.0 108.299 171.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -124.23 133.8 53.42 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 102.78 -3.045 . . . . 0.0 102.78 156.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.58 135.29 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 106.833 -1.544 . . . . 0.0 106.833 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -115.69 141.81 47.58 Favored 'General case' 0 C--N 1.362 1.142 1 N-CA-C 99.577 -4.231 . . . . 0.0 99.577 -179.74 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.353 . . -147.71 -179.97 1.06 Allowed Pre-proline 0 CA--C 1.494 -1.211 0 CA-C-N 120.024 1.283 . . . . 0.0 112.517 -168.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -68.91 137.69 38.63 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 121.109 1.206 . . . . 0.0 109.673 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp . . . . . 0 CA--C 1.488 -1.43 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.439 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 . . . . . 0 CA--C 1.483 -1.607 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.43 HG23 ' HD3' ' A' ' 123' ' ' LYS . 88.1 t -102.49 118.12 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 163.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -103.19 175.12 5.58 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 159.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -145.97 153.33 40.67 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 tp -134.38 164.0 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -119.5 153.13 35.8 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.349 161.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.471 ' CE2' HG23 ' A' ' 148' ' ' VAL . 40.1 m-85 -127.85 164.01 23.16 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 171.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.419 -2.019 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -170.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 CA--C 1.475 -1.916 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.401 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.6 OUTLIER -84.92 -65.11 1.05 Allowed 'General case' 0 CA--C 1.481 -1.704 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.519 -164.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.324 0.0 OUTLIER -62.29 -9.37 7.81 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 178.051 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 64.7 t -60.67 -46.9 95.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 122.359 1.076 . . . . 0.0 109.864 158.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -90.83 -3.21 57.56 Favored 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 tt -77.44 -32.16 54.35 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 162.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.446 ' HA ' HG12 ' A' ' 115' ' ' ILE . 41.7 ttt180 -61.94 -42.41 99.07 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.041 169.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.5 m -59.56 -43.61 93.51 Favored 'General case' 0 C--N 1.38 1.902 0 C-N-CA 118.44 -1.304 . . . . 0.0 113.975 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.263 47.4 mt -64.03 -30.56 71.63 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 175.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.45 ' CG2' ' HG ' ' A' ' 155' ' ' LEU 0.265 4.0 mm -61.98 -47.73 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.92 0 CA-C-N 119.936 1.243 . . . . 0.0 108.699 177.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -54.0 -43.16 69.82 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 125.765 1.915 . . . . 0.0 110.214 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -59.72 -51.65 68.87 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.78 0.832 . . . . 0.0 112.542 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 mt -71.98 -19.57 61.86 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 126.466 1.906 . . . . 0.0 114.452 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -73.14 -35.4 66.5 Favored 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 125.978 1.711 . . . . 0.0 110.122 171.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -68.25 -23.79 64.83 Favored 'General case' 0 C--N 1.36 1.063 0 C-N-CA 122.575 0.35 . . . . 0.0 110.144 168.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.63 69.31 1.38 Allowed Glycine 0 CA--C 1.466 -2.99 0 N-CA-C 104.762 -3.335 . . . . 0.0 104.762 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -123.38 165.11 17.57 Favored 'General case' 0 CA--C 1.458 -2.573 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.43 ' HD3' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -101.66 107.36 18.58 Favored 'General case' 0 N--CA 1.404 -2.735 1 N-CA-C 98.762 -4.533 . . . . 0.0 98.762 178.123 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.71 122.38 41.87 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -174.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -95.77 122.1 38.2 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -173.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.9 mm -83.57 131.65 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.533 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 23.4 m -116.7 116.54 27.72 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 167.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.483 HD22 ' CZ ' ' A' ' 130' ' ' PHE . 17.5 tp -77.95 151.69 33.56 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 169.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -150.23 96.75 2.46 Favored 'General case' 0 N--CA 1.407 -2.611 1 N-CA-C 100.054 -4.054 . . . . 0.0 100.054 -175.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.483 ' CZ ' HD22 ' A' ' 128' ' ' LEU 0.267 68.4 m-85 . . . . . 0 N--CA 1.428 -1.559 0 CA-C-N 111.739 -2.482 . . . . 0.0 109.72 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.252 53.1 mt . . . . . 0 N--CA 1.424 -1.743 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.49 -60.05 4.22 Favored Glycine 0 N--CA 1.408 -3.181 0 N-CA-C 115.241 0.856 . . . . 0.0 115.241 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -87.4 0.89 54.82 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 118.569 -0.729 . . . . 0.0 112.932 -160.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.255 0.6 OUTLIER -59.4 -60.81 3.26 Favored 'General case' 0 CA--C 1.461 -2.466 0 C-N-CA 114.94 -2.704 . . . . 0.0 114.987 146.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.0 t -64.7 -64.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.927 0 O-C-N 125.956 2.035 . . . . 0.0 109.433 -164.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 49.4 mt -44.88 -54.31 6.59 Favored 'General case' 0 CA--C 1.488 -1.405 0 C-N-CA 128.242 2.617 . . . . 0.0 113.891 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -63.6 -30.93 71.97 Favored 'General case' 0 CA--C 1.465 -2.304 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -80.82 -14.86 57.67 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.354 173.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.471 HG23 ' CE2' ' A' ' 98' ' ' PHE . 2.0 t -76.59 -45.29 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.802 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 174.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.438 ' HE2' ' HB ' ' A' ' 158' ' ' VAL . 33.6 ttmt -54.42 -51.33 65.26 Favored 'General case' 0 CA--C 1.462 -2.417 0 CA-C-O 117.368 -1.301 . . . . 0.0 111.238 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.13 -40.09 75.05 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 125.477 1.511 . . . . 0.0 108.857 -169.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.94 -23.2 58.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 116.366 -2.134 . . . . 0.0 115.206 172.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.271 0.1 OUTLIER -81.85 -36.32 28.41 Favored 'General case' 0 CA--C 1.476 -1.872 0 CA-C-O 116.939 -1.505 . . . . 0.0 111.86 179.035 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -27.91 -32.3 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.664 1 C-N-CA 135.614 5.566 . . . . 0.0 119.142 -168.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -51.2 -47.2 62.31 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 128.914 2.886 . . . . 0.0 114.126 172.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.45 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 3.1 tm? -116.84 -51.61 2.56 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 128.384 2.673 . . . . 0.0 107.258 -161.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.315 . . -114.41 143.6 44.66 Favored 'General case' 0 CA--C 1.462 -2.421 0 CA-C-O 117.788 -1.101 . . . . 0.0 109.815 -175.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.5 m -129.54 164.47 32.04 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.125 0 N-CA-C 120.717 3.599 . . . . 0.0 120.717 148.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.4 t -80.49 147.73 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.957 0 CA-C-N 110.877 -2.874 . . . . 0.0 108.207 -176.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -82.37 -39.4 22.8 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.426 -1.715 . . . . 0.0 106.419 -172.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -151.6 142.36 22.84 Favored 'General case' 0 CA--C 1.464 -2.346 0 N-CA-C 104.805 -2.295 . . . . 0.0 104.805 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.6 t80 . . . . . 0 N--CA 1.42 -1.969 0 N-CA-C 100.757 -3.794 . . . . 0.0 100.757 163.807 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.269 29.9 mt-30 . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 23.8 ttm -122.96 122.78 39.39 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.533 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 19.3 mm -82.81 124.79 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 171.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.1 ttp -108.42 130.39 55.23 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 103.166 -2.901 . . . . 0.0 103.166 160.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 32.8 t -96.43 137.49 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 118.873 -1.131 . . . . 0.0 108.42 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 1.1 tp -128.88 144.32 51.14 Favored 'General case' 0 C--N 1.362 1.149 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 -174.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.361 . . -148.5 175.02 2.96 Favored Pre-proline 0 CA--C 1.493 -1.241 0 CA-C-O 117.501 -1.238 . . . . 0.0 110.216 -169.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -73.53 144.92 36.8 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 CA-C-N 121.621 1.614 . . . . 0.0 108.022 -177.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt . . . . . 0 CA--C 1.487 -1.473 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 176.265 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 . . . . . 0 CA--C 1.486 -1.511 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.503 HG21 ' HZ1' ' A' ' 123' ' ' LYS . 15.3 t -92.3 115.21 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.558 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 169.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -108.46 178.97 4.33 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.569 154.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -142.53 157.07 45.12 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 -171.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 tp -140.31 166.75 19.34 Favored 'Isoleucine or valine' 0 C--N 1.356 0.848 0 N-CA-C 102.544 -3.132 . . . . 0.0 102.544 164.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -116.17 158.69 22.87 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-N 118.943 0.792 . . . . 0.0 111.021 166.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -149.46 99.84 2.94 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 . . . . . 0 N--CA 1.436 -1.175 0 C-N-CA 125.573 1.549 . . . . 0.0 109.541 -177.053 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 N--CA 1.425 -1.681 0 CA-C-O 122.569 1.176 . . . . 0.0 108.019 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.435 ' HH ' HG21 ' A' ' 148' ' ' VAL . 1.1 t80 -88.81 -69.93 0.68 Allowed 'General case' 0 CA--C 1.473 -1.992 0 CA-C-N 112.611 -2.086 . . . . 0.0 111.316 -158.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.35 0.0 OUTLIER -56.02 -18.56 9.79 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 118.783 2.883 . . . . 0.0 118.783 172.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.59 -49.65 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 CA-C-O 122.391 1.091 . . . . 0.0 110.091 163.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -91.54 9.08 33.54 Favored 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -85.03 -32.67 22.78 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 163.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.446 ' HA ' HG12 ' A' ' 115' ' ' ILE . 55.2 ttt180 -62.27 -42.89 99.73 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 118.807 -0.616 . . . . 0.0 110.928 167.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 t -54.46 -45.88 73.21 Favored 'General case' 0 C--N 1.379 1.862 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 171.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.4 mt -63.35 -34.36 77.55 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 117.608 2.447 . . . . 0.0 117.608 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.9 mm -55.99 -48.57 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 O-C-N 124.3 1.0 . . . . 0.0 108.899 173.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -51.6 -45.62 63.26 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 126.033 1.733 . . . . 0.0 113.402 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -57.49 -50.58 72.58 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 mt -72.61 -21.18 61.16 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 125.304 1.442 . . . . 0.0 113.902 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -75.13 -33.22 61.53 Favored 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 125.671 1.588 . . . . 0.0 110.391 173.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -68.91 -26.31 65.03 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 167.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.46 78.24 1.22 Allowed Glycine 0 CA--C 1.47 -2.778 0 N-CA-C 106.338 -2.705 . . . . 0.0 106.338 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -134.31 168.3 19.14 Favored 'General case' 0 CA--C 1.465 -2.318 1 N-CA-C 99.902 -4.111 . . . . 0.0 99.902 168.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.503 ' HZ1' HG21 ' A' ' 93' ' ' VAL 0.317 0.0 OUTLIER -88.29 121.14 30.35 Favored 'General case' 0 CA--C 1.457 -2.631 1 N-CA-C 99.719 -4.178 . . . . 0.0 99.719 156.903 . . . . . . . . 5 4 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.53 123.38 33.58 Favored 'General case' 0 N--CA 1.41 -2.443 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 166.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -102.18 125.27 48.83 Favored 'General case' 0 CA--C 1.469 -2.149 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -175.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.3 mm -86.16 125.29 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.43 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.543 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 11.2 m -103.31 121.62 43.11 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 176.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . 0.313 0.2 OUTLIER -81.0 150.53 28.86 Favored 'General case' 0 CA--C 1.456 -2.655 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 166.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -147.25 89.23 1.77 Allowed 'General case' 0 N--CA 1.402 -2.838 1 N-CA-C 98.645 -4.576 . . . . 0.0 98.645 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 . . . . . 0 CA--C 1.487 -1.457 0 CA-C-N 111.259 -2.7 . . . . 0.0 109.877 -166.655 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.426 -1.632 0 N-CA-C 111.424 0.157 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.81 -65.19 2.18 Favored Glycine 0 N--CA 1.419 -2.458 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 75.0 mtm -93.04 11.75 26.48 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -159.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -72.75 -53.38 11.77 Favored 'General case' 0 CA--C 1.444 -3.1 0 C-N-CA 117.155 -1.818 . . . . 0.0 113.153 143.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.2 t -67.71 -66.94 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.446 -3.019 0 O-C-N 126.539 2.399 . . . . 0.0 107.681 -160.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 97.3 mt -46.97 -49.7 20.28 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 128.563 2.745 . . . . 0.0 115.387 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -59.34 -38.96 81.69 Favored 'General case' 0 CA--C 1.477 -1.833 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 172.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -80.65 -14.75 57.89 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.614 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.435 HG21 ' HH ' ' A' ' 107' ' ' TYR . 1.8 t -76.53 -47.91 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.69 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.288 12.7 ttmt -55.0 -43.46 73.61 Favored 'General case' 0 CA--C 1.466 -2.286 0 C-N-CA 126.015 1.726 . . . . 0.0 113.128 172.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -40.11 65.3 Favored 'General case' 0 N--CA 1.41 -2.452 0 C-N-CA 124.162 0.985 . . . . 0.0 109.446 -174.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -73.93 -26.3 60.43 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 116.579 -2.049 . . . . 0.0 115.569 170.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.271 0.2 OUTLIER -80.9 -32.42 34.79 Favored 'General case' 0 CA--C 1.47 -2.101 0 CA-C-O 116.749 -1.596 . . . . 0.0 112.223 -178.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -28.8 -23.52 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.69 1 C-N-CA 135.528 5.531 . . . . 0.0 119.987 -174.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -53.33 -56.75 14.16 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 126.557 1.943 . . . . 0.0 111.989 167.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.3 tt -107.94 -52.25 2.79 Favored 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 126.557 1.943 . . . . 0.0 108.529 -167.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.294 . . -110.5 138.37 46.98 Favored 'General case' 0 CA--C 1.467 -2.241 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.505 -173.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.84 165.12 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.496 0 N-CA-C 119.445 3.128 . . . . 0.0 119.445 147.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.529 HG11 ' H ' ' A' ' 160' ' ' SER . 3.9 t -76.96 153.02 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.135 0 CA-C-N 111.562 -2.563 . . . . 0.0 108.401 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.06 -39.91 25.0 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.753 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.529 ' H ' HG11 ' A' ' 158' ' ' VAL . 0.9 OUTLIER -150.38 137.2 19.17 Favored 'General case' 0 CA--C 1.469 -2.171 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 -173.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.7 t80 . . . . . 0 CA--C 1.486 -1.517 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 177.171 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 N--CA 1.446 -0.668 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 28.8 ttp -115.8 118.86 34.2 Favored 'General case' 0 C--N 1.369 1.444 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -165.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.543 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 11.4 mm -84.03 124.46 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 O-C-N 120.633 -1.292 . . . . 0.0 108.964 170.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -99.44 133.0 44.39 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 102.141 -3.281 . . . . 0.0 102.141 156.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 24.7 t -99.94 116.22 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 118.239 -1.384 . . . . 0.0 110.013 -177.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 1.1 tp -106.57 107.62 18.73 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 -167.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.265 . . -99.57 179.54 1.02 Allowed Pre-proline 0 CA--C 1.486 -1.481 0 C-N-CA 124.746 1.218 . . . . 0.0 113.169 -176.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -70.55 153.76 65.1 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 N-CA-C 106.483 -2.161 . . . . 0.0 106.483 170.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt . . . . . 0 N--CA 1.431 -1.383 0 CA-C-O 123.026 1.393 . . . . 0.0 110.125 -175.279 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 . . . . . 0 CA--C 1.484 -1.566 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.4 t -105.17 125.12 60.29 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.485 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 167.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -106.8 174.9 5.69 Favored 'General case' 0 CA--C 1.464 -2.339 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 155.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -149.28 147.05 27.9 Favored 'General case' 0 N--CA 1.422 -1.851 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.084 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tp -129.21 162.42 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -122.22 152.78 39.64 Favored 'General case' 0 CA--C 1.488 -1.44 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.979 162.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.465 ' CE2' HG23 ' A' ' 148' ' ' VAL . 45.2 m-85 -130.82 146.73 52.34 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 172.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.435 -1.181 0 C-N-CA 123.644 0.777 . . . . 0.0 109.08 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 N--CA 1.424 -1.736 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.445 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -73.79 -75.59 0.15 Allowed 'General case' 0 CA--C 1.48 -1.714 0 CA-C-N 113.189 -1.823 . . . . 0.0 108.678 -169.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.341 0.0 OUTLIER -58.66 -12.31 4.04 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 120.389 3.477 . . . . 0.0 120.389 178.427 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 66.3 t -61.75 -45.42 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 CA-C-O 122.59 1.186 . . . . 0.0 110.041 161.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -91.77 -0.83 57.56 Favored 'General case' 0 CA--C 1.472 -2.037 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 tt -78.17 -32.0 49.94 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 161.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.441 ' HA ' HG12 ' A' ' 115' ' ' ILE . 48.4 ttt180 -63.52 -43.13 98.06 Favored 'General case' 0 C--N 1.361 1.077 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.242 170.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.8 m -63.92 -37.28 86.82 Favored 'General case' 0 C--N 1.377 1.788 0 C-N-CA 118.648 -1.221 . . . . 0.0 113.405 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.296 60.5 tp -70.38 -28.96 65.5 Favored 'General case' 0 N--CA 1.401 -2.91 0 C-N-CA 125.196 1.398 . . . . 0.0 113.782 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.441 HG12 ' HA ' ' A' ' 112' ' ' ARG . 9.7 mm -58.57 -50.59 78.44 Favored 'Isoleucine or valine' 0 C--N 1.371 1.507 0 CA-C-N 120.982 1.719 . . . . 0.0 110.033 170.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -52.28 -44.11 64.79 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 127.697 2.399 . . . . 0.0 110.668 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -59.44 -50.03 75.51 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 125.868 1.667 . . . . 0.0 113.04 176.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.46 -34.6 74.25 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 175.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -72.1 -32.12 66.7 Favored 'General case' 0 CA--C 1.487 -1.468 0 C-N-CA 127.745 2.418 . . . . 0.0 110.913 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -64.81 -20.83 66.6 Favored 'General case' 0 C--N 1.36 1.023 0 C-N-CA 123.117 0.567 . . . . 0.0 111.444 171.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 89.17 59.51 1.56 Allowed Glycine 0 CA--C 1.466 -2.987 0 N-CA-C 104.65 -3.38 . . . . 0.0 104.65 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -123.21 167.73 13.35 Favored 'General case' 0 CA--C 1.455 -2.701 0 N-CA-C 102.121 -3.289 . . . . 0.0 102.121 171.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -94.22 132.32 38.9 Favored 'General case' 0 CA--C 1.449 -2.942 0 N-CA-C 100.602 -3.851 . . . . 0.0 100.602 162.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.22 115.71 30.63 Favored 'General case' 0 N--CA 1.4 -2.942 0 C-N-CA 117.378 -1.729 . . . . 0.0 106.593 -173.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -97.26 122.39 40.23 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.543 0.687 . . . . 0.0 109.275 -163.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.6 mm -84.16 133.78 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.961 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.9 m -112.97 117.12 31.19 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 165.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.493 HD22 ' CZ ' ' A' ' 130' ' ' PHE . 10.4 tp -79.61 153.17 29.61 Favored 'General case' 0 CA--C 1.474 -1.97 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 167.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -152.88 94.12 1.83 Allowed 'General case' 0 N--CA 1.4 -2.938 0 N-CA-C 101.335 -3.579 . . . . 0.0 101.335 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.493 ' CZ ' HD22 ' A' ' 128' ' ' LEU 0.311 94.2 m-85 . . . . . 0 N--CA 1.429 -1.521 0 C-N-CA 126.909 2.084 . . . . 0.0 109.837 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 51.9 mt . . . . . 0 N--CA 1.423 -1.798 0 CA-C-O 120.43 0.157 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -70.58 -60.42 4.68 Favored Glycine 0 CA--C 1.458 -3.53 0 O-C-N 123.951 0.782 . . . . 0.0 113.958 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -85.78 -1.52 57.31 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -159.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.271 2.0 tp10 -61.44 -60.67 3.36 Favored 'General case' 0 CA--C 1.454 -2.747 0 C-N-CA 114.412 -2.915 . . . . 0.0 115.394 146.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 23.1 t -66.26 -65.87 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.91 0 O-C-N 125.978 2.049 . . . . 0.0 108.7 -162.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 32.0 mt -44.85 -54.17 6.7 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 129.131 2.972 . . . . 0.0 114.316 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -66.16 -28.34 68.71 Favored 'General case' 0 CA--C 1.468 -2.179 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 174.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -80.35 -15.34 57.09 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.222 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.465 HG23 ' CE2' ' A' ' 98' ' ' PHE . 1.9 t -76.08 -44.47 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.78 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.412 ' HE2' ' HB ' ' A' ' 158' ' ' VAL 0.262 34.9 ttmt -52.98 -48.76 67.19 Favored 'General case' 0 CA--C 1.47 -2.105 0 C-N-CA 125.435 1.494 . . . . 0.0 112.435 171.326 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.1 -38.39 66.38 Favored 'General case' 0 N--CA 1.409 -2.508 0 C-N-CA 125.853 1.661 . . . . 0.0 109.605 -171.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.53 -25.72 54.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 116.462 -2.095 . . . . 0.0 115.201 170.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.298 0.1 OUTLIER -77.31 -30.84 54.29 Favored 'General case' 0 CA--C 1.473 -1.992 0 CA-C-O 116.525 -1.703 . . . . 0.0 113.451 176.069 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -29.44 -20.13 0.0 OUTLIER 'General case' 0 C--N 1.366 1.302 1 C-N-CA 134.91 5.284 . . . . 0.0 120.224 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -56.29 -62.15 1.91 Allowed 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 127.187 2.195 . . . . 0.0 111.178 167.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.13 -56.01 2.78 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 125.542 1.537 . . . . 0.0 109.048 -174.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.434 ' CB ' HD12 ' A' ' 174' ' ' LEU 0.269 . . -98.48 146.66 25.53 Favored 'General case' 0 CA--C 1.449 -2.934 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.877 -165.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.2 m -121.59 172.2 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.454 -2.723 0 C-N-CA 114.626 -2.83 . . . . 0.0 116.384 134.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 3.8 t -82.31 153.4 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.831 0 CA-C-N 111.784 -2.462 . . . . 0.0 107.157 -177.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -81.59 -41.22 21.86 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 -173.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.4 t -157.29 143.15 17.61 Favored 'General case' 0 CA--C 1.46 -2.499 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.0 t80 . . . . . 0 N--CA 1.423 -1.806 0 N-CA-C 100.996 -3.705 . . . . 0.0 100.996 167.158 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.503 -0.844 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 48.5 ttm -122.11 122.86 40.21 Favored 'General case' 0 CA--C 1.481 -1.678 0 C-N-CA 123.547 0.739 . . . . 0.0 109.405 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.2 mm -81.99 122.7 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 166.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 3.9 ttp -106.55 129.53 54.48 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 101.582 -3.488 . . . . 0.0 101.582 161.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.5 t -94.48 137.33 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -117.81 150.22 39.51 Favored 'General case' 0 C--N 1.357 0.898 1 N-CA-C 99.516 -4.253 . . . . 0.0 99.516 -179.987 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.26 . . -140.75 -178.92 0.89 Allowed Pre-proline 0 N--CA 1.432 -1.341 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.681 -170.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -69.85 147.45 62.31 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 C-N-CA 122.395 2.063 . . . . 0.0 109.055 165.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt . . . . . 0 CA--C 1.491 -1.297 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 171.147 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 . . . . . 0 CA--C 1.48 -1.749 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.445 HG21 ' HE2' ' A' ' 123' ' ' LYS . 46.4 t -105.99 121.82 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.874 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 162.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -101.51 175.94 5.4 Favored 'General case' 0 CA--C 1.468 -2.2 0 C-N-CA 116.427 -2.109 . . . . 0.0 105.715 166.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -143.08 152.67 42.11 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 tp -135.03 163.03 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 103.028 -2.953 . . . . 0.0 103.028 167.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -115.13 153.33 30.98 Favored 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.567 162.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.463 ' CE2' HG23 ' A' ' 148' ' ' VAL . 32.6 m-85 -125.42 131.33 52.94 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 169.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 . . . . . 0 N--CA 1.433 -1.304 0 C-N-CA 124.258 1.023 . . . . 0.0 109.254 -175.421 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . 0.363 53.9 m-20 . . . . . 0 N--CA 1.4 -2.957 0 CA-C-O 121.644 0.735 . . . . 0.0 109.766 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.473 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -75.58 -72.1 0.33 Allowed 'General case' 0 CA--C 1.484 -1.595 0 CA-C-N 112.747 -2.024 . . . . 0.0 109.799 -161.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.417 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.293 0.0 OUTLIER -63.52 -7.68 7.58 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 119.843 3.275 . . . . 0.0 119.843 178.122 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.67 -42.95 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 C-N-CA 124.015 0.926 . . . . 0.0 110.025 160.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.0 mmtt -92.74 -5.06 52.04 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -75.69 -35.02 60.44 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 163.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.424 ' HA ' HG12 ' A' ' 115' ' ' ILE . 7.4 ttm180 -59.31 -43.65 92.61 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 125.541 1.536 . . . . 0.0 111.318 169.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.8 t -56.79 -46.59 81.46 Favored 'General case' 0 C--N 1.377 1.791 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.267 71.0 mt -67.56 -28.12 67.51 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 176.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.424 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.7 mm -59.78 -49.5 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.709 0 CA-C-N 119.696 1.134 . . . . 0.0 108.83 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -51.57 -44.58 62.79 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 127.26 2.224 . . . . 0.0 110.1 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -63.65 -52.77 59.27 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.91 -29.48 68.58 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 125.605 1.562 . . . . 0.0 114.699 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.62 -29.53 51.84 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 124.03 0.932 . . . . 0.0 110.842 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -82.84 -1.2 51.29 Favored 'General case' 0 C--N 1.362 1.139 0 CA-C-O 120.602 0.239 . . . . 0.0 110.829 170.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.05 70.16 1.32 Allowed Glycine 0 CA--C 1.473 -2.59 0 C-N-CA 126.242 1.877 . . . . 0.0 109.552 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -128.04 163.64 24.13 Favored 'General case' 0 CA--C 1.449 -2.92 0 N-CA-C 100.786 -3.783 . . . . 0.0 100.786 169.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HE2' HG21 ' A' ' 93' ' ' VAL . 1.6 tmmm? -98.33 106.03 18.26 Favored 'General case' 0 N--CA 1.399 -3.019 1 N-CA-C 97.706 -4.924 . . . . 0.0 97.706 172.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.08 155.25 21.59 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -133.47 129.95 37.91 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 119.844 -1.785 . . . . 0.0 106.552 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.8 mm -82.74 137.98 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.576 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.446 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 24.1 m -117.14 127.51 54.2 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 167.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.472 HD21 ' CE1' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -85.83 153.56 22.17 Favored 'General case' 0 CA--C 1.462 -2.441 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 166.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -151.36 91.41 1.67 Allowed 'General case' 0 N--CA 1.394 -3.231 1 N-CA-C 98.715 -4.55 . . . . 0.0 98.715 -175.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.472 ' CE1' HD21 ' A' ' 128' ' ' LEU 0.253 97.6 m-85 . . . . . 0 N--CA 1.428 -1.554 0 CA-C-N 111.438 -2.619 . . . . 0.0 105.903 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.29 68.1 mt . . . . . 0 N--CA 1.406 -2.639 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -78.34 -66.6 1.72 Allowed Glycine 0 N--CA 1.408 -3.193 0 CA-C-N 114.372 -1.285 . . . . 0.0 113.574 178.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 43.0 mtt -95.03 24.21 5.04 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -164.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -71.14 -55.7 7.63 Favored 'General case' 0 CA--C 1.456 -2.652 0 C-N-CA 116.521 -2.072 . . . . 0.0 114.644 133.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.4 t -64.16 -66.25 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.443 -3.172 0 O-C-N 126.174 2.171 . . . . 0.0 107.834 -163.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 71.1 mt -44.61 -55.03 5.53 Favored 'General case' 0 CA--C 1.478 -1.824 0 O-C-N 126.543 2.402 . . . . 0.0 114.108 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.36 -36.79 74.01 Favored 'General case' 0 CA--C 1.473 -2.017 0 C-N-CA 127.229 2.212 . . . . 0.0 114.062 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -81.71 -14.98 55.84 Favored 'General case' 0 N--CA 1.418 -2.027 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.882 175.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.473 HG21 ' HH ' ' A' ' 107' ' ' TYR . 1.4 t -75.24 -43.64 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.74 0 CA-C-O 116.374 -1.774 . . . . 0.0 107.355 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -53.49 -52.88 58.14 Favored 'General case' 0 CA--C 1.463 -2.394 0 CA-C-O 116.861 -1.542 . . . . 0.0 109.884 169.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -67.52 -39.43 85.08 Favored 'General case' 0 N--CA 1.41 -2.47 0 C-N-CA 124.22 1.008 . . . . 0.0 109.359 -166.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -75.05 -26.84 59.71 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 116.447 -2.101 . . . . 0.0 116.075 171.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.281 0.1 OUTLIER -81.1 -33.28 33.42 Favored 'General case' 0 CA--C 1.479 -1.757 0 CA-C-O 117.107 -1.425 . . . . 0.0 113.605 -178.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -28.5 -29.94 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.478 1 C-N-CA 135.555 5.542 . . . . 0.0 118.85 -173.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.9 -53.32 54.22 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 127.509 2.324 . . . . 0.0 113.204 173.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.17 -53.53 2.67 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.624 -165.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.308 . . -96.81 153.08 18.09 Favored 'General case' 0 CA--C 1.447 -2.998 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.3 m -116.39 -164.14 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.905 0 C-N-CA 113.69 -3.204 . . . . 0.0 112.343 138.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.488 HG11 ' H ' ' A' ' 160' ' ' SER 0.28 3.3 t -108.35 162.93 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.559 0 C-N-CA 128.326 2.65 . . . . 0.0 106.009 177.239 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.44 -42.49 18.47 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.488 ' H ' HG11 ' A' ' 158' ' ' VAL . 1.2 t -162.02 154.2 19.34 Favored 'General case' 0 CA--C 1.479 -1.777 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.581 -166.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.42 -1.939 0 N-CA-C 103.366 -2.827 . . . . 0.0 103.366 168.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.285 30.3 mt-30 . . . . . 0 CA--C 1.507 -0.702 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 58.7 ttp -142.86 117.22 9.62 Favored 'General case' 0 C--N 1.364 1.196 0 CA-C-O 121.756 0.789 . . . . 0.0 111.703 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.446 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 10.9 mm -80.16 138.44 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 O-C-N 120.105 -1.622 . . . . 0.0 109.816 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.436 ' SD ' HG12 ' A' ' 158' ' ' VAL . 3.3 tmm? -113.85 135.24 54.18 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 154.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.85 127.86 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.13 73.76 0.83 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 117.241 2.312 . . . . 0.0 117.241 -166.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.432 . . -105.46 156.6 36.1 Favored Pre-proline 0 C--N 1.355 0.815 0 N-CA-C 120.024 3.342 . . . . 0.0 120.024 -167.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -67.45 142.12 58.38 Favored 'Trans proline' 0 CA--C 1.492 -1.62 0 C-N-CA 123.258 2.639 . . . . 0.0 111.276 -161.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt . . . . . 0 CA--C 1.49 -1.357 0 O-C-N 125.029 1.456 . . . . 0.0 107.907 -174.974 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 . . . . . 0 CA--C 1.482 -1.664 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.0 t -99.69 120.88 49.67 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 161.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -103.68 172.31 6.87 Favored 'General case' 0 CA--C 1.472 -2.04 0 C-N-CA 116.924 -1.911 . . . . 0.0 106.896 155.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -145.09 148.24 33.43 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tp -128.28 162.24 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 174.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -119.74 153.68 35.3 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.702 163.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.427 ' CE2' HG23 ' A' ' 148' ' ' VAL . 41.7 m-85 -127.12 141.73 51.69 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 168.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 . . . . . 0 N--CA 1.423 -1.788 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 173.177 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.2 t70 . . . . . 0 N--CA 1.425 -1.684 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.43 ' HH ' ' HG2' ' A' ' 147' ' ' ARG . 0.8 OUTLIER -70.74 -72.53 0.2 Allowed 'General case' 0 CA--C 1.477 -1.847 0 C-N-CA 126.574 1.949 . . . . 0.0 109.313 -172.071 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.35 0.0 OUTLIER -58.47 -15.19 9.97 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 119.816 3.265 . . . . 0.0 119.816 175.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.87 -38.69 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 C-N-CA 123.966 0.906 . . . . 0.0 111.229 164.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -92.82 -1.37 56.83 Favored 'General case' 0 CA--C 1.476 -1.875 0 O-C-N 120.159 -1.588 . . . . 0.0 114.708 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.7 tt -79.53 -31.62 42.11 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 163.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.435 ' HA ' HG12 ' A' ' 115' ' ' ILE . 3.3 tpp180 -60.36 -46.09 91.16 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 125.123 1.369 . . . . 0.0 110.772 168.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.8 t -59.81 -44.55 93.93 Favored 'General case' 0 C--N 1.375 1.697 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.303 61.4 tp -67.9 -29.79 68.98 Favored 'General case' 0 N--CA 1.407 -2.595 0 C-N-CA 127.321 2.248 . . . . 0.0 113.562 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.273 9.4 mm -57.78 -51.41 70.61 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.872 0 CA-C-N 120.941 1.7 . . . . 0.0 108.686 170.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.6 tpt85 -54.75 -39.95 68.82 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 126.703 2.001 . . . . 0.0 111.042 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -63.04 -50.64 69.86 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 124.229 1.012 . . . . 0.0 112.263 176.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -37.27 76.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 176.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -75.26 -35.73 61.33 Favored 'General case' 0 CA--C 1.487 -1.462 0 C-N-CA 128.931 2.892 . . . . 0.0 109.907 -169.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.55 6.08 11.36 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 123.605 0.762 . . . . 0.0 111.472 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.18 64.11 2.16 Favored Glycine 0 CA--C 1.467 -2.932 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 174.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -128.52 165.17 21.24 Favored 'General case' 0 CA--C 1.448 -2.945 0 N-CA-C 102.306 -3.22 . . . . 0.0 102.306 169.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.93 115.62 30.08 Favored 'General case' 0 N--CA 1.395 -3.211 1 N-CA-C 97.952 -4.832 . . . . 0.0 97.952 173.162 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.69 160.5 18.08 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -136.56 131.3 33.65 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 168.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.0 mm -83.19 135.24 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 171.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.533 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 17.3 m -113.57 115.65 28.29 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 163.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.428 ' CD2' ' CZ ' ' A' ' 130' ' ' PHE . 17.1 tp -84.93 150.06 25.21 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 168.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -153.8 103.05 2.57 Favored 'General case' 0 N--CA 1.406 -2.674 1 N-CA-C 99.834 -4.136 . . . . 0.0 99.834 -170.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.428 ' CZ ' ' CD2' ' A' ' 128' ' ' LEU 0.347 81.9 m-85 . . . . . 0 CA--C 1.488 -1.434 0 C-N-CA 126.535 1.934 . . . . 0.0 109.297 -171.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 70.8 mt . . . . . 0 N--CA 1.428 -1.53 0 N-CA-C 110.877 -0.046 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.404 ' HA2' ' CD2' ' A' ' 128' ' ' LEU . . . -70.62 -60.72 4.49 Favored Glycine 0 CA--C 1.456 -3.607 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.961 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -85.57 -1.15 56.81 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -157.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.257 0.5 OUTLIER -61.76 -63.54 1.23 Allowed 'General case' 0 CA--C 1.46 -2.484 0 C-N-CA 115.035 -2.666 . . . . 0.0 115.694 147.393 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.8 t -62.77 -67.5 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.448 -2.944 0 O-C-N 126.021 2.076 . . . . 0.0 109.007 -166.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 34.4 mt -43.49 -55.32 4.28 Favored 'General case' 0 CA--C 1.482 -1.666 0 C-N-CA 128.858 2.863 . . . . 0.0 114.564 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -63.23 -30.41 71.56 Favored 'General case' 0 CA--C 1.467 -2.229 0 N-CA-C 117.689 2.478 . . . . 0.0 117.689 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.43 ' HG2' ' HH ' ' A' ' 107' ' ' TYR . 17.6 ttp180 -81.15 -14.57 57.52 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.612 172.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.427 HG23 ' CE2' ' A' ' 98' ' ' PHE . 1.7 t -76.79 -44.14 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.787 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 175.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.256 33.9 ttmt -52.84 -49.95 64.72 Favored 'General case' 0 CA--C 1.467 -2.219 0 C-N-CA 125.631 1.573 . . . . 0.0 112.033 171.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -37.69 64.41 Favored 'General case' 0 N--CA 1.409 -2.521 0 C-N-CA 125.506 1.522 . . . . 0.0 109.456 -169.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -75.33 -25.63 57.98 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 116.372 -2.131 . . . . 0.0 114.993 169.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.308 0.1 OUTLIER -78.41 -32.42 48.71 Favored 'General case' 0 CA--C 1.472 -2.05 0 CA-C-O 116.792 -1.575 . . . . 0.0 112.614 178.392 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -29.58 -22.26 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.403 1 C-N-CA 135.237 5.415 . . . . 0.0 119.884 -174.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -56.4 -61.71 2.22 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.94 2.096 . . . . 0.0 110.974 168.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.69 -55.64 2.94 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 113.877 -1.511 . . . . 0.0 107.973 -171.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.255 . . -98.25 150.87 21.07 Favored 'General case' 0 CA--C 1.443 -3.136 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.565 -166.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.53 173.25 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.662 0 C-N-CA 114.11 -3.036 . . . . 0.0 116.113 130.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . 0.3 3.1 t -81.2 151.6 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.104 0 CA-C-N 110.133 -3.212 . . . . 0.0 104.911 173.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -81.71 -38.47 25.74 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -174.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.39 136.73 14.92 Favored 'General case' 0 N--CA 1.408 -2.54 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -177.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 N--CA 1.417 -2.1 1 N-CA-C 97.632 -4.951 . . . . 0.0 97.632 156.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 11.3 ttm -107.63 119.08 38.43 Favored 'General case' 0 CA--C 1.472 -2.036 0 CA-C-O 121.201 0.524 . . . . 0.0 111.838 -166.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.533 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 22.6 mm -83.27 122.1 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 167.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.4 ttp -105.81 127.47 53.12 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 102.448 -3.167 . . . . 0.0 102.448 162.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.2 t -91.62 140.29 16.33 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 C-N-CA 118.336 -1.345 . . . . 0.0 109.093 -174.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.65 75.75 1.44 Allowed 'General case' 0 C--N 1.366 1.288 0 N-CA-C 120.334 3.457 . . . . 0.0 120.334 -169.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.256 . . -85.31 -176.2 0.74 Allowed Pre-proline 0 CA--C 1.502 -0.872 0 O-C-N 119.374 -2.079 . . . . 0.0 115.357 -169.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -65.55 153.77 76.7 Favored 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 122.292 1.994 . . . . 0.0 109.969 160.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm . . . . . 0 CA--C 1.489 -1.373 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 170.405 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 . . . . . 0 CA--C 1.483 -1.627 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.404 HG23 ' HE3' ' A' ' 123' ' ' LYS . 79.3 t -99.31 120.65 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.431 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 170.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -104.22 173.16 6.42 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 154.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -142.62 154.65 44.58 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -176.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.9 tp -138.7 167.28 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 170.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -119.84 156.25 31.04 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.214 161.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.463 ' CE2' HG23 ' A' ' 148' ' ' VAL . 29.4 m-85 -130.52 160.54 33.82 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 170.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 . . . . . 0 N--CA 1.43 -1.438 0 C-N-CA 125.213 1.405 . . . . 0.0 108.611 -179.07 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.2 t70 . . . . . 0 N--CA 1.422 -1.836 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -80.22 -65.44 1.01 Allowed 'General case' 0 CA--C 1.481 -1.673 0 O-C-N 124.29 0.994 . . . . 0.0 109.567 -165.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.337 0.0 OUTLIER -62.26 -9.6 8.38 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 120.472 3.508 . . . . 0.0 120.472 178.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.53 -44.2 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-O 122.684 1.23 . . . . 0.0 109.72 160.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -89.19 -6.87 56.58 Favored 'General case' 0 CA--C 1.469 -2.149 0 O-C-N 120.395 -1.441 . . . . 0.0 114.727 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 tt -72.34 -35.26 68.52 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 162.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.445 ' HA ' HG12 ' A' ' 115' ' ' ILE . 2.4 tpt180 -56.99 -40.68 77.0 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.484 1.114 . . . . 0.0 111.222 168.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.7 t -59.56 -47.69 84.55 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.306 1.4 mm? -67.4 -25.55 66.0 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 175.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.445 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.271 3.0 mm -62.24 -47.74 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.767 0 CA-C-N 120.53 1.514 . . . . 0.0 107.993 177.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -52.53 -47.03 66.95 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 127.766 2.426 . . . . 0.0 109.751 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -61.24 -51.88 67.1 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.531 1.132 . . . . 0.0 113.028 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.49 -21.25 61.96 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 126.998 2.119 . . . . 0.0 113.75 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -68.86 -41.74 78.01 Favored 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 126.94 2.096 . . . . 0.0 109.245 171.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.78 -26.68 67.81 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 123.037 0.535 . . . . 0.0 110.785 173.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.34 68.01 1.47 Allowed Glycine 0 CA--C 1.469 -2.802 0 N-CA-C 104.477 -3.449 . . . . 0.0 104.477 -171.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -120.59 164.26 16.75 Favored 'General case' 0 CA--C 1.447 -2.995 1 N-CA-C 97.985 -4.82 . . . . 0.0 97.985 168.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.404 ' HE3' HG23 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -101.19 114.88 29.24 Favored 'General case' 0 N--CA 1.393 -3.276 1 N-CA-C 97.175 -5.12 . . . . 0.0 97.175 170.551 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.07 160.44 20.95 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 173.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -135.38 128.66 32.03 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.9 mm -82.04 135.44 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.44 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 15.1 m -109.84 118.29 36.09 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 163.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.491 HD22 ' CZ ' ' A' ' 130' ' ' PHE . 11.0 tp -81.07 149.53 29.18 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 168.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -150.76 95.76 2.26 Favored 'General case' 0 N--CA 1.398 -3.026 1 N-CA-C 97.007 -5.183 . . . . 0.0 97.007 -175.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.491 ' CZ ' HD22 ' A' ' 128' ' ' LEU . 95.4 m-85 . . . . . 0 N--CA 1.421 -1.883 0 CA-C-N 111.262 -2.699 . . . . 0.0 104.748 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 69.4 mt . . . . . 0 N--CA 1.417 -2.087 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.74 -56.67 5.82 Favored Glycine 0 CA--C 1.459 -3.455 0 CA-C-O 118.744 -1.031 . . . . 0.0 113.438 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 5.6 ptt? -84.85 0.0 52.45 Favored 'General case' 0 N--CA 1.41 -2.438 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -161.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.261 2.8 tp10 -61.19 -61.12 2.79 Favored 'General case' 0 CA--C 1.461 -2.456 0 C-N-CA 114.879 -2.728 . . . . 0.0 115.308 147.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.96 -65.2 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.938 0 O-C-N 125.651 1.844 . . . . 0.0 109.293 -163.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.419 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 26.4 mt -45.79 -55.74 6.21 Favored 'General case' 0 N--CA 1.427 -1.619 0 C-N-CA 129.315 3.046 . . . . 0.0 114.431 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.261 2.4 t30 -62.81 -31.01 71.92 Favored 'General case' 0 CA--C 1.47 -2.133 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 173.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -79.5 -15.72 57.26 Favored 'General case' 0 N--CA 1.421 -1.91 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.193 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.463 HG23 ' CE2' ' A' ' 98' ' ' PHE . 1.6 t -72.33 -50.24 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.823 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 175.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.261 31.4 ttmt -50.1 -50.96 46.68 Favored 'General case' 0 CA--C 1.466 -2.255 0 C-N-CA 125.682 1.593 . . . . 0.0 112.69 173.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.08 -39.59 68.88 Favored 'General case' 0 N--CA 1.407 -2.604 0 C-N-CA 126.216 1.807 . . . . 0.0 109.451 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -76.22 -27.46 56.83 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 115.716 -2.393 . . . . 0.0 115.198 172.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.346 0.4 OUTLIER -81.23 -29.54 34.43 Favored 'General case' 0 CA--C 1.458 -2.595 0 CA-C-O 116.137 -1.887 . . . . 0.0 114.474 179.347 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -26.03 -26.54 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.683 1 C-N-CA 136.065 5.746 . . . . 0.0 119.756 -173.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -51.94 -55.45 20.24 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 126.58 1.952 . . . . 0.0 112.742 166.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.429 ' HG ' ' CG2' ' A' ' 115' ' ' ILE 0.3 1.2 mm? -94.73 -58.82 2.07 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 128.048 2.539 . . . . 0.0 107.191 -169.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.298 . . -109.28 151.32 26.71 Favored 'General case' 0 CA--C 1.446 -3.055 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.974 -161.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.59 176.53 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.543 0 C-N-CA 115.216 -2.594 . . . . 0.0 116.65 140.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.4 t -84.96 150.29 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 168.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -80.64 -37.76 30.4 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.3 t -159.84 144.04 14.68 Favored 'General case' 0 CA--C 1.461 -2.477 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.3 t80 . . . . . 0 N--CA 1.426 -1.627 0 N-CA-C 101.979 -3.341 . . . . 0.0 101.979 170.243 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.302 32.1 mt-30 . . . . . 0 CA--C 1.498 -1.055 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 59.6 ttp -134.61 117.96 16.7 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 120.883 0.373 . . . . 0.0 110.165 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.44 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 11.2 mm -77.95 133.3 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' A' ' 145' ' ' LEU . 2.8 ttt -119.69 131.3 55.38 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 165.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 1.6 t -100.21 143.01 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -171.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.59 70.51 1.45 Allowed 'General case' 0 C--N 1.364 1.23 0 N-CA-C 119.469 3.137 . . . . 0.0 119.469 -161.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.284 . . -92.31 173.75 4.83 Favored Pre-proline 0 C--N 1.358 0.962 0 N-CA-C 119.416 3.117 . . . . 0.0 119.416 -171.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -70.46 142.03 43.85 Favored 'Trans proline' 0 N--CA 1.443 -1.493 0 CA-C-N 120.591 1.247 . . . . 0.0 110.842 -175.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp . . . . . 0 CA--C 1.485 -1.55 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 175.551 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 . . . . . 0 CA--C 1.48 -1.743 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.4 t -98.69 117.16 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.712 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 157.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -106.66 170.66 7.8 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 155.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -137.85 157.22 46.87 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -167.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.21 159.27 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 N-CA-C 102.329 -3.212 . . . . 0.0 102.329 174.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -117.85 157.45 26.6 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 118.937 0.79 . . . . 0.0 111.587 166.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CE2' HG23 ' A' ' 148' ' ' VAL . 28.5 m-85 -139.89 90.94 2.43 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 172.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 . . . . . 0 N--CA 1.436 -1.153 0 C-N-CA 123.849 0.86 . . . . 0.0 108.937 -179.34 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 t70 . . . . . 0 N--CA 1.424 -1.768 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.46 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -86.57 -70.43 0.61 Allowed 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 113.265 -1.789 . . . . 0.0 110.261 -158.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.326 0.0 OUTLIER -59.01 -14.06 8.35 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 119.004 2.964 . . . . 0.0 119.004 173.604 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.24 -45.75 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 122.096 0.95 . . . . 0.0 110.225 161.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -91.36 4.37 52.57 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 tt -83.51 -30.63 26.98 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 162.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.463 ' HA ' HG12 ' A' ' 115' ' ' ILE . 25.1 ttt85 -62.51 -42.42 99.5 Favored 'General case' 0 C--N 1.361 1.082 0 CA-C-O 118.686 -0.674 . . . . 0.0 110.664 167.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.25 65.7 m -55.1 -44.97 75.41 Favored 'General case' 0 C--N 1.379 1.866 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 169.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.7 mt -65.08 -29.53 70.41 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 177.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.463 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.2 mm -61.04 -45.51 98.42 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.378 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -52.7 43.54 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.542 1.537 . . . . 0.0 111.302 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -57.34 -46.32 83.41 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -54.48 -44.53 72.72 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 127.802 2.441 . . . . 0.0 112.848 172.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -79.54 -20.09 47.94 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 126.555 1.942 . . . . 0.0 112.416 -174.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -68.11 -21.59 64.94 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.139 0.576 . . . . 0.0 110.745 170.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.73 51.4 3.64 Favored Glycine 0 CA--C 1.474 -2.474 0 N-CA-C 105.804 -2.918 . . . . 0.0 105.804 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -126.78 165.97 18.29 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.53 119.82 35.72 Favored 'General case' 0 N--CA 1.409 -2.5 1 N-CA-C 99.795 -4.15 . . . . 0.0 99.795 178.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -91.98 144.04 25.86 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 103.176 -2.898 . . . . 0.0 103.176 -172.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -118.72 125.05 48.81 Favored 'General case' 0 CA--C 1.479 -1.785 0 O-C-N 117.893 -3.004 . . . . 0.0 106.314 173.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.2 mm -86.34 131.99 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 173.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.519 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 32.8 m -121.76 123.92 42.97 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 173.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . 0.362 0.4 OUTLIER -76.58 150.16 36.53 Favored 'General case' 0 CA--C 1.468 -2.188 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 164.787 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -145.15 88.96 1.91 Allowed 'General case' 0 N--CA 1.399 -3.008 1 N-CA-C 99.735 -4.172 . . . . 0.0 99.735 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . 0.25 70.1 m-85 . . . . . 0 N--CA 1.428 -1.559 0 CA-C-N 110.986 -2.824 . . . . 0.0 109.144 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.399 57.5 mt . . . . . 0 N--CA 1.429 -1.499 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.4 -64.9 2.59 Favored Glycine 0 N--CA 1.418 -2.513 0 CA-C-O 119.474 -0.626 . . . . 0.0 112.676 173.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -87.1 -5.85 58.88 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -153.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.02 -48.46 78.67 Favored 'General case' 0 CA--C 1.457 -2.615 0 C-N-CA 116.496 -2.081 . . . . 0.0 113.837 156.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.39 -67.77 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.444 -3.133 0 O-C-N 126.023 2.077 . . . . 0.0 106.936 -167.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 42.7 mt -43.0 -54.15 4.42 Favored 'General case' 0 CA--C 1.476 -1.898 0 C-N-CA 128.495 2.718 . . . . 0.0 115.679 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -63.87 -31.91 73.25 Favored 'General case' 0 CA--C 1.461 -2.474 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.3 ttp180 -81.81 -14.51 56.25 Favored 'General case' 0 N--CA 1.419 -2.013 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.014 172.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.46 HG21 ' HH ' ' A' ' 107' ' ' TYR . 1.8 t -76.27 -46.6 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.81 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 176.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.4 ' HE2' ' HB ' ' A' ' 158' ' ' VAL . 31.4 ttmt -51.9 -51.21 58.52 Favored 'General case' 0 CA--C 1.461 -2.453 0 C-N-CA 125.239 1.416 . . . . 0.0 111.003 172.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.81 -35.85 67.43 Favored 'General case' 0 N--CA 1.409 -2.513 0 C-N-CA 124.612 1.165 . . . . 0.0 110.529 -168.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -72.84 -39.41 66.57 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 116.291 -2.164 . . . . 0.0 114.941 170.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.303 0.2 OUTLIER -80.87 -19.56 44.18 Favored 'General case' 0 CA--C 1.464 -2.341 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -178.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -27.11 -25.07 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.363 1 C-N-CA 134.586 5.154 . . . . 0.0 119.064 174.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.24 -57.77 9.92 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 126.903 2.081 . . . . 0.0 113.361 167.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.38 -51.39 2.88 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 113.498 -1.683 . . . . 0.0 108.525 -164.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.434 ' HA ' HD13 ' A' ' 118' ' ' LEU 0.321 . . -91.65 146.13 24.03 Favored 'General case' 0 CA--C 1.455 -2.685 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 177.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.4 m -121.12 171.6 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.457 -2.615 0 C-N-CA 114.265 -2.974 . . . . 0.0 116.307 126.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.4 ' HB ' ' HE2' ' A' ' 149' ' ' LYS 0.298 3.2 t -81.8 155.11 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 C-N-CA 130.524 3.53 . . . . 0.0 107.313 179.391 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -82.15 -42.45 19.05 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.03 141.31 18.58 Favored 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -174.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.417 -2.077 1 N-CA-C 98.766 -4.531 . . . . 0.0 98.766 158.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.279 15.5 mt-30 . . . . . 0 CA--C 1.492 -1.257 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 21.6 ttm -104.57 158.35 16.55 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 102.45 -3.167 . . . . 0.0 102.45 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.519 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 32.7 mm -118.43 131.53 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.157 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 159.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.5 ttp -108.12 128.4 54.65 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 153.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 37.0 t -91.47 130.39 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 C-N-CA 118.17 -1.412 . . . . 0.0 108.597 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.1 tp -101.82 144.07 30.94 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 130.213 3.405 . . . . 0.0 116.915 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.261 . . -143.08 -179.3 0.93 Allowed Pre-proline 0 CA--C 1.483 -1.599 0 O-C-N 119.255 -2.153 . . . . 0.0 108.991 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -65.24 145.24 83.5 Favored 'Trans proline' 0 N--CA 1.436 -1.877 0 C-N-CA 123.025 2.483 . . . . 0.0 109.197 158.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt . . . . . 0 CA--C 1.492 -1.28 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 165.928 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 N--CA 1.429 -1.485 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.5 t -102.65 119.47 51.06 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.789 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 161.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -115.19 178.59 4.23 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 160.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -141.7 158.98 43.15 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -171.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.1 tp -134.37 164.74 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 168.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -120.24 154.62 34.65 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.113 162.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.458 ' CE2' HG23 ' A' ' 148' ' ' VAL . 37.9 m-85 -128.9 136.66 50.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 102.922 -2.992 . . . . 0.0 102.922 167.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 . . . . . 0 N--CA 1.432 -1.344 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -177.663 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.5 t70 . . . . . 0 N--CA 1.427 -1.616 0 CA-C-O 122.681 1.229 . . . . 0.0 108.044 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.445 ' HH ' HG21 ' A' ' 148' ' ' VAL . 1.0 OUTLIER -87.19 -72.79 0.5 Allowed 'General case' 0 CA--C 1.47 -2.105 0 CA-C-N 112.283 -2.235 . . . . 0.0 111.036 -157.733 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.312 0.0 OUTLIER -60.18 -13.45 12.34 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 118.808 2.892 . . . . 0.0 118.808 174.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 94.9 t -60.47 -48.74 87.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 C-N-CA 124.209 1.004 . . . . 0.0 109.997 160.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -91.72 7.41 41.83 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.3 tt -86.21 -31.14 21.89 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 163.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.455 ' HA ' HG12 ' A' ' 115' ' ' ILE . 56.9 ttt-85 -62.25 -43.8 97.99 Favored 'General case' 0 C--N 1.363 1.158 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.021 167.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.1 m -60.14 -42.37 94.71 Favored 'General case' 0 C--N 1.378 1.838 0 C-N-CA 118.181 -1.408 . . . . 0.0 113.175 174.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.9 mt -62.48 -30.77 71.5 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.455 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.6 mm -58.33 -51.58 69.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.733 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 25.9 tpt85 -50.38 -45.96 55.69 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 126.716 2.007 . . . . 0.0 112.745 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -61.22 -54.54 42.96 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -39.46 76.74 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 177.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -78.43 -29.91 47.32 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 128.703 2.801 . . . . 0.0 110.252 -169.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.92 7.47 8.82 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 123.067 0.547 . . . . 0.0 111.406 173.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.09 61.13 2.57 Favored Glycine 0 CA--C 1.467 -2.937 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 173.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -131.88 168.57 17.63 Favored 'General case' 0 CA--C 1.448 -2.971 0 N-CA-C 101.194 -3.632 . . . . 0.0 101.194 170.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.25 116.71 32.48 Favored 'General case' 0 N--CA 1.39 -3.472 1 N-CA-C 98.091 -4.781 . . . . 0.0 98.091 173.373 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -82.72 158.22 22.97 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 102.586 -3.116 . . . . 0.0 102.586 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.306 33.2 mtmm -126.29 144.49 50.78 Favored 'General case' 0 CA--C 1.481 -1.677 0 O-C-N 118.795 -2.441 . . . . 0.0 105.47 155.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.4 mm -86.62 137.37 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 167.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.557 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 23.9 m -117.17 123.78 47.52 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 166.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . 0.258 0.2 OUTLIER -80.18 153.78 28.4 Favored 'General case' 0 CA--C 1.467 -2.213 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 166.573 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -148.21 94.79 2.37 Favored 'General case' 0 N--CA 1.404 -2.756 1 N-CA-C 99.51 -4.255 . . . . 0.0 99.51 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 . . . . . 0 N--CA 1.424 -1.759 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.116 -170.84 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.253 68.4 mt . . . . . 0 CA--C 1.489 -1.37 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -70.11 -64.5 2.87 Favored Glycine 0 N--CA 1.416 -2.657 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -84.78 -5.66 59.33 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -155.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.32 -53.72 48.33 Favored 'General case' 0 CA--C 1.459 -2.529 0 C-N-CA 115.925 -2.31 . . . . 0.0 114.126 154.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.11 -67.05 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.443 -3.144 0 O-C-N 126.028 2.08 . . . . 0.0 107.499 -167.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.9 mt -41.08 -56.63 2.27 Favored 'General case' 0 CA--C 1.476 -1.877 0 C-N-CA 128.977 2.911 . . . . 0.0 115.15 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.31 -31.41 72.55 Favored 'General case' 0 CA--C 1.466 -2.285 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 175.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -82.69 -13.68 55.96 Favored 'General case' 0 N--CA 1.419 -2.012 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.868 173.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.458 HG23 ' CE2' ' A' ' 98' ' ' PHE . 1.7 t -76.31 -46.96 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 177.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.251 35.3 ttmt -51.21 -49.83 60.27 Favored 'General case' 0 CA--C 1.464 -2.357 0 C-N-CA 125.642 1.577 . . . . 0.0 111.991 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -37.39 64.93 Favored 'General case' 0 N--CA 1.408 -2.57 0 C-N-CA 125.276 1.43 . . . . 0.0 109.978 -169.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -72.22 -38.21 69.02 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 116.412 -2.115 . . . . 0.0 114.923 171.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.296 0.2 OUTLIER -81.84 -20.68 38.49 Favored 'General case' 0 CA--C 1.461 -2.443 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -178.318 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -25.87 -28.2 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.305 1 C-N-CA 134.305 5.042 . . . . 0.0 119.142 175.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -50.88 -54.05 27.23 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 128.101 2.56 . . . . 0.0 113.747 168.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.1 tt -113.22 -51.0 2.84 Favored 'General case' 0 N--CA 1.42 -1.932 0 C-N-CA 126.163 1.785 . . . . 0.0 108.611 -167.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.343 . . -104.7 142.0 35.46 Favored 'General case' 0 CA--C 1.449 -2.937 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.822 -177.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.5 m -120.04 171.76 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.65 0 CA-C-O 125.117 2.389 . . . . 0.0 116.022 140.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 158' ' ' VAL 0.289 2.7 t -81.82 152.86 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 109.917 -3.311 . . . . 0.0 106.336 177.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -83.33 -39.2 21.06 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -176.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.76 140.95 18.51 Favored 'General case' 0 CA--C 1.468 -2.193 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -174.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.6 t80 . . . . . 0 N--CA 1.422 -1.845 0 N-CA-C 101.259 -3.608 . . . . 0.0 101.259 164.492 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.314 19.8 mt-30 . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 4.6 ttm -116.14 112.99 22.49 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-N 119.805 1.184 . . . . 0.0 109.878 -175.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.557 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 14.9 mm -80.92 123.57 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 O-C-N 121.06 -1.025 . . . . 0.0 108.646 170.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.9 ttt -107.49 131.24 54.52 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 159.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 39.1 t -93.09 140.86 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.017 -173.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.92 81.1 1.99 Allowed 'General case' 0 C--N 1.364 1.208 0 N-CA-C 118.988 2.958 . . . . 0.0 118.988 -169.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.276 . . -85.94 178.73 2.16 Favored Pre-proline 0 CA--C 1.499 -0.993 0 O-C-N 119.644 -1.91 . . . . 0.0 115.998 -171.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -62.06 142.97 94.29 Favored 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 122.849 2.366 . . . . 0.0 109.786 159.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 . . . . . 0 CA--C 1.482 -1.655 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.3 t -100.78 119.99 49.67 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.588 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -104.85 172.44 6.79 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 155.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -143.78 154.23 43.22 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -175.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 tp -138.71 165.26 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 103.918 -2.623 . . . . 0.0 103.918 171.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -117.13 155.04 30.0 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-N 118.744 0.702 . . . . 0.0 110.903 163.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.427 ' CE2' HG23 ' A' ' 148' ' ' VAL . 26.7 m-85 -128.9 145.47 51.21 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 170.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 . . . . . 0 N--CA 1.438 -1.046 0 C-N-CA 126.341 1.856 . . . . 0.0 106.719 -176.5 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.6 t70 . . . . . 0 N--CA 1.423 -1.825 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.542 ' HH ' ' HG2' ' A' ' 147' ' ' ARG . 0.6 OUTLIER -84.66 -63.82 1.27 Allowed 'General case' 0 CA--C 1.481 -1.708 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.678 -161.758 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.325 0.0 OUTLIER -61.87 -11.89 15.05 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 119.64 3.2 . . . . 0.0 119.64 177.392 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.5 t -60.96 -48.05 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-O 122.37 1.081 . . . . 0.0 109.552 160.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -91.41 -1.65 57.52 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tt -78.5 -33.42 48.1 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 162.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.439 ' HA ' HG12 ' A' ' 115' ' ' ILE . 46.7 ttt-85 -61.91 -40.57 95.91 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 117.672 -1.156 . . . . 0.0 110.997 169.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.6 m -57.43 -46.17 83.84 Favored 'General case' 0 C--N 1.38 1.913 0 C-N-CA 119.001 -1.08 . . . . 0.0 113.84 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.268 84.4 mt -65.49 -30.87 71.69 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.9 mm -58.75 -49.7 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.676 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -55.85 -39.55 71.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 126.801 2.041 . . . . 0.0 111.32 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -62.45 -51.7 66.46 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 123.581 0.752 . . . . 0.0 112.081 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.414 HD12 HD12 ' A' ' 174' ' ' LEU . 0.6 OUTLIER -66.83 -23.09 66.0 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 126.232 1.813 . . . . 0.0 114.978 177.331 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -69.98 -38.2 75.96 Favored 'General case' 0 CA--C 1.491 -1.306 0 C-N-CA 126.216 1.806 . . . . 0.0 109.875 172.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -66.63 -26.08 66.9 Favored 'General case' 0 C--N 1.361 1.083 0 O-C-N 123.28 0.363 . . . . 0.0 110.893 171.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.41 65.36 1.52 Allowed Glycine 0 CA--C 1.471 -2.702 0 N-CA-C 104.743 -3.343 . . . . 0.0 104.743 -172.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -121.52 164.72 16.76 Favored 'General case' 0 CA--C 1.449 -2.929 1 N-CA-C 98.79 -4.522 . . . . 0.0 98.79 170.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.5 117.6 35.26 Favored 'General case' 0 N--CA 1.396 -3.173 1 N-CA-C 97.538 -4.986 . . . . 0.0 97.538 169.106 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.63 160.6 20.37 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 172.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -134.42 131.43 38.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 169.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.1 mm -82.93 135.87 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.4 m -113.19 119.23 37.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 165.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.73 153.75 22.86 Favored 'General case' 0 CA--C 1.474 -1.963 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 167.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -151.62 103.05 2.92 Favored 'General case' 0 N--CA 1.395 -3.183 1 N-CA-C 96.504 -5.369 . . . . 0.0 96.504 -173.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 . . . . . 0 N--CA 1.431 -1.391 0 CA-C-N 112.537 -2.119 . . . . 0.0 109.987 -174.714 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.8 mt . . . . . 0 CA--C 1.467 -2.24 0 CA-C-O 120.803 0.335 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.94 -53.47 4.23 Favored Glycine 0 CA--C 1.458 -3.498 0 O-C-N 124.876 1.36 . . . . 0.0 110.517 -168.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 71.1 mtm -85.74 3.1 42.79 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -166.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.261 2.2 tp10 -62.42 -64.82 0.81 Allowed 'General case' 0 CA--C 1.466 -2.26 0 C-N-CA 115.199 -2.6 . . . . 0.0 115.876 141.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.1 t -62.59 -65.29 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.447 -2.994 0 O-C-N 125.907 2.005 . . . . 0.0 109.264 -162.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.3 mt -42.4 -53.99 4.0 Favored 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 129.435 3.094 . . . . 0.0 114.641 176.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -61.83 -35.89 79.58 Favored 'General case' 0 CA--C 1.466 -2.254 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.542 ' HG2' ' HH ' ' A' ' 107' ' ' TYR . 15.3 ttp180 -80.15 -14.71 58.26 Favored 'General case' 0 N--CA 1.419 -2.01 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.486 174.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.427 HG23 ' CE2' ' A' ' 98' ' ' PHE . 1.9 t -76.72 -46.46 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.725 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.271 31.4 ttmt -53.73 -48.31 69.75 Favored 'General case' 0 CA--C 1.467 -2.241 0 C-N-CA 126.007 1.723 . . . . 0.0 112.587 173.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -39.33 66.75 Favored 'General case' 0 N--CA 1.407 -2.596 0 C-N-CA 125.476 1.51 . . . . 0.0 108.77 -171.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -75.07 -22.95 58.0 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 115.637 -2.425 . . . . 0.0 115.63 170.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.313 0.2 OUTLIER -83.26 -31.12 27.12 Favored 'General case' 0 CA--C 1.473 -1.999 0 CA-C-O 116.887 -1.53 . . . . 0.0 112.827 -179.649 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -29.11 -26.48 0.0 OUTLIER 'General case' 0 C--N 1.367 1.346 1 C-N-CA 134.93 5.292 . . . . 0.0 119.346 -175.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -50.86 -53.28 33.69 Favored 'General case' 0 CA--C 1.491 -1.297 0 C-N-CA 128.642 2.777 . . . . 0.0 112.611 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . 0.251 0.2 OUTLIER -111.31 -53.53 2.69 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 113.701 -1.591 . . . . 0.0 108.593 -169.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.318 . . -105.65 154.33 20.58 Favored 'General case' 0 CA--C 1.444 -3.112 0 CA-C-N 113.732 -1.576 . . . . 0.0 107.756 -166.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.58 178.58 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.506 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 139.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.8 151.74 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.996 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 166.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -80.29 -38.59 30.47 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 6.8 t -123.02 -175.96 3.3 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -175.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 8.8 t80 . . . . . 0 N--CA 1.419 -1.992 0 N-CA-C 102.343 -3.206 . . . . 0.0 102.343 144.131 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.257 26.0 mt-30 . . . . . 0 CA--C 1.499 -1.013 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -120.78 115.17 22.77 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -173.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.1 mm -79.07 123.86 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 167.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.4 ttt -107.21 136.89 46.28 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 163.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.97 134.88 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 118.176 -1.409 . . . . 0.0 108.782 -172.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.414 HD12 HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -122.71 69.27 0.98 Allowed 'General case' 0 C--N 1.356 0.883 0 N-CA-C 119.782 3.253 . . . . 0.0 119.782 -164.709 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.312 . . -89.59 172.71 6.83 Favored Pre-proline 0 C--N 1.356 0.85 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 -172.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -72.04 139.44 32.84 Favored 'Trans proline' 0 CA--C 1.493 -1.545 0 N-CA-C 107.905 -1.613 . . . . 0.0 107.905 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.1 pttp . . . . . 0 N--CA 1.433 -1.315 0 O-C-N 124.126 0.892 . . . . 0.0 111.521 -179.264 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 . . . . . 0 CA--C 1.48 -1.724 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.403 HG23 ' HE2' ' A' ' 123' ' ' LYS . 55.2 t -96.42 123.75 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 160.1 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -103.28 172.42 6.82 Favored 'General case' 0 CA--C 1.468 -2.187 0 C-N-CA 116.105 -2.238 . . . . 0.0 105.985 160.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -144.29 148.34 34.7 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 tp -131.83 160.65 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 102.372 -3.196 . . . . 0.0 102.372 172.056 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -113.86 154.15 27.97 Favored 'General case' 0 CA--C 1.484 -1.566 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.207 164.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -137.13 130.29 30.95 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 . . . . . 0 N--CA 1.422 -1.839 0 C-N-CA 124.013 0.925 . . . . 0.0 110.648 179.234 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 t70 . . . . . 0 CA--C 1.477 -1.845 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.411 ' HH ' HG23 ' A' ' 148' ' ' VAL . 0.5 OUTLIER -88.91 -60.73 1.88 Allowed 'General case' 0 CA--C 1.479 -1.765 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.772 -161.265 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.346 0.0 OUTLIER -61.43 -12.74 15.78 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 119.281 3.067 . . . . 0.0 119.281 174.638 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.61 -47.81 91.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-O 122.201 1.001 . . . . 0.0 109.613 160.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -90.81 3.57 54.07 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 178.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.6 tt -82.61 -30.55 29.41 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 162.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.449 ' HA ' HG12 ' A' ' 115' ' ' ILE . 59.0 ttt-85 -62.3 -41.98 98.97 Favored 'General case' 0 C--N 1.361 1.105 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.731 166.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 t -57.0 -45.38 83.07 Favored 'General case' 0 C--N 1.378 1.807 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 175.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.336 29.3 mt -66.98 -29.0 68.73 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 175.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.273 7.1 mm -61.67 -48.42 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.882 0 CA-C-N 120.049 1.295 . . . . 0.0 108.064 174.624 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -54.2 -43.85 71.11 Favored 'General case' 0 CA--C 1.479 -1.759 0 C-N-CA 126.929 2.092 . . . . 0.0 110.026 -178.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -63.28 -48.73 76.88 Favored 'General case' 0 CA--C 1.487 -1.45 0 O-C-N 124.385 1.053 . . . . 0.0 112.636 177.15 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -44.13 97.64 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -178.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -85.61 -17.8 35.12 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 126.813 2.045 . . . . 0.0 112.02 -169.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -81.71 -0.95 45.15 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 167.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.74 64.23 1.5 Allowed Glycine 0 CA--C 1.47 -2.74 0 C-N-CA 125.939 1.733 . . . . 0.0 108.947 171.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -134.92 165.96 24.1 Favored 'General case' 0 CA--C 1.445 -3.073 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 171.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.403 ' HE2' HG23 ' A' ' 93' ' ' VAL . 2.6 tmmm? -102.56 117.34 34.48 Favored 'General case' 0 N--CA 1.394 -3.232 1 N-CA-C 95.804 -5.628 . . . . 0.0 95.804 178.367 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.09 162.37 16.81 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -144.53 130.25 19.14 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 119.188 -2.195 . . . . 0.0 106.663 170.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.4 mm -84.02 136.39 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 174.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -108.52 119.92 40.93 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 161.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.485 HD12 ' CZ ' ' A' ' 130' ' ' PHE 0.281 0.3 OUTLIER -71.84 147.49 47.12 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.394 . . . . . . . . 4 4 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 53.1 ttm-85 -149.22 96.24 2.5 Favored 'General case' 0 N--CA 1.405 -2.717 1 N-CA-C 99.165 -4.383 . . . . 0.0 99.165 -178.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.485 ' CZ ' HD12 ' A' ' 128' ' ' LEU . 76.6 m-85 . . . . . 0 N--CA 1.422 -1.826 0 CA-C-N 111.787 -2.46 . . . . 0.0 109.417 -177.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.256 59.4 mt . . . . . 0 N--CA 1.423 -1.821 0 CA-C-O 120.578 0.228 . . . . 0.0 111.061 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.33 -54.98 5.86 Favored Glycine 0 N--CA 1.412 -2.962 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.16 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -85.68 -0.53 55.41 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -163.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.26 2.2 tp10 -60.46 -57.97 10.49 Favored 'General case' 0 CA--C 1.453 -2.776 0 C-N-CA 114.687 -2.805 . . . . 0.0 114.805 147.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.1 t -67.15 -64.82 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.448 -2.956 0 O-C-N 126.118 2.136 . . . . 0.0 108.981 -161.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 51.2 mt -47.32 -52.43 16.44 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 128.227 2.611 . . . . 0.0 115.286 178.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.265 1.7 t30 -63.44 -30.73 71.81 Favored 'General case' 0 CA--C 1.479 -1.761 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 174.175 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -80.61 -15.88 55.5 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.858 173.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.411 HG23 ' HH ' ' A' ' 107' ' ' TYR . 2.0 t -75.58 -43.95 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.614 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.441 ' HE2' ' HB ' ' A' ' 158' ' ' VAL 0.283 23.2 ttmt -52.52 -49.53 64.63 Favored 'General case' 0 CA--C 1.47 -2.133 0 C-N-CA 126.222 1.809 . . . . 0.0 113.391 173.669 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -73.24 -41.45 63.7 Favored 'General case' 0 N--CA 1.404 -2.745 0 C-N-CA 127.78 2.432 . . . . 0.0 108.545 -172.216 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -75.04 -24.5 58.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 116.474 -2.09 . . . . 0.0 114.813 172.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.308 0.1 OUTLIER -81.93 -31.41 31.33 Favored 'General case' 0 CA--C 1.47 -2.13 0 CA-C-O 116.063 -1.922 . . . . 0.0 112.339 178.172 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -28.45 -26.92 0.0 OUTLIER 'General case' 0 C--N 1.37 1.461 1 C-N-CA 134.745 5.218 . . . . 0.0 119.651 -173.33 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -48.24 -50.06 30.98 Favored 'General case' 0 CA--C 1.49 -1.349 0 C-N-CA 129.151 2.98 . . . . 0.0 113.458 167.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.35 -48.35 1.84 Allowed 'General case' 0 N--CA 1.416 -2.155 0 C-N-CA 126.057 1.743 . . . . 0.0 109.293 -164.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.347 . . -107.14 151.24 25.66 Favored 'General case' 0 CA--C 1.449 -2.934 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.536 -177.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.04 175.37 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.545 0 C-N-CA 115.803 -2.359 . . . . 0.0 116.304 136.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.441 ' HB ' ' HE2' ' A' ' 149' ' ' LYS 0.372 74.8 t -76.98 147.88 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.25 0 CA-C-N 110.935 -2.848 . . . . 0.0 105.04 168.931 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -84.1 -39.5 19.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -172.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.8 t -160.06 142.41 13.24 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 113.73 -1.577 . . . . 0.0 106.898 -171.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.9 t80 . . . . . 0 N--CA 1.432 -1.373 0 N-CA-C 101.539 -3.504 . . . . 0.0 101.539 171.872 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.494 -1.177 0 CA-C-O 121.355 0.597 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 13.3 ttm -124.33 168.64 12.73 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 -178.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 23.5 mm -112.69 141.07 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.937 0 C-N-CA 126.183 1.793 . . . . 0.0 108.022 163.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -116.22 131.89 56.82 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 103.05 -2.944 . . . . 0.0 103.05 151.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.5 t -89.21 134.05 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.91 74.08 0.89 Allowed 'General case' 0 C--N 1.357 0.92 0 N-CA-C 117.946 2.573 . . . . 0.0 117.946 -170.627 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -86.53 -178.3 1.1 Allowed Pre-proline 0 CA--C 1.509 -0.615 0 N-CA-C 117.965 2.579 . . . . 0.0 117.965 -170.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 123' ' ' LYS . 85.4 Cg_exo -66.59 144.65 73.38 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 122.498 2.132 . . . . 0.0 109.44 160.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.5 pttp . . . . . 0 N--CA 1.428 -1.525 0 CA-C-O 122.063 0.935 . . . . 0.0 111.785 179.894 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 . . . . . 0 N--CA 1.427 -1.606 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 82.9 t -103.89 121.85 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.525 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 168.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -104.05 174.76 5.73 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 155.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -143.95 151.29 39.58 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 -178.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 tp -132.04 161.84 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 171.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -116.65 151.7 35.75 Favored 'General case' 0 CA--C 1.482 -1.662 0 C-N-CA 118.739 -1.184 . . . . 0.0 110.825 160.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.471 ' CE2' HG23 ' A' ' 148' ' ' VAL . 36.7 m-85 -124.33 133.03 53.57 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 168.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.58 ' HE ' ' H ' ' A' ' 99' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.427 -1.589 0 C-N-CA 124.58 1.152 . . . . 0.0 108.41 -173.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.0 t70 . . . . . 0 N--CA 1.424 -1.736 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.451 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.6 OUTLIER -72.2 -73.49 0.19 Allowed 'General case' 0 CA--C 1.482 -1.65 0 C-N-CA 126.659 1.984 . . . . 0.0 108.455 -174.103 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.333 0.0 OUTLIER -59.75 -11.14 4.6 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 120.65 3.574 . . . . 0.0 120.65 176.159 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.42 -39.86 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-O 122.005 0.907 . . . . 0.0 110.421 160.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -93.18 -1.95 55.76 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 176.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 tt -79.13 -31.32 44.07 Favored 'General case' 0 N--CA 1.417 -2.083 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 162.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.444 ' HA ' HG12 ' A' ' 115' ' ' ILE . 7.4 ttm-85 -60.11 -44.65 94.7 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 124.806 1.242 . . . . 0.0 111.298 169.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.3 t -60.14 -41.76 93.38 Favored 'General case' 0 C--N 1.371 1.515 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 76.0 mt -65.29 -29.79 70.58 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 173.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.444 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.252 5.3 mm -60.61 -48.92 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 CA-C-N 119.751 1.16 . . . . 0.0 108.361 176.836 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -51.19 -45.02 61.69 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 127.274 2.229 . . . . 0.0 110.146 178.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -61.75 -49.93 74.44 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.5 -20.32 61.38 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.268 1.427 . . . . 0.0 114.298 179.248 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.73 -33.75 64.48 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 125.333 1.453 . . . . 0.0 110.677 172.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -67.62 -27.98 67.36 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 169.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.52 67.85 1.38 Allowed Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 105.213 -3.155 . . . . 0.0 105.213 -173.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -123.67 169.27 11.66 Favored 'General case' 0 CA--C 1.452 -2.797 1 N-CA-C 97.852 -4.87 . . . . 0.0 97.852 169.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.81 134.76 39.69 Favored 'General case' 0 CA--C 1.455 -2.704 1 N-CA-C 98.169 -4.752 . . . . 0.0 98.169 157.475 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.24 161.2 21.57 Favored 'General case' 0 N--CA 1.418 -2.037 0 C-N-CA 115.032 -2.667 . . . . 0.0 105.37 160.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -111.78 136.24 51.31 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 159.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.9 mm -82.47 128.64 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 165.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.3 m -111.99 120.31 41.46 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 169.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.44 HD21 ' CE1' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -82.42 153.89 25.46 Favored 'General case' 0 CA--C 1.464 -2.341 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 167.162 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -148.94 95.39 2.4 Favored 'General case' 0 N--CA 1.393 -3.318 1 N-CA-C 95.736 -5.653 . . . . 0.0 95.736 -176.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.44 ' CE1' HD21 ' A' ' 128' ' ' LEU . 97.4 m-85 . . . . . 0 N--CA 1.413 -2.285 0 N-CA-C 102.347 -3.205 . . . . 0.0 102.347 175.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.271 74.8 mt . . . . . 0 CA--C 1.474 -1.974 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.33 -60.59 3.47 Favored Glycine 0 N--CA 1.405 -3.41 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.872 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -89.61 5.61 44.9 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -160.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -62.56 -58.45 7.53 Favored 'General case' 0 CA--C 1.46 -2.504 0 C-N-CA 114.907 -2.717 . . . . 0.0 114.595 143.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.2 t -68.11 -63.06 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.442 -3.194 0 O-C-N 126.096 2.123 . . . . 0.0 107.335 -160.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 17.7 mt -41.05 -60.15 1.29 Allowed 'General case' 0 CA--C 1.464 -2.344 0 C-N-CA 128.351 2.66 . . . . 0.0 113.454 176.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -55.72 -37.8 68.9 Favored 'General case' 0 CA--C 1.464 -2.333 0 C-N-CA 125.996 1.718 . . . . 0.0 115.327 177.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.5 ttt85 -81.01 -14.04 58.29 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 119.861 -0.735 . . . . 0.0 111.914 175.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.471 HG23 ' CE2' ' A' ' 98' ' ' PHE . 1.8 t -75.36 -46.72 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.747 0 CA-C-O 116.037 -1.935 . . . . 0.0 106.495 176.006 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.438 ' HB2' HG23 ' A' ' 158' ' ' VAL . 1.2 ttpp -54.65 -57.03 13.07 Favored 'General case' 0 CA--C 1.459 -2.523 0 CA-C-O 116.244 -1.836 . . . . 0.0 108.22 171.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -34.58 78.22 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 120.116 1.325 . . . . 0.0 111.26 -166.587 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.6 -39.47 62.16 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 168.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.329 0.2 OUTLIER -80.61 -24.29 39.19 Favored 'General case' 0 CA--C 1.47 -2.109 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -176.82 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -26.07 -31.06 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.812 1 C-N-CA 136.5 5.92 . . . . 0.0 118.357 -177.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 1.8 mt-10 -52.35 -52.92 50.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.734 2.014 . . . . 0.0 114.298 170.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.442 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 3.2 tm? -107.52 -55.86 2.29 Favored 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 128.5 2.72 . . . . 0.0 108.434 -160.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.279 . . -102.0 154.88 18.56 Favored 'General case' 0 CA--C 1.449 -2.935 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 -176.1 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 18.7 m -118.66 -179.05 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.458 -2.594 0 C-N-CA 113.661 -3.216 . . . . 0.0 115.494 139.401 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 149' ' ' LYS . 3.3 t -94.89 149.92 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.989 0 N-CA-C 104.94 -2.245 . . . . 0.0 104.94 166.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -82.28 -41.9 19.54 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 -176.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -153.43 148.23 26.43 Favored 'General case' 0 CA--C 1.47 -2.12 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -172.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.46 -2.512 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 171.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.314 19.7 mt-30 . . . . . 0 CA--C 1.503 -0.863 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.4 ttp -125.32 118.66 26.42 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 118.561 0.618 . . . . 0.0 111.395 -173.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.7 mm -80.38 124.93 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 CA-C-O 122.47 1.128 . . . . 0.0 108.534 169.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.9 ttt -105.95 136.98 44.64 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 159.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.0 t -102.32 134.28 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 117.682 -1.607 . . . . 0.0 109.123 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.438 ' CD1' HG21 ' A' ' 158' ' ' VAL . 11.7 tp -112.38 86.78 2.42 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 121.338 3.829 . . . . 0.0 121.338 -177.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.388 . . -107.77 155.54 39.65 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -178.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -70.2 150.6 65.77 Favored 'Trans proline' 0 CA--C 1.486 -1.877 0 C-N-CA 122.885 2.39 . . . . 0.0 109.378 -163.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt . . . . . 0 N--CA 1.433 -1.323 0 O-C-N 124.853 1.346 . . . . 0.0 108.21 -175.456 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 . . . . . 0 CA--C 1.48 -1.726 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.433 HG23 ' HE3' ' A' ' 123' ' ' LYS . 83.1 t -101.94 121.83 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.66 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 174.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -107.15 -178.23 3.58 Favored 'General case' 0 CA--C 1.472 -2.029 0 C-N-CA 117.373 -1.731 . . . . 0.0 107.535 162.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -150.03 150.12 31.32 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.058 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 tp -132.82 161.6 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 173.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -122.1 153.75 38.27 Favored 'General case' 0 CA--C 1.485 -1.535 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.071 164.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.475 ' CE2' HG23 ' A' ' 148' ' ' VAL . 40.6 m-85 -134.07 136.76 44.18 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.6 ttt85 . . . . . 0 N--CA 1.433 -1.276 0 CA-C-O 117.612 -1.185 . . . . 0.0 108.817 -173.713 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 N--CA 1.425 -1.712 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.467 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -72.8 -74.06 0.18 Allowed 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 126.525 1.93 . . . . 0.0 109.12 -169.615 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.326 0.0 OUTLIER -59.64 -11.27 4.62 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 120.335 3.457 . . . . 0.0 120.335 177.175 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.12 -40.57 89.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 122.094 0.949 . . . . 0.0 110.296 161.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -92.87 -4.28 53.16 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 176.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 tt -75.84 -33.27 60.03 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 161.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.437 ' HA ' HG12 ' A' ' 115' ' ' ILE . 16.2 ttp180 -60.4 -44.93 95.22 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 125.175 1.39 . . . . 0.0 111.146 170.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 t -62.46 -42.63 99.61 Favored 'General case' 0 C--N 1.375 1.687 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.327 51.2 tp -68.69 -30.38 69.03 Favored 'General case' 0 N--CA 1.402 -2.835 0 C-N-CA 125.706 1.602 . . . . 0.0 113.519 177.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.437 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.283 8.9 mm -56.3 -52.03 56.59 Favored 'Isoleucine or valine' 0 C--N 1.378 1.833 0 CA-C-N 120.94 1.7 . . . . 0.0 109.402 171.099 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -53.47 -40.16 65.08 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 128.386 2.674 . . . . 0.0 110.559 -177.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -61.01 -54.16 48.39 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 124.393 1.077 . . . . 0.0 112.043 175.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -67.76 -21.08 65.28 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -72.52 -36.21 68.29 Favored 'General case' 0 CA--C 1.491 -1.317 0 C-N-CA 126.043 1.737 . . . . 0.0 110.25 172.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -67.16 -22.2 65.77 Favored 'General case' 0 C--N 1.36 1.031 0 O-C-N 123.185 0.303 . . . . 0.0 111.214 169.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.83 68.1 1.42 Allowed Glycine 0 CA--C 1.469 -2.839 0 N-CA-C 104.81 -3.316 . . . . 0.0 104.81 -174.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -123.28 163.4 20.78 Favored 'General case' 0 CA--C 1.448 -2.971 0 N-CA-C 100.641 -3.837 . . . . 0.0 100.641 171.019 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.433 ' HE3' HG23 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -105.45 106.27 16.69 Favored 'General case' 0 N--CA 1.399 -3.007 1 N-CA-C 99.101 -4.407 . . . . 0.0 99.101 173.892 . . . . . . . . 4 4 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -97.77 128.54 44.48 Favored 'General case' 0 N--CA 1.411 -2.39 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.561 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -96.07 129.88 43.24 Favored 'General case' 0 CA--C 1.474 -1.969 0 CA-C-O 121.621 0.724 . . . . 0.0 109.325 -176.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.6 mm -82.9 132.92 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 171.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.403 ' HA ' HD12 ' A' ' 171' ' ' ILE . 21.8 m -113.82 120.81 42.05 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 167.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.471 HD12 ' CZ ' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -74.2 145.65 43.98 Favored 'General case' 0 CA--C 1.474 -1.962 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 165.808 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -147.48 94.96 2.45 Favored 'General case' 0 N--CA 1.4 -2.93 1 N-CA-C 98.591 -4.596 . . . . 0.0 98.591 -178.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.471 ' CZ ' HD12 ' A' ' 128' ' ' LEU . 77.1 m-85 . . . . . 0 N--CA 1.427 -1.596 0 CA-C-N 111.267 -2.697 . . . . 0.0 108.009 178.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.323 63.1 mt . . . . . 0 N--CA 1.415 -2.179 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.15 -61.14 3.32 Favored Glycine 0 N--CA 1.409 -3.112 0 CA-C-N 114.911 -1.041 . . . . 0.0 114.134 171.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 6.7 ptt? -85.43 -2.59 58.28 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -158.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.61 -53.23 59.96 Favored 'General case' 0 CA--C 1.455 -2.688 0 C-N-CA 114.807 -2.757 . . . . 0.0 114.461 150.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.7 t -69.77 -65.33 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.447 -2.998 0 O-C-N 126.011 2.069 . . . . 0.0 107.765 -164.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 14.5 mt -44.07 -55.07 4.98 Favored 'General case' 0 CA--C 1.481 -1.674 0 C-N-CA 128.757 2.823 . . . . 0.0 115.675 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -63.76 -30.95 71.99 Favored 'General case' 0 CA--C 1.462 -2.404 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 174.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -81.44 -15.16 55.95 Favored 'General case' 0 N--CA 1.419 -1.993 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.853 172.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.475 HG23 ' CE2' ' A' ' 98' ' ' PHE . 2.0 t -74.71 -47.13 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.819 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 176.137 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.427 ' HE2' ' HB ' ' A' ' 158' ' ' VAL . 35.2 ttmt -51.61 -53.95 32.96 Favored 'General case' 0 CA--C 1.459 -2.558 0 C-N-CA 125.47 1.508 . . . . 0.0 110.642 172.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.19 -35.99 71.77 Favored 'General case' 0 N--CA 1.411 -2.415 0 C-N-CA 125.241 1.416 . . . . 0.0 110.172 -167.149 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -71.59 -34.98 70.38 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 115.872 -2.331 . . . . 0.0 114.885 170.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.262 0.2 OUTLIER -81.31 -26.26 35.81 Favored 'General case' 0 CA--C 1.463 -2.372 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -178.178 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -28.62 -21.61 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.511 1 C-N-CA 135.896 5.679 . . . . 0.0 119.292 178.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -53.99 -58.45 7.27 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 125.753 1.621 . . . . 0.0 112.733 164.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 tt -111.45 -43.57 3.66 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 127.338 2.255 . . . . 0.0 109.666 -159.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.303 . . -115.59 142.14 47.13 Favored 'General case' 0 CA--C 1.464 -2.357 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.809 179.554 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.3 m -130.02 164.83 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.021 0 N-CA-C 121.776 3.991 . . . . 0.0 121.776 147.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.7 t -79.81 149.27 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.973 0 CA-C-N 111.06 -2.791 . . . . 0.0 107.944 -174.021 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.76 -38.87 25.0 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 113.033 -1.894 . . . . 0.0 106.079 -172.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.2 t -162.57 150.01 13.69 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -171.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.4 t80 . . . . . 0 N--CA 1.427 -1.589 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 173.142 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.291 17.7 mt-30 . . . . . 0 CA--C 1.496 -1.12 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 15.9 ttm -118.7 170.75 8.71 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 172.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 127' ' ' THR . 28.2 mm -117.74 142.25 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 C-N-CA 126.727 2.011 . . . . 0.0 108.232 161.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.7 ttt -124.33 133.81 53.35 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 102.988 -2.967 . . . . 0.0 102.988 157.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 1.6 t -100.75 139.75 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.021 -171.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 1.4 tp -131.54 130.59 42.49 Favored 'General case' 0 C--N 1.365 1.263 0 CA-C-N 121.688 2.04 . . . . 0.0 106.625 -172.418 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.299 . . -129.56 178.26 1.78 Allowed Pre-proline 0 CA--C 1.49 -1.329 0 C-N-CA 125.819 1.648 . . . . 0.0 111.819 -173.106 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -71.35 158.24 54.84 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 CA-C-N 120.925 1.366 . . . . 0.0 111.036 -177.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? . . . . . 0 CA--C 1.491 -1.302 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 174.36 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 . . . . . 0 CA--C 1.475 -1.916 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.2 t -88.88 117.32 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.903 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 162.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -110.29 169.75 8.53 Favored 'General case' 0 CA--C 1.483 -1.601 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 151.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -136.37 157.95 45.59 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.812 -163.164 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 tp -131.58 163.67 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 165.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -119.57 154.42 33.93 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 119.479 -0.888 . . . . 0.0 112.321 162.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.528 ' CE2' HG23 ' A' ' 148' ' ' VAL . 45.9 m-85 -129.09 147.31 50.93 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 169.571 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 . . . . . 0 N--CA 1.431 -1.401 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.877 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.8 t70 . . . . . 0 N--CA 1.414 -2.229 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.6 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.8 OUTLIER -86.61 -71.62 0.54 Allowed 'General case' 0 CA--C 1.482 -1.649 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.798 -166.691 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.311 0.0 OUTLIER -61.08 -14.76 26.21 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 118.872 2.916 . . . . 0.0 118.872 172.414 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.17 -41.71 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.982 0.913 . . . . 0.0 109.791 162.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -93.15 6.76 46.86 Favored 'General case' 0 CA--C 1.486 -1.513 0 O-C-N 120.376 -1.452 . . . . 0.0 114.905 175.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.8 -31.32 22.39 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 162.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -60.47 -45.36 94.0 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.654 1.182 . . . . 0.0 109.843 168.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 t -58.89 -43.07 90.91 Favored 'General case' 0 C--N 1.375 1.705 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 173.375 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.3 mt -60.95 -33.1 72.66 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 175.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.451 ' CG2' ' HG ' ' A' ' 155' ' ' LEU . 3.1 mm -61.06 -46.79 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 177.285 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -53.09 22.39 Favored 'General case' 0 CA--C 1.497 -1.07 0 O-C-N 125.985 2.053 . . . . 0.0 110.923 178.146 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -58.41 -46.37 86.56 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 178.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.06 -36.64 82.22 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 176.119 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -79.19 -21.54 46.21 Favored 'General case' 0 CA--C 1.487 -1.469 0 C-N-CA 127.671 2.388 . . . . 0.0 112.638 -173.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -71.56 -15.15 62.27 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 169.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.61 65.5 1.5 Allowed Glycine 0 CA--C 1.462 -3.252 0 N-CA-C 104.469 -3.452 . . . . 0.0 104.469 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -133.14 173.69 11.17 Favored 'General case' 0 CA--C 1.447 -3.012 1 N-CA-C 97.724 -4.917 . . . . 0.0 97.724 170.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.01 135.02 33.9 Favored 'General case' 0 N--CA 1.399 -2.978 1 N-CA-C 97.898 -4.853 . . . . 0.0 97.898 158.611 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.09 156.74 28.19 Favored 'General case' 0 N--CA 1.405 -2.677 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 156.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -140.06 133.13 29.52 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 101.121 -3.659 . . . . 0.0 101.121 169.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.5 mm -83.83 134.56 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.112 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -178.358 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.557 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 23.6 m -116.28 121.53 42.29 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 168.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.32 154.18 33.09 Favored 'General case' 0 CA--C 1.47 -2.103 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 166.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.405 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 35.2 ttp85 -146.07 96.67 2.83 Favored 'General case' 0 N--CA 1.397 -3.1 1 N-CA-C 96.073 -5.529 . . . . 0.0 96.073 -179.482 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 . . . . . 0 N--CA 1.419 -2.022 0 CA-C-N 111.88 -2.418 . . . . 0.0 106.212 178.101 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.424 -1.772 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -68.12 -59.78 6.11 Favored Glycine 0 N--CA 1.416 -2.677 0 O-C-N 124.222 0.951 . . . . 0.0 111.439 -176.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 6.8 ptm -90.88 6.36 44.83 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -161.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.09 -56.02 15.4 Favored 'General case' 0 CA--C 1.455 -2.703 0 C-N-CA 115.875 -2.33 . . . . 0.0 113.559 146.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.89 -66.46 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.44 -3.251 0 O-C-N 126.498 2.374 . . . . 0.0 107.39 -164.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.8 mt -39.27 -57.04 1.42 Allowed 'General case' 0 CA--C 1.467 -2.224 0 C-N-CA 128.138 2.575 . . . . 0.0 114.018 178.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 161' ' ' PHE . 1.2 t-20 -52.99 -45.05 67.68 Favored 'General case' 0 CA--C 1.47 -2.132 0 C-N-CA 126.607 1.963 . . . . 0.0 115.911 175.454 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -83.27 -12.86 56.3 Favored 'General case' 0 N--CA 1.424 -1.768 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.41 179.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.6 HG21 ' HH ' ' A' ' 107' ' ' TYR . 2.1 t -76.27 -40.0 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.697 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 177.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.4 ' HZ1' HD23 ' A' ' 174' ' ' LEU . 0.5 OUTLIER -63.41 -52.16 62.72 Favored 'General case' 0 CA--C 1.449 -2.934 0 CA-C-O 117.332 -1.318 . . . . 0.0 113.108 176.696 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -60.15 -39.1 85.17 Favored 'General case' 0 N--CA 1.404 -2.747 0 C-N-CA 127.097 2.159 . . . . 0.0 108.836 -178.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.52 -28.55 59.16 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 117.403 2.371 . . . . 0.0 117.403 169.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.424 ' HG ' ' HB2' ' A' ' 156' ' ' ALA 0.269 0.0 OUTLIER -75.53 -37.12 60.27 Favored 'General case' 0 CA--C 1.477 -1.841 0 CA-C-N 120.185 1.357 . . . . 0.0 112.79 179.258 . . . . . . . . 4 4 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -27.66 -32.61 0.0 OUTLIER 'General case' 0 CA--C 1.474 -1.946 1 C-N-CA 137.071 6.148 . . . . 0.0 119.079 -164.653 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 4.7 mt-10 -52.43 -51.3 59.86 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 127.37 2.268 . . . . 0.0 113.153 172.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.451 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 2.7 tm? -109.4 -47.81 3.34 Favored 'General case' 0 N--CA 1.42 -1.953 0 C-N-CA 128.716 2.806 . . . . 0.0 107.472 -161.171 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.424 ' HB2' ' HG ' ' A' ' 152' ' ' LEU 0.327 . . -119.64 140.59 50.37 Favored 'General case' 0 CA--C 1.457 -2.606 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.372 -176.765 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.2 m -126.32 -176.36 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.47 -2.111 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 155.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.35 166.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.58 0 C-N-CA 126.619 1.968 . . . . 0.0 110.159 -165.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -85.87 -41.65 14.8 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 154.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -164.59 146.24 8.27 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.997 -171.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.435 ' CZ ' ' SD ' ' A' ' 172' ' ' MET . 0.2 OUTLIER . . . . . 0 CA--C 1.462 -2.408 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 170.404 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.405 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.337 18.7 mt-30 . . . . . 0 CA--C 1.502 -0.866 0 CA-C-O 119.059 -0.496 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 22.4 ttp -115.32 115.53 26.78 Favored 'General case' 0 CA--C 1.481 -1.692 0 CA-C-O 121.472 0.654 . . . . 0.0 111.679 -171.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.557 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 16.0 mm -81.72 126.88 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.367 0 CA-C-O 122.123 0.964 . . . . 0.0 108.76 172.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.435 ' SD ' ' CZ ' ' A' ' 161' ' ' PHE . 3.2 ttt -112.65 142.96 44.63 Favored 'General case' 0 CA--C 1.476 -1.875 0 N-CA-C 103.167 -2.901 . . . . 0.0 103.167 155.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.6 t -98.87 153.37 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 118.589 -1.244 . . . . 0.0 107.696 -175.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.4 HD23 ' HZ1' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -134.92 81.75 1.92 Allowed 'General case' 0 C--N 1.36 1.053 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -174.836 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.278 . . -83.34 174.4 6.05 Favored Pre-proline 0 CA--C 1.505 -0.787 0 O-C-N 119.637 -1.914 . . . . 0.0 115.038 -175.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -68.33 135.93 35.55 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.363 2.042 . . . . 0.0 108.996 165.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt . . . . . 0 N--CA 1.43 -1.466 0 O-C-N 124.037 0.836 . . . . 0.0 110.864 171.851 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.8 m . . . . . 0 CA--C 1.482 -1.656 0 CA-C-O 122.241 1.019 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.7 mm -92.2 126.57 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 113.141 -1.845 . . . . 0.0 108.176 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -95.95 167.89 10.96 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.412 HG23 ' HD3' ' A' ' 123' ' ' LYS . 70.2 t -102.04 114.32 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.665 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 161.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -108.94 -179.83 3.97 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 156.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -143.82 158.42 43.69 Favored 'General case' 0 N--CA 1.433 -1.309 0 O-C-N 123.462 0.476 . . . . 0.0 110.544 -169.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.9 tp -135.35 162.23 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 166.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -120.91 157.26 30.25 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 118.863 0.756 . . . . 0.0 111.396 165.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.489 ' CE2' HG23 ' A' ' 148' ' ' VAL . 39.8 m-85 -136.92 100.32 4.27 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 173.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -85.45 171.31 10.97 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 124.124 0.97 . . . . 0.0 109.086 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -74.5 140.89 27.52 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 N-CA-C 106.202 -2.268 . . . . 0.0 106.202 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.36 9.9 59.91 Favored Glycine 0 CA--C 1.483 -1.952 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 95.6 m -106.04 92.79 4.3 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 170.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -128.71 174.88 9.04 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-N 112.692 -2.049 . . . . 0.0 108.993 172.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -27.32 -56.21 0.09 Allowed 'General case' 0 CA--C 1.486 -1.485 1 C-N-CA 132.399 4.28 . . . . 0.0 116.097 -145.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -21.26 -75.1 0.01 OUTLIER Glycine 0 CA--C 1.472 -2.625 1 C-N-CA 130.745 4.021 . . . . 0.0 118.539 163.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -81.58 -33.07 31.81 Favored 'General case' 0 N--CA 1.424 -1.757 0 C-N-CA 128.931 2.893 . . . . 0.0 109.357 -175.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.501 ' HH ' HG21 ' A' ' 148' ' ' VAL . 1.2 t80 -73.95 -71.17 0.34 Allowed 'General case' 0 CA--C 1.474 -1.977 0 CA-C-N 111.572 -2.558 . . . . 0.0 113.082 -161.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.33 0.0 OUTLIER -60.63 -14.11 18.47 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 119.639 3.2 . . . . 0.0 119.639 175.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 87.5 t -60.65 -47.82 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.18 0.99 . . . . 0.0 109.444 161.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -91.94 7.66 41.09 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.08 -32.78 24.6 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 162.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.46 ' HA ' HG12 ' A' ' 115' ' ' ILE . 58.3 ttt-85 -61.87 -42.79 99.48 Favored 'General case' 0 C--N 1.363 1.189 0 CA-C-O 118.739 -0.648 . . . . 0.0 110.677 168.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.6 t -61.56 -41.31 97.19 Favored 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.512 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.434 HD13 HD22 ' A' ' 174' ' ' LEU . 65.0 tp -70.08 -29.29 66.24 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-O 117.088 -1.434 . . . . 0.0 113.541 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.46 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.269 10.0 mm -55.47 -53.08 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.957 0 CA-C-N 120.293 1.406 . . . . 0.0 107.569 170.014 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -47.29 -48.9 24.71 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 128.649 2.78 . . . . 0.0 111.776 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -56.81 -55.71 30.83 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.94 -36.17 64.99 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -89.1 -14.9 35.21 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 128.929 2.892 . . . . 0.0 110.341 -166.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -67.57 -24.94 65.57 Favored 'General case' 0 C--N 1.36 1.023 0 C-N-CA 122.981 0.512 . . . . 0.0 109.706 161.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 93.42 57.52 1.35 Allowed Glycine 0 CA--C 1.472 -2.655 0 N-CA-C 104.542 -3.423 . . . . 0.0 104.542 -174.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -126.53 167.73 15.23 Favored 'General case' 0 CA--C 1.462 -2.408 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.412 ' HD3' HG23 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -101.54 115.61 30.91 Favored 'General case' 0 N--CA 1.407 -2.597 1 N-CA-C 99.762 -4.162 . . . . 0.0 99.762 176.689 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.77 115.7 31.11 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.065 -1.425 . . . . 0.0 107.751 -168.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -97.44 121.58 39.51 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -171.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.1 mm -84.04 134.22 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.527 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 25.7 m -119.62 124.06 45.4 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 173.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.507 HD23 ' CE1' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -88.02 155.84 19.61 Favored 'General case' 0 CA--C 1.467 -2.236 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 167.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -152.07 91.52 1.62 Allowed 'General case' 0 N--CA 1.397 -3.115 1 N-CA-C 99.221 -4.363 . . . . 0.0 99.221 -174.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.507 ' CE1' HD23 ' A' ' 128' ' ' LEU . 92.0 m-85 -76.1 151.41 37.05 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 112.437 -2.165 . . . . 0.0 108.755 -173.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 4.9 tmt_? -82.66 92.63 7.2 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 101.675 -3.454 . . . . 0.0 101.675 153.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 176.07 -150.21 10.5 Favored Glycine 0 N--CA 1.423 -2.204 0 C-N-CA 116.067 -2.968 . . . . 0.0 112.118 -162.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.5 mtm105 -150.82 -164.24 1.97 Allowed 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -158.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -67.69 -29.41 68.67 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 126.562 1.945 . . . . 0.0 111.496 176.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 28.5 ttt -126.32 93.4 3.79 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 102.936 -2.987 . . . . 0.0 102.936 155.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.07 -57.02 6.78 Favored 'General case' 0 CA--C 1.469 -2.17 0 CA-C-O 124.729 2.204 . . . . 0.0 110.865 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.466 ' HB2' ' H ' ' A' ' 140' ' ' ILE . 14.6 p80 -118.37 172.11 7.68 Favored 'General case' 0 N--CA 1.416 -2.167 1 CA-C-N 108.174 -4.103 . . . . 0.0 112.226 -155.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.406 ' H ' ' H ' ' A' ' 139' ' ' GLN . 18.1 pt20 -134.21 4.58 3.47 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 104.257 -2.498 . . . . 0.0 104.257 149.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.415 ' H ' ' HB2' ' A' ' 137' ' ' HIS . 12.3 mt-30 -120.84 -57.41 1.89 Allowed 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.116 -166.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.466 ' H ' ' HB2' ' A' ' 137' ' ' HIS . 82.1 mt -52.4 -48.27 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.188 0 C-N-CA 128.963 2.905 . . . . 0.0 111.476 -169.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.59 -60.95 2.38 Favored Glycine 0 N--CA 1.41 -3.099 0 C-N-CA 118.867 -1.635 . . . . 0.0 111.926 -170.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 72.4 mtm -89.51 0.08 57.14 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -161.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -67.77 -50.37 57.47 Favored 'General case' 0 CA--C 1.457 -2.614 0 C-N-CA 116.096 -2.242 . . . . 0.0 113.295 151.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.81 -69.22 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.443 -3.168 0 O-C-N 125.946 2.028 . . . . 0.0 108.15 -166.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.403 ' HG ' HD13 ' A' ' 128' ' ' LEU . 27.8 mt -42.22 -53.31 4.12 Favored 'General case' 0 CA--C 1.476 -1.887 0 C-N-CA 128.929 2.891 . . . . 0.0 115.119 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -62.9 -36.16 82.43 Favored 'General case' 0 CA--C 1.46 -2.508 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -81.76 -14.15 56.82 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.603 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.501 HG21 ' HH ' ' A' ' 107' ' ' TYR . 1.6 t -77.68 -46.2 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.768 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -51.93 -50.62 60.79 Favored 'General case' 0 CA--C 1.463 -2.401 0 C-N-CA 125.583 1.553 . . . . 0.0 111.003 171.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.64 -36.62 70.76 Favored 'General case' 0 N--CA 1.411 -2.404 0 C-N-CA 124.447 1.099 . . . . 0.0 110.187 -169.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -72.69 -40.09 66.5 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 116.305 -2.158 . . . . 0.0 115.299 170.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.289 0.2 OUTLIER -80.2 -19.97 45.78 Favored 'General case' 0 CA--C 1.464 -2.352 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -177.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -26.38 -27.04 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.443 1 C-N-CA 134.457 5.103 . . . . 0.0 118.901 173.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -55.28 -59.04 5.35 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 127.045 2.138 . . . . 0.0 112.902 169.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.42 -52.1 3.19 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 125.842 1.657 . . . . 0.0 107.805 -167.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.431 ' HB3' ' CD1' ' A' ' 174' ' ' LEU 0.281 . . -100.28 141.44 33.12 Favored 'General case' 0 CA--C 1.459 -2.546 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.882 -178.217 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.5 m -123.93 164.25 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.421 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 139.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.5 t -84.08 153.46 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.104 0 CA-C-N 110.021 -3.263 . . . . 0.0 108.478 -172.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -82.32 -41.25 20.32 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.3 t -152.45 151.17 30.44 Favored 'General case' 0 CA--C 1.468 -2.174 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -99.89 104.4 28.32 Favored Pre-proline 0 N--CA 1.424 -1.768 0 N-CA-C 101.199 -3.63 . . . . 0.0 101.199 164.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -74.19 -44.81 0.4 Allowed 'Trans proline' 0 CA--C 1.485 -1.954 0 C-N-CA 124.074 3.182 . . . . 0.0 111.241 -148.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . 0.283 1.9 m 8.22 50.41 0.0 OUTLIER 'General case' 0 N--CA 1.412 -2.339 1 C-N-CA 136.185 5.794 . . . . 0.0 118.764 -156.918 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.32 105.16 7.94 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 111.33 -2.668 . . . . 0.0 106.022 163.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -81.79 141.58 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -119.35 105.89 11.75 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.77 -152.28 31.61 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -173.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -95.54 33.83 1.56 Allowed 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 125.25 1.42 . . . . 0.0 111.23 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.3 38.0 mt-30 -165.78 144.85 6.19 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 124.338 1.055 . . . . 0.0 108.221 -167.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 51.8 ttp -134.93 118.73 17.2 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 119.155 0.889 . . . . 0.0 111.671 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.527 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 22.0 mm -82.49 123.94 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 O-C-N 121.31 -0.869 . . . . 0.0 108.666 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.9 ttt -101.07 130.29 47.07 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 159.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.16 134.87 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -173.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 1.1 tp -129.19 143.73 50.96 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 -174.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.32 . . -131.98 178.36 1.79 Allowed Pre-proline 0 CA--C 1.488 -1.424 0 C-N-CA 123.813 0.845 . . . . 0.0 110.065 -174.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -62.73 148.23 93.66 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 122.932 2.421 . . . . 0.0 109.059 160.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -74.0 125.28 27.91 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -77.03 126.91 31.74 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 113.277 -1.783 . . . . 0.0 109.726 -167.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -72.43 126.98 31.16 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 . . . . . 0 C--O 1.26 1.642 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.889 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 CA--C 1.482 -1.635 0 CA-C-O 122.204 1.002 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.4 mm -84.89 122.23 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.497 0 CA-C-N 112.842 -1.981 . . . . 0.0 106.289 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -96.72 167.05 11.35 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 -167.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 82.0 t -103.03 124.77 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -108.38 171.74 7.24 Favored 'General case' 0 CA--C 1.479 -1.784 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 154.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -144.43 146.65 32.6 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.415 HG23 HD23 ' A' ' 114' ' ' LEU . 4.8 tp -124.97 160.07 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.085 0 N-CA-C 103.169 -2.9 . . . . 0.0 103.169 173.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -119.22 154.12 33.89 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 119.414 -0.915 . . . . 0.0 110.447 162.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.464 ' CE2' HG23 ' A' ' 148' ' ' VAL . 34.1 m-85 -134.03 110.83 9.91 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -89.16 165.45 26.4 Favored Pre-proline 0 N--CA 1.429 -1.486 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -70.84 138.46 34.43 Favored 'Trans proline' 0 N--CA 1.437 -1.847 0 C-N-CA 123.377 2.718 . . . . 0.0 106.479 167.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.04 7.8 67.65 Favored Glycine 0 CA--C 1.482 -2.028 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.6 m -101.21 91.4 4.5 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 169.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -133.85 -150.55 0.41 Allowed 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 170.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -61.2 -66.62 0.51 Allowed 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 118.76 0.709 . . . . 0.0 109.188 -85.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -104.75 33.53 6.5 Favored Glycine 0 CA--C 1.486 -1.778 0 CA-C-N 118.676 0.671 . . . . 0.0 112.854 -177.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.19 -38.02 9.47 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 152.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.436 ' HH ' ' HG2' ' A' ' 147' ' ' ARG . 0.9 OUTLIER -66.91 -73.71 0.13 Allowed 'General case' 0 CA--C 1.477 -1.86 0 C-N-CA 127.209 2.203 . . . . 0.0 110.371 -173.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.275 0.0 OUTLIER -65.49 -9.02 22.32 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 119.394 3.109 . . . . 0.0 119.394 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.84 -42.79 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 122.169 0.985 . . . . 0.0 110.793 161.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -91.67 -1.53 57.4 Favored 'General case' 0 CA--C 1.477 -1.831 0 O-C-N 120.352 -1.468 . . . . 0.0 114.686 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 tt -76.79 -31.98 57.36 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 161.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.487 ' HA ' HG12 ' A' ' 115' ' ' ILE . 31.4 ttt180 -62.47 -45.03 94.88 Favored 'General case' 0 C--N 1.363 1.19 0 C-N-CA 123.812 0.845 . . . . 0.0 111.482 170.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.1 m -61.77 -42.31 98.83 Favored 'General case' 0 C--N 1.377 1.796 0 C-N-CA 118.666 -1.214 . . . . 0.0 113.761 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.415 HD23 HG23 ' A' ' 96' ' ' ILE 0.323 52.4 tp -68.0 -27.92 66.98 Favored 'General case' 0 N--CA 1.406 -2.644 0 C-N-CA 126.73 2.012 . . . . 0.0 113.67 177.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.487 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.289 9.4 mm -57.33 -52.87 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.901 0 CA-C-N 121.036 1.744 . . . . 0.0 108.217 170.534 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -53.78 -42.64 68.5 Favored 'General case' 0 CA--C 1.492 -1.262 0 O-C-N 125.816 1.947 . . . . 0.0 110.402 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -58.21 -54.11 50.66 Favored 'General case' 0 CA--C 1.481 -1.701 0 C-N-CA 125.343 1.457 . . . . 0.0 112.639 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -33.07 72.84 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -73.58 -31.56 63.66 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 129.116 2.966 . . . . 0.0 109.798 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -64.67 -19.75 65.9 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 124.213 1.005 . . . . 0.0 111.679 171.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.53 54.79 2.72 Favored Glycine 0 CA--C 1.469 -2.825 0 N-CA-C 103.995 -3.642 . . . . 0.0 103.995 -174.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -120.42 163.52 17.77 Favored 'General case' 0 CA--C 1.447 -2.984 1 N-CA-C 99.82 -4.141 . . . . 0.0 99.82 170.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.04 116.13 32.12 Favored 'General case' 0 N--CA 1.393 -3.285 1 N-CA-C 98.644 -4.576 . . . . 0.0 98.644 171.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.52 156.71 25.12 Favored 'General case' 0 N--CA 1.407 -2.585 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 173.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.314 27.4 mtpp -131.44 138.76 49.19 Favored 'General case' 0 CA--C 1.487 -1.458 0 O-C-N 118.688 -2.507 . . . . 0.0 104.248 163.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.9 mm -85.43 136.77 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.527 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 27.5 m -117.51 130.11 56.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 169.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.483 HD21 ' CE1' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -92.19 160.09 15.34 Favored 'General case' 0 CA--C 1.468 -2.189 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 167.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -152.48 96.26 2.13 Favored 'General case' 0 N--CA 1.402 -2.843 1 N-CA-C 99.036 -4.431 . . . . 0.0 99.036 -174.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.483 ' CE1' HD21 ' A' ' 128' ' ' LEU . 96.8 m-85 -80.49 103.96 10.7 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 113.068 -1.878 . . . . 0.0 106.438 -175.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -133.54 21.13 3.94 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.67 -50.08 4.85 Favored Glycine 0 CA--C 1.46 -3.375 0 N-CA-C 105.113 -3.195 . . . . 0.0 105.113 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -122.33 153.53 38.85 Favored 'General case' 0 CA--C 1.481 -1.71 0 N-CA-C 100.603 -3.851 . . . . 0.0 100.603 161.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -54.92 -42.4 72.17 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 125.001 1.321 . . . . 0.0 111.901 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 9.7 ptm -61.81 -100.57 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 171.27 112.3 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -145.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -130.38 147.9 52.14 Favored 'General case' 0 CA--C 1.477 -1.829 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.91 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.12 9.03 43.45 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -79.36 -55.39 5.1 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 103.831 -2.655 . . . . 0.0 103.831 163.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 89.5 mt -52.2 -48.96 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.843 0 C-N-CA 126.405 1.882 . . . . 0.0 111.011 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -78.94 -57.85 3.14 Favored Glycine 0 N--CA 1.407 -3.245 0 C-N-CA 119.355 -1.403 . . . . 0.0 112.505 -167.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 58.4 mtm -93.92 18.24 10.84 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -170.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.86 -61.25 1.96 Allowed 'General case' 0 CA--C 1.456 -2.657 0 C-N-CA 115.138 -2.625 . . . . 0.0 114.573 133.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 23.7 t -64.07 -66.14 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.444 -3.111 0 O-C-N 126.213 2.196 . . . . 0.0 109.064 -160.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.1 mt -43.58 -55.81 4.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 127.811 2.444 . . . . 0.0 114.003 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -53.62 -43.12 68.41 Favored 'General case' 0 CA--C 1.485 -1.522 0 C-N-CA 126.791 2.036 . . . . 0.0 114.159 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.436 ' HG2' ' HH ' ' A' ' 107' ' ' TYR . 17.0 ttp180 -82.48 -14.26 55.33 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.464 HG23 ' CE2' ' A' ' 98' ' ' PHE . 2.5 t -72.93 -44.57 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.597 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.22 -53.94 51.74 Favored 'General case' 0 CA--C 1.45 -2.888 0 O-C-N 125.126 1.516 . . . . 0.0 112.722 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.88 -38.68 82.91 Favored 'General case' 0 N--CA 1.403 -2.791 0 C-N-CA 127.686 2.394 . . . . 0.0 109.241 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.01 -40.48 71.79 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 116.065 -2.254 . . . . 0.0 116.901 168.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.277 0.2 OUTLIER -80.2 -22.89 41.39 Favored 'General case' 0 CA--C 1.463 -2.384 0 N-CA-C 117.263 2.319 . . . . 0.0 117.263 -175.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -27.51 -27.96 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.44 1 C-N-CA 135.376 5.47 . . . . 0.0 118.483 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -50.77 -53.52 31.06 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 127.353 2.261 . . . . 0.0 112.842 168.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -53.56 2.99 Favored 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 126.102 1.761 . . . . 0.0 110.309 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.299 . . -110.32 136.54 49.34 Favored 'General case' 0 CA--C 1.452 -2.821 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -163.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.1 m -126.16 -179.57 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.407 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 161.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 160' ' ' SER . 0.0 OUTLIER -85.71 163.41 2.67 Favored 'Isoleucine or valine' 1 N--CA 1.377 -4.091 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.54 -166.312 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -84.5 -41.72 16.25 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 156.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.417 ' H ' HG13 ' A' ' 158' ' ' VAL 0.269 0.4 OUTLIER -169.85 150.87 4.0 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.921 -169.106 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -102.37 91.68 2.78 Favored Pre-proline 0 N--CA 1.426 -1.649 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 167.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 17.6 Cg_exo -83.79 -91.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.216 0 O-C-N 123.318 1.167 . . . . 0.0 110.156 -130.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.626 HG23 ' H ' ' A' ' 164' ' ' LYS 0.389 1.1 m -132.49 -104.58 0.26 Allowed 'General case' 0 N--CA 1.408 -2.537 0 N-CA-C 102.979 -2.971 . . . . 0.0 102.979 -144.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.626 ' H ' HG23 ' A' ' 163' ' ' THR . 18.1 ptpt -153.81 170.48 20.87 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 102.577 -3.12 . . . . 0.0 102.577 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.7 mt -79.7 137.11 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 CA-C-O 122.621 1.201 . . . . 0.0 108.33 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -124.78 109.39 13.03 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.98 -147.68 30.8 Favored Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -170.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 81.4 mtt85 -104.66 36.16 2.52 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.935 -1.132 . . . . 0.0 110.487 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.267 32.3 mt-30 -169.32 145.11 3.24 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -166.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 56.1 ttp -141.29 116.29 9.86 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-O 122.079 0.942 . . . . 0.0 112.063 -173.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.527 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 8.7 mm -80.35 135.95 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.841 0 O-C-N 120.944 -1.098 . . . . 0.0 109.005 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -108.53 131.42 54.85 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 151.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.47 135.81 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.82 81.98 1.85 Allowed 'General case' 0 C--N 1.356 0.884 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -170.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -87.03 179.01 1.92 Allowed Pre-proline 0 CA--C 1.509 -0.599 0 O-C-N 118.407 -2.683 . . . . 0.0 117.128 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -64.35 137.69 56.97 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 122.702 2.268 . . . . 0.0 111.966 169.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -81.14 135.97 35.84 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 168.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.32 107.44 17.33 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 172.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -71.63 120.68 17.56 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 . . . . . 0 C--O 1.26 1.642 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.707 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 CA--C 1.483 -1.613 0 CA-C-O 121.762 0.792 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.2 mm -86.64 121.4 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 C-N-CA 126.537 1.935 . . . . 0.0 107.657 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -113.5 161.88 16.82 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -160.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.44 117.48 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.744 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -112.24 173.99 6.1 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 153.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -139.5 159.25 42.59 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 123.34 0.4 . . . . 0.0 109.951 -165.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 tp -137.03 162.8 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 165.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -121.35 153.27 37.98 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.675 0.75 . . . . 0.0 112.225 164.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.477 ' CE2' HG23 ' A' ' 148' ' ' VAL . 43.7 m-85 -130.27 135.04 47.68 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 170.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.429 ' HD3' HH21 ' A' ' 129' ' ' ARG . 22.1 mtm-85 -113.84 171.88 4.03 Favored Pre-proline 0 N--CA 1.434 -1.249 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -73.74 136.67 23.6 Favored 'Trans proline' 0 N--CA 1.433 -2.067 0 N-CA-C 105.158 -2.67 . . . . 0.0 105.158 162.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.38 9.18 62.0 Favored Glycine 0 CA--C 1.483 -1.96 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.2 m -104.16 89.91 3.42 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -121.96 -175.63 3.15 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 112.325 -2.216 . . . . 0.0 106.249 172.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -51.18 -42.1 60.63 Favored 'General case' 0 CA--C 1.481 -1.685 0 C-N-CA 127.116 2.167 . . . . 0.0 115.103 -132.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.7 -6.52 80.0 Favored Glycine 0 N--CA 1.417 -2.621 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 -170.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -98.16 -30.8 12.44 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 125.42 1.488 . . . . 0.0 107.349 167.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.7 -73.29 0.45 Allowed 'General case' 0 CA--C 1.475 -1.904 0 CA-C-N 112.316 -2.22 . . . . 0.0 110.868 -156.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.331 0.0 OUTLIER -58.13 -15.85 11.11 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 119.038 2.977 . . . . 0.0 119.038 174.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.67 -48.94 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-O 122.488 1.137 . . . . 0.0 110.233 162.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -91.72 8.07 38.73 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.7 tt -84.29 -32.23 24.49 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 161.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.437 ' HA ' HG12 ' A' ' 115' ' ' ILE . 57.4 ttt180 -62.84 -44.2 96.77 Favored 'General case' 0 C--N 1.363 1.157 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.636 168.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 69.3 m -60.08 -40.38 89.34 Favored 'General case' 0 C--N 1.378 1.824 0 C-N-CA 118.464 -1.295 . . . . 0.0 113.532 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 mt -61.02 -33.68 73.65 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.437 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.3 mm -58.52 -48.86 84.24 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.648 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -49.82 -51.26 41.16 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 125.814 1.946 . . . . 0.0 112.255 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -54.75 -50.38 68.56 Favored 'General case' 0 CA--C 1.476 -1.874 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -43.24 99.23 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.3 -12.63 56.46 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 125.723 1.609 . . . . 0.0 112.358 -171.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.18 -12.7 60.97 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 124.112 0.965 . . . . 0.0 109.759 166.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.82 60.73 1.57 Allowed Glycine 0 CA--C 1.467 -2.908 0 N-CA-C 106.45 -2.66 . . . . 0.0 106.45 175.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -135.93 175.49 9.55 Favored 'General case' 0 CA--C 1.462 -2.42 0 N-CA-C 102.301 -3.222 . . . . 0.0 102.301 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.299 21.0 mtpt -89.21 148.05 23.82 Favored 'General case' 0 N--CA 1.405 -2.682 1 N-CA-C 100.046 -4.057 . . . . 0.0 100.046 165.35 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.26 115.41 25.23 Favored 'General case' 0 N--CA 1.407 -2.585 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 173.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -100.63 116.56 32.84 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.9 mm -85.73 132.23 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 28.1 m -119.65 127.92 53.36 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . 0.26 0.2 OUTLIER -79.91 154.88 28.03 Favored 'General case' 0 CA--C 1.469 -2.148 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 167.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.429 HH21 ' HD3' ' A' ' 99' ' ' ARG . 47.0 ttp180 -145.18 91.19 2.11 Favored 'General case' 0 N--CA 1.404 -2.759 1 N-CA-C 100.154 -4.017 . . . . 0.0 100.154 178.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -75.48 153.37 37.58 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 111.84 -2.437 . . . . 0.0 110.301 -170.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -116.88 19.77 14.22 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 170.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.0 -25.01 13.57 Favored Glycine 0 CA--C 1.482 -2.019 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 61.04 -179.85 0.11 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 129.796 3.238 . . . . 0.0 115.814 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 3.83 99.05 0.01 OUTLIER 'General case' 0 C--N 1.363 1.191 1 C-N-CA 132.907 4.483 . . . . 0.0 116.915 -169.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 37.3 tpp 55.58 73.71 0.41 Allowed 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 126.872 2.069 . . . . 0.0 107.955 -172.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.411 ' HB3' ' H ' ' A' ' 137' ' ' HIS . . . -81.27 -143.52 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 123.576 1.655 . . . . 0.0 115.159 -164.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.521 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 74.6 m-70 -87.79 155.84 19.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.271 2.628 . . . . 0.0 115.604 -168.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -120.21 7.08 10.73 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 169.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -89.28 -56.57 3.21 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 137' ' ' HIS . 93.6 mt -59.47 -43.83 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 C-N-CA 127.586 2.354 . . . . 0.0 110.41 177.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.38 -69.37 1.4 Allowed Glycine 0 N--CA 1.412 -2.918 0 O-C-N 124.094 0.871 . . . . 0.0 111.747 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 55.0 mtm -96.56 23.57 6.76 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -163.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -72.92 -55.86 6.0 Favored 'General case' 0 CA--C 1.452 -2.824 0 C-N-CA 116.355 -2.138 . . . . 0.0 113.072 135.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 38.9 t -64.69 -67.28 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.445 -3.063 0 O-C-N 126.512 2.382 . . . . 0.0 108.526 -163.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.0 mt -42.02 -54.98 3.34 Favored 'General case' 0 CA--C 1.475 -1.942 0 C-N-CA 127.662 2.385 . . . . 0.0 113.768 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -54.48 -44.76 72.92 Favored 'General case' 0 CA--C 1.484 -1.559 0 C-N-CA 126.619 1.967 . . . . 0.0 114.031 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -83.26 -12.29 56.9 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 118.386 0.539 . . . . 0.0 112.102 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.477 HG23 ' CE2' ' A' ' 98' ' ' PHE . 2.3 t -73.87 -44.46 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.419 ' HZ3' ' HB2' ' A' ' 174' ' ' LEU . 0.8 OUTLIER -61.12 -53.76 53.01 Favored 'General case' 0 CA--C 1.451 -2.859 0 O-C-N 125.366 1.666 . . . . 0.0 112.341 179.598 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -61.9 -36.75 82.25 Favored 'General case' 0 N--CA 1.403 -2.784 0 C-N-CA 126.807 2.043 . . . . 0.0 109.716 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.87 -34.1 66.5 Favored 'General case' 0 C--N 1.358 0.948 0 C-N-CA 115.955 -2.298 . . . . 0.0 116.469 169.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.31 0.2 OUTLIER -81.31 -27.91 34.83 Favored 'General case' 0 CA--C 1.464 -2.331 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -176.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -28.42 -25.78 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.531 1 C-N-CA 136.116 5.766 . . . . 0.0 118.885 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -48.71 -50.44 33.47 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 127.65 2.38 . . . . 0.0 113.234 166.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 tt -114.66 -48.57 2.85 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 126.282 1.833 . . . . 0.0 108.895 -170.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.5 ' HB3' ' CD1' ' A' ' 174' ' ' LEU 0.284 . . -110.82 131.02 55.41 Favored 'General case' 0 CA--C 1.463 -2.398 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -170.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.2 m -128.12 175.33 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.029 0 N-CA-C 119.929 3.307 . . . . 0.0 119.929 162.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.48 HG13 ' H ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -83.14 162.49 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.388 0 C-N-CA 126.309 1.844 . . . . 0.0 111.054 -159.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.61 -44.19 12.83 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 159.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.48 ' H ' HG13 ' A' ' 158' ' ' VAL 0.265 0.9 OUTLIER -167.92 145.81 4.43 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.621 -171.51 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -105.74 111.21 64.69 Favored Pre-proline 0 CA--C 1.478 -1.817 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 172.058 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 73.0 Cg_endo -133.2 -119.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.419 -2.895 0 N-CA-C 103.235 -3.41 . . . . 0.0 103.235 -157.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -170.4 -40.92 0.02 OUTLIER 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 -128.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -85.94 97.57 10.31 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-O 121.256 0.55 . . . . 0.0 110.704 -155.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.03 129.0 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 169.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -108.51 94.58 5.13 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 111.694 -2.503 . . . . 0.0 105.712 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.56 -127.41 8.3 Favored Glycine 0 CA--C 1.479 -2.178 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -108.9 44.83 1.09 Allowed 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 112.473 -1.863 . . . . 0.0 109.865 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.281 20.2 mt-30 -162.25 130.6 4.1 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-O 118.585 -0.721 . . . . 0.0 111.014 -175.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 32.5 ttp -118.43 117.54 29.31 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 119.743 1.156 . . . . 0.0 113.841 -169.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.7 mm -84.37 127.16 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.356 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.51 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -105.53 130.3 53.62 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 101.339 -3.578 . . . . 0.0 101.339 150.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.3 t -91.93 136.32 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.5 ' CD1' ' HB3' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -122.25 147.64 45.97 Favored 'General case' 0 N--CA 1.439 -0.988 1 N-CA-C 99.177 -4.379 . . . . 0.0 99.177 -176.997 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.351 . . -137.19 179.87 1.24 Allowed Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 125.61 1.564 . . . . 0.0 109.426 -173.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -63.75 138.16 62.4 Favored 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 122.681 2.254 . . . . 0.0 110.176 167.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -78.35 141.36 38.47 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 165.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.49 102.85 1.2 Allowed 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 125.412 1.485 . . . . 0.0 110.007 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -81.96 125.49 30.83 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 . . . . . 0 C--O 1.259 1.589 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 179.78 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 CA--C 1.478 -1.793 0 CA-C-O 122.868 1.318 . . . . 0.0 111.445 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -93.12 149.36 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.035 0 N-CA-C 102.095 -3.298 . . . . 0.0 102.095 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -97.91 163.04 12.95 Favored 'General case' 0 CA--C 1.48 -1.73 0 C-N-CA 118.088 -1.445 . . . . 0.0 109.053 -167.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.0 t -88.49 114.26 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.793 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -109.9 179.84 4.0 Favored 'General case' 0 CA--C 1.472 -2.057 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 160.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -146.68 158.01 43.82 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.585 -168.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 tp -135.59 163.25 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 169.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -116.46 154.2 30.76 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-O 121.522 0.677 . . . . 0.0 111.496 162.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.476 ' CE2' HG23 ' A' ' 148' ' ' VAL . 40.9 m-85 -130.52 131.4 45.06 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 102.866 -3.012 . . . . 0.0 102.866 166.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -113.33 171.0 4.7 Favored Pre-proline 0 N--CA 1.431 -1.376 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -74.02 140.83 28.93 Favored 'Trans proline' 0 N--CA 1.432 -2.121 0 N-CA-C 105.377 -2.586 . . . . 0.0 105.377 165.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.42 6.07 68.82 Favored Glycine 0 CA--C 1.485 -1.843 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.9 m -108.21 92.51 4.09 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 168.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -126.46 175.36 7.94 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 112.996 -1.911 . . . . 0.0 107.014 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -24.0 -57.16 0.04 OUTLIER 'General case' 0 CA--C 1.487 -1.472 1 C-N-CA 132.507 4.323 . . . . 0.0 116.223 -149.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -21.81 -77.01 0.01 OUTLIER Glycine 0 CA--C 1.47 -2.764 1 C-N-CA 131.148 4.213 . . . . 0.0 117.903 165.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . 0.328 52.6 m-20 -81.24 -32.4 33.38 Favored 'General case' 0 N--CA 1.404 -2.726 0 C-N-CA 131.052 3.741 . . . . 0.0 110.806 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.424 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.8 OUTLIER -72.83 -72.58 0.24 Allowed 'General case' 0 CA--C 1.479 -1.775 0 CA-C-N 112.579 -2.101 . . . . 0.0 111.138 -163.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.34 0.0 OUTLIER -58.5 -14.67 8.5 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 119.548 3.166 . . . . 0.0 119.548 176.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.08 -45.86 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 C-N-CA 124.092 0.957 . . . . 0.0 110.183 163.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -91.8 4.95 51.67 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.1 tt -82.97 -32.52 27.03 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 162.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.44 ' HA ' HG12 ' A' ' 115' ' ' ILE . 57.5 ttt180 -63.05 -42.74 99.79 Favored 'General case' 0 C--N 1.362 1.122 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.73 168.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.8 m -59.71 -40.93 89.6 Favored 'General case' 0 C--N 1.377 1.799 0 C-N-CA 118.509 -1.276 . . . . 0.0 113.36 173.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.6 mt -62.6 -32.84 73.91 Favored 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.0 mm -59.21 -46.67 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.533 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 174.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.57 -47.88 66.54 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 126.04 1.736 . . . . 0.0 113.079 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -54.93 -49.7 70.67 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.7 -37.28 81.13 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -80.09 -20.82 44.23 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 128.26 2.624 . . . . 0.0 112.46 -173.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -71.97 -15.83 62.07 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 168.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.42 69.58 1.33 Allowed Glycine 0 CA--C 1.463 -3.174 0 N-CA-C 104.182 -3.567 . . . . 0.0 104.182 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -143.62 177.77 8.25 Favored 'General case' 0 CA--C 1.459 -2.529 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 171.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -116.94 114.08 23.33 Favored 'General case' 0 N--CA 1.393 -3.3 1 N-CA-C 96.929 -5.212 . . . . 0.0 96.929 -170.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -103.42 111.54 24.02 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.361 -1.335 . . . . 0.0 108.237 -162.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -97.6 122.85 41.16 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -164.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.3 mm -85.49 133.46 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.2 m -119.57 123.13 43.17 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . 0.266 0.2 OUTLIER -80.05 150.91 30.18 Favored 'General case' 0 CA--C 1.471 -2.065 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 166.058 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -145.75 95.39 2.64 Favored 'General case' 0 N--CA 1.403 -2.798 1 N-CA-C 98.712 -4.551 . . . . 0.0 98.712 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -72.75 157.5 37.39 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 112.01 -2.359 . . . . 0.0 110.476 -172.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.6 ttp-105 -129.2 28.05 5.3 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -128.09 -5.0 5.36 Favored Glycine 0 CA--C 1.483 -1.961 0 N-CA-C 105.99 -2.844 . . . . 0.0 105.99 172.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -29.74 101.7 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 130.797 3.639 . . . . 0.0 119.005 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -114.88 -110.18 0.36 Allowed 'General case' 0 N--CA 1.432 -1.338 1 N-CA-C 99.95 -4.093 . . . . 0.0 99.95 148.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 96.6 mtp -85.06 111.85 20.11 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 101.714 -3.439 . . . . 0.0 101.714 148.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.65 -151.29 0.08 Allowed 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 117.155 2.28 . . . . 0.0 117.155 -157.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.524 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 63.7 m-70 -97.33 143.55 27.97 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 127.037 2.135 . . . . 0.0 113.717 -166.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -107.19 8.14 29.85 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 169.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -83.57 -59.98 2.27 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 171.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 137' ' ' HIS . 76.8 mt -54.56 -48.09 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 C-N-CA 128.434 2.694 . . . . 0.0 111.448 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.46 -58.83 4.06 Favored Glycine 0 N--CA 1.415 -2.729 0 O-C-N 123.695 0.622 . . . . 0.0 112.07 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 22.4 mtm -92.85 2.96 56.49 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 113.502 0.926 . . . . 0.0 113.502 -160.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.252 1.2 tm-20 -54.74 -71.65 0.08 Allowed 'General case' 0 CA--C 1.449 -2.913 0 C-N-CA 115.083 -2.647 . . . . 0.0 114.767 138.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' A' ' 98' ' ' PHE . 39.2 t -56.51 -67.6 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.441 -3.216 0 O-C-N 127.411 2.944 . . . . 0.0 108.973 -161.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.2 mt -39.09 -53.78 1.79 Allowed 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 128.399 2.68 . . . . 0.0 115.213 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.406 ' HA ' ' CE2' ' A' ' 161' ' ' PHE . 1.7 t-20 -62.82 -36.71 84.09 Favored 'General case' 0 CA--C 1.46 -2.5 0 N-CA-C 117.591 2.441 . . . . 0.0 117.591 175.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -81.09 -14.46 57.73 Favored 'General case' 0 N--CA 1.417 -2.097 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.233 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.476 HG23 ' CE2' ' A' ' 98' ' ' PHE . 1.5 t -77.58 -43.11 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.42 ' HE2' ' HB ' ' A' ' 158' ' ' VAL . 30.5 ttmt -52.93 -51.09 62.55 Favored 'General case' 0 CA--C 1.464 -2.364 0 CA-C-O 117.024 -1.465 . . . . 0.0 110.8 169.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.75 -38.2 73.48 Favored 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 124.27 1.028 . . . . 0.0 110.071 -168.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -75.65 -28.78 58.88 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 116.673 -2.011 . . . . 0.0 115.414 171.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.286 0.1 OUTLIER -76.39 -33.02 58.88 Favored 'General case' 0 CA--C 1.475 -1.931 0 CA-C-O 116.827 -1.559 . . . . 0.0 113.084 178.107 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -28.26 -26.94 0.0 OUTLIER 'General case' 0 CA--C 1.483 -1.623 1 C-N-CA 135.468 5.507 . . . . 0.0 119.525 -172.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -57.63 -59.0 5.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.155 2.182 . . . . 0.0 112.246 171.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.08 -52.18 3.48 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.39 -1.732 . . . . 0.0 108.186 -167.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.449 ' CB ' HD12 ' A' ' 174' ' ' LEU 0.284 . . -98.85 147.53 24.84 Favored 'General case' 0 CA--C 1.459 -2.533 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.773 -178.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.43 171.41 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.765 0 C-N-CA 114.794 -2.762 . . . . 0.0 116.405 134.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.7 t -82.37 155.88 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.979 0 C-N-CA 128.948 2.899 . . . . 0.0 109.798 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -82.16 -42.93 18.39 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 113.7 -1.591 . . . . 0.0 106.885 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.7 t -152.87 144.97 23.81 Favored 'General case' 0 CA--C 1.464 -2.328 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.406 ' CE2' ' HA ' ' A' ' 146' ' ' ASN . 2.7 t80 -107.69 111.83 62.41 Favored Pre-proline 0 N--CA 1.421 -1.918 0 N-CA-C 101.087 -3.671 . . . . 0.0 101.087 163.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -107.44 -116.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.412 -3.312 1 N-CA-C 100.622 -4.415 . . . . 0.0 100.622 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 175.28 -48.47 0.01 OUTLIER 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 100.387 -3.931 . . . . 0.0 100.387 -140.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -85.26 115.6 23.13 Favored 'General case' 0 CA--C 1.487 -1.458 0 CA-C-O 123.052 1.406 . . . . 0.0 111.705 -155.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.4 mt -82.41 143.43 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 CA-C-N 113.022 -1.899 . . . . 0.0 107.258 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -104.85 84.28 2.12 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 176.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.93 -129.34 9.14 Favored Glycine 0 CA--C 1.482 -2.008 0 CA-C-O 122.94 1.3 . . . . 0.0 110.857 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -94.43 25.18 4.03 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 126.722 2.009 . . . . 0.0 114.155 -172.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.251 20.4 mt-30 -172.13 130.93 0.62 Allowed 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -165.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.7 ttp -113.6 113.59 25.28 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 118.742 0.701 . . . . 0.0 110.326 -172.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.1 mm -82.17 124.98 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 O-C-N 121.227 -0.921 . . . . 0.0 108.756 170.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.2 ttp -106.92 135.44 48.47 Favored 'General case' 0 CA--C 1.471 -2.081 0 N-CA-C 101.783 -3.414 . . . . 0.0 101.783 156.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 t -98.1 132.94 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 C-N-CA 116.486 -2.085 . . . . 0.0 106.894 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 0.3 OUTLIER -116.47 148.33 40.86 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 100.255 -3.98 . . . . 0.0 100.255 -177.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -142.06 -173.96 0.39 Allowed Pre-proline 0 N--CA 1.431 -1.401 0 CA-C-O 117.009 -1.472 . . . . 0.0 110.242 -172.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -68.88 153.67 72.34 Favored 'Trans proline' 0 N--CA 1.437 -1.823 0 C-N-CA 122.564 2.176 . . . . 0.0 108.817 165.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -77.55 113.94 15.88 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 169.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.42 ' HZ1' ' HB2' ' A' ' 178' ' ' LYS . 10.3 mtmp? -100.96 79.63 2.05 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -75.48 117.06 16.85 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 . . . . . 0 C--O 1.261 1.664 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -178.691 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 CA--C 1.479 -1.766 0 CA-C-O 122.174 0.988 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.4 mm -86.27 116.97 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 CA-C-N 112.874 -1.967 . . . . 0.0 106.808 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -95.08 164.82 12.71 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -170.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.3 t -103.22 120.67 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.627 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 172.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -104.34 171.81 7.14 Favored 'General case' 0 CA--C 1.482 -1.661 0 C-N-CA 117.863 -1.535 . . . . 0.0 107.203 152.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -144.46 154.73 43.23 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.52 165.23 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 171.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -111.32 153.71 25.57 Favored 'General case' 0 CA--C 1.487 -1.456 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.113 166.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -140.24 98.9 3.53 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 172.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -87.71 172.97 7.02 Favored Pre-proline 0 N--CA 1.435 -1.193 0 C-N-CA 125.376 1.471 . . . . 0.0 110.013 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.74 135.53 26.07 Favored 'Trans proline' 0 N--CA 1.433 -2.078 0 N-CA-C 105.596 -2.501 . . . . 0.0 105.596 168.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.61 13.89 60.6 Favored Glycine 0 CA--C 1.483 -1.952 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.1 m -107.54 88.45 2.74 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 168.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.256 0.6 OUTLIER -111.42 -179.5 3.73 Favored 'General case' 1 N--CA 1.373 -4.317 0 C-N-CA 128.867 2.867 . . . . 0.0 109.998 176.553 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -51.04 -40.21 57.74 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 127.747 2.419 . . . . 0.0 114.689 -138.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.83 -17.55 69.99 Favored Glycine 0 N--CA 1.414 -2.793 0 N-CA-C 117.169 1.628 . . . . 0.0 117.169 -171.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . 0.263 0.9 OUTLIER -93.86 -27.29 16.5 Favored 'General case' 0 N--CA 1.404 -2.728 0 C-N-CA 126.169 1.788 . . . . 0.0 108.376 169.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.401 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.8 OUTLIER -87.14 -72.18 0.52 Allowed 'General case' 0 CA--C 1.477 -1.833 0 CA-C-N 113.953 -1.476 . . . . 0.0 109.787 -158.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.35 0.0 OUTLIER -55.61 -15.36 2.85 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 120.018 3.34 . . . . 0.0 120.018 173.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.4 t -61.54 -46.82 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 123.397 1.57 . . . . 0.0 110.373 163.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -89.25 -18.5 26.91 Favored 'General case' 0 CA--C 1.468 -2.207 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 tt -56.23 -38.26 70.83 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.094 154.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.476 ' HA ' HG12 ' A' ' 115' ' ' ILE . 42.3 ttt-85 -60.02 -42.93 95.42 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-N 119.193 0.906 . . . . 0.0 111.756 169.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.0 t -56.78 -45.87 81.87 Favored 'General case' 0 C--N 1.376 1.756 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.272 72.2 mt -67.7 -24.83 65.44 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.284 7.2 mm -60.74 -51.09 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.437 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 172.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.37 -43.72 68.03 Favored 'General case' 0 N--CA 1.426 -1.63 0 O-C-N 126.196 2.185 . . . . 0.0 109.898 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -60.51 -53.8 53.2 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.49 -21.01 63.72 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 126.926 2.091 . . . . 0.0 114.649 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -73.26 -37.1 66.42 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 127.188 2.195 . . . . 0.0 108.625 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -66.51 -26.98 67.42 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 123.14 0.576 . . . . 0.0 110.669 170.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.45 65.05 1.47 Allowed Glycine 0 CA--C 1.471 -2.662 0 N-CA-C 104.717 -3.353 . . . . 0.0 104.717 -171.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -119.97 166.41 13.38 Favored 'General case' 0 CA--C 1.451 -2.848 1 N-CA-C 97.775 -4.898 . . . . 0.0 97.775 169.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.63 116.97 32.85 Favored 'General case' 0 N--CA 1.395 -3.202 1 N-CA-C 97.365 -5.05 . . . . 0.0 97.365 171.018 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.27 159.09 21.02 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.258 44.8 mtmt -128.08 133.54 49.06 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 163.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.9 mm -86.3 129.96 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.3 m -100.38 126.16 46.72 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 168.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . 0.278 0.3 OUTLIER -80.28 152.1 29.2 Favored 'General case' 0 CA--C 1.462 -2.412 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 164.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -149.42 96.42 2.5 Favored 'General case' 0 N--CA 1.395 -3.216 1 N-CA-C 96.853 -5.24 . . . . 0.0 96.853 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -71.5 -175.35 1.28 Allowed 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 112.227 -2.26 . . . . 0.0 111.542 -172.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -57.54 -76.75 0.03 OUTLIER 'General case' 0 CA--C 1.481 -1.693 0 CA-C-O 123.552 1.644 . . . . 0.0 107.537 166.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 171.26 138.64 2.57 Favored Glycine 0 CA--C 1.474 -2.502 0 CA-C-N 111.686 -2.507 . . . . 0.0 109.395 148.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -149.84 177.54 9.73 Favored 'General case' 0 CA--C 1.496 -1.131 0 C-N-CA 118.204 -1.398 . . . . 0.0 107.409 158.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.81 -60.0 3.05 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 123.516 0.726 . . . . 0.0 109.464 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 94.9 mmm -109.68 105.29 14.49 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 102.837 -3.023 . . . . 0.0 102.837 159.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.18 172.71 3.61 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.597 ' CD2' ' H ' ' A' ' 137' ' ' HIS . 13.0 m-70 -22.05 120.31 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 129.581 3.153 . . . . 0.0 114.316 147.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -106.47 7.27 30.88 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -89.61 -51.3 5.6 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.465 HD11 ' CG ' ' A' ' 137' ' ' HIS . 67.5 mt -52.62 -41.82 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.624 2.37 . . . . 0.0 111.709 173.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.47 -61.4 3.9 Favored Glycine 0 N--CA 1.417 -2.627 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 8.4 ptm -87.51 -3.2 59.0 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -156.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -53.37 57.46 Favored 'General case' 0 CA--C 1.452 -2.813 0 C-N-CA 115.391 -2.524 . . . . 0.0 114.095 152.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.1 t -69.62 -64.33 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.445 -3.071 0 O-C-N 126.308 2.255 . . . . 0.0 107.859 -162.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 90.2 mt -47.13 -52.98 13.99 Favored 'General case' 0 CA--C 1.477 -1.831 0 C-N-CA 128.274 2.63 . . . . 0.0 114.789 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.258 1.5 t30 -62.9 -30.86 71.86 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 174.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -82.83 -14.31 54.58 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.385 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.401 HG21 ' HH ' ' A' ' 107' ' ' TYR . 2.1 t -76.23 -46.67 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.628 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 177.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.265 25.2 ttmt -49.51 -53.68 22.06 Favored 'General case' 0 CA--C 1.458 -2.56 0 C-N-CA 125.895 1.678 . . . . 0.0 111.539 173.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -37.2 63.69 Favored 'General case' 0 N--CA 1.408 -2.56 0 C-N-CA 126.469 1.907 . . . . 0.0 109.985 -167.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.79 -31.62 66.79 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 116.339 -2.144 . . . . 0.0 114.678 171.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.296 0.2 OUTLIER -83.51 -27.48 29.34 Favored 'General case' 0 CA--C 1.46 -2.51 0 CA-C-O 115.702 -2.094 . . . . 0.0 115.326 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -28.07 -22.31 0.0 OUTLIER 'General case' 0 CA--C 1.483 -1.624 1 C-N-CA 136.163 5.785 . . . . 0.0 119.786 -174.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -50.16 -49.58 51.72 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 126.342 1.857 . . . . 0.0 115.042 162.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.409 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 2.6 tm? -121.6 -52.77 2.01 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 128.06 2.544 . . . . 0.0 107.23 -157.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.362 . . -112.1 148.16 34.54 Favored 'General case' 0 CA--C 1.452 -2.791 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -176.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -119.93 -178.27 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.459 -2.528 0 C-N-CA 116.128 -2.229 . . . . 0.0 115.672 147.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.569 HG11 ' H ' ' A' ' 160' ' ' SER . 6.0 t -86.64 148.63 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 165.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -82.39 -39.54 22.56 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.569 ' H ' HG11 ' A' ' 158' ' ' VAL . 0.9 OUTLIER -150.61 131.0 13.74 Favored 'General case' 0 CA--C 1.465 -2.316 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -174.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -106.67 117.81 55.95 Favored Pre-proline 0 N--CA 1.424 -1.755 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -132.69 -118.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.413 -3.208 1 N-CA-C 101.054 -4.248 . . . . 0.0 101.054 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -174.22 -44.2 0.01 OUTLIER 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 -133.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -85.61 103.81 14.77 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-O 122.26 1.029 . . . . 0.0 110.866 -159.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.6 mt -81.78 142.02 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.254 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -119.31 100.61 7.42 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.74 -143.89 27.18 Favored Glycine 0 CA--C 1.482 -1.969 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -173.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 43.0 ptt85 -96.46 38.14 1.22 Allowed 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 125.673 1.589 . . . . 0.0 110.707 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.317 25.6 mt-30 -166.72 135.5 2.85 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.229 0.612 . . . . 0.0 110.635 -172.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 38.1 ttp -123.0 117.27 25.09 Favored 'General case' 0 C--N 1.364 1.214 0 CA-C-N 118.802 0.728 . . . . 0.0 112.633 -172.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.7 mm -82.19 123.84 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 O-C-N 120.555 -1.341 . . . . 0.0 109.058 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -100.47 128.57 46.49 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 157.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.22 122.94 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.404 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.2 69.12 0.84 Allowed 'General case' 0 C--N 1.354 0.765 0 C-N-CA 127.654 2.382 . . . . 0.0 117.281 -170.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.335 . . -91.48 172.59 6.37 Favored Pre-proline 0 C--N 1.359 0.99 0 N-CA-C 119.604 3.187 . . . . 0.0 119.604 -171.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -68.85 140.08 45.24 Favored 'Trans proline' 0 CA--C 1.491 -1.661 0 CA-C-N 120.912 1.362 . . . . 0.0 110.922 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -79.95 135.27 36.36 Favored 'General case' 0 CA--C 1.483 -1.597 0 O-C-N 125.0 1.438 . . . . 0.0 107.263 176.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -72.66 118.43 15.57 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 113.969 -1.468 . . . . 0.0 107.142 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -70.68 134.7 47.75 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.559 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 . . . . . 0 C--O 1.26 1.638 0 CA-C-O 117.79 -1.1 . . . . 0.0 108.657 -178.449 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.47 -2.124 0 CA-C-O 124.631 2.157 . . . . 0.0 107.684 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.0 mm -87.34 121.0 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 CA-C-N 108.67 -3.877 . . . . 0.0 107.801 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -111.04 164.99 12.25 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -162.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 75.3 t -90.2 120.62 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.801 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 161.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -112.09 166.54 11.15 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 150.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -133.94 155.72 49.42 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.002 -164.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 tp -135.72 162.82 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 101.881 -3.377 . . . . 0.0 101.881 166.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -111.15 157.78 19.65 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 119.413 1.006 . . . . 0.0 109.612 163.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.454 ' CE2' HG23 ' A' ' 148' ' ' VAL . 17.1 m-85 -125.74 135.15 51.73 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 166.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.461 ' HE ' ' H ' ' A' ' 99' ' ' ARG . 1.3 mpm_? -104.7 167.79 9.39 Favored Pre-proline 0 N--CA 1.424 -1.735 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.359 -167.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -57.72 138.16 84.73 Favored 'Trans proline' 0 CA--C 1.483 -2.052 0 C-N-CA 125.115 3.876 . . . . 0.0 112.841 169.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.42 -119.32 9.23 Favored Glycine 0 CA--C 1.479 -2.182 0 N-CA-C 106.803 -2.519 . . . . 0.0 106.803 -170.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.5 m 52.34 103.82 0.01 OUTLIER 'General case' 0 CA--C 1.481 -1.674 0 C-N-CA 130.212 3.405 . . . . 0.0 114.038 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -131.39 -139.44 0.21 Allowed 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 103.668 -2.715 . . . . 0.0 103.668 170.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.06 -72.76 0.12 Allowed 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -84.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.39 44.54 1.53 Allowed Glycine 0 CA--C 1.485 -1.841 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.606 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -106.18 -39.49 5.94 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 147.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.489 ' HH ' HG21 ' A' ' 148' ' ' VAL . 1.0 OUTLIER -73.9 -71.78 0.31 Allowed 'General case' 0 CA--C 1.481 -1.693 0 C-N-CA 126.265 1.826 . . . . 0.0 109.475 -170.214 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.325 0.0 OUTLIER -59.32 -15.48 16.36 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 119.487 3.144 . . . . 0.0 119.487 173.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.66 -43.56 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 121.556 0.693 . . . . 0.0 109.937 162.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -92.39 7.38 43.21 Favored 'General case' 0 CA--C 1.485 -1.556 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.2 tt -85.13 -31.5 23.26 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 104.038 -2.579 . . . . 0.0 104.038 161.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.453 ' HA ' HG12 ' A' ' 115' ' ' ILE . 31.7 ttt180 -62.97 -43.2 99.45 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 122.88 0.472 . . . . 0.0 110.969 168.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.2 t -56.51 -45.26 81.15 Favored 'General case' 0 C--N 1.376 1.732 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.66 -30.23 71.37 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.8 mm -58.54 -48.49 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.521 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 173.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.1 tpt85 -52.37 -50.29 62.7 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 125.466 1.729 . . . . 0.0 112.391 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -57.58 -44.97 85.75 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -35.39 80.7 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 176.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -77.69 -20.87 52.92 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 127.821 2.448 . . . . 0.0 112.417 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -67.87 -19.91 65.07 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 123.658 0.783 . . . . 0.0 109.422 169.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.45 61.59 1.7 Allowed Glycine 0 CA--C 1.46 -3.357 0 N-CA-C 103.561 -3.816 . . . . 0.0 103.561 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -134.19 175.45 9.49 Favored 'General case' 0 CA--C 1.446 -3.043 1 N-CA-C 99.003 -4.443 . . . . 0.0 99.003 173.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.263 17.8 mtpt -89.12 140.19 29.71 Favored 'General case' 0 N--CA 1.396 -3.167 1 N-CA-C 97.55 -4.981 . . . . 0.0 97.55 163.622 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.49 160.34 20.56 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 155.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -142.33 125.87 16.79 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 102.673 -3.084 . . . . 0.0 102.673 167.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.0 mm -86.14 122.72 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.9 m -92.66 123.0 35.63 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 163.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.432 HD12 ' CZ ' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -84.11 152.05 24.55 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 165.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -152.56 91.5 1.58 Allowed 'General case' 0 N--CA 1.393 -3.281 1 N-CA-C 98.752 -4.536 . . . . 0.0 98.752 -172.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.432 ' CZ ' HD12 ' A' ' 128' ' ' LEU . 93.9 m-85 -79.6 158.09 27.18 Favored 'General case' 0 N--CA 1.417 -2.075 0 CA-C-N 112.638 -2.074 . . . . 0.0 107.128 -175.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -89.77 80.99 6.44 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 104.06 -2.571 . . . . 0.0 104.06 155.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.67 -144.31 7.91 Favored Glycine 0 CA--C 1.478 -2.259 0 C-N-CA 120.07 -1.062 . . . . 0.0 114.237 -143.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.34 -168.13 2.81 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -170.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -66.06 -55.68 15.36 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 124.334 1.054 . . . . 0.0 110.464 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 35.3 mtt -111.93 113.61 26.03 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 102.437 -3.172 . . . . 0.0 102.437 153.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.8 178.14 7.07 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.426 ' CD2' HD11 ' A' ' 140' ' ' ILE . 98.5 m-70 0.43 -95.75 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.359 1 C-N-CA 131.754 4.022 . . . . 0.0 120.127 172.17 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 73.9 13.96 4.1 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 127.131 2.173 . . . . 0.0 110.278 -165.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.413 HE21 ' HD1' ' A' ' 137' ' ' HIS . 20.8 mt-30 -106.71 -55.65 2.3 Favored 'General case' 0 CA--C 1.48 -1.733 0 N-CA-C 101.118 -3.66 . . . . 0.0 101.118 171.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.426 HD11 ' CD2' ' A' ' 137' ' ' HIS . 66.8 mt -54.17 -42.43 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 C-N-CA 127.344 2.258 . . . . 0.0 110.908 167.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.57 -59.82 3.17 Favored Glycine 0 CA--C 1.466 -2.982 0 C-N-CA 119.059 -1.543 . . . . 0.0 113.122 -172.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 60.5 mtm -88.02 -0.07 56.58 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -166.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -68.16 -47.7 67.31 Favored 'General case' 0 CA--C 1.457 -2.632 0 C-N-CA 114.73 -2.788 . . . . 0.0 113.33 151.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 98' ' ' PHE . 31.9 t -70.1 -68.98 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.436 -3.426 0 O-C-N 125.67 1.856 . . . . 0.0 107.343 -163.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 mp -48.79 -50.54 33.69 Favored 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 129.217 3.007 . . . . 0.0 113.259 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -61.03 -37.01 81.07 Favored 'General case' 0 CA--C 1.471 -2.061 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -81.02 -14.22 58.11 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.512 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.489 HG21 ' HH ' ' A' ' 107' ' ' TYR . 1.7 t -76.14 -49.1 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.645 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.281 11.9 ttmt -51.95 -45.84 64.53 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 126.394 1.878 . . . . 0.0 113.096 171.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.57 -36.48 63.07 Favored 'General case' 0 N--CA 1.409 -2.492 0 C-N-CA 124.347 1.059 . . . . 0.0 110.024 -171.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -72.94 -39.72 66.0 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 116.473 -2.091 . . . . 0.0 115.178 169.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.306 0.2 OUTLIER -79.61 -20.24 47.32 Favored 'General case' 0 CA--C 1.46 -2.514 0 CA-C-O 116.357 -1.782 . . . . 0.0 115.759 -177.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -26.24 -23.79 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.493 1 C-N-CA 135.042 5.337 . . . . 0.0 119.55 175.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -51.69 -56.54 13.1 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 126.993 2.117 . . . . 0.0 113.21 165.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.3 tt -116.38 -47.42 2.74 Favored 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 126.455 1.902 . . . . 0.0 109.291 -162.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.352 . . -110.14 143.45 40.21 Favored 'General case' 0 CA--C 1.448 -2.954 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.043 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.8 m -120.46 171.98 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.483 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 140.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.456 HG11 ' H ' ' A' ' 160' ' ' SER . 4.0 t -81.46 151.54 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.931 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 172.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -80.92 -38.35 28.02 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 125.581 1.552 . . . . 0.0 107.005 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.456 ' H ' HG11 ' A' ' 158' ' ' VAL . 5.4 t -118.44 -176.32 3.05 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -130.73 101.82 16.77 Favored Pre-proline 0 N--CA 1.42 -1.959 0 N-CA-C 101.111 -3.663 . . . . 0.0 101.111 139.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -75.5 -38.41 1.41 Allowed 'Trans proline' 0 CA--C 1.485 -1.941 0 C-N-CA 122.301 2.001 . . . . 0.0 112.458 -145.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . 0.318 2.4 m 9.66 48.78 0.0 OUTLIER 'General case' 0 N--CA 1.416 -2.165 1 C-N-CA 135.684 5.593 . . . . 0.0 118.713 -160.142 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -123.09 97.85 5.62 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 111.423 -2.626 . . . . 0.0 105.096 164.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.4 HG22 ' HB2' ' A' ' 170' ' ' MET . 0.7 OUTLIER -75.28 139.48 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 -177.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -112.01 85.41 2.14 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.916 -1.493 . . . . 0.0 107.694 -175.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.66 -140.54 20.39 Favored Glycine 0 CA--C 1.485 -1.819 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.1 ttp85 -92.74 28.25 2.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 125.412 1.485 . . . . 0.0 111.214 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.291 36.4 mt-30 -169.04 155.13 6.47 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -167.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.4 ' HB2' HG22 ' A' ' 165' ' ' ILE . 60.7 ttp -146.47 120.85 9.63 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 118.933 0.788 . . . . 0.0 110.765 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.4 mm -79.64 126.89 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 O-C-N 120.786 -1.196 . . . . 0.0 108.627 173.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.7 ttp -105.5 135.24 47.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 160.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.58 126.39 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 118.299 -1.36 . . . . 0.0 109.68 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.78 80.32 1.29 Allowed 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 -168.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.279 . . -85.82 174.91 5.0 Favored Pre-proline 0 CA--C 1.498 -1.032 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -169.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -64.15 141.48 76.34 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 C-N-CA 123.243 2.629 . . . . 0.0 108.263 160.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -76.88 153.83 34.36 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 124.216 0.947 . . . . 0.0 110.856 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -68.76 115.27 7.91 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 170.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -76.49 105.84 7.78 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 . . . . . 0 C--O 1.261 1.672 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -176.659 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.469 -2.135 0 CA-C-O 124.7 2.191 . . . . 0.0 107.645 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.1 mm -91.18 130.85 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 CA-C-N 108.703 -3.862 . . . . 0.0 108.908 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -89.64 162.79 15.44 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.9 t -96.67 115.7 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.792 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 160.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -107.35 175.45 5.49 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 152.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -135.17 155.34 50.85 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 tp -134.66 162.79 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 102.573 -3.121 . . . . 0.0 102.573 164.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -112.31 159.96 18.14 Favored 'General case' 0 CA--C 1.487 -1.465 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.195 161.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.484 ' CE2' HG23 ' A' ' 148' ' ' VAL . 10.8 m-85 -129.31 149.23 51.19 Favored 'General case' 0 CA--C 1.475 -1.924 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 166.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.89 157.81 40.8 Favored Pre-proline 0 N--CA 1.417 -2.109 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.845 -171.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.574 ' HG3' ' H ' ' A' ' 131' ' ' ARG . 18.2 Cg_endo -67.28 124.65 12.37 Favored 'Trans proline' 0 N--CA 1.44 -1.652 1 C-N-CA 125.475 4.117 . . . . 0.0 108.314 168.47 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 26.01 98.24 0.01 OUTLIER Glycine 0 CA--C 1.478 -2.229 0 C-N-CA 130.559 3.933 . . . . 0.0 115.214 -176.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.0 m -163.63 119.08 1.64 Allowed 'General case' 0 CA--C 1.472 -2.047 0 N-CA-C 101.928 -3.36 . . . . 0.0 101.928 -165.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -117.41 -130.5 0.3 Allowed 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -58.16 -81.35 0.02 OUTLIER 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -90.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.33 43.24 1.8 Allowed Glycine 0 CA--C 1.482 -1.987 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.851 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -104.26 -41.0 5.91 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 150.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -74.92 -72.73 0.28 Allowed 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 125.902 1.681 . . . . 0.0 108.677 -171.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.328 0.0 OUTLIER -58.57 -12.42 4.04 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 120.417 3.488 . . . . 0.0 120.417 178.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.56 -41.82 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 C-N-CA 124.197 0.999 . . . . 0.0 110.184 161.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -92.58 -0.09 57.36 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.6 tt -77.52 -35.1 53.75 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 162.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.415 ' HA ' HG12 ' A' ' 115' ' ' ILE . 9.3 ttp180 -60.87 -44.74 96.64 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 125.093 1.357 . . . . 0.0 110.67 171.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.4 m -59.64 -42.18 92.16 Favored 'General case' 0 C--N 1.378 1.831 0 C-N-CA 118.755 -1.178 . . . . 0.0 113.396 174.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.5 mt -62.2 -33.58 74.82 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.2 mm -55.43 -50.52 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 O-C-N 124.433 1.083 . . . . 0.0 108.37 173.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.9 tpt85 -51.71 -45.73 63.67 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 126.207 1.803 . . . . 0.0 112.783 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -58.08 -51.72 68.54 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.21 -19.61 61.7 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -73.45 -34.51 65.44 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 125.257 1.423 . . . . 0.0 110.294 173.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -67.89 -27.84 67.0 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 169.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.56 61.73 1.68 Allowed Glycine 0 CA--C 1.471 -2.678 0 N-CA-C 105.73 -2.948 . . . . 0.0 105.73 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -122.44 170.55 9.85 Favored 'General case' 0 CA--C 1.461 -2.467 1 N-CA-C 98.541 -4.614 . . . . 0.0 98.541 171.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -105.58 122.94 47.06 Favored 'General case' 0 N--CA 1.401 -2.879 1 N-CA-C 97.079 -5.156 . . . . 0.0 97.079 171.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.03 155.32 22.78 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 114.897 -2.721 . . . . 0.0 103.807 167.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -115.71 127.35 55.07 Favored 'General case' 0 CA--C 1.476 -1.899 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 165.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.401 HD13 HD23 ' A' ' 174' ' ' LEU . 3.2 mm -86.65 116.03 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 176.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.3 m -98.13 119.01 36.03 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 172.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.528 HD12 ' CZ ' ' A' ' 130' ' ' PHE 0.287 0.3 OUTLIER -79.95 145.49 32.57 Favored 'General case' 0 CA--C 1.466 -2.263 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 167.844 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -150.46 89.17 1.54 Allowed 'General case' 0 N--CA 1.401 -2.895 1 N-CA-C 96.192 -5.484 . . . . 0.0 96.192 -172.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.528 ' CZ ' HD12 ' A' ' 128' ' ' LEU . 56.0 m-85 -76.3 113.83 14.3 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 101.37 -3.567 . . . . 0.0 101.37 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.574 ' H ' ' HG3' ' A' ' 100' ' ' PRO . 84.2 mtm180 -76.99 -61.71 1.89 Allowed 'General case' 0 CA--C 1.467 -2.246 0 CA-C-O 124.856 2.265 . . . . 0.0 105.346 -176.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 174.82 117.99 0.5 Allowed Glycine 0 CA--C 1.46 -3.345 0 CA-C-N 108.809 -3.814 . . . . 0.0 104.549 148.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -85.75 -64.32 1.17 Allowed 'General case' 0 CA--C 1.472 -2.041 0 CA-C-O 123.763 1.744 . . . . 0.0 106.349 170.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -120.82 26.11 9.29 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 110.48 -3.054 . . . . 0.0 106.219 168.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 58.9 mtt 78.33 -173.27 0.07 Allowed 'General case' 0 C--N 1.36 1.027 0 C-N-CA 127.384 2.274 . . . . 0.0 107.355 -159.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.26 114.7 9.59 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -121.65 170.14 10.01 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 171.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -96.1 20.98 9.39 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 123.953 0.901 . . . . 0.0 108.929 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -99.22 -46.81 5.42 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 167.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.293 89.2 mt -67.28 -38.67 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.608 0 C-N-CA 129.104 2.961 . . . . 0.0 107.484 -174.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -80.85 -58.61 2.62 Favored Glycine 0 N--CA 1.417 -2.61 0 CA-C-N 114.438 -1.255 . . . . 0.0 113.986 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.4 mtm -89.25 1.4 55.76 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -163.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -55.53 -67.71 0.26 Allowed 'General case' 0 CA--C 1.445 -3.063 0 C-N-CA 115.391 -2.524 . . . . 0.0 114.284 140.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.69 -66.63 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.438 -3.346 0 O-C-N 127.269 2.856 . . . . 0.0 108.336 -158.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 22.6 mt -45.99 -55.2 7.15 Favored 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 129.0 2.92 . . . . 0.0 115.299 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -62.21 -31.64 72.21 Favored 'General case' 0 CA--C 1.462 -2.429 0 N-CA-C 117.94 2.57 . . . . 0.0 117.94 173.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -82.26 -16.6 48.92 Favored 'General case' 0 N--CA 1.419 -1.991 0 C-N-CA 117.592 -1.643 . . . . 0.0 109.253 173.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.484 HG23 ' CE2' ' A' ' 98' ' ' PHE . 1.5 t -72.89 -45.82 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.856 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.416 ' HE2' ' HB ' ' A' ' 158' ' ' VAL . 35.7 ttmt -50.59 -51.67 46.24 Favored 'General case' 0 CA--C 1.464 -2.359 0 C-N-CA 125.775 1.63 . . . . 0.0 111.863 172.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -70.1 -41.13 74.43 Favored 'General case' 0 N--CA 1.406 -2.66 0 C-N-CA 125.936 1.695 . . . . 0.0 109.275 -168.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -74.18 -32.79 63.22 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 116.701 -2.0 . . . . 0.0 115.527 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.348 0.3 OUTLIER -81.93 -26.2 34.25 Favored 'General case' 0 CA--C 1.461 -2.464 0 CA-C-O 116.409 -1.758 . . . . 0.0 115.128 -178.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -25.43 -29.94 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.489 1 C-N-CA 135.02 5.328 . . . . 0.0 119.202 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -49.24 -50.38 38.86 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 128.413 2.685 . . . . 0.0 113.993 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 tt -118.26 -50.62 2.45 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 126.339 1.855 . . . . 0.0 109.881 -164.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.346 . . -106.58 147.22 29.72 Favored 'General case' 0 CA--C 1.443 -3.17 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 -177.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.5 m -118.34 -174.54 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.529 0 C-N-CA 114.841 -2.744 . . . . 0.0 114.321 141.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.417 HG11 ' H ' ' A' ' 160' ' ' SER . 2.8 t -88.08 151.02 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.233 0 CA-C-N 111.762 -2.472 . . . . 0.0 105.717 168.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -81.89 -39.59 23.61 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.417 ' H ' HG11 ' A' ' 158' ' ' VAL . 1.1 t -160.69 142.0 12.04 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -171.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -103.06 90.08 2.25 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 101.751 -3.426 . . . . 0.0 101.751 169.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -101.55 -94.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.736 0 N-CA-C 108.055 -1.556 . . . . 0.0 108.055 -139.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.48 -103.07 0.31 Allowed 'General case' 0 N--CA 1.4 -2.956 0 C-N-CA 118.337 -1.345 . . . . 0.0 108.855 -136.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -156.16 156.81 34.85 Favored 'General case' 0 N--CA 1.422 -1.874 1 N-CA-C 99.565 -4.235 . . . . 0.0 99.565 -174.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.3 mt -73.64 134.13 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.306 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 172.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -106.47 108.36 19.83 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 75.54 -139.4 24.6 Favored Glycine 0 CA--C 1.482 -2.006 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 -171.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -114.05 60.06 0.67 Allowed 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 113.095 -1.553 . . . . 0.0 107.79 174.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -173.14 131.19 0.48 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 10.7 ttm -121.53 162.6 20.28 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.6 mt -122.02 152.11 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 158.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.1 ttt -122.22 129.33 52.16 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 103.313 -2.847 . . . . 0.0 103.313 162.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 25.7 t -88.5 138.06 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.401 HD23 HD13 ' A' ' 126' ' ' ILE . 6.0 tp -118.87 90.15 3.27 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 131.104 3.762 . . . . 0.0 121.1 -177.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.391 . . -104.9 165.41 13.29 Favored Pre-proline 0 CA--C 1.5 -0.975 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -71.97 141.01 35.9 Favored 'Trans proline' 0 CA--C 1.492 -1.614 0 C-N-CA 121.762 1.641 . . . . 0.0 108.412 -171.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.9 tmmt? -77.84 132.24 37.9 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 125.097 1.498 . . . . 0.0 107.593 -173.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -70.4 111.55 6.05 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.941 -174.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -78.94 111.87 15.56 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 166.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 . . . . . 0 C--O 1.26 1.652 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 -176.594 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.468 -2.178 0 CA-C-O 124.942 2.306 . . . . 0.0 107.276 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.5 mm -96.52 119.17 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.452 0 CA-C-N 108.653 -3.885 . . . . 0.0 107.057 176.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -93.62 169.07 10.61 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.2 t -101.07 115.73 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 161.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -99.62 172.52 7.23 Favored 'General case' 0 CA--C 1.476 -1.892 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 157.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -148.08 148.2 30.38 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -172.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.8 tp -131.43 161.06 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 103.733 -2.691 . . . . 0.0 103.733 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -121.88 154.25 37.34 Favored 'General case' 0 CA--C 1.487 -1.48 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.606 163.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.469 ' CE2' HG23 ' A' ' 148' ' ' VAL . 46.4 m-85 -129.62 143.5 50.85 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 170.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -121.01 167.39 13.21 Favored Pre-proline 0 N--CA 1.428 -1.543 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -73.5 143.1 33.97 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 122.846 2.364 . . . . 0.0 107.338 170.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.55 9.73 80.91 Favored Glycine 0 CA--C 1.483 -1.947 0 O-C-N 124.16 0.912 . . . . 0.0 110.941 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.5 m -102.08 96.06 6.76 Favored 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 173.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -130.5 -146.49 0.31 Allowed 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 111.932 -2.394 . . . . 0.0 104.67 169.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.64 -69.32 0.25 Allowed 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -84.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.84 39.5 2.79 Favored Glycine 0 CA--C 1.484 -1.862 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.33 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -102.52 -39.16 7.23 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 148.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.483 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -69.91 -75.95 0.11 Allowed 'General case' 0 CA--C 1.478 -1.798 0 C-N-CA 126.784 2.034 . . . . 0.0 109.976 -171.713 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.331 0.0 OUTLIER -59.49 -12.7 6.73 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 119.967 3.321 . . . . 0.0 119.967 176.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.24 -43.74 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 122.126 0.965 . . . . 0.0 110.259 162.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -91.7 -1.09 57.56 Favored 'General case' 0 CA--C 1.475 -1.938 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.3 tt -79.05 -31.15 44.41 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 161.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.469 ' HA ' HG12 ' A' ' 115' ' ' ILE . 19.1 ttt85 -62.69 -43.0 99.92 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 118.599 -0.715 . . . . 0.0 111.276 169.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.4 m -61.69 -40.97 96.87 Favored 'General case' 0 C--N 1.378 1.819 0 C-N-CA 118.899 -1.12 . . . . 0.0 113.51 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.408 HD12 HD22 ' A' ' 174' ' ' LEU 0.282 55.8 tp -69.09 -26.97 65.2 Favored 'General case' 0 N--CA 1.402 -2.863 0 C-N-CA 126.259 1.823 . . . . 0.0 113.952 178.073 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.469 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.268 5.6 mm -60.96 -49.37 84.98 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.873 0 CA-C-N 121.061 1.755 . . . . 0.0 109.232 170.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -52.39 -48.36 65.69 Favored 'General case' 0 CA--C 1.494 -1.203 0 C-N-CA 126.662 1.985 . . . . 0.0 108.899 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -56.5 -53.85 52.67 Favored 'General case' 0 CA--C 1.483 -1.622 0 C-N-CA 125.992 1.717 . . . . 0.0 111.647 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.4 -39.83 80.76 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.23 -14.06 44.99 Favored 'General case' 0 C--N 1.364 1.212 0 C-N-CA 125.767 1.627 . . . . 0.0 111.746 -170.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -65.79 -25.06 67.08 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 123.073 0.549 . . . . 0.0 109.839 161.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.2 59.47 1.3 Allowed Glycine 0 CA--C 1.468 -2.865 0 N-CA-C 103.917 -3.673 . . . . 0.0 103.917 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -125.32 164.5 20.24 Favored 'General case' 0 CA--C 1.461 -2.475 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 171.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.02 121.54 42.36 Favored 'General case' 0 N--CA 1.407 -2.601 1 N-CA-C 99.869 -4.122 . . . . 0.0 99.869 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.91 115.91 29.76 Favored 'General case' 0 N--CA 1.415 -2.191 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.597 -166.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -98.3 119.68 37.39 Favored 'General case' 0 CA--C 1.491 -1.315 0 O-C-N 121.683 -0.636 . . . . 0.0 110.717 -167.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.9 mm -83.82 134.8 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.51 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 18.6 m -116.64 115.38 25.58 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 165.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.463 HD22 ' CZ ' ' A' ' 130' ' ' PHE . 18.4 tp -82.4 148.49 28.19 Favored 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 167.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -150.58 103.82 3.15 Favored 'General case' 0 N--CA 1.405 -2.708 1 N-CA-C 98.44 -4.652 . . . . 0.0 98.44 -174.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.463 ' CZ ' HD22 ' A' ' 128' ' ' LEU 0.294 77.6 m-85 -74.41 97.69 3.12 Favored 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 127.345 2.258 . . . . 0.0 109.227 -175.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -107.78 28.96 7.68 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 125.036 1.335 . . . . 0.0 110.008 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.19 -46.38 7.03 Favored Glycine 0 CA--C 1.473 -2.581 1 N-CA-C 102.471 -4.252 . . . . 0.0 102.471 161.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 57.26 42.45 25.23 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 109.734 -3.233 . . . . 0.0 112.248 168.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -82.15 -62.17 1.7 Allowed 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 102.246 -3.242 . . . . 0.0 102.246 159.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 25.7 mmt -121.91 -98.25 0.44 Allowed 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.521 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 169.58 108.2 0.01 OUTLIER 'General case' 0 N--CA 1.418 -2.048 1 N-CA-C 98.299 -4.704 . . . . 0.0 98.299 -165.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.518 ' CD2' HD11 ' A' ' 140' ' ' ILE . 6.0 m-70 -110.64 161.95 15.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -159.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -91.92 -10.83 38.09 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.648 170.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -77.33 -58.26 3.37 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 174.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.518 HD11 ' CD2' ' A' ' 137' ' ' HIS . 91.3 mt -54.91 -49.32 71.41 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 C-N-CA 126.934 2.094 . . . . 0.0 111.774 -178.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.402 ' HA2' ' CD2' ' A' ' 128' ' ' LEU . . . -77.0 -57.99 3.56 Favored Glycine 0 CA--C 1.458 -3.515 0 C-N-CA 119.07 -1.538 . . . . 0.0 113.733 -171.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 53.0 mtm -84.54 -0.04 51.62 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 118.123 -0.942 . . . . 0.0 113.09 -166.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.303 2.8 tp10 -64.34 -69.73 0.27 Allowed 'General case' 0 CA--C 1.454 -2.741 0 C-N-CA 115.051 -2.659 . . . . 0.0 115.012 143.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 39.7 t -59.98 -66.9 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.455 -2.707 0 O-C-N 126.261 2.226 . . . . 0.0 110.884 -161.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 73.4 mt -46.07 -55.06 7.45 Favored 'General case' 0 CA--C 1.483 -1.631 0 C-N-CA 128.421 2.688 . . . . 0.0 114.278 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -60.7 -30.01 69.68 Favored 'General case' 0 CA--C 1.469 -2.151 0 N-CA-C 118.609 2.818 . . . . 0.0 118.609 172.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -82.24 -15.35 53.37 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 119.41 -0.329 . . . . 0.0 110.486 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.483 HG21 ' HH ' ' A' ' 107' ' ' TYR . 1.9 t -77.37 -42.47 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.666 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 175.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.43 ' HE2' ' HB ' ' A' ' 158' ' ' VAL 0.254 31.8 ttmt -53.91 -52.04 61.83 Favored 'General case' 0 CA--C 1.462 -2.409 0 C-N-CA 124.943 1.297 . . . . 0.0 111.014 171.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -71.88 -38.75 69.95 Favored 'General case' 0 N--CA 1.407 -2.608 0 C-N-CA 125.674 1.59 . . . . 0.0 109.18 -169.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -74.53 -24.84 59.03 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 116.802 -1.959 . . . . 0.0 114.647 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.267 0.1 OUTLIER -78.92 -37.06 40.78 Favored 'General case' 0 CA--C 1.477 -1.833 0 CA-C-O 116.26 -1.829 . . . . 0.0 111.958 177.259 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -27.63 -29.89 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.488 1 C-N-CA 135.8 5.64 . . . . 0.0 119.642 -167.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -51.51 -47.69 63.19 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 128.789 2.836 . . . . 0.0 114.202 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.43 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 2.0 tm? -120.24 -51.88 2.19 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 128.167 2.587 . . . . 0.0 105.47 -159.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.448 ' HB3' HD13 ' A' ' 174' ' ' LEU 0.302 . . -107.43 144.62 34.09 Favored 'General case' 0 CA--C 1.452 -2.806 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.303 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.3 m -122.71 164.72 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.762 0 C-N-CA 115.286 -2.565 . . . . 0.0 117.604 141.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 5.8 t -81.82 149.37 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.257 0 CA-C-N 110.067 -3.242 . . . . 0.0 105.968 -174.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.76 -38.9 27.81 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -173.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -162.65 144.82 10.64 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -173.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -104.28 88.7 2.17 Favored Pre-proline 0 N--CA 1.424 -1.74 0 N-CA-C 100.64 -3.837 . . . . 0.0 100.64 165.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.72 ' HB2' ' HG1' ' A' ' 163' ' ' THR . 14.5 Cg_endo -94.67 -93.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.657 0 N-CA-C 108.687 -1.313 . . . . 0.0 108.687 -137.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.72 ' HG1' ' HB2' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -102.4 -104.91 0.27 Allowed 'General case' 0 N--CA 1.4 -2.974 0 C-N-CA 117.997 -1.481 . . . . 0.0 107.464 -139.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -157.02 150.76 24.53 Favored 'General case' 0 N--CA 1.42 -1.942 1 N-CA-C 97.63 -4.952 . . . . 0.0 97.63 176.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.433 ' H ' HG13 ' A' ' 165' ' ' ILE . 4.0 mt -74.21 133.7 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.285 0 CA-C-O 122.567 1.175 . . . . 0.0 108.61 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -113.98 116.22 28.87 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.74 -149.6 36.75 Favored Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -172.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -105.26 40.3 1.56 Allowed 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 125.393 1.477 . . . . 0.0 109.792 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -171.41 122.15 0.53 Allowed 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.798 -167.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 39.4 ttm -118.49 123.89 46.25 Favored 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 124.008 0.923 . . . . 0.0 108.815 -174.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.51 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 15.5 mm -83.72 130.05 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 O-C-N 120.968 -1.082 . . . . 0.0 108.282 168.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 3.2 ttp -110.87 124.31 51.81 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 160.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 43.5 t -88.46 136.51 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 0.5 OUTLIER -124.77 150.31 46.41 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 101.673 -3.455 . . . . 0.0 101.673 -178.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.337 . . -142.26 -179.32 0.94 Allowed Pre-proline 0 CA--C 1.488 -1.42 0 CA-C-O 117.824 -1.084 . . . . 0.0 109.458 -173.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -64.93 143.4 79.23 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 122.82 2.347 . . . . 0.0 110.111 165.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -79.7 158.2 27.02 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 165.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -62.36 129.24 39.82 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 123.709 0.803 . . . . 0.0 109.38 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 96.6 mttt 61.17 69.92 0.64 Allowed 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 126.408 1.883 . . . . 0.0 109.827 -169.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 . . . . . 0 C--O 1.259 1.587 0 C-N-CA 127.269 2.227 . . . . 0.0 112.183 179.527 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.482 -1.643 0 CA-C-O 122.073 0.939 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.4 mm -86.85 121.66 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-N 112.964 -1.925 . . . . 0.0 106.549 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -110.74 158.81 18.23 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 -161.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.62 113.61 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.813 0 C-N-CA 118.641 -1.224 . . . . 0.0 108.028 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -107.76 177.42 4.83 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 155.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -139.14 155.8 47.6 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.482 -172.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 tp -133.85 161.37 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 102.936 -2.987 . . . . 0.0 102.936 166.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -118.16 159.36 23.42 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 118.845 0.748 . . . . 0.0 110.175 165.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.41 ' CE2' HG23 ' A' ' 148' ' ' VAL . 25.8 m-85 -138.51 114.01 9.68 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 167.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -93.2 170.66 8.37 Favored Pre-proline 0 N--CA 1.433 -1.286 0 C-N-CA 124.586 1.154 . . . . 0.0 107.911 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -73.84 137.99 25.4 Favored 'Trans proline' 0 N--CA 1.43 -2.238 0 N-CA-C 105.354 -2.595 . . . . 0.0 105.354 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.55 8.0 66.31 Favored Glycine 0 CA--C 1.483 -1.923 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 78.8 m -100.73 89.85 4.03 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 167.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -124.59 -173.61 2.83 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 112.481 -2.145 . . . . 0.0 105.984 173.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -52.97 -43.79 66.65 Favored 'General case' 0 CA--C 1.481 -1.704 0 C-N-CA 126.682 1.993 . . . . 0.0 114.406 -128.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.43 -5.47 79.11 Favored Glycine 0 N--CA 1.417 -2.624 0 N-CA-C 116.332 1.293 . . . . 0.0 116.332 -170.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -98.25 -30.14 12.79 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 124.826 1.251 . . . . 0.0 107.857 168.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.491 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -86.78 -71.08 0.57 Allowed 'General case' 0 CA--C 1.469 -2.154 0 CA-C-N 112.351 -2.204 . . . . 0.0 111.235 -157.345 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.431 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.323 0.0 OUTLIER -58.94 -14.97 10.7 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 118.844 2.905 . . . . 0.0 118.844 174.057 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.03 -45.71 98.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 C-N-CA 124.711 1.205 . . . . 0.0 110.328 161.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -92.84 5.15 52.29 Favored 'General case' 0 CA--C 1.485 -1.541 0 O-C-N 120.137 -1.602 . . . . 0.0 115.269 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -83.45 -32.42 26.05 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 163.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.425 ' HA ' HG12 ' A' ' 115' ' ' ILE . 14.9 ttp180 -60.33 -45.62 92.77 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 125.158 1.383 . . . . 0.0 110.122 169.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.5 t -62.0 -40.38 95.45 Favored 'General case' 0 C--N 1.374 1.66 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.5 tp -67.42 -33.4 75.08 Favored 'General case' 0 N--CA 1.401 -2.88 0 C-N-CA 125.069 1.348 . . . . 0.0 113.844 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.425 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.255 8.5 mm -54.16 -50.75 53.12 Favored 'Isoleucine or valine' 0 C--N 1.373 1.626 0 CA-C-N 119.155 0.889 . . . . 0.0 108.865 170.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -50.01 -45.22 51.64 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 128.172 2.589 . . . . 0.0 112.464 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -55.94 -54.23 47.23 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 172.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.51 -22.35 64.53 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -76.27 -31.4 58.26 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 126.188 1.795 . . . . 0.0 111.175 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.1 -23.93 63.13 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 168.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.28 72.89 1.24 Allowed Glycine 0 CA--C 1.466 -2.977 0 N-CA-C 104.778 -3.329 . . . . 0.0 104.778 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -129.14 170.91 12.95 Favored 'General case' 0 CA--C 1.449 -2.941 1 N-CA-C 97.749 -4.908 . . . . 0.0 97.749 169.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -104.72 113.48 27.1 Favored 'General case' 0 N--CA 1.393 -3.314 1 N-CA-C 96.395 -5.409 . . . . 0.0 96.395 171.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.99 154.34 25.75 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.279 78.9 mttt -118.68 137.53 53.25 Favored 'General case' 0 CA--C 1.469 -2.145 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 164.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.5 mm -83.18 128.92 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.37 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.8 m -110.78 122.84 48.84 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 169.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.487 HD23 ' CE1' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -87.01 155.37 20.19 Favored 'General case' 0 CA--C 1.469 -2.163 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 170.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -151.57 89.69 1.51 Allowed 'General case' 0 N--CA 1.405 -2.694 0 N-CA-C 101.042 -3.688 . . . . 0.0 101.042 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.487 ' CE1' HD23 ' A' ' 128' ' ' LEU . 95.8 m-85 -78.35 163.18 25.9 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 112.237 -2.256 . . . . 0.0 109.394 -171.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -113.2 32.84 5.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 170.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -114.12 -13.08 10.3 Favored Glycine 0 CA--C 1.47 -2.747 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.5 mtm-85 70.98 -146.33 0.07 Allowed 'General case' 0 CA--C 1.491 -1.321 0 O-C-N 125.604 1.414 . . . . 0.0 109.793 170.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -48.72 107.37 0.13 Allowed 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 127.812 2.445 . . . . 0.0 112.6 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 1.3 mtp 49.37 77.88 0.1 Allowed 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 127.187 2.195 . . . . 0.0 111.546 -169.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.35 -163.35 0.5 Allowed 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 122.706 1.241 . . . . 0.0 113.608 -173.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.427 ' CB ' ' HB ' ' A' ' 140' ' ' ILE . 70.5 m-70 -32.51 153.18 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 131.176 3.79 . . . . 0.0 117.701 159.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -124.06 -2.83 8.13 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 170.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -83.81 -55.05 4.46 Favored 'General case' 0 CA--C 1.481 -1.702 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.427 ' HB ' ' CB ' ' A' ' 137' ' ' HIS . 64.2 mt -83.01 110.66 18.28 Favored 'Isoleucine or valine' 1 N--CA 1.376 -4.163 1 N-CA-C 95.296 -5.816 . . . . 0.0 95.296 166.289 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.88 -71.01 0.33 Allowed Glycine 1 N--CA 1.381 -4.999 2 C-N-CA 134.887 5.994 . . . . 0.0 108.273 165.293 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.4 mtm -94.86 20.07 9.32 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -169.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -50.68 25.45 Favored 'General case' 0 CA--C 1.454 -2.726 0 C-N-CA 116.4 -2.12 . . . . 0.0 113.939 137.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.0 t -68.14 -67.72 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.429 -3.696 0 O-C-N 126.469 2.356 . . . . 0.0 106.669 -159.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.13 -55.93 3.05 Favored 'General case' 0 CA--C 1.459 -2.546 0 C-N-CA 129.336 3.055 . . . . 0.0 111.843 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.51 -37.96 73.83 Favored 'General case' 0 CA--C 1.469 -2.157 0 C-N-CA 125.924 1.689 . . . . 0.0 114.509 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -81.82 -14.83 55.8 Favored 'General case' 0 N--CA 1.421 -1.925 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.747 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.491 HG21 ' HH ' ' A' ' 107' ' ' TYR . 1.4 t -75.25 -47.77 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.764 0 CA-C-O 116.082 -1.913 . . . . 0.0 106.55 176.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.414 ' HB2' HG23 ' A' ' 158' ' ' VAL . 3.5 ttmt -53.06 -51.87 60.37 Favored 'General case' 0 CA--C 1.46 -2.482 0 CA-C-O 117.248 -1.358 . . . . 0.0 110.02 171.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.41 -36.53 81.46 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 119.01 0.823 . . . . 0.0 110.268 -168.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.29 -43.97 66.09 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 116.519 -2.072 . . . . 0.0 116.414 168.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.275 0.2 OUTLIER -82.74 -18.17 41.68 Favored 'General case' 0 CA--C 1.468 -2.176 0 N-CA-C 118.064 2.616 . . . . 0.0 118.064 -172.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -25.64 -31.52 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.154 1 C-N-CA 133.571 4.748 . . . . 0.0 118.321 170.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -53.11 -50.32 64.7 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 127.998 2.519 . . . . 0.0 114.459 173.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 tt -112.4 -51.76 2.82 Favored 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 125.97 1.708 . . . . 0.0 110.633 -169.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.308 . . -104.46 144.46 31.63 Favored 'General case' 0 CA--C 1.452 -2.821 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.572 -174.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.5 m -128.84 159.78 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.484 0 N-CA-C 120.196 3.406 . . . . 0.0 120.196 148.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 149' ' ' LYS . 2.4 t -83.2 150.07 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.257 0 CA-C-N 110.108 -3.224 . . . . 0.0 105.841 -173.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -81.54 -39.75 24.18 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 -174.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.4 t -159.78 157.74 29.89 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -169.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -116.32 103.52 52.88 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 175.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.565 ' HB2' ' HG1' ' A' ' 163' ' ' THR . 38.0 Cg_endo -145.99 -120.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.422 1 C-N-CA 111.733 -5.045 . . . . 0.0 106.351 -136.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.565 ' HG1' ' HB2' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -80.32 -84.41 0.1 Allowed 'General case' 0 N--CA 1.408 -2.553 0 C-N-CA 116.581 -2.048 . . . . 0.0 110.521 -84.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -156.19 152.68 28.13 Favored 'General case' 0 N--CA 1.419 -2.009 1 N-CA-C 99.586 -4.227 . . . . 0.0 99.586 175.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 3.3 mt -81.46 127.66 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -120.49 103.52 9.24 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 111.351 -2.659 . . . . 0.0 104.728 -171.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.26 -139.47 24.11 Favored Glycine 0 CA--C 1.481 -2.073 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 -168.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -97.4 29.83 3.09 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.395 -1.402 . . . . 0.0 112.104 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.322 28.5 mt-30 -167.08 145.46 4.99 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 118.378 0.536 . . . . 0.0 112.371 -157.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 41.9 ttm -129.98 121.11 25.9 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 121.275 0.559 . . . . 0.0 110.519 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.7 mm -83.02 128.99 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 O-C-N 120.895 -1.128 . . . . 0.0 109.205 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.408 ' SD ' ' CE1' ' A' ' 161' ' ' PHE . 1.2 ttp -108.48 140.61 41.56 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 156.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.1 t -106.17 135.79 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 C-N-CA 119.171 -1.011 . . . . 0.0 109.299 -173.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.1 tp -118.81 96.66 5.35 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 121.626 3.935 . . . . 0.0 121.626 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.271 . . -98.84 168.43 9.75 Favored Pre-proline 0 CA--C 1.499 -0.987 0 N-CA-C 115.899 1.815 . . . . 0.0 115.899 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -75.7 135.6 18.02 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 N-CA-C 105.039 -2.716 . . . . 0.0 105.039 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -80.72 163.06 23.82 Favored 'General case' 0 CA--C 1.49 -1.349 0 C-N-CA 118.365 -1.334 . . . . 0.0 113.905 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -84.42 122.66 29.27 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 166.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -67.84 126.87 30.79 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 . . . . . 0 C--O 1.259 1.589 0 CA-C-O 117.787 -1.101 . . . . 0.0 108.545 -179.668 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.469 -2.136 0 CA-C-O 124.836 2.255 . . . . 0.0 107.568 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.4 mm -86.0 120.55 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.496 0 CA-C-N 108.526 -3.943 . . . . 0.0 107.046 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -98.98 164.67 12.09 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -166.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.8 t -97.84 120.34 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -102.5 168.5 9.25 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 152.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -136.12 153.27 51.35 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 tp -135.57 160.93 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 167.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -117.27 155.73 28.99 Favored 'General case' 0 CA--C 1.484 -1.564 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.831 165.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -139.44 139.29 37.03 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -104.77 175.2 2.27 Favored Pre-proline 0 N--CA 1.434 -1.253 0 CA-C-O 118.804 -0.617 . . . . 0.0 109.403 -172.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.99 136.52 61.66 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 C-N-CA 123.518 2.812 . . . . 0.0 111.383 171.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 26.88 95.58 0.01 OUTLIER Glycine 0 CA--C 1.468 -2.851 0 C-N-CA 130.628 3.966 . . . . 0.0 114.463 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.99 -157.24 0.59 Allowed 'General case' 0 N--CA 1.397 -3.116 0 CA-C-N 111.4 -2.4 . . . . 0.0 106.264 -169.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.443 0.7 OUTLIER -144.47 167.0 23.53 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 110.637 -2.983 . . . . 0.0 110.781 -142.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -68.8 -76.53 0.09 Allowed 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -107.02 47.06 1.08 Allowed Glycine 0 CA--C 1.478 -2.259 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.619 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -104.97 -42.32 5.36 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 144.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -82.51 -64.02 1.26 Allowed 'General case' 0 CA--C 1.483 -1.609 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.138 -163.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.336 0.0 OUTLIER -61.44 -12.02 12.88 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 119.649 3.203 . . . . 0.0 119.649 176.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.84 -44.69 99.73 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-O 122.649 1.214 . . . . 0.0 110.06 161.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -91.46 0.55 57.49 Favored 'General case' 0 CA--C 1.477 -1.842 0 O-C-N 120.454 -1.404 . . . . 0.0 114.568 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.66 -28.76 33.43 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 162.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.464 ' HA ' HG12 ' A' ' 115' ' ' ILE . 40.7 ttt180 -62.08 -42.78 99.56 Favored 'General case' 0 C--N 1.361 1.096 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.874 166.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.4 m -58.88 -43.6 90.96 Favored 'General case' 0 C--N 1.38 1.9 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 173.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.261 83.5 mt -64.75 -29.2 70.17 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 116.585 2.069 . . . . 0.0 116.585 175.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.254 10.1 mm -58.32 -51.44 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.899 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.085 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -50.08 -46.88 53.78 Favored 'General case' 0 CA--C 1.49 -1.329 0 O-C-N 126.025 2.078 . . . . 0.0 109.713 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -59.76 -56.05 26.65 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.221 1.008 . . . . 0.0 112.848 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.71 -27.66 65.18 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 125.737 1.615 . . . . 0.0 115.321 -177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -82.8 -17.34 44.43 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 124.113 0.965 . . . . 0.0 111.81 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -71.44 -29.64 65.12 Favored 'General case' 0 C--N 1.362 1.137 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 162.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.02 65.27 1.13 Allowed Glycine 0 CA--C 1.474 -2.483 0 N-CA-C 105.558 -3.017 . . . . 0.0 105.558 -172.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -125.82 173.34 9.15 Favored 'General case' 0 CA--C 1.456 -2.654 1 N-CA-C 98.069 -4.789 . . . . 0.0 98.069 169.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.12 122.49 47.39 Favored 'General case' 0 N--CA 1.4 -2.974 1 N-CA-C 96.983 -5.191 . . . . 0.0 96.983 170.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.98 160.11 21.1 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 115.453 -2.499 . . . . 0.0 105.708 169.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -133.26 119.3 19.62 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 171.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.8 mm -85.23 134.65 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.704 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.1 m -122.89 127.97 49.7 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . 0.377 0.3 OUTLIER -80.47 153.35 28.24 Favored 'General case' 0 CA--C 1.454 -2.739 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 169.365 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 33.4 ttt-85 -148.34 91.77 1.95 Allowed 'General case' 0 N--CA 1.399 -3.024 1 N-CA-C 98.556 -4.609 . . . . 0.0 98.556 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -65.56 141.38 58.46 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 110.598 -3.001 . . . . 0.0 109.139 -172.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.0 ttm105 -110.92 25.56 11.65 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -80.39 -47.49 6.86 Favored Glycine 0 CA--C 1.475 -2.418 1 N-CA-C 102.85 -4.1 . . . . 0.0 102.85 156.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 65.03 30.87 11.53 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 129.835 3.254 . . . . 0.0 112.088 169.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 176.75 -42.2 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.514 1 N-CA-C 100.188 -4.004 . . . . 0.0 100.188 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 67.7 mtm -79.12 -25.33 42.97 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.094 -174.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 4.48 115.76 0.0 OUTLIER 'General case' 0 C--N 1.37 1.468 1 C-N-CA 131.85 4.06 . . . . 0.0 117.871 176.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.546 ' HB2' ' H ' ' A' ' 140' ' ' ILE . 4.0 m170 -111.36 167.33 10.38 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -161.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -94.21 -4.33 49.18 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 121.566 0.698 . . . . 0.0 109.73 169.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -82.83 -54.42 5.12 Favored 'General case' 0 CA--C 1.476 -1.868 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.546 ' H ' ' HB2' ' A' ' 137' ' ' HIS . 82.8 mt -56.31 -47.5 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.125 0 C-N-CA 126.51 1.924 . . . . 0.0 110.753 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.85 -63.55 2.82 Favored Glycine 0 N--CA 1.414 -2.809 0 O-C-N 123.814 0.696 . . . . 0.0 112.404 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 71.5 mtm -96.84 24.75 5.83 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -163.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -62.3 1.49 Allowed 'General case' 0 CA--C 1.453 -2.756 0 C-N-CA 116.171 -2.212 . . . . 0.0 115.545 129.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.7 t -61.94 -64.03 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.45 -2.899 0 O-C-N 126.435 2.335 . . . . 0.0 109.183 -161.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 72.9 mt -43.45 -55.53 4.12 Favored 'General case' 0 CA--C 1.48 -1.725 0 C-N-CA 127.686 2.395 . . . . 0.0 114.086 176.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -57.62 -37.6 73.56 Favored 'General case' 0 CA--C 1.476 -1.879 0 C-N-CA 126.484 1.914 . . . . 0.0 114.298 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -80.2 -15.29 57.36 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 118.845 0.748 . . . . 0.0 111.38 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.8 t -74.2 -47.07 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.724 0 CA-C-O 116.459 -1.734 . . . . 0.0 106.732 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.439 ' HB2' HG23 ' A' ' 158' ' ' VAL . 10.7 ttmt -55.41 -50.78 68.87 Favored 'General case' 0 CA--C 1.461 -2.452 0 CA-C-O 116.776 -1.583 . . . . 0.0 110.011 172.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -66.84 -36.45 82.36 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 119.733 1.151 . . . . 0.0 110.105 -168.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.09 -48.44 57.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 116.662 -2.015 . . . . 0.0 115.843 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.283 0.2 OUTLIER -82.62 -14.38 54.86 Favored 'General case' 0 CA--C 1.468 -2.198 0 N-CA-C 118.147 2.647 . . . . 0.0 118.147 -172.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -25.4 -30.23 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.263 1 C-N-CA 133.815 4.846 . . . . 0.0 118.358 168.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.36 -54.37 27.09 Favored 'General case' 0 CA--C 1.488 -1.428 0 C-N-CA 127.478 2.311 . . . . 0.0 113.828 170.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.3 tt -113.52 -53.7 2.67 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.38 -1.736 . . . . 0.0 110.491 -168.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.301 . . -92.65 148.22 22.24 Favored 'General case' 0 CA--C 1.455 -2.698 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.2 m -118.58 -164.04 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.452 -2.821 0 C-N-CA 114.305 -2.958 . . . . 0.0 111.155 141.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.545 HG13 ' H ' ' A' ' 160' ' ' SER 0.277 2.9 t -111.93 163.01 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.394 0 C-N-CA 129.649 3.18 . . . . 0.0 107.364 -177.319 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -84.09 -43.97 14.53 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 172.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.545 ' H ' HG13 ' A' ' 158' ' ' VAL . 0.9 OUTLIER -157.29 147.62 21.01 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.557 -167.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.5 99.62 38.07 Favored Pre-proline 0 N--CA 1.416 -2.15 0 N-CA-C 103.136 -2.912 . . . . 0.0 103.136 165.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -100.35 -111.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.41 -3.382 0 N-CA-C 101.795 -3.963 . . . . 0.0 101.795 -163.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 179.44 -46.53 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.575 0 N-CA-C 102.785 -3.043 . . . . 0.0 102.785 -144.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -83.26 102.91 12.25 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 122.681 1.229 . . . . 0.0 113.043 -146.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.1 mt -80.07 131.03 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.119 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 166.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -125.26 98.81 5.79 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 -175.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.15 -139.07 17.27 Favored Glycine 0 CA--C 1.483 -1.939 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 -169.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.01 38.87 1.74 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.136 1.774 . . . . 0.0 109.637 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -169.68 139.22 1.97 Allowed 'General case' 0 C--N 1.359 0.988 0 O-C-N 121.383 -0.823 . . . . 0.0 111.835 -168.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 31.2 ttm -123.36 121.86 36.85 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -170.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.4 mt -87.69 142.69 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 C-N-CA 117.755 -1.578 . . . . 0.0 110.758 173.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.403 ' SD ' HG11 ' A' ' 158' ' ' VAL . 3.3 tmm? -111.72 126.84 55.47 Favored 'General case' 0 CA--C 1.476 -1.894 0 N-CA-C 101.421 -3.548 . . . . 0.0 101.421 153.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.2 t -91.72 124.93 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 118.052 -1.459 . . . . 0.0 108.45 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.422 HD11 HG21 ' A' ' 158' ' ' VAL . 14.5 tp -104.45 84.43 2.19 Favored 'General case' 0 C--N 1.349 0.556 0 N-CA-C 121.324 3.824 . . . . 0.0 121.324 -174.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.438 . . -108.08 155.66 39.7 Favored Pre-proline 0 C--N 1.359 0.993 0 N-CA-C 119.279 3.066 . . . . 0.0 119.279 -173.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.25 139.39 45.84 Favored 'Trans proline' 0 CA--C 1.491 -1.653 0 C-N-CA 123.398 2.732 . . . . 0.0 111.545 -160.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -79.63 144.29 33.93 Favored 'General case' 0 CA--C 1.49 -1.343 0 O-C-N 125.053 1.471 . . . . 0.0 107.614 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -66.69 113.08 4.55 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.591 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -76.92 127.53 32.89 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 175.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 . . . . . 0 C--O 1.26 1.63 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.243 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.469 -2.167 0 CA-C-O 124.734 2.207 . . . . 0.0 107.404 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.9 mm -88.92 116.37 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 108.732 -3.849 . . . . 0.0 107.295 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -107.06 158.79 16.79 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -167.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.496 HG21 ' HZ3' ' A' ' 123' ' ' LYS . 72.3 t -90.18 112.43 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -104.58 177.08 4.95 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 157.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -140.01 156.29 46.69 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 117.778 0.263 . . . . 0.0 111.265 -170.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 tp -139.51 168.64 18.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 164.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -118.23 155.61 30.24 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 118.833 0.742 . . . . 0.0 111.178 162.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.415 ' CE2' HG22 ' A' ' 148' ' ' VAL . 19.2 m-85 -124.55 153.49 42.04 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 168.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -131.17 166.57 26.75 Favored Pre-proline 0 N--CA 1.437 -1.101 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.828 -170.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.561 ' HG3' ' H ' ' A' ' 131' ' ' ARG . 22.1 Cg_endo -78.29 140.22 17.28 Favored 'Trans proline' 0 CA--C 1.49 -1.689 0 C-N-CA 124.092 3.195 . . . . 0.0 108.31 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.65 13.72 83.19 Favored Glycine 0 CA--C 1.484 -1.872 0 O-C-N 124.14 0.9 . . . . 0.0 112.0 173.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.2 m -103.5 98.74 8.58 Favored 'General case' 0 N--CA 1.408 -2.546 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -126.69 -138.09 0.26 Allowed 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 110.889 -2.869 . . . . 0.0 103.636 166.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.52 -81.56 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -86.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.13 43.73 1.73 Allowed Glycine 0 CA--C 1.485 -1.785 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.554 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -103.89 -39.38 6.64 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 150.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.502 ' HH ' HG23 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -73.23 -71.69 0.29 Allowed 'General case' 0 CA--C 1.479 -1.76 0 C-N-CA 126.556 1.942 . . . . 0.0 109.112 -171.731 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.427 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.368 0.0 OUTLIER -57.49 -15.42 6.97 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 119.8 3.259 . . . . 0.0 119.8 175.11 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.97 -43.89 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-O 122.014 0.911 . . . . 0.0 110.699 163.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -91.96 2.78 56.33 Favored 'General case' 0 CA--C 1.477 -1.858 0 O-C-N 120.495 -1.378 . . . . 0.0 114.367 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 tt -81.82 -31.96 31.47 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 163.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.434 ' HA ' HG12 ' A' ' 115' ' ' ILE . 50.4 ttt180 -62.64 -42.36 99.55 Favored 'General case' 0 C--N 1.361 1.095 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.696 168.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.7 m -60.18 -38.0 81.91 Favored 'General case' 0 C--N 1.377 1.798 0 C-N-CA 118.632 -1.227 . . . . 0.0 113.728 172.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 72.2 mt -65.24 -33.74 76.71 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 175.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 112' ' ' ARG . 4.7 mm -58.62 -46.11 90.34 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.391 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -49.64 -48.78 49.02 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 128.14 2.576 . . . . 0.0 111.835 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -58.97 -50.05 75.56 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.56 -21.77 62.66 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 124.853 1.261 . . . . 0.0 114.119 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -71.29 -37.7 71.84 Favored 'General case' 0 CA--C 1.491 -1.327 0 C-N-CA 126.75 2.02 . . . . 0.0 109.694 173.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -66.82 -28.22 68.19 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-O 120.732 0.301 . . . . 0.0 110.61 170.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.53 71.47 1.29 Allowed Glycine 0 CA--C 1.473 -2.579 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 -175.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -134.79 174.45 10.56 Favored 'General case' 0 N--CA 1.414 -2.229 1 N-CA-C 99.97 -4.085 . . . . 0.0 99.97 170.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.496 ' HZ3' HG21 ' A' ' 93' ' ' VAL 0.333 13.9 mtmt -88.5 147.47 24.63 Favored 'General case' 0 CA--C 1.459 -2.554 0 N-CA-C 100.918 -3.734 . . . . 0.0 100.918 159.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.18 123.2 47.21 Favored 'General case' 0 CA--C 1.457 -2.623 0 C-N-CA 115.331 -2.548 . . . . 0.0 106.091 160.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -99.75 117.67 34.59 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -168.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.6 mm -85.29 125.92 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -178.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.3 m -97.79 117.22 31.61 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 159.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.46 148.5 37.2 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 166.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -151.14 92.61 1.82 Allowed 'General case' 0 N--CA 1.402 -2.837 1 N-CA-C 97.009 -5.182 . . . . 0.0 97.009 -167.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.493 ' CE2' HD11 ' A' ' 165' ' ' ILE . 90.5 m-85 -76.0 134.27 40.18 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 101.423 -3.547 . . . . 0.0 101.423 174.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.561 ' H ' ' HG3' ' A' ' 100' ' ' PRO . 0.6 OUTLIER -88.58 84.58 6.75 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 103.336 -2.839 . . . . 0.0 103.336 168.81 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -172.06 -130.88 1.29 Allowed Glycine 0 N--CA 1.42 -2.423 0 C-N-CA 116.352 -2.832 . . . . 0.0 112.642 -148.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 64.86 44.99 3.4 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 112.408 -1.896 . . . . 0.0 106.166 -148.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.443 ' H ' ' H ' ' A' ' 136' ' ' ALA . 12.9 pt-20 178.44 -26.21 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 100.592 -3.855 . . . . 0.0 100.592 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.406 ' H ' ' H ' ' A' ' 134' ' ' GLU . 25.6 mmt -113.88 -2.49 13.6 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 169.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.443 ' H ' ' H ' ' A' ' 134' ' ' GLU . . . -77.77 102.12 7.02 Favored 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 121.67 -0.644 . . . . 0.0 109.43 165.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.556 ' HB2' ' H ' ' A' ' 140' ' ' ILE . 21.6 m170 -108.02 -128.86 0.28 Allowed 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.901 0.858 . . . . 0.0 111.352 -173.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.411 ' H ' ' H ' ' A' ' 139' ' ' GLN . 15.6 pt20 -149.35 0.45 0.51 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 103.024 -2.954 . . . . 0.0 103.024 158.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.411 ' H ' ' H ' ' A' ' 138' ' ' GLN . 64.8 mm-40 -86.32 -51.81 6.01 Favored 'General case' 0 CA--C 1.476 -1.894 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.556 ' H ' ' HB2' ' A' ' 137' ' ' HIS . 16.6 mt -90.8 98.9 8.87 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.623 1 N-CA-C 94.153 -6.24 . . . . 0.0 94.153 169.684 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 157.7 -89.67 0.11 Allowed Glycine 0 N--CA 1.412 -2.943 1 CA-C-N 107.883 -4.235 . . . . 0.0 108.857 -174.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.528 ' HG2' ' CE1' ' A' ' 161' ' ' PHE 0.254 75.0 mtp -90.09 5.16 47.96 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 128.779 2.832 . . . . 0.0 113.876 -168.394 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.251 2.3 tp10 -75.48 -45.67 37.06 Favored 'General case' 0 CA--C 1.433 -3.529 0 C-N-CA 116.111 -2.236 . . . . 0.0 111.823 151.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.51 -74.9 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.444 -3.113 0 O-C-N 126.693 2.495 . . . . 0.0 107.539 -161.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.46 -47.4 63.12 Favored 'General case' 0 CA--C 1.481 -1.675 0 C-N-CA 129.908 3.283 . . . . 0.0 112.102 -177.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.253 1.5 t30 -64.98 -32.31 73.97 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -81.39 -15.58 54.78 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.363 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.502 HG23 ' HH ' ' A' ' 107' ' ' TYR . 1.7 t -74.78 -46.42 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.885 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.444 ' HE2' ' HB ' ' A' ' 158' ' ' VAL 0.303 19.7 ttmt -51.27 -48.48 62.19 Favored 'General case' 0 CA--C 1.472 -2.051 0 C-N-CA 126.781 2.032 . . . . 0.0 113.424 172.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.89 -39.65 61.36 Favored 'General case' 0 N--CA 1.408 -2.554 0 C-N-CA 127.238 2.215 . . . . 0.0 109.577 -171.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -75.24 -25.06 57.8 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 116.623 -2.031 . . . . 0.0 115.0 170.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.307 0.2 OUTLIER -79.44 -31.55 42.56 Favored 'General case' 0 CA--C 1.466 -2.252 0 CA-C-O 116.152 -1.88 . . . . 0.0 112.223 178.192 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -30.57 -17.88 0.0 OUTLIER 'General case' 0 C--N 1.371 1.526 1 C-N-CA 135.237 5.415 . . . . 0.0 120.336 -175.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -53.58 -58.41 7.28 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 126.379 1.872 . . . . 0.0 111.378 163.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.58 -54.09 2.73 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 126.002 1.721 . . . . 0.0 109.286 -172.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.307 . . -110.67 140.16 45.28 Favored 'General case' 0 CA--C 1.459 -2.557 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.652 -164.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.8 m -126.73 166.87 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.527 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 144.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 174' ' ' LEU 0.305 70.2 t -74.54 146.83 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.874 0 CA-C-N 111.121 -2.763 . . . . 0.0 107.349 176.137 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.46 -41.42 16.62 Favored 'General case' 0 CA--C 1.473 -2.016 0 CA-C-N 110.895 -2.866 . . . . 0.0 105.695 -170.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -160.18 140.15 11.41 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 -169.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.528 ' CE1' ' HG2' ' A' ' 142' ' ' MET . 1.8 t80 -102.48 91.96 3.02 Favored Pre-proline 0 N--CA 1.425 -1.689 0 N-CA-C 100.373 -3.936 . . . . 0.0 100.373 170.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -96.34 -82.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.632 0 CA-C-N 121.66 1.628 . . . . 0.0 108.823 -139.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.5 -105.03 0.29 Allowed 'General case' 0 N--CA 1.399 -2.987 0 C-N-CA 117.684 -1.607 . . . . 0.0 109.012 -138.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -155.7 161.5 40.73 Favored 'General case' 0 N--CA 1.422 -1.84 1 N-CA-C 96.302 -5.444 . . . . 0.0 96.302 -177.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.493 HD11 ' CE2' ' A' ' 130' ' ' PHE . 2.7 mt -74.78 126.93 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.125 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 169.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -113.7 106.38 14.43 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 111.908 -2.406 . . . . 0.0 104.8 -176.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.41 -141.89 27.37 Favored Glycine 0 CA--C 1.484 -1.852 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -171.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -101.68 36.03 2.16 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 113.288 -1.456 . . . . 0.0 110.189 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.264 18.3 mt-30 -167.03 137.26 3.02 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 118.89 0.768 . . . . 0.0 111.406 -169.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 46.6 ttm -124.41 119.12 28.29 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.0 mm -81.9 136.57 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 O-C-N 120.624 -1.297 . . . . 0.0 108.299 171.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -124.23 133.8 53.42 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 102.78 -3.045 . . . . 0.0 102.78 156.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.58 135.29 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 106.833 -1.544 . . . . 0.0 106.833 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -115.69 141.81 47.58 Favored 'General case' 0 C--N 1.362 1.142 1 N-CA-C 99.577 -4.231 . . . . 0.0 99.577 -179.74 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.353 . . -147.71 -179.97 1.06 Allowed Pre-proline 0 CA--C 1.494 -1.211 0 CA-C-N 120.024 1.283 . . . . 0.0 112.517 -168.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -68.91 137.69 38.63 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 121.109 1.206 . . . . 0.0 109.673 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -81.42 138.68 35.54 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -80.69 141.23 35.09 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.207 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.414 ' HZ2' ' HB3' ' A' ' 179' ' ' LYS . 8.8 mtpm? 60.23 59.9 2.2 Favored 'General case' 0 CA--C 1.495 -1.162 0 C-N-CA 126.634 1.974 . . . . 0.0 110.031 -173.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? . . . . . 0 C--O 1.26 1.643 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 178.517 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.469 -2.151 0 CA-C-O 124.948 2.308 . . . . 0.0 107.385 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.7 mm -97.12 119.69 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.36 0 CA-C-N 108.669 -3.878 . . . . 0.0 107.841 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -94.07 169.51 10.21 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.43 HG23 ' HD3' ' A' ' 123' ' ' LYS . 88.1 t -102.49 118.12 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 163.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -103.19 175.12 5.58 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 159.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -145.97 153.33 40.67 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 tp -134.38 164.0 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -119.5 153.13 35.8 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.349 161.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.471 ' CE2' HG23 ' A' ' 148' ' ' VAL . 40.1 m-85 -127.85 164.01 23.16 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 171.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.12 176.8 1.49 Allowed Pre-proline 0 N--CA 1.419 -2.019 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -170.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -58.51 144.09 97.33 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 125.267 3.978 . . . . 0.0 111.931 164.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -13.69 101.5 0.01 OUTLIER Glycine 0 CA--C 1.469 -2.84 1 C-N-CA 131.039 4.161 . . . . 0.0 114.996 -173.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.12 -153.82 0.5 Allowed 'General case' 0 N--CA 1.399 -2.988 0 CA-C-N 111.163 -2.519 . . . . 0.0 108.408 -152.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.434 0.7 OUTLIER -121.87 166.88 13.73 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-N 109.996 -3.275 . . . . 0.0 111.703 -152.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.38 -74.31 0.13 Allowed 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -107.04 46.22 1.2 Allowed Glycine 0 CA--C 1.476 -2.385 0 C-N-CA 119.983 -1.103 . . . . 0.0 112.912 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -106.34 -41.17 5.39 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 145.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.401 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.6 OUTLIER -84.92 -65.11 1.05 Allowed 'General case' 0 CA--C 1.481 -1.704 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.519 -164.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.324 0.0 OUTLIER -62.29 -9.37 7.81 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 178.051 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 64.7 t -60.67 -46.9 95.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 122.359 1.076 . . . . 0.0 109.864 158.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -90.83 -3.21 57.56 Favored 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 tt -77.44 -32.16 54.35 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 162.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.446 ' HA ' HG12 ' A' ' 115' ' ' ILE . 41.7 ttt180 -61.94 -42.41 99.07 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.041 169.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.5 m -59.56 -43.61 93.51 Favored 'General case' 0 C--N 1.38 1.902 0 C-N-CA 118.44 -1.304 . . . . 0.0 113.975 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.263 47.4 mt -64.03 -30.56 71.63 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 175.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.45 ' CG2' ' HG ' ' A' ' 155' ' ' LEU 0.265 4.0 mm -61.98 -47.73 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.92 0 CA-C-N 119.936 1.243 . . . . 0.0 108.699 177.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -54.0 -43.16 69.82 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 125.765 1.915 . . . . 0.0 110.214 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -59.72 -51.65 68.87 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.78 0.832 . . . . 0.0 112.542 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 mt -71.98 -19.57 61.86 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 126.466 1.906 . . . . 0.0 114.452 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -73.14 -35.4 66.5 Favored 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 125.978 1.711 . . . . 0.0 110.122 171.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -68.25 -23.79 64.83 Favored 'General case' 0 C--N 1.36 1.063 0 C-N-CA 122.575 0.35 . . . . 0.0 110.144 168.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.63 69.31 1.38 Allowed Glycine 0 CA--C 1.466 -2.99 0 N-CA-C 104.762 -3.335 . . . . 0.0 104.762 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -123.38 165.11 17.57 Favored 'General case' 0 CA--C 1.458 -2.573 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.43 ' HD3' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -101.66 107.36 18.58 Favored 'General case' 0 N--CA 1.404 -2.735 1 N-CA-C 98.762 -4.533 . . . . 0.0 98.762 178.123 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.71 122.38 41.87 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -174.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -95.77 122.1 38.2 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -173.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.9 mm -83.57 131.65 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.533 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 23.4 m -116.7 116.54 27.72 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 167.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.483 HD22 ' CZ ' ' A' ' 130' ' ' PHE . 17.5 tp -77.95 151.69 33.56 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 169.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -150.23 96.75 2.46 Favored 'General case' 0 N--CA 1.407 -2.611 1 N-CA-C 100.054 -4.054 . . . . 0.0 100.054 -175.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.483 ' CZ ' HD22 ' A' ' 128' ' ' LEU 0.267 68.4 m-85 -73.04 153.41 40.88 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 111.739 -2.482 . . . . 0.0 109.72 -179.324 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -117.93 29.43 7.82 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 163.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 130' ' ' PHE . . . -82.74 -122.52 0.75 Allowed Glycine 0 CA--C 1.483 -1.913 0 C-N-CA 125.594 1.569 . . . . 0.0 111.5 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -92.23 -160.23 0.72 Allowed 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 112.804 -1.698 . . . . 0.0 108.613 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -67.36 -92.15 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 166.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 51.9 mtt -77.74 110.83 12.93 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 161.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.39 -146.41 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -157.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.595 ' HD1' HE21 ' A' ' 139' ' ' GLN . 15.0 m-70 -76.62 -71.48 0.39 Allowed 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -162.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 74.29 27.37 1.48 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 126.666 1.986 . . . . 0.0 108.014 -160.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.595 HE21 ' HD1' ' A' ' 137' ' ' HIS . 28.2 mt-30 -126.97 -51.3 1.44 Allowed 'General case' 0 CA--C 1.475 -1.934 0 N-CA-C 101.164 -3.643 . . . . 0.0 101.164 169.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 137' ' ' HIS 0.252 53.1 mt -54.32 -42.27 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-N 112.863 -1.971 . . . . 0.0 110.022 165.36 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.49 -60.05 4.22 Favored Glycine 0 N--CA 1.408 -3.181 0 N-CA-C 115.241 0.856 . . . . 0.0 115.241 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -87.4 0.89 54.82 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 118.569 -0.729 . . . . 0.0 112.932 -160.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.255 0.6 OUTLIER -59.4 -60.81 3.26 Favored 'General case' 0 CA--C 1.461 -2.466 0 C-N-CA 114.94 -2.704 . . . . 0.0 114.987 146.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.0 t -64.7 -64.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.927 0 O-C-N 125.956 2.035 . . . . 0.0 109.433 -164.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 49.4 mt -44.88 -54.31 6.59 Favored 'General case' 0 CA--C 1.488 -1.405 0 C-N-CA 128.242 2.617 . . . . 0.0 113.891 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -63.6 -30.93 71.97 Favored 'General case' 0 CA--C 1.465 -2.304 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -80.82 -14.86 57.67 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.354 173.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.471 HG23 ' CE2' ' A' ' 98' ' ' PHE . 2.0 t -76.59 -45.29 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.802 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 174.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.438 ' HE2' ' HB ' ' A' ' 158' ' ' VAL . 33.6 ttmt -54.42 -51.33 65.26 Favored 'General case' 0 CA--C 1.462 -2.417 0 CA-C-O 117.368 -1.301 . . . . 0.0 111.238 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.13 -40.09 75.05 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 125.477 1.511 . . . . 0.0 108.857 -169.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.94 -23.2 58.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 116.366 -2.134 . . . . 0.0 115.206 172.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.271 0.1 OUTLIER -81.85 -36.32 28.41 Favored 'General case' 0 CA--C 1.476 -1.872 0 CA-C-O 116.939 -1.505 . . . . 0.0 111.86 179.035 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -27.91 -32.3 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.664 1 C-N-CA 135.614 5.566 . . . . 0.0 119.142 -168.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -51.2 -47.2 62.31 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 128.914 2.886 . . . . 0.0 114.126 172.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.45 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 3.1 tm? -116.84 -51.61 2.56 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 128.384 2.673 . . . . 0.0 107.258 -161.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.315 . . -114.41 143.6 44.66 Favored 'General case' 0 CA--C 1.462 -2.421 0 CA-C-O 117.788 -1.101 . . . . 0.0 109.815 -175.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.5 m -129.54 164.47 32.04 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.125 0 N-CA-C 120.717 3.599 . . . . 0.0 120.717 148.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.4 t -80.49 147.73 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.957 0 CA-C-N 110.877 -2.874 . . . . 0.0 108.207 -176.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -82.37 -39.4 22.8 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.426 -1.715 . . . . 0.0 106.419 -172.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -151.6 142.36 22.84 Favored 'General case' 0 CA--C 1.464 -2.346 0 N-CA-C 104.805 -2.295 . . . . 0.0 104.805 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -105.42 98.25 16.36 Favored Pre-proline 0 N--CA 1.42 -1.969 0 N-CA-C 100.757 -3.794 . . . . 0.0 100.757 163.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -98.09 -113.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.411 -3.336 0 N-CA-C 101.735 -3.986 . . . . 0.0 101.735 -168.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -174.63 -48.45 0.01 OUTLIER 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 -146.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -86.88 102.77 14.65 Favored 'General case' 0 CA--C 1.486 -1.482 0 CA-C-O 121.792 0.806 . . . . 0.0 112.952 -145.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.9 mt -85.43 134.51 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.069 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 173.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -129.1 112.28 13.82 Favored 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.48 -150.36 34.81 Favored Glycine 0 CA--C 1.484 -1.887 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 -167.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -98.92 46.91 0.98 Allowed 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.964 1.306 . . . . 0.0 108.17 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.269 29.9 mt-30 -165.62 134.46 3.24 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 121.905 -0.497 . . . . 0.0 109.91 -170.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 23.8 ttm -122.96 122.78 39.39 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.533 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 19.3 mm -82.81 124.79 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 171.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.1 ttp -108.42 130.39 55.23 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 103.166 -2.901 . . . . 0.0 103.166 160.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 32.8 t -96.43 137.49 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 118.873 -1.131 . . . . 0.0 108.42 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 1.1 tp -128.88 144.32 51.14 Favored 'General case' 0 C--N 1.362 1.149 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 -174.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.361 . . -148.5 175.02 2.96 Favored Pre-proline 0 CA--C 1.493 -1.241 0 CA-C-O 117.501 -1.238 . . . . 0.0 110.216 -169.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -73.53 144.92 36.8 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 CA-C-N 121.621 1.614 . . . . 0.0 108.022 -177.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -79.94 132.99 36.17 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -78.55 100.28 6.86 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.852 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -91.17 84.34 5.66 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 . . . . . 0 C--O 1.26 1.646 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -176.167 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.467 -2.238 0 CA-C-O 124.775 2.226 . . . . 0.0 107.667 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.8 mm -86.85 116.23 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 108.621 -3.899 . . . . 0.0 107.09 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -101.07 162.9 12.56 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -170.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.503 HG21 ' HZ1' ' A' ' 123' ' ' LYS . 15.3 t -92.3 115.21 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.558 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 169.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -108.46 178.97 4.33 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.569 154.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -142.53 157.07 45.12 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 -171.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 tp -140.31 166.75 19.34 Favored 'Isoleucine or valine' 0 C--N 1.356 0.848 0 N-CA-C 102.544 -3.132 . . . . 0.0 102.544 164.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -116.17 158.69 22.87 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-N 118.943 0.792 . . . . 0.0 111.021 166.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -149.46 99.84 2.94 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -87.42 173.53 6.41 Favored Pre-proline 0 N--CA 1.436 -1.175 0 C-N-CA 125.573 1.549 . . . . 0.0 109.541 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -72.02 132.68 20.15 Favored 'Trans proline' 0 N--CA 1.433 -2.06 0 N-CA-C 105.135 -2.679 . . . . 0.0 105.135 163.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.69 4.64 60.43 Favored Glycine 0 CA--C 1.484 -1.878 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 60.6 m -103.71 89.62 3.39 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 164.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -127.39 -171.82 2.51 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 112.816 -1.993 . . . . 0.0 105.885 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.57 -41.52 69.92 Favored 'General case' 0 CA--C 1.481 -1.709 0 C-N-CA 125.987 1.715 . . . . 0.0 114.54 -127.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.18 -5.06 80.64 Favored Glycine 0 N--CA 1.419 -2.497 0 N-CA-C 116.478 1.351 . . . . 0.0 116.478 -171.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -100.21 -29.17 12.62 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 124.947 1.299 . . . . 0.0 108.019 168.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.435 ' HH ' HG21 ' A' ' 148' ' ' VAL . 1.1 t80 -88.81 -69.93 0.68 Allowed 'General case' 0 CA--C 1.473 -1.992 0 CA-C-N 112.611 -2.086 . . . . 0.0 111.316 -158.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.35 0.0 OUTLIER -56.02 -18.56 9.79 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 118.783 2.883 . . . . 0.0 118.783 172.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.59 -49.65 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 CA-C-O 122.391 1.091 . . . . 0.0 110.091 163.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -91.54 9.08 33.54 Favored 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -85.03 -32.67 22.78 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 163.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.446 ' HA ' HG12 ' A' ' 115' ' ' ILE . 55.2 ttt180 -62.27 -42.89 99.73 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 118.807 -0.616 . . . . 0.0 110.928 167.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 t -54.46 -45.88 73.21 Favored 'General case' 0 C--N 1.379 1.862 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 171.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.4 mt -63.35 -34.36 77.55 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 117.608 2.447 . . . . 0.0 117.608 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.9 mm -55.99 -48.57 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 O-C-N 124.3 1.0 . . . . 0.0 108.899 173.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -51.6 -45.62 63.26 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 126.033 1.733 . . . . 0.0 113.402 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -57.49 -50.58 72.58 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 mt -72.61 -21.18 61.16 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 125.304 1.442 . . . . 0.0 113.902 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -75.13 -33.22 61.53 Favored 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 125.671 1.588 . . . . 0.0 110.391 173.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -68.91 -26.31 65.03 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 167.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.46 78.24 1.22 Allowed Glycine 0 CA--C 1.47 -2.778 0 N-CA-C 106.338 -2.705 . . . . 0.0 106.338 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -134.31 168.3 19.14 Favored 'General case' 0 CA--C 1.465 -2.318 1 N-CA-C 99.902 -4.111 . . . . 0.0 99.902 168.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.503 ' HZ1' HG21 ' A' ' 93' ' ' VAL 0.317 0.0 OUTLIER -88.29 121.14 30.35 Favored 'General case' 0 CA--C 1.457 -2.631 1 N-CA-C 99.719 -4.178 . . . . 0.0 99.719 156.903 . . . . . . . . 5 4 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.53 123.38 33.58 Favored 'General case' 0 N--CA 1.41 -2.443 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 166.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -102.18 125.27 48.83 Favored 'General case' 0 CA--C 1.469 -2.149 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -175.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.3 mm -86.16 125.29 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.43 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.543 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 11.2 m -103.31 121.62 43.11 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 176.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . 0.313 0.2 OUTLIER -81.0 150.53 28.86 Favored 'General case' 0 CA--C 1.456 -2.655 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 166.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -147.25 89.23 1.77 Allowed 'General case' 0 N--CA 1.402 -2.838 1 N-CA-C 98.645 -4.576 . . . . 0.0 98.645 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.439 ' CE1' ' CD2' ' A' ' 137' ' ' HIS . 74.5 m-85 -71.83 143.42 49.46 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-N 111.259 -2.7 . . . . 0.0 109.877 -166.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -96.14 84.92 3.88 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 102.46 -3.163 . . . . 0.0 102.46 157.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -172.3 -142.97 3.94 Favored Glycine 0 N--CA 1.424 -2.11 0 C-N-CA 118.581 -1.771 . . . . 0.0 109.128 -160.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.492 ' H ' ' HB1' ' A' ' 136' ' ' ALA . 20.2 ttt180 -136.3 -167.94 2.15 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -165.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 135' ' ' MET . 4.3 pt-20 -51.3 -69.84 0.1 Allowed 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 127.095 2.158 . . . . 0.0 110.171 173.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.438 ' H ' ' HG3' ' A' ' 134' ' ' GLU . 9.2 ptt? -98.97 106.2 18.43 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 103.9 -2.629 . . . . 0.0 103.9 155.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.492 ' HB1' ' H ' ' A' ' 133' ' ' ARG . . . -73.64 -53.65 9.95 Favored 'General case' 0 CA--C 1.473 -2.013 0 CA-C-O 124.764 2.221 . . . . 0.0 111.287 -176.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.439 ' CD2' ' CE1' ' A' ' 130' ' ' PHE . 17.9 p80 -115.15 169.05 9.4 Favored 'General case' 0 N--CA 1.417 -2.109 1 CA-C-N 108.205 -4.089 . . . . 0.0 114.538 -148.017 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.408 ' H ' ' H ' ' A' ' 139' ' ' GLN . 15.4 pt20 -128.4 -2.67 5.56 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 140.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.408 ' H ' ' H ' ' A' ' 138' ' ' GLN . 9.9 mt-30 -106.76 -56.94 2.12 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 113.372 -1.74 . . . . 0.0 112.121 -166.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 74.7 mt -58.42 -52.11 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 C-N-CA 127.169 2.187 . . . . 0.0 111.424 -171.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.81 -65.19 2.18 Favored Glycine 0 N--CA 1.419 -2.458 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 75.0 mtm -93.04 11.75 26.48 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -159.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -72.75 -53.38 11.77 Favored 'General case' 0 CA--C 1.444 -3.1 0 C-N-CA 117.155 -1.818 . . . . 0.0 113.153 143.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.2 t -67.71 -66.94 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.446 -3.019 0 O-C-N 126.539 2.399 . . . . 0.0 107.681 -160.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 97.3 mt -46.97 -49.7 20.28 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 128.563 2.745 . . . . 0.0 115.387 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -59.34 -38.96 81.69 Favored 'General case' 0 CA--C 1.477 -1.833 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 172.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -80.65 -14.75 57.89 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.614 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.435 HG21 ' HH ' ' A' ' 107' ' ' TYR . 1.8 t -76.53 -47.91 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.69 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.288 12.7 ttmt -55.0 -43.46 73.61 Favored 'General case' 0 CA--C 1.466 -2.286 0 C-N-CA 126.015 1.726 . . . . 0.0 113.128 172.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -40.11 65.3 Favored 'General case' 0 N--CA 1.41 -2.452 0 C-N-CA 124.162 0.985 . . . . 0.0 109.446 -174.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -73.93 -26.3 60.43 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 116.579 -2.049 . . . . 0.0 115.569 170.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.271 0.2 OUTLIER -80.9 -32.42 34.79 Favored 'General case' 0 CA--C 1.47 -2.101 0 CA-C-O 116.749 -1.596 . . . . 0.0 112.223 -178.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -28.8 -23.52 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.69 1 C-N-CA 135.528 5.531 . . . . 0.0 119.987 -174.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -53.33 -56.75 14.16 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 126.557 1.943 . . . . 0.0 111.989 167.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.3 tt -107.94 -52.25 2.79 Favored 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 126.557 1.943 . . . . 0.0 108.529 -167.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.294 . . -110.5 138.37 46.98 Favored 'General case' 0 CA--C 1.467 -2.241 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.505 -173.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.84 165.12 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.496 0 N-CA-C 119.445 3.128 . . . . 0.0 119.445 147.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.529 HG11 ' H ' ' A' ' 160' ' ' SER . 3.9 t -76.96 153.02 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.135 0 CA-C-N 111.562 -2.563 . . . . 0.0 108.401 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.06 -39.91 25.0 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.753 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.529 ' H ' HG11 ' A' ' 158' ' ' VAL . 0.9 OUTLIER -150.38 137.2 19.17 Favored 'General case' 0 CA--C 1.469 -2.171 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 -173.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -114.23 98.55 48.81 Favored Pre-proline 0 CA--C 1.486 -1.517 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 177.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -135.36 -117.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.42 -2.832 0 C-N-CA 114.09 -3.473 . . . . 0.0 103.918 -152.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -169.13 -38.15 0.02 OUTLIER 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -128.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.426 ' HB3' ' HZ2' ' A' ' 164' ' ' LYS . 9.3 mtpm? -85.53 92.58 8.56 Favored 'General case' 0 CA--C 1.489 -1.378 0 CA-C-O 121.254 0.549 . . . . 0.0 111.334 -159.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -83.96 137.22 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.244 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 174.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -106.06 94.31 5.1 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.43 -134.37 14.09 Favored Glycine 0 CA--C 1.481 -2.069 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -170.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.04 48.32 0.84 Allowed 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 125.914 1.685 . . . . 0.0 107.304 178.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -168.27 116.34 0.72 Allowed 'General case' 0 C--N 1.353 0.722 0 O-C-N 121.909 -0.495 . . . . 0.0 110.46 -170.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 28.8 ttp -115.8 118.86 34.2 Favored 'General case' 0 C--N 1.369 1.444 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -165.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.543 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 11.4 mm -84.03 124.46 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 O-C-N 120.633 -1.292 . . . . 0.0 108.964 170.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -99.44 133.0 44.39 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 102.141 -3.281 . . . . 0.0 102.141 156.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 24.7 t -99.94 116.22 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 118.239 -1.384 . . . . 0.0 110.013 -177.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 1.1 tp -106.57 107.62 18.73 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 -167.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.265 . . -99.57 179.54 1.02 Allowed Pre-proline 0 CA--C 1.486 -1.481 0 C-N-CA 124.746 1.218 . . . . 0.0 113.169 -176.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -70.55 153.76 65.1 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 N-CA-C 106.483 -2.161 . . . . 0.0 106.483 170.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -73.4 120.86 19.59 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 123.026 1.393 . . . . 0.0 110.125 -175.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -70.51 -174.08 0.82 Allowed 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 129.217 3.007 . . . . 0.0 113.227 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -62.36 104.7 0.52 Allowed 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.233 1.413 . . . . 0.0 109.941 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 . . . . . 0 C--O 1.26 1.628 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 176.658 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.468 -2.206 0 CA-C-O 124.724 2.202 . . . . 0.0 107.555 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.4 mm -87.29 114.8 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 108.62 -3.9 . . . . 0.0 107.376 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -100.66 176.19 5.4 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -170.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.4 t -105.17 125.12 60.29 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.485 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 167.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -106.8 174.9 5.69 Favored 'General case' 0 CA--C 1.464 -2.339 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 155.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -149.28 147.05 27.9 Favored 'General case' 0 N--CA 1.422 -1.851 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.084 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tp -129.21 162.42 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -122.22 152.78 39.64 Favored 'General case' 0 CA--C 1.488 -1.44 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.979 162.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.465 ' CE2' HG23 ' A' ' 148' ' ' VAL . 45.2 m-85 -130.82 146.73 52.34 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 172.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.32 169.8 6.18 Favored Pre-proline 0 N--CA 1.435 -1.181 0 C-N-CA 123.644 0.777 . . . . 0.0 109.08 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -58.36 138.13 84.2 Favored 'Trans proline' 0 N--CA 1.436 -1.883 1 C-N-CA 125.506 4.138 . . . . 0.0 110.933 167.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.16 -125.1 20.97 Favored Glycine 0 CA--C 1.479 -2.196 0 N-CA-C 106.786 -2.526 . . . . 0.0 106.786 -173.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.7 m 55.7 106.58 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.759 0 C-N-CA 129.492 3.117 . . . . 0.0 112.958 173.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -125.17 -131.04 0.25 Allowed 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 105.026 -2.212 . . . . 0.0 105.026 171.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -55.58 -80.05 0.02 OUTLIER 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -89.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.51 45.5 1.35 Allowed Glycine 0 CA--C 1.484 -1.902 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.671 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -101.95 -42.73 6.01 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 146.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.445 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -73.79 -75.59 0.15 Allowed 'General case' 0 CA--C 1.48 -1.714 0 CA-C-N 113.189 -1.823 . . . . 0.0 108.678 -169.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.341 0.0 OUTLIER -58.66 -12.31 4.04 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 120.389 3.477 . . . . 0.0 120.389 178.427 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 66.3 t -61.75 -45.42 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 CA-C-O 122.59 1.186 . . . . 0.0 110.041 161.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -91.77 -0.83 57.56 Favored 'General case' 0 CA--C 1.472 -2.037 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 tt -78.17 -32.0 49.94 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 161.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.441 ' HA ' HG12 ' A' ' 115' ' ' ILE . 48.4 ttt180 -63.52 -43.13 98.06 Favored 'General case' 0 C--N 1.361 1.077 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.242 170.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.8 m -63.92 -37.28 86.82 Favored 'General case' 0 C--N 1.377 1.788 0 C-N-CA 118.648 -1.221 . . . . 0.0 113.405 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.296 60.5 tp -70.38 -28.96 65.5 Favored 'General case' 0 N--CA 1.401 -2.91 0 C-N-CA 125.196 1.398 . . . . 0.0 113.782 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.441 HG12 ' HA ' ' A' ' 112' ' ' ARG . 9.7 mm -58.57 -50.59 78.44 Favored 'Isoleucine or valine' 0 C--N 1.371 1.507 0 CA-C-N 120.982 1.719 . . . . 0.0 110.033 170.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -52.28 -44.11 64.79 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 127.697 2.399 . . . . 0.0 110.668 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -59.44 -50.03 75.51 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 125.868 1.667 . . . . 0.0 113.04 176.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.46 -34.6 74.25 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 175.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -72.1 -32.12 66.7 Favored 'General case' 0 CA--C 1.487 -1.468 0 C-N-CA 127.745 2.418 . . . . 0.0 110.913 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -64.81 -20.83 66.6 Favored 'General case' 0 C--N 1.36 1.023 0 C-N-CA 123.117 0.567 . . . . 0.0 111.444 171.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 89.17 59.51 1.56 Allowed Glycine 0 CA--C 1.466 -2.987 0 N-CA-C 104.65 -3.38 . . . . 0.0 104.65 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -123.21 167.73 13.35 Favored 'General case' 0 CA--C 1.455 -2.701 0 N-CA-C 102.121 -3.289 . . . . 0.0 102.121 171.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -94.22 132.32 38.9 Favored 'General case' 0 CA--C 1.449 -2.942 0 N-CA-C 100.602 -3.851 . . . . 0.0 100.602 162.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.22 115.71 30.63 Favored 'General case' 0 N--CA 1.4 -2.942 0 C-N-CA 117.378 -1.729 . . . . 0.0 106.593 -173.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -97.26 122.39 40.23 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.543 0.687 . . . . 0.0 109.275 -163.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.6 mm -84.16 133.78 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.961 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.9 m -112.97 117.12 31.19 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 165.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.493 HD22 ' CZ ' ' A' ' 130' ' ' PHE . 10.4 tp -79.61 153.17 29.61 Favored 'General case' 0 CA--C 1.474 -1.97 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 167.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -152.88 94.12 1.83 Allowed 'General case' 0 N--CA 1.4 -2.938 0 N-CA-C 101.335 -3.579 . . . . 0.0 101.335 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.493 ' CZ ' HD22 ' A' ' 128' ' ' LEU 0.311 94.2 m-85 -71.55 173.46 7.97 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 126.909 2.084 . . . . 0.0 109.837 178.283 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.8 tpt85 -98.84 79.88 2.45 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 104.616 -2.365 . . . . 0.0 104.616 148.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -112.2 -101.65 2.57 Favored Glycine 0 CA--C 1.472 -2.64 0 CA-C-O 122.899 1.277 . . . . 0.0 110.249 -167.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 77.8 70.61 0.05 Allowed 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 110.808 -2.696 . . . . 0.0 109.237 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -169.34 -139.09 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.189 1 N-CA-C 98.927 -4.472 . . . . 0.0 98.927 167.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -99.48 103.57 15.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 100.774 -3.787 . . . . 0.0 100.774 143.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.402 ' HB3' ' CD2' ' A' ' 137' ' ' HIS . . . -84.62 -149.13 0.11 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -160.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.493 ' CG ' HD11 ' A' ' 140' ' ' ILE . 32.0 m-70 -39.19 130.36 1.62 Allowed 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 130.368 3.467 . . . . 0.0 114.533 166.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -116.34 10.48 14.75 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -90.54 -53.11 4.57 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.493 HD11 ' CG ' ' A' ' 137' ' ' HIS . 51.9 mt -52.75 -41.53 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 C-N-CA 127.971 2.509 . . . . 0.0 111.361 174.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -70.58 -60.42 4.68 Favored Glycine 0 CA--C 1.458 -3.53 0 O-C-N 123.951 0.782 . . . . 0.0 113.958 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -85.78 -1.52 57.31 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -159.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.271 2.0 tp10 -61.44 -60.67 3.36 Favored 'General case' 0 CA--C 1.454 -2.747 0 C-N-CA 114.412 -2.915 . . . . 0.0 115.394 146.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 23.1 t -66.26 -65.87 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.91 0 O-C-N 125.978 2.049 . . . . 0.0 108.7 -162.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 32.0 mt -44.85 -54.17 6.7 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 129.131 2.972 . . . . 0.0 114.316 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -66.16 -28.34 68.71 Favored 'General case' 0 CA--C 1.468 -2.179 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 174.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -80.35 -15.34 57.09 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.222 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.465 HG23 ' CE2' ' A' ' 98' ' ' PHE . 1.9 t -76.08 -44.47 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.78 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.412 ' HE2' ' HB ' ' A' ' 158' ' ' VAL 0.262 34.9 ttmt -52.98 -48.76 67.19 Favored 'General case' 0 CA--C 1.47 -2.105 0 C-N-CA 125.435 1.494 . . . . 0.0 112.435 171.326 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.1 -38.39 66.38 Favored 'General case' 0 N--CA 1.409 -2.508 0 C-N-CA 125.853 1.661 . . . . 0.0 109.605 -171.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.53 -25.72 54.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 116.462 -2.095 . . . . 0.0 115.201 170.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.298 0.1 OUTLIER -77.31 -30.84 54.29 Favored 'General case' 0 CA--C 1.473 -1.992 0 CA-C-O 116.525 -1.703 . . . . 0.0 113.451 176.069 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -29.44 -20.13 0.0 OUTLIER 'General case' 0 C--N 1.366 1.302 1 C-N-CA 134.91 5.284 . . . . 0.0 120.224 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -56.29 -62.15 1.91 Allowed 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 127.187 2.195 . . . . 0.0 111.178 167.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.13 -56.01 2.78 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 125.542 1.537 . . . . 0.0 109.048 -174.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.434 ' CB ' HD12 ' A' ' 174' ' ' LEU 0.269 . . -98.48 146.66 25.53 Favored 'General case' 0 CA--C 1.449 -2.934 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.877 -165.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.2 m -121.59 172.2 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.454 -2.723 0 C-N-CA 114.626 -2.83 . . . . 0.0 116.384 134.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 3.8 t -82.31 153.4 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.831 0 CA-C-N 111.784 -2.462 . . . . 0.0 107.157 -177.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -81.59 -41.22 21.86 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 -173.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.4 t -157.29 143.15 17.61 Favored 'General case' 0 CA--C 1.46 -2.499 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -104.46 94.38 7.0 Favored Pre-proline 0 N--CA 1.423 -1.806 0 N-CA-C 100.996 -3.705 . . . . 0.0 100.996 167.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -102.05 -110.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.412 -3.294 0 N-CA-C 103.273 -3.395 . . . . 0.0 103.273 -155.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -170.62 -40.82 0.02 OUTLIER 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -139.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -86.61 79.03 9.04 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -147.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.1 mt -84.16 124.08 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.091 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 168.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -123.34 101.79 7.56 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 111.752 -2.476 . . . . 0.0 105.519 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 86.27 -144.36 19.94 Favored Glycine 0 CA--C 1.483 -1.937 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -172.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -97.1 41.15 1.12 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.145 1.378 . . . . 0.0 109.418 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -170.72 141.18 1.79 Allowed 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 121.76 -0.587 . . . . 0.0 111.999 -172.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 48.5 ttm -122.11 122.86 40.21 Favored 'General case' 0 CA--C 1.481 -1.678 0 C-N-CA 123.547 0.739 . . . . 0.0 109.405 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.2 mm -81.99 122.7 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 166.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 3.9 ttp -106.55 129.53 54.48 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 101.582 -3.488 . . . . 0.0 101.582 161.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.5 t -94.48 137.33 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -117.81 150.22 39.51 Favored 'General case' 0 C--N 1.357 0.898 1 N-CA-C 99.516 -4.253 . . . . 0.0 99.516 -179.987 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.26 . . -140.75 -178.92 0.89 Allowed Pre-proline 0 N--CA 1.432 -1.341 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.681 -170.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -69.85 147.45 62.31 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 C-N-CA 122.395 2.063 . . . . 0.0 109.055 165.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -80.07 141.83 35.46 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 171.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -76.5 95.89 3.97 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 168.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -81.24 110.27 16.55 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 . . . . . 0 C--O 1.26 1.649 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -178.359 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 CA--C 1.472 -2.035 0 CA-C-O 124.906 2.288 . . . . 0.0 107.694 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.2 mm -93.16 124.79 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.503 0 CA-C-N 108.73 -3.85 . . . . 0.0 107.194 176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -92.59 168.09 11.48 Favored 'General case' 0 CA--C 1.48 -1.749 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.445 HG21 ' HE2' ' A' ' 123' ' ' LYS . 46.4 t -105.99 121.82 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.874 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 162.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -101.51 175.94 5.4 Favored 'General case' 0 CA--C 1.468 -2.2 0 C-N-CA 116.427 -2.109 . . . . 0.0 105.715 166.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -143.08 152.67 42.11 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 tp -135.03 163.03 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 103.028 -2.953 . . . . 0.0 103.028 167.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -115.13 153.33 30.98 Favored 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.567 162.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.463 ' CE2' HG23 ' A' ' 148' ' ' VAL . 32.6 m-85 -125.42 131.33 52.94 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 169.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -93.84 169.43 10.03 Favored Pre-proline 0 N--CA 1.433 -1.304 0 C-N-CA 124.258 1.023 . . . . 0.0 109.254 -175.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.2 139.5 42.31 Favored 'Trans proline' 0 CA--C 1.489 -1.726 0 C-N-CA 124.417 3.411 . . . . 0.0 107.502 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.3 -122.51 8.79 Favored Glycine 0 CA--C 1.482 -1.971 0 N-CA-C 106.33 -2.708 . . . . 0.0 106.33 -166.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.0 m 55.78 103.74 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.923 0 C-N-CA 129.904 3.282 . . . . 0.0 112.887 177.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -121.94 -167.79 1.6 Allowed 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.142 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -27.06 -59.3 0.09 Allowed 'General case' 0 CA--C 1.482 -1.657 1 C-N-CA 131.873 4.069 . . . . 0.0 115.283 -146.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -17.28 -74.6 0.01 OUTLIER Glycine 0 CA--C 1.459 -3.463 1 C-N-CA 133.173 5.178 . . . . 0.0 118.098 168.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . 0.363 53.9 m-20 -89.7 -33.94 16.42 Favored 'General case' 0 N--CA 1.4 -2.957 0 CA-C-N 109.869 -3.165 . . . . 0.0 109.766 -174.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.473 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -75.58 -72.1 0.33 Allowed 'General case' 0 CA--C 1.484 -1.595 0 CA-C-N 112.747 -2.024 . . . . 0.0 109.799 -161.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.417 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.293 0.0 OUTLIER -63.52 -7.68 7.58 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 119.843 3.275 . . . . 0.0 119.843 178.122 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.67 -42.95 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 C-N-CA 124.015 0.926 . . . . 0.0 110.025 160.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.0 mmtt -92.74 -5.06 52.04 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -75.69 -35.02 60.44 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 163.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.424 ' HA ' HG12 ' A' ' 115' ' ' ILE . 7.4 ttm180 -59.31 -43.65 92.61 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 125.541 1.536 . . . . 0.0 111.318 169.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.8 t -56.79 -46.59 81.46 Favored 'General case' 0 C--N 1.377 1.791 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.267 71.0 mt -67.56 -28.12 67.51 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 176.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.424 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.7 mm -59.78 -49.5 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.709 0 CA-C-N 119.696 1.134 . . . . 0.0 108.83 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -51.57 -44.58 62.79 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 127.26 2.224 . . . . 0.0 110.1 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -63.65 -52.77 59.27 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.91 -29.48 68.58 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 125.605 1.562 . . . . 0.0 114.699 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.62 -29.53 51.84 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 124.03 0.932 . . . . 0.0 110.842 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -82.84 -1.2 51.29 Favored 'General case' 0 C--N 1.362 1.139 0 CA-C-O 120.602 0.239 . . . . 0.0 110.829 170.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.05 70.16 1.32 Allowed Glycine 0 CA--C 1.473 -2.59 0 C-N-CA 126.242 1.877 . . . . 0.0 109.552 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -128.04 163.64 24.13 Favored 'General case' 0 CA--C 1.449 -2.92 0 N-CA-C 100.786 -3.783 . . . . 0.0 100.786 169.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HE2' HG21 ' A' ' 93' ' ' VAL . 1.6 tmmm? -98.33 106.03 18.26 Favored 'General case' 0 N--CA 1.399 -3.019 1 N-CA-C 97.706 -4.924 . . . . 0.0 97.706 172.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.08 155.25 21.59 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -133.47 129.95 37.91 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 119.844 -1.785 . . . . 0.0 106.552 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.8 mm -82.74 137.98 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.576 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.446 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 24.1 m -117.14 127.51 54.2 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 167.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.472 HD21 ' CE1' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -85.83 153.56 22.17 Favored 'General case' 0 CA--C 1.462 -2.441 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 166.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -151.36 91.41 1.67 Allowed 'General case' 0 N--CA 1.394 -3.231 1 N-CA-C 98.715 -4.55 . . . . 0.0 98.715 -175.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.472 ' CE1' HD21 ' A' ' 128' ' ' LEU 0.253 97.6 m-85 -74.35 164.62 26.39 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 111.438 -2.619 . . . . 0.0 105.903 179.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -78.9 99.5 6.81 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 161.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.24 126.58 41.81 Favored Glycine 0 CA--C 1.478 -2.219 0 N-CA-C 117.936 1.935 . . . . 0.0 117.936 -149.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . 0.32 11.8 ptp85 57.89 24.51 11.0 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 129.188 2.995 . . . . 0.0 116.043 171.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.94 -26.76 3.4 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 101.874 -3.38 . . . . 0.0 101.874 163.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 25.3 mmt -129.5 5.44 5.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.667 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.411 ' HA ' ' CD1' ' A' ' 130' ' ' PHE . . . -76.48 90.57 3.29 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-N 120.373 1.442 . . . . 0.0 112.267 167.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.427 ' HB2' ' H ' ' A' ' 140' ' ' ILE . 9.9 m170 -126.15 164.88 19.95 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -98.37 15.36 24.93 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -89.03 -49.72 6.6 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 166.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.427 ' H ' ' HB2' ' A' ' 137' ' ' HIS 0.29 68.1 mt -66.45 -37.32 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 0 C-N-CA 128.369 2.668 . . . . 0.0 108.281 -177.126 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -78.34 -66.6 1.72 Allowed Glycine 0 N--CA 1.408 -3.193 0 CA-C-N 114.372 -1.285 . . . . 0.0 113.574 178.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 43.0 mtt -95.03 24.21 5.04 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -164.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -71.14 -55.7 7.63 Favored 'General case' 0 CA--C 1.456 -2.652 0 C-N-CA 116.521 -2.072 . . . . 0.0 114.644 133.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.4 t -64.16 -66.25 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.443 -3.172 0 O-C-N 126.174 2.171 . . . . 0.0 107.834 -163.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 71.1 mt -44.61 -55.03 5.53 Favored 'General case' 0 CA--C 1.478 -1.824 0 O-C-N 126.543 2.402 . . . . 0.0 114.108 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.36 -36.79 74.01 Favored 'General case' 0 CA--C 1.473 -2.017 0 C-N-CA 127.229 2.212 . . . . 0.0 114.062 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -81.71 -14.98 55.84 Favored 'General case' 0 N--CA 1.418 -2.027 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.882 175.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.473 HG21 ' HH ' ' A' ' 107' ' ' TYR . 1.4 t -75.24 -43.64 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.74 0 CA-C-O 116.374 -1.774 . . . . 0.0 107.355 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -53.49 -52.88 58.14 Favored 'General case' 0 CA--C 1.463 -2.394 0 CA-C-O 116.861 -1.542 . . . . 0.0 109.884 169.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -67.52 -39.43 85.08 Favored 'General case' 0 N--CA 1.41 -2.47 0 C-N-CA 124.22 1.008 . . . . 0.0 109.359 -166.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -75.05 -26.84 59.71 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 116.447 -2.101 . . . . 0.0 116.075 171.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.281 0.1 OUTLIER -81.1 -33.28 33.42 Favored 'General case' 0 CA--C 1.479 -1.757 0 CA-C-O 117.107 -1.425 . . . . 0.0 113.605 -178.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -28.5 -29.94 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.478 1 C-N-CA 135.555 5.542 . . . . 0.0 118.85 -173.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.9 -53.32 54.22 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 127.509 2.324 . . . . 0.0 113.204 173.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.17 -53.53 2.67 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.624 -165.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.308 . . -96.81 153.08 18.09 Favored 'General case' 0 CA--C 1.447 -2.998 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.3 m -116.39 -164.14 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.905 0 C-N-CA 113.69 -3.204 . . . . 0.0 112.343 138.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.488 HG11 ' H ' ' A' ' 160' ' ' SER 0.28 3.3 t -108.35 162.93 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.559 0 C-N-CA 128.326 2.65 . . . . 0.0 106.009 177.239 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.44 -42.49 18.47 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.488 ' H ' HG11 ' A' ' 158' ' ' VAL . 1.2 t -162.02 154.2 19.34 Favored 'General case' 0 CA--C 1.479 -1.777 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.581 -166.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.88 87.26 3.57 Favored Pre-proline 0 N--CA 1.42 -1.939 0 N-CA-C 103.366 -2.827 . . . . 0.0 103.366 168.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.481 ' HB2' ' HG1' ' A' ' 163' ' ' THR . 9.2 Cg_endo -95.89 -79.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.412 0 N-CA-C 109.529 -0.989 . . . . 0.0 109.529 -136.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.481 ' HG1' ' HB2' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -93.99 -158.01 0.59 Allowed 'General case' 1 N--CA 1.376 -4.159 0 CA-C-O 125.928 2.775 . . . . 0.0 112.071 -141.32 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -142.31 132.98 25.4 Favored 'General case' 0 N--CA 1.423 -1.796 2 N-CA-C 98.745 -4.539 . . . . 0.0 98.745 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.423 HG13 ' H ' ' A' ' 165' ' ' ILE . 3.5 mt -70.44 132.13 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 CA-C-O 123.212 1.482 . . . . 0.0 110.086 -166.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -125.94 122.71 36.77 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.58 -155.11 39.04 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -172.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -103.84 27.48 7.52 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.992 -1.104 . . . . 0.0 112.398 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.285 30.3 mt-30 -172.73 147.63 1.79 Allowed 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -159.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 58.7 ttp -142.86 117.22 9.62 Favored 'General case' 0 C--N 1.364 1.196 0 CA-C-O 121.756 0.789 . . . . 0.0 111.703 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.446 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 10.9 mm -80.16 138.44 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 O-C-N 120.105 -1.622 . . . . 0.0 109.816 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.436 ' SD ' HG12 ' A' ' 158' ' ' VAL . 3.3 tmm? -113.85 135.24 54.18 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 154.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.85 127.86 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.13 73.76 0.83 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 117.241 2.312 . . . . 0.0 117.241 -166.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.432 . . -105.46 156.6 36.1 Favored Pre-proline 0 C--N 1.355 0.815 0 N-CA-C 120.024 3.342 . . . . 0.0 120.024 -167.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -67.45 142.12 58.38 Favored 'Trans proline' 0 CA--C 1.492 -1.62 0 C-N-CA 123.258 2.639 . . . . 0.0 111.276 -161.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -77.7 133.41 38.34 Favored 'General case' 0 CA--C 1.49 -1.357 0 O-C-N 125.029 1.456 . . . . 0.0 107.907 -174.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -60.26 126.18 26.52 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 125.939 1.696 . . . . 0.0 110.718 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -77.66 146.93 35.78 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.379 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 . . . . . 0 C--O 1.261 1.696 0 CA-C-O 117.494 -1.241 . . . . 0.0 108.352 177.927 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.467 -2.223 0 CA-C-O 124.93 2.3 . . . . 0.0 107.384 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.7 mm -97.36 119.25 45.15 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 CA-C-N 108.765 -3.834 . . . . 0.0 107.102 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -95.31 170.95 9.02 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.0 t -99.69 120.88 49.67 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 161.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -103.68 172.31 6.87 Favored 'General case' 0 CA--C 1.472 -2.04 0 C-N-CA 116.924 -1.911 . . . . 0.0 106.896 155.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -145.09 148.24 33.43 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tp -128.28 162.24 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 174.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -119.74 153.68 35.3 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.702 163.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.427 ' CE2' HG23 ' A' ' 148' ' ' VAL . 41.7 m-85 -127.12 141.73 51.69 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 168.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -113.04 166.08 11.83 Favored Pre-proline 0 N--CA 1.423 -1.788 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 173.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.8 138.08 47.56 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 C-N-CA 123.924 3.083 . . . . 0.0 108.312 165.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.91 14.59 74.84 Favored Glycine 0 CA--C 1.482 -1.974 0 O-C-N 124.143 0.902 . . . . 0.0 111.919 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.4 m -104.92 99.72 9.35 Favored 'General case' 0 CA--C 1.466 -2.25 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 173.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.35 -142.35 0.27 Allowed 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 112.005 -2.362 . . . . 0.0 105.023 168.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -59.95 -76.6 0.05 OUTLIER 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -84.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.62 41.97 2.02 Favored Glycine 0 CA--C 1.485 -1.842 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.099 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -103.28 -38.98 7.01 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 149.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.43 ' HH ' ' HG2' ' A' ' 147' ' ' ARG . 0.8 OUTLIER -70.74 -72.53 0.2 Allowed 'General case' 0 CA--C 1.477 -1.847 0 C-N-CA 126.574 1.949 . . . . 0.0 109.313 -172.071 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.35 0.0 OUTLIER -58.47 -15.19 9.97 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 119.816 3.265 . . . . 0.0 119.816 175.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.87 -38.69 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 C-N-CA 123.966 0.906 . . . . 0.0 111.229 164.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -92.82 -1.37 56.83 Favored 'General case' 0 CA--C 1.476 -1.875 0 O-C-N 120.159 -1.588 . . . . 0.0 114.708 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.7 tt -79.53 -31.62 42.11 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 163.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.435 ' HA ' HG12 ' A' ' 115' ' ' ILE . 3.3 tpp180 -60.36 -46.09 91.16 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 125.123 1.369 . . . . 0.0 110.772 168.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.8 t -59.81 -44.55 93.93 Favored 'General case' 0 C--N 1.375 1.697 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.303 61.4 tp -67.9 -29.79 68.98 Favored 'General case' 0 N--CA 1.407 -2.595 0 C-N-CA 127.321 2.248 . . . . 0.0 113.562 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.273 9.4 mm -57.78 -51.41 70.61 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.872 0 CA-C-N 120.941 1.7 . . . . 0.0 108.686 170.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.6 tpt85 -54.75 -39.95 68.82 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 126.703 2.001 . . . . 0.0 111.042 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -63.04 -50.64 69.86 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 124.229 1.012 . . . . 0.0 112.263 176.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -37.27 76.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 176.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -75.26 -35.73 61.33 Favored 'General case' 0 CA--C 1.487 -1.462 0 C-N-CA 128.931 2.892 . . . . 0.0 109.907 -169.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.55 6.08 11.36 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 123.605 0.762 . . . . 0.0 111.472 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.18 64.11 2.16 Favored Glycine 0 CA--C 1.467 -2.932 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 174.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -128.52 165.17 21.24 Favored 'General case' 0 CA--C 1.448 -2.945 0 N-CA-C 102.306 -3.22 . . . . 0.0 102.306 169.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.93 115.62 30.08 Favored 'General case' 0 N--CA 1.395 -3.211 1 N-CA-C 97.952 -4.832 . . . . 0.0 97.952 173.162 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.69 160.5 18.08 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -136.56 131.3 33.65 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 168.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.0 mm -83.19 135.24 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 171.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.533 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 17.3 m -113.57 115.65 28.29 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 163.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.428 ' CD2' ' CZ ' ' A' ' 130' ' ' PHE . 17.1 tp -84.93 150.06 25.21 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 168.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -153.8 103.05 2.57 Favored 'General case' 0 N--CA 1.406 -2.674 1 N-CA-C 99.834 -4.136 . . . . 0.0 99.834 -170.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.428 ' CZ ' ' CD2' ' A' ' 128' ' ' LEU 0.347 81.9 m-85 -83.15 86.48 7.01 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 126.535 1.934 . . . . 0.0 109.297 -171.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -123.71 30.55 6.16 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -97.19 -34.88 5.47 Favored Glycine 0 CA--C 1.466 -3.022 0 N-CA-C 104.714 -3.354 . . . . 0.0 104.714 171.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.435 HH11 ' CE1' ' A' ' 137' ' ' HIS . 42.3 ttm180 -144.54 123.41 12.7 Favored 'General case' 0 CA--C 1.475 -1.928 1 N-CA-C 99.699 -4.186 . . . . 0.0 99.699 165.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.61 -16.02 54.48 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -161.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 35.1 tpp -71.68 -103.28 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 123.15 0.58 . . . . 0.0 111.394 174.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 173.55 110.41 0.02 OUTLIER 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -157.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.477 ' CD2' HD11 ' A' ' 140' ' ' ILE . 15.5 m-70 -119.96 149.25 42.43 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 121.252 0.549 . . . . 0.0 111.455 -178.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -82.24 -13.09 57.59 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 121.272 0.558 . . . . 0.0 109.894 173.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -84.29 -53.6 5.37 Favored 'General case' 0 CA--C 1.481 -1.691 0 C-N-CA 125.862 1.665 . . . . 0.0 108.667 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.477 HD11 ' CD2' ' A' ' 137' ' ' HIS . 70.8 mt -51.98 -44.7 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 C-N-CA 126.548 1.939 . . . . 0.0 110.877 176.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.404 ' HA2' ' CD2' ' A' ' 128' ' ' LEU . . . -70.62 -60.72 4.49 Favored Glycine 0 CA--C 1.456 -3.607 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.961 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -85.57 -1.15 56.81 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -157.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.257 0.5 OUTLIER -61.76 -63.54 1.23 Allowed 'General case' 0 CA--C 1.46 -2.484 0 C-N-CA 115.035 -2.666 . . . . 0.0 115.694 147.393 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.8 t -62.77 -67.5 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.448 -2.944 0 O-C-N 126.021 2.076 . . . . 0.0 109.007 -166.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 34.4 mt -43.49 -55.32 4.28 Favored 'General case' 0 CA--C 1.482 -1.666 0 C-N-CA 128.858 2.863 . . . . 0.0 114.564 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -63.23 -30.41 71.56 Favored 'General case' 0 CA--C 1.467 -2.229 0 N-CA-C 117.689 2.478 . . . . 0.0 117.689 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.43 ' HG2' ' HH ' ' A' ' 107' ' ' TYR . 17.6 ttp180 -81.15 -14.57 57.52 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.612 172.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.427 HG23 ' CE2' ' A' ' 98' ' ' PHE . 1.7 t -76.79 -44.14 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.787 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 175.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.256 33.9 ttmt -52.84 -49.95 64.72 Favored 'General case' 0 CA--C 1.467 -2.219 0 C-N-CA 125.631 1.573 . . . . 0.0 112.033 171.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -37.69 64.41 Favored 'General case' 0 N--CA 1.409 -2.521 0 C-N-CA 125.506 1.522 . . . . 0.0 109.456 -169.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -75.33 -25.63 57.98 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 116.372 -2.131 . . . . 0.0 114.993 169.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.308 0.1 OUTLIER -78.41 -32.42 48.71 Favored 'General case' 0 CA--C 1.472 -2.05 0 CA-C-O 116.792 -1.575 . . . . 0.0 112.614 178.392 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -29.58 -22.26 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.403 1 C-N-CA 135.237 5.415 . . . . 0.0 119.884 -174.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -56.4 -61.71 2.22 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.94 2.096 . . . . 0.0 110.974 168.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.69 -55.64 2.94 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 113.877 -1.511 . . . . 0.0 107.973 -171.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.255 . . -98.25 150.87 21.07 Favored 'General case' 0 CA--C 1.443 -3.136 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.565 -166.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.53 173.25 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.662 0 C-N-CA 114.11 -3.036 . . . . 0.0 116.113 130.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . 0.3 3.1 t -81.2 151.6 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.104 0 CA-C-N 110.133 -3.212 . . . . 0.0 104.911 173.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -81.71 -38.47 25.74 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -174.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.39 136.73 14.92 Favored 'General case' 0 N--CA 1.408 -2.54 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -177.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.63 123.49 56.0 Favored Pre-proline 0 N--CA 1.417 -2.1 1 N-CA-C 97.632 -4.951 . . . . 0.0 97.632 156.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -74.29 -85.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.267 1 N-CA-C 101.111 -4.227 . . . . 0.0 101.111 167.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 176.6 -55.49 0.01 OUTLIER 'General case' 0 N--CA 1.394 -3.257 1 N-CA-C 94.583 -6.08 . . . . 0.0 94.583 172.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -129.85 176.11 8.31 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.585 -161.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.583 HG22 ' H ' ' A' ' 169' ' ' GLN . 0.6 OUTLIER -93.61 150.93 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 C-N-CA 126.108 1.763 . . . . 0.0 109.819 -172.085 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -115.25 84.74 2.14 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 160.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.72 -162.5 24.68 Favored Glycine 0 C--N 1.353 1.527 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 -170.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -114.86 32.84 5.74 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.223 1.009 . . . . 0.0 111.341 -173.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.583 ' H ' HG22 ' A' ' 165' ' ' ILE . 39.4 tt0 173.5 115.17 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 -158.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.408 ' HB2' HG13 ' A' ' 165' ' ' ILE . 11.3 ttm -107.63 119.08 38.43 Favored 'General case' 0 CA--C 1.472 -2.036 0 CA-C-O 121.201 0.524 . . . . 0.0 111.838 -166.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.533 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 22.6 mm -83.27 122.1 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 167.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.4 ttp -105.81 127.47 53.12 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 102.448 -3.167 . . . . 0.0 102.448 162.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.2 t -91.62 140.29 16.33 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 C-N-CA 118.336 -1.345 . . . . 0.0 109.093 -174.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.65 75.75 1.44 Allowed 'General case' 0 C--N 1.366 1.288 0 N-CA-C 120.334 3.457 . . . . 0.0 120.334 -169.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.256 . . -85.31 -176.2 0.74 Allowed Pre-proline 0 CA--C 1.502 -0.872 0 O-C-N 119.374 -2.079 . . . . 0.0 115.357 -169.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -65.55 153.77 76.7 Favored 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 122.292 1.994 . . . . 0.0 109.969 160.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -77.25 126.32 30.75 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 170.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -60.53 137.78 58.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.325 1.45 . . . . 0.0 111.899 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 28.1 tptp 59.28 83.23 0.13 Allowed 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 126.134 1.773 . . . . 0.0 108.709 -166.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 . . . . . 0 C--O 1.259 1.575 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.952 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.468 -2.187 0 CA-C-O 124.81 2.243 . . . . 0.0 107.436 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.5 mm -88.25 114.97 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 108.513 -3.949 . . . . 0.0 106.927 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -98.98 167.27 10.84 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -168.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.404 HG23 ' HE3' ' A' ' 123' ' ' LYS . 79.3 t -99.31 120.65 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.431 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 170.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -104.22 173.16 6.42 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 154.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -142.62 154.65 44.58 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -176.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.9 tp -138.7 167.28 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 170.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -119.84 156.25 31.04 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.214 161.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.463 ' CE2' HG23 ' A' ' 148' ' ' VAL . 29.4 m-85 -130.52 160.54 33.82 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 170.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -103.04 174.28 2.92 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 125.213 1.405 . . . . 0.0 108.611 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -58.47 146.48 90.33 Favored 'Trans proline' 0 N--CA 1.438 -1.78 1 C-N-CA 125.354 4.036 . . . . 0.0 111.001 158.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -9.04 102.65 0.01 OUTLIER Glycine 0 CA--C 1.474 -2.499 1 C-N-CA 131.017 4.151 . . . . 0.0 115.241 -174.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.48 ' H ' ' HG1' ' A' ' 102' ' ' THR . 0.2 OUTLIER -101.16 -152.14 0.42 Allowed 'General case' 0 N--CA 1.403 -2.804 0 CA-C-N 111.015 -2.592 . . . . 0.0 108.812 -150.3 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.451 0.7 OUTLIER -123.77 164.32 19.39 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 109.947 -3.297 . . . . 0.0 110.822 -154.469 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -69.51 -79.24 0.06 Allowed 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -106.77 46.26 1.19 Allowed Glycine 0 CA--C 1.477 -2.295 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.109 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -103.13 -41.82 5.97 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 143.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -80.22 -65.44 1.01 Allowed 'General case' 0 CA--C 1.481 -1.673 0 O-C-N 124.29 0.994 . . . . 0.0 109.567 -165.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.337 0.0 OUTLIER -62.26 -9.6 8.38 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 120.472 3.508 . . . . 0.0 120.472 178.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.53 -44.2 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-O 122.684 1.23 . . . . 0.0 109.72 160.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -89.19 -6.87 56.58 Favored 'General case' 0 CA--C 1.469 -2.149 0 O-C-N 120.395 -1.441 . . . . 0.0 114.727 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 tt -72.34 -35.26 68.52 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 162.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.445 ' HA ' HG12 ' A' ' 115' ' ' ILE . 2.4 tpt180 -56.99 -40.68 77.0 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.484 1.114 . . . . 0.0 111.222 168.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.7 t -59.56 -47.69 84.55 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.306 1.4 mm? -67.4 -25.55 66.0 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 175.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.445 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.271 3.0 mm -62.24 -47.74 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.767 0 CA-C-N 120.53 1.514 . . . . 0.0 107.993 177.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -52.53 -47.03 66.95 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 127.766 2.426 . . . . 0.0 109.751 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -61.24 -51.88 67.1 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.531 1.132 . . . . 0.0 113.028 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.49 -21.25 61.96 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 126.998 2.119 . . . . 0.0 113.75 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -68.86 -41.74 78.01 Favored 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 126.94 2.096 . . . . 0.0 109.245 171.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.78 -26.68 67.81 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 123.037 0.535 . . . . 0.0 110.785 173.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.34 68.01 1.47 Allowed Glycine 0 CA--C 1.469 -2.802 0 N-CA-C 104.477 -3.449 . . . . 0.0 104.477 -171.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -120.59 164.26 16.75 Favored 'General case' 0 CA--C 1.447 -2.995 1 N-CA-C 97.985 -4.82 . . . . 0.0 97.985 168.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.404 ' HE3' HG23 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -101.19 114.88 29.24 Favored 'General case' 0 N--CA 1.393 -3.276 1 N-CA-C 97.175 -5.12 . . . . 0.0 97.175 170.551 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.07 160.44 20.95 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 173.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -135.38 128.66 32.03 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.9 mm -82.04 135.44 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.44 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 15.1 m -109.84 118.29 36.09 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 163.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.491 HD22 ' CZ ' ' A' ' 130' ' ' PHE . 11.0 tp -81.07 149.53 29.18 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 168.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -150.76 95.76 2.26 Favored 'General case' 0 N--CA 1.398 -3.026 1 N-CA-C 97.007 -5.183 . . . . 0.0 97.007 -175.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.491 ' CZ ' HD22 ' A' ' 128' ' ' LEU . 95.4 m-85 -66.54 121.6 15.72 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 111.262 -2.699 . . . . 0.0 104.748 174.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -77.37 105.67 8.64 Favored 'General case' 0 CA--C 1.482 -1.659 1 N-CA-C 100.082 -4.044 . . . . 0.0 100.082 164.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.28 115.58 7.24 Favored Glycine 0 CA--C 1.473 -2.557 0 O-C-N 124.909 1.381 . . . . 0.0 112.799 -154.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -74.74 -85.92 0.04 OUTLIER 'General case' 0 CA--C 1.477 -1.86 0 CA-C-N 112.496 -1.852 . . . . 0.0 107.743 173.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -68.57 -65.45 0.7 Allowed 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 158.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 17.2 ttt -165.71 -33.72 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 174.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 172.49 109.48 0.01 OUTLIER 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -152.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.543 ' HB2' ' H ' ' A' ' 140' ' ' ILE . 5.8 m170 -119.08 156.99 28.73 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-O 120.763 0.316 . . . . 0.0 110.404 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -95.53 22.32 7.19 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 121.485 -0.759 . . . . 0.0 109.164 168.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -104.37 -49.83 3.48 Favored 'General case' 0 CA--C 1.476 -1.894 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 168.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.543 ' H ' ' HB2' ' A' ' 137' ' ' HIS . 69.4 mt -56.28 -44.5 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.087 0 C-N-CA 127.41 2.284 . . . . 0.0 110.092 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.74 -56.67 5.82 Favored Glycine 0 CA--C 1.459 -3.455 0 CA-C-O 118.744 -1.031 . . . . 0.0 113.438 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 5.6 ptt? -84.85 0.0 52.45 Favored 'General case' 0 N--CA 1.41 -2.438 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -161.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.261 2.8 tp10 -61.19 -61.12 2.79 Favored 'General case' 0 CA--C 1.461 -2.456 0 C-N-CA 114.879 -2.728 . . . . 0.0 115.308 147.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.96 -65.2 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.938 0 O-C-N 125.651 1.844 . . . . 0.0 109.293 -163.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.419 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 26.4 mt -45.79 -55.74 6.21 Favored 'General case' 0 N--CA 1.427 -1.619 0 C-N-CA 129.315 3.046 . . . . 0.0 114.431 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.261 2.4 t30 -62.81 -31.01 71.92 Favored 'General case' 0 CA--C 1.47 -2.133 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 173.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -79.5 -15.72 57.26 Favored 'General case' 0 N--CA 1.421 -1.91 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.193 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.463 HG23 ' CE2' ' A' ' 98' ' ' PHE . 1.6 t -72.33 -50.24 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.823 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 175.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.261 31.4 ttmt -50.1 -50.96 46.68 Favored 'General case' 0 CA--C 1.466 -2.255 0 C-N-CA 125.682 1.593 . . . . 0.0 112.69 173.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.08 -39.59 68.88 Favored 'General case' 0 N--CA 1.407 -2.604 0 C-N-CA 126.216 1.807 . . . . 0.0 109.451 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -76.22 -27.46 56.83 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 115.716 -2.393 . . . . 0.0 115.198 172.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.346 0.4 OUTLIER -81.23 -29.54 34.43 Favored 'General case' 0 CA--C 1.458 -2.595 0 CA-C-O 116.137 -1.887 . . . . 0.0 114.474 179.347 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -26.03 -26.54 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.683 1 C-N-CA 136.065 5.746 . . . . 0.0 119.756 -173.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -51.94 -55.45 20.24 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 126.58 1.952 . . . . 0.0 112.742 166.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.429 ' HG ' ' CG2' ' A' ' 115' ' ' ILE 0.3 1.2 mm? -94.73 -58.82 2.07 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 128.048 2.539 . . . . 0.0 107.191 -169.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.298 . . -109.28 151.32 26.71 Favored 'General case' 0 CA--C 1.446 -3.055 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.974 -161.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.59 176.53 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.543 0 C-N-CA 115.216 -2.594 . . . . 0.0 116.65 140.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.4 t -84.96 150.29 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 168.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -80.64 -37.76 30.4 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.3 t -159.84 144.04 14.68 Favored 'General case' 0 CA--C 1.461 -2.477 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -100.28 90.81 1.48 Allowed Pre-proline 0 N--CA 1.426 -1.627 0 N-CA-C 101.979 -3.341 . . . . 0.0 101.979 170.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.487 ' HB2' ' HG1' ' A' ' 163' ' ' THR . 12.3 Cg_endo -98.39 -82.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.446 0 CA-C-N 120.717 1.292 . . . . 0.0 109.406 -137.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.487 ' HG1' ' HB2' ' A' ' 162' ' ' PRO . 0.1 OUTLIER -95.23 -162.29 0.94 Allowed 'General case' 1 N--CA 1.375 -4.223 0 CA-C-O 126.05 2.833 . . . . 0.0 112.658 -137.727 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -122.79 124.69 43.89 Favored 'General case' 0 N--CA 1.423 -1.789 2 CA-C-N 107.031 -4.622 . . . . 0.0 99.737 171.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.444 ' H ' HG13 ' A' ' 165' ' ' ILE . 3.2 mt -73.44 132.96 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 CA-C-O 122.752 1.263 . . . . 0.0 109.854 -172.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -115.41 128.85 56.34 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 172.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.31 -156.22 46.61 Favored Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -108.62 43.3 1.26 Allowed 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 124.326 1.051 . . . . 0.0 109.589 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.302 32.1 mt-30 -167.03 137.79 3.12 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -174.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 59.6 ttp -134.61 117.96 16.7 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 120.883 0.373 . . . . 0.0 110.165 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.44 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 11.2 mm -77.95 133.3 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' A' ' 145' ' ' LEU . 2.8 ttt -119.69 131.3 55.38 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 165.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 1.6 t -100.21 143.01 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -171.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.59 70.51 1.45 Allowed 'General case' 0 C--N 1.364 1.23 0 N-CA-C 119.469 3.137 . . . . 0.0 119.469 -161.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.284 . . -92.31 173.75 4.83 Favored Pre-proline 0 C--N 1.358 0.962 0 N-CA-C 119.416 3.117 . . . . 0.0 119.416 -171.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -70.46 142.03 43.85 Favored 'Trans proline' 0 N--CA 1.443 -1.493 0 CA-C-N 120.591 1.247 . . . . 0.0 110.842 -175.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -81.62 129.83 34.83 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 175.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -86.38 101.36 13.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.479 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -76.11 123.65 26.15 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 C--O 1.26 1.623 0 C-N-CA 124.749 1.219 . . . . 0.0 109.408 179.324 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 CA--C 1.483 -1.606 0 CA-C-O 122.34 1.067 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.9 mm -92.04 127.11 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-N 113.013 -1.903 . . . . 0.0 107.066 176.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -94.16 167.42 11.57 Favored 'General case' 0 CA--C 1.48 -1.743 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -174.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.4 t -98.69 117.16 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.712 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 157.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -106.66 170.66 7.8 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 155.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -137.85 157.22 46.87 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -167.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.21 159.27 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 N-CA-C 102.329 -3.212 . . . . 0.0 102.329 174.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -117.85 157.45 26.6 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 118.937 0.79 . . . . 0.0 111.587 166.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CE2' HG23 ' A' ' 148' ' ' VAL . 28.5 m-85 -139.89 90.94 2.43 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 172.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -84.31 170.49 13.66 Favored Pre-proline 0 N--CA 1.436 -1.153 0 C-N-CA 123.849 0.86 . . . . 0.0 108.937 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -74.72 145.3 32.41 Favored 'Trans proline' 0 N--CA 1.436 -1.88 0 C-N-CA 122.218 1.945 . . . . 0.0 107.309 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.64 8.64 63.65 Favored Glycine 0 CA--C 1.483 -1.925 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 m -108.27 94.45 5.07 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 170.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -124.7 -168.49 1.82 Allowed 'General case' 0 N--CA 1.411 -2.404 0 CA-C-N 112.79 -2.004 . . . . 0.0 106.933 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -50.69 -48.7 58.58 Favored 'General case' 0 CA--C 1.479 -1.759 0 C-N-CA 127.514 2.326 . . . . 0.0 113.659 -128.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.41 0.18 77.4 Favored Glycine 0 N--CA 1.42 -2.395 0 N-CA-C 116.035 1.174 . . . . 0.0 116.035 -169.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -101.45 -29.42 12.02 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.46 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -86.57 -70.43 0.61 Allowed 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 113.265 -1.789 . . . . 0.0 110.261 -158.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.326 0.0 OUTLIER -59.01 -14.06 8.35 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 119.004 2.964 . . . . 0.0 119.004 173.604 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.24 -45.75 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 122.096 0.95 . . . . 0.0 110.225 161.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -91.36 4.37 52.57 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 tt -83.51 -30.63 26.98 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 162.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.463 ' HA ' HG12 ' A' ' 115' ' ' ILE . 25.1 ttt85 -62.51 -42.42 99.5 Favored 'General case' 0 C--N 1.361 1.082 0 CA-C-O 118.686 -0.674 . . . . 0.0 110.664 167.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.25 65.7 m -55.1 -44.97 75.41 Favored 'General case' 0 C--N 1.379 1.866 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 169.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.7 mt -65.08 -29.53 70.41 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 177.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.463 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.2 mm -61.04 -45.51 98.42 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.378 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -52.7 43.54 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.542 1.537 . . . . 0.0 111.302 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -57.34 -46.32 83.41 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -54.48 -44.53 72.72 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 127.802 2.441 . . . . 0.0 112.848 172.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -79.54 -20.09 47.94 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 126.555 1.942 . . . . 0.0 112.416 -174.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -68.11 -21.59 64.94 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.139 0.576 . . . . 0.0 110.745 170.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.73 51.4 3.64 Favored Glycine 0 CA--C 1.474 -2.474 0 N-CA-C 105.804 -2.918 . . . . 0.0 105.804 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -126.78 165.97 18.29 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.53 119.82 35.72 Favored 'General case' 0 N--CA 1.409 -2.5 1 N-CA-C 99.795 -4.15 . . . . 0.0 99.795 178.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -91.98 144.04 25.86 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 103.176 -2.898 . . . . 0.0 103.176 -172.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -118.72 125.05 48.81 Favored 'General case' 0 CA--C 1.479 -1.785 0 O-C-N 117.893 -3.004 . . . . 0.0 106.314 173.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.2 mm -86.34 131.99 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 173.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.519 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 32.8 m -121.76 123.92 42.97 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 173.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . 0.362 0.4 OUTLIER -76.58 150.16 36.53 Favored 'General case' 0 CA--C 1.468 -2.188 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 164.787 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -145.15 88.96 1.91 Allowed 'General case' 0 N--CA 1.399 -3.008 1 N-CA-C 99.735 -4.172 . . . . 0.0 99.735 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.596 ' HB3' ' CE1' ' A' ' 137' ' ' HIS 0.25 70.1 m-85 -63.11 144.44 56.9 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 110.986 -2.824 . . . . 0.0 109.144 -177.69 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -119.49 29.16 7.76 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -124.46 -17.17 2.97 Favored Glycine 0 CA--C 1.482 -1.991 0 N-CA-C 105.878 -2.889 . . . . 0.0 105.878 169.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 1.18 79.37 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.071 1 C-N-CA 133.306 4.642 . . . . 0.0 118.169 177.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -141.5 21.54 2.19 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 169.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 58.3 mtt 55.48 72.11 0.5 Allowed 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 125.416 1.486 . . . . 0.0 107.292 -156.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.72 ' HB2' ' CD2' ' A' ' 137' ' ' HIS . . . -89.01 -38.25 14.56 Favored 'General case' 0 CA--C 1.473 -1.996 0 CA-C-O 125.214 2.435 . . . . 0.0 109.709 -169.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.72 ' CD2' ' HB2' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -106.4 159.44 16.14 Favored 'General case' 0 N--CA 1.413 -2.312 1 CA-C-N 107.531 -4.395 . . . . 0.0 111.019 -148.139 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -138.73 0.84 2.05 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 102.536 -3.135 . . . . 0.0 102.536 142.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -90.47 -50.92 5.68 Favored 'General case' 0 CA--C 1.477 -1.85 0 CA-C-N 113.808 -1.542 . . . . 0.0 108.838 -167.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.399 57.5 mt -52.83 -38.92 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 126.945 2.098 . . . . 0.0 112.329 174.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.4 -64.9 2.59 Favored Glycine 0 N--CA 1.418 -2.513 0 CA-C-O 119.474 -0.626 . . . . 0.0 112.676 173.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -87.1 -5.85 58.88 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -153.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.02 -48.46 78.67 Favored 'General case' 0 CA--C 1.457 -2.615 0 C-N-CA 116.496 -2.081 . . . . 0.0 113.837 156.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.39 -67.77 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.444 -3.133 0 O-C-N 126.023 2.077 . . . . 0.0 106.936 -167.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 42.7 mt -43.0 -54.15 4.42 Favored 'General case' 0 CA--C 1.476 -1.898 0 C-N-CA 128.495 2.718 . . . . 0.0 115.679 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -63.87 -31.91 73.25 Favored 'General case' 0 CA--C 1.461 -2.474 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.3 ttp180 -81.81 -14.51 56.25 Favored 'General case' 0 N--CA 1.419 -2.013 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.014 172.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.46 HG21 ' HH ' ' A' ' 107' ' ' TYR . 1.8 t -76.27 -46.6 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.81 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 176.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.4 ' HE2' ' HB ' ' A' ' 158' ' ' VAL . 31.4 ttmt -51.9 -51.21 58.52 Favored 'General case' 0 CA--C 1.461 -2.453 0 C-N-CA 125.239 1.416 . . . . 0.0 111.003 172.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.81 -35.85 67.43 Favored 'General case' 0 N--CA 1.409 -2.513 0 C-N-CA 124.612 1.165 . . . . 0.0 110.529 -168.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -72.84 -39.41 66.57 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 116.291 -2.164 . . . . 0.0 114.941 170.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.303 0.2 OUTLIER -80.87 -19.56 44.18 Favored 'General case' 0 CA--C 1.464 -2.341 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -178.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -27.11 -25.07 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.363 1 C-N-CA 134.586 5.154 . . . . 0.0 119.064 174.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.24 -57.77 9.92 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 126.903 2.081 . . . . 0.0 113.361 167.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.537 ' HG ' ' HZ3' ' A' ' 179' ' ' LYS . 0.9 OUTLIER -109.38 -51.39 2.88 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 113.498 -1.683 . . . . 0.0 108.525 -164.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.434 ' HA ' HD13 ' A' ' 118' ' ' LEU 0.321 . . -91.65 146.13 24.03 Favored 'General case' 0 CA--C 1.455 -2.685 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 177.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.4 m -121.12 171.6 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.457 -2.615 0 C-N-CA 114.265 -2.974 . . . . 0.0 116.307 126.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.4 ' HB ' ' HE2' ' A' ' 149' ' ' LYS 0.298 3.2 t -81.8 155.11 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 C-N-CA 130.524 3.53 . . . . 0.0 107.313 179.391 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -82.15 -42.45 19.05 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.03 141.31 18.58 Favored 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -174.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -98.22 109.73 53.33 Favored Pre-proline 0 N--CA 1.417 -2.077 1 N-CA-C 98.766 -4.531 . . . . 0.0 98.766 158.128 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -86.4 -100.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.536 0 N-CA-C 102.886 -3.544 . . . . 0.0 102.886 -169.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -162.84 -62.9 0.04 OUTLIER 'General case' 0 N--CA 1.405 -2.71 0 N-CA-C 103.402 -2.814 . . . . 0.0 103.402 -160.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -151.56 162.92 40.15 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 122.81 1.29 . . . . 0.0 110.768 -161.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.472 ' CD1' ' HD1' ' A' ' 137' ' ' HIS . 2.9 mt -53.01 142.96 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 1 C-N-CA 132.234 4.213 . . . . 0.0 111.933 172.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -131.09 96.8 4.13 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 89.83 -143.8 17.33 Favored Glycine 0 CA--C 1.486 -1.729 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -171.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -97.42 27.29 4.32 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 125.327 1.451 . . . . 0.0 112.298 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.279 15.5 mt-30 -171.99 142.26 1.44 Allowed 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 -157.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 21.6 ttm -104.57 158.35 16.55 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 102.45 -3.167 . . . . 0.0 102.45 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.519 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 32.7 mm -118.43 131.53 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.157 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 159.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.5 ttp -108.12 128.4 54.65 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 153.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 37.0 t -91.47 130.39 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 C-N-CA 118.17 -1.412 . . . . 0.0 108.597 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.1 tp -101.82 144.07 30.94 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 130.213 3.405 . . . . 0.0 116.915 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.261 . . -143.08 -179.3 0.93 Allowed Pre-proline 0 CA--C 1.483 -1.599 0 O-C-N 119.255 -2.153 . . . . 0.0 108.991 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -65.24 145.24 83.5 Favored 'Trans proline' 0 N--CA 1.436 -1.877 0 C-N-CA 123.025 2.483 . . . . 0.0 109.197 158.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -76.91 143.4 39.61 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 165.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -69.81 105.19 2.69 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 170.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.537 ' HZ3' ' HG ' ' A' ' 155' ' ' LEU . 99.3 mttt -101.03 77.53 1.84 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 . . . . . 0 C--O 1.26 1.61 0 C-N-CA 125.226 1.411 . . . . 0.0 110.038 -176.186 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 CA--C 1.481 -1.687 0 CA-C-O 122.128 0.966 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.6 mm -90.3 117.54 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 113.183 -1.826 . . . . 0.0 108.685 176.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -89.93 169.89 10.85 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.5 t -102.65 119.47 51.06 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.789 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 161.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -115.19 178.59 4.23 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 160.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -141.7 158.98 43.15 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -171.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.1 tp -134.37 164.74 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 168.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -120.24 154.62 34.65 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.113 162.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.458 ' CE2' HG23 ' A' ' 148' ' ' VAL . 37.9 m-85 -128.9 136.66 50.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 102.922 -2.992 . . . . 0.0 102.922 167.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -114.33 174.22 2.46 Favored Pre-proline 0 N--CA 1.432 -1.344 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -72.88 135.72 23.91 Favored 'Trans proline' 0 N--CA 1.432 -2.093 0 N-CA-C 105.472 -2.549 . . . . 0.0 105.472 163.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.32 10.2 64.23 Favored Glycine 0 CA--C 1.484 -1.893 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 88.2 m -100.51 90.13 4.18 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 169.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -125.02 -171.9 2.46 Favored 'General case' 0 N--CA 1.41 -2.441 0 CA-C-N 112.122 -2.308 . . . . 0.0 106.523 172.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -48.14 -49.96 30.43 Favored 'General case' 0 CA--C 1.48 -1.731 0 C-N-CA 128.155 2.582 . . . . 0.0 113.793 -131.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.84 1.1 77.62 Favored Glycine 0 N--CA 1.418 -2.523 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -168.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -100.51 -30.15 11.96 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 125.08 1.352 . . . . 0.0 108.044 166.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.445 ' HH ' HG21 ' A' ' 148' ' ' VAL . 1.0 OUTLIER -87.19 -72.79 0.5 Allowed 'General case' 0 CA--C 1.47 -2.105 0 CA-C-N 112.283 -2.235 . . . . 0.0 111.036 -157.733 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.312 0.0 OUTLIER -60.18 -13.45 12.34 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 118.808 2.892 . . . . 0.0 118.808 174.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 94.9 t -60.47 -48.74 87.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 C-N-CA 124.209 1.004 . . . . 0.0 109.997 160.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -91.72 7.41 41.83 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.3 tt -86.21 -31.14 21.89 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 163.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.455 ' HA ' HG12 ' A' ' 115' ' ' ILE . 56.9 ttt-85 -62.25 -43.8 97.99 Favored 'General case' 0 C--N 1.363 1.158 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.021 167.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.1 m -60.14 -42.37 94.71 Favored 'General case' 0 C--N 1.378 1.838 0 C-N-CA 118.181 -1.408 . . . . 0.0 113.175 174.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.9 mt -62.48 -30.77 71.5 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.455 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.6 mm -58.33 -51.58 69.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.733 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 25.9 tpt85 -50.38 -45.96 55.69 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 126.716 2.007 . . . . 0.0 112.745 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -61.22 -54.54 42.96 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -39.46 76.74 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 177.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -78.43 -29.91 47.32 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 128.703 2.801 . . . . 0.0 110.252 -169.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.92 7.47 8.82 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 123.067 0.547 . . . . 0.0 111.406 173.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.09 61.13 2.57 Favored Glycine 0 CA--C 1.467 -2.937 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 173.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -131.88 168.57 17.63 Favored 'General case' 0 CA--C 1.448 -2.971 0 N-CA-C 101.194 -3.632 . . . . 0.0 101.194 170.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.25 116.71 32.48 Favored 'General case' 0 N--CA 1.39 -3.472 1 N-CA-C 98.091 -4.781 . . . . 0.0 98.091 173.373 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -82.72 158.22 22.97 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 102.586 -3.116 . . . . 0.0 102.586 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.306 33.2 mtmm -126.29 144.49 50.78 Favored 'General case' 0 CA--C 1.481 -1.677 0 O-C-N 118.795 -2.441 . . . . 0.0 105.47 155.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.4 mm -86.62 137.37 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 167.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.557 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 23.9 m -117.17 123.78 47.52 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 166.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . 0.258 0.2 OUTLIER -80.18 153.78 28.4 Favored 'General case' 0 CA--C 1.467 -2.213 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 166.573 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -148.21 94.79 2.37 Favored 'General case' 0 N--CA 1.404 -2.756 1 N-CA-C 99.51 -4.255 . . . . 0.0 99.51 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -77.15 175.79 9.32 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.116 -170.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -66.27 108.49 2.33 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 152.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.86 121.67 10.94 Favored Glycine 0 CA--C 1.479 -2.161 0 CA-C-O 122.214 0.897 . . . . 0.0 114.599 -155.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -129.32 172.8 11.12 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -61.89 -73.6 0.1 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.107 0.963 . . . . 0.0 110.539 176.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 14.2 tpt -104.3 102.08 11.78 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 103.36 -2.83 . . . . 0.0 103.36 166.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.99 -171.66 3.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -171.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.523 ' CG ' HD11 ' A' ' 140' ' ' ILE . 40.1 m-70 -35.34 121.54 0.58 Allowed 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 130.397 3.479 . . . . 0.0 114.898 165.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -98.12 -0.81 43.68 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -87.79 -51.9 5.6 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -175.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.523 HD11 ' CG ' ' A' ' 137' ' ' HIS 0.253 68.4 mt -52.9 -41.12 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 C-N-CA 127.306 2.242 . . . . 0.0 111.67 173.16 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -70.11 -64.5 2.87 Favored Glycine 0 N--CA 1.416 -2.657 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -84.78 -5.66 59.33 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -155.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.32 -53.72 48.33 Favored 'General case' 0 CA--C 1.459 -2.529 0 C-N-CA 115.925 -2.31 . . . . 0.0 114.126 154.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.11 -67.05 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.443 -3.144 0 O-C-N 126.028 2.08 . . . . 0.0 107.499 -167.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.9 mt -41.08 -56.63 2.27 Favored 'General case' 0 CA--C 1.476 -1.877 0 C-N-CA 128.977 2.911 . . . . 0.0 115.15 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.31 -31.41 72.55 Favored 'General case' 0 CA--C 1.466 -2.285 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 175.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -82.69 -13.68 55.96 Favored 'General case' 0 N--CA 1.419 -2.012 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.868 173.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.458 HG23 ' CE2' ' A' ' 98' ' ' PHE . 1.7 t -76.31 -46.96 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 177.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.251 35.3 ttmt -51.21 -49.83 60.27 Favored 'General case' 0 CA--C 1.464 -2.357 0 C-N-CA 125.642 1.577 . . . . 0.0 111.991 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -37.39 64.93 Favored 'General case' 0 N--CA 1.408 -2.57 0 C-N-CA 125.276 1.43 . . . . 0.0 109.978 -169.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -72.22 -38.21 69.02 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 116.412 -2.115 . . . . 0.0 114.923 171.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.296 0.2 OUTLIER -81.84 -20.68 38.49 Favored 'General case' 0 CA--C 1.461 -2.443 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -178.318 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -25.87 -28.2 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.305 1 C-N-CA 134.305 5.042 . . . . 0.0 119.142 175.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -50.88 -54.05 27.23 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 128.101 2.56 . . . . 0.0 113.747 168.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.1 tt -113.22 -51.0 2.84 Favored 'General case' 0 N--CA 1.42 -1.932 0 C-N-CA 126.163 1.785 . . . . 0.0 108.611 -167.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.343 . . -104.7 142.0 35.46 Favored 'General case' 0 CA--C 1.449 -2.937 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.822 -177.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.5 m -120.04 171.76 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.65 0 CA-C-O 125.117 2.389 . . . . 0.0 116.022 140.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 158' ' ' VAL 0.289 2.7 t -81.82 152.86 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 109.917 -3.311 . . . . 0.0 106.336 177.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -83.33 -39.2 21.06 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -176.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.76 140.95 18.51 Favored 'General case' 0 CA--C 1.468 -2.193 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -174.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -103.94 106.37 52.63 Favored Pre-proline 0 N--CA 1.422 -1.845 0 N-CA-C 101.259 -3.608 . . . . 0.0 101.259 164.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -102.95 -110.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.413 -3.233 1 N-CA-C 101.209 -4.189 . . . . 0.0 101.209 -174.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 179.66 -47.68 0.01 OUTLIER 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 101.657 -3.46 . . . . 0.0 101.657 -146.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -83.76 112.79 20.4 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-O 121.964 0.887 . . . . 0.0 111.915 -148.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -76.85 129.1 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 102.494 -3.15 . . . . 0.0 102.494 170.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -120.37 100.43 7.15 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.21 -145.71 23.38 Favored Glycine 0 CA--C 1.484 -1.859 0 N-CA-C 107.306 -2.318 . . . . 0.0 107.306 -168.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -99.85 36.71 1.75 Allowed 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 125.158 1.383 . . . . 0.0 110.472 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.314 19.8 mt-30 -170.61 141.48 1.89 Allowed 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 124.663 1.185 . . . . 0.0 108.024 -157.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 4.6 ttm -116.14 112.99 22.49 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-N 119.805 1.184 . . . . 0.0 109.878 -175.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.557 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 14.9 mm -80.92 123.57 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 O-C-N 121.06 -1.025 . . . . 0.0 108.646 170.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.9 ttt -107.49 131.24 54.52 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 159.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 39.1 t -93.09 140.86 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.017 -173.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.92 81.1 1.99 Allowed 'General case' 0 C--N 1.364 1.208 0 N-CA-C 118.988 2.958 . . . . 0.0 118.988 -169.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.276 . . -85.94 178.73 2.16 Favored Pre-proline 0 CA--C 1.499 -0.993 0 O-C-N 119.644 -1.91 . . . . 0.0 115.998 -171.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -62.06 142.97 94.29 Favored 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 122.849 2.366 . . . . 0.0 109.786 159.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -78.14 131.38 37.2 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -74.95 104.41 5.54 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 171.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -78.2 121.33 24.22 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 . . . . . 0 C--O 1.259 1.588 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -177.931 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.472 -2.05 0 CA-C-O 124.947 2.308 . . . . 0.0 107.489 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.54 123.75 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 CA-C-N 108.448 -3.978 . . . . 0.0 106.785 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -97.48 163.83 12.7 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 -166.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.3 t -100.78 119.99 49.67 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.588 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -104.85 172.44 6.79 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 155.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -143.78 154.23 43.22 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -175.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 tp -138.71 165.26 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 103.918 -2.623 . . . . 0.0 103.918 171.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -117.13 155.04 30.0 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-N 118.744 0.702 . . . . 0.0 110.903 163.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.427 ' CE2' HG23 ' A' ' 148' ' ' VAL . 26.7 m-85 -128.9 145.47 51.21 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 170.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -100.23 166.52 12.52 Favored Pre-proline 0 N--CA 1.438 -1.046 0 C-N-CA 126.341 1.856 . . . . 0.0 106.719 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -56.09 139.14 84.86 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 C-N-CA 124.751 3.634 . . . . 0.0 113.399 169.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 3.82 98.17 0.0 OUTLIER Glycine 0 CA--C 1.468 -2.898 1 C-N-CA 131.989 4.614 . . . . 0.0 114.816 -173.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.57 -154.99 0.49 Allowed 'General case' 0 N--CA 1.397 -3.122 0 CA-C-N 111.104 -2.548 . . . . 0.0 108.731 -154.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.435 0.7 OUTLIER -125.56 166.55 16.49 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-N 109.734 -3.394 . . . . 0.0 111.372 -149.631 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.67 -75.02 0.12 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -107.14 45.79 1.26 Allowed Glycine 0 CA--C 1.476 -2.395 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.742 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -105.19 -42.7 5.21 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 144.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.542 ' HH ' ' HG2' ' A' ' 147' ' ' ARG . 0.6 OUTLIER -84.66 -63.82 1.27 Allowed 'General case' 0 CA--C 1.481 -1.708 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.678 -161.758 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.325 0.0 OUTLIER -61.87 -11.89 15.05 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 119.64 3.2 . . . . 0.0 119.64 177.392 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.5 t -60.96 -48.05 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-O 122.37 1.081 . . . . 0.0 109.552 160.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -91.41 -1.65 57.52 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tt -78.5 -33.42 48.1 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 162.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.439 ' HA ' HG12 ' A' ' 115' ' ' ILE . 46.7 ttt-85 -61.91 -40.57 95.91 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 117.672 -1.156 . . . . 0.0 110.997 169.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.6 m -57.43 -46.17 83.84 Favored 'General case' 0 C--N 1.38 1.913 0 C-N-CA 119.001 -1.08 . . . . 0.0 113.84 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.268 84.4 mt -65.49 -30.87 71.69 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.9 mm -58.75 -49.7 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.676 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -55.85 -39.55 71.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 126.801 2.041 . . . . 0.0 111.32 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -62.45 -51.7 66.46 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 123.581 0.752 . . . . 0.0 112.081 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.414 HD12 HD12 ' A' ' 174' ' ' LEU . 0.6 OUTLIER -66.83 -23.09 66.0 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 126.232 1.813 . . . . 0.0 114.978 177.331 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -69.98 -38.2 75.96 Favored 'General case' 0 CA--C 1.491 -1.306 0 C-N-CA 126.216 1.806 . . . . 0.0 109.875 172.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -66.63 -26.08 66.9 Favored 'General case' 0 C--N 1.361 1.083 0 O-C-N 123.28 0.363 . . . . 0.0 110.893 171.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.41 65.36 1.52 Allowed Glycine 0 CA--C 1.471 -2.702 0 N-CA-C 104.743 -3.343 . . . . 0.0 104.743 -172.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -121.52 164.72 16.76 Favored 'General case' 0 CA--C 1.449 -2.929 1 N-CA-C 98.79 -4.522 . . . . 0.0 98.79 170.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.5 117.6 35.26 Favored 'General case' 0 N--CA 1.396 -3.173 1 N-CA-C 97.538 -4.986 . . . . 0.0 97.538 169.106 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.63 160.6 20.37 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 172.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -134.42 131.43 38.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 169.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.1 mm -82.93 135.87 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.4 m -113.19 119.23 37.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 165.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.73 153.75 22.86 Favored 'General case' 0 CA--C 1.474 -1.963 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 167.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -151.62 103.05 2.92 Favored 'General case' 0 N--CA 1.395 -3.183 1 N-CA-C 96.504 -5.369 . . . . 0.0 96.504 -173.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -72.48 176.69 5.17 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 112.537 -2.119 . . . . 0.0 109.987 -174.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -73.4 -18.12 61.19 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-O 122.895 1.331 . . . . 0.0 113.939 -169.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.415 ' H ' ' H ' ' A' ' 133' ' ' ARG . . . 173.39 -5.76 0.03 OUTLIER Glycine 0 CA--C 1.472 -2.602 0 N-CA-C 106.657 -2.577 . . . . 0.0 106.657 165.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.415 ' H ' ' H ' ' A' ' 132' ' ' GLY . 48.5 ttp180 55.92 52.44 10.64 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 112.738 -1.731 . . . . 0.0 106.937 -147.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -87.68 -51.8 5.68 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 172.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 59.3 ttm -90.36 -64.99 1.06 Allowed 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 170.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.536 ' HB2' HG13 ' A' ' 140' ' ' ILE . . . -165.74 -138.24 0.03 OUTLIER 'General case' 0 CA--C 1.481 -1.698 0 CA-C-O 122.579 1.18 . . . . 0.0 112.529 -157.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.581 ' CG ' HD13 ' A' ' 165' ' ' ILE . 7.0 m170 166.33 -76.86 0.0 OUTLIER 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 110.84 -2.891 . . . . 0.0 113.018 -106.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -95.56 -25.52 16.15 Favored 'General case' 0 CA--C 1.475 -1.931 0 CA-C-O 122.274 1.035 . . . . 0.0 111.46 -161.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -81.48 -52.71 6.96 Favored 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.536 HG13 ' HB2' ' A' ' 136' ' ' ALA . 5.8 mt -53.57 -50.2 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.24 0 C-N-CA 128.834 2.853 . . . . 0.0 111.602 -177.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.94 -53.47 4.23 Favored Glycine 0 CA--C 1.458 -3.498 0 O-C-N 124.876 1.36 . . . . 0.0 110.517 -168.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 71.1 mtm -85.74 3.1 42.79 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -166.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.261 2.2 tp10 -62.42 -64.82 0.81 Allowed 'General case' 0 CA--C 1.466 -2.26 0 C-N-CA 115.199 -2.6 . . . . 0.0 115.876 141.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.1 t -62.59 -65.29 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.447 -2.994 0 O-C-N 125.907 2.005 . . . . 0.0 109.264 -162.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.3 mt -42.4 -53.99 4.0 Favored 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 129.435 3.094 . . . . 0.0 114.641 176.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -61.83 -35.89 79.58 Favored 'General case' 0 CA--C 1.466 -2.254 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.542 ' HG2' ' HH ' ' A' ' 107' ' ' TYR . 15.3 ttp180 -80.15 -14.71 58.26 Favored 'General case' 0 N--CA 1.419 -2.01 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.486 174.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.427 HG23 ' CE2' ' A' ' 98' ' ' PHE . 1.9 t -76.72 -46.46 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.725 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.271 31.4 ttmt -53.73 -48.31 69.75 Favored 'General case' 0 CA--C 1.467 -2.241 0 C-N-CA 126.007 1.723 . . . . 0.0 112.587 173.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -39.33 66.75 Favored 'General case' 0 N--CA 1.407 -2.596 0 C-N-CA 125.476 1.51 . . . . 0.0 108.77 -171.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -75.07 -22.95 58.0 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 115.637 -2.425 . . . . 0.0 115.63 170.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.313 0.2 OUTLIER -83.26 -31.12 27.12 Favored 'General case' 0 CA--C 1.473 -1.999 0 CA-C-O 116.887 -1.53 . . . . 0.0 112.827 -179.649 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -29.11 -26.48 0.0 OUTLIER 'General case' 0 C--N 1.367 1.346 1 C-N-CA 134.93 5.292 . . . . 0.0 119.346 -175.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -50.86 -53.28 33.69 Favored 'General case' 0 CA--C 1.491 -1.297 0 C-N-CA 128.642 2.777 . . . . 0.0 112.611 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . 0.251 0.2 OUTLIER -111.31 -53.53 2.69 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 113.701 -1.591 . . . . 0.0 108.593 -169.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.318 . . -105.65 154.33 20.58 Favored 'General case' 0 CA--C 1.444 -3.112 0 CA-C-N 113.732 -1.576 . . . . 0.0 107.756 -166.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.58 178.58 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.506 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 139.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.8 151.74 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.996 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 166.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -80.29 -38.59 30.47 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 6.8 t -123.02 -175.96 3.3 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -175.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -131.84 94.51 24.79 Favored Pre-proline 0 N--CA 1.419 -1.992 0 N-CA-C 102.343 -3.206 . . . . 0.0 102.343 144.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -77.46 -48.54 0.11 Allowed 'Trans proline' 0 CA--C 1.489 -1.726 0 CA-C-N 121.3 1.5 . . . . 0.0 113.152 -139.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . 0.254 1.3 m 5.84 51.32 0.0 OUTLIER 'General case' 0 N--CA 1.421 -1.911 1 C-N-CA 135.439 5.496 . . . . 0.0 119.648 -158.422 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -114.01 74.64 0.88 Allowed 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 109.781 -3.372 . . . . 0.0 103.337 158.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.581 HD13 ' CG ' ' A' ' 137' ' ' HIS . 8.3 mt -68.06 138.14 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 C-N-CA 125.05 1.34 . . . . 0.0 109.324 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -111.24 104.92 13.45 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 113.194 -1.821 . . . . 0.0 107.035 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.64 -147.61 29.75 Favored Glycine 0 CA--C 1.485 -1.806 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 -175.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -102.18 38.8 1.59 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.734 1.614 . . . . 0.0 110.202 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.257 26.0 mt-30 -169.78 132.99 1.2 Allowed 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -170.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -120.78 115.17 22.77 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -173.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.1 mm -79.07 123.86 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 167.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.4 ttt -107.21 136.89 46.28 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 163.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.97 134.88 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 118.176 -1.409 . . . . 0.0 108.782 -172.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.414 HD12 HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -122.71 69.27 0.98 Allowed 'General case' 0 C--N 1.356 0.883 0 N-CA-C 119.782 3.253 . . . . 0.0 119.782 -164.709 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.312 . . -89.59 172.71 6.83 Favored Pre-proline 0 C--N 1.356 0.85 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 -172.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -72.04 139.44 32.84 Favored 'Trans proline' 0 CA--C 1.493 -1.545 0 N-CA-C 107.905 -1.613 . . . . 0.0 107.905 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -81.06 168.01 19.12 Favored 'General case' 0 N--CA 1.433 -1.315 0 O-C-N 124.126 0.892 . . . . 0.0 111.521 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.18 111.52 2.99 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 125.324 1.449 . . . . 0.0 110.31 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -75.2 116.58 16.09 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 171.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 . . . . . 0 C--O 1.261 1.678 0 CA-C-O 117.001 -1.476 . . . . 0.0 108.679 -171.955 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.469 -2.139 0 CA-C-O 124.983 2.325 . . . . 0.0 107.549 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.9 mm -94.86 124.44 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 CA-C-N 108.658 -3.883 . . . . 0.0 107.061 176.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -94.61 167.84 11.22 Favored 'General case' 0 CA--C 1.48 -1.724 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -174.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.403 HG23 ' HE2' ' A' ' 123' ' ' LYS . 55.2 t -96.42 123.75 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 160.1 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -103.28 172.42 6.82 Favored 'General case' 0 CA--C 1.468 -2.187 0 C-N-CA 116.105 -2.238 . . . . 0.0 105.985 160.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -144.29 148.34 34.7 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 tp -131.83 160.65 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 102.372 -3.196 . . . . 0.0 102.372 172.056 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -113.86 154.15 27.97 Favored 'General case' 0 CA--C 1.484 -1.566 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.207 164.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -137.13 130.29 30.95 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -86.94 179.57 1.73 Allowed Pre-proline 0 N--CA 1.422 -1.839 0 C-N-CA 124.013 0.925 . . . . 0.0 110.648 179.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -56.73 146.64 76.24 Favored 'Trans proline' 0 N--CA 1.441 -1.597 1 C-N-CA 125.612 4.208 . . . . 0.0 113.826 173.272 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -13.37 103.29 0.01 OUTLIER Glycine 0 CA--C 1.472 -2.645 1 C-N-CA 131.263 4.268 . . . . 0.0 115.04 -173.456 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.13 -152.41 0.48 Allowed 'General case' 0 N--CA 1.402 -2.855 0 CA-C-N 111.032 -2.584 . . . . 0.0 108.151 -153.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.426 0.7 OUTLIER -124.39 166.31 16.18 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 110.042 -3.254 . . . . 0.0 111.134 -153.183 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.64 -73.4 0.16 Allowed 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -105.19 46.54 1.16 Allowed Glycine 0 CA--C 1.477 -2.295 0 C-N-CA 119.95 -1.119 . . . . 0.0 113.264 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -106.91 -42.47 4.91 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 145.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.411 ' HH ' HG23 ' A' ' 148' ' ' VAL . 0.5 OUTLIER -88.91 -60.73 1.88 Allowed 'General case' 0 CA--C 1.479 -1.765 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.772 -161.265 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.346 0.0 OUTLIER -61.43 -12.74 15.78 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 119.281 3.067 . . . . 0.0 119.281 174.638 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.61 -47.81 91.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-O 122.201 1.001 . . . . 0.0 109.613 160.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -90.81 3.57 54.07 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 178.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.6 tt -82.61 -30.55 29.41 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 162.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.449 ' HA ' HG12 ' A' ' 115' ' ' ILE . 59.0 ttt-85 -62.3 -41.98 98.97 Favored 'General case' 0 C--N 1.361 1.105 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.731 166.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 t -57.0 -45.38 83.07 Favored 'General case' 0 C--N 1.378 1.807 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 175.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.336 29.3 mt -66.98 -29.0 68.73 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 175.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.273 7.1 mm -61.67 -48.42 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.882 0 CA-C-N 120.049 1.295 . . . . 0.0 108.064 174.624 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -54.2 -43.85 71.11 Favored 'General case' 0 CA--C 1.479 -1.759 0 C-N-CA 126.929 2.092 . . . . 0.0 110.026 -178.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -63.28 -48.73 76.88 Favored 'General case' 0 CA--C 1.487 -1.45 0 O-C-N 124.385 1.053 . . . . 0.0 112.636 177.15 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -44.13 97.64 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -178.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -85.61 -17.8 35.12 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 126.813 2.045 . . . . 0.0 112.02 -169.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -81.71 -0.95 45.15 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 167.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.74 64.23 1.5 Allowed Glycine 0 CA--C 1.47 -2.74 0 C-N-CA 125.939 1.733 . . . . 0.0 108.947 171.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -134.92 165.96 24.1 Favored 'General case' 0 CA--C 1.445 -3.073 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 171.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.403 ' HE2' HG23 ' A' ' 93' ' ' VAL . 2.6 tmmm? -102.56 117.34 34.48 Favored 'General case' 0 N--CA 1.394 -3.232 1 N-CA-C 95.804 -5.628 . . . . 0.0 95.804 178.367 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.09 162.37 16.81 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -144.53 130.25 19.14 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 119.188 -2.195 . . . . 0.0 106.663 170.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.4 mm -84.02 136.39 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 174.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -108.52 119.92 40.93 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 161.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.485 HD12 ' CZ ' ' A' ' 130' ' ' PHE 0.281 0.3 OUTLIER -71.84 147.49 47.12 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.394 . . . . . . . . 4 4 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 53.1 ttm-85 -149.22 96.24 2.5 Favored 'General case' 0 N--CA 1.405 -2.717 1 N-CA-C 99.165 -4.383 . . . . 0.0 99.165 -178.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.485 ' CZ ' HD12 ' A' ' 128' ' ' LEU . 76.6 m-85 -70.47 146.09 50.52 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 111.787 -2.46 . . . . 0.0 109.417 -177.428 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -120.3 25.84 9.58 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 168.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.45 -115.05 0.11 Allowed Glycine 0 CA--C 1.478 -2.228 0 C-N-CA 126.351 1.929 . . . . 0.0 110.451 178.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -114.36 -165.74 1.04 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 112.601 -1.799 . . . . 0.0 107.891 177.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -58.8 -89.05 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 125.912 1.685 . . . . 0.0 111.261 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 26.1 ttt -77.38 104.63 8.01 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 103.612 -2.736 . . . . 0.0 103.612 162.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.69 -158.25 0.19 Allowed 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -158.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.425 ' CD2' HD11 ' A' ' 140' ' ' ILE . 1.1 m170 -96.58 140.19 31.56 Favored 'General case' 0 CA--C 1.476 -1.866 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.849 -170.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -88.31 1.2 55.09 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 121.325 0.583 . . . . 0.0 110.316 174.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -83.49 -50.62 8.1 Favored 'General case' 0 CA--C 1.481 -1.685 0 C-N-CA 126.667 1.987 . . . . 0.0 107.29 174.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.425 HD11 ' CD2' ' A' ' 137' ' ' HIS 0.256 59.4 mt -53.79 -42.41 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 C-N-CA 127.476 2.31 . . . . 0.0 111.061 177.474 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.33 -54.98 5.86 Favored Glycine 0 N--CA 1.412 -2.962 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.16 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -85.68 -0.53 55.41 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -163.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.26 2.2 tp10 -60.46 -57.97 10.49 Favored 'General case' 0 CA--C 1.453 -2.776 0 C-N-CA 114.687 -2.805 . . . . 0.0 114.805 147.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.1 t -67.15 -64.82 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.448 -2.956 0 O-C-N 126.118 2.136 . . . . 0.0 108.981 -161.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 51.2 mt -47.32 -52.43 16.44 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 128.227 2.611 . . . . 0.0 115.286 178.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.265 1.7 t30 -63.44 -30.73 71.81 Favored 'General case' 0 CA--C 1.479 -1.761 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 174.175 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -80.61 -15.88 55.5 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.858 173.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.411 HG23 ' HH ' ' A' ' 107' ' ' TYR . 2.0 t -75.58 -43.95 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.614 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.441 ' HE2' ' HB ' ' A' ' 158' ' ' VAL 0.283 23.2 ttmt -52.52 -49.53 64.63 Favored 'General case' 0 CA--C 1.47 -2.133 0 C-N-CA 126.222 1.809 . . . . 0.0 113.391 173.669 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -73.24 -41.45 63.7 Favored 'General case' 0 N--CA 1.404 -2.745 0 C-N-CA 127.78 2.432 . . . . 0.0 108.545 -172.216 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -75.04 -24.5 58.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 116.474 -2.09 . . . . 0.0 114.813 172.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.308 0.1 OUTLIER -81.93 -31.41 31.33 Favored 'General case' 0 CA--C 1.47 -2.13 0 CA-C-O 116.063 -1.922 . . . . 0.0 112.339 178.172 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -28.45 -26.92 0.0 OUTLIER 'General case' 0 C--N 1.37 1.461 1 C-N-CA 134.745 5.218 . . . . 0.0 119.651 -173.33 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -48.24 -50.06 30.98 Favored 'General case' 0 CA--C 1.49 -1.349 0 C-N-CA 129.151 2.98 . . . . 0.0 113.458 167.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.35 -48.35 1.84 Allowed 'General case' 0 N--CA 1.416 -2.155 0 C-N-CA 126.057 1.743 . . . . 0.0 109.293 -164.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.347 . . -107.14 151.24 25.66 Favored 'General case' 0 CA--C 1.449 -2.934 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.536 -177.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.04 175.37 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.545 0 C-N-CA 115.803 -2.359 . . . . 0.0 116.304 136.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.441 ' HB ' ' HE2' ' A' ' 149' ' ' LYS 0.372 74.8 t -76.98 147.88 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.25 0 CA-C-N 110.935 -2.848 . . . . 0.0 105.04 168.931 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -84.1 -39.5 19.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -172.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.8 t -160.06 142.41 13.24 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 113.73 -1.577 . . . . 0.0 106.898 -171.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -102.46 90.03 1.99 Allowed Pre-proline 0 N--CA 1.432 -1.373 0 N-CA-C 101.539 -3.504 . . . . 0.0 101.539 171.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -104.44 -87.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.472 0 CA-C-N 120.853 1.34 . . . . 0.0 108.707 -138.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.49 ' H ' ' HG1' ' A' ' 163' ' ' THR . 0.2 OUTLIER -97.92 -158.14 0.65 Allowed 'General case' 1 N--CA 1.376 -4.16 0 CA-C-O 125.583 2.611 . . . . 0.0 111.01 -143.923 . . . . . . . . 4 4 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -107.29 144.21 34.44 Favored 'General case' 0 N--CA 1.424 -1.748 1 CA-C-N 108.083 -4.144 . . . . 0.0 103.395 174.215 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.1 mt -74.15 135.17 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 176.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -116.95 110.82 18.78 Favored 'General case' 0 CA--C 1.481 -1.703 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 177.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 75.79 -149.23 37.79 Favored Glycine 0 CA--C 1.483 -1.939 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 -171.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -99.73 39.91 1.28 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 125.35 1.46 . . . . 0.0 109.718 -176.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -170.11 139.36 1.8 Allowed 'General case' 0 CA--C 1.494 -1.177 0 O-C-N 121.351 -0.843 . . . . 0.0 110.515 -175.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 13.3 ttm -124.33 168.64 12.73 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 -178.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 23.5 mm -112.69 141.07 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.937 0 C-N-CA 126.183 1.793 . . . . 0.0 108.022 163.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -116.22 131.89 56.82 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 103.05 -2.944 . . . . 0.0 103.05 151.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.5 t -89.21 134.05 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.91 74.08 0.89 Allowed 'General case' 0 C--N 1.357 0.92 0 N-CA-C 117.946 2.573 . . . . 0.0 117.946 -170.627 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -86.53 -178.3 1.1 Allowed Pre-proline 0 CA--C 1.509 -0.615 0 N-CA-C 117.965 2.579 . . . . 0.0 117.965 -170.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 123' ' ' LYS . 85.4 Cg_exo -66.59 144.65 73.38 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 122.498 2.132 . . . . 0.0 109.44 160.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -78.72 146.89 33.66 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-O 122.063 0.935 . . . . 0.0 111.785 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -106.14 63.66 0.66 Allowed 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -79.43 116.97 19.98 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 C--O 1.261 1.702 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 177.013 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.483 -1.633 0 CA-C-O 122.28 1.038 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.1 mm -86.47 117.4 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 CA-C-N 112.811 -1.995 . . . . 0.0 106.855 177.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -97.18 169.96 9.44 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -170.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 82.9 t -103.89 121.85 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.525 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 168.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -104.05 174.76 5.73 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 155.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -143.95 151.29 39.58 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 -178.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 tp -132.04 161.84 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 171.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -116.65 151.7 35.75 Favored 'General case' 0 CA--C 1.482 -1.662 0 C-N-CA 118.739 -1.184 . . . . 0.0 110.825 160.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.471 ' CE2' HG23 ' A' ' 148' ' ' VAL . 36.7 m-85 -124.33 133.03 53.57 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 168.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.58 ' HE ' ' H ' ' A' ' 99' ' ' ARG . 0.3 OUTLIER -98.39 169.1 8.82 Favored Pre-proline 0 N--CA 1.427 -1.589 0 C-N-CA 124.58 1.152 . . . . 0.0 108.41 -173.959 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -63.24 139.81 74.03 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 123.535 2.823 . . . . 0.0 111.321 171.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.43 -125.77 21.19 Favored Glycine 0 CA--C 1.479 -2.206 0 N-CA-C 106.746 -2.541 . . . . 0.0 106.746 -171.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.6 m 57.76 107.8 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.744 0 C-N-CA 129.437 3.095 . . . . 0.0 113.108 173.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -127.39 -131.83 0.23 Allowed 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 170.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -55.24 -81.79 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -86.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.08 49.84 0.93 Allowed Glycine 0 CA--C 1.482 -1.989 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.749 179.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -105.96 -40.96 5.52 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 147.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.451 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.6 OUTLIER -72.2 -73.49 0.19 Allowed 'General case' 0 CA--C 1.482 -1.65 0 C-N-CA 126.659 1.984 . . . . 0.0 108.455 -174.103 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.333 0.0 OUTLIER -59.75 -11.14 4.6 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 120.65 3.574 . . . . 0.0 120.65 176.159 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.42 -39.86 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-O 122.005 0.907 . . . . 0.0 110.421 160.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -93.18 -1.95 55.76 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 176.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 tt -79.13 -31.32 44.07 Favored 'General case' 0 N--CA 1.417 -2.083 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 162.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.444 ' HA ' HG12 ' A' ' 115' ' ' ILE . 7.4 ttm-85 -60.11 -44.65 94.7 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 124.806 1.242 . . . . 0.0 111.298 169.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.3 t -60.14 -41.76 93.38 Favored 'General case' 0 C--N 1.371 1.515 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 76.0 mt -65.29 -29.79 70.58 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 173.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.444 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.252 5.3 mm -60.61 -48.92 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 CA-C-N 119.751 1.16 . . . . 0.0 108.361 176.836 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -51.19 -45.02 61.69 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 127.274 2.229 . . . . 0.0 110.146 178.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -61.75 -49.93 74.44 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.5 -20.32 61.38 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.268 1.427 . . . . 0.0 114.298 179.248 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.73 -33.75 64.48 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 125.333 1.453 . . . . 0.0 110.677 172.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -67.62 -27.98 67.36 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 169.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.52 67.85 1.38 Allowed Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 105.213 -3.155 . . . . 0.0 105.213 -173.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -123.67 169.27 11.66 Favored 'General case' 0 CA--C 1.452 -2.797 1 N-CA-C 97.852 -4.87 . . . . 0.0 97.852 169.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.81 134.76 39.69 Favored 'General case' 0 CA--C 1.455 -2.704 1 N-CA-C 98.169 -4.752 . . . . 0.0 98.169 157.475 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.24 161.2 21.57 Favored 'General case' 0 N--CA 1.418 -2.037 0 C-N-CA 115.032 -2.667 . . . . 0.0 105.37 160.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -111.78 136.24 51.31 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 159.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.9 mm -82.47 128.64 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 165.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.3 m -111.99 120.31 41.46 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 169.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.44 HD21 ' CE1' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -82.42 153.89 25.46 Favored 'General case' 0 CA--C 1.464 -2.341 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 167.162 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -148.94 95.39 2.4 Favored 'General case' 0 N--CA 1.393 -3.318 1 N-CA-C 95.736 -5.653 . . . . 0.0 95.736 -176.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.44 ' CE1' HD21 ' A' ' 128' ' ' LEU . 97.4 m-85 -74.06 116.77 15.08 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 102.347 -3.205 . . . . 0.0 102.347 175.043 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -87.93 91.12 8.65 Favored 'General case' 0 CA--C 1.484 -1.588 0 N-CA-C 101.216 -3.624 . . . . 0.0 101.216 172.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -62.13 120.64 22.81 Favored Glycine 0 CA--C 1.468 -2.847 0 O-C-N 125.694 1.871 . . . . 0.0 113.947 -140.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -73.51 -72.2 0.27 Allowed 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 113.07 -1.565 . . . . 0.0 107.806 172.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.434 ' H ' ' CE1' ' A' ' 137' ' ' HIS . 35.2 tt0 -72.46 -78.73 0.08 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 110.912 -2.858 . . . . 0.0 104.474 159.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.405 ' H ' ' H ' ' A' ' 136' ' ' ALA . 17.2 ptt? -173.27 -19.67 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.405 ' H ' ' H ' ' A' ' 135' ' ' MET . . . 175.42 114.75 0.02 OUTLIER 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 -156.094 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.465 ' CB ' ' HB ' ' A' ' 140' ' ' ILE . 85.5 m-70 -126.59 149.11 49.64 Favored 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -163.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -107.32 26.65 9.94 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 163.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.453 ' H ' ' HB3' ' A' ' 137' ' ' HIS . 7.3 mt-30 -125.87 -57.0 1.45 Allowed 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -177.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.465 ' HB ' ' CB ' ' A' ' 137' ' ' HIS 0.271 74.8 mt -56.58 -38.67 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.974 0 C-N-CA 127.987 2.515 . . . . 0.0 109.518 171.767 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.33 -60.59 3.47 Favored Glycine 0 N--CA 1.405 -3.41 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.872 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -89.61 5.61 44.9 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -160.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -62.56 -58.45 7.53 Favored 'General case' 0 CA--C 1.46 -2.504 0 C-N-CA 114.907 -2.717 . . . . 0.0 114.595 143.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.2 t -68.11 -63.06 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.442 -3.194 0 O-C-N 126.096 2.123 . . . . 0.0 107.335 -160.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 17.7 mt -41.05 -60.15 1.29 Allowed 'General case' 0 CA--C 1.464 -2.344 0 C-N-CA 128.351 2.66 . . . . 0.0 113.454 176.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -55.72 -37.8 68.9 Favored 'General case' 0 CA--C 1.464 -2.333 0 C-N-CA 125.996 1.718 . . . . 0.0 115.327 177.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.5 ttt85 -81.01 -14.04 58.29 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 119.861 -0.735 . . . . 0.0 111.914 175.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.471 HG23 ' CE2' ' A' ' 98' ' ' PHE . 1.8 t -75.36 -46.72 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.747 0 CA-C-O 116.037 -1.935 . . . . 0.0 106.495 176.006 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.438 ' HB2' HG23 ' A' ' 158' ' ' VAL . 1.2 ttpp -54.65 -57.03 13.07 Favored 'General case' 0 CA--C 1.459 -2.523 0 CA-C-O 116.244 -1.836 . . . . 0.0 108.22 171.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -34.58 78.22 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 120.116 1.325 . . . . 0.0 111.26 -166.587 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.6 -39.47 62.16 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 168.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.329 0.2 OUTLIER -80.61 -24.29 39.19 Favored 'General case' 0 CA--C 1.47 -2.109 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -176.82 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -26.07 -31.06 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.812 1 C-N-CA 136.5 5.92 . . . . 0.0 118.357 -177.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 1.8 mt-10 -52.35 -52.92 50.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.734 2.014 . . . . 0.0 114.298 170.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.442 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 3.2 tm? -107.52 -55.86 2.29 Favored 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 128.5 2.72 . . . . 0.0 108.434 -160.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.279 . . -102.0 154.88 18.56 Favored 'General case' 0 CA--C 1.449 -2.935 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 -176.1 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 18.7 m -118.66 -179.05 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.458 -2.594 0 C-N-CA 113.661 -3.216 . . . . 0.0 115.494 139.401 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 149' ' ' LYS . 3.3 t -94.89 149.92 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.989 0 N-CA-C 104.94 -2.245 . . . . 0.0 104.94 166.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -82.28 -41.9 19.54 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 -176.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -153.43 148.23 26.43 Favored 'General case' 0 CA--C 1.47 -2.12 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -172.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -107.41 104.7 53.6 Favored Pre-proline 0 CA--C 1.46 -2.512 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 171.495 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 1.6 Cg_endo -103.82 -128.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.408 -3.536 1 N-CA-C 100.76 -4.361 . . . . 0.0 100.76 -156.179 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 179.68 -48.74 0.01 OUTLIER 'General case' 0 N--CA 1.411 -2.389 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 -137.294 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -88.63 97.09 10.92 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-O 121.387 0.613 . . . . 0.0 111.375 -153.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.9 mt -89.0 135.13 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 175.213 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -121.02 109.62 15.27 Favored 'General case' 0 CA--C 1.481 -1.694 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.2 -141.72 26.35 Favored Glycine 0 CA--C 1.482 -2.002 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 -170.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -104.83 45.14 0.98 Allowed 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 113.243 -1.479 . . . . 0.0 109.385 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.314 19.7 mt-30 -167.31 136.68 2.77 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -173.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.4 ttp -125.32 118.66 26.42 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 118.561 0.618 . . . . 0.0 111.395 -173.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.7 mm -80.38 124.93 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 CA-C-O 122.47 1.128 . . . . 0.0 108.534 169.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.9 ttt -105.95 136.98 44.64 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 159.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.0 t -102.32 134.28 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 117.682 -1.607 . . . . 0.0 109.123 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.438 ' CD1' HG21 ' A' ' 158' ' ' VAL . 11.7 tp -112.38 86.78 2.42 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 121.338 3.829 . . . . 0.0 121.338 -177.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.388 . . -107.77 155.54 39.65 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -178.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -70.2 150.6 65.77 Favored 'Trans proline' 0 CA--C 1.486 -1.877 0 C-N-CA 122.885 2.39 . . . . 0.0 109.378 -163.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -76.78 120.33 21.79 Favored 'General case' 0 N--CA 1.433 -1.323 0 O-C-N 124.853 1.346 . . . . 0.0 108.21 -175.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -85.54 104.07 14.97 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 171.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -75.85 133.13 40.68 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 . . . . . 0 C--O 1.261 1.685 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.913 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.47 -2.105 0 CA-C-O 125.001 2.334 . . . . 0.0 107.391 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.6 mm -85.3 124.52 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 1 CA-C-N 108.215 -4.084 . . . . 0.0 106.319 178.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -97.29 162.71 13.21 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 -167.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.433 HG23 ' HE3' ' A' ' 123' ' ' LYS . 83.1 t -101.94 121.83 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.66 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 174.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -107.15 -178.23 3.58 Favored 'General case' 0 CA--C 1.472 -2.029 0 C-N-CA 117.373 -1.731 . . . . 0.0 107.535 162.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -150.03 150.12 31.32 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.058 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 tp -132.82 161.6 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 173.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -122.1 153.75 38.27 Favored 'General case' 0 CA--C 1.485 -1.535 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.071 164.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.475 ' CE2' HG23 ' A' ' 148' ' ' VAL . 40.6 m-85 -134.07 136.76 44.18 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.6 ttt85 -110.71 160.99 26.64 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-O 117.612 -1.185 . . . . 0.0 108.817 -173.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.6 137.22 58.22 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 124.81 3.673 . . . . 0.0 110.608 177.062 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 51.65 57.33 12.5 Favored Glycine 0 CA--C 1.473 -2.567 0 C-N-CA 126.511 2.005 . . . . 0.0 112.005 173.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 84.3 m -129.64 107.21 9.27 Favored 'General case' 0 CA--C 1.463 -2.37 0 N-CA-C 102.708 -3.071 . . . . 0.0 102.708 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -124.68 -137.38 0.28 Allowed 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 171.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.02 -78.02 0.03 OUTLIER 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -86.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.45 42.96 1.8 Allowed Glycine 0 CA--C 1.483 -1.963 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.488 -177.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -101.48 -41.55 6.59 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 147.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.467 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -72.8 -74.06 0.18 Allowed 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 126.525 1.93 . . . . 0.0 109.12 -169.615 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.326 0.0 OUTLIER -59.64 -11.27 4.62 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 120.335 3.457 . . . . 0.0 120.335 177.175 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.12 -40.57 89.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 122.094 0.949 . . . . 0.0 110.296 161.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -92.87 -4.28 53.16 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 176.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 tt -75.84 -33.27 60.03 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 161.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.437 ' HA ' HG12 ' A' ' 115' ' ' ILE . 16.2 ttp180 -60.4 -44.93 95.22 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 125.175 1.39 . . . . 0.0 111.146 170.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 t -62.46 -42.63 99.61 Favored 'General case' 0 C--N 1.375 1.687 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.327 51.2 tp -68.69 -30.38 69.03 Favored 'General case' 0 N--CA 1.402 -2.835 0 C-N-CA 125.706 1.602 . . . . 0.0 113.519 177.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.437 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.283 8.9 mm -56.3 -52.03 56.59 Favored 'Isoleucine or valine' 0 C--N 1.378 1.833 0 CA-C-N 120.94 1.7 . . . . 0.0 109.402 171.099 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -53.47 -40.16 65.08 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 128.386 2.674 . . . . 0.0 110.559 -177.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -61.01 -54.16 48.39 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 124.393 1.077 . . . . 0.0 112.043 175.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -67.76 -21.08 65.28 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -72.52 -36.21 68.29 Favored 'General case' 0 CA--C 1.491 -1.317 0 C-N-CA 126.043 1.737 . . . . 0.0 110.25 172.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -67.16 -22.2 65.77 Favored 'General case' 0 C--N 1.36 1.031 0 O-C-N 123.185 0.303 . . . . 0.0 111.214 169.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.83 68.1 1.42 Allowed Glycine 0 CA--C 1.469 -2.839 0 N-CA-C 104.81 -3.316 . . . . 0.0 104.81 -174.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -123.28 163.4 20.78 Favored 'General case' 0 CA--C 1.448 -2.971 0 N-CA-C 100.641 -3.837 . . . . 0.0 100.641 171.019 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.433 ' HE3' HG23 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -105.45 106.27 16.69 Favored 'General case' 0 N--CA 1.399 -3.007 1 N-CA-C 99.101 -4.407 . . . . 0.0 99.101 173.892 . . . . . . . . 4 4 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -97.77 128.54 44.48 Favored 'General case' 0 N--CA 1.411 -2.39 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.561 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -96.07 129.88 43.24 Favored 'General case' 0 CA--C 1.474 -1.969 0 CA-C-O 121.621 0.724 . . . . 0.0 109.325 -176.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.6 mm -82.9 132.92 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 171.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.403 ' HA ' HD12 ' A' ' 171' ' ' ILE . 21.8 m -113.82 120.81 42.05 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 167.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.471 HD12 ' CZ ' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -74.2 145.65 43.98 Favored 'General case' 0 CA--C 1.474 -1.962 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 165.808 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -147.48 94.96 2.45 Favored 'General case' 0 N--CA 1.4 -2.93 1 N-CA-C 98.591 -4.596 . . . . 0.0 98.591 -178.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.559 ' CD1' ' HA ' ' A' ' 136' ' ' ALA . 77.1 m-85 -67.46 164.03 19.66 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 111.267 -2.697 . . . . 0.0 108.009 178.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 49.7 tpt85 -81.24 82.42 7.13 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 158.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.84 111.91 3.44 Favored Glycine 0 CA--C 1.455 -3.673 0 C-N-CA 118.473 -1.822 . . . . 0.0 112.94 -139.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.437 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 23.1 tpt85 -165.45 -133.97 0.02 OUTLIER 'General case' 0 CA--C 1.485 -1.53 0 CA-C-N 112.443 -1.879 . . . . 0.0 107.365 -168.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.437 ' H ' ' HG3' ' A' ' 133' ' ' ARG . 46.0 mm-40 -86.56 17.92 3.61 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 125.758 1.623 . . . . 0.0 108.855 156.001 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -120.31 27.44 8.6 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 161.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.559 ' HA ' ' CD1' ' A' ' 130' ' ' PHE . . . -113.3 98.11 6.9 Favored 'General case' 0 CA--C 1.484 -1.594 0 C-N-CA 124.788 1.235 . . . . 0.0 108.557 163.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -129.15 171.47 12.38 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.154 -172.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -85.94 8.82 18.87 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 121.84 -0.538 . . . . 0.0 110.8 166.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -97.23 -47.34 5.78 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 173.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.323 63.1 mt -65.07 -35.58 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 C-N-CA 127.65 2.38 . . . . 0.0 109.335 -177.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.15 -61.14 3.32 Favored Glycine 0 N--CA 1.409 -3.112 0 CA-C-N 114.911 -1.041 . . . . 0.0 114.134 171.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 6.7 ptt? -85.43 -2.59 58.28 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -158.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.61 -53.23 59.96 Favored 'General case' 0 CA--C 1.455 -2.688 0 C-N-CA 114.807 -2.757 . . . . 0.0 114.461 150.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.7 t -69.77 -65.33 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.447 -2.998 0 O-C-N 126.011 2.069 . . . . 0.0 107.765 -164.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 14.5 mt -44.07 -55.07 4.98 Favored 'General case' 0 CA--C 1.481 -1.674 0 C-N-CA 128.757 2.823 . . . . 0.0 115.675 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -63.76 -30.95 71.99 Favored 'General case' 0 CA--C 1.462 -2.404 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 174.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -81.44 -15.16 55.95 Favored 'General case' 0 N--CA 1.419 -1.993 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.853 172.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.475 HG23 ' CE2' ' A' ' 98' ' ' PHE . 2.0 t -74.71 -47.13 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.819 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 176.137 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.427 ' HE2' ' HB ' ' A' ' 158' ' ' VAL . 35.2 ttmt -51.61 -53.95 32.96 Favored 'General case' 0 CA--C 1.459 -2.558 0 C-N-CA 125.47 1.508 . . . . 0.0 110.642 172.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.19 -35.99 71.77 Favored 'General case' 0 N--CA 1.411 -2.415 0 C-N-CA 125.241 1.416 . . . . 0.0 110.172 -167.149 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -71.59 -34.98 70.38 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 115.872 -2.331 . . . . 0.0 114.885 170.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.262 0.2 OUTLIER -81.31 -26.26 35.81 Favored 'General case' 0 CA--C 1.463 -2.372 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -178.178 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -28.62 -21.61 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.511 1 C-N-CA 135.896 5.679 . . . . 0.0 119.292 178.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -53.99 -58.45 7.27 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 125.753 1.621 . . . . 0.0 112.733 164.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 tt -111.45 -43.57 3.66 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 127.338 2.255 . . . . 0.0 109.666 -159.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . 0.303 . . -115.59 142.14 47.13 Favored 'General case' 0 CA--C 1.464 -2.357 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.809 179.554 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.3 m -130.02 164.83 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.021 0 N-CA-C 121.776 3.991 . . . . 0.0 121.776 147.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.7 t -79.81 149.27 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.973 0 CA-C-N 111.06 -2.791 . . . . 0.0 107.944 -174.021 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.76 -38.87 25.0 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 113.033 -1.894 . . . . 0.0 106.079 -172.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.2 t -162.57 150.01 13.69 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -171.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -108.19 103.36 50.12 Favored Pre-proline 0 N--CA 1.427 -1.589 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 173.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -132.91 -106.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 115.016 -2.856 . . . . 0.0 108.137 -142.262 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.0 -94.36 0.13 Allowed 'General case' 0 N--CA 1.406 -2.635 0 C-N-CA 117.355 -1.738 . . . . 0.0 113.093 -109.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -153.11 132.56 12.9 Favored 'General case' 0 CA--C 1.476 -1.872 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 -169.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.0 mt -76.22 131.1 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 N-CA-C 103.987 -2.598 . . . . 0.0 103.987 166.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -133.55 113.62 12.65 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 102.589 -3.115 . . . . 0.0 102.589 -178.153 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.29 -141.02 24.44 Favored Glycine 0 CA--C 1.483 -1.947 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -168.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -101.04 33.72 2.75 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 113.073 -1.564 . . . . 0.0 110.897 -174.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.291 17.7 mt-30 -171.22 141.22 1.58 Allowed 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.511 -162.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 15.9 ttm -118.7 170.75 8.71 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 172.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 127' ' ' THR . 28.2 mm -117.74 142.25 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 C-N-CA 126.727 2.011 . . . . 0.0 108.232 161.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.7 ttt -124.33 133.81 53.35 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 102.988 -2.967 . . . . 0.0 102.988 157.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 1.6 t -100.75 139.75 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.021 -171.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 1.4 tp -131.54 130.59 42.49 Favored 'General case' 0 C--N 1.365 1.263 0 CA-C-N 121.688 2.04 . . . . 0.0 106.625 -172.418 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.299 . . -129.56 178.26 1.78 Allowed Pre-proline 0 CA--C 1.49 -1.329 0 C-N-CA 125.819 1.648 . . . . 0.0 111.819 -173.106 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -71.35 158.24 54.84 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 CA-C-N 120.925 1.366 . . . . 0.0 111.036 -177.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -76.65 118.81 19.66 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 174.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -78.21 117.34 19.39 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 165.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -59.54 118.74 6.41 Favored 'General case' 0 CA--C 1.496 -1.126 0 C-N-CA 124.92 1.288 . . . . 0.0 112.148 -168.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 . . . . . 0 C--O 1.259 1.583 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.339 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 CA--C 1.48 -1.719 0 CA-C-O 122.166 0.984 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.1 mm -89.57 114.04 26.89 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 CA-C-N 113.104 -1.862 . . . . 0.0 106.311 171.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -107.38 164.09 12.49 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -163.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.2 t -88.88 117.32 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.903 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 162.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -110.29 169.75 8.53 Favored 'General case' 0 CA--C 1.483 -1.601 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 151.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -136.37 157.95 45.59 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.812 -163.164 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 tp -131.58 163.67 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 165.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -119.57 154.42 33.93 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 119.479 -0.888 . . . . 0.0 112.321 162.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.528 ' CE2' HG23 ' A' ' 148' ' ' VAL . 45.9 m-85 -129.09 147.31 50.93 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 169.571 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -114.91 170.78 5.1 Favored Pre-proline 0 N--CA 1.431 -1.401 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.409 ' HG3' ' H ' ' A' ' 131' ' ' ARG . 5.8 Cg_endo -70.36 152.22 66.08 Favored 'Trans proline' 0 CA--C 1.487 -1.845 0 C-N-CA 123.463 2.776 . . . . 0.0 109.147 172.087 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.22 -127.53 17.82 Favored Glycine 0 CA--C 1.479 -2.203 0 N-CA-C 105.293 -3.123 . . . . 0.0 105.293 -168.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.2 m 49.26 100.6 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.731 0 C-N-CA 129.867 3.267 . . . . 0.0 112.38 178.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -117.52 -157.54 0.67 Allowed 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.48 -176.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -62.04 -43.78 98.1 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -121.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -104.6 60.55 0.42 Allowed Glycine 0 N--CA 1.42 -2.399 0 CA-C-O 123.951 1.862 . . . . 0.0 111.473 -171.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -169.76 -41.0 0.02 OUTLIER 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 130.308 3.443 . . . . 0.0 103.76 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.6 ' HH ' HG21 ' A' ' 148' ' ' VAL . 0.8 OUTLIER -86.61 -71.62 0.54 Allowed 'General case' 0 CA--C 1.482 -1.649 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.798 -166.691 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.311 0.0 OUTLIER -61.08 -14.76 26.21 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 118.872 2.916 . . . . 0.0 118.872 172.414 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.17 -41.71 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.982 0.913 . . . . 0.0 109.791 162.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -93.15 6.76 46.86 Favored 'General case' 0 CA--C 1.486 -1.513 0 O-C-N 120.376 -1.452 . . . . 0.0 114.905 175.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.8 -31.32 22.39 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 162.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -60.47 -45.36 94.0 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.654 1.182 . . . . 0.0 109.843 168.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 t -58.89 -43.07 90.91 Favored 'General case' 0 C--N 1.375 1.705 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 173.375 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.3 mt -60.95 -33.1 72.66 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 175.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.451 ' CG2' ' HG ' ' A' ' 155' ' ' LEU . 3.1 mm -61.06 -46.79 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 177.285 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -53.09 22.39 Favored 'General case' 0 CA--C 1.497 -1.07 0 O-C-N 125.985 2.053 . . . . 0.0 110.923 178.146 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -58.41 -46.37 86.56 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 178.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.06 -36.64 82.22 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 176.119 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -79.19 -21.54 46.21 Favored 'General case' 0 CA--C 1.487 -1.469 0 C-N-CA 127.671 2.388 . . . . 0.0 112.638 -173.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -71.56 -15.15 62.27 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 169.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.61 65.5 1.5 Allowed Glycine 0 CA--C 1.462 -3.252 0 N-CA-C 104.469 -3.452 . . . . 0.0 104.469 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -133.14 173.69 11.17 Favored 'General case' 0 CA--C 1.447 -3.012 1 N-CA-C 97.724 -4.917 . . . . 0.0 97.724 170.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.01 135.02 33.9 Favored 'General case' 0 N--CA 1.399 -2.978 1 N-CA-C 97.898 -4.853 . . . . 0.0 97.898 158.611 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.09 156.74 28.19 Favored 'General case' 0 N--CA 1.405 -2.677 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 156.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -140.06 133.13 29.52 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 101.121 -3.659 . . . . 0.0 101.121 169.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.5 mm -83.83 134.56 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.112 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -178.358 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.557 ' HG1' ' CD1' ' A' ' 171' ' ' ILE . 23.6 m -116.28 121.53 42.29 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 168.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.32 154.18 33.09 Favored 'General case' 0 CA--C 1.47 -2.103 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 166.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.405 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 35.2 ttp85 -146.07 96.67 2.83 Favored 'General case' 0 N--CA 1.397 -3.1 1 N-CA-C 96.073 -5.529 . . . . 0.0 96.073 -179.482 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -70.31 126.0 28.39 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 111.88 -2.418 . . . . 0.0 106.212 178.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.409 ' H ' ' HG3' ' A' ' 100' ' ' PRO . 22.4 tpp180 -77.22 108.06 10.06 Favored 'General case' 0 CA--C 1.479 -1.753 1 N-CA-C 99.779 -4.156 . . . . 0.0 99.779 160.016 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.47 118.11 6.52 Favored Glycine 0 CA--C 1.467 -2.963 0 O-C-N 124.865 1.353 . . . . 0.0 112.303 -157.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -117.61 19.4 13.91 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-N 112.73 -1.735 . . . . 0.0 108.919 169.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 179.15 -11.96 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 101.355 -3.572 . . . . 0.0 101.355 -176.446 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 54.7 mtt 80.23 -5.51 1.8 Allowed 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 129.272 3.029 . . . . 0.0 111.894 -170.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -179.42 112.66 0.05 Allowed 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.548 -161.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.547 ' CG ' HD11 ' A' ' 140' ' ' ILE . 1.7 m-70 -131.49 154.84 48.34 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.142 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -108.84 46.1 0.99 Allowed 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 160.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -130.51 -54.25 1.09 Allowed 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 103.579 -2.749 . . . . 0.0 103.579 172.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.547 HD11 ' CG ' ' A' ' 137' ' ' HIS . 1.7 mp -50.46 -52.54 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.772 0 C-N-CA 127.23 2.212 . . . . 0.0 109.424 167.295 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -68.12 -59.78 6.11 Favored Glycine 0 N--CA 1.416 -2.677 0 O-C-N 124.222 0.951 . . . . 0.0 111.439 -176.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 6.8 ptm -90.88 6.36 44.83 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -161.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.09 -56.02 15.4 Favored 'General case' 0 CA--C 1.455 -2.703 0 C-N-CA 115.875 -2.33 . . . . 0.0 113.559 146.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.89 -66.46 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.44 -3.251 0 O-C-N 126.498 2.374 . . . . 0.0 107.39 -164.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.8 mt -39.27 -57.04 1.42 Allowed 'General case' 0 CA--C 1.467 -2.224 0 C-N-CA 128.138 2.575 . . . . 0.0 114.018 178.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 161' ' ' PHE . 1.2 t-20 -52.99 -45.05 67.68 Favored 'General case' 0 CA--C 1.47 -2.132 0 C-N-CA 126.607 1.963 . . . . 0.0 115.911 175.454 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -83.27 -12.86 56.3 Favored 'General case' 0 N--CA 1.424 -1.768 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.41 179.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.6 HG21 ' HH ' ' A' ' 107' ' ' TYR . 2.1 t -76.27 -40.0 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.697 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 177.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.4 ' HZ1' HD23 ' A' ' 174' ' ' LEU . 0.5 OUTLIER -63.41 -52.16 62.72 Favored 'General case' 0 CA--C 1.449 -2.934 0 CA-C-O 117.332 -1.318 . . . . 0.0 113.108 176.696 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -60.15 -39.1 85.17 Favored 'General case' 0 N--CA 1.404 -2.747 0 C-N-CA 127.097 2.159 . . . . 0.0 108.836 -178.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.52 -28.55 59.16 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 117.403 2.371 . . . . 0.0 117.403 169.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.424 ' HG ' ' HB2' ' A' ' 156' ' ' ALA 0.269 0.0 OUTLIER -75.53 -37.12 60.27 Favored 'General case' 0 CA--C 1.477 -1.841 0 CA-C-N 120.185 1.357 . . . . 0.0 112.79 179.258 . . . . . . . . 4 4 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -27.66 -32.61 0.0 OUTLIER 'General case' 0 CA--C 1.474 -1.946 1 C-N-CA 137.071 6.148 . . . . 0.0 119.079 -164.653 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 4.7 mt-10 -52.43 -51.3 59.86 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 127.37 2.268 . . . . 0.0 113.153 172.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.451 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 2.7 tm? -109.4 -47.81 3.34 Favored 'General case' 0 N--CA 1.42 -1.953 0 C-N-CA 128.716 2.806 . . . . 0.0 107.472 -161.171 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.424 ' HB2' ' HG ' ' A' ' 152' ' ' LEU 0.327 . . -119.64 140.59 50.37 Favored 'General case' 0 CA--C 1.457 -2.606 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.372 -176.765 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.2 m -126.32 -176.36 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.47 -2.111 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 155.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.35 166.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.58 0 C-N-CA 126.619 1.968 . . . . 0.0 110.159 -165.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -85.87 -41.65 14.8 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 154.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -164.59 146.24 8.27 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.997 -171.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.435 ' CZ ' ' SD ' ' A' ' 172' ' ' MET . 0.2 OUTLIER -100.29 117.4 63.15 Favored Pre-proline 0 CA--C 1.462 -2.408 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 170.404 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -133.12 -128.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.409 -3.448 1 N-CA-C 101.553 -4.056 . . . . 0.0 101.553 -158.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -178.18 -42.1 0.01 OUTLIER 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 -120.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -85.63 88.18 7.5 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 121.667 0.746 . . . . 0.0 111.483 -158.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mt -84.01 129.57 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 172.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -125.32 102.82 7.61 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 -173.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.45 -139.74 21.25 Favored Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 -171.45 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -101.44 39.42 1.43 Allowed 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 112.831 -1.685 . . . . 0.0 109.538 -176.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.405 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.337 18.7 mt-30 -172.1 133.12 0.68 Allowed 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 121.866 -0.522 . . . . 0.0 110.301 -162.415 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 22.4 ttp -115.32 115.53 26.78 Favored 'General case' 0 CA--C 1.481 -1.692 0 CA-C-O 121.472 0.654 . . . . 0.0 111.679 -171.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.557 ' CD1' ' HG1' ' A' ' 127' ' ' THR . 16.0 mm -81.72 126.88 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.367 0 CA-C-O 122.123 0.964 . . . . 0.0 108.76 172.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.435 ' SD ' ' CZ ' ' A' ' 161' ' ' PHE . 3.2 ttt -112.65 142.96 44.63 Favored 'General case' 0 CA--C 1.476 -1.875 0 N-CA-C 103.167 -2.901 . . . . 0.0 103.167 155.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.6 t -98.87 153.37 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 118.589 -1.244 . . . . 0.0 107.696 -175.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.4 HD23 ' HZ1' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -134.92 81.75 1.92 Allowed 'General case' 0 C--N 1.36 1.053 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -174.836 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.278 . . -83.34 174.4 6.05 Favored Pre-proline 0 CA--C 1.505 -0.787 0 O-C-N 119.637 -1.914 . . . . 0.0 115.038 -175.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -68.33 135.93 35.55 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.363 2.042 . . . . 0.0 108.996 165.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -80.08 163.19 24.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 124.037 0.836 . . . . 0.0 110.864 171.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -74.06 107.12 6.07 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -67.87 105.89 2.12 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 124.701 1.2 . . . . 0.0 110.358 -173.015 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 C--O 1.26 1.635 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -179.389 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 . . . . . 0 CA--C 1.481 -1.676 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.642 HG22 ' HD3' ' A' ' 123' ' ' LYS . 70.2 t -102.04 114.32 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.665 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 161.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -108.94 -179.83 3.97 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 156.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -143.82 158.42 43.69 Favored 'General case' 0 N--CA 1.433 -1.309 0 O-C-N 123.462 0.476 . . . . 0.0 110.544 -169.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.9 tp -135.35 162.23 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 166.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -120.91 157.26 30.25 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 118.863 0.756 . . . . 0.0 111.396 165.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.627 ' HB3' HG11 ' A' ' 144' ' ' VAL . 39.8 m-85 -136.92 100.32 4.27 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 173.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 . . . . . 0 N--CA 1.434 -1.274 0 C-N-CA 124.124 0.97 . . . . 0.0 109.086 178.862 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.0 t70 . . . . . 0 N--CA 1.424 -1.757 0 CA-C-O 122.758 1.266 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -73.95 -71.17 0.34 Allowed 'General case' 0 CA--C 1.474 -1.977 0 CA-C-N 111.572 -2.558 . . . . 0.0 113.082 -161.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.33 0.0 OUTLIER -60.63 -14.11 18.47 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 119.639 3.2 . . . . 0.0 119.639 175.693 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 87.5 t -60.65 -47.82 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.18 0.99 . . . . 0.0 109.444 161.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -91.94 7.66 41.09 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 6.0 tt -84.08 -32.78 24.6 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 162.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.481 ' HA ' HG12 ' A' ' 115' ' ' ILE . 58.3 ttt-85 -61.87 -42.79 99.48 Favored 'General case' 0 C--N 1.363 1.189 0 CA-C-O 118.739 -0.648 . . . . 0.0 110.677 168.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.6 t -61.56 -41.31 97.19 Favored 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.512 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.46 HD11 HD23 ' A' ' 174' ' ' LEU . 65.0 tp -70.08 -29.29 66.24 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-O 117.088 -1.434 . . . . 0.0 113.541 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.481 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.269 10.0 mm -55.47 -53.08 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.957 0 CA-C-N 120.293 1.406 . . . . 0.0 107.569 170.014 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -47.29 -48.9 24.71 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 128.649 2.78 . . . . 0.0 111.776 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -56.81 -55.71 30.83 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.561 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -54.94 -36.17 64.99 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 174.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -89.1 -14.9 35.21 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 128.929 2.892 . . . . 0.0 110.341 -166.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -67.57 -24.94 65.57 Favored 'General case' 0 C--N 1.36 1.023 0 C-N-CA 122.981 0.512 . . . . 0.0 109.706 161.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 93.42 57.52 1.35 Allowed Glycine 0 CA--C 1.472 -2.655 0 N-CA-C 104.542 -3.423 . . . . 0.0 104.542 -174.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -126.53 167.73 15.23 Favored 'General case' 0 CA--C 1.462 -2.408 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.642 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -101.54 115.61 30.91 Favored 'General case' 0 N--CA 1.407 -2.597 1 N-CA-C 99.762 -4.162 . . . . 0.0 99.762 176.689 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.77 115.7 31.11 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.065 -1.425 . . . . 0.0 107.751 -168.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -97.44 121.58 39.51 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -171.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.1 mm -84.04 134.22 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.486 ' HA ' HD13 ' A' ' 171' ' ' ILE . 25.7 m -119.62 124.06 45.4 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 173.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.662 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.1 OUTLIER -88.02 155.84 19.61 Favored 'General case' 0 CA--C 1.467 -2.236 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 167.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.478 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 22.2 ttt85 -152.07 91.52 1.62 Allowed 'General case' 0 N--CA 1.397 -3.115 1 N-CA-C 99.221 -4.363 . . . . 0.0 99.221 -174.515 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.498 ' CE1' HD22 ' A' ' 128' ' ' LEU . 92.0 m-85 . . . . . 0 N--CA 1.422 -1.854 0 CA-C-N 112.437 -2.165 . . . . 0.0 108.755 -173.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 82.1 mt . . . . . 0 CA--C 1.468 -2.188 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.662 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -79.59 -60.95 2.38 Favored Glycine 0 N--CA 1.41 -3.099 0 C-N-CA 118.867 -1.635 . . . . 0.0 111.926 -170.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 72.4 mtm -89.51 0.08 57.14 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -161.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -67.77 -50.37 57.47 Favored 'General case' 0 CA--C 1.457 -2.614 0 C-N-CA 116.096 -2.242 . . . . 0.0 113.295 151.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.627 HG11 ' HB3' ' A' ' 98' ' ' PHE . 21.8 t -67.81 -69.22 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.443 -3.168 0 O-C-N 125.946 2.028 . . . . 0.0 108.15 -166.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' A' ' 172' ' ' MET . 27.8 mt -42.22 -53.31 4.12 Favored 'General case' 0 CA--C 1.476 -1.887 0 C-N-CA 128.929 2.891 . . . . 0.0 115.119 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -62.9 -36.16 82.43 Favored 'General case' 0 CA--C 1.46 -2.508 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -81.76 -14.15 56.82 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.603 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.6 t -77.68 -46.2 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.768 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.455 ' HB2' HG21 ' A' ' 158' ' ' VAL . 29.7 ttmt -51.93 -50.62 60.79 Favored 'General case' 0 CA--C 1.463 -2.401 0 C-N-CA 125.583 1.553 . . . . 0.0 111.003 171.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.64 -36.62 70.76 Favored 'General case' 0 N--CA 1.411 -2.404 0 C-N-CA 124.447 1.099 . . . . 0.0 110.187 -169.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -72.69 -40.09 66.5 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 116.305 -2.158 . . . . 0.0 115.299 170.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.289 0.2 OUTLIER -80.2 -19.97 45.78 Favored 'General case' 0 CA--C 1.464 -2.352 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -177.549 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -26.38 -27.04 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.443 1 C-N-CA 134.457 5.103 . . . . 0.0 118.901 173.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -55.28 -59.04 5.35 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 127.045 2.138 . . . . 0.0 112.902 169.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.42 -52.1 3.19 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 125.842 1.657 . . . . 0.0 107.805 -167.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.929 ' HB1' HD11 ' A' ' 174' ' ' LEU 0.281 . . -100.28 141.44 33.12 Favored 'General case' 0 CA--C 1.459 -2.546 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.882 -178.217 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.5 m -123.93 164.25 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.421 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 139.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.5 t -84.08 153.46 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.104 0 CA-C-N 110.021 -3.263 . . . . 0.0 108.478 -172.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -82.32 -41.25 20.32 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.3 t -152.45 151.17 30.44 Favored 'General case' 0 CA--C 1.468 -2.174 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 N--CA 1.424 -1.768 0 N-CA-C 101.199 -3.63 . . . . 0.0 101.199 164.771 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.478 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.3 38.0 mt-30 . . . . . 0 CA--C 1.504 -0.79 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 51.8 ttp -134.93 118.73 17.2 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 119.155 0.889 . . . . 0.0 111.671 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 127' ' ' THR . 22.0 mm -82.49 123.94 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 O-C-N 121.31 -0.869 . . . . 0.0 108.666 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.403 ' HB3' HD22 ' A' ' 145' ' ' LEU . 2.9 ttt -101.07 130.29 47.07 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 159.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.16 134.87 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -173.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.929 HD11 ' HB1' ' A' ' 156' ' ' ALA . 1.1 tp -129.19 143.73 50.96 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 -174.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.32 . . -131.98 178.36 1.79 Allowed Pre-proline 0 CA--C 1.488 -1.424 0 C-N-CA 123.813 0.845 . . . . 0.0 110.065 -174.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.523 ' HA ' HD21 ' A' ' 118' ' ' LEU . 78.0 Cg_exo -62.73 148.23 93.66 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 122.932 2.421 . . . . 0.0 109.059 160.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt . . . . . 0 CA--C 1.492 -1.273 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 174.54 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 . . . . . 0 CA--C 1.481 -1.706 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.509 HG22 ' HE3' ' A' ' 123' ' ' LYS . 82.0 t -103.03 124.77 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -108.38 171.74 7.24 Favored 'General case' 0 CA--C 1.479 -1.784 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 154.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -144.43 146.65 32.6 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 tp -124.97 160.07 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.085 0 N-CA-C 103.169 -2.9 . . . . 0.0 103.169 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -119.22 154.12 33.89 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 119.414 -0.915 . . . . 0.0 110.447 162.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.588 ' HB3' HG11 ' A' ' 144' ' ' VAL . 34.1 m-85 -134.03 110.83 9.91 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 . . . . . 0 N--CA 1.429 -1.486 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.187 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.4 t70 . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.91 -73.71 0.13 Allowed 'General case' 0 CA--C 1.477 -1.86 0 C-N-CA 127.209 2.203 . . . . 0.0 110.371 -173.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.487 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.275 0.0 OUTLIER -65.49 -9.02 22.32 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 119.394 3.109 . . . . 0.0 119.394 -179.321 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.84 -42.79 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 122.169 0.985 . . . . 0.0 110.793 161.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -91.67 -1.53 57.4 Favored 'General case' 0 CA--C 1.477 -1.831 0 O-C-N 120.352 -1.468 . . . . 0.0 114.686 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.5 tt -76.79 -31.98 57.36 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 161.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.536 ' HA ' HG12 ' A' ' 115' ' ' ILE . 31.4 ttt180 -62.47 -45.03 94.88 Favored 'General case' 0 C--N 1.363 1.19 0 C-N-CA 123.812 0.845 . . . . 0.0 111.482 170.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.1 m -61.77 -42.31 98.83 Favored 'General case' 0 C--N 1.377 1.796 0 C-N-CA 118.666 -1.214 . . . . 0.0 113.761 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.653 HD11 HD12 ' A' ' 174' ' ' LEU 0.323 52.4 tp -68.0 -27.92 66.98 Favored 'General case' 0 N--CA 1.406 -2.644 0 C-N-CA 126.73 2.012 . . . . 0.0 113.67 177.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.289 9.4 mm -57.33 -52.87 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.901 0 CA-C-N 121.036 1.744 . . . . 0.0 108.217 170.534 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -53.78 -42.64 68.5 Favored 'General case' 0 CA--C 1.492 -1.262 0 O-C-N 125.816 1.947 . . . . 0.0 110.402 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -58.21 -54.11 50.66 Favored 'General case' 0 CA--C 1.481 -1.701 0 C-N-CA 125.343 1.457 . . . . 0.0 112.639 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.552 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -61.16 -33.07 72.84 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 177.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -73.58 -31.56 63.66 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 129.116 2.966 . . . . 0.0 109.798 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -64.67 -19.75 65.9 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 124.213 1.005 . . . . 0.0 111.679 171.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.53 54.79 2.72 Favored Glycine 0 CA--C 1.469 -2.825 0 N-CA-C 103.995 -3.642 . . . . 0.0 103.995 -174.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -120.42 163.52 17.77 Favored 'General case' 0 CA--C 1.447 -2.984 1 N-CA-C 99.82 -4.141 . . . . 0.0 99.82 170.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.509 ' HE3' HG22 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -101.04 116.13 32.12 Favored 'General case' 0 N--CA 1.393 -3.285 1 N-CA-C 98.644 -4.576 . . . . 0.0 98.644 171.526 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.52 156.71 25.12 Favored 'General case' 0 N--CA 1.407 -2.585 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 173.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.314 27.4 mtpp -131.44 138.76 49.19 Favored 'General case' 0 CA--C 1.487 -1.458 0 O-C-N 118.688 -2.507 . . . . 0.0 104.248 163.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.9 mm -85.43 136.77 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 27.5 m -117.51 130.11 56.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 169.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.643 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.1 OUTLIER -92.19 160.09 15.34 Favored 'General case' 0 CA--C 1.468 -2.189 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 167.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.413 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 56.1 ttt180 -152.48 96.26 2.13 Favored 'General case' 0 N--CA 1.402 -2.843 1 N-CA-C 99.036 -4.431 . . . . 0.0 99.036 -174.545 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.503 ' CE1' HD22 ' A' ' 128' ' ' LEU . 96.8 m-85 . . . . . 0 CA--C 1.485 -1.551 0 CA-C-N 113.068 -1.878 . . . . 0.0 106.438 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 89.5 mt . . . . . 0 CA--C 1.477 -1.843 0 CA-C-O 119.997 -0.049 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.643 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -78.94 -57.85 3.14 Favored Glycine 0 N--CA 1.407 -3.245 0 C-N-CA 119.355 -1.403 . . . . 0.0 112.505 -167.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 58.4 mtm -93.92 18.24 10.84 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -170.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.86 -61.25 1.96 Allowed 'General case' 0 CA--C 1.456 -2.657 0 C-N-CA 115.138 -2.625 . . . . 0.0 114.573 133.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.588 HG11 ' HB3' ' A' ' 98' ' ' PHE . 23.7 t -64.07 -66.14 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.444 -3.111 0 O-C-N 126.213 2.196 . . . . 0.0 109.064 -160.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.1 mt -43.58 -55.81 4.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 127.811 2.444 . . . . 0.0 114.003 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -53.62 -43.12 68.41 Favored 'General case' 0 CA--C 1.485 -1.522 0 C-N-CA 126.791 2.036 . . . . 0.0 114.159 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -82.48 -14.26 55.33 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 144' ' ' VAL . 2.5 t -72.93 -44.57 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.597 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.448 ' CE ' HG22 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -60.22 -53.94 51.74 Favored 'General case' 0 CA--C 1.45 -2.888 0 O-C-N 125.126 1.516 . . . . 0.0 112.722 179.433 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.88 -38.68 82.91 Favored 'General case' 0 N--CA 1.403 -2.791 0 C-N-CA 127.686 2.394 . . . . 0.0 109.241 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.412 ' HB3' HD11 ' A' ' 111' ' ' LEU . 25.4 t70 -71.01 -40.48 71.79 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 116.065 -2.254 . . . . 0.0 116.901 168.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.483 HD13 HD11 ' A' ' 174' ' ' LEU 0.277 0.2 OUTLIER -80.2 -22.89 41.39 Favored 'General case' 0 CA--C 1.463 -2.384 0 N-CA-C 117.263 2.319 . . . . 0.0 117.263 -175.285 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -27.51 -27.96 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.44 1 C-N-CA 135.376 5.47 . . . . 0.0 118.483 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 3.4 mt-10 -50.77 -53.52 31.06 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 127.353 2.261 . . . . 0.0 112.842 168.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -53.56 2.99 Favored 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 126.102 1.761 . . . . 0.0 110.309 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.552 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.299 . . -110.32 136.54 49.34 Favored 'General case' 0 CA--C 1.452 -2.821 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -163.286 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.433 HG22 ' HA ' ' A' ' 177' ' ' LYS . 12.1 m -126.16 -179.57 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.407 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 161.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.448 HG22 ' CE ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -85.71 163.41 2.67 Favored 'Isoleucine or valine' 1 N--CA 1.377 -4.091 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.54 -166.312 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -84.5 -41.72 16.25 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 156.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.422 ' H ' HG12 ' A' ' 158' ' ' VAL 0.269 0.4 OUTLIER -169.85 150.87 4.0 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.921 -169.106 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.426 -1.649 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 167.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.413 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.267 32.3 mt-30 . . . . . 0 CA--C 1.51 -0.562 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 56.1 ttp -141.29 116.29 9.86 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-O 122.079 0.942 . . . . 0.0 112.063 -173.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 8.7 mm -80.35 135.95 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.841 0 O-C-N 120.944 -1.098 . . . . 0.0 109.005 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -108.53 131.42 54.85 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 151.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.47 135.81 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.653 HD12 HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -120.82 81.98 1.85 Allowed 'General case' 0 C--N 1.356 0.884 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -170.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -87.03 179.01 1.92 Allowed Pre-proline 0 CA--C 1.509 -0.599 0 O-C-N 118.407 -2.683 . . . . 0.0 117.128 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.503 ' HA ' HD21 ' A' ' 118' ' ' LEU . 68.0 Cg_exo -64.35 137.69 56.97 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 122.702 2.268 . . . . 0.0 111.966 169.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.433 ' HA ' HG22 ' A' ' 157' ' ' VAL . 33.9 ttpt . . . . . 0 CA--C 1.487 -1.455 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 168.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 . . . . . 0 CA--C 1.481 -1.697 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.44 117.48 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.744 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -112.24 173.99 6.1 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 153.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -139.5 159.25 42.59 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 123.34 0.4 . . . . 0.0 109.951 -165.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 tp -137.03 162.8 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 165.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -121.35 153.27 37.98 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.675 0.75 . . . . 0.0 112.225 164.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.595 ' HB3' HG11 ' A' ' 144' ' ' VAL . 43.7 m-85 -130.27 135.04 47.68 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 170.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.444 ' HD3' HH21 ' A' ' 129' ' ' ARG . 22.1 mtm-85 . . . . . 0 N--CA 1.434 -1.249 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 -176.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 47.1 t0 . . . . . 0 N--CA 1.427 -1.589 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.7 -73.29 0.45 Allowed 'General case' 0 CA--C 1.475 -1.904 0 CA-C-N 112.316 -2.22 . . . . 0.0 110.868 -156.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.5 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.331 0.0 OUTLIER -58.13 -15.85 11.11 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 119.038 2.977 . . . . 0.0 119.038 174.66 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.67 -48.94 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-O 122.488 1.137 . . . . 0.0 110.233 162.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -91.72 8.07 38.73 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.7 tt -84.29 -32.23 24.49 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 161.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.467 ' HA ' HG12 ' A' ' 115' ' ' ILE . 57.4 ttt180 -62.84 -44.2 96.77 Favored 'General case' 0 C--N 1.363 1.157 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.636 168.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 69.3 m -60.08 -40.38 89.34 Favored 'General case' 0 C--N 1.378 1.824 0 C-N-CA 118.464 -1.295 . . . . 0.0 113.532 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.588 HD11 HD12 ' A' ' 126' ' ' ILE . 5.9 mt -61.02 -33.68 73.65 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.3 mm -58.52 -48.86 84.24 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.648 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -49.82 -51.26 41.16 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 125.814 1.946 . . . . 0.0 112.255 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -54.75 -50.38 68.56 Favored 'General case' 0 CA--C 1.476 -1.874 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.621 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -61.73 -43.24 99.23 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 178.347 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.3 -12.63 56.46 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 125.723 1.609 . . . . 0.0 112.358 -171.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.18 -12.7 60.97 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 124.112 0.965 . . . . 0.0 109.759 166.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.82 60.73 1.57 Allowed Glycine 0 CA--C 1.467 -2.908 0 N-CA-C 106.45 -2.66 . . . . 0.0 106.45 175.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -135.93 175.49 9.55 Favored 'General case' 0 CA--C 1.462 -2.42 0 N-CA-C 102.301 -3.222 . . . . 0.0 102.301 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.299 21.0 mtpt -89.21 148.05 23.82 Favored 'General case' 0 N--CA 1.405 -2.682 1 N-CA-C 100.046 -4.057 . . . . 0.0 100.046 165.35 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.469 ' HB1' ' CD2' ' A' ' 114' ' ' LEU . . . -117.26 115.41 25.23 Favored 'General case' 0 N--CA 1.407 -2.585 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 173.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -100.63 116.56 32.84 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.588 HD12 HD11 ' A' ' 114' ' ' LEU . 6.9 mm -85.73 132.23 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 28.1 m -119.65 127.92 53.36 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.429 ' CB ' ' H ' ' A' ' 170' ' ' MET 0.26 0.2 OUTLIER -79.91 154.88 28.03 Favored 'General case' 0 CA--C 1.469 -2.148 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 167.54 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.485 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 47.0 ttp180 -145.18 91.19 2.11 Favored 'General case' 0 N--CA 1.404 -2.759 1 N-CA-C 100.154 -4.017 . . . . 0.0 100.154 178.056 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 . . . . . 0 N--CA 1.429 -1.502 0 CA-C-N 111.84 -2.437 . . . . 0.0 110.301 -170.92 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.424 -1.762 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.38 -69.37 1.4 Allowed Glycine 0 N--CA 1.412 -2.918 0 O-C-N 124.094 0.871 . . . . 0.0 111.747 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 55.0 mtm -96.56 23.57 6.76 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -163.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -72.92 -55.86 6.0 Favored 'General case' 0 CA--C 1.452 -2.824 0 C-N-CA 116.355 -2.138 . . . . 0.0 113.072 135.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 98' ' ' PHE . 38.9 t -64.69 -67.28 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.445 -3.063 0 O-C-N 126.512 2.382 . . . . 0.0 108.526 -163.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.0 mt -42.02 -54.98 3.34 Favored 'General case' 0 CA--C 1.475 -1.942 0 C-N-CA 127.662 2.385 . . . . 0.0 113.768 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -54.48 -44.76 72.92 Favored 'General case' 0 CA--C 1.484 -1.559 0 C-N-CA 126.619 1.967 . . . . 0.0 114.031 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -83.26 -12.29 56.9 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 118.386 0.539 . . . . 0.0 112.102 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 144' ' ' VAL . 2.3 t -73.87 -44.46 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.683 ' NZ ' HD13 ' A' ' 174' ' ' LEU . 0.8 OUTLIER -61.12 -53.76 53.01 Favored 'General case' 0 CA--C 1.451 -2.859 0 O-C-N 125.366 1.666 . . . . 0.0 112.341 179.598 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -61.9 -36.75 82.25 Favored 'General case' 0 N--CA 1.403 -2.784 0 C-N-CA 126.807 2.043 . . . . 0.0 109.716 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.426 ' HB3' HD11 ' A' ' 111' ' ' LEU . 24.9 t70 -72.87 -34.1 66.5 Favored 'General case' 0 C--N 1.358 0.948 0 C-N-CA 115.955 -2.298 . . . . 0.0 116.469 169.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.31 0.2 OUTLIER -81.31 -27.91 34.83 Favored 'General case' 0 CA--C 1.464 -2.331 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -176.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -28.42 -25.78 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.531 1 C-N-CA 136.116 5.766 . . . . 0.0 118.885 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 5.4 mt-10 -48.71 -50.44 33.47 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 127.65 2.38 . . . . 0.0 113.234 166.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 tt -114.66 -48.57 2.85 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 126.282 1.833 . . . . 0.0 108.895 -170.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 1.046 ' HB1' HD11 ' A' ' 174' ' ' LEU 0.284 . . -110.82 131.02 55.41 Favored 'General case' 0 CA--C 1.463 -2.398 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -170.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 177' ' ' LYS . 4.2 m -128.12 175.33 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.029 0 N-CA-C 119.929 3.307 . . . . 0.0 119.929 162.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -83.14 162.49 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.388 0 C-N-CA 126.309 1.844 . . . . 0.0 111.054 -159.572 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.61 -44.19 12.83 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 159.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.491 ' H ' HG12 ' A' ' 158' ' ' VAL 0.265 0.9 OUTLIER -167.92 145.81 4.43 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.621 -171.51 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.478 -1.817 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 172.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.485 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.281 20.2 mt-30 . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 118.585 -0.721 . . . . 0.0 111.014 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.429 ' H ' ' CB ' ' A' ' 128' ' ' LEU . 32.5 ttp -118.43 117.54 29.31 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 119.743 1.156 . . . . 0.0 113.841 -169.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.7 mm -84.37 127.16 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.356 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.51 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -105.53 130.3 53.62 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 101.339 -3.578 . . . . 0.0 101.339 150.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.3 t -91.93 136.32 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 1.046 HD11 ' HB1' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -122.25 147.64 45.97 Favored 'General case' 0 N--CA 1.439 -0.988 1 N-CA-C 99.177 -4.379 . . . . 0.0 99.177 -176.997 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.431 ' H ' HD12 ' A' ' 174' ' ' LEU 0.351 . . -137.19 179.87 1.24 Allowed Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 125.61 1.564 . . . . 0.0 109.426 -173.682 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.463 ' HA ' HD21 ' A' ' 118' ' ' LEU . 84.2 Cg_exo -63.75 138.16 62.4 Favored 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 122.681 2.254 . . . . 0.0 110.176 167.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.494 ' HA ' HG22 ' A' ' 157' ' ' VAL . 36.6 ttpt . . . . . 0 CA--C 1.488 -1.424 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 165.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 . . . . . 0 CA--C 1.48 -1.73 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.555 HG22 ' HE2' ' A' ' 123' ' ' LYS . 69.0 t -88.49 114.26 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.793 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 174.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -109.9 179.84 4.0 Favored 'General case' 0 CA--C 1.472 -2.057 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 160.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -146.68 158.01 43.82 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.585 -168.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 tp -135.59 163.25 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 169.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -116.46 154.2 30.76 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-O 121.522 0.677 . . . . 0.0 111.496 162.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.663 ' HB3' HG11 ' A' ' 144' ' ' VAL . 40.9 m-85 -130.52 131.4 45.06 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 102.866 -3.012 . . . . 0.0 102.866 166.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 . . . . . 0 N--CA 1.431 -1.376 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -179.452 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . 0.328 52.6 m-20 . . . . . 0 N--CA 1.404 -2.726 0 CA-C-O 122.204 1.002 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -72.83 -72.58 0.24 Allowed 'General case' 0 CA--C 1.479 -1.775 0 CA-C-N 112.579 -2.101 . . . . 0.0 111.138 -163.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.419 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.34 0.0 OUTLIER -58.5 -14.67 8.5 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 119.548 3.166 . . . . 0.0 119.548 176.77 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.08 -45.86 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 C-N-CA 124.092 0.957 . . . . 0.0 110.183 163.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -91.8 4.95 51.67 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 151' ' ' ASP . 6.1 tt -82.97 -32.52 27.03 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 162.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.451 ' HA ' HG12 ' A' ' 115' ' ' ILE . 57.5 ttt180 -63.05 -42.74 99.79 Favored 'General case' 0 C--N 1.362 1.122 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.73 168.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.8 m -59.71 -40.93 89.6 Favored 'General case' 0 C--N 1.377 1.799 0 C-N-CA 118.509 -1.276 . . . . 0.0 113.36 173.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.572 HD11 HD12 ' A' ' 126' ' ' ILE . 7.6 mt -62.6 -32.84 73.91 Favored 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 175.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.0 mm -59.21 -46.67 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.533 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 174.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.57 -47.88 66.54 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 126.04 1.736 . . . . 0.0 113.079 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -54.93 -49.7 70.67 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.455 HD21 ' HA ' ' A' ' 176' ' ' PRO . 0.1 OUTLIER -60.7 -37.28 81.13 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 177.283 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -80.09 -20.82 44.23 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 128.26 2.624 . . . . 0.0 112.46 -173.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -71.97 -15.83 62.07 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 168.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.42 69.58 1.33 Allowed Glycine 0 CA--C 1.463 -3.174 0 N-CA-C 104.182 -3.567 . . . . 0.0 104.182 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -143.62 177.77 8.25 Favored 'General case' 0 CA--C 1.459 -2.529 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 171.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.555 ' HE2' HG22 ' A' ' 93' ' ' VAL . 4.0 tmmm? -116.94 114.08 23.33 Favored 'General case' 0 N--CA 1.393 -3.3 1 N-CA-C 96.929 -5.212 . . . . 0.0 96.929 -170.131 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -103.42 111.54 24.02 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.361 -1.335 . . . . 0.0 108.237 -162.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -97.6 122.85 41.16 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -164.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.572 HD12 HD11 ' A' ' 114' ' ' LEU . 6.3 mm -85.49 133.46 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.2 m -119.57 123.13 43.17 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . 0.266 0.2 OUTLIER -80.05 150.91 30.18 Favored 'General case' 0 CA--C 1.471 -2.065 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 166.058 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -145.75 95.39 2.64 Favored 'General case' 0 N--CA 1.403 -2.798 1 N-CA-C 98.712 -4.551 . . . . 0.0 98.712 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 . . . . . 0 N--CA 1.426 -1.665 0 CA-C-N 112.01 -2.359 . . . . 0.0 110.476 -172.107 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.8 mt . . . . . 0 N--CA 1.424 -1.759 0 N-CA-C 111.448 0.166 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.46 -58.83 4.06 Favored Glycine 0 N--CA 1.415 -2.729 0 O-C-N 123.695 0.622 . . . . 0.0 112.07 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 22.4 mtm -92.85 2.96 56.49 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 113.502 0.926 . . . . 0.0 113.502 -160.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.252 1.2 tm-20 -54.74 -71.65 0.08 Allowed 'General case' 0 CA--C 1.449 -2.913 0 C-N-CA 115.083 -2.647 . . . . 0.0 114.767 138.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.663 HG11 ' HB3' ' A' ' 98' ' ' PHE . 39.2 t -56.51 -67.6 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.441 -3.216 0 O-C-N 127.411 2.944 . . . . 0.0 108.973 -161.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.569 HD22 ' HB3' ' A' ' 172' ' ' MET . 62.2 mt -39.09 -53.78 1.79 Allowed 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 128.399 2.68 . . . . 0.0 115.213 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.409 ' HA ' ' CE2' ' A' ' 161' ' ' PHE . 1.7 t-20 -62.82 -36.71 84.09 Favored 'General case' 0 CA--C 1.46 -2.5 0 N-CA-C 117.591 2.441 . . . . 0.0 117.591 175.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -81.09 -14.46 57.73 Favored 'General case' 0 N--CA 1.417 -2.097 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.233 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.5 t -77.58 -43.11 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.48 ' HB2' HG21 ' A' ' 158' ' ' VAL . 30.5 ttmt -52.93 -51.09 62.55 Favored 'General case' 0 CA--C 1.464 -2.364 0 CA-C-O 117.024 -1.465 . . . . 0.0 110.8 169.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.75 -38.2 73.48 Favored 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 124.27 1.028 . . . . 0.0 110.071 -168.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.429 ' HB3' HD11 ' A' ' 111' ' ' LEU . 9.9 t70 -75.65 -28.78 58.88 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 116.673 -2.011 . . . . 0.0 115.414 171.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 156' ' ' ALA 0.286 0.1 OUTLIER -76.39 -33.02 58.88 Favored 'General case' 0 CA--C 1.475 -1.931 0 CA-C-O 116.827 -1.559 . . . . 0.0 113.084 178.107 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -28.26 -26.94 0.0 OUTLIER 'General case' 0 CA--C 1.483 -1.623 1 C-N-CA 135.468 5.507 . . . . 0.0 119.525 -172.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.417 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.7 mt-10 -57.63 -59.0 5.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.155 2.182 . . . . 0.0 112.246 171.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.08 -52.18 3.48 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.39 -1.732 . . . . 0.0 108.186 -167.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.541 ' CB ' HD11 ' A' ' 174' ' ' LEU 0.284 . . -98.85 147.53 24.84 Favored 'General case' 0 CA--C 1.459 -2.533 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.773 -178.731 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.43 171.41 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.765 0 C-N-CA 114.794 -2.762 . . . . 0.0 116.405 134.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.7 t -82.37 155.88 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.979 0 C-N-CA 128.948 2.899 . . . . 0.0 109.798 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -82.16 -42.93 18.39 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 113.7 -1.591 . . . . 0.0 106.885 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.7 t -152.87 144.97 23.81 Favored 'General case' 0 CA--C 1.464 -2.328 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.409 ' CE2' ' HA ' ' A' ' 146' ' ' ASN . 2.7 t80 . . . . . 0 N--CA 1.421 -1.918 0 N-CA-C 101.087 -3.671 . . . . 0.0 101.087 163.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.251 20.4 mt-30 . . . . . 0 CA--C 1.506 -0.718 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.7 ttp -113.6 113.59 25.28 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 118.742 0.701 . . . . 0.0 110.326 -172.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.1 mm -82.17 124.98 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 O-C-N 121.227 -0.921 . . . . 0.0 108.756 170.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.569 ' HB3' HD22 ' A' ' 145' ' ' LEU . 4.2 ttp -106.92 135.44 48.47 Favored 'General case' 0 CA--C 1.471 -2.081 0 N-CA-C 101.783 -3.414 . . . . 0.0 101.783 156.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 t -98.1 132.94 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 C-N-CA 116.486 -2.085 . . . . 0.0 106.894 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.541 HD11 ' CB ' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -116.47 148.33 40.86 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 100.255 -3.98 . . . . 0.0 100.255 -177.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -142.06 -173.96 0.39 Allowed Pre-proline 0 N--CA 1.431 -1.401 0 CA-C-O 117.009 -1.472 . . . . 0.0 110.242 -172.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.455 ' HA ' HD21 ' A' ' 118' ' ' LEU . 71.3 Cg_exo -68.88 153.67 72.34 Favored 'Trans proline' 0 N--CA 1.437 -1.823 0 C-N-CA 122.564 2.176 . . . . 0.0 108.817 165.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt . . . . . 0 CA--C 1.488 -1.427 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 169.706 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 . . . . . 0 CA--C 1.484 -1.582 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.471 HG22 ' HE3' ' A' ' 123' ' ' LYS . 99.3 t -103.22 120.67 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.627 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 172.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -104.34 171.81 7.14 Favored 'General case' 0 CA--C 1.482 -1.661 0 C-N-CA 117.863 -1.535 . . . . 0.0 107.203 152.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -144.46 154.73 43.23 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.52 165.23 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 171.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -111.32 153.71 25.57 Favored 'General case' 0 CA--C 1.487 -1.456 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.113 166.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.593 ' HB3' HG11 ' A' ' 144' ' ' VAL . 3.1 m-85 -140.24 98.9 3.53 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 172.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 . . . . . 0 N--CA 1.435 -1.193 0 C-N-CA 125.376 1.471 . . . . 0.0 110.013 -173.703 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . 0.263 0.9 OUTLIER . . . . . 0 N--CA 1.404 -2.728 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -87.14 -72.18 0.52 Allowed 'General case' 0 CA--C 1.477 -1.833 0 CA-C-N 113.953 -1.476 . . . . 0.0 109.787 -158.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.453 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.35 0.0 OUTLIER -55.61 -15.36 2.85 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 120.018 3.34 . . . . 0.0 120.018 173.905 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.4 t -61.54 -46.82 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 123.397 1.57 . . . . 0.0 110.373 163.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -89.25 -18.5 26.91 Favored 'General case' 0 CA--C 1.468 -2.207 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.415 ' CB ' ' HA ' ' A' ' 108' ' ' GLN . 2.0 tt -56.23 -38.26 70.83 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.094 154.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.549 ' HA ' HG12 ' A' ' 115' ' ' ILE . 42.3 ttt-85 -60.02 -42.93 95.42 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-N 119.193 0.906 . . . . 0.0 111.756 169.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.0 t -56.78 -45.87 81.87 Favored 'General case' 0 C--N 1.376 1.756 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.272 72.2 mt -67.7 -24.83 65.44 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.549 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.284 7.2 mm -60.74 -51.09 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.437 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 172.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.37 -43.72 68.03 Favored 'General case' 0 N--CA 1.426 -1.63 0 O-C-N 126.196 2.185 . . . . 0.0 109.898 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -60.51 -53.8 53.2 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.682 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -69.49 -21.01 63.72 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 126.926 2.091 . . . . 0.0 114.649 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -73.26 -37.1 66.42 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 127.188 2.195 . . . . 0.0 108.625 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -66.51 -26.98 67.42 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 123.14 0.576 . . . . 0.0 110.669 170.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.45 65.05 1.47 Allowed Glycine 0 CA--C 1.471 -2.662 0 N-CA-C 104.717 -3.353 . . . . 0.0 104.717 -171.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -119.97 166.41 13.38 Favored 'General case' 0 CA--C 1.451 -2.848 1 N-CA-C 97.775 -4.898 . . . . 0.0 97.775 169.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.471 ' HE3' HG22 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -106.63 116.97 32.85 Favored 'General case' 0 N--CA 1.395 -3.202 1 N-CA-C 97.365 -5.05 . . . . 0.0 97.365 171.018 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.27 159.09 21.02 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.416 ' HA ' ' H ' ' A' ' 174' ' ' LEU 0.258 44.8 mtmt -128.08 133.54 49.06 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 163.162 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.421 HG12 ' SD ' ' A' ' 172' ' ' MET . 6.9 mm -86.3 129.96 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.3 m -100.38 126.16 46.72 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 168.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.614 HD23 HD11 ' A' ' 145' ' ' LEU 0.278 0.3 OUTLIER -80.28 152.1 29.2 Favored 'General case' 0 CA--C 1.462 -2.412 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 164.724 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.517 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 42.3 ttt180 -149.42 96.42 2.5 Favored 'General case' 0 N--CA 1.395 -3.216 1 N-CA-C 96.853 -5.24 . . . . 0.0 96.853 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 . . . . . 0 N--CA 1.427 -1.578 0 CA-C-N 112.227 -2.26 . . . . 0.0 111.542 -172.943 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 67.5 mt . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.47 -61.4 3.9 Favored Glycine 0 N--CA 1.417 -2.627 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.513 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 8.4 ptm -87.51 -3.2 59.0 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -156.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -53.37 57.46 Favored 'General case' 0 CA--C 1.452 -2.813 0 C-N-CA 115.391 -2.524 . . . . 0.0 114.095 152.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.593 HG11 ' HB3' ' A' ' 98' ' ' PHE . 20.1 t -69.62 -64.33 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.445 -3.071 0 O-C-N 126.308 2.255 . . . . 0.0 107.859 -162.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.754 HD13 ' HB2' ' A' ' 172' ' ' MET . 90.2 mt -47.13 -52.98 13.99 Favored 'General case' 0 CA--C 1.477 -1.831 0 C-N-CA 128.274 2.63 . . . . 0.0 114.789 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 142' ' ' MET 0.258 1.5 t30 -62.9 -30.86 71.86 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 174.484 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -82.83 -14.31 54.58 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.385 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.441 HG12 HD12 ' A' ' 152' ' ' LEU . 2.1 t -76.23 -46.67 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.628 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 177.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.449 ' HE3' ' CG2' ' A' ' 158' ' ' VAL 0.265 25.2 ttmt -49.51 -53.68 22.06 Favored 'General case' 0 CA--C 1.458 -2.56 0 C-N-CA 125.895 1.678 . . . . 0.0 111.539 173.643 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -37.2 63.69 Favored 'General case' 0 N--CA 1.408 -2.56 0 C-N-CA 126.469 1.907 . . . . 0.0 109.985 -167.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.79 -31.62 66.79 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 116.339 -2.144 . . . . 0.0 114.678 171.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.441 HD12 HG12 ' A' ' 148' ' ' VAL 0.296 0.2 OUTLIER -83.51 -27.48 29.34 Favored 'General case' 0 CA--C 1.46 -2.51 0 CA-C-O 115.702 -2.094 . . . . 0.0 115.326 179.892 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -28.07 -22.31 0.0 OUTLIER 'General case' 0 CA--C 1.483 -1.624 1 C-N-CA 136.163 5.785 . . . . 0.0 119.786 -174.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -50.16 -49.58 51.72 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 126.342 1.857 . . . . 0.0 115.042 162.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -121.6 -52.77 2.01 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 128.06 2.544 . . . . 0.0 107.23 -157.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.682 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.362 . . -112.1 148.16 34.54 Favored 'General case' 0 CA--C 1.452 -2.791 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -176.277 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -119.93 -178.27 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.459 -2.528 0 C-N-CA 116.128 -2.229 . . . . 0.0 115.672 147.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 160' ' ' SER . 6.0 t -86.64 148.63 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 165.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -82.39 -39.54 22.56 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.532 ' H ' HG12 ' A' ' 158' ' ' VAL . 0.9 OUTLIER -150.61 131.0 13.74 Favored 'General case' 0 CA--C 1.465 -2.316 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -174.279 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.0 t80 . . . . . 0 N--CA 1.424 -1.755 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 172.001 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.517 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.317 46.2 mt-30 . . . . . 0 N--CA 1.443 -0.781 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.635 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 38.1 ttp -123.0 117.27 25.09 Favored 'General case' 0 C--N 1.364 1.214 0 CA-C-N 118.802 0.728 . . . . 0.0 112.633 -172.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.7 mm -82.19 123.84 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 O-C-N 120.555 -1.341 . . . . 0.0 109.058 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.754 ' HB2' HD13 ' A' ' 145' ' ' LEU . 2.8 tmm? -100.47 128.57 46.49 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 157.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.22 122.94 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.404 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.553 HD13 ' CD1' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -105.2 69.12 0.84 Allowed 'General case' 0 C--N 1.354 0.765 0 C-N-CA 127.654 2.382 . . . . 0.0 117.281 -170.506 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.335 . . -91.48 172.59 6.37 Favored Pre-proline 0 C--N 1.359 0.99 0 N-CA-C 119.604 3.187 . . . . 0.0 119.604 -171.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -68.85 140.08 45.24 Favored 'Trans proline' 0 CA--C 1.491 -1.661 0 CA-C-N 120.912 1.362 . . . . 0.0 110.922 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp . . . . . 0 CA--C 1.483 -1.597 0 O-C-N 125.0 1.438 . . . . 0.0 107.263 176.772 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 . . . . . 0 CA--C 1.479 -1.755 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.465 HG22 ' HE2' ' A' ' 123' ' ' LYS . 75.3 t -90.2 120.62 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.801 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 161.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -112.09 166.54 11.15 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 150.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -133.94 155.72 49.42 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.002 -164.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 tp -135.72 162.82 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 101.881 -3.377 . . . . 0.0 101.881 166.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -111.15 157.78 19.65 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 119.413 1.006 . . . . 0.0 109.612 163.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.67 ' HB3' HG11 ' A' ' 144' ' ' VAL . 17.1 m-85 -125.74 135.15 51.73 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 166.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mpm_? . . . . . 0 N--CA 1.424 -1.735 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.359 -167.914 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 N--CA 1.425 -1.677 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.9 -71.78 0.31 Allowed 'General case' 0 CA--C 1.481 -1.693 0 C-N-CA 126.265 1.826 . . . . 0.0 109.475 -170.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.325 0.0 OUTLIER -59.32 -15.48 16.36 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 119.487 3.144 . . . . 0.0 119.487 173.517 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.66 -43.56 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 121.556 0.693 . . . . 0.0 109.937 162.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -92.39 7.38 43.21 Favored 'General case' 0 CA--C 1.485 -1.556 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 6.2 tt -85.13 -31.5 23.26 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 104.038 -2.579 . . . . 0.0 104.038 161.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.495 ' HA ' HG12 ' A' ' 115' ' ' ILE . 31.7 ttt180 -62.97 -43.2 99.45 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 122.88 0.472 . . . . 0.0 110.969 168.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.2 t -56.51 -45.26 81.15 Favored 'General case' 0 C--N 1.376 1.732 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.66 -30.23 71.37 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.495 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.8 mm -58.54 -48.49 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.521 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 173.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.1 tpt85 -52.37 -50.29 62.7 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 125.466 1.729 . . . . 0.0 112.391 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -57.58 -44.97 85.75 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.53 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -65.57 -35.39 80.7 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 176.539 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -77.69 -20.87 52.92 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 127.821 2.448 . . . . 0.0 112.417 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -67.87 -19.91 65.07 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 123.658 0.783 . . . . 0.0 109.422 169.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.45 61.59 1.7 Allowed Glycine 0 CA--C 1.46 -3.357 0 N-CA-C 103.561 -3.816 . . . . 0.0 103.561 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -134.19 175.45 9.49 Favored 'General case' 0 CA--C 1.446 -3.043 1 N-CA-C 99.003 -4.443 . . . . 0.0 99.003 173.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HE2' HG22 ' A' ' 93' ' ' VAL 0.263 17.8 mtpt -89.12 140.19 29.71 Favored 'General case' 0 N--CA 1.396 -3.167 1 N-CA-C 97.55 -4.981 . . . . 0.0 97.55 163.622 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.582 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -84.49 160.34 20.56 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 155.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -142.33 125.87 16.79 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 102.673 -3.084 . . . . 0.0 102.673 167.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.556 HG21 ' HD2' ' A' ' 98' ' ' PHE . 4.0 mm -86.14 122.72 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.41 ' HA ' HD13 ' A' ' 171' ' ' ILE . 11.9 m -92.66 123.0 35.63 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 163.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.803 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.2 OUTLIER -84.11 152.05 24.55 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 165.391 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.444 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 28.0 ttm180 -152.56 91.5 1.58 Allowed 'General case' 0 N--CA 1.393 -3.281 1 N-CA-C 98.752 -4.536 . . . . 0.0 98.752 -172.753 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.476 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 93.9 m-85 . . . . . 0 N--CA 1.417 -2.075 0 CA-C-N 112.638 -2.074 . . . . 0.0 107.128 -175.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 66.8 mt . . . . . 0 N--CA 1.421 -1.9 0 CA-C-O 119.822 -0.132 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.803 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -76.57 -59.82 3.17 Favored Glycine 0 CA--C 1.466 -2.982 0 C-N-CA 119.059 -1.543 . . . . 0.0 113.122 -172.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 60.5 mtm -88.02 -0.07 56.58 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -166.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -68.16 -47.7 67.31 Favored 'General case' 0 CA--C 1.457 -2.632 0 C-N-CA 114.73 -2.788 . . . . 0.0 113.33 151.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.67 HG11 ' HB3' ' A' ' 98' ' ' PHE . 31.9 t -70.1 -68.98 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.436 -3.426 0 O-C-N 125.67 1.856 . . . . 0.0 107.343 -163.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.537 HD21 HD12 ' A' ' 128' ' ' LEU . 1.3 mp -48.79 -50.54 33.69 Favored 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 129.217 3.007 . . . . 0.0 113.259 -175.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -61.03 -37.01 81.07 Favored 'General case' 0 CA--C 1.471 -2.061 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -81.02 -14.22 58.11 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.512 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.7 t -76.14 -49.1 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.645 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.281 11.9 ttmt -51.95 -45.84 64.53 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 126.394 1.878 . . . . 0.0 113.096 171.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.57 -36.48 63.07 Favored 'General case' 0 N--CA 1.409 -2.492 0 C-N-CA 124.347 1.059 . . . . 0.0 110.024 -171.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -72.94 -39.72 66.0 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 116.473 -2.091 . . . . 0.0 115.178 169.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.47 HD13 HD11 ' A' ' 174' ' ' LEU 0.306 0.2 OUTLIER -79.61 -20.24 47.32 Favored 'General case' 0 CA--C 1.46 -2.514 0 CA-C-O 116.357 -1.782 . . . . 0.0 115.759 -177.271 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -26.24 -23.79 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.493 1 C-N-CA 135.042 5.337 . . . . 0.0 119.55 175.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 6.0 mt-10 -51.69 -56.54 13.1 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 126.993 2.117 . . . . 0.0 113.21 165.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.3 tt -116.38 -47.42 2.74 Favored 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 126.455 1.902 . . . . 0.0 109.291 -162.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.53 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.352 . . -110.14 143.45 40.21 Favored 'General case' 0 CA--C 1.448 -2.954 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.043 -179.557 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.8 m -120.46 171.98 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.483 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 140.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.522 HG22 HD23 ' A' ' 174' ' ' LEU . 4.0 t -81.46 151.54 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.931 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 172.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -80.92 -38.35 28.02 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 125.581 1.552 . . . . 0.0 107.005 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.478 ' H ' HG12 ' A' ' 158' ' ' VAL . 5.4 t -118.44 -176.32 3.05 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 145' ' ' LEU . 10.7 t80 . . . . . 0 N--CA 1.42 -1.959 0 N-CA-C 101.111 -3.663 . . . . 0.0 101.111 139.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.444 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.291 36.4 mt-30 . . . . . 0 CA--C 1.495 -1.165 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 60.7 ttp -146.47 120.85 9.63 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 118.933 0.788 . . . . 0.0 110.765 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 127' ' ' THR . 14.4 mm -79.64 126.89 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 O-C-N 120.786 -1.196 . . . . 0.0 108.627 173.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.404 ' SD ' HG11 ' A' ' 158' ' ' VAL . 4.7 ttp -105.5 135.24 47.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 160.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.58 126.39 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 118.299 -1.36 . . . . 0.0 109.68 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.582 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 0.1 OUTLIER -110.78 80.32 1.29 Allowed 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 -168.129 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.279 . . -85.82 174.91 5.0 Favored Pre-proline 0 CA--C 1.498 -1.032 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -169.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -64.15 141.48 76.34 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 C-N-CA 123.243 2.629 . . . . 0.0 108.263 160.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? . . . . . 0 N--CA 1.431 -1.395 0 O-C-N 124.216 0.947 . . . . 0.0 110.856 -177.857 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 N--CA 1.431 -1.411 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.9 t -96.67 115.7 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.792 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 160.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -107.35 175.45 5.49 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 152.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -135.17 155.34 50.85 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 tp -134.66 162.79 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 102.573 -3.121 . . . . 0.0 102.573 164.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -112.31 159.96 18.14 Favored 'General case' 0 CA--C 1.487 -1.465 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.195 161.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.551 ' HB3' HG11 ' A' ' 144' ' ' VAL . 10.8 m-85 -129.31 149.23 51.19 Favored 'General case' 0 CA--C 1.475 -1.924 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 166.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.417 -2.109 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.845 -171.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 N--CA 1.423 -1.818 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -74.92 -72.73 0.28 Allowed 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 125.902 1.681 . . . . 0.0 108.677 -171.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.439 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.328 0.0 OUTLIER -58.57 -12.42 4.04 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 120.417 3.488 . . . . 0.0 120.417 178.494 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.56 -41.82 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 C-N-CA 124.197 0.999 . . . . 0.0 110.184 161.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -92.58 -0.09 57.36 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.418 HD11 ' HB3' ' A' ' 151' ' ' ASP . 5.6 tt -77.52 -35.1 53.75 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 162.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.435 ' HA ' HG12 ' A' ' 115' ' ' ILE . 9.3 ttp180 -60.87 -44.74 96.64 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 125.093 1.357 . . . . 0.0 110.67 171.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.4 m -59.64 -42.18 92.16 Favored 'General case' 0 C--N 1.378 1.831 0 C-N-CA 118.755 -1.178 . . . . 0.0 113.396 174.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.49 HD11 HD12 ' A' ' 126' ' ' ILE . 40.5 mt -62.2 -33.58 74.82 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 176.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.2 mm -55.43 -50.52 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 O-C-N 124.433 1.083 . . . . 0.0 108.37 173.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.9 tpt85 -51.71 -45.73 63.67 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 126.207 1.803 . . . . 0.0 112.783 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -58.08 -51.72 68.54 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.825 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -72.21 -19.61 61.7 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -73.45 -34.51 65.44 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 125.257 1.423 . . . . 0.0 110.294 173.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -67.89 -27.84 67.0 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 169.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.56 61.73 1.68 Allowed Glycine 0 CA--C 1.471 -2.678 0 N-CA-C 105.73 -2.948 . . . . 0.0 105.73 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -122.44 170.55 9.85 Favored 'General case' 0 CA--C 1.461 -2.467 1 N-CA-C 98.541 -4.614 . . . . 0.0 98.541 171.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -105.58 122.94 47.06 Favored 'General case' 0 N--CA 1.401 -2.879 1 N-CA-C 97.079 -5.156 . . . . 0.0 97.079 171.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.03 155.32 22.78 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 114.897 -2.721 . . . . 0.0 103.807 167.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.407 ' HG2' HG13 ' A' ' 173' ' ' VAL . 87.4 mttt -115.71 127.35 55.07 Favored 'General case' 0 CA--C 1.476 -1.899 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 165.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.635 HD11 HD22 ' A' ' 174' ' ' LEU . 3.2 mm -86.65 116.03 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 176.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.3 m -98.13 119.01 36.03 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 172.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.719 HD12 HD11 ' A' ' 145' ' ' LEU 0.287 0.3 OUTLIER -79.95 145.49 32.57 Favored 'General case' 0 CA--C 1.466 -2.263 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 167.844 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -150.46 89.17 1.54 Allowed 'General case' 0 N--CA 1.401 -2.895 1 N-CA-C 96.192 -5.484 . . . . 0.0 96.192 -172.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.548 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 56.0 m-85 . . . . . 0 N--CA 1.417 -2.097 0 N-CA-C 101.37 -3.567 . . . . 0.0 101.37 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.293 89.2 mt . . . . . 0 N--CA 1.407 -2.608 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.566 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -80.85 -58.61 2.62 Favored Glycine 0 N--CA 1.417 -2.61 0 CA-C-N 114.438 -1.255 . . . . 0.0 113.986 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.4 mtm -89.25 1.4 55.76 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -163.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -55.53 -67.71 0.26 Allowed 'General case' 0 CA--C 1.445 -3.063 0 C-N-CA 115.391 -2.524 . . . . 0.0 114.284 140.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 98' ' ' PHE . 22.6 t -59.69 -66.63 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.438 -3.346 0 O-C-N 127.269 2.856 . . . . 0.0 108.336 -158.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.719 HD11 HD12 ' A' ' 128' ' ' LEU . 22.6 mt -45.99 -55.2 7.15 Favored 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 129.0 2.92 . . . . 0.0 115.299 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -62.21 -31.64 72.21 Favored 'General case' 0 CA--C 1.462 -2.429 0 N-CA-C 117.94 2.57 . . . . 0.0 117.94 173.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -82.26 -16.6 48.92 Favored 'General case' 0 N--CA 1.419 -1.991 0 C-N-CA 117.592 -1.643 . . . . 0.0 109.253 173.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.521 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.5 t -72.89 -45.82 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.856 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.547 ' HE3' HG21 ' A' ' 158' ' ' VAL . 35.7 ttmt -50.59 -51.67 46.24 Favored 'General case' 0 CA--C 1.464 -2.359 0 C-N-CA 125.775 1.63 . . . . 0.0 111.863 172.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -70.1 -41.13 74.43 Favored 'General case' 0 N--CA 1.406 -2.66 0 C-N-CA 125.936 1.695 . . . . 0.0 109.275 -168.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.418 ' HB3' HD11 ' A' ' 111' ' ' LEU . 22.9 t70 -74.18 -32.79 63.22 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 116.701 -2.0 . . . . 0.0 115.527 173.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.507 HD12 HG12 ' A' ' 148' ' ' VAL 0.348 0.3 OUTLIER -81.93 -26.2 34.25 Favored 'General case' 0 CA--C 1.461 -2.464 0 CA-C-O 116.409 -1.758 . . . . 0.0 115.128 -178.606 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -25.43 -29.94 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.489 1 C-N-CA 135.02 5.328 . . . . 0.0 119.202 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 5.9 mt-10 -49.24 -50.38 38.86 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 128.413 2.685 . . . . 0.0 113.993 169.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 tt -118.26 -50.62 2.45 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 126.339 1.855 . . . . 0.0 109.881 -164.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.825 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.346 . . -106.58 147.22 29.72 Favored 'General case' 0 CA--C 1.443 -3.17 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 -177.437 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.5 m -118.34 -174.54 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.529 0 C-N-CA 114.841 -2.744 . . . . 0.0 114.321 141.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.547 HG21 ' HE3' ' A' ' 149' ' ' LYS . 2.8 t -88.08 151.02 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.233 0 CA-C-N 111.762 -2.472 . . . . 0.0 105.717 168.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -81.89 -39.59 23.61 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.451 ' H ' HG12 ' A' ' 158' ' ' VAL . 1.1 t -160.69 142.0 12.04 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -171.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.426 -1.632 0 N-CA-C 101.751 -3.426 . . . . 0.0 101.751 169.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 . . . . . 0 N--CA 1.443 -0.777 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 10.7 ttm -121.53 162.6 20.28 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.6 mt -122.02 152.11 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 158.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.1 ttt -122.22 129.33 52.16 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 103.313 -2.847 . . . . 0.0 103.313 162.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.407 HG13 ' HG2' ' A' ' 125' ' ' LYS . 25.7 t -88.5 138.06 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -176.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.651 HD23 HD11 ' A' ' 118' ' ' LEU . 6.0 tp -118.87 90.15 3.27 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 131.104 3.762 . . . . 0.0 121.1 -177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.391 . . -104.9 165.41 13.29 Favored Pre-proline 0 CA--C 1.5 -0.975 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -71.97 141.01 35.9 Favored 'Trans proline' 0 CA--C 1.492 -1.614 0 C-N-CA 121.762 1.641 . . . . 0.0 108.412 -171.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.9 tmmt? . . . . . 0 CA--C 1.488 -1.432 0 O-C-N 125.097 1.498 . . . . 0.0 107.593 -173.136 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 . . . . . 0 CA--C 1.481 -1.7 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.498 HG22 ' HD3' ' A' ' 123' ' ' LYS . 92.2 t -101.07 115.73 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 161.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -99.62 172.52 7.23 Favored 'General case' 0 CA--C 1.476 -1.892 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 157.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -148.08 148.2 30.38 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -172.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.8 tp -131.43 161.06 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 103.733 -2.691 . . . . 0.0 103.733 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -121.88 154.25 37.34 Favored 'General case' 0 CA--C 1.487 -1.48 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.606 163.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.494 ' HB3' HG11 ' A' ' 144' ' ' VAL . 46.4 m-85 -129.62 143.5 50.85 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 170.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 . . . . . 0 N--CA 1.428 -1.543 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 174.273 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 N--CA 1.427 -1.616 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.91 -75.95 0.11 Allowed 'General case' 0 CA--C 1.478 -1.798 0 C-N-CA 126.784 2.034 . . . . 0.0 109.976 -171.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.432 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.331 0.0 OUTLIER -59.49 -12.7 6.73 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 119.967 3.321 . . . . 0.0 119.967 176.622 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.24 -43.74 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 122.126 0.965 . . . . 0.0 110.259 162.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -91.7 -1.09 57.56 Favored 'General case' 0 CA--C 1.475 -1.938 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.411 HD21 HD22 ' A' ' 152' ' ' LEU . 5.3 tt -79.05 -31.15 44.41 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 161.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.513 ' HA ' HG12 ' A' ' 115' ' ' ILE . 19.1 ttt85 -62.69 -43.0 99.92 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 118.599 -0.715 . . . . 0.0 111.276 169.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.4 m -61.69 -40.97 96.87 Favored 'General case' 0 C--N 1.378 1.819 0 C-N-CA 118.899 -1.12 . . . . 0.0 113.51 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.476 HD11 HD23 ' A' ' 174' ' ' LEU 0.282 55.8 tp -69.09 -26.97 65.2 Favored 'General case' 0 N--CA 1.402 -2.863 0 C-N-CA 126.259 1.823 . . . . 0.0 113.952 178.073 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.513 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.268 5.6 mm -60.96 -49.37 84.98 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.873 0 CA-C-N 121.061 1.755 . . . . 0.0 109.232 170.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -52.39 -48.36 65.69 Favored 'General case' 0 CA--C 1.494 -1.203 0 C-N-CA 126.662 1.985 . . . . 0.0 108.899 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -56.5 -53.85 52.67 Favored 'General case' 0 CA--C 1.483 -1.622 0 C-N-CA 125.992 1.717 . . . . 0.0 111.647 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.515 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -58.4 -39.83 80.76 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 179.243 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.23 -14.06 44.99 Favored 'General case' 0 C--N 1.364 1.212 0 C-N-CA 125.767 1.627 . . . . 0.0 111.746 -170.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -65.79 -25.06 67.08 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 123.073 0.549 . . . . 0.0 109.839 161.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.2 59.47 1.3 Allowed Glycine 0 CA--C 1.468 -2.865 0 N-CA-C 103.917 -3.673 . . . . 0.0 103.917 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -125.32 164.5 20.24 Favored 'General case' 0 CA--C 1.461 -2.475 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 171.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.498 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -102.02 121.54 42.36 Favored 'General case' 0 N--CA 1.407 -2.601 1 N-CA-C 99.869 -4.122 . . . . 0.0 99.869 179.401 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.446 ' HB1' ' CD1' ' A' ' 114' ' ' LEU . . . -111.91 115.91 29.76 Favored 'General case' 0 N--CA 1.415 -2.191 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.597 -166.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -98.3 119.68 37.39 Favored 'General case' 0 CA--C 1.491 -1.315 0 O-C-N 121.683 -0.636 . . . . 0.0 110.717 -167.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.9 mm -83.82 134.8 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.442 ' HA ' HD13 ' A' ' 171' ' ' ILE . 18.6 m -116.64 115.38 25.58 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 165.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.78 HD21 ' HA2' ' A' ' 141' ' ' GLY . 18.4 tp -82.4 148.49 28.19 Favored 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 167.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -150.58 103.82 3.15 Favored 'General case' 0 N--CA 1.405 -2.708 1 N-CA-C 98.44 -4.652 . . . . 0.0 98.44 -174.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.572 ' CZ ' HD23 ' A' ' 128' ' ' LEU 0.294 77.6 m-85 . . . . . 0 CA--C 1.491 -1.321 0 C-N-CA 127.345 2.258 . . . . 0.0 109.227 -175.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 91.3 mt . . . . . 0 CA--C 1.478 -1.8 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.78 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -77.0 -57.99 3.56 Favored Glycine 0 CA--C 1.458 -3.515 0 C-N-CA 119.07 -1.538 . . . . 0.0 113.733 -171.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 53.0 mtm -84.54 -0.04 51.62 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 118.123 -0.942 . . . . 0.0 113.09 -166.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.303 2.8 tp10 -64.34 -69.73 0.27 Allowed 'General case' 0 CA--C 1.454 -2.741 0 C-N-CA 115.051 -2.659 . . . . 0.0 115.012 143.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.494 HG11 ' HB3' ' A' ' 98' ' ' PHE . 39.7 t -59.98 -66.9 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.455 -2.707 0 O-C-N 126.261 2.226 . . . . 0.0 110.884 -161.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.452 HD11 HD22 ' A' ' 128' ' ' LEU . 73.4 mt -46.07 -55.06 7.45 Favored 'General case' 0 CA--C 1.483 -1.631 0 C-N-CA 128.421 2.688 . . . . 0.0 114.278 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.7 -30.01 69.68 Favored 'General case' 0 CA--C 1.469 -2.151 0 N-CA-C 118.609 2.818 . . . . 0.0 118.609 172.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -82.24 -15.35 53.37 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 119.41 -0.329 . . . . 0.0 110.486 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.463 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.9 t -77.37 -42.47 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.666 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 175.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.481 ' HB2' HG21 ' A' ' 158' ' ' VAL 0.254 31.8 ttmt -53.91 -52.04 61.83 Favored 'General case' 0 CA--C 1.462 -2.409 0 C-N-CA 124.943 1.297 . . . . 0.0 111.014 171.659 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -71.88 -38.75 69.95 Favored 'General case' 0 N--CA 1.407 -2.608 0 C-N-CA 125.674 1.59 . . . . 0.0 109.18 -169.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -74.53 -24.84 59.03 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 116.802 -1.959 . . . . 0.0 114.647 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 156' ' ' ALA 0.267 0.1 OUTLIER -78.92 -37.06 40.78 Favored 'General case' 0 CA--C 1.477 -1.833 0 CA-C-O 116.26 -1.829 . . . . 0.0 111.958 177.259 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 156' ' ' ALA . 3.9 tt0 -27.63 -29.89 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.488 1 C-N-CA 135.8 5.64 . . . . 0.0 119.642 -167.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 7.4 mt-10 -51.51 -47.69 63.19 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 128.789 2.836 . . . . 0.0 114.202 170.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -120.24 -51.88 2.19 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 128.167 2.587 . . . . 0.0 105.47 -159.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.875 ' HB1' HD11 ' A' ' 174' ' ' LEU 0.302 . . -107.43 144.62 34.09 Favored 'General case' 0 CA--C 1.452 -2.806 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.303 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.3 m -122.71 164.72 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.762 0 C-N-CA 115.286 -2.565 . . . . 0.0 117.604 141.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 5.8 t -81.82 149.37 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.257 0 CA-C-N 110.067 -3.242 . . . . 0.0 105.968 -174.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.76 -38.9 27.81 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -173.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -162.65 144.82 10.64 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -173.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.424 -1.74 0 N-CA-C 100.64 -3.837 . . . . 0.0 100.64 165.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.444 -0.74 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 39.4 ttm -118.49 123.89 46.25 Favored 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 124.008 0.923 . . . . 0.0 108.815 -174.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 127' ' ' THR . 15.5 mm -83.72 130.05 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 O-C-N 120.968 -1.082 . . . . 0.0 108.282 168.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.41 ' HB3' HD22 ' A' ' 145' ' ' LEU . 3.2 ttp -110.87 124.31 51.81 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 160.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 43.5 t -88.46 136.51 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.875 HD11 ' HB1' ' A' ' 156' ' ' ALA . 0.5 OUTLIER -124.77 150.31 46.41 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 101.673 -3.455 . . . . 0.0 101.673 -178.564 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.337 . . -142.26 -179.32 0.94 Allowed Pre-proline 0 CA--C 1.488 -1.42 0 CA-C-O 117.824 -1.084 . . . . 0.0 109.458 -173.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.434 ' HA ' HD21 ' A' ' 118' ' ' LEU . 82.2 Cg_exo -64.93 143.4 79.23 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 122.82 2.347 . . . . 0.0 110.111 165.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp . . . . . 0 N--CA 1.434 -1.226 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 165.855 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 . . . . . 0 CA--C 1.478 -1.807 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.62 113.61 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.813 0 C-N-CA 118.641 -1.224 . . . . 0.0 108.028 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -107.76 177.42 4.83 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 155.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -139.14 155.8 47.6 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.482 -172.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 tp -133.85 161.37 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 102.936 -2.987 . . . . 0.0 102.936 166.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -118.16 159.36 23.42 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 118.845 0.748 . . . . 0.0 110.175 165.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.654 ' HB3' HG11 ' A' ' 144' ' ' VAL . 25.8 m-85 -138.51 114.01 9.68 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 167.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.433 -1.286 0 C-N-CA 124.586 1.154 . . . . 0.0 107.911 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 N--CA 1.425 -1.686 0 CA-C-O 122.648 1.214 . . . . 0.0 107.857 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -86.78 -71.08 0.57 Allowed 'General case' 0 CA--C 1.469 -2.154 0 CA-C-N 112.351 -2.204 . . . . 0.0 111.235 -157.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.471 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.323 0.0 OUTLIER -58.94 -14.97 10.7 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 118.844 2.905 . . . . 0.0 118.844 174.057 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.03 -45.71 98.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 C-N-CA 124.711 1.205 . . . . 0.0 110.328 161.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -92.84 5.15 52.29 Favored 'General case' 0 CA--C 1.485 -1.541 0 O-C-N 120.137 -1.602 . . . . 0.0 115.269 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -83.45 -32.42 26.05 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 163.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.451 ' HA ' HG12 ' A' ' 115' ' ' ILE . 14.9 ttp180 -60.33 -45.62 92.77 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 125.158 1.383 . . . . 0.0 110.122 169.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.5 t -62.0 -40.38 95.45 Favored 'General case' 0 C--N 1.374 1.66 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.5 tp -67.42 -33.4 75.08 Favored 'General case' 0 N--CA 1.401 -2.88 0 C-N-CA 125.069 1.348 . . . . 0.0 113.844 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.255 8.5 mm -54.16 -50.75 53.12 Favored 'Isoleucine or valine' 0 C--N 1.373 1.626 0 CA-C-N 119.155 0.889 . . . . 0.0 108.865 170.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -50.01 -45.22 51.64 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 128.172 2.589 . . . . 0.0 112.464 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -55.94 -54.23 47.23 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 172.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.598 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -68.51 -22.35 64.53 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -76.27 -31.4 58.26 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 126.188 1.795 . . . . 0.0 111.175 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.1 -23.93 63.13 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 168.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.28 72.89 1.24 Allowed Glycine 0 CA--C 1.466 -2.977 0 N-CA-C 104.778 -3.329 . . . . 0.0 104.778 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -129.14 170.91 12.95 Favored 'General case' 0 CA--C 1.449 -2.941 1 N-CA-C 97.749 -4.908 . . . . 0.0 97.749 169.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -104.72 113.48 27.1 Favored 'General case' 0 N--CA 1.393 -3.314 1 N-CA-C 96.395 -5.409 . . . . 0.0 96.395 171.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.99 154.34 25.75 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.406 ' HG2' HG13 ' A' ' 173' ' ' VAL 0.279 78.9 mttt -118.68 137.53 53.25 Favored 'General case' 0 CA--C 1.469 -2.145 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 164.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.5 mm -83.18 128.92 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.37 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.8 m -110.78 122.84 48.84 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 169.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.542 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.2 OUTLIER -87.01 155.37 20.19 Favored 'General case' 0 CA--C 1.469 -2.163 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 170.225 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -151.57 89.69 1.51 Allowed 'General case' 0 N--CA 1.405 -2.694 0 N-CA-C 101.042 -3.688 . . . . 0.0 101.042 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.488 ' CE1' HD22 ' A' ' 128' ' ' LEU . 95.8 m-85 . . . . . 0 N--CA 1.425 -1.707 0 CA-C-N 112.237 -2.256 . . . . 0.0 109.394 -171.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.2 mt . . . . . 1 N--CA 1.376 -4.163 1 N-CA-C 95.296 -5.816 . . . . 0.0 95.296 . . . . . . . . . 2 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.542 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . 147.88 -71.01 0.33 Allowed Glycine 1 N--CA 1.381 -4.999 2 C-N-CA 134.887 5.994 . . . . 0.0 108.273 165.293 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.4 mtm -94.86 20.07 9.32 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -169.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -50.68 25.45 Favored 'General case' 0 CA--C 1.454 -2.726 0 C-N-CA 116.4 -2.12 . . . . 0.0 113.939 137.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.654 HG11 ' HB3' ' A' ' 98' ' ' PHE . 15.0 t -68.14 -67.72 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.429 -3.696 0 O-C-N 126.469 2.356 . . . . 0.0 106.669 -159.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.13 -55.93 3.05 Favored 'General case' 0 CA--C 1.459 -2.546 0 C-N-CA 129.336 3.055 . . . . 0.0 111.843 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -57.51 -37.96 73.83 Favored 'General case' 0 CA--C 1.469 -2.157 0 C-N-CA 125.924 1.689 . . . . 0.0 114.509 178.645 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -81.82 -14.83 55.8 Favored 'General case' 0 N--CA 1.421 -1.925 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.747 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.4 t -75.25 -47.77 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.764 0 CA-C-O 116.082 -1.913 . . . . 0.0 106.55 176.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.608 ' HB2' HG21 ' A' ' 158' ' ' VAL . 3.5 ttmt -53.06 -51.87 60.37 Favored 'General case' 0 CA--C 1.46 -2.482 0 CA-C-O 117.248 -1.358 . . . . 0.0 110.02 171.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.41 -36.53 81.46 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 119.01 0.823 . . . . 0.0 110.268 -168.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.29 -43.97 66.09 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 116.519 -2.072 . . . . 0.0 116.414 168.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.275 0.2 OUTLIER -82.74 -18.17 41.68 Favored 'General case' 0 CA--C 1.468 -2.176 0 N-CA-C 118.064 2.616 . . . . 0.0 118.064 -172.734 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -25.64 -31.52 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.154 1 C-N-CA 133.571 4.748 . . . . 0.0 118.321 170.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.4 mt-10 -53.11 -50.32 64.7 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 127.998 2.519 . . . . 0.0 114.459 173.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 tt -112.4 -51.76 2.82 Favored 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 125.97 1.708 . . . . 0.0 110.633 -169.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.598 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.308 . . -104.46 144.46 31.63 Favored 'General case' 0 CA--C 1.452 -2.821 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.572 -174.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 177' ' ' LYS . 5.5 m -128.84 159.78 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.484 0 N-CA-C 120.196 3.406 . . . . 0.0 120.196 148.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 149' ' ' LYS . 2.4 t -83.2 150.07 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.257 0 CA-C-N 110.108 -3.224 . . . . 0.0 105.841 -173.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -81.54 -39.75 24.18 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 -174.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.4 t -159.78 157.74 29.89 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -169.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 146' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.423 -1.819 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.322 28.5 mt-30 . . . . . 0 CA--C 1.504 -0.817 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 41.9 ttm -129.98 121.11 25.9 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 121.275 0.559 . . . . 0.0 110.519 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.7 mm -83.02 128.99 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 O-C-N 120.895 -1.128 . . . . 0.0 109.205 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.408 ' SD ' ' CE1' ' A' ' 161' ' ' PHE . 1.2 ttp -108.48 140.61 41.56 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 156.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.406 HG13 ' HG2' ' A' ' 125' ' ' LYS . 11.1 t -106.17 135.79 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 C-N-CA 119.171 -1.011 . . . . 0.0 109.299 -173.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.558 HD13 HG22 ' A' ' 158' ' ' VAL . 6.1 tp -118.81 96.66 5.35 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 121.626 3.935 . . . . 0.0 121.626 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.271 . . -98.84 168.43 9.75 Favored Pre-proline 0 CA--C 1.499 -0.987 0 N-CA-C 115.899 1.815 . . . . 0.0 115.899 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -75.7 135.6 18.02 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 N-CA-C 105.039 -2.716 . . . . 0.0 105.039 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.427 ' HB3' HG13 ' A' ' 157' ' ' VAL . 58.2 pttt . . . . . 0 CA--C 1.49 -1.349 0 C-N-CA 118.365 -1.334 . . . . 0.0 113.905 -175.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 . . . . . 0 CA--C 1.482 -1.667 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.8 t -97.84 120.34 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -102.5 168.5 9.25 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 152.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -136.12 153.27 51.35 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 tp -135.57 160.93 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 167.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -117.27 155.73 28.99 Favored 'General case' 0 CA--C 1.484 -1.564 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.831 165.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.55 ' HB3' HG11 ' A' ' 144' ' ' VAL . 5.4 m-85 -139.44 139.29 37.03 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 . . . . . 0 N--CA 1.434 -1.253 0 CA-C-O 118.804 -0.617 . . . . 0.0 109.403 -172.01 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 N--CA 1.423 -1.811 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.413 ' HD1' ' CE1' ' A' ' 98' ' ' PHE . 0.6 OUTLIER -82.51 -64.02 1.26 Allowed 'General case' 0 CA--C 1.483 -1.609 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.138 -163.519 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.336 0.0 OUTLIER -61.44 -12.02 12.88 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 119.649 3.203 . . . . 0.0 119.649 176.738 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.84 -44.69 99.73 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-O 122.649 1.214 . . . . 0.0 110.06 161.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -91.46 0.55 57.49 Favored 'General case' 0 CA--C 1.477 -1.842 0 O-C-N 120.454 -1.404 . . . . 0.0 114.568 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.3 tt -81.66 -28.76 33.43 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 162.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.494 ' HA ' HG12 ' A' ' 115' ' ' ILE . 40.7 ttt180 -62.08 -42.78 99.56 Favored 'General case' 0 C--N 1.361 1.096 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.874 166.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.4 m -58.88 -43.6 90.96 Favored 'General case' 0 C--N 1.38 1.9 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 173.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.261 83.5 mt -64.75 -29.2 70.17 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 116.585 2.069 . . . . 0.0 116.585 175.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.254 10.1 mm -58.32 -51.44 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.899 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.085 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -50.08 -46.88 53.78 Favored 'General case' 0 CA--C 1.49 -1.329 0 O-C-N 126.025 2.078 . . . . 0.0 109.713 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -59.76 -56.05 26.65 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.221 1.008 . . . . 0.0 112.848 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -69.71 -27.66 65.18 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 125.737 1.615 . . . . 0.0 115.321 -177.597 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -82.8 -17.34 44.43 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 124.113 0.965 . . . . 0.0 111.81 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -71.44 -29.64 65.12 Favored 'General case' 0 C--N 1.362 1.137 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 162.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.02 65.27 1.13 Allowed Glycine 0 CA--C 1.474 -2.483 0 N-CA-C 105.558 -3.017 . . . . 0.0 105.558 -172.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -125.82 173.34 9.15 Favored 'General case' 0 CA--C 1.456 -2.654 1 N-CA-C 98.069 -4.789 . . . . 0.0 98.069 169.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.12 122.49 47.39 Favored 'General case' 0 N--CA 1.4 -2.974 1 N-CA-C 96.983 -5.191 . . . . 0.0 96.983 170.901 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.98 160.11 21.1 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 115.453 -2.499 . . . . 0.0 105.708 169.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -133.26 119.3 19.62 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 171.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.585 HD11 HD22 ' A' ' 174' ' ' LEU . 7.8 mm -85.23 134.65 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.704 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.1 m -122.89 127.97 49.7 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.481 HD21 ' HA2' ' A' ' 141' ' ' GLY 0.377 0.3 OUTLIER -80.47 153.35 28.24 Favored 'General case' 0 CA--C 1.454 -2.739 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 169.365 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 33.4 ttt-85 -148.34 91.77 1.95 Allowed 'General case' 0 N--CA 1.399 -3.024 1 N-CA-C 98.556 -4.609 . . . . 0.0 98.556 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 . . . . . 0 N--CA 1.423 -1.82 0 CA-C-N 110.598 -3.001 . . . . 0.0 109.139 -172.882 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.416 -2.125 0 N-CA-C 110.753 -0.091 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.481 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -72.85 -63.55 2.82 Favored Glycine 0 N--CA 1.414 -2.809 0 O-C-N 123.814 0.696 . . . . 0.0 112.404 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 71.5 mtm -96.84 24.75 5.83 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -163.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -62.3 1.49 Allowed 'General case' 0 CA--C 1.453 -2.756 0 C-N-CA 116.171 -2.212 . . . . 0.0 115.545 129.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.55 HG11 ' HB3' ' A' ' 98' ' ' PHE . 25.7 t -61.94 -64.03 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.45 -2.899 0 O-C-N 126.435 2.335 . . . . 0.0 109.183 -161.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' A' ' 172' ' ' MET . 72.9 mt -43.45 -55.53 4.12 Favored 'General case' 0 CA--C 1.48 -1.725 0 C-N-CA 127.686 2.395 . . . . 0.0 114.086 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -57.62 -37.6 73.56 Favored 'General case' 0 CA--C 1.476 -1.879 0 C-N-CA 126.484 1.914 . . . . 0.0 114.298 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.419 ' HA ' ' HB2' ' A' ' 150' ' ' ASP . 15.9 ttp180 -80.2 -15.29 57.36 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 118.845 0.748 . . . . 0.0 111.38 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.8 t -74.2 -47.07 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.724 0 CA-C-O 116.459 -1.734 . . . . 0.0 106.732 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.607 ' HE3' HG21 ' A' ' 158' ' ' VAL . 10.7 ttmt -55.41 -50.78 68.87 Favored 'General case' 0 CA--C 1.461 -2.452 0 CA-C-O 116.776 -1.583 . . . . 0.0 110.011 172.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.419 ' HB2' ' HA ' ' A' ' 147' ' ' ARG . 69.0 m-20 -66.84 -36.45 82.36 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 119.733 1.151 . . . . 0.0 110.105 -168.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.09 -48.44 57.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 116.662 -2.015 . . . . 0.0 115.843 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.465 HD13 HD21 ' A' ' 174' ' ' LEU 0.283 0.2 OUTLIER -82.62 -14.38 54.86 Favored 'General case' 0 CA--C 1.468 -2.198 0 N-CA-C 118.147 2.647 . . . . 0.0 118.147 -172.297 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -25.4 -30.23 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.263 1 C-N-CA 133.815 4.846 . . . . 0.0 118.358 168.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.3 mt-10 -51.36 -54.37 27.09 Favored 'General case' 0 CA--C 1.488 -1.428 0 C-N-CA 127.478 2.311 . . . . 0.0 113.828 170.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.3 tt -113.52 -53.7 2.67 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.38 -1.736 . . . . 0.0 110.491 -168.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.519 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.301 . . -92.65 148.22 22.24 Favored 'General case' 0 CA--C 1.455 -2.698 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -177.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.486 ' HB ' ' H ' ' A' ' 158' ' ' VAL . 15.2 m -118.58 -164.04 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.452 -2.821 0 C-N-CA 114.305 -2.958 . . . . 0.0 111.155 141.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.607 HG21 ' HE3' ' A' ' 149' ' ' LYS 0.277 2.9 t -111.93 163.01 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.394 0 C-N-CA 129.649 3.18 . . . . 0.0 107.364 -177.319 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -84.09 -43.97 14.53 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 172.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.584 ' H ' HG12 ' A' ' 158' ' ' VAL . 0.9 OUTLIER -157.29 147.62 21.01 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.557 -167.777 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.416 -2.15 0 N-CA-C 103.136 -2.912 . . . . 0.0 103.136 165.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.508 -0.671 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 31.2 ttm -123.36 121.86 36.85 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -170.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.46 HG21 HD13 ' A' ' 171' ' ' ILE . 1.4 mt -87.69 142.69 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 C-N-CA 117.755 -1.578 . . . . 0.0 110.758 173.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.458 ' HB3' HD22 ' A' ' 145' ' ' LEU . 3.3 tmm? -111.72 126.84 55.47 Favored 'General case' 0 CA--C 1.476 -1.894 0 N-CA-C 101.421 -3.548 . . . . 0.0 101.421 153.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.2 t -91.72 124.93 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 118.052 -1.459 . . . . 0.0 108.45 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.585 HD22 HD11 ' A' ' 126' ' ' ILE . 14.5 tp -104.45 84.43 2.19 Favored 'General case' 0 C--N 1.349 0.556 0 N-CA-C 121.324 3.824 . . . . 0.0 121.324 -174.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.438 . . -108.08 155.66 39.7 Favored Pre-proline 0 C--N 1.359 0.993 0 N-CA-C 119.279 3.066 . . . . 0.0 119.279 -173.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.25 139.39 45.84 Favored 'Trans proline' 0 CA--C 1.491 -1.653 0 C-N-CA 123.398 2.732 . . . . 0.0 111.545 -160.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp . . . . . 0 CA--C 1.49 -1.343 0 O-C-N 125.053 1.471 . . . . 0.0 107.614 -178.777 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 . . . . . 0 CA--C 1.484 -1.571 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.463 HG22 ' HD2' ' A' ' 123' ' ' LYS . 72.3 t -90.18 112.43 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -104.58 177.08 4.95 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 157.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -140.01 156.29 46.69 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 117.778 0.263 . . . . 0.0 111.265 -170.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 tp -139.51 168.64 18.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 164.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -118.23 155.61 30.24 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 118.833 0.742 . . . . 0.0 111.178 162.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.548 ' HD2' HG21 ' A' ' 126' ' ' ILE . 19.2 m-85 -124.55 153.49 42.04 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 168.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 . . . . . 0 N--CA 1.437 -1.101 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.828 -170.501 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 N--CA 1.424 -1.731 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.23 -71.69 0.29 Allowed 'General case' 0 CA--C 1.479 -1.76 0 C-N-CA 126.556 1.942 . . . . 0.0 109.112 -171.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.461 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.368 0.0 OUTLIER -57.49 -15.42 6.97 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 119.8 3.259 . . . . 0.0 119.8 175.11 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.97 -43.89 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-O 122.014 0.911 . . . . 0.0 110.699 163.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -91.96 2.78 56.33 Favored 'General case' 0 CA--C 1.477 -1.858 0 O-C-N 120.495 -1.378 . . . . 0.0 114.367 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 151' ' ' ASP . 5.9 tt -81.82 -31.96 31.47 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 163.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.438 ' HA ' HG12 ' A' ' 115' ' ' ILE . 50.4 ttt180 -62.64 -42.36 99.55 Favored 'General case' 0 C--N 1.361 1.095 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.696 168.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.7 m -60.18 -38.0 81.91 Favored 'General case' 0 C--N 1.377 1.798 0 C-N-CA 118.632 -1.227 . . . . 0.0 113.728 172.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.469 HD22 ' HB3' ' A' ' 124' ' ' ALA . 72.2 mt -65.24 -33.74 76.71 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 175.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 112' ' ' ARG . 4.7 mm -58.62 -46.11 90.34 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.391 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -49.64 -48.78 49.02 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 128.14 2.576 . . . . 0.0 111.835 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -58.97 -50.05 75.56 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.739 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -70.56 -21.77 62.66 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 124.853 1.261 . . . . 0.0 114.119 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -71.29 -37.7 71.84 Favored 'General case' 0 CA--C 1.491 -1.327 0 C-N-CA 126.75 2.02 . . . . 0.0 109.694 173.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -66.82 -28.22 68.19 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-O 120.732 0.301 . . . . 0.0 110.61 170.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.53 71.47 1.29 Allowed Glycine 0 CA--C 1.473 -2.579 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 -175.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -134.79 174.45 10.56 Favored 'General case' 0 N--CA 1.414 -2.229 1 N-CA-C 99.97 -4.085 . . . . 0.0 99.97 170.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HD2' HG22 ' A' ' 93' ' ' VAL 0.333 13.9 mtmt -88.5 147.47 24.63 Favored 'General case' 0 CA--C 1.459 -2.554 0 N-CA-C 100.918 -3.734 . . . . 0.0 100.918 159.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.469 ' HB3' HD22 ' A' ' 114' ' ' LEU . . . -116.18 123.2 47.21 Favored 'General case' 0 CA--C 1.457 -2.623 0 C-N-CA 115.331 -2.548 . . . . 0.0 106.091 160.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -99.75 117.67 34.59 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -168.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.548 HG21 ' HD2' ' A' ' 98' ' ' PHE . 3.6 mm -85.29 125.92 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.445 ' HA ' HD13 ' A' ' 171' ' ' ILE . 17.3 m -97.79 117.22 31.61 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 159.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.767 HD13 ' CZ ' ' A' ' 130' ' ' PHE . 0.5 OUTLIER -76.46 148.5 37.2 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 166.328 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.518 ' H ' HD23 ' A' ' 128' ' ' LEU . 24.4 ttt180 -151.14 92.61 1.82 Allowed 'General case' 0 N--CA 1.402 -2.837 1 N-CA-C 97.009 -5.182 . . . . 0.0 97.009 -167.618 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.767 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 90.5 m-85 . . . . . 0 N--CA 1.418 -2.031 0 N-CA-C 101.423 -3.547 . . . . 0.0 101.423 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.411 HG22 ' CD1' ' A' ' 130' ' ' PHE . 16.6 mt . . . . . 1 N--CA 1.367 -4.623 1 N-CA-C 94.153 -6.24 . . . . 0.0 94.153 . . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.404 ' HA2' ' CD1' ' A' ' 128' ' ' LEU . . . 157.7 -89.67 0.11 Allowed Glycine 0 N--CA 1.412 -2.943 1 CA-C-N 107.883 -4.235 . . . . 0.0 108.857 -174.147 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.541 ' HG2' ' CE1' ' A' ' 161' ' ' PHE 0.254 75.0 mtp -90.09 5.16 47.96 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 128.779 2.832 . . . . 0.0 113.876 -168.394 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.251 2.3 tp10 -75.48 -45.67 37.06 Favored 'General case' 0 CA--C 1.433 -3.529 0 C-N-CA 116.111 -2.236 . . . . 0.0 111.823 151.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 98' ' ' PHE . 38.5 t -68.51 -74.9 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.444 -3.113 0 O-C-N 126.693 2.495 . . . . 0.0 107.539 -161.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.579 ' CD2' HD12 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -51.46 -47.4 63.12 Favored 'General case' 0 CA--C 1.481 -1.675 0 C-N-CA 129.908 3.283 . . . . 0.0 112.102 -177.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.253 1.5 t30 -64.98 -32.31 73.97 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -81.39 -15.58 54.78 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.363 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.48 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.7 t -74.78 -46.42 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.885 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.47 ' CE ' ' HB ' ' A' ' 158' ' ' VAL 0.303 19.7 ttmt -51.27 -48.48 62.19 Favored 'General case' 0 CA--C 1.472 -2.051 0 C-N-CA 126.781 2.032 . . . . 0.0 113.424 172.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.89 -39.65 61.36 Favored 'General case' 0 N--CA 1.408 -2.554 0 C-N-CA 127.238 2.215 . . . . 0.0 109.577 -171.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.413 ' HB3' HD11 ' A' ' 111' ' ' LEU . 14.2 t70 -75.24 -25.06 57.8 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 116.623 -2.031 . . . . 0.0 115.0 170.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.415 HD11 ' HA ' ' A' ' 115' ' ' ILE 0.307 0.2 OUTLIER -79.44 -31.55 42.56 Favored 'General case' 0 CA--C 1.466 -2.252 0 CA-C-O 116.152 -1.88 . . . . 0.0 112.223 178.192 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -30.57 -17.88 0.0 OUTLIER 'General case' 0 C--N 1.371 1.526 1 C-N-CA 135.237 5.415 . . . . 0.0 120.336 -175.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 4.4 mt-10 -53.58 -58.41 7.28 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 126.379 1.872 . . . . 0.0 111.378 163.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.58 -54.09 2.73 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 126.002 1.721 . . . . 0.0 109.286 -172.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.739 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.307 . . -110.67 140.16 45.28 Favored 'General case' 0 CA--C 1.459 -2.557 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.652 -164.344 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.8 m -126.73 166.87 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.527 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 144.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 174' ' ' LEU 0.305 70.2 t -74.54 146.83 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.874 0 CA-C-N 111.121 -2.763 . . . . 0.0 107.349 176.137 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.46 -41.42 16.62 Favored 'General case' 0 CA--C 1.473 -2.016 0 CA-C-N 110.895 -2.866 . . . . 0.0 105.695 -170.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -160.18 140.15 11.41 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 -169.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.541 ' CE1' ' HG2' ' A' ' 142' ' ' MET . 1.8 t80 . . . . . 0 N--CA 1.425 -1.689 0 N-CA-C 100.373 -3.936 . . . . 0.0 100.373 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.264 18.3 mt-30 . . . . . 0 CA--C 1.506 -0.749 0 CA-C-O 119.78 -0.152 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 46.6 ttm -124.41 119.12 28.29 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 127' ' ' THR . 16.0 mm -81.9 136.57 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 O-C-N 120.624 -1.297 . . . . 0.0 108.299 171.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.448 ' HG2' HG13 ' A' ' 158' ' ' VAL . 6.5 tmm? -124.23 133.8 53.42 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 102.78 -3.045 . . . . 0.0 102.78 156.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.58 135.29 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 106.833 -1.544 . . . . 0.0 106.833 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -115.69 141.81 47.58 Favored 'General case' 0 C--N 1.362 1.142 1 N-CA-C 99.577 -4.231 . . . . 0.0 99.577 -179.74 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.353 . . -147.71 -179.97 1.06 Allowed Pre-proline 0 CA--C 1.494 -1.211 0 CA-C-N 120.024 1.283 . . . . 0.0 112.517 -168.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -68.91 137.69 38.63 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 121.109 1.206 . . . . 0.0 109.673 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp . . . . . 0 CA--C 1.488 -1.43 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.439 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 . . . . . 0 CA--C 1.483 -1.607 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.533 HG22 ' HD3' ' A' ' 123' ' ' LYS . 88.1 t -102.49 118.12 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 163.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -103.19 175.12 5.58 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 159.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -145.97 153.33 40.67 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 tp -134.38 164.0 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -119.5 153.13 35.8 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.349 161.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.516 ' HB3' HG11 ' A' ' 144' ' ' VAL . 40.1 m-85 -127.85 164.01 23.16 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 171.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.419 -2.019 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -170.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 CA--C 1.475 -1.916 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -84.92 -65.11 1.05 Allowed 'General case' 0 CA--C 1.481 -1.704 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.519 -164.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.461 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.324 0.0 OUTLIER -62.29 -9.37 7.81 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 178.051 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 64.7 t -60.67 -46.9 95.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 122.359 1.076 . . . . 0.0 109.864 158.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -90.83 -3.21 57.56 Favored 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.443 HD23 HD11 ' A' ' 115' ' ' ILE . 4.5 tt -77.44 -32.16 54.35 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 162.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.471 ' HA ' HG12 ' A' ' 115' ' ' ILE . 41.7 ttt180 -61.94 -42.41 99.07 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.041 169.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.5 m -59.56 -43.61 93.51 Favored 'General case' 0 C--N 1.38 1.902 0 C-N-CA 118.44 -1.304 . . . . 0.0 113.975 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.538 ' O ' HD12 ' A' ' 118' ' ' LEU 0.263 47.4 mt -64.03 -30.56 71.63 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 175.3 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.265 4.0 mm -61.98 -47.73 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.92 0 CA-C-N 119.936 1.243 . . . . 0.0 108.699 177.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -54.0 -43.16 69.82 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 125.765 1.915 . . . . 0.0 110.214 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -59.72 -51.65 68.87 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.78 0.832 . . . . 0.0 112.542 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 156' ' ' ALA . 1.8 mt -71.98 -19.57 61.86 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 126.466 1.906 . . . . 0.0 114.452 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -73.14 -35.4 66.5 Favored 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 125.978 1.711 . . . . 0.0 110.122 171.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -68.25 -23.79 64.83 Favored 'General case' 0 C--N 1.36 1.063 0 C-N-CA 122.575 0.35 . . . . 0.0 110.144 168.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.63 69.31 1.38 Allowed Glycine 0 CA--C 1.466 -2.99 0 N-CA-C 104.762 -3.335 . . . . 0.0 104.762 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -123.38 165.11 17.57 Favored 'General case' 0 CA--C 1.458 -2.573 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.533 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -101.66 107.36 18.58 Favored 'General case' 0 N--CA 1.404 -2.735 1 N-CA-C 98.762 -4.533 . . . . 0.0 98.762 178.123 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.71 122.38 41.87 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -174.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -95.77 122.1 38.2 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -173.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.9 mm -83.57 131.65 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.451 ' HA ' HD13 ' A' ' 171' ' ' ILE . 23.4 m -116.7 116.54 27.72 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 167.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.876 HD21 ' HA2' ' A' ' 141' ' ' GLY . 17.5 tp -77.95 151.69 33.56 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 169.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -150.23 96.75 2.46 Favored 'General case' 0 N--CA 1.407 -2.611 1 N-CA-C 100.054 -4.054 . . . . 0.0 100.054 -175.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.527 ' CE2' HD23 ' A' ' 128' ' ' LEU 0.267 68.4 m-85 . . . . . 0 N--CA 1.428 -1.559 0 CA-C-N 111.739 -2.482 . . . . 0.0 109.72 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.252 53.1 mt . . . . . 0 N--CA 1.424 -1.743 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.876 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -72.49 -60.05 4.22 Favored Glycine 0 N--CA 1.408 -3.181 0 N-CA-C 115.241 0.856 . . . . 0.0 115.241 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 7.6 ptt? -87.4 0.89 54.82 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 118.569 -0.729 . . . . 0.0 112.932 -160.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.255 0.6 OUTLIER -59.4 -60.81 3.26 Favored 'General case' 0 CA--C 1.461 -2.466 0 C-N-CA 114.94 -2.704 . . . . 0.0 114.987 146.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' A' ' 98' ' ' PHE . 34.0 t -64.7 -64.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.927 0 O-C-N 125.956 2.035 . . . . 0.0 109.433 -164.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.435 HD11 HD22 ' A' ' 128' ' ' LEU . 49.4 mt -44.88 -54.31 6.59 Favored 'General case' 0 CA--C 1.488 -1.405 0 C-N-CA 128.242 2.617 . . . . 0.0 113.891 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.8 t30 -63.6 -30.93 71.97 Favored 'General case' 0 CA--C 1.465 -2.304 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 174.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -80.82 -14.86 57.67 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.354 173.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.449 HG21 ' CE2' ' A' ' 98' ' ' PHE . 2.0 t -76.59 -45.29 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.802 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 174.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.493 ' HB2' HG21 ' A' ' 158' ' ' VAL . 33.6 ttmt -54.42 -51.33 65.26 Favored 'General case' 0 CA--C 1.462 -2.417 0 CA-C-O 117.368 -1.301 . . . . 0.0 111.238 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.13 -40.09 75.05 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 125.477 1.511 . . . . 0.0 108.857 -169.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.421 ' HB3' HD11 ' A' ' 111' ' ' LEU . 24.3 t70 -74.94 -23.2 58.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 116.366 -2.134 . . . . 0.0 115.206 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.413 HD22 HD21 ' A' ' 111' ' ' LEU 0.271 0.1 OUTLIER -81.85 -36.32 28.41 Favored 'General case' 0 CA--C 1.476 -1.872 0 CA-C-O 116.939 -1.505 . . . . 0.0 111.86 179.035 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -27.91 -32.3 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.664 1 C-N-CA 135.614 5.566 . . . . 0.0 119.142 -168.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 6.3 mt-10 -51.2 -47.2 62.31 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 128.914 2.886 . . . . 0.0 114.126 172.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.424 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 3.1 tm? -116.84 -51.61 2.56 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 128.384 2.673 . . . . 0.0 107.258 -161.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.315 . . -114.41 143.6 44.66 Favored 'General case' 0 CA--C 1.462 -2.421 0 CA-C-O 117.788 -1.101 . . . . 0.0 109.815 -175.27 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.5 m -129.54 164.47 32.04 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.125 0 N-CA-C 120.717 3.599 . . . . 0.0 120.717 148.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.4 t -80.49 147.73 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.957 0 CA-C-N 110.877 -2.874 . . . . 0.0 108.207 -176.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -82.37 -39.4 22.8 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.426 -1.715 . . . . 0.0 106.419 -172.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -151.6 142.36 22.84 Favored 'General case' 0 CA--C 1.464 -2.346 0 N-CA-C 104.805 -2.295 . . . . 0.0 104.805 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.6 t80 . . . . . 0 N--CA 1.42 -1.969 0 N-CA-C 100.757 -3.794 . . . . 0.0 100.757 163.807 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.269 41.5 mt-30 . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.469 ' H ' ' HB3' ' A' ' 128' ' ' LEU . 23.8 ttm -122.96 122.78 39.39 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -176.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 127' ' ' THR . 19.3 mm -82.81 124.79 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 171.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.1 ttp -108.42 130.39 55.23 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 103.166 -2.901 . . . . 0.0 103.166 160.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 32.8 t -96.43 137.49 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 118.873 -1.131 . . . . 0.0 108.42 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.795 HD11 ' HB1' ' A' ' 156' ' ' ALA . 1.1 tp -128.88 144.32 51.14 Favored 'General case' 0 C--N 1.362 1.149 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 -174.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.361 . . -148.5 175.02 2.96 Favored Pre-proline 0 CA--C 1.493 -1.241 0 CA-C-O 117.501 -1.238 . . . . 0.0 110.216 -169.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -73.53 144.92 36.8 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 CA-C-N 121.621 1.614 . . . . 0.0 108.022 -177.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt . . . . . 0 CA--C 1.487 -1.473 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 176.265 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 . . . . . 0 CA--C 1.486 -1.511 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.3 t -92.3 115.21 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.558 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -108.46 178.97 4.33 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.569 154.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -142.53 157.07 45.12 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 -171.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 tp -140.31 166.75 19.34 Favored 'Isoleucine or valine' 0 C--N 1.356 0.848 0 N-CA-C 102.544 -3.132 . . . . 0.0 102.544 164.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -116.17 158.69 22.87 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-N 118.943 0.792 . . . . 0.0 111.021 166.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.587 ' HB3' HG11 ' A' ' 144' ' ' VAL . 2.4 m-85 -149.46 99.84 2.94 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 . . . . . 0 N--CA 1.436 -1.175 0 C-N-CA 125.573 1.549 . . . . 0.0 109.541 -177.053 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 N--CA 1.425 -1.681 0 CA-C-O 122.569 1.176 . . . . 0.0 108.019 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -88.81 -69.93 0.68 Allowed 'General case' 0 CA--C 1.473 -1.992 0 CA-C-N 112.611 -2.086 . . . . 0.0 111.316 -158.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.485 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.35 0.0 OUTLIER -56.02 -18.56 9.79 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 118.783 2.883 . . . . 0.0 118.783 172.504 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.59 -49.65 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 CA-C-O 122.391 1.091 . . . . 0.0 110.091 163.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -91.54 9.08 33.54 Favored 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 7.1 tt -85.03 -32.67 22.78 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 163.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.468 ' HA ' HG12 ' A' ' 115' ' ' ILE . 55.2 ttt180 -62.27 -42.89 99.73 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 118.807 -0.616 . . . . 0.0 110.928 167.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 t -54.46 -45.88 73.21 Favored 'General case' 0 C--N 1.379 1.862 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 171.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 118' ' ' LEU . 46.4 mt -63.35 -34.36 77.55 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 117.608 2.447 . . . . 0.0 117.608 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.468 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.9 mm -55.99 -48.57 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 O-C-N 124.3 1.0 . . . . 0.0 108.899 173.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -51.6 -45.62 63.26 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 126.033 1.733 . . . . 0.0 113.402 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -57.49 -50.58 72.58 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' A' ' 156' ' ' ALA . 1.8 mt -72.61 -21.18 61.16 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 125.304 1.442 . . . . 0.0 113.902 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -75.13 -33.22 61.53 Favored 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 125.671 1.588 . . . . 0.0 110.391 173.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -68.91 -26.31 65.03 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 167.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.46 78.24 1.22 Allowed Glycine 0 CA--C 1.47 -2.778 0 N-CA-C 106.338 -2.705 . . . . 0.0 106.338 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -134.31 168.3 19.14 Favored 'General case' 0 CA--C 1.465 -2.318 1 N-CA-C 99.902 -4.111 . . . . 0.0 99.902 168.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.317 0.0 OUTLIER -88.29 121.14 30.35 Favored 'General case' 0 CA--C 1.457 -2.631 1 N-CA-C 99.719 -4.178 . . . . 0.0 99.719 156.903 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.53 123.38 33.58 Favored 'General case' 0 N--CA 1.41 -2.443 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 166.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.459 ' HG2' HG13 ' A' ' 173' ' ' VAL . 36.2 mtmt -102.18 125.27 48.83 Favored 'General case' 0 CA--C 1.469 -2.149 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -175.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.421 HD12 HD11 ' A' ' 114' ' ' LEU . 6.3 mm -86.16 125.29 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.43 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.2 m -103.31 121.62 43.11 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.704 HD23 HD11 ' A' ' 145' ' ' LEU 0.313 0.2 OUTLIER -81.0 150.53 28.86 Favored 'General case' 0 CA--C 1.456 -2.655 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 166.597 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -147.25 89.23 1.77 Allowed 'General case' 0 N--CA 1.402 -2.838 1 N-CA-C 98.645 -4.576 . . . . 0.0 98.645 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 . . . . . 0 CA--C 1.487 -1.457 0 CA-C-N 111.259 -2.7 . . . . 0.0 109.877 -166.655 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.426 -1.632 0 N-CA-C 111.424 0.157 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.81 -65.19 2.18 Favored Glycine 0 N--CA 1.419 -2.458 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 75.0 mtm -93.04 11.75 26.48 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -159.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -72.75 -53.38 11.77 Favored 'General case' 0 CA--C 1.444 -3.1 0 C-N-CA 117.155 -1.818 . . . . 0.0 113.153 143.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.587 HG11 ' HB3' ' A' ' 98' ' ' PHE . 31.2 t -67.71 -66.94 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.446 -3.019 0 O-C-N 126.539 2.399 . . . . 0.0 107.681 -160.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.704 HD11 HD23 ' A' ' 128' ' ' LEU . 97.3 mt -46.97 -49.7 20.28 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 128.563 2.745 . . . . 0.0 115.387 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -59.34 -38.96 81.69 Favored 'General case' 0 CA--C 1.477 -1.833 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 172.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -80.65 -14.75 57.89 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.614 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.447 HG23 ' HA ' ' A' ' 145' ' ' LEU . 1.8 t -76.53 -47.91 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.69 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.288 12.7 ttmt -55.0 -43.46 73.61 Favored 'General case' 0 CA--C 1.466 -2.286 0 C-N-CA 126.015 1.726 . . . . 0.0 113.128 172.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -40.11 65.3 Favored 'General case' 0 N--CA 1.41 -2.452 0 C-N-CA 124.162 0.985 . . . . 0.0 109.446 -174.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -73.93 -26.3 60.43 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 116.579 -2.049 . . . . 0.0 115.569 170.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.271 0.2 OUTLIER -80.9 -32.42 34.79 Favored 'General case' 0 CA--C 1.47 -2.101 0 CA-C-O 116.749 -1.596 . . . . 0.0 112.223 -178.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -28.8 -23.52 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.69 1 C-N-CA 135.528 5.531 . . . . 0.0 119.987 -174.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -53.33 -56.75 14.16 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 126.557 1.943 . . . . 0.0 111.989 167.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.3 tt -107.94 -52.25 2.79 Favored 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 126.557 1.943 . . . . 0.0 108.529 -167.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.62 ' CB ' HD11 ' A' ' 174' ' ' LEU 0.294 . . -110.5 138.37 46.98 Favored 'General case' 0 CA--C 1.467 -2.241 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.505 -173.295 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 177' ' ' LYS . 29.7 m -128.84 165.12 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.496 0 N-CA-C 119.445 3.128 . . . . 0.0 119.445 147.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 160' ' ' SER . 3.9 t -76.96 153.02 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.135 0 CA-C-N 111.562 -2.563 . . . . 0.0 108.401 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.06 -39.91 25.0 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.753 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.548 ' H ' HG12 ' A' ' 158' ' ' VAL . 0.9 OUTLIER -150.38 137.2 19.17 Favored 'General case' 0 CA--C 1.469 -2.171 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 -173.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.7 t80 . . . . . 0 CA--C 1.486 -1.517 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 177.171 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 N--CA 1.446 -0.668 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 28.8 ttp -115.8 118.86 34.2 Favored 'General case' 0 C--N 1.369 1.444 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -165.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.4 mm -84.03 124.46 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 O-C-N 120.633 -1.292 . . . . 0.0 108.964 170.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.598 ' HB2' HD13 ' A' ' 145' ' ' LEU . 1.9 tmm? -99.44 133.0 44.39 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 102.141 -3.281 . . . . 0.0 102.141 156.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.459 HG13 ' HG2' ' A' ' 125' ' ' LYS . 24.7 t -99.94 116.22 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 118.239 -1.384 . . . . 0.0 110.013 -177.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.62 HD11 ' CB ' ' A' ' 156' ' ' ALA . 1.1 tp -106.57 107.62 18.73 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 -167.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.265 . . -99.57 179.54 1.02 Allowed Pre-proline 0 CA--C 1.486 -1.481 0 C-N-CA 124.746 1.218 . . . . 0.0 113.169 -176.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -70.55 153.76 65.1 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 N-CA-C 106.483 -2.161 . . . . 0.0 106.483 170.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.579 ' HA ' HG22 ' A' ' 157' ' ' VAL . 33.2 ttmt . . . . . 0 N--CA 1.431 -1.383 0 CA-C-O 123.026 1.393 . . . . 0.0 110.125 -175.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 . . . . . 0 CA--C 1.484 -1.566 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.4 t -105.17 125.12 60.29 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.485 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 167.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -106.8 174.9 5.69 Favored 'General case' 0 CA--C 1.464 -2.339 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 155.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -149.28 147.05 27.9 Favored 'General case' 0 N--CA 1.422 -1.851 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.084 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tp -129.21 162.42 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -122.22 152.78 39.64 Favored 'General case' 0 CA--C 1.488 -1.44 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.979 162.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.526 ' HB3' HG11 ' A' ' 144' ' ' VAL . 45.2 m-85 -130.82 146.73 52.34 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 172.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.435 -1.181 0 C-N-CA 123.644 0.777 . . . . 0.0 109.08 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 N--CA 1.424 -1.736 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -73.79 -75.59 0.15 Allowed 'General case' 0 CA--C 1.48 -1.714 0 CA-C-N 113.189 -1.823 . . . . 0.0 108.678 -169.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.431 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.341 0.0 OUTLIER -58.66 -12.31 4.04 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 120.389 3.477 . . . . 0.0 120.389 178.427 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 66.3 t -61.75 -45.42 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 CA-C-O 122.59 1.186 . . . . 0.0 110.041 161.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -91.77 -0.83 57.56 Favored 'General case' 0 CA--C 1.472 -2.037 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.491 HD12 HG13 ' A' ' 148' ' ' VAL . 5.8 tt -78.17 -32.0 49.94 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 161.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.457 ' HA ' HG12 ' A' ' 115' ' ' ILE . 48.4 ttt180 -63.52 -43.13 98.06 Favored 'General case' 0 C--N 1.361 1.077 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.242 170.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.8 m -63.92 -37.28 86.82 Favored 'General case' 0 C--N 1.377 1.788 0 C-N-CA 118.648 -1.221 . . . . 0.0 113.405 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.493 HD11 HD23 ' A' ' 174' ' ' LEU 0.296 60.5 tp -70.38 -28.96 65.5 Favored 'General case' 0 N--CA 1.401 -2.91 0 C-N-CA 125.196 1.398 . . . . 0.0 113.782 176.611 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 112' ' ' ARG . 9.7 mm -58.57 -50.59 78.44 Favored 'Isoleucine or valine' 0 C--N 1.371 1.507 0 CA-C-N 120.982 1.719 . . . . 0.0 110.033 170.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -52.28 -44.11 64.79 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 127.697 2.399 . . . . 0.0 110.668 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -59.44 -50.03 75.51 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 125.868 1.667 . . . . 0.0 113.04 176.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.444 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -60.46 -34.6 74.25 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 175.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -72.1 -32.12 66.7 Favored 'General case' 0 CA--C 1.487 -1.468 0 C-N-CA 127.745 2.418 . . . . 0.0 110.913 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -64.81 -20.83 66.6 Favored 'General case' 0 C--N 1.36 1.023 0 C-N-CA 123.117 0.567 . . . . 0.0 111.444 171.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 89.17 59.51 1.56 Allowed Glycine 0 CA--C 1.466 -2.987 0 N-CA-C 104.65 -3.38 . . . . 0.0 104.65 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -123.21 167.73 13.35 Favored 'General case' 0 CA--C 1.455 -2.701 0 N-CA-C 102.121 -3.289 . . . . 0.0 102.121 171.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -94.22 132.32 38.9 Favored 'General case' 0 CA--C 1.449 -2.942 0 N-CA-C 100.602 -3.851 . . . . 0.0 100.602 162.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.422 ' HB1' HD12 ' A' ' 114' ' ' LEU . . . -108.22 115.71 30.63 Favored 'General case' 0 N--CA 1.4 -2.942 0 C-N-CA 117.378 -1.729 . . . . 0.0 106.593 -173.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -97.26 122.39 40.23 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.543 0.687 . . . . 0.0 109.275 -163.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.6 mm -84.16 133.78 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.961 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.9 m -112.97 117.12 31.19 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 165.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.849 HD21 ' HA2' ' A' ' 141' ' ' GLY . 10.4 tp -79.61 153.17 29.61 Favored 'General case' 0 CA--C 1.474 -1.97 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 167.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -152.88 94.12 1.83 Allowed 'General case' 0 N--CA 1.4 -2.938 0 N-CA-C 101.335 -3.579 . . . . 0.0 101.335 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.545 ' CZ ' HD23 ' A' ' 128' ' ' LEU 0.311 94.2 m-85 . . . . . 0 N--CA 1.429 -1.521 0 C-N-CA 126.909 2.084 . . . . 0.0 109.837 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 51.9 mt . . . . . 0 N--CA 1.423 -1.798 0 CA-C-O 120.43 0.157 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.849 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -70.58 -60.42 4.68 Favored Glycine 0 CA--C 1.458 -3.53 0 O-C-N 123.951 0.782 . . . . 0.0 113.958 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.424 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 5.1 ptt? -85.78 -1.52 57.31 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -159.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.271 2.0 tp10 -61.44 -60.67 3.36 Favored 'General case' 0 CA--C 1.454 -2.747 0 C-N-CA 114.412 -2.915 . . . . 0.0 115.394 146.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 98' ' ' PHE . 23.1 t -66.26 -65.87 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.91 0 O-C-N 125.978 2.049 . . . . 0.0 108.7 -162.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.521 HD11 HD22 ' A' ' 128' ' ' LEU . 32.0 mt -44.85 -54.17 6.7 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 129.131 2.972 . . . . 0.0 114.316 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 142' ' ' MET . 2.0 t-20 -66.16 -28.34 68.71 Favored 'General case' 0 CA--C 1.468 -2.179 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 174.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -80.35 -15.34 57.09 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.222 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.491 HG13 HD12 ' A' ' 111' ' ' LEU . 1.9 t -76.08 -44.47 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.78 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.448 ' HE3' HG21 ' A' ' 158' ' ' VAL 0.262 34.9 ttmt -52.98 -48.76 67.19 Favored 'General case' 0 CA--C 1.47 -2.105 0 C-N-CA 125.435 1.494 . . . . 0.0 112.435 171.326 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.1 -38.39 66.38 Favored 'General case' 0 N--CA 1.409 -2.508 0 C-N-CA 125.853 1.661 . . . . 0.0 109.605 -171.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.53 -25.72 54.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 116.462 -2.095 . . . . 0.0 115.201 170.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 156' ' ' ALA 0.298 0.1 OUTLIER -77.31 -30.84 54.29 Favored 'General case' 0 CA--C 1.473 -1.992 0 CA-C-O 116.525 -1.703 . . . . 0.0 113.451 176.069 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -29.44 -20.13 0.0 OUTLIER 'General case' 0 C--N 1.366 1.302 1 C-N-CA 134.91 5.284 . . . . 0.0 120.224 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.2 mt-10 -56.29 -62.15 1.91 Allowed 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 127.187 2.195 . . . . 0.0 111.178 167.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.13 -56.01 2.78 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 125.542 1.537 . . . . 0.0 109.048 -174.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.466 ' CB ' HD11 ' A' ' 174' ' ' LEU 0.269 . . -98.48 146.66 25.53 Favored 'General case' 0 CA--C 1.449 -2.934 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.877 -165.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.2 m -121.59 172.2 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.454 -2.723 0 C-N-CA 114.626 -2.83 . . . . 0.0 116.384 134.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 3.8 t -82.31 153.4 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.831 0 CA-C-N 111.784 -2.462 . . . . 0.0 107.157 -177.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -81.59 -41.22 21.86 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 -173.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.4 t -157.29 143.15 17.61 Favored 'General case' 0 CA--C 1.46 -2.499 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.0 t80 . . . . . 0 N--CA 1.423 -1.806 0 N-CA-C 100.996 -3.705 . . . . 0.0 100.996 167.158 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 . . . . . 0 CA--C 1.503 -0.844 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.471 ' H ' ' HB3' ' A' ' 128' ' ' LEU . 48.5 ttm -122.11 122.86 40.21 Favored 'General case' 0 CA--C 1.481 -1.678 0 C-N-CA 123.547 0.739 . . . . 0.0 109.405 -176.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.2 mm -81.99 122.7 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 166.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 3.9 ttp -106.55 129.53 54.48 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 101.582 -3.488 . . . . 0.0 101.582 161.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.5 t -94.48 137.33 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -117.81 150.22 39.51 Favored 'General case' 0 C--N 1.357 0.898 1 N-CA-C 99.516 -4.253 . . . . 0.0 99.516 -179.987 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.26 . . -140.75 -178.92 0.89 Allowed Pre-proline 0 N--CA 1.432 -1.341 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.681 -170.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.416 ' HA ' HD21 ' A' ' 118' ' ' LEU . 75.8 Cg_exo -69.85 147.45 62.31 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 C-N-CA 122.395 2.063 . . . . 0.0 109.055 165.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt . . . . . 0 CA--C 1.491 -1.297 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 171.147 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 . . . . . 0 CA--C 1.48 -1.749 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.498 HG22 ' HE2' ' A' ' 123' ' ' LYS . 46.4 t -105.99 121.82 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.874 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 162.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -101.51 175.94 5.4 Favored 'General case' 0 CA--C 1.468 -2.2 0 C-N-CA 116.427 -2.109 . . . . 0.0 105.715 166.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -143.08 152.67 42.11 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 tp -135.03 163.03 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 103.028 -2.953 . . . . 0.0 103.028 167.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -115.13 153.33 30.98 Favored 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.567 162.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.515 ' HB3' HG11 ' A' ' 144' ' ' VAL . 32.6 m-85 -125.42 131.33 52.94 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 169.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 . . . . . 0 N--CA 1.433 -1.304 0 C-N-CA 124.258 1.023 . . . . 0.0 109.254 -175.421 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . 0.363 53.9 m-20 . . . . . 0 N--CA 1.4 -2.957 0 CA-C-O 121.644 0.735 . . . . 0.0 109.766 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.58 -72.1 0.33 Allowed 'General case' 0 CA--C 1.484 -1.595 0 CA-C-N 112.747 -2.024 . . . . 0.0 109.799 -161.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.444 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.293 0.0 OUTLIER -63.52 -7.68 7.58 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 119.843 3.275 . . . . 0.0 119.843 178.122 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.67 -42.95 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 C-N-CA 124.015 0.926 . . . . 0.0 110.025 160.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.0 mmtt -92.74 -5.06 52.04 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.2 tt -75.69 -35.02 60.44 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 163.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.459 ' HA ' HG12 ' A' ' 115' ' ' ILE . 7.4 ttm180 -59.31 -43.65 92.61 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 125.541 1.536 . . . . 0.0 111.318 169.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.8 t -56.79 -46.59 81.46 Favored 'General case' 0 C--N 1.377 1.791 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.267 71.0 mt -67.56 -28.12 67.51 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 176.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.7 mm -59.78 -49.5 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.709 0 CA-C-N 119.696 1.134 . . . . 0.0 108.83 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -51.57 -44.58 62.79 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 127.26 2.224 . . . . 0.0 110.1 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -63.65 -52.77 59.27 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.686 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -67.91 -29.48 68.58 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 125.605 1.562 . . . . 0.0 114.699 -178.584 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.62 -29.53 51.84 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 124.03 0.932 . . . . 0.0 110.842 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -82.84 -1.2 51.29 Favored 'General case' 0 C--N 1.362 1.139 0 CA-C-O 120.602 0.239 . . . . 0.0 110.829 170.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.05 70.16 1.32 Allowed Glycine 0 CA--C 1.473 -2.59 0 C-N-CA 126.242 1.877 . . . . 0.0 109.552 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -128.04 163.64 24.13 Favored 'General case' 0 CA--C 1.449 -2.92 0 N-CA-C 100.786 -3.783 . . . . 0.0 100.786 169.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.498 ' HE2' HG22 ' A' ' 93' ' ' VAL . 1.6 tmmm? -98.33 106.03 18.26 Favored 'General case' 0 N--CA 1.399 -3.019 1 N-CA-C 97.706 -4.924 . . . . 0.0 97.706 172.864 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.08 155.25 21.59 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -133.47 129.95 37.91 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 119.844 -1.785 . . . . 0.0 106.552 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.8 mm -82.74 137.98 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.576 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.1 m -117.14 127.51 54.2 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 167.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.663 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.1 OUTLIER -85.83 153.56 22.17 Favored 'General case' 0 CA--C 1.462 -2.441 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 166.426 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.439 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 56.9 ttt180 -151.36 91.41 1.67 Allowed 'General case' 0 N--CA 1.394 -3.231 1 N-CA-C 98.715 -4.55 . . . . 0.0 98.715 -175.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.552 ' CE1' HD22 ' A' ' 128' ' ' LEU 0.253 97.6 m-85 . . . . . 0 N--CA 1.428 -1.554 0 CA-C-N 111.438 -2.619 . . . . 0.0 105.903 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.29 68.1 mt . . . . . 0 N--CA 1.406 -2.639 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.663 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -78.34 -66.6 1.72 Allowed Glycine 0 N--CA 1.408 -3.193 0 CA-C-N 114.372 -1.285 . . . . 0.0 113.574 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 43.0 mtt -95.03 24.21 5.04 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -164.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -71.14 -55.7 7.63 Favored 'General case' 0 CA--C 1.456 -2.652 0 C-N-CA 116.521 -2.072 . . . . 0.0 114.644 133.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 98' ' ' PHE . 19.4 t -64.16 -66.25 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.443 -3.172 0 O-C-N 126.174 2.171 . . . . 0.0 107.834 -163.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 172' ' ' MET . 71.1 mt -44.61 -55.03 5.53 Favored 'General case' 0 CA--C 1.478 -1.824 0 O-C-N 126.543 2.402 . . . . 0.0 114.108 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.36 -36.79 74.01 Favored 'General case' 0 CA--C 1.473 -2.017 0 C-N-CA 127.229 2.212 . . . . 0.0 114.062 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.407 ' HA ' ' HB2' ' A' ' 150' ' ' ASP . 18.5 ttp180 -81.71 -14.98 55.84 Favored 'General case' 0 N--CA 1.418 -2.027 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.882 175.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.472 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.4 t -75.24 -43.64 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.74 0 CA-C-O 116.374 -1.774 . . . . 0.0 107.355 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.517 ' HB2' HG21 ' A' ' 158' ' ' VAL . 14.6 ttmt -53.49 -52.88 58.14 Favored 'General case' 0 CA--C 1.463 -2.394 0 CA-C-O 116.861 -1.542 . . . . 0.0 109.884 169.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.407 ' HB2' ' HA ' ' A' ' 147' ' ' ARG . 66.8 m-20 -67.52 -39.43 85.08 Favored 'General case' 0 N--CA 1.41 -2.47 0 C-N-CA 124.22 1.008 . . . . 0.0 109.359 -166.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -75.05 -26.84 59.71 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 116.447 -2.101 . . . . 0.0 116.075 171.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.281 0.1 OUTLIER -81.1 -33.28 33.42 Favored 'General case' 0 CA--C 1.479 -1.757 0 CA-C-O 117.107 -1.425 . . . . 0.0 113.605 -178.934 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -28.5 -29.94 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.478 1 C-N-CA 135.555 5.542 . . . . 0.0 118.85 -173.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.9 -53.32 54.22 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 127.509 2.324 . . . . 0.0 113.204 173.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.17 -53.53 2.67 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.624 -165.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.686 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.308 . . -96.81 153.08 18.09 Favored 'General case' 0 CA--C 1.447 -2.998 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 -177.703 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.417 ' HB ' ' H ' ' A' ' 158' ' ' VAL . 20.3 m -116.39 -164.14 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.905 0 C-N-CA 113.69 -3.204 . . . . 0.0 112.343 138.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 160' ' ' SER 0.28 3.3 t -108.35 162.93 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.559 0 C-N-CA 128.326 2.65 . . . . 0.0 106.009 177.239 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.44 -42.49 18.47 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.548 ' H ' HG12 ' A' ' 158' ' ' VAL . 1.2 t -162.02 154.2 19.34 Favored 'General case' 0 CA--C 1.479 -1.777 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.581 -166.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.42 -1.939 0 N-CA-C 103.366 -2.827 . . . . 0.0 103.366 168.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.439 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.285 30.3 mt-30 . . . . . 0 CA--C 1.507 -0.702 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.406 ' O ' ' HB2' ' A' ' 128' ' ' LEU . 58.7 ttp -142.86 117.22 9.62 Favored 'General case' 0 C--N 1.364 1.196 0 CA-C-O 121.756 0.789 . . . . 0.0 111.703 -174.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.9 mm -80.16 138.44 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 O-C-N 120.105 -1.622 . . . . 0.0 109.816 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.455 ' SD ' HG13 ' A' ' 158' ' ' VAL . 3.3 tmm? -113.85 135.24 54.18 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 154.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.85 127.86 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.612 HD13 ' CD1' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -112.13 73.76 0.83 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 117.241 2.312 . . . . 0.0 117.241 -166.801 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.432 . . -105.46 156.6 36.1 Favored Pre-proline 0 C--N 1.355 0.815 0 N-CA-C 120.024 3.342 . . . . 0.0 120.024 -167.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -67.45 142.12 58.38 Favored 'Trans proline' 0 CA--C 1.492 -1.62 0 C-N-CA 123.258 2.639 . . . . 0.0 111.276 -161.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt . . . . . 0 CA--C 1.49 -1.357 0 O-C-N 125.029 1.456 . . . . 0.0 107.907 -174.974 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 . . . . . 0 CA--C 1.482 -1.664 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.577 HG22 ' HD3' ' A' ' 123' ' ' LYS . 95.0 t -99.69 120.88 49.67 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 161.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -103.68 172.31 6.87 Favored 'General case' 0 CA--C 1.472 -2.04 0 C-N-CA 116.924 -1.911 . . . . 0.0 106.896 155.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -145.09 148.24 33.43 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tp -128.28 162.24 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 174.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -119.74 153.68 35.3 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.702 163.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.556 ' HB3' HG11 ' A' ' 144' ' ' VAL . 41.7 m-85 -127.12 141.73 51.69 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 168.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 . . . . . 0 N--CA 1.423 -1.788 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 173.177 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.2 t70 . . . . . 0 N--CA 1.425 -1.684 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -70.74 -72.53 0.2 Allowed 'General case' 0 CA--C 1.477 -1.847 0 C-N-CA 126.574 1.949 . . . . 0.0 109.313 -172.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.418 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.35 0.0 OUTLIER -58.47 -15.19 9.97 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 119.816 3.265 . . . . 0.0 119.816 175.881 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.87 -38.69 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 C-N-CA 123.966 0.906 . . . . 0.0 111.229 164.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -92.82 -1.37 56.83 Favored 'General case' 0 CA--C 1.476 -1.875 0 O-C-N 120.159 -1.588 . . . . 0.0 114.708 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 151' ' ' ASP . 5.7 tt -79.53 -31.62 42.11 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 163.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.457 ' HA ' HG12 ' A' ' 115' ' ' ILE . 3.3 tpp180 -60.36 -46.09 91.16 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 125.123 1.369 . . . . 0.0 110.772 168.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.8 t -59.81 -44.55 93.93 Favored 'General case' 0 C--N 1.375 1.697 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.651 HD11 HD12 ' A' ' 174' ' ' LEU 0.303 61.4 tp -67.9 -29.79 68.98 Favored 'General case' 0 N--CA 1.407 -2.595 0 C-N-CA 127.321 2.248 . . . . 0.0 113.562 178.421 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.273 9.4 mm -57.78 -51.41 70.61 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.872 0 CA-C-N 120.941 1.7 . . . . 0.0 108.686 170.808 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.6 tpt85 -54.75 -39.95 68.82 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 126.703 2.001 . . . . 0.0 111.042 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -63.04 -50.64 69.86 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 124.229 1.012 . . . . 0.0 112.263 176.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.545 ' CD1' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -59.1 -37.27 76.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 176.709 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -75.26 -35.73 61.33 Favored 'General case' 0 CA--C 1.487 -1.462 0 C-N-CA 128.931 2.892 . . . . 0.0 109.907 -169.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.55 6.08 11.36 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 123.605 0.762 . . . . 0.0 111.472 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.18 64.11 2.16 Favored Glycine 0 CA--C 1.467 -2.932 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 174.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -128.52 165.17 21.24 Favored 'General case' 0 CA--C 1.448 -2.945 0 N-CA-C 102.306 -3.22 . . . . 0.0 102.306 169.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.577 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -99.93 115.62 30.08 Favored 'General case' 0 N--CA 1.395 -3.211 1 N-CA-C 97.952 -4.832 . . . . 0.0 97.952 173.162 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -87.69 160.5 18.08 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.477 ' HD3' HD12 ' A' ' 171' ' ' ILE . 35.7 ttmt -136.56 131.3 33.65 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 168.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.457 HD11 ' HG ' ' A' ' 174' ' ' LEU . 10.0 mm -83.19 135.24 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 171.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.472 ' HA ' HD13 ' A' ' 171' ' ' ILE . 17.3 m -113.57 115.65 28.29 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 163.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.801 HD21 ' HA2' ' A' ' 141' ' ' GLY . 17.1 tp -84.93 150.06 25.21 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 168.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -153.8 103.05 2.57 Favored 'General case' 0 N--CA 1.406 -2.674 1 N-CA-C 99.834 -4.136 . . . . 0.0 99.834 -170.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.599 ' CZ ' HD23 ' A' ' 128' ' ' LEU 0.347 81.9 m-85 . . . . . 0 CA--C 1.488 -1.434 0 C-N-CA 126.535 1.934 . . . . 0.0 109.297 -171.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 70.8 mt . . . . . 0 N--CA 1.428 -1.53 0 N-CA-C 110.877 -0.046 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.801 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -70.62 -60.72 4.49 Favored Glycine 0 CA--C 1.456 -3.607 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.961 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 4.3 ptt? -85.57 -1.15 56.81 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -157.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.257 0.5 OUTLIER -61.76 -63.54 1.23 Allowed 'General case' 0 CA--C 1.46 -2.484 0 C-N-CA 115.035 -2.666 . . . . 0.0 115.694 147.393 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.556 HG11 ' HB3' ' A' ' 98' ' ' PHE . 35.8 t -62.77 -67.5 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.448 -2.944 0 O-C-N 126.021 2.076 . . . . 0.0 109.007 -166.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.464 HD11 HD22 ' A' ' 128' ' ' LEU . 34.4 mt -43.49 -55.32 4.28 Favored 'General case' 0 CA--C 1.482 -1.666 0 C-N-CA 128.858 2.863 . . . . 0.0 114.564 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 142' ' ' MET . 2.3 t30 -63.23 -30.41 71.56 Favored 'General case' 0 CA--C 1.467 -2.229 0 N-CA-C 117.689 2.478 . . . . 0.0 117.689 174.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -81.15 -14.57 57.52 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.612 172.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.7 t -76.79 -44.14 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.787 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 175.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.514 ' HE3' HG21 ' A' ' 158' ' ' VAL 0.256 33.9 ttmt -52.84 -49.95 64.72 Favored 'General case' 0 CA--C 1.467 -2.219 0 C-N-CA 125.631 1.573 . . . . 0.0 112.033 171.02 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -37.69 64.41 Favored 'General case' 0 N--CA 1.409 -2.521 0 C-N-CA 125.506 1.522 . . . . 0.0 109.456 -169.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.405 ' HB3' HD11 ' A' ' 111' ' ' LEU . 17.8 t70 -75.33 -25.63 57.98 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 116.372 -2.131 . . . . 0.0 114.993 169.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 156' ' ' ALA 0.308 0.1 OUTLIER -78.41 -32.42 48.71 Favored 'General case' 0 CA--C 1.472 -2.05 0 CA-C-O 116.792 -1.575 . . . . 0.0 112.614 178.392 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -29.58 -22.26 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.403 1 C-N-CA 135.237 5.415 . . . . 0.0 119.884 -174.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -56.4 -61.71 2.22 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.94 2.096 . . . . 0.0 110.974 168.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.69 -55.64 2.94 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 113.877 -1.511 . . . . 0.0 107.973 -171.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.478 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.255 . . -98.25 150.87 21.07 Favored 'General case' 0 CA--C 1.443 -3.136 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.565 -166.901 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.53 173.25 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.662 0 C-N-CA 114.11 -3.036 . . . . 0.0 116.113 130.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.514 HG21 ' HE3' ' A' ' 149' ' ' LYS 0.3 3.1 t -81.2 151.6 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.104 0 CA-C-N 110.133 -3.212 . . . . 0.0 104.911 173.764 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -81.71 -38.47 25.74 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -174.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.39 136.73 14.92 Favored 'General case' 0 N--CA 1.408 -2.54 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -177.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 N--CA 1.417 -2.1 1 N-CA-C 97.632 -4.951 . . . . 0.0 97.632 156.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 11.3 ttm -107.63 119.08 38.43 Favored 'General case' 0 CA--C 1.472 -2.036 0 CA-C-O 121.201 0.524 . . . . 0.0 111.838 -166.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.477 HD12 ' HD3' ' A' ' 125' ' ' LYS . 22.6 mm -83.27 122.1 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 167.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.4 ttp -105.81 127.47 53.12 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 102.448 -3.167 . . . . 0.0 102.448 162.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.2 t -91.62 140.29 16.33 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 C-N-CA 118.336 -1.345 . . . . 0.0 109.093 -174.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.651 HD12 HD11 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -124.65 75.75 1.44 Allowed 'General case' 0 C--N 1.366 1.288 0 N-CA-C 120.334 3.457 . . . . 0.0 120.334 -169.467 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.256 . . -85.31 -176.2 0.74 Allowed Pre-proline 0 CA--C 1.502 -0.872 0 O-C-N 119.374 -2.079 . . . . 0.0 115.357 -169.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.472 ' HA ' HD21 ' A' ' 118' ' ' LEU . 79.9 Cg_exo -65.55 153.77 76.7 Favored 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 122.292 1.994 . . . . 0.0 109.969 160.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm . . . . . 0 CA--C 1.489 -1.373 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 170.405 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 . . . . . 0 CA--C 1.483 -1.627 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.58 HG22 ' HE3' ' A' ' 123' ' ' LYS . 79.3 t -99.31 120.65 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.431 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 170.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -104.22 173.16 6.42 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 154.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -142.62 154.65 44.58 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -176.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.701 HG21 HD21 ' A' ' 114' ' ' LEU . 3.9 tp -138.7 167.28 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 170.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -119.84 156.25 31.04 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.214 161.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.515 ' HB3' HG11 ' A' ' 144' ' ' VAL . 29.4 m-85 -130.52 160.54 33.82 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 170.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 . . . . . 0 N--CA 1.43 -1.438 0 C-N-CA 125.213 1.405 . . . . 0.0 108.611 -179.07 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.2 t70 . . . . . 0 N--CA 1.422 -1.836 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -80.22 -65.44 1.01 Allowed 'General case' 0 CA--C 1.481 -1.673 0 O-C-N 124.29 0.994 . . . . 0.0 109.567 -165.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.444 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.337 0.0 OUTLIER -62.26 -9.6 8.38 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 120.472 3.508 . . . . 0.0 120.472 178.878 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.53 -44.2 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-O 122.684 1.23 . . . . 0.0 109.72 160.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.623 ' O ' HD22 ' A' ' 114' ' ' LEU . 22.1 mmtp -89.19 -6.87 56.58 Favored 'General case' 0 CA--C 1.469 -2.149 0 O-C-N 120.395 -1.441 . . . . 0.0 114.727 177.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 2.7 tt -72.34 -35.26 68.52 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 162.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.48 ' HA ' HG12 ' A' ' 115' ' ' ILE . 2.4 tpt180 -56.99 -40.68 77.0 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.484 1.114 . . . . 0.0 111.222 168.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.7 t -59.56 -47.69 84.55 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.701 HD21 HG21 ' A' ' 96' ' ' ILE 0.306 1.4 mm? -67.4 -25.55 66.0 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 175.63 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.271 3.0 mm -62.24 -47.74 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.767 0 CA-C-N 120.53 1.514 . . . . 0.0 107.993 177.759 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -52.53 -47.03 66.95 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 127.766 2.426 . . . . 0.0 109.751 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -61.24 -51.88 67.1 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.531 1.132 . . . . 0.0 113.028 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.805 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -71.49 -21.25 61.96 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 126.998 2.119 . . . . 0.0 113.75 -178.711 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -68.86 -41.74 78.01 Favored 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 126.94 2.096 . . . . 0.0 109.245 171.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.78 -26.68 67.81 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 123.037 0.535 . . . . 0.0 110.785 173.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.34 68.01 1.47 Allowed Glycine 0 CA--C 1.469 -2.802 0 N-CA-C 104.477 -3.449 . . . . 0.0 104.477 -171.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -120.59 164.26 16.75 Favored 'General case' 0 CA--C 1.447 -2.995 1 N-CA-C 97.985 -4.82 . . . . 0.0 97.985 168.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.628 ' HD3' HG12 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -101.19 114.88 29.24 Favored 'General case' 0 N--CA 1.393 -3.276 1 N-CA-C 97.175 -5.12 . . . . 0.0 97.175 170.551 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.508 ' CB ' HD12 ' A' ' 114' ' ' LEU . . . -84.07 160.44 20.95 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 173.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -135.38 128.66 32.03 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.9 mm -82.04 135.44 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.436 ' HA ' HD13 ' A' ' 171' ' ' ILE . 15.1 m -109.84 118.29 36.09 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 163.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.843 HD21 ' HA2' ' A' ' 141' ' ' GLY . 11.0 tp -81.07 149.53 29.18 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 168.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.413 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 28.4 ttm180 -150.76 95.76 2.26 Favored 'General case' 0 N--CA 1.398 -3.026 1 N-CA-C 97.007 -5.183 . . . . 0.0 97.007 -175.915 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.516 ' CZ ' HD23 ' A' ' 128' ' ' LEU . 95.4 m-85 . . . . . 0 N--CA 1.421 -1.883 0 CA-C-N 111.262 -2.699 . . . . 0.0 104.748 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 69.4 mt . . . . . 0 N--CA 1.417 -2.087 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.843 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -72.74 -56.67 5.82 Favored Glycine 0 CA--C 1.459 -3.455 0 CA-C-O 118.744 -1.031 . . . . 0.0 113.438 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.403 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 5.6 ptt? -84.85 0.0 52.45 Favored 'General case' 0 N--CA 1.41 -2.438 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -161.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.261 2.8 tp10 -61.19 -61.12 2.79 Favored 'General case' 0 CA--C 1.461 -2.456 0 C-N-CA 114.879 -2.728 . . . . 0.0 115.308 147.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 98' ' ' PHE . 22.0 t -65.96 -65.2 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.938 0 O-C-N 125.651 1.844 . . . . 0.0 109.293 -163.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.536 HD11 HD22 ' A' ' 128' ' ' LEU . 26.4 mt -45.79 -55.74 6.21 Favored 'General case' 0 N--CA 1.427 -1.619 0 C-N-CA 129.315 3.046 . . . . 0.0 114.431 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 142' ' ' MET 0.261 2.4 t30 -62.81 -31.01 71.92 Favored 'General case' 0 CA--C 1.47 -2.133 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 173.174 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -79.5 -15.72 57.26 Favored 'General case' 0 N--CA 1.421 -1.91 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.193 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.514 HG12 HD12 ' A' ' 152' ' ' LEU . 1.6 t -72.33 -50.24 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.823 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 175.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.456 ' HE3' ' CG2' ' A' ' 158' ' ' VAL 0.261 31.4 ttmt -50.1 -50.96 46.68 Favored 'General case' 0 CA--C 1.466 -2.255 0 C-N-CA 125.682 1.593 . . . . 0.0 112.69 173.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.08 -39.59 68.88 Favored 'General case' 0 N--CA 1.407 -2.604 0 C-N-CA 126.216 1.807 . . . . 0.0 109.451 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -76.22 -27.46 56.83 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 115.716 -2.393 . . . . 0.0 115.198 172.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.514 HD12 HG12 ' A' ' 148' ' ' VAL 0.346 0.4 OUTLIER -81.23 -29.54 34.43 Favored 'General case' 0 CA--C 1.458 -2.595 0 CA-C-O 116.137 -1.887 . . . . 0.0 114.474 179.347 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -26.03 -26.54 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.683 1 C-N-CA 136.065 5.746 . . . . 0.0 119.756 -173.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -51.94 -55.45 20.24 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 126.58 1.952 . . . . 0.0 112.742 166.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.421 ' HG ' ' CG2' ' A' ' 115' ' ' ILE 0.3 1.2 mm? -94.73 -58.82 2.07 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 128.048 2.539 . . . . 0.0 107.191 -169.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.805 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.298 . . -109.28 151.32 26.71 Favored 'General case' 0 CA--C 1.446 -3.055 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.974 -161.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.59 176.53 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.543 0 C-N-CA 115.216 -2.594 . . . . 0.0 116.65 140.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.456 ' CG2' ' HE3' ' A' ' 149' ' ' LYS . 3.4 t -84.96 150.29 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 168.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -80.64 -37.76 30.4 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.402 ' H ' HG12 ' A' ' 158' ' ' VAL . 3.3 t -159.84 144.04 14.68 Favored 'General case' 0 CA--C 1.461 -2.477 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -174.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.3 t80 . . . . . 0 N--CA 1.426 -1.627 0 N-CA-C 101.979 -3.341 . . . . 0.0 101.979 170.243 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.413 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.302 39.4 mt-30 . . . . . 0 CA--C 1.498 -1.055 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 59.6 ttp -134.61 117.96 16.7 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 120.883 0.373 . . . . 0.0 110.165 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.436 HD13 ' HA ' ' A' ' 127' ' ' THR . 11.2 mm -77.95 133.3 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 145' ' ' LEU . 2.8 ttt -119.69 131.3 55.38 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 165.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.628 HG12 ' HD3' ' A' ' 123' ' ' LYS . 1.6 t -100.21 143.01 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -171.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.551 HD13 HD11 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -130.59 70.51 1.45 Allowed 'General case' 0 C--N 1.364 1.23 0 N-CA-C 119.469 3.137 . . . . 0.0 119.469 -161.64 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 123' ' ' LYS 0.284 . . -92.31 173.75 4.83 Favored Pre-proline 0 C--N 1.358 0.962 0 N-CA-C 119.416 3.117 . . . . 0.0 119.416 -171.084 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -70.46 142.03 43.85 Favored 'Trans proline' 0 N--CA 1.443 -1.493 0 CA-C-N 120.591 1.247 . . . . 0.0 110.842 -175.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp . . . . . 0 CA--C 1.485 -1.55 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 175.551 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 . . . . . 0 CA--C 1.48 -1.743 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.581 HG22 ' HD3' ' A' ' 123' ' ' LYS . 86.4 t -98.69 117.16 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.712 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 157.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -106.66 170.66 7.8 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 155.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -137.85 157.22 46.87 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -167.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.21 159.27 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 N-CA-C 102.329 -3.212 . . . . 0.0 102.329 174.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -117.85 157.45 26.6 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 118.937 0.79 . . . . 0.0 111.587 166.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.614 ' HB3' HG11 ' A' ' 144' ' ' VAL . 28.5 m-85 -139.89 90.94 2.43 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 172.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 . . . . . 0 N--CA 1.436 -1.153 0 C-N-CA 123.849 0.86 . . . . 0.0 108.937 -179.34 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 t70 . . . . . 0 N--CA 1.424 -1.768 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -86.57 -70.43 0.61 Allowed 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 113.265 -1.789 . . . . 0.0 110.261 -158.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.422 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.326 0.0 OUTLIER -59.01 -14.06 8.35 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 119.004 2.964 . . . . 0.0 119.004 173.604 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.24 -45.75 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 122.096 0.95 . . . . 0.0 110.225 161.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -91.36 4.37 52.57 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.417 HD12 HG13 ' A' ' 148' ' ' VAL . 6.0 tt -83.51 -30.63 26.98 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 162.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.498 ' HA ' HG12 ' A' ' 115' ' ' ILE . 25.1 ttt85 -62.51 -42.42 99.5 Favored 'General case' 0 C--N 1.361 1.082 0 CA-C-O 118.686 -0.674 . . . . 0.0 110.664 167.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.25 65.7 m -55.1 -44.97 75.41 Favored 'General case' 0 C--N 1.379 1.866 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 169.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.607 HD11 HD12 ' A' ' 126' ' ' ILE . 13.7 mt -65.08 -29.53 70.41 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.2 mm -61.04 -45.51 98.42 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.378 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -52.7 43.54 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.542 1.537 . . . . 0.0 111.302 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -57.34 -46.32 83.41 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.423 HD11 ' HA ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -54.48 -44.53 72.72 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 127.802 2.441 . . . . 0.0 112.848 172.682 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -79.54 -20.09 47.94 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 126.555 1.942 . . . . 0.0 112.416 -174.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -68.11 -21.59 64.94 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.139 0.576 . . . . 0.0 110.745 170.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.73 51.4 3.64 Favored Glycine 0 CA--C 1.474 -2.474 0 N-CA-C 105.804 -2.918 . . . . 0.0 105.804 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -126.78 165.97 18.29 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.581 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -96.53 119.82 35.72 Favored 'General case' 0 N--CA 1.409 -2.5 1 N-CA-C 99.795 -4.15 . . . . 0.0 99.795 178.562 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -91.98 144.04 25.86 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 103.176 -2.898 . . . . 0.0 103.176 -172.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.432 ' HD3' HD12 ' A' ' 171' ' ' ILE . 22.4 ttmm -118.72 125.05 48.81 Favored 'General case' 0 CA--C 1.479 -1.785 0 O-C-N 117.893 -3.004 . . . . 0.0 106.314 173.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.7 HD11 HD22 ' A' ' 174' ' ' LEU . 4.2 mm -86.34 131.99 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 173.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.485 ' HA ' HD13 ' A' ' 171' ' ' ILE . 32.8 m -121.76 123.92 42.97 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 173.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.485 HD23 HD11 ' A' ' 145' ' ' LEU 0.362 0.4 OUTLIER -76.58 150.16 36.53 Favored 'General case' 0 CA--C 1.468 -2.188 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 164.787 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.513 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 56.6 ttt180 -145.15 88.96 1.91 Allowed 'General case' 0 N--CA 1.399 -3.008 1 N-CA-C 99.735 -4.172 . . . . 0.0 99.735 177.549 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . 0.25 70.1 m-85 . . . . . 0 N--CA 1.428 -1.559 0 CA-C-N 110.986 -2.824 . . . . 0.0 109.144 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.399 57.5 mt . . . . . 0 N--CA 1.429 -1.499 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.47 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -71.4 -64.9 2.59 Favored Glycine 0 N--CA 1.418 -2.513 0 CA-C-O 119.474 -0.626 . . . . 0.0 112.676 173.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.569 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 7.4 ptt? -87.1 -5.85 58.88 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -153.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.02 -48.46 78.67 Favored 'General case' 0 CA--C 1.457 -2.615 0 C-N-CA 116.496 -2.081 . . . . 0.0 113.837 156.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.614 HG11 ' HB3' ' A' ' 98' ' ' PHE . 21.4 t -69.39 -67.77 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.444 -3.133 0 O-C-N 126.023 2.077 . . . . 0.0 106.936 -167.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.58 HD13 ' HB2' ' A' ' 172' ' ' MET . 42.7 mt -43.0 -54.15 4.42 Favored 'General case' 0 CA--C 1.476 -1.898 0 C-N-CA 128.495 2.718 . . . . 0.0 115.679 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.569 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.5 t-20 -63.87 -31.91 73.25 Favored 'General case' 0 CA--C 1.461 -2.474 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 175.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.3 ttp180 -81.81 -14.51 56.25 Favored 'General case' 0 N--CA 1.419 -2.013 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.014 172.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.8 t -76.27 -46.6 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.81 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 176.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.544 ' HE3' HG21 ' A' ' 158' ' ' VAL . 31.4 ttmt -51.9 -51.21 58.52 Favored 'General case' 0 CA--C 1.461 -2.453 0 C-N-CA 125.239 1.416 . . . . 0.0 111.003 172.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.81 -35.85 67.43 Favored 'General case' 0 N--CA 1.409 -2.513 0 C-N-CA 124.612 1.165 . . . . 0.0 110.529 -168.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -72.84 -39.41 66.57 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 116.291 -2.164 . . . . 0.0 114.941 170.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.303 0.2 OUTLIER -80.87 -19.56 44.18 Favored 'General case' 0 CA--C 1.464 -2.341 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -178.293 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -27.11 -25.07 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.363 1 C-N-CA 134.586 5.154 . . . . 0.0 119.064 174.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.2 mt-10 -54.24 -57.77 9.92 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 126.903 2.081 . . . . 0.0 113.361 167.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.38 -51.39 2.88 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 113.498 -1.683 . . . . 0.0 108.525 -164.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.423 ' HA ' HD11 ' A' ' 118' ' ' LEU 0.321 . . -91.65 146.13 24.03 Favored 'General case' 0 CA--C 1.455 -2.685 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 177.689 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.4 m -121.12 171.6 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.457 -2.615 0 C-N-CA 114.265 -2.974 . . . . 0.0 116.307 126.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.544 HG21 ' HE3' ' A' ' 149' ' ' LYS 0.298 3.2 t -81.8 155.11 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 C-N-CA 130.524 3.53 . . . . 0.0 107.313 179.391 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -82.15 -42.45 19.05 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.03 141.31 18.58 Favored 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -174.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.417 -2.077 1 N-CA-C 98.766 -4.531 . . . . 0.0 98.766 158.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.279 57.8 mt-30 . . . . . 0 CA--C 1.492 -1.257 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.41 ' HB3' ' HB2' ' A' ' 128' ' ' LEU . 21.6 ttm -104.57 158.35 16.55 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 102.45 -3.167 . . . . 0.0 102.45 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 127' ' ' THR . 32.7 mm -118.43 131.53 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.157 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 159.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.58 ' HB2' HD13 ' A' ' 145' ' ' LEU . 2.5 ttp -108.12 128.4 54.65 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 153.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 37.0 t -91.47 130.39 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 C-N-CA 118.17 -1.412 . . . . 0.0 108.597 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.7 HD22 HD11 ' A' ' 126' ' ' ILE . 13.1 tp -101.82 144.07 30.94 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 130.213 3.405 . . . . 0.0 116.915 174.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.261 . . -143.08 -179.3 0.93 Allowed Pre-proline 0 CA--C 1.483 -1.599 0 O-C-N 119.255 -2.153 . . . . 0.0 108.991 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -65.24 145.24 83.5 Favored 'Trans proline' 0 N--CA 1.436 -1.877 0 C-N-CA 123.025 2.483 . . . . 0.0 109.197 158.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt . . . . . 0 CA--C 1.492 -1.28 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 165.928 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 N--CA 1.429 -1.485 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.503 HG22 ' HD3' ' A' ' 123' ' ' LYS . 54.5 t -102.65 119.47 51.06 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.789 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 161.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -115.19 178.59 4.23 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 160.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -141.7 158.98 43.15 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -171.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.1 tp -134.37 164.74 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 168.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -120.24 154.62 34.65 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.113 162.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.599 ' HB3' HG11 ' A' ' 144' ' ' VAL . 37.9 m-85 -128.9 136.66 50.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 102.922 -2.992 . . . . 0.0 102.922 167.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 . . . . . 0 N--CA 1.432 -1.344 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -177.663 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.5 t70 . . . . . 0 N--CA 1.427 -1.616 0 CA-C-O 122.681 1.229 . . . . 0.0 108.044 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.19 -72.79 0.5 Allowed 'General case' 0 CA--C 1.47 -2.105 0 CA-C-N 112.283 -2.235 . . . . 0.0 111.036 -157.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.457 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.312 0.0 OUTLIER -60.18 -13.45 12.34 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 118.808 2.892 . . . . 0.0 118.808 174.435 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 94.9 t -60.47 -48.74 87.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 C-N-CA 124.209 1.004 . . . . 0.0 109.997 160.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -91.72 7.41 41.83 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 5.3 tt -86.21 -31.14 21.89 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 163.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.461 ' HA ' HG12 ' A' ' 115' ' ' ILE . 56.9 ttt-85 -62.25 -43.8 97.99 Favored 'General case' 0 C--N 1.363 1.158 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.021 167.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.1 m -60.14 -42.37 94.71 Favored 'General case' 0 C--N 1.378 1.838 0 C-N-CA 118.181 -1.408 . . . . 0.0 113.175 174.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.52 HD11 HD12 ' A' ' 126' ' ' ILE . 9.9 mt -62.48 -30.77 71.5 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 175.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.6 mm -58.33 -51.58 69.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.733 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 25.9 tpt85 -50.38 -45.96 55.69 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 126.716 2.007 . . . . 0.0 112.745 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -61.22 -54.54 42.96 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -57.56 -39.46 76.74 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 177.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -78.43 -29.91 47.32 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 128.703 2.801 . . . . 0.0 110.252 -169.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.92 7.47 8.82 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 123.067 0.547 . . . . 0.0 111.406 173.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.09 61.13 2.57 Favored Glycine 0 CA--C 1.467 -2.937 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 173.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -131.88 168.57 17.63 Favored 'General case' 0 CA--C 1.448 -2.971 0 N-CA-C 101.194 -3.632 . . . . 0.0 101.194 170.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.503 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -108.25 116.71 32.48 Favored 'General case' 0 N--CA 1.39 -3.472 1 N-CA-C 98.091 -4.781 . . . . 0.0 98.091 173.373 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -82.72 158.22 22.97 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 102.586 -3.116 . . . . 0.0 102.586 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.306 33.2 mtmm -126.29 144.49 50.78 Favored 'General case' 0 CA--C 1.481 -1.677 0 O-C-N 118.795 -2.441 . . . . 0.0 105.47 155.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.52 HD12 HD11 ' A' ' 114' ' ' LEU . 6.4 mm -86.62 137.37 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 167.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.9 m -117.17 123.78 47.52 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 166.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 170' ' ' MET 0.258 0.2 OUTLIER -80.18 153.78 28.4 Favored 'General case' 0 CA--C 1.467 -2.213 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 166.573 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -148.21 94.79 2.37 Favored 'General case' 0 N--CA 1.404 -2.756 1 N-CA-C 99.51 -4.255 . . . . 0.0 99.51 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 . . . . . 0 N--CA 1.424 -1.759 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.116 -170.84 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.253 68.4 mt . . . . . 0 CA--C 1.489 -1.37 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -70.11 -64.5 2.87 Favored Glycine 0 N--CA 1.416 -2.657 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.556 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 7.1 ptt? -84.78 -5.66 59.33 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -155.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.32 -53.72 48.33 Favored 'General case' 0 CA--C 1.459 -2.529 0 C-N-CA 115.925 -2.31 . . . . 0.0 114.126 154.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.599 HG11 ' HB3' ' A' ' 98' ' ' PHE . 21.8 t -66.11 -67.05 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.443 -3.144 0 O-C-N 126.028 2.08 . . . . 0.0 107.499 -167.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.438 HD22 ' HB3' ' A' ' 172' ' ' MET . 23.9 mt -41.08 -56.63 2.27 Favored 'General case' 0 CA--C 1.476 -1.877 0 C-N-CA 128.977 2.911 . . . . 0.0 115.15 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.4 t-20 -63.31 -31.41 72.55 Favored 'General case' 0 CA--C 1.466 -2.285 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 175.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -82.69 -13.68 55.96 Favored 'General case' 0 N--CA 1.419 -2.012 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.868 173.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.7 t -76.31 -46.96 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 177.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.531 ' HE3' HG21 ' A' ' 158' ' ' VAL 0.251 35.3 ttmt -51.21 -49.83 60.27 Favored 'General case' 0 CA--C 1.464 -2.357 0 C-N-CA 125.642 1.577 . . . . 0.0 111.991 172.65 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -37.39 64.93 Favored 'General case' 0 N--CA 1.408 -2.57 0 C-N-CA 125.276 1.43 . . . . 0.0 109.978 -169.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -72.22 -38.21 69.02 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 116.412 -2.115 . . . . 0.0 114.923 171.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.423 HD13 HD11 ' A' ' 174' ' ' LEU 0.296 0.2 OUTLIER -81.84 -20.68 38.49 Favored 'General case' 0 CA--C 1.461 -2.443 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -178.318 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -25.87 -28.2 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.305 1 C-N-CA 134.305 5.042 . . . . 0.0 119.142 175.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 5.2 mt-10 -50.88 -54.05 27.23 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 128.101 2.56 . . . . 0.0 113.747 168.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.1 tt -113.22 -51.0 2.84 Favored 'General case' 0 N--CA 1.42 -1.932 0 C-N-CA 126.163 1.785 . . . . 0.0 108.611 -167.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.534 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.343 . . -104.7 142.0 35.46 Favored 'General case' 0 CA--C 1.449 -2.937 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.822 -177.707 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.5 m -120.04 171.76 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.65 0 CA-C-O 125.117 2.389 . . . . 0.0 116.022 140.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.531 HG21 ' HE3' ' A' ' 149' ' ' LYS 0.289 2.7 t -81.82 152.86 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 109.917 -3.311 . . . . 0.0 106.336 177.978 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -83.33 -39.2 21.06 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -176.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.76 140.95 18.51 Favored 'General case' 0 CA--C 1.468 -2.193 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -174.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.6 t80 . . . . . 0 N--CA 1.422 -1.845 0 N-CA-C 101.259 -3.608 . . . . 0.0 101.259 164.492 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.314 19.8 mt-30 . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.406 ' HB3' ' HB2' ' A' ' 128' ' ' LEU . 4.6 ttm -116.14 112.99 22.49 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-N 119.805 1.184 . . . . 0.0 109.878 -175.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.9 mm -80.92 123.57 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 O-C-N 121.06 -1.025 . . . . 0.0 108.646 170.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.438 ' HB3' HD22 ' A' ' 145' ' ' LEU . 2.9 ttt -107.49 131.24 54.52 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 159.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 39.1 t -93.09 140.86 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.017 -173.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -126.92 81.1 1.99 Allowed 'General case' 0 C--N 1.364 1.208 0 N-CA-C 118.988 2.958 . . . . 0.0 118.988 -169.055 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.276 . . -85.94 178.73 2.16 Favored Pre-proline 0 CA--C 1.499 -0.993 0 O-C-N 119.644 -1.91 . . . . 0.0 115.998 -171.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.442 ' HA ' HD21 ' A' ' 118' ' ' LEU . 84.4 Cg_exo -62.06 142.97 94.29 Favored 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 122.849 2.366 . . . . 0.0 109.786 159.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.968 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 . . . . . 0 CA--C 1.482 -1.655 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.575 HG22 ' HE3' ' A' ' 123' ' ' LYS . 76.3 t -100.78 119.99 49.67 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.588 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -104.85 172.44 6.79 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 155.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -143.78 154.23 43.22 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -175.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 tp -138.71 165.26 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 103.918 -2.623 . . . . 0.0 103.918 171.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -117.13 155.04 30.0 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-N 118.744 0.702 . . . . 0.0 110.903 163.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.57 ' HB3' HG11 ' A' ' 144' ' ' VAL . 26.7 m-85 -128.9 145.47 51.21 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 170.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 . . . . . 0 N--CA 1.438 -1.046 0 C-N-CA 126.341 1.856 . . . . 0.0 106.719 -176.5 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.6 t70 . . . . . 0 N--CA 1.423 -1.825 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.425 ' HD1' ' CE1' ' A' ' 98' ' ' PHE . 0.6 OUTLIER -84.66 -63.82 1.27 Allowed 'General case' 0 CA--C 1.481 -1.708 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.678 -161.758 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.467 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.325 0.0 OUTLIER -61.87 -11.89 15.05 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 119.64 3.2 . . . . 0.0 119.64 177.392 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.5 t -60.96 -48.05 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-O 122.37 1.081 . . . . 0.0 109.552 160.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -91.41 -1.65 57.52 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tt -78.5 -33.42 48.1 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 162.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.451 ' HA ' HG12 ' A' ' 115' ' ' ILE . 46.7 ttt-85 -61.91 -40.57 95.91 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 117.672 -1.156 . . . . 0.0 110.997 169.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.6 m -57.43 -46.17 83.84 Favored 'General case' 0 C--N 1.38 1.913 0 C-N-CA 119.001 -1.08 . . . . 0.0 113.84 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.268 84.4 mt -65.49 -30.87 71.69 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.9 mm -58.75 -49.7 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.676 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -55.85 -39.55 71.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 126.801 2.041 . . . . 0.0 111.32 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -62.45 -51.7 66.46 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 123.581 0.752 . . . . 0.0 112.081 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.737 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -66.83 -23.09 66.0 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 126.232 1.813 . . . . 0.0 114.978 177.331 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -69.98 -38.2 75.96 Favored 'General case' 0 CA--C 1.491 -1.306 0 C-N-CA 126.216 1.806 . . . . 0.0 109.875 172.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -66.63 -26.08 66.9 Favored 'General case' 0 C--N 1.361 1.083 0 O-C-N 123.28 0.363 . . . . 0.0 110.893 171.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.41 65.36 1.52 Allowed Glycine 0 CA--C 1.471 -2.702 0 N-CA-C 104.743 -3.343 . . . . 0.0 104.743 -172.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -121.52 164.72 16.76 Favored 'General case' 0 CA--C 1.449 -2.929 1 N-CA-C 98.79 -4.522 . . . . 0.0 98.79 170.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.575 ' HE3' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -101.5 117.6 35.26 Favored 'General case' 0 N--CA 1.396 -3.173 1 N-CA-C 97.538 -4.986 . . . . 0.0 97.538 169.106 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.63 160.6 20.37 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 172.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -134.42 131.43 38.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 169.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.1 mm -82.93 135.87 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.416 ' HA ' HD13 ' A' ' 171' ' ' ILE . 16.4 m -113.19 119.23 37.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 165.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.739 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.2 OUTLIER -84.73 153.75 22.86 Favored 'General case' 0 CA--C 1.474 -1.963 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 167.532 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.493 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 24.8 ttm-85 -151.62 103.05 2.92 Favored 'General case' 0 N--CA 1.395 -3.183 1 N-CA-C 96.504 -5.369 . . . . 0.0 96.504 -173.804 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.451 ' CE1' HD22 ' A' ' 128' ' ' LEU . 60.2 m-85 . . . . . 0 N--CA 1.431 -1.391 0 CA-C-N 112.537 -2.119 . . . . 0.0 109.987 -174.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.8 mt . . . . . 0 CA--C 1.467 -2.24 0 CA-C-O 120.803 0.335 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.739 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -79.94 -53.47 4.23 Favored Glycine 0 CA--C 1.458 -3.498 0 O-C-N 124.876 1.36 . . . . 0.0 110.517 -168.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 71.1 mtm -85.74 3.1 42.79 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -166.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.261 2.2 tp10 -62.42 -64.82 0.81 Allowed 'General case' 0 CA--C 1.466 -2.26 0 C-N-CA 115.199 -2.6 . . . . 0.0 115.876 141.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.57 HG11 ' HB3' ' A' ' 98' ' ' PHE . 16.1 t -62.59 -65.29 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.447 -2.994 0 O-C-N 125.907 2.005 . . . . 0.0 109.264 -162.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.3 mt -42.4 -53.99 4.0 Favored 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 129.435 3.094 . . . . 0.0 114.641 176.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -61.83 -35.89 79.58 Favored 'General case' 0 CA--C 1.466 -2.254 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -80.15 -14.71 58.26 Favored 'General case' 0 N--CA 1.419 -2.01 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.486 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.444 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.9 t -76.72 -46.46 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.725 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.422 ' HE3' ' CG2' ' A' ' 158' ' ' VAL 0.271 31.4 ttmt -53.73 -48.31 69.75 Favored 'General case' 0 CA--C 1.467 -2.241 0 C-N-CA 126.007 1.723 . . . . 0.0 112.587 173.382 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -39.33 66.75 Favored 'General case' 0 N--CA 1.407 -2.596 0 C-N-CA 125.476 1.51 . . . . 0.0 108.77 -171.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -75.07 -22.95 58.0 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 115.637 -2.425 . . . . 0.0 115.63 170.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.407 HD23 HG12 ' A' ' 148' ' ' VAL 0.313 0.2 OUTLIER -83.26 -31.12 27.12 Favored 'General case' 0 CA--C 1.473 -1.999 0 CA-C-O 116.887 -1.53 . . . . 0.0 112.827 -179.649 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -29.11 -26.48 0.0 OUTLIER 'General case' 0 C--N 1.367 1.346 1 C-N-CA 134.93 5.292 . . . . 0.0 119.346 -175.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 5.7 mt-10 -50.86 -53.28 33.69 Favored 'General case' 0 CA--C 1.491 -1.297 0 C-N-CA 128.642 2.777 . . . . 0.0 112.611 170.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . 0.251 0.2 OUTLIER -111.31 -53.53 2.69 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 113.701 -1.591 . . . . 0.0 108.593 -169.59 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.737 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.318 . . -105.65 154.33 20.58 Favored 'General case' 0 CA--C 1.444 -3.112 0 CA-C-N 113.732 -1.576 . . . . 0.0 107.756 -166.946 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.58 178.58 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.506 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 139.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.43 HG22 HD23 ' A' ' 174' ' ' LEU . 2.7 t -83.8 151.74 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.996 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 166.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -80.29 -38.59 30.47 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 6.8 t -123.02 -175.96 3.3 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -175.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 8.8 t80 . . . . . 0 N--CA 1.419 -1.992 0 N-CA-C 102.343 -3.206 . . . . 0.0 102.343 144.131 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.493 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.257 26.0 mt-30 . . . . . 0 CA--C 1.499 -1.013 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -120.78 115.17 22.77 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -173.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 127' ' ' THR . 16.1 mm -79.07 123.86 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 167.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.412 ' HG3' ' CG1' ' A' ' 158' ' ' VAL . 2.4 ttt -107.21 136.89 46.28 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 163.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.97 134.88 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 118.176 -1.409 . . . . 0.0 108.782 -172.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.576 HD13 HD11 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -122.71 69.27 0.98 Allowed 'General case' 0 C--N 1.356 0.883 0 N-CA-C 119.782 3.253 . . . . 0.0 119.782 -164.709 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.312 . . -89.59 172.71 6.83 Favored Pre-proline 0 C--N 1.356 0.85 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 -172.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -72.04 139.44 32.84 Favored 'Trans proline' 0 CA--C 1.493 -1.545 0 N-CA-C 107.905 -1.613 . . . . 0.0 107.905 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.1 pttp . . . . . 0 N--CA 1.433 -1.315 0 O-C-N 124.126 0.892 . . . . 0.0 111.521 -179.264 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 . . . . . 0 CA--C 1.48 -1.724 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.559 HG22 ' HE2' ' A' ' 123' ' ' LYS . 55.2 t -96.42 123.75 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 160.1 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -103.28 172.42 6.82 Favored 'General case' 0 CA--C 1.468 -2.187 0 C-N-CA 116.105 -2.238 . . . . 0.0 105.985 160.616 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -144.29 148.34 34.7 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 tp -131.83 160.65 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 102.372 -3.196 . . . . 0.0 102.372 172.056 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -113.86 154.15 27.97 Favored 'General case' 0 CA--C 1.484 -1.566 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.207 164.131 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.547 ' HB3' HG11 ' A' ' 144' ' ' VAL . 4.7 m-85 -137.13 130.29 30.95 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.419 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 . . . . . 0 N--CA 1.422 -1.839 0 C-N-CA 124.013 0.925 . . . . 0.0 110.648 179.234 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 t70 . . . . . 0 CA--C 1.477 -1.845 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -88.91 -60.73 1.88 Allowed 'General case' 0 CA--C 1.479 -1.765 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.772 -161.265 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.346 0.0 OUTLIER -61.43 -12.74 15.78 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 119.281 3.067 . . . . 0.0 119.281 174.638 . . . . . . . . 4 4 . 1 . 021 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.61 -47.81 91.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-O 122.201 1.001 . . . . 0.0 109.613 160.026 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -90.81 3.57 54.07 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 178.5 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.441 HD12 HG13 ' A' ' 148' ' ' VAL . 5.6 tt -82.61 -30.55 29.41 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 162.708 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.458 ' HA ' HG12 ' A' ' 115' ' ' ILE . 59.0 ttt-85 -62.3 -41.98 98.97 Favored 'General case' 0 C--N 1.361 1.105 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.731 166.399 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 t -57.0 -45.38 83.07 Favored 'General case' 0 C--N 1.378 1.807 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 175.039 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.336 29.3 mt -66.98 -29.0 68.73 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 175.676 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.273 7.1 mm -61.67 -48.42 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.882 0 CA-C-N 120.049 1.295 . . . . 0.0 108.064 174.624 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -54.2 -43.85 71.11 Favored 'General case' 0 CA--C 1.479 -1.759 0 C-N-CA 126.929 2.092 . . . . 0.0 110.026 -178.166 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -63.28 -48.73 76.88 Favored 'General case' 0 CA--C 1.487 -1.45 0 O-C-N 124.385 1.053 . . . . 0.0 112.636 177.15 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.533 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -61.49 -44.13 97.64 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -178.455 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -85.61 -17.8 35.12 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 126.813 2.045 . . . . 0.0 112.02 -169.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -81.71 -0.95 45.15 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 167.184 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.74 64.23 1.5 Allowed Glycine 0 CA--C 1.47 -2.74 0 C-N-CA 125.939 1.733 . . . . 0.0 108.947 171.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -134.92 165.96 24.1 Favored 'General case' 0 CA--C 1.445 -3.073 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 171.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.559 ' HE2' HG22 ' A' ' 93' ' ' VAL . 2.6 tmmm? -102.56 117.34 34.48 Favored 'General case' 0 N--CA 1.394 -3.232 1 N-CA-C 95.804 -5.628 . . . . 0.0 95.804 178.367 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.09 162.37 16.81 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -144.53 130.25 19.14 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 119.188 -2.195 . . . . 0.0 106.663 170.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.4 mm -84.02 136.39 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 174.542 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.479 ' HA ' HD13 ' A' ' 171' ' ' ILE . 20.1 m -108.52 119.92 40.93 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 161.098 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.772 HD12 HD11 ' A' ' 145' ' ' LEU 0.281 0.3 OUTLIER -71.84 147.49 47.12 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.394 . . . . . . . . 4 4 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 53.1 ttm-85 -149.22 96.24 2.5 Favored 'General case' 0 N--CA 1.405 -2.717 1 N-CA-C 99.165 -4.383 . . . . 0.0 99.165 -178.533 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.413 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 76.6 m-85 . . . . . 0 N--CA 1.422 -1.826 0 CA-C-N 111.787 -2.46 . . . . 0.0 109.417 -177.428 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.256 59.4 mt . . . . . 0 N--CA 1.423 -1.821 0 CA-C-O 120.578 0.228 . . . . 0.0 111.061 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.529 ' CA ' HD11 ' A' ' 128' ' ' LEU . . . -74.33 -54.98 5.86 Favored Glycine 0 N--CA 1.412 -2.962 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.16 -178.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.477 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 6.3 ptt? -85.68 -0.53 55.41 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -163.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.26 2.2 tp10 -60.46 -57.97 10.49 Favored 'General case' 0 CA--C 1.453 -2.776 0 C-N-CA 114.687 -2.805 . . . . 0.0 114.805 147.486 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 98' ' ' PHE . 17.1 t -67.15 -64.82 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.448 -2.956 0 O-C-N 126.118 2.136 . . . . 0.0 108.981 -161.401 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.772 HD11 HD12 ' A' ' 128' ' ' LEU . 51.2 mt -47.32 -52.43 16.44 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 128.227 2.611 . . . . 0.0 115.286 178.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 142' ' ' MET 0.265 1.7 t30 -63.44 -30.73 71.81 Favored 'General case' 0 CA--C 1.479 -1.761 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 174.175 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -80.61 -15.88 55.5 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.858 173.342 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 98' ' ' PHE . 2.0 t -75.58 -43.95 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.614 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.444 ' HB2' HG21 ' A' ' 158' ' ' VAL 0.283 23.2 ttmt -52.52 -49.53 64.63 Favored 'General case' 0 CA--C 1.47 -2.133 0 C-N-CA 126.222 1.809 . . . . 0.0 113.391 173.669 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -73.24 -41.45 63.7 Favored 'General case' 0 N--CA 1.404 -2.745 0 C-N-CA 127.78 2.432 . . . . 0.0 108.545 -172.216 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -75.04 -24.5 58.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 116.474 -2.09 . . . . 0.0 114.813 172.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 156' ' ' ALA 0.308 0.1 OUTLIER -81.93 -31.41 31.33 Favored 'General case' 0 CA--C 1.47 -2.13 0 CA-C-O 116.063 -1.922 . . . . 0.0 112.339 178.172 . . . . . . . . 4 4 . 1 . 021 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -28.45 -26.92 0.0 OUTLIER 'General case' 0 C--N 1.37 1.461 1 C-N-CA 134.745 5.218 . . . . 0.0 119.651 -173.33 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -48.24 -50.06 30.98 Favored 'General case' 0 CA--C 1.49 -1.349 0 C-N-CA 129.151 2.98 . . . . 0.0 113.458 167.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.35 -48.35 1.84 Allowed 'General case' 0 N--CA 1.416 -2.155 0 C-N-CA 126.057 1.743 . . . . 0.0 109.293 -164.682 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.533 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.347 . . -107.14 151.24 25.66 Favored 'General case' 0 CA--C 1.449 -2.934 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.536 -177.364 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.04 175.37 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.545 0 C-N-CA 115.803 -2.359 . . . . 0.0 116.304 136.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.476 HG13 ' HG2' ' A' ' 172' ' ' MET 0.372 74.8 t -76.98 147.88 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.25 0 CA-C-N 110.935 -2.848 . . . . 0.0 105.04 168.931 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -84.1 -39.5 19.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -172.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.8 t -160.06 142.41 13.24 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 113.73 -1.577 . . . . 0.0 106.898 -171.196 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.9 t80 . . . . . 0 N--CA 1.432 -1.373 0 N-CA-C 101.539 -3.504 . . . . 0.0 101.539 171.872 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 CA--C 1.494 -1.177 0 CA-C-O 121.355 0.597 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 13.3 ttm -124.33 168.64 12.73 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 -178.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 127' ' ' THR . 23.5 mm -112.69 141.07 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.937 0 C-N-CA 126.183 1.793 . . . . 0.0 108.022 163.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.576 ' HB2' HD13 ' A' ' 145' ' ' LEU . 5.1 tmm? -116.22 131.89 56.82 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 103.05 -2.944 . . . . 0.0 103.05 151.507 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.5 t -89.21 134.05 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.248 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -116.91 74.08 0.89 Allowed 'General case' 0 C--N 1.357 0.92 0 N-CA-C 117.946 2.573 . . . . 0.0 117.946 -170.627 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -86.53 -178.3 1.1 Allowed Pre-proline 0 CA--C 1.509 -0.615 0 N-CA-C 117.965 2.579 . . . . 0.0 117.965 -170.372 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.415 ' HA ' HD21 ' A' ' 118' ' ' LEU . 85.4 Cg_exo -66.59 144.65 73.38 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 122.498 2.132 . . . . 0.0 109.44 160.742 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.5 pttp . . . . . 0 N--CA 1.428 -1.525 0 CA-C-O 122.063 0.935 . . . . 0.0 111.785 179.894 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 . . . . . 0 N--CA 1.427 -1.606 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 82.9 t -103.89 121.85 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.525 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 168.396 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.407 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 26.4 mmmt -104.05 174.76 5.73 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 155.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -143.95 151.29 39.58 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 -178.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 tp -132.04 161.84 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 171.163 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -116.65 151.7 35.75 Favored 'General case' 0 CA--C 1.482 -1.662 0 C-N-CA 118.739 -1.184 . . . . 0.0 110.825 160.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.609 ' HB3' HG11 ' A' ' 144' ' ' VAL . 36.7 m-85 -124.33 133.03 53.57 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 168.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.57 ' HE ' ' H ' ' A' ' 99' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.427 -1.589 0 C-N-CA 124.58 1.152 . . . . 0.0 108.41 -173.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.0 t70 . . . . . 0 N--CA 1.424 -1.736 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.2 -73.49 0.19 Allowed 'General case' 0 CA--C 1.482 -1.65 0 C-N-CA 126.659 1.984 . . . . 0.0 108.455 -174.103 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.449 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.333 0.0 OUTLIER -59.75 -11.14 4.6 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 120.65 3.574 . . . . 0.0 120.65 176.159 . . . . . . . . 4 4 . 1 . 022 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.42 -39.86 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-O 122.005 0.907 . . . . 0.0 110.421 160.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -93.18 -1.95 55.76 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 176.104 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 tt -79.13 -31.32 44.07 Favored 'General case' 0 N--CA 1.417 -2.083 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 162.253 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.499 ' HA ' HG12 ' A' ' 115' ' ' ILE . 7.4 ttm-85 -60.11 -44.65 94.7 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 124.806 1.242 . . . . 0.0 111.298 169.186 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.3 t -60.14 -41.76 93.38 Favored 'General case' 0 C--N 1.371 1.515 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 76.0 mt -65.29 -29.79 70.58 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 173.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.252 5.3 mm -60.61 -48.92 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 CA-C-N 119.751 1.16 . . . . 0.0 108.361 176.836 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -51.19 -45.02 61.69 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 127.274 2.229 . . . . 0.0 110.146 178.456 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.407 ' CD2' ' HB2' ' A' ' 94' ' ' LYS . 12.2 m-30 -61.75 -49.93 74.44 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -179.275 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.695 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -72.5 -20.32 61.38 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.268 1.427 . . . . 0.0 114.298 179.248 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.73 -33.75 64.48 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 125.333 1.453 . . . . 0.0 110.677 172.397 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -67.62 -27.98 67.36 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 169.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.52 67.85 1.38 Allowed Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 105.213 -3.155 . . . . 0.0 105.213 -173.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -123.67 169.27 11.66 Favored 'General case' 0 CA--C 1.452 -2.797 1 N-CA-C 97.852 -4.87 . . . . 0.0 97.852 169.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.81 134.76 39.69 Favored 'General case' 0 CA--C 1.455 -2.704 1 N-CA-C 98.169 -4.752 . . . . 0.0 98.169 157.475 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.24 161.2 21.57 Favored 'General case' 0 N--CA 1.418 -2.037 0 C-N-CA 115.032 -2.667 . . . . 0.0 105.37 160.171 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -111.78 136.24 51.31 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 159.525 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.562 HD11 HD22 ' A' ' 174' ' ' LEU . 4.9 mm -82.47 128.64 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 165.215 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.3 m -111.99 120.31 41.46 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 169.394 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.717 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.1 OUTLIER -82.42 153.89 25.46 Favored 'General case' 0 CA--C 1.464 -2.341 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 167.162 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.496 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 67.5 ttt180 -148.94 95.39 2.4 Favored 'General case' 0 N--CA 1.393 -3.318 1 N-CA-C 95.736 -5.653 . . . . 0.0 95.736 -176.861 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.487 ' CE1' HD22 ' A' ' 128' ' ' LEU . 97.4 m-85 . . . . . 0 N--CA 1.413 -2.285 0 N-CA-C 102.347 -3.205 . . . . 0.0 102.347 175.043 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.271 74.8 mt . . . . . 0 CA--C 1.474 -1.974 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.717 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -74.33 -60.59 3.47 Favored Glycine 0 N--CA 1.405 -3.41 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.872 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.448 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 4.9 ptt? -89.61 5.61 44.9 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -160.365 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -62.56 -58.45 7.53 Favored 'General case' 0 CA--C 1.46 -2.504 0 C-N-CA 114.907 -2.717 . . . . 0.0 114.595 143.624 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.609 HG11 ' HB3' ' A' ' 98' ' ' PHE . 15.2 t -68.11 -63.06 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.442 -3.194 0 O-C-N 126.096 2.123 . . . . 0.0 107.335 -160.631 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 145' ' ' LEU . 17.7 mt -41.05 -60.15 1.29 Allowed 'General case' 0 CA--C 1.464 -2.344 0 C-N-CA 128.351 2.66 . . . . 0.0 113.454 176.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.3 t-20 -55.72 -37.8 68.9 Favored 'General case' 0 CA--C 1.464 -2.333 0 C-N-CA 125.996 1.718 . . . . 0.0 115.327 177.161 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.5 ttt85 -81.01 -14.04 58.29 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 119.861 -0.735 . . . . 0.0 111.914 175.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.8 t -75.36 -46.72 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.747 0 CA-C-O 116.037 -1.935 . . . . 0.0 106.495 176.006 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.629 ' HB2' HG21 ' A' ' 158' ' ' VAL . 1.2 ttpp -54.65 -57.03 13.07 Favored 'General case' 0 CA--C 1.459 -2.523 0 CA-C-O 116.244 -1.836 . . . . 0.0 108.22 171.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -34.58 78.22 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 120.116 1.325 . . . . 0.0 111.26 -166.587 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.6 -39.47 62.16 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 168.631 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.329 0.2 OUTLIER -80.61 -24.29 39.19 Favored 'General case' 0 CA--C 1.47 -2.109 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -176.82 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -26.07 -31.06 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.812 1 C-N-CA 136.5 5.92 . . . . 0.0 118.357 -177.882 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -52.35 -52.92 50.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.734 2.014 . . . . 0.0 114.298 170.638 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.423 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 3.2 tm? -107.52 -55.86 2.29 Favored 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 128.5 2.72 . . . . 0.0 108.434 -160.773 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.695 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.279 . . -102.0 154.88 18.56 Favored 'General case' 0 CA--C 1.449 -2.935 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 -176.1 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 18.7 m -118.66 -179.05 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.458 -2.594 0 C-N-CA 113.661 -3.216 . . . . 0.0 115.494 139.401 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.629 HG21 ' HB2' ' A' ' 149' ' ' LYS . 3.3 t -94.89 149.92 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.989 0 N-CA-C 104.94 -2.245 . . . . 0.0 104.94 166.865 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -82.28 -41.9 19.54 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 -176.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -153.43 148.23 26.43 Favored 'General case' 0 CA--C 1.47 -2.12 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -172.921 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.438 ' CZ ' ' HA ' ' A' ' 146' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.46 -2.512 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 171.495 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.496 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.314 60.1 mt-30 . . . . . 0 CA--C 1.503 -0.863 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.4 ttp -125.32 118.66 26.42 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 118.561 0.618 . . . . 0.0 111.395 -173.461 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.7 mm -80.38 124.93 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 CA-C-O 122.47 1.128 . . . . 0.0 108.534 169.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.9 ttt -105.95 136.98 44.64 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 159.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.0 t -102.32 134.28 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 117.682 -1.607 . . . . 0.0 109.123 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.562 HD22 HD11 ' A' ' 126' ' ' ILE . 11.7 tp -112.38 86.78 2.42 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 121.338 3.829 . . . . 0.0 121.338 -177.68 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.388 . . -107.77 155.54 39.65 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -178.614 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -70.2 150.6 65.77 Favored 'Trans proline' 0 CA--C 1.486 -1.877 0 C-N-CA 122.885 2.39 . . . . 0.0 109.378 -163.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt . . . . . 0 N--CA 1.433 -1.323 0 O-C-N 124.853 1.346 . . . . 0.0 108.21 -175.456 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 . . . . . 0 CA--C 1.48 -1.726 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.474 HG22 ' HE3' ' A' ' 123' ' ' LYS . 83.1 t -101.94 121.83 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.66 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 174.524 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -107.15 -178.23 3.58 Favored 'General case' 0 CA--C 1.472 -2.029 0 C-N-CA 117.373 -1.731 . . . . 0.0 107.535 162.472 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -150.03 150.12 31.32 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.058 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 tp -132.82 161.6 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 173.414 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -122.1 153.75 38.27 Favored 'General case' 0 CA--C 1.485 -1.535 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.071 164.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.59 ' HB3' HG11 ' A' ' 144' ' ' VAL . 40.6 m-85 -134.07 136.76 44.18 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.557 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.6 ttt85 . . . . . 0 N--CA 1.433 -1.276 0 CA-C-O 117.612 -1.185 . . . . 0.0 108.817 -173.713 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 N--CA 1.425 -1.712 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.8 -74.06 0.18 Allowed 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 126.525 1.93 . . . . 0.0 109.12 -169.615 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.433 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.326 0.0 OUTLIER -59.64 -11.27 4.62 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 120.335 3.457 . . . . 0.0 120.335 177.175 . . . . . . . . 4 4 . 1 . 023 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.12 -40.57 89.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 122.094 0.949 . . . . 0.0 110.296 161.387 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -92.87 -4.28 53.16 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 176.359 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.5 tt -75.84 -33.27 60.03 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 161.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.476 ' HA ' HG12 ' A' ' 115' ' ' ILE . 16.2 ttp180 -60.4 -44.93 95.22 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 125.175 1.39 . . . . 0.0 111.146 170.651 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 t -62.46 -42.63 99.61 Favored 'General case' 0 C--N 1.375 1.687 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 118' ' ' LEU 0.327 51.2 tp -68.69 -30.38 69.03 Favored 'General case' 0 N--CA 1.402 -2.835 0 C-N-CA 125.706 1.602 . . . . 0.0 113.519 177.707 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.283 8.9 mm -56.3 -52.03 56.59 Favored 'Isoleucine or valine' 0 C--N 1.378 1.833 0 CA-C-N 120.94 1.7 . . . . 0.0 109.402 171.099 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -53.47 -40.16 65.08 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 128.386 2.674 . . . . 0.0 110.559 -177.396 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -61.01 -54.16 48.39 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 124.393 1.077 . . . . 0.0 112.043 175.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.677 HD13 ' HB2' ' A' ' 156' ' ' ALA . 1.3 mt -67.76 -21.08 65.28 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -72.52 -36.21 68.29 Favored 'General case' 0 CA--C 1.491 -1.317 0 C-N-CA 126.043 1.737 . . . . 0.0 110.25 172.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -67.16 -22.2 65.77 Favored 'General case' 0 C--N 1.36 1.031 0 O-C-N 123.185 0.303 . . . . 0.0 111.214 169.303 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.83 68.1 1.42 Allowed Glycine 0 CA--C 1.469 -2.839 0 N-CA-C 104.81 -3.316 . . . . 0.0 104.81 -174.833 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -123.28 163.4 20.78 Favored 'General case' 0 CA--C 1.448 -2.971 0 N-CA-C 100.641 -3.837 . . . . 0.0 100.641 171.019 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.639 ' HD3' HG12 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -105.45 106.27 16.69 Favored 'General case' 0 N--CA 1.399 -3.007 1 N-CA-C 99.101 -4.407 . . . . 0.0 99.101 173.892 . . . . . . . . 4 4 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -97.77 128.54 44.48 Favored 'General case' 0 N--CA 1.411 -2.39 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.561 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -96.07 129.88 43.24 Favored 'General case' 0 CA--C 1.474 -1.969 0 CA-C-O 121.621 0.724 . . . . 0.0 109.325 -176.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.6 mm -82.9 132.92 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 171.381 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.526 ' HA ' HD13 ' A' ' 171' ' ' ILE . 21.8 m -113.82 120.81 42.05 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 167.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.656 HD12 HD11 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -74.2 145.65 43.98 Favored 'General case' 0 CA--C 1.474 -1.962 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 165.808 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.448 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 52.3 ttp180 -147.48 94.96 2.45 Favored 'General case' 0 N--CA 1.4 -2.93 1 N-CA-C 98.591 -4.596 . . . . 0.0 98.591 -178.739 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 . . . . . 0 N--CA 1.427 -1.596 0 CA-C-N 111.267 -2.697 . . . . 0.0 108.009 178.563 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.323 63.1 mt . . . . . 0 N--CA 1.415 -2.179 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.576 ' CA ' HD11 ' A' ' 128' ' ' LEU . . . -74.15 -61.14 3.32 Favored Glycine 0 N--CA 1.409 -3.112 0 CA-C-N 114.911 -1.041 . . . . 0.0 114.134 171.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.496 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 6.7 ptt? -85.43 -2.59 58.28 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -158.915 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.61 -53.23 59.96 Favored 'General case' 0 CA--C 1.455 -2.688 0 C-N-CA 114.807 -2.757 . . . . 0.0 114.461 150.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.59 HG11 ' HB3' ' A' ' 98' ' ' PHE . 12.7 t -69.77 -65.33 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.447 -2.998 0 O-C-N 126.011 2.069 . . . . 0.0 107.765 -164.055 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.656 HD11 HD12 ' A' ' 128' ' ' LEU . 14.5 mt -44.07 -55.07 4.98 Favored 'General case' 0 CA--C 1.481 -1.674 0 C-N-CA 128.757 2.823 . . . . 0.0 115.675 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.6 t-20 -63.76 -30.95 71.99 Favored 'General case' 0 CA--C 1.462 -2.404 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 174.234 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -81.44 -15.16 55.95 Favored 'General case' 0 N--CA 1.419 -1.993 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.853 172.387 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.466 HG21 ' CE2' ' A' ' 98' ' ' PHE . 2.0 t -74.71 -47.13 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.819 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 176.137 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.478 ' HE3' HG21 ' A' ' 158' ' ' VAL . 35.2 ttmt -51.61 -53.95 32.96 Favored 'General case' 0 CA--C 1.459 -2.558 0 C-N-CA 125.47 1.508 . . . . 0.0 110.642 172.85 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.19 -35.99 71.77 Favored 'General case' 0 N--CA 1.411 -2.415 0 C-N-CA 125.241 1.416 . . . . 0.0 110.172 -167.149 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -71.59 -34.98 70.38 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 115.872 -2.331 . . . . 0.0 114.885 170.25 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 115' ' ' ILE 0.262 0.2 OUTLIER -81.31 -26.26 35.81 Favored 'General case' 0 CA--C 1.463 -2.372 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -178.178 . . . . . . . . 4 4 . 1 . 023 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -28.62 -21.61 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.511 1 C-N-CA 135.896 5.679 . . . . 0.0 119.292 178.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -53.99 -58.45 7.27 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 125.753 1.621 . . . . 0.0 112.733 164.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 tt -111.45 -43.57 3.66 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 127.338 2.255 . . . . 0.0 109.666 -159.21 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.854 ' HB1' HD11 ' A' ' 174' ' ' LEU 0.303 . . -115.59 142.14 47.13 Favored 'General case' 0 CA--C 1.464 -2.357 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.809 179.554 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.3 m -130.02 164.83 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.021 0 N-CA-C 121.776 3.991 . . . . 0.0 121.776 147.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.7 t -79.81 149.27 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.973 0 CA-C-N 111.06 -2.791 . . . . 0.0 107.944 -174.021 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.76 -38.87 25.0 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 113.033 -1.894 . . . . 0.0 106.079 -172.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.2 t -162.57 150.01 13.69 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -171.743 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.4 t80 . . . . . 0 N--CA 1.427 -1.589 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 173.142 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.448 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.291 58.2 mt-30 . . . . . 0 CA--C 1.496 -1.12 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 15.9 ttm -118.7 170.75 8.71 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 172.365 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.526 HD13 ' HA ' ' A' ' 127' ' ' THR . 28.2 mm -117.74 142.25 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 C-N-CA 126.727 2.011 . . . . 0.0 108.232 161.553 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.7 ttt -124.33 133.81 53.35 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 102.988 -2.967 . . . . 0.0 102.988 157.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.639 HG12 ' HD3' ' A' ' 123' ' ' LYS . 1.6 t -100.75 139.75 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.021 -171.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.854 HD11 ' HB1' ' A' ' 156' ' ' ALA . 1.4 tp -131.54 130.59 42.49 Favored 'General case' 0 C--N 1.365 1.263 0 CA-C-N 121.688 2.04 . . . . 0.0 106.625 -172.418 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.299 . . -129.56 178.26 1.78 Allowed Pre-proline 0 CA--C 1.49 -1.329 0 C-N-CA 125.819 1.648 . . . . 0.0 111.819 -173.106 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -71.35 158.24 54.84 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 CA-C-N 120.925 1.366 . . . . 0.0 111.036 -177.49 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? . . . . . 0 CA--C 1.491 -1.302 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 174.36 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 . . . . . 0 CA--C 1.475 -1.916 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.532 HG22 ' HE2' ' A' ' 123' ' ' LYS . 69.2 t -88.88 117.32 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.903 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 162.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -110.29 169.75 8.53 Favored 'General case' 0 CA--C 1.483 -1.601 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 151.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -136.37 157.95 45.59 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.812 -163.164 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 tp -131.58 163.67 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 165.469 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -119.57 154.42 33.93 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 119.479 -0.888 . . . . 0.0 112.321 162.57 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.628 ' HB3' HG11 ' A' ' 144' ' ' VAL . 45.9 m-85 -129.09 147.31 50.93 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 169.571 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 . . . . . 0 N--CA 1.431 -1.401 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.877 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.8 t70 . . . . . 0 N--CA 1.414 -2.229 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -86.61 -71.62 0.54 Allowed 'General case' 0 CA--C 1.482 -1.649 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.798 -166.691 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.506 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.311 0.0 OUTLIER -61.08 -14.76 26.21 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 118.872 2.916 . . . . 0.0 118.872 172.414 . . . . . . . . 4 4 . 1 . 024 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.17 -41.71 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.982 0.913 . . . . 0.0 109.791 162.626 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -93.15 6.76 46.86 Favored 'General case' 0 CA--C 1.486 -1.513 0 O-C-N 120.376 -1.452 . . . . 0.0 114.905 175.602 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.8 tt -85.8 -31.32 22.39 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 162.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.428 ' HA ' HG12 ' A' ' 115' ' ' ILE . 14.3 ttp180 -60.47 -45.36 94.0 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.654 1.182 . . . . 0.0 109.843 168.061 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 t -58.89 -43.07 90.91 Favored 'General case' 0 C--N 1.375 1.705 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 173.375 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.432 HD11 HD12 ' A' ' 126' ' ' ILE . 10.3 mt -60.95 -33.1 72.66 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 175.493 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.434 ' CG2' ' HG ' ' A' ' 155' ' ' LEU . 3.1 mm -61.06 -46.79 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 177.285 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -53.09 22.39 Favored 'General case' 0 CA--C 1.497 -1.07 0 O-C-N 125.985 2.053 . . . . 0.0 110.923 178.146 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -58.41 -46.37 86.56 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 178.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.533 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -62.06 -36.64 82.22 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 176.119 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -79.19 -21.54 46.21 Favored 'General case' 0 CA--C 1.487 -1.469 0 C-N-CA 127.671 2.388 . . . . 0.0 112.638 -173.558 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -71.56 -15.15 62.27 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 169.22 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.61 65.5 1.5 Allowed Glycine 0 CA--C 1.462 -3.252 0 N-CA-C 104.469 -3.452 . . . . 0.0 104.469 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -133.14 173.69 11.17 Favored 'General case' 0 CA--C 1.447 -3.012 1 N-CA-C 97.724 -4.917 . . . . 0.0 97.724 170.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.532 ' HE2' HG22 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -90.01 135.02 33.9 Favored 'General case' 0 N--CA 1.399 -2.978 1 N-CA-C 97.898 -4.853 . . . . 0.0 97.898 158.611 . . . . . . . . 4 4 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -79.09 156.74 28.19 Favored 'General case' 0 N--CA 1.405 -2.677 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 156.231 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -140.06 133.13 29.52 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 101.121 -3.659 . . . . 0.0 101.121 169.719 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.475 HD11 HD12 ' A' ' 174' ' ' LEU . 8.5 mm -83.83 134.56 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.112 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -178.358 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.6 m -116.28 121.53 42.29 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 168.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.32 154.18 33.09 Favored 'General case' 0 CA--C 1.47 -2.103 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 166.778 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.558 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 35.2 ttp85 -146.07 96.67 2.83 Favored 'General case' 0 N--CA 1.397 -3.1 1 N-CA-C 96.073 -5.529 . . . . 0.0 96.073 -179.482 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 . . . . . 0 N--CA 1.419 -2.022 0 CA-C-N 111.88 -2.418 . . . . 0.0 106.212 178.101 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.424 -1.772 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -68.12 -59.78 6.11 Favored Glycine 0 N--CA 1.416 -2.677 0 O-C-N 124.222 0.951 . . . . 0.0 111.439 -176.418 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.482 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 6.8 ptm -90.88 6.36 44.83 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -161.121 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.09 -56.02 15.4 Favored 'General case' 0 CA--C 1.455 -2.703 0 C-N-CA 115.875 -2.33 . . . . 0.0 113.559 146.224 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.628 HG11 ' HB3' ' A' ' 98' ' ' PHE . 24.3 t -67.89 -66.46 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.44 -3.251 0 O-C-N 126.498 2.374 . . . . 0.0 107.39 -164.477 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.8 mt -39.27 -57.04 1.42 Allowed 'General case' 0 CA--C 1.467 -2.224 0 C-N-CA 128.138 2.575 . . . . 0.0 114.018 178.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 161' ' ' PHE . 1.2 t-20 -52.99 -45.05 67.68 Favored 'General case' 0 CA--C 1.47 -2.132 0 C-N-CA 126.607 1.963 . . . . 0.0 115.911 175.454 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -83.27 -12.86 56.3 Favored 'General case' 0 N--CA 1.424 -1.768 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.41 179.331 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 144' ' ' VAL . 2.1 t -76.27 -40.0 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.697 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 177.367 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.41 -52.16 62.72 Favored 'General case' 0 CA--C 1.449 -2.934 0 CA-C-O 117.332 -1.318 . . . . 0.0 113.108 176.696 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -60.15 -39.1 85.17 Favored 'General case' 0 N--CA 1.404 -2.747 0 C-N-CA 127.097 2.159 . . . . 0.0 108.836 -178.13 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.458 ' HB3' HD11 ' A' ' 111' ' ' LEU . 21.1 t70 -75.52 -28.55 59.16 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 117.403 2.371 . . . . 0.0 117.403 169.462 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.629 ' HG ' ' HB3' ' A' ' 156' ' ' ALA 0.269 0.0 OUTLIER -75.53 -37.12 60.27 Favored 'General case' 0 CA--C 1.477 -1.841 0 CA-C-N 120.185 1.357 . . . . 0.0 112.79 179.258 . . . . . . . . 4 4 . 1 . 024 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -27.66 -32.61 0.0 OUTLIER 'General case' 0 CA--C 1.474 -1.946 1 C-N-CA 137.071 6.148 . . . . 0.0 119.079 -164.653 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 4.7 mt-10 -52.43 -51.3 59.86 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 127.37 2.268 . . . . 0.0 113.153 172.299 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.434 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 2.7 tm? -109.4 -47.81 3.34 Favored 'General case' 0 N--CA 1.42 -1.953 0 C-N-CA 128.716 2.806 . . . . 0.0 107.472 -161.171 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.629 ' HB3' ' HG ' ' A' ' 152' ' ' LEU 0.327 . . -119.64 140.59 50.37 Favored 'General case' 0 CA--C 1.457 -2.606 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.372 -176.765 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.2 m -126.32 -176.36 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.47 -2.111 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 155.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.35 166.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.58 0 C-N-CA 126.619 1.968 . . . . 0.0 110.159 -165.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -85.87 -41.65 14.8 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 154.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -164.59 146.24 8.27 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.997 -171.742 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.495 ' CZ ' ' HA ' ' A' ' 146' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.462 -2.408 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 170.404 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.558 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.337 59.0 mt-30 . . . . . 0 CA--C 1.502 -0.866 0 CA-C-O 119.059 -0.496 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 22.4 ttp -115.32 115.53 26.78 Favored 'General case' 0 CA--C 1.481 -1.692 0 CA-C-O 121.472 0.654 . . . . 0.0 111.679 -171.706 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.0 mm -81.72 126.88 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.367 0 CA-C-O 122.123 0.964 . . . . 0.0 108.76 172.41 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.435 ' SD ' ' CZ ' ' A' ' 161' ' ' PHE . 3.2 ttt -112.65 142.96 44.63 Favored 'General case' 0 CA--C 1.476 -1.875 0 N-CA-C 103.167 -2.901 . . . . 0.0 103.167 155.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.6 t -98.87 153.37 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 118.589 -1.244 . . . . 0.0 107.696 -175.258 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.475 HD12 HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -134.92 81.75 1.92 Allowed 'General case' 0 C--N 1.36 1.053 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -174.836 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.278 . . -83.34 174.4 6.05 Favored Pre-proline 0 CA--C 1.505 -0.787 0 O-C-N 119.637 -1.914 . . . . 0.0 115.038 -175.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -68.33 135.93 35.55 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.363 2.042 . . . . 0.0 108.996 165.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt . . . . . 0 N--CA 1.43 -1.466 0 O-C-N 124.037 0.836 . . . . 0.0 110.864 171.851 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.8 m . . . . . 0 CA--C 1.482 -1.656 0 CA-C-O 122.241 1.019 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.7 mm -92.2 126.57 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 113.141 -1.845 . . . . 0.0 108.176 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -95.95 167.89 10.96 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.642 HG22 ' HD3' ' A' ' 123' ' ' LYS . 70.2 t -102.04 114.32 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.665 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 161.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -108.94 -179.83 3.97 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 156.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -143.82 158.42 43.69 Favored 'General case' 0 N--CA 1.433 -1.309 0 O-C-N 123.462 0.476 . . . . 0.0 110.544 -169.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.9 tp -135.35 162.23 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 166.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -120.91 157.26 30.25 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 118.863 0.756 . . . . 0.0 111.396 165.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.627 ' HB3' HG11 ' A' ' 144' ' ' VAL . 39.8 m-85 -136.92 100.32 4.27 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 173.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -85.45 171.31 10.97 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 124.124 0.97 . . . . 0.0 109.086 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.443 ' HG3' ' H ' ' A' ' 131' ' ' ARG . 9.2 Cg_endo -74.5 140.89 27.52 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 N-CA-C 106.202 -2.268 . . . . 0.0 106.202 174.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.36 9.9 59.91 Favored Glycine 0 CA--C 1.483 -1.952 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 95.6 m -106.04 92.79 4.3 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 170.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -128.71 174.88 9.04 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-N 112.692 -2.049 . . . . 0.0 108.993 172.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -27.32 -56.21 0.09 Allowed 'General case' 0 CA--C 1.486 -1.485 1 C-N-CA 132.399 4.28 . . . . 0.0 116.097 -145.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -21.26 -75.1 0.01 OUTLIER Glycine 0 CA--C 1.472 -2.625 1 C-N-CA 130.745 4.021 . . . . 0.0 118.539 163.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -81.58 -33.07 31.81 Favored 'General case' 0 N--CA 1.424 -1.757 0 C-N-CA 128.931 2.893 . . . . 0.0 109.357 -175.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -73.95 -71.17 0.34 Allowed 'General case' 0 CA--C 1.474 -1.977 0 CA-C-N 111.572 -2.558 . . . . 0.0 113.082 -161.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.33 0.0 OUTLIER -60.63 -14.11 18.47 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 119.639 3.2 . . . . 0.0 119.639 175.693 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 87.5 t -60.65 -47.82 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.18 0.99 . . . . 0.0 109.444 161.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -91.94 7.66 41.09 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 6.0 tt -84.08 -32.78 24.6 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 162.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.481 ' HA ' HG12 ' A' ' 115' ' ' ILE . 58.3 ttt-85 -61.87 -42.79 99.48 Favored 'General case' 0 C--N 1.363 1.189 0 CA-C-O 118.739 -0.648 . . . . 0.0 110.677 168.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.6 t -61.56 -41.31 97.19 Favored 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.512 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.46 HD11 HD23 ' A' ' 174' ' ' LEU . 65.0 tp -70.08 -29.29 66.24 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-O 117.088 -1.434 . . . . 0.0 113.541 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.481 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.269 10.0 mm -55.47 -53.08 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.957 0 CA-C-N 120.293 1.406 . . . . 0.0 107.569 170.014 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -47.29 -48.9 24.71 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 128.649 2.78 . . . . 0.0 111.776 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -56.81 -55.71 30.83 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.561 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -54.94 -36.17 64.99 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 174.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -89.1 -14.9 35.21 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 128.929 2.892 . . . . 0.0 110.341 -166.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -67.57 -24.94 65.57 Favored 'General case' 0 C--N 1.36 1.023 0 C-N-CA 122.981 0.512 . . . . 0.0 109.706 161.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 93.42 57.52 1.35 Allowed Glycine 0 CA--C 1.472 -2.655 0 N-CA-C 104.542 -3.423 . . . . 0.0 104.542 -174.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -126.53 167.73 15.23 Favored 'General case' 0 CA--C 1.462 -2.408 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.642 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -101.54 115.61 30.91 Favored 'General case' 0 N--CA 1.407 -2.597 1 N-CA-C 99.762 -4.162 . . . . 0.0 99.762 176.689 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.77 115.7 31.11 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.065 -1.425 . . . . 0.0 107.751 -168.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -97.44 121.58 39.51 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -171.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.1 mm -84.04 134.22 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.486 ' HA ' HD13 ' A' ' 171' ' ' ILE . 25.7 m -119.62 124.06 45.4 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 173.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.662 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.1 OUTLIER -88.02 155.84 19.61 Favored 'General case' 0 CA--C 1.467 -2.236 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 167.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.478 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 22.2 ttt85 -152.07 91.52 1.62 Allowed 'General case' 0 N--CA 1.397 -3.115 1 N-CA-C 99.221 -4.363 . . . . 0.0 99.221 -174.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.498 ' CE1' HD22 ' A' ' 128' ' ' LEU . 92.0 m-85 -76.1 151.41 37.05 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 112.437 -2.165 . . . . 0.0 108.755 -173.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.443 ' H ' ' HG3' ' A' ' 100' ' ' PRO . 4.9 tmt_? -82.66 92.63 7.2 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 101.675 -3.454 . . . . 0.0 101.675 153.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 176.07 -150.21 10.5 Favored Glycine 0 N--CA 1.423 -2.204 0 C-N-CA 116.067 -2.968 . . . . 0.0 112.118 -162.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.5 mtm105 -150.82 -164.24 1.97 Allowed 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -158.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -67.69 -29.41 68.67 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 126.562 1.945 . . . . 0.0 111.496 176.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 28.5 ttt -126.32 93.4 3.79 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 102.936 -2.987 . . . . 0.0 102.936 155.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.07 -57.02 6.78 Favored 'General case' 0 CA--C 1.469 -2.17 0 CA-C-O 124.729 2.204 . . . . 0.0 110.865 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.516 ' HB2' ' H ' ' A' ' 139' ' ' GLN . 14.6 p80 -118.37 172.11 7.68 Favored 'General case' 0 N--CA 1.416 -2.167 1 CA-C-N 108.174 -4.103 . . . . 0.0 112.226 -155.582 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -134.21 4.58 3.47 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 104.257 -2.498 . . . . 0.0 104.257 149.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.516 ' H ' ' HB2' ' A' ' 137' ' ' HIS . 12.3 mt-30 -120.84 -57.41 1.89 Allowed 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.116 -166.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.491 ' H ' ' HB2' ' A' ' 137' ' ' HIS . 82.1 mt -52.4 -48.27 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.188 0 C-N-CA 128.963 2.905 . . . . 0.0 111.476 -169.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.662 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -79.59 -60.95 2.38 Favored Glycine 0 N--CA 1.41 -3.099 0 C-N-CA 118.867 -1.635 . . . . 0.0 111.926 -170.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 72.4 mtm -89.51 0.08 57.14 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -161.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -67.77 -50.37 57.47 Favored 'General case' 0 CA--C 1.457 -2.614 0 C-N-CA 116.096 -2.242 . . . . 0.0 113.295 151.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.627 HG11 ' HB3' ' A' ' 98' ' ' PHE . 21.8 t -67.81 -69.22 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.443 -3.168 0 O-C-N 125.946 2.028 . . . . 0.0 108.15 -166.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' A' ' 172' ' ' MET . 27.8 mt -42.22 -53.31 4.12 Favored 'General case' 0 CA--C 1.476 -1.887 0 C-N-CA 128.929 2.891 . . . . 0.0 115.119 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -62.9 -36.16 82.43 Favored 'General case' 0 CA--C 1.46 -2.508 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -81.76 -14.15 56.82 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.603 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.6 t -77.68 -46.2 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.768 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.455 ' HB2' HG21 ' A' ' 158' ' ' VAL . 29.7 ttmt -51.93 -50.62 60.79 Favored 'General case' 0 CA--C 1.463 -2.401 0 C-N-CA 125.583 1.553 . . . . 0.0 111.003 171.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.64 -36.62 70.76 Favored 'General case' 0 N--CA 1.411 -2.404 0 C-N-CA 124.447 1.099 . . . . 0.0 110.187 -169.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -72.69 -40.09 66.5 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 116.305 -2.158 . . . . 0.0 115.299 170.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.289 0.2 OUTLIER -80.2 -19.97 45.78 Favored 'General case' 0 CA--C 1.464 -2.352 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -177.549 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -26.38 -27.04 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.443 1 C-N-CA 134.457 5.103 . . . . 0.0 118.901 173.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -55.28 -59.04 5.35 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 127.045 2.138 . . . . 0.0 112.902 169.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.42 -52.1 3.19 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 125.842 1.657 . . . . 0.0 107.805 -167.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.929 ' HB1' HD11 ' A' ' 174' ' ' LEU 0.281 . . -100.28 141.44 33.12 Favored 'General case' 0 CA--C 1.459 -2.546 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.882 -178.217 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.5 m -123.93 164.25 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.421 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 139.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.5 t -84.08 153.46 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.104 0 CA-C-N 110.021 -3.263 . . . . 0.0 108.478 -172.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -82.32 -41.25 20.32 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.3 t -152.45 151.17 30.44 Favored 'General case' 0 CA--C 1.468 -2.174 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -99.89 104.4 28.32 Favored Pre-proline 0 N--CA 1.424 -1.768 0 N-CA-C 101.199 -3.63 . . . . 0.0 101.199 164.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -74.19 -44.81 0.4 Allowed 'Trans proline' 0 CA--C 1.485 -1.954 0 C-N-CA 124.074 3.182 . . . . 0.0 111.241 -148.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.427 ' HA ' ' SD ' ' A' ' 170' ' ' MET 0.283 1.9 m 8.22 50.41 0.0 OUTLIER 'General case' 0 N--CA 1.412 -2.339 1 C-N-CA 136.185 5.794 . . . . 0.0 118.764 -156.918 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.32 105.16 7.94 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 111.33 -2.668 . . . . 0.0 106.022 163.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.402 HG23 ' HB2' ' A' ' 170' ' ' MET . 0.6 OUTLIER -81.79 141.58 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -119.35 105.89 11.75 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.77 -152.28 31.61 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -173.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -95.54 33.83 1.56 Allowed 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 125.25 1.42 . . . . 0.0 111.23 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.478 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.3 38.0 mt-30 -165.78 144.85 6.19 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 124.338 1.055 . . . . 0.0 108.221 -167.524 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.427 ' SD ' ' HA ' ' A' ' 163' ' ' THR . 51.8 ttp -134.93 118.73 17.2 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 119.155 0.889 . . . . 0.0 111.671 -173.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 127' ' ' THR . 22.0 mm -82.49 123.94 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 O-C-N 121.31 -0.869 . . . . 0.0 108.666 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.403 ' HB3' HD22 ' A' ' 145' ' ' LEU . 2.9 ttt -101.07 130.29 47.07 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 159.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.16 134.87 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -173.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.929 HD11 ' HB1' ' A' ' 156' ' ' ALA . 1.1 tp -129.19 143.73 50.96 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 -174.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.32 . . -131.98 178.36 1.79 Allowed Pre-proline 0 CA--C 1.488 -1.424 0 C-N-CA 123.813 0.845 . . . . 0.0 110.065 -174.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.523 ' HA ' HD21 ' A' ' 118' ' ' LEU . 78.0 Cg_exo -62.73 148.23 93.66 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 122.932 2.421 . . . . 0.0 109.059 160.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -74.0 125.28 27.91 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -77.03 126.91 31.74 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 113.277 -1.783 . . . . 0.0 109.726 -167.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -72.43 126.98 31.16 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 . . . . . 0 C--O 1.26 1.642 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.889 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 CA--C 1.482 -1.635 0 CA-C-O 122.204 1.002 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.4 mm -84.89 122.23 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.497 0 CA-C-N 112.842 -1.981 . . . . 0.0 106.289 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -96.72 167.05 11.35 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 -167.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.509 HG22 ' HE3' ' A' ' 123' ' ' LYS . 82.0 t -103.03 124.77 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -108.38 171.74 7.24 Favored 'General case' 0 CA--C 1.479 -1.784 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 154.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -144.43 146.65 32.6 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 tp -124.97 160.07 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.085 0 N-CA-C 103.169 -2.9 . . . . 0.0 103.169 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -119.22 154.12 33.89 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 119.414 -0.915 . . . . 0.0 110.447 162.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.588 ' HB3' HG11 ' A' ' 144' ' ' VAL . 34.1 m-85 -134.03 110.83 9.91 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -89.16 165.45 26.4 Favored Pre-proline 0 N--CA 1.429 -1.486 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.443 ' HB3' HG23 ' A' ' 140' ' ' ILE . 10.1 Cg_endo -70.84 138.46 34.43 Favored 'Trans proline' 0 N--CA 1.437 -1.847 0 C-N-CA 123.377 2.718 . . . . 0.0 106.479 167.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.04 7.8 67.65 Favored Glycine 0 CA--C 1.482 -2.028 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.6 m -101.21 91.4 4.5 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 169.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -133.85 -150.55 0.41 Allowed 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 170.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -61.2 -66.62 0.51 Allowed 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 118.76 0.709 . . . . 0.0 109.188 -85.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -104.75 33.53 6.5 Favored Glycine 0 CA--C 1.486 -1.778 0 CA-C-N 118.676 0.671 . . . . 0.0 112.854 -177.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.19 -38.02 9.47 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 152.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.91 -73.71 0.13 Allowed 'General case' 0 CA--C 1.477 -1.86 0 C-N-CA 127.209 2.203 . . . . 0.0 110.371 -173.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.487 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.275 0.0 OUTLIER -65.49 -9.02 22.32 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 119.394 3.109 . . . . 0.0 119.394 -179.321 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.84 -42.79 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 122.169 0.985 . . . . 0.0 110.793 161.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -91.67 -1.53 57.4 Favored 'General case' 0 CA--C 1.477 -1.831 0 O-C-N 120.352 -1.468 . . . . 0.0 114.686 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.5 tt -76.79 -31.98 57.36 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 161.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.536 ' HA ' HG12 ' A' ' 115' ' ' ILE . 31.4 ttt180 -62.47 -45.03 94.88 Favored 'General case' 0 C--N 1.363 1.19 0 C-N-CA 123.812 0.845 . . . . 0.0 111.482 170.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.1 m -61.77 -42.31 98.83 Favored 'General case' 0 C--N 1.377 1.796 0 C-N-CA 118.666 -1.214 . . . . 0.0 113.761 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.653 HD11 HD12 ' A' ' 174' ' ' LEU 0.323 52.4 tp -68.0 -27.92 66.98 Favored 'General case' 0 N--CA 1.406 -2.644 0 C-N-CA 126.73 2.012 . . . . 0.0 113.67 177.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.289 9.4 mm -57.33 -52.87 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.901 0 CA-C-N 121.036 1.744 . . . . 0.0 108.217 170.534 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -53.78 -42.64 68.5 Favored 'General case' 0 CA--C 1.492 -1.262 0 O-C-N 125.816 1.947 . . . . 0.0 110.402 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -58.21 -54.11 50.66 Favored 'General case' 0 CA--C 1.481 -1.701 0 C-N-CA 125.343 1.457 . . . . 0.0 112.639 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.552 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -61.16 -33.07 72.84 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 177.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -73.58 -31.56 63.66 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 129.116 2.966 . . . . 0.0 109.798 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -64.67 -19.75 65.9 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 124.213 1.005 . . . . 0.0 111.679 171.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.53 54.79 2.72 Favored Glycine 0 CA--C 1.469 -2.825 0 N-CA-C 103.995 -3.642 . . . . 0.0 103.995 -174.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -120.42 163.52 17.77 Favored 'General case' 0 CA--C 1.447 -2.984 1 N-CA-C 99.82 -4.141 . . . . 0.0 99.82 170.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.509 ' HE3' HG22 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -101.04 116.13 32.12 Favored 'General case' 0 N--CA 1.393 -3.285 1 N-CA-C 98.644 -4.576 . . . . 0.0 98.644 171.526 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.52 156.71 25.12 Favored 'General case' 0 N--CA 1.407 -2.585 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 173.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.314 27.4 mtpp -131.44 138.76 49.19 Favored 'General case' 0 CA--C 1.487 -1.458 0 O-C-N 118.688 -2.507 . . . . 0.0 104.248 163.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.9 mm -85.43 136.77 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 27.5 m -117.51 130.11 56.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 169.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.643 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.1 OUTLIER -92.19 160.09 15.34 Favored 'General case' 0 CA--C 1.468 -2.189 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 167.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.413 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 56.1 ttt180 -152.48 96.26 2.13 Favored 'General case' 0 N--CA 1.402 -2.843 1 N-CA-C 99.036 -4.431 . . . . 0.0 99.036 -174.545 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.667 ' CE2' HD13 ' A' ' 165' ' ' ILE . 96.8 m-85 -80.49 103.96 10.7 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 113.068 -1.878 . . . . 0.0 106.438 -175.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -133.54 21.13 3.94 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.67 -50.08 4.85 Favored Glycine 0 CA--C 1.46 -3.375 0 N-CA-C 105.113 -3.195 . . . . 0.0 105.113 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -122.33 153.53 38.85 Favored 'General case' 0 CA--C 1.481 -1.71 0 N-CA-C 100.603 -3.851 . . . . 0.0 100.603 161.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -54.92 -42.4 72.17 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 125.001 1.321 . . . . 0.0 111.901 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 9.7 ptm -61.81 -100.57 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.528 ' HB1' HD12 ' A' ' 165' ' ' ILE . . . 171.27 112.3 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -145.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.438 ' CD2' HD12 ' A' ' 140' ' ' ILE . 10.2 m-70 -130.38 147.9 52.14 Favored 'General case' 0 CA--C 1.477 -1.829 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.91 173.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.12 9.03 43.45 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -79.36 -55.39 5.1 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 103.831 -2.655 . . . . 0.0 103.831 163.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.443 HG23 ' HB3' ' A' ' 100' ' ' PRO . 89.5 mt -52.2 -48.96 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.843 0 C-N-CA 126.405 1.882 . . . . 0.0 111.011 175.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.643 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -78.94 -57.85 3.14 Favored Glycine 0 N--CA 1.407 -3.245 0 C-N-CA 119.355 -1.403 . . . . 0.0 112.505 -167.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 58.4 mtm -93.92 18.24 10.84 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -170.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.86 -61.25 1.96 Allowed 'General case' 0 CA--C 1.456 -2.657 0 C-N-CA 115.138 -2.625 . . . . 0.0 114.573 133.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.588 HG11 ' HB3' ' A' ' 98' ' ' PHE . 23.7 t -64.07 -66.14 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.444 -3.111 0 O-C-N 126.213 2.196 . . . . 0.0 109.064 -160.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.1 mt -43.58 -55.81 4.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 127.811 2.444 . . . . 0.0 114.003 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -53.62 -43.12 68.41 Favored 'General case' 0 CA--C 1.485 -1.522 0 C-N-CA 126.791 2.036 . . . . 0.0 114.159 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -82.48 -14.26 55.33 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 144' ' ' VAL . 2.5 t -72.93 -44.57 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.597 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.448 ' CE ' HG22 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -60.22 -53.94 51.74 Favored 'General case' 0 CA--C 1.45 -2.888 0 O-C-N 125.126 1.516 . . . . 0.0 112.722 179.433 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.88 -38.68 82.91 Favored 'General case' 0 N--CA 1.403 -2.791 0 C-N-CA 127.686 2.394 . . . . 0.0 109.241 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.412 ' HB3' HD11 ' A' ' 111' ' ' LEU . 25.4 t70 -71.01 -40.48 71.79 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 116.065 -2.254 . . . . 0.0 116.901 168.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.483 HD13 HD11 ' A' ' 174' ' ' LEU 0.277 0.2 OUTLIER -80.2 -22.89 41.39 Favored 'General case' 0 CA--C 1.463 -2.384 0 N-CA-C 117.263 2.319 . . . . 0.0 117.263 -175.285 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -27.51 -27.96 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.44 1 C-N-CA 135.376 5.47 . . . . 0.0 118.483 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 3.4 mt-10 -50.77 -53.52 31.06 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 127.353 2.261 . . . . 0.0 112.842 168.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -53.56 2.99 Favored 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 126.102 1.761 . . . . 0.0 110.309 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.552 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.299 . . -110.32 136.54 49.34 Favored 'General case' 0 CA--C 1.452 -2.821 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -163.286 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.433 HG22 ' HA ' ' A' ' 177' ' ' LYS . 12.1 m -126.16 -179.57 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.407 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 161.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.448 HG22 ' CE ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -85.71 163.41 2.67 Favored 'Isoleucine or valine' 1 N--CA 1.377 -4.091 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.54 -166.312 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -84.5 -41.72 16.25 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 156.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.422 ' H ' HG12 ' A' ' 158' ' ' VAL 0.269 0.4 OUTLIER -169.85 150.87 4.0 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.921 -169.106 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.37 91.68 2.78 Favored Pre-proline 0 N--CA 1.426 -1.649 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 167.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -83.79 -91.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.216 0 O-C-N 123.318 1.167 . . . . 0.0 110.156 -130.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.739 HG22 ' H ' ' A' ' 164' ' ' LYS 0.389 1.1 m -132.49 -104.58 0.26 Allowed 'General case' 0 N--CA 1.408 -2.537 0 N-CA-C 102.979 -2.971 . . . . 0.0 102.979 -144.183 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.739 ' H ' HG22 ' A' ' 163' ' ' THR . 18.1 ptpt -153.81 170.48 20.87 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 102.577 -3.12 . . . . 0.0 102.577 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.667 HD13 ' CE2' ' A' ' 130' ' ' PHE . 2.7 mt -79.7 137.11 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 CA-C-O 122.621 1.201 . . . . 0.0 108.33 -175.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -124.78 109.39 13.03 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.98 -147.68 30.8 Favored Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -170.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 81.4 mtt85 -104.66 36.16 2.52 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.935 -1.132 . . . . 0.0 110.487 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.413 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.267 32.3 mt-30 -169.32 145.11 3.24 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -166.195 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 56.1 ttp -141.29 116.29 9.86 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-O 122.079 0.942 . . . . 0.0 112.063 -173.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 8.7 mm -80.35 135.95 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.841 0 O-C-N 120.944 -1.098 . . . . 0.0 109.005 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -108.53 131.42 54.85 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 151.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.47 135.81 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.653 HD12 HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -120.82 81.98 1.85 Allowed 'General case' 0 C--N 1.356 0.884 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -170.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -87.03 179.01 1.92 Allowed Pre-proline 0 CA--C 1.509 -0.599 0 O-C-N 118.407 -2.683 . . . . 0.0 117.128 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.503 ' HA ' HD21 ' A' ' 118' ' ' LEU . 68.0 Cg_exo -64.35 137.69 56.97 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 122.702 2.268 . . . . 0.0 111.966 169.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.433 ' HA ' HG22 ' A' ' 157' ' ' VAL . 33.9 ttpt -81.14 135.97 35.84 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 168.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.32 107.44 17.33 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 172.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -71.63 120.68 17.56 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 . . . . . 0 C--O 1.26 1.642 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.707 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 CA--C 1.483 -1.613 0 CA-C-O 121.762 0.792 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.417 HG22 ' HG3' ' A' ' 123' ' ' LYS . 33.2 mm -86.64 121.4 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 C-N-CA 126.537 1.935 . . . . 0.0 107.657 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -113.5 161.88 16.82 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -160.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.44 117.48 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.744 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -112.24 173.99 6.1 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 153.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -139.5 159.25 42.59 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 123.34 0.4 . . . . 0.0 109.951 -165.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 tp -137.03 162.8 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 165.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -121.35 153.27 37.98 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.675 0.75 . . . . 0.0 112.225 164.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.595 ' HB3' HG11 ' A' ' 144' ' ' VAL . 43.7 m-85 -130.27 135.04 47.68 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 170.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.444 ' HD3' HH21 ' A' ' 129' ' ' ARG . 22.1 mtm-85 -113.84 171.88 4.03 Favored Pre-proline 0 N--CA 1.434 -1.249 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -73.74 136.67 23.6 Favored 'Trans proline' 0 N--CA 1.433 -2.067 0 N-CA-C 105.158 -2.67 . . . . 0.0 105.158 162.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.38 9.18 62.0 Favored Glycine 0 CA--C 1.483 -1.96 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.2 m -104.16 89.91 3.42 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -121.96 -175.63 3.15 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 112.325 -2.216 . . . . 0.0 106.249 172.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -51.18 -42.1 60.63 Favored 'General case' 0 CA--C 1.481 -1.685 0 C-N-CA 127.116 2.167 . . . . 0.0 115.103 -132.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.7 -6.52 80.0 Favored Glycine 0 N--CA 1.417 -2.621 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 -170.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -98.16 -30.8 12.44 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 125.42 1.488 . . . . 0.0 107.349 167.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.7 -73.29 0.45 Allowed 'General case' 0 CA--C 1.475 -1.904 0 CA-C-N 112.316 -2.22 . . . . 0.0 110.868 -156.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.5 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.331 0.0 OUTLIER -58.13 -15.85 11.11 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 119.038 2.977 . . . . 0.0 119.038 174.66 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.67 -48.94 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-O 122.488 1.137 . . . . 0.0 110.233 162.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -91.72 8.07 38.73 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.7 tt -84.29 -32.23 24.49 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 161.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.467 ' HA ' HG12 ' A' ' 115' ' ' ILE . 57.4 ttt180 -62.84 -44.2 96.77 Favored 'General case' 0 C--N 1.363 1.157 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.636 168.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 69.3 m -60.08 -40.38 89.34 Favored 'General case' 0 C--N 1.378 1.824 0 C-N-CA 118.464 -1.295 . . . . 0.0 113.532 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.588 HD11 HD12 ' A' ' 126' ' ' ILE . 5.9 mt -61.02 -33.68 73.65 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.3 mm -58.52 -48.86 84.24 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.648 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -49.82 -51.26 41.16 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 125.814 1.946 . . . . 0.0 112.255 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -54.75 -50.38 68.56 Favored 'General case' 0 CA--C 1.476 -1.874 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.621 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -61.73 -43.24 99.23 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 178.347 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.3 -12.63 56.46 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 125.723 1.609 . . . . 0.0 112.358 -171.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.18 -12.7 60.97 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 124.112 0.965 . . . . 0.0 109.759 166.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.82 60.73 1.57 Allowed Glycine 0 CA--C 1.467 -2.908 0 N-CA-C 106.45 -2.66 . . . . 0.0 106.45 175.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -135.93 175.49 9.55 Favored 'General case' 0 CA--C 1.462 -2.42 0 N-CA-C 102.301 -3.222 . . . . 0.0 102.301 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.417 ' HG3' HG22 ' A' ' 91' ' ' ILE 0.299 21.0 mtpt -89.21 148.05 23.82 Favored 'General case' 0 N--CA 1.405 -2.682 1 N-CA-C 100.046 -4.057 . . . . 0.0 100.046 165.35 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.469 ' HB1' ' CD2' ' A' ' 114' ' ' LEU . . . -117.26 115.41 25.23 Favored 'General case' 0 N--CA 1.407 -2.585 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 173.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -100.63 116.56 32.84 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.588 HD12 HD11 ' A' ' 114' ' ' LEU . 6.9 mm -85.73 132.23 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 28.1 m -119.65 127.92 53.36 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.429 ' CB ' ' H ' ' A' ' 170' ' ' MET 0.26 0.2 OUTLIER -79.91 154.88 28.03 Favored 'General case' 0 CA--C 1.469 -2.148 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 167.54 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.485 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 47.0 ttp180 -145.18 91.19 2.11 Favored 'General case' 0 N--CA 1.404 -2.759 1 N-CA-C 100.154 -4.017 . . . . 0.0 100.154 178.056 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -75.48 153.37 37.58 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 111.84 -2.437 . . . . 0.0 110.301 -170.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -116.88 19.77 14.22 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 170.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.0 -25.01 13.57 Favored Glycine 0 CA--C 1.482 -2.019 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 61.04 -179.85 0.11 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 129.796 3.238 . . . . 0.0 115.814 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 3.83 99.05 0.01 OUTLIER 'General case' 0 C--N 1.363 1.191 1 C-N-CA 132.907 4.483 . . . . 0.0 116.915 -169.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 37.3 tpp 55.58 73.71 0.41 Allowed 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 126.872 2.069 . . . . 0.0 107.955 -172.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.443 ' HB1' ' H ' ' A' ' 137' ' ' HIS . . . -81.27 -143.52 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 123.576 1.655 . . . . 0.0 115.159 -164.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.619 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 69.4 m80 -87.79 155.84 19.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.271 2.628 . . . . 0.0 115.604 -168.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -120.21 7.08 10.73 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 169.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -89.28 -56.57 3.21 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.619 ' HB ' ' HB2' ' A' ' 137' ' ' HIS . 93.6 mt -59.47 -43.83 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 C-N-CA 127.586 2.354 . . . . 0.0 110.41 177.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.38 -69.37 1.4 Allowed Glycine 0 N--CA 1.412 -2.918 0 O-C-N 124.094 0.871 . . . . 0.0 111.747 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 55.0 mtm -96.56 23.57 6.76 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -163.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -72.92 -55.86 6.0 Favored 'General case' 0 CA--C 1.452 -2.824 0 C-N-CA 116.355 -2.138 . . . . 0.0 113.072 135.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 98' ' ' PHE . 38.9 t -64.69 -67.28 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.445 -3.063 0 O-C-N 126.512 2.382 . . . . 0.0 108.526 -163.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.0 mt -42.02 -54.98 3.34 Favored 'General case' 0 CA--C 1.475 -1.942 0 C-N-CA 127.662 2.385 . . . . 0.0 113.768 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -54.48 -44.76 72.92 Favored 'General case' 0 CA--C 1.484 -1.559 0 C-N-CA 126.619 1.967 . . . . 0.0 114.031 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -83.26 -12.29 56.9 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 118.386 0.539 . . . . 0.0 112.102 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 144' ' ' VAL . 2.3 t -73.87 -44.46 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.683 ' NZ ' HD13 ' A' ' 174' ' ' LEU . 0.8 OUTLIER -61.12 -53.76 53.01 Favored 'General case' 0 CA--C 1.451 -2.859 0 O-C-N 125.366 1.666 . . . . 0.0 112.341 179.598 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -61.9 -36.75 82.25 Favored 'General case' 0 N--CA 1.403 -2.784 0 C-N-CA 126.807 2.043 . . . . 0.0 109.716 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.426 ' HB3' HD11 ' A' ' 111' ' ' LEU . 24.9 t70 -72.87 -34.1 66.5 Favored 'General case' 0 C--N 1.358 0.948 0 C-N-CA 115.955 -2.298 . . . . 0.0 116.469 169.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.31 0.2 OUTLIER -81.31 -27.91 34.83 Favored 'General case' 0 CA--C 1.464 -2.331 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -176.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -28.42 -25.78 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.531 1 C-N-CA 136.116 5.766 . . . . 0.0 118.885 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 5.4 mt-10 -48.71 -50.44 33.47 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 127.65 2.38 . . . . 0.0 113.234 166.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 tt -114.66 -48.57 2.85 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 126.282 1.833 . . . . 0.0 108.895 -170.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 1.046 ' HB1' HD11 ' A' ' 174' ' ' LEU 0.284 . . -110.82 131.02 55.41 Favored 'General case' 0 CA--C 1.463 -2.398 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -170.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 177' ' ' LYS . 4.2 m -128.12 175.33 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.029 0 N-CA-C 119.929 3.307 . . . . 0.0 119.929 162.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -83.14 162.49 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.388 0 C-N-CA 126.309 1.844 . . . . 0.0 111.054 -159.572 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.61 -44.19 12.83 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 159.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.491 ' H ' HG12 ' A' ' 158' ' ' VAL 0.265 0.9 OUTLIER -167.92 145.81 4.43 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.621 -171.51 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -105.74 111.21 64.69 Favored Pre-proline 0 CA--C 1.478 -1.817 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 172.058 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 73.0 Cg_endo -133.2 -119.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.419 -2.895 0 N-CA-C 103.235 -3.41 . . . . 0.0 103.235 -157.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -170.4 -40.92 0.02 OUTLIER 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 -128.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -85.94 97.57 10.31 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-O 121.256 0.55 . . . . 0.0 110.704 -155.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.03 129.0 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 169.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -108.51 94.58 5.13 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 111.694 -2.503 . . . . 0.0 105.712 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.56 -127.41 8.3 Favored Glycine 0 CA--C 1.479 -2.178 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -108.9 44.83 1.09 Allowed 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 112.473 -1.863 . . . . 0.0 109.865 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.485 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.281 20.2 mt-30 -162.25 130.6 4.1 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-O 118.585 -0.721 . . . . 0.0 111.014 -175.52 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.429 ' H ' ' CB ' ' A' ' 128' ' ' LEU . 32.5 ttp -118.43 117.54 29.31 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 119.743 1.156 . . . . 0.0 113.841 -169.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.7 mm -84.37 127.16 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.356 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.51 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -105.53 130.3 53.62 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 101.339 -3.578 . . . . 0.0 101.339 150.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.3 t -91.93 136.32 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 1.046 HD11 ' HB1' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -122.25 147.64 45.97 Favored 'General case' 0 N--CA 1.439 -0.988 1 N-CA-C 99.177 -4.379 . . . . 0.0 99.177 -176.997 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.431 ' H ' HD12 ' A' ' 174' ' ' LEU 0.351 . . -137.19 179.87 1.24 Allowed Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 125.61 1.564 . . . . 0.0 109.426 -173.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.463 ' HA ' HD21 ' A' ' 118' ' ' LEU . 84.2 Cg_exo -63.75 138.16 62.4 Favored 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 122.681 2.254 . . . . 0.0 110.176 167.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.494 ' HA ' HG22 ' A' ' 157' ' ' VAL . 36.6 ttpt -78.35 141.36 38.47 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 165.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.49 102.85 1.2 Allowed 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 125.412 1.485 . . . . 0.0 110.007 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -81.96 125.49 30.83 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 . . . . . 0 C--O 1.259 1.589 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 179.78 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 CA--C 1.478 -1.793 0 CA-C-O 122.868 1.318 . . . . 0.0 111.445 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -93.12 149.36 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.035 0 N-CA-C 102.095 -3.298 . . . . 0.0 102.095 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -97.91 163.04 12.95 Favored 'General case' 0 CA--C 1.48 -1.73 0 C-N-CA 118.088 -1.445 . . . . 0.0 109.053 -167.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.555 HG22 ' HE2' ' A' ' 123' ' ' LYS . 69.0 t -88.49 114.26 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.793 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 174.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -109.9 179.84 4.0 Favored 'General case' 0 CA--C 1.472 -2.057 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 160.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -146.68 158.01 43.82 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.585 -168.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 tp -135.59 163.25 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 169.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -116.46 154.2 30.76 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-O 121.522 0.677 . . . . 0.0 111.496 162.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.663 ' HB3' HG11 ' A' ' 144' ' ' VAL . 40.9 m-85 -130.52 131.4 45.06 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 102.866 -3.012 . . . . 0.0 102.866 166.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -113.33 171.0 4.7 Favored Pre-proline 0 N--CA 1.431 -1.376 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -74.02 140.83 28.93 Favored 'Trans proline' 0 N--CA 1.432 -2.121 0 N-CA-C 105.377 -2.586 . . . . 0.0 105.377 165.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.42 6.07 68.82 Favored Glycine 0 CA--C 1.485 -1.843 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.9 m -108.21 92.51 4.09 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 168.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -126.46 175.36 7.94 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 112.996 -1.911 . . . . 0.0 107.014 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -24.0 -57.16 0.04 OUTLIER 'General case' 0 CA--C 1.487 -1.472 1 C-N-CA 132.507 4.323 . . . . 0.0 116.223 -149.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -21.81 -77.01 0.01 OUTLIER Glycine 0 CA--C 1.47 -2.764 1 C-N-CA 131.148 4.213 . . . . 0.0 117.903 165.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . 0.328 52.6 m-20 -81.24 -32.4 33.38 Favored 'General case' 0 N--CA 1.404 -2.726 0 C-N-CA 131.052 3.741 . . . . 0.0 110.806 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -72.83 -72.58 0.24 Allowed 'General case' 0 CA--C 1.479 -1.775 0 CA-C-N 112.579 -2.101 . . . . 0.0 111.138 -163.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.419 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.34 0.0 OUTLIER -58.5 -14.67 8.5 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 119.548 3.166 . . . . 0.0 119.548 176.77 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.08 -45.86 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 C-N-CA 124.092 0.957 . . . . 0.0 110.183 163.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -91.8 4.95 51.67 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 151' ' ' ASP . 6.1 tt -82.97 -32.52 27.03 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 162.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.451 ' HA ' HG12 ' A' ' 115' ' ' ILE . 57.5 ttt180 -63.05 -42.74 99.79 Favored 'General case' 0 C--N 1.362 1.122 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.73 168.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.8 m -59.71 -40.93 89.6 Favored 'General case' 0 C--N 1.377 1.799 0 C-N-CA 118.509 -1.276 . . . . 0.0 113.36 173.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.572 HD11 HD12 ' A' ' 126' ' ' ILE . 7.6 mt -62.6 -32.84 73.91 Favored 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 175.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.0 mm -59.21 -46.67 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.533 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 174.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.57 -47.88 66.54 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 126.04 1.736 . . . . 0.0 113.079 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -54.93 -49.7 70.67 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.455 HD21 ' HA ' ' A' ' 176' ' ' PRO . 0.1 OUTLIER -60.7 -37.28 81.13 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 177.283 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -80.09 -20.82 44.23 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 128.26 2.624 . . . . 0.0 112.46 -173.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -71.97 -15.83 62.07 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 168.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.42 69.58 1.33 Allowed Glycine 0 CA--C 1.463 -3.174 0 N-CA-C 104.182 -3.567 . . . . 0.0 104.182 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -143.62 177.77 8.25 Favored 'General case' 0 CA--C 1.459 -2.529 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 171.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.555 ' HE2' HG22 ' A' ' 93' ' ' VAL . 4.0 tmmm? -116.94 114.08 23.33 Favored 'General case' 0 N--CA 1.393 -3.3 1 N-CA-C 96.929 -5.212 . . . . 0.0 96.929 -170.131 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -103.42 111.54 24.02 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.361 -1.335 . . . . 0.0 108.237 -162.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -97.6 122.85 41.16 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -164.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.572 HD12 HD11 ' A' ' 114' ' ' LEU . 6.3 mm -85.49 133.46 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.2 m -119.57 123.13 43.17 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . 0.266 0.2 OUTLIER -80.05 150.91 30.18 Favored 'General case' 0 CA--C 1.471 -2.065 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 166.058 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -145.75 95.39 2.64 Favored 'General case' 0 N--CA 1.403 -2.798 1 N-CA-C 98.712 -4.551 . . . . 0.0 98.712 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -72.75 157.5 37.39 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 112.01 -2.359 . . . . 0.0 110.476 -172.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.6 ttp-105 -129.2 28.05 5.3 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -128.09 -5.0 5.36 Favored Glycine 0 CA--C 1.483 -1.961 0 N-CA-C 105.99 -2.844 . . . . 0.0 105.99 172.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -29.74 101.7 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 130.797 3.639 . . . . 0.0 119.005 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -114.88 -110.18 0.36 Allowed 'General case' 0 N--CA 1.432 -1.338 1 N-CA-C 99.95 -4.093 . . . . 0.0 99.95 148.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 96.6 mtp -85.06 111.85 20.11 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 101.714 -3.439 . . . . 0.0 101.714 148.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.414 ' HB1' ' H ' ' A' ' 137' ' ' HIS . . . -80.65 -151.29 0.08 Allowed 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 117.155 2.28 . . . . 0.0 117.155 -157.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.59 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 56.6 m80 -97.33 143.55 27.97 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 127.037 2.135 . . . . 0.0 113.717 -166.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -107.19 8.14 29.85 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 169.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -83.57 -59.98 2.27 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 171.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' A' ' 137' ' ' HIS . 76.8 mt -54.56 -48.09 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 C-N-CA 128.434 2.694 . . . . 0.0 111.448 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.46 -58.83 4.06 Favored Glycine 0 N--CA 1.415 -2.729 0 O-C-N 123.695 0.622 . . . . 0.0 112.07 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 22.4 mtm -92.85 2.96 56.49 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 113.502 0.926 . . . . 0.0 113.502 -160.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.252 1.2 tm-20 -54.74 -71.65 0.08 Allowed 'General case' 0 CA--C 1.449 -2.913 0 C-N-CA 115.083 -2.647 . . . . 0.0 114.767 138.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.663 HG11 ' HB3' ' A' ' 98' ' ' PHE . 39.2 t -56.51 -67.6 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.441 -3.216 0 O-C-N 127.411 2.944 . . . . 0.0 108.973 -161.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.569 HD22 ' HB3' ' A' ' 172' ' ' MET . 62.2 mt -39.09 -53.78 1.79 Allowed 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 128.399 2.68 . . . . 0.0 115.213 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.409 ' HA ' ' CE2' ' A' ' 161' ' ' PHE . 1.7 t-20 -62.82 -36.71 84.09 Favored 'General case' 0 CA--C 1.46 -2.5 0 N-CA-C 117.591 2.441 . . . . 0.0 117.591 175.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -81.09 -14.46 57.73 Favored 'General case' 0 N--CA 1.417 -2.097 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.233 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.5 t -77.58 -43.11 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.48 ' HB2' HG21 ' A' ' 158' ' ' VAL . 30.5 ttmt -52.93 -51.09 62.55 Favored 'General case' 0 CA--C 1.464 -2.364 0 CA-C-O 117.024 -1.465 . . . . 0.0 110.8 169.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.75 -38.2 73.48 Favored 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 124.27 1.028 . . . . 0.0 110.071 -168.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.429 ' HB3' HD11 ' A' ' 111' ' ' LEU . 9.9 t70 -75.65 -28.78 58.88 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 116.673 -2.011 . . . . 0.0 115.414 171.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 156' ' ' ALA 0.286 0.1 OUTLIER -76.39 -33.02 58.88 Favored 'General case' 0 CA--C 1.475 -1.931 0 CA-C-O 116.827 -1.559 . . . . 0.0 113.084 178.107 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -28.26 -26.94 0.0 OUTLIER 'General case' 0 CA--C 1.483 -1.623 1 C-N-CA 135.468 5.507 . . . . 0.0 119.525 -172.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.417 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.7 mt-10 -57.63 -59.0 5.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.155 2.182 . . . . 0.0 112.246 171.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.08 -52.18 3.48 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.39 -1.732 . . . . 0.0 108.186 -167.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.541 ' CB ' HD11 ' A' ' 174' ' ' LEU 0.284 . . -98.85 147.53 24.84 Favored 'General case' 0 CA--C 1.459 -2.533 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.773 -178.731 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.43 171.41 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.765 0 C-N-CA 114.794 -2.762 . . . . 0.0 116.405 134.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.7 t -82.37 155.88 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.979 0 C-N-CA 128.948 2.899 . . . . 0.0 109.798 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -82.16 -42.93 18.39 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 113.7 -1.591 . . . . 0.0 106.885 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.7 t -152.87 144.97 23.81 Favored 'General case' 0 CA--C 1.464 -2.328 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.409 ' CE2' ' HA ' ' A' ' 146' ' ' ASN . 2.7 t80 -107.69 111.83 62.41 Favored Pre-proline 0 N--CA 1.421 -1.918 0 N-CA-C 101.087 -3.671 . . . . 0.0 101.087 163.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -107.44 -116.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.412 -3.312 1 N-CA-C 100.622 -4.415 . . . . 0.0 100.622 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 175.28 -48.47 0.01 OUTLIER 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 100.387 -3.931 . . . . 0.0 100.387 -140.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -85.26 115.6 23.13 Favored 'General case' 0 CA--C 1.487 -1.458 0 CA-C-O 123.052 1.406 . . . . 0.0 111.705 -155.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.4 mt -82.41 143.43 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 CA-C-N 113.022 -1.899 . . . . 0.0 107.258 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -104.85 84.28 2.12 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 176.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.93 -129.34 9.14 Favored Glycine 0 CA--C 1.482 -2.008 0 CA-C-O 122.94 1.3 . . . . 0.0 110.857 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -94.43 25.18 4.03 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 126.722 2.009 . . . . 0.0 114.155 -172.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.251 20.4 mt-30 -172.13 130.93 0.62 Allowed 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -165.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.7 ttp -113.6 113.59 25.28 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 118.742 0.701 . . . . 0.0 110.326 -172.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.1 mm -82.17 124.98 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 O-C-N 121.227 -0.921 . . . . 0.0 108.756 170.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.569 ' HB3' HD22 ' A' ' 145' ' ' LEU . 4.2 ttp -106.92 135.44 48.47 Favored 'General case' 0 CA--C 1.471 -2.081 0 N-CA-C 101.783 -3.414 . . . . 0.0 101.783 156.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 t -98.1 132.94 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 C-N-CA 116.486 -2.085 . . . . 0.0 106.894 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.541 HD11 ' CB ' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -116.47 148.33 40.86 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 100.255 -3.98 . . . . 0.0 100.255 -177.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -142.06 -173.96 0.39 Allowed Pre-proline 0 N--CA 1.431 -1.401 0 CA-C-O 117.009 -1.472 . . . . 0.0 110.242 -172.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.455 ' HA ' HD21 ' A' ' 118' ' ' LEU . 71.3 Cg_exo -68.88 153.67 72.34 Favored 'Trans proline' 0 N--CA 1.437 -1.823 0 C-N-CA 122.564 2.176 . . . . 0.0 108.817 165.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -77.55 113.94 15.88 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 169.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -100.96 79.63 2.05 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -75.48 117.06 16.85 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 . . . . . 0 C--O 1.261 1.664 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -178.691 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 CA--C 1.479 -1.766 0 CA-C-O 122.174 0.988 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.4 mm -86.27 116.97 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 CA-C-N 112.874 -1.967 . . . . 0.0 106.808 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -95.08 164.82 12.71 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -170.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.471 HG22 ' HE3' ' A' ' 123' ' ' LYS . 99.3 t -103.22 120.67 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.627 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 172.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -104.34 171.81 7.14 Favored 'General case' 0 CA--C 1.482 -1.661 0 C-N-CA 117.863 -1.535 . . . . 0.0 107.203 152.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -144.46 154.73 43.23 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.52 165.23 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 171.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -111.32 153.71 25.57 Favored 'General case' 0 CA--C 1.487 -1.456 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.113 166.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.593 ' HB3' HG11 ' A' ' 144' ' ' VAL . 3.1 m-85 -140.24 98.9 3.53 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 172.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -87.71 172.97 7.02 Favored Pre-proline 0 N--CA 1.435 -1.193 0 C-N-CA 125.376 1.471 . . . . 0.0 110.013 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.74 135.53 26.07 Favored 'Trans proline' 0 N--CA 1.433 -2.078 0 N-CA-C 105.596 -2.501 . . . . 0.0 105.596 168.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.61 13.89 60.6 Favored Glycine 0 CA--C 1.483 -1.952 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 106' ' ' ASP . 38.1 m -107.54 88.45 2.74 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 168.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.256 0.6 OUTLIER -111.42 -179.5 3.73 Favored 'General case' 1 N--CA 1.373 -4.317 0 C-N-CA 128.867 2.867 . . . . 0.0 109.998 176.553 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -51.04 -40.21 57.74 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 127.747 2.419 . . . . 0.0 114.689 -138.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.83 -17.55 69.99 Favored Glycine 0 N--CA 1.414 -2.793 0 N-CA-C 117.169 1.628 . . . . 0.0 117.169 -171.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.406 ' HB3' HG23 ' A' ' 102' ' ' THR 0.263 0.9 OUTLIER -93.86 -27.29 16.5 Favored 'General case' 0 N--CA 1.404 -2.728 0 C-N-CA 126.169 1.788 . . . . 0.0 108.376 169.556 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -87.14 -72.18 0.52 Allowed 'General case' 0 CA--C 1.477 -1.833 0 CA-C-N 113.953 -1.476 . . . . 0.0 109.787 -158.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.453 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.35 0.0 OUTLIER -55.61 -15.36 2.85 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 120.018 3.34 . . . . 0.0 120.018 173.905 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.4 t -61.54 -46.82 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 123.397 1.57 . . . . 0.0 110.373 163.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -89.25 -18.5 26.91 Favored 'General case' 0 CA--C 1.468 -2.207 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.415 ' CB ' ' HA ' ' A' ' 108' ' ' GLN . 2.0 tt -56.23 -38.26 70.83 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.094 154.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.549 ' HA ' HG12 ' A' ' 115' ' ' ILE . 42.3 ttt-85 -60.02 -42.93 95.42 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-N 119.193 0.906 . . . . 0.0 111.756 169.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.0 t -56.78 -45.87 81.87 Favored 'General case' 0 C--N 1.376 1.756 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.272 72.2 mt -67.7 -24.83 65.44 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.549 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.284 7.2 mm -60.74 -51.09 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.437 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 172.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.37 -43.72 68.03 Favored 'General case' 0 N--CA 1.426 -1.63 0 O-C-N 126.196 2.185 . . . . 0.0 109.898 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -60.51 -53.8 53.2 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.682 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -69.49 -21.01 63.72 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 126.926 2.091 . . . . 0.0 114.649 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -73.26 -37.1 66.42 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 127.188 2.195 . . . . 0.0 108.625 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -66.51 -26.98 67.42 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 123.14 0.576 . . . . 0.0 110.669 170.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.45 65.05 1.47 Allowed Glycine 0 CA--C 1.471 -2.662 0 N-CA-C 104.717 -3.353 . . . . 0.0 104.717 -171.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -119.97 166.41 13.38 Favored 'General case' 0 CA--C 1.451 -2.848 1 N-CA-C 97.775 -4.898 . . . . 0.0 97.775 169.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.471 ' HE3' HG22 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -106.63 116.97 32.85 Favored 'General case' 0 N--CA 1.395 -3.202 1 N-CA-C 97.365 -5.05 . . . . 0.0 97.365 171.018 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.27 159.09 21.02 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.416 ' HA ' ' H ' ' A' ' 174' ' ' LEU 0.258 44.8 mtmt -128.08 133.54 49.06 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 163.162 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.421 HG12 ' SD ' ' A' ' 172' ' ' MET . 6.9 mm -86.3 129.96 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.3 m -100.38 126.16 46.72 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 168.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.614 HD23 HD11 ' A' ' 145' ' ' LEU 0.278 0.3 OUTLIER -80.28 152.1 29.2 Favored 'General case' 0 CA--C 1.462 -2.412 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 164.724 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.517 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 42.3 ttt180 -149.42 96.42 2.5 Favored 'General case' 0 N--CA 1.395 -3.216 1 N-CA-C 96.853 -5.24 . . . . 0.0 96.853 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -71.5 -175.35 1.28 Allowed 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 112.227 -2.26 . . . . 0.0 111.542 -172.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -57.54 -76.75 0.03 OUTLIER 'General case' 0 CA--C 1.481 -1.693 0 CA-C-O 123.552 1.644 . . . . 0.0 107.537 166.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 171.26 138.64 2.57 Favored Glycine 0 CA--C 1.474 -2.502 0 CA-C-N 111.686 -2.507 . . . . 0.0 109.395 148.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -149.84 177.54 9.73 Favored 'General case' 0 CA--C 1.496 -1.131 0 C-N-CA 118.204 -1.398 . . . . 0.0 107.409 158.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.81 -60.0 3.05 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 123.516 0.726 . . . . 0.0 109.464 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 94.9 mmm -109.68 105.29 14.49 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 102.837 -3.023 . . . . 0.0 102.837 159.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.18 172.71 3.61 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.465 ' CG ' HD12 ' A' ' 140' ' ' ILE . 7.3 m80 -22.05 120.31 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 129.581 3.153 . . . . 0.0 114.316 147.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -106.47 7.27 30.88 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -89.61 -51.3 5.6 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.465 HD12 ' CG ' ' A' ' 137' ' ' HIS . 67.5 mt -52.62 -41.82 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.624 2.37 . . . . 0.0 111.709 173.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.47 -61.4 3.9 Favored Glycine 0 N--CA 1.417 -2.627 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.513 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 8.4 ptm -87.51 -3.2 59.0 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -156.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -53.37 57.46 Favored 'General case' 0 CA--C 1.452 -2.813 0 C-N-CA 115.391 -2.524 . . . . 0.0 114.095 152.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.593 HG11 ' HB3' ' A' ' 98' ' ' PHE . 20.1 t -69.62 -64.33 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.445 -3.071 0 O-C-N 126.308 2.255 . . . . 0.0 107.859 -162.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.754 HD13 ' HB2' ' A' ' 172' ' ' MET . 90.2 mt -47.13 -52.98 13.99 Favored 'General case' 0 CA--C 1.477 -1.831 0 C-N-CA 128.274 2.63 . . . . 0.0 114.789 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 142' ' ' MET 0.258 1.5 t30 -62.9 -30.86 71.86 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 174.484 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -82.83 -14.31 54.58 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.385 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.441 HG12 HD12 ' A' ' 152' ' ' LEU . 2.1 t -76.23 -46.67 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.628 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 177.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.449 ' HE3' ' CG2' ' A' ' 158' ' ' VAL 0.265 25.2 ttmt -49.51 -53.68 22.06 Favored 'General case' 0 CA--C 1.458 -2.56 0 C-N-CA 125.895 1.678 . . . . 0.0 111.539 173.643 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -37.2 63.69 Favored 'General case' 0 N--CA 1.408 -2.56 0 C-N-CA 126.469 1.907 . . . . 0.0 109.985 -167.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.79 -31.62 66.79 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 116.339 -2.144 . . . . 0.0 114.678 171.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.441 HD12 HG12 ' A' ' 148' ' ' VAL 0.296 0.2 OUTLIER -83.51 -27.48 29.34 Favored 'General case' 0 CA--C 1.46 -2.51 0 CA-C-O 115.702 -2.094 . . . . 0.0 115.326 179.892 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -28.07 -22.31 0.0 OUTLIER 'General case' 0 CA--C 1.483 -1.624 1 C-N-CA 136.163 5.785 . . . . 0.0 119.786 -174.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -50.16 -49.58 51.72 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 126.342 1.857 . . . . 0.0 115.042 162.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -121.6 -52.77 2.01 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 128.06 2.544 . . . . 0.0 107.23 -157.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.682 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.362 . . -112.1 148.16 34.54 Favored 'General case' 0 CA--C 1.452 -2.791 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -176.277 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -119.93 -178.27 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.459 -2.528 0 C-N-CA 116.128 -2.229 . . . . 0.0 115.672 147.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 160' ' ' SER . 6.0 t -86.64 148.63 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 165.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -82.39 -39.54 22.56 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.532 ' H ' HG12 ' A' ' 158' ' ' VAL . 0.9 OUTLIER -150.61 131.0 13.74 Favored 'General case' 0 CA--C 1.465 -2.316 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -174.279 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -106.67 117.81 55.95 Favored Pre-proline 0 N--CA 1.424 -1.755 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -132.69 -118.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.413 -3.208 1 N-CA-C 101.054 -4.248 . . . . 0.0 101.054 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -174.22 -44.2 0.01 OUTLIER 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 -133.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -85.61 103.81 14.77 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-O 122.26 1.029 . . . . 0.0 110.866 -159.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.6 mt -81.78 142.02 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.254 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -119.31 100.61 7.42 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.74 -143.89 27.18 Favored Glycine 0 CA--C 1.482 -1.969 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -173.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 43.0 ptt85 -96.46 38.14 1.22 Allowed 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 125.673 1.589 . . . . 0.0 110.707 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.517 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.317 46.2 mt-30 -166.72 135.5 2.85 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.229 0.612 . . . . 0.0 110.635 -172.358 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 38.1 ttp -123.0 117.27 25.09 Favored 'General case' 0 C--N 1.364 1.214 0 CA-C-N 118.802 0.728 . . . . 0.0 112.633 -172.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.7 mm -82.19 123.84 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 O-C-N 120.555 -1.341 . . . . 0.0 109.058 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.754 ' HB2' HD13 ' A' ' 145' ' ' LEU . 2.8 tmm? -100.47 128.57 46.49 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 157.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.22 122.94 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.404 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.553 HD13 ' CD1' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -105.2 69.12 0.84 Allowed 'General case' 0 C--N 1.354 0.765 0 C-N-CA 127.654 2.382 . . . . 0.0 117.281 -170.506 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.335 . . -91.48 172.59 6.37 Favored Pre-proline 0 C--N 1.359 0.99 0 N-CA-C 119.604 3.187 . . . . 0.0 119.604 -171.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -68.85 140.08 45.24 Favored 'Trans proline' 0 CA--C 1.491 -1.661 0 CA-C-N 120.912 1.362 . . . . 0.0 110.922 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -79.95 135.27 36.36 Favored 'General case' 0 CA--C 1.483 -1.597 0 O-C-N 125.0 1.438 . . . . 0.0 107.263 176.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -72.66 118.43 15.57 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 113.969 -1.468 . . . . 0.0 107.142 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -70.68 134.7 47.75 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.559 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 . . . . . 0 C--O 1.26 1.638 0 CA-C-O 117.79 -1.1 . . . . 0.0 108.657 -178.449 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.47 -2.124 0 CA-C-O 124.631 2.157 . . . . 0.0 107.684 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.0 mm -87.34 121.0 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 CA-C-N 108.67 -3.877 . . . . 0.0 107.801 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -111.04 164.99 12.25 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -162.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.465 HG22 ' HE2' ' A' ' 123' ' ' LYS . 75.3 t -90.2 120.62 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.801 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 161.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -112.09 166.54 11.15 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 150.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -133.94 155.72 49.42 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.002 -164.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 tp -135.72 162.82 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 101.881 -3.377 . . . . 0.0 101.881 166.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -111.15 157.78 19.65 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 119.413 1.006 . . . . 0.0 109.612 163.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.67 ' HB3' HG11 ' A' ' 144' ' ' VAL . 17.1 m-85 -125.74 135.15 51.73 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 166.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mpm_? -104.7 167.79 9.39 Favored Pre-proline 0 N--CA 1.424 -1.735 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.359 -167.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.496 ' HA ' HG23 ' A' ' 140' ' ' ILE . 21.8 Cg_exo -57.72 138.16 84.73 Favored 'Trans proline' 0 CA--C 1.483 -2.052 0 C-N-CA 125.115 3.876 . . . . 0.0 112.841 169.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.42 -119.32 9.23 Favored Glycine 0 CA--C 1.479 -2.182 0 N-CA-C 106.803 -2.519 . . . . 0.0 106.803 -170.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.5 m 52.34 103.82 0.01 OUTLIER 'General case' 0 CA--C 1.481 -1.674 0 C-N-CA 130.212 3.405 . . . . 0.0 114.038 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -131.39 -139.44 0.21 Allowed 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 103.668 -2.715 . . . . 0.0 103.668 170.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.06 -72.76 0.12 Allowed 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -84.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.39 44.54 1.53 Allowed Glycine 0 CA--C 1.485 -1.841 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.606 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -106.18 -39.49 5.94 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 147.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.9 -71.78 0.31 Allowed 'General case' 0 CA--C 1.481 -1.693 0 C-N-CA 126.265 1.826 . . . . 0.0 109.475 -170.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.325 0.0 OUTLIER -59.32 -15.48 16.36 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 119.487 3.144 . . . . 0.0 119.487 173.517 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.66 -43.56 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 121.556 0.693 . . . . 0.0 109.937 162.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -92.39 7.38 43.21 Favored 'General case' 0 CA--C 1.485 -1.556 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 6.2 tt -85.13 -31.5 23.26 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 104.038 -2.579 . . . . 0.0 104.038 161.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.495 ' HA ' HG12 ' A' ' 115' ' ' ILE . 31.7 ttt180 -62.97 -43.2 99.45 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 122.88 0.472 . . . . 0.0 110.969 168.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.2 t -56.51 -45.26 81.15 Favored 'General case' 0 C--N 1.376 1.732 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.66 -30.23 71.37 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.495 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.8 mm -58.54 -48.49 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.521 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 173.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.1 tpt85 -52.37 -50.29 62.7 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 125.466 1.729 . . . . 0.0 112.391 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -57.58 -44.97 85.75 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.53 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -65.57 -35.39 80.7 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 176.539 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -77.69 -20.87 52.92 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 127.821 2.448 . . . . 0.0 112.417 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -67.87 -19.91 65.07 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 123.658 0.783 . . . . 0.0 109.422 169.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.45 61.59 1.7 Allowed Glycine 0 CA--C 1.46 -3.357 0 N-CA-C 103.561 -3.816 . . . . 0.0 103.561 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -134.19 175.45 9.49 Favored 'General case' 0 CA--C 1.446 -3.043 1 N-CA-C 99.003 -4.443 . . . . 0.0 99.003 173.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HE2' HG22 ' A' ' 93' ' ' VAL 0.263 17.8 mtpt -89.12 140.19 29.71 Favored 'General case' 0 N--CA 1.396 -3.167 1 N-CA-C 97.55 -4.981 . . . . 0.0 97.55 163.622 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.582 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -84.49 160.34 20.56 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 155.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -142.33 125.87 16.79 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 102.673 -3.084 . . . . 0.0 102.673 167.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.556 HG21 ' HD2' ' A' ' 98' ' ' PHE . 4.0 mm -86.14 122.72 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.41 ' HA ' HD13 ' A' ' 171' ' ' ILE . 11.9 m -92.66 123.0 35.63 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 163.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.803 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.2 OUTLIER -84.11 152.05 24.55 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 165.391 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.444 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 28.0 ttm180 -152.56 91.5 1.58 Allowed 'General case' 0 N--CA 1.393 -3.281 1 N-CA-C 98.752 -4.536 . . . . 0.0 98.752 -172.753 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.476 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 93.9 m-85 -79.6 158.09 27.18 Favored 'General case' 0 N--CA 1.417 -2.075 0 CA-C-N 112.638 -2.074 . . . . 0.0 107.128 -175.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -89.77 80.99 6.44 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 104.06 -2.571 . . . . 0.0 104.06 155.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.67 -144.31 7.91 Favored Glycine 0 CA--C 1.478 -2.259 0 C-N-CA 120.07 -1.062 . . . . 0.0 114.237 -143.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.492 ' H ' ' HB2' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -144.34 -168.13 2.81 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -170.742 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -66.06 -55.68 15.36 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 124.334 1.054 . . . . 0.0 110.464 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 35.3 mtt -111.93 113.61 26.03 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 102.437 -3.172 . . . . 0.0 102.437 153.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.492 ' HB2' ' H ' ' A' ' 133' ' ' ARG . . . -76.8 178.14 7.07 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -172.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.442 ' HB3' ' H ' ' A' ' 139' ' ' GLN . 98.5 m-70 0.43 -95.75 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.359 1 C-N-CA 131.754 4.022 . . . . 0.0 120.127 172.17 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 73.9 13.96 4.1 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 127.131 2.173 . . . . 0.0 110.278 -165.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.442 ' H ' ' HB3' ' A' ' 137' ' ' HIS . 20.8 mt-30 -106.71 -55.65 2.3 Favored 'General case' 0 CA--C 1.48 -1.733 0 N-CA-C 101.118 -3.66 . . . . 0.0 101.118 171.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.496 HG23 ' HA ' ' A' ' 100' ' ' PRO . 66.8 mt -54.17 -42.43 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 C-N-CA 127.344 2.258 . . . . 0.0 110.908 167.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.803 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -76.57 -59.82 3.17 Favored Glycine 0 CA--C 1.466 -2.982 0 C-N-CA 119.059 -1.543 . . . . 0.0 113.122 -172.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 60.5 mtm -88.02 -0.07 56.58 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -166.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -68.16 -47.7 67.31 Favored 'General case' 0 CA--C 1.457 -2.632 0 C-N-CA 114.73 -2.788 . . . . 0.0 113.33 151.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.67 HG11 ' HB3' ' A' ' 98' ' ' PHE . 31.9 t -70.1 -68.98 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.436 -3.426 0 O-C-N 125.67 1.856 . . . . 0.0 107.343 -163.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.537 HD21 HD12 ' A' ' 128' ' ' LEU . 1.3 mp -48.79 -50.54 33.69 Favored 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 129.217 3.007 . . . . 0.0 113.259 -175.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -61.03 -37.01 81.07 Favored 'General case' 0 CA--C 1.471 -2.061 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -81.02 -14.22 58.11 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.512 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.7 t -76.14 -49.1 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.645 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.281 11.9 ttmt -51.95 -45.84 64.53 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 126.394 1.878 . . . . 0.0 113.096 171.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.57 -36.48 63.07 Favored 'General case' 0 N--CA 1.409 -2.492 0 C-N-CA 124.347 1.059 . . . . 0.0 110.024 -171.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -72.94 -39.72 66.0 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 116.473 -2.091 . . . . 0.0 115.178 169.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.47 HD13 HD11 ' A' ' 174' ' ' LEU 0.306 0.2 OUTLIER -79.61 -20.24 47.32 Favored 'General case' 0 CA--C 1.46 -2.514 0 CA-C-O 116.357 -1.782 . . . . 0.0 115.759 -177.271 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -26.24 -23.79 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.493 1 C-N-CA 135.042 5.337 . . . . 0.0 119.55 175.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 6.0 mt-10 -51.69 -56.54 13.1 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 126.993 2.117 . . . . 0.0 113.21 165.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.3 tt -116.38 -47.42 2.74 Favored 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 126.455 1.902 . . . . 0.0 109.291 -162.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.53 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.352 . . -110.14 143.45 40.21 Favored 'General case' 0 CA--C 1.448 -2.954 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.043 -179.557 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.8 m -120.46 171.98 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.483 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 140.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.522 HG22 HD23 ' A' ' 174' ' ' LEU . 4.0 t -81.46 151.54 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.931 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 172.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -80.92 -38.35 28.02 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 125.581 1.552 . . . . 0.0 107.005 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.478 ' H ' HG12 ' A' ' 158' ' ' VAL . 5.4 t -118.44 -176.32 3.05 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 145' ' ' LEU . 10.7 t80 -130.73 101.82 16.77 Favored Pre-proline 0 N--CA 1.42 -1.959 0 N-CA-C 101.111 -3.663 . . . . 0.0 101.111 139.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -75.5 -38.41 1.41 Allowed 'Trans proline' 0 CA--C 1.485 -1.941 0 C-N-CA 122.301 2.001 . . . . 0.0 112.458 -145.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . 0.318 2.4 m 9.66 48.78 0.0 OUTLIER 'General case' 0 N--CA 1.416 -2.165 1 C-N-CA 135.684 5.593 . . . . 0.0 118.713 -160.142 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -123.09 97.85 5.62 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 111.423 -2.626 . . . . 0.0 105.096 164.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -75.28 139.48 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -112.01 85.41 2.14 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.916 -1.493 . . . . 0.0 107.694 -175.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.66 -140.54 20.39 Favored Glycine 0 CA--C 1.485 -1.819 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.1 ttp85 -92.74 28.25 2.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 125.412 1.485 . . . . 0.0 111.214 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.444 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.291 36.4 mt-30 -169.04 155.13 6.47 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -167.261 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 60.7 ttp -146.47 120.85 9.63 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 118.933 0.788 . . . . 0.0 110.765 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 127' ' ' THR . 14.4 mm -79.64 126.89 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 O-C-N 120.786 -1.196 . . . . 0.0 108.627 173.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.404 ' SD ' HG11 ' A' ' 158' ' ' VAL . 4.7 ttp -105.5 135.24 47.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 160.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.58 126.39 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 118.299 -1.36 . . . . 0.0 109.68 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.582 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 0.1 OUTLIER -110.78 80.32 1.29 Allowed 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 -168.129 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.279 . . -85.82 174.91 5.0 Favored Pre-proline 0 CA--C 1.498 -1.032 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -169.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -64.15 141.48 76.34 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 C-N-CA 123.243 2.629 . . . . 0.0 108.263 160.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -76.88 153.83 34.36 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 124.216 0.947 . . . . 0.0 110.856 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -68.76 115.27 7.91 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 170.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -76.49 105.84 7.78 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 . . . . . 0 C--O 1.261 1.672 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -176.659 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.469 -2.135 0 CA-C-O 124.7 2.191 . . . . 0.0 107.645 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.1 mm -91.18 130.85 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 CA-C-N 108.703 -3.862 . . . . 0.0 108.908 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -89.64 162.79 15.44 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.9 t -96.67 115.7 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.792 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 160.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -107.35 175.45 5.49 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 152.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -135.17 155.34 50.85 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 tp -134.66 162.79 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 102.573 -3.121 . . . . 0.0 102.573 164.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -112.31 159.96 18.14 Favored 'General case' 0 CA--C 1.487 -1.465 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.195 161.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.551 ' HB3' HG11 ' A' ' 144' ' ' VAL . 10.8 m-85 -129.31 149.23 51.19 Favored 'General case' 0 CA--C 1.475 -1.924 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 166.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.89 157.81 40.8 Favored Pre-proline 0 N--CA 1.417 -2.109 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.845 -171.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.558 ' HG3' ' H ' ' A' ' 131' ' ' ARG . 18.2 Cg_endo -67.28 124.65 12.37 Favored 'Trans proline' 0 N--CA 1.44 -1.652 1 C-N-CA 125.475 4.117 . . . . 0.0 108.314 168.47 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 26.01 98.24 0.01 OUTLIER Glycine 0 CA--C 1.478 -2.229 0 C-N-CA 130.559 3.933 . . . . 0.0 115.214 -176.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.0 m -163.63 119.08 1.64 Allowed 'General case' 0 CA--C 1.472 -2.047 0 N-CA-C 101.928 -3.36 . . . . 0.0 101.928 -165.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -117.41 -130.5 0.3 Allowed 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -58.16 -81.35 0.02 OUTLIER 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -90.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.33 43.24 1.8 Allowed Glycine 0 CA--C 1.482 -1.987 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.851 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -104.26 -41.0 5.91 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 150.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -74.92 -72.73 0.28 Allowed 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 125.902 1.681 . . . . 0.0 108.677 -171.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.439 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.328 0.0 OUTLIER -58.57 -12.42 4.04 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 120.417 3.488 . . . . 0.0 120.417 178.494 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.56 -41.82 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 C-N-CA 124.197 0.999 . . . . 0.0 110.184 161.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -92.58 -0.09 57.36 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.418 HD11 ' HB3' ' A' ' 151' ' ' ASP . 5.6 tt -77.52 -35.1 53.75 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 162.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.435 ' HA ' HG12 ' A' ' 115' ' ' ILE . 9.3 ttp180 -60.87 -44.74 96.64 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 125.093 1.357 . . . . 0.0 110.67 171.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.4 m -59.64 -42.18 92.16 Favored 'General case' 0 C--N 1.378 1.831 0 C-N-CA 118.755 -1.178 . . . . 0.0 113.396 174.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.49 HD11 HD12 ' A' ' 126' ' ' ILE . 40.5 mt -62.2 -33.58 74.82 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 176.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.2 mm -55.43 -50.52 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 O-C-N 124.433 1.083 . . . . 0.0 108.37 173.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.9 tpt85 -51.71 -45.73 63.67 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 126.207 1.803 . . . . 0.0 112.783 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -58.08 -51.72 68.54 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.825 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -72.21 -19.61 61.7 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -73.45 -34.51 65.44 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 125.257 1.423 . . . . 0.0 110.294 173.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -67.89 -27.84 67.0 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 169.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.56 61.73 1.68 Allowed Glycine 0 CA--C 1.471 -2.678 0 N-CA-C 105.73 -2.948 . . . . 0.0 105.73 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -122.44 170.55 9.85 Favored 'General case' 0 CA--C 1.461 -2.467 1 N-CA-C 98.541 -4.614 . . . . 0.0 98.541 171.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -105.58 122.94 47.06 Favored 'General case' 0 N--CA 1.401 -2.879 1 N-CA-C 97.079 -5.156 . . . . 0.0 97.079 171.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.03 155.32 22.78 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 114.897 -2.721 . . . . 0.0 103.807 167.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.407 ' HG2' HG13 ' A' ' 173' ' ' VAL . 87.4 mttt -115.71 127.35 55.07 Favored 'General case' 0 CA--C 1.476 -1.899 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 165.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.635 HD11 HD22 ' A' ' 174' ' ' LEU . 3.2 mm -86.65 116.03 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 176.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.3 m -98.13 119.01 36.03 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 172.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.719 HD12 HD11 ' A' ' 145' ' ' LEU 0.287 0.3 OUTLIER -79.95 145.49 32.57 Favored 'General case' 0 CA--C 1.466 -2.263 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 167.844 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -150.46 89.17 1.54 Allowed 'General case' 0 N--CA 1.401 -2.895 1 N-CA-C 96.192 -5.484 . . . . 0.0 96.192 -172.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.548 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 56.0 m-85 -76.3 113.83 14.3 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 101.37 -3.567 . . . . 0.0 101.37 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.558 ' H ' ' HG3' ' A' ' 100' ' ' PRO . 84.2 mtm180 -76.99 -61.71 1.89 Allowed 'General case' 0 CA--C 1.467 -2.246 0 CA-C-O 124.856 2.265 . . . . 0.0 105.346 -176.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 174.82 117.99 0.5 Allowed Glycine 0 CA--C 1.46 -3.345 0 CA-C-N 108.809 -3.814 . . . . 0.0 104.549 148.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.424 ' HB3' HD13 ' A' ' 140' ' ' ILE . 74.3 ttt-85 -85.75 -64.32 1.17 Allowed 'General case' 0 CA--C 1.472 -2.041 0 CA-C-O 123.763 1.744 . . . . 0.0 106.349 170.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -120.82 26.11 9.29 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 110.48 -3.054 . . . . 0.0 106.219 168.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 58.9 mtt 78.33 -173.27 0.07 Allowed 'General case' 0 C--N 1.36 1.027 0 C-N-CA 127.384 2.274 . . . . 0.0 107.355 -159.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.26 114.7 9.59 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -121.65 170.14 10.01 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 171.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -96.1 20.98 9.39 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 123.953 0.901 . . . . 0.0 108.929 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -99.22 -46.81 5.42 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 167.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.424 HD13 ' HB3' ' A' ' 133' ' ' ARG 0.293 89.2 mt -67.28 -38.67 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.608 0 C-N-CA 129.104 2.961 . . . . 0.0 107.484 -174.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.566 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -80.85 -58.61 2.62 Favored Glycine 0 N--CA 1.417 -2.61 0 CA-C-N 114.438 -1.255 . . . . 0.0 113.986 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.4 mtm -89.25 1.4 55.76 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -163.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -55.53 -67.71 0.26 Allowed 'General case' 0 CA--C 1.445 -3.063 0 C-N-CA 115.391 -2.524 . . . . 0.0 114.284 140.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 98' ' ' PHE . 22.6 t -59.69 -66.63 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.438 -3.346 0 O-C-N 127.269 2.856 . . . . 0.0 108.336 -158.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.719 HD11 HD12 ' A' ' 128' ' ' LEU . 22.6 mt -45.99 -55.2 7.15 Favored 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 129.0 2.92 . . . . 0.0 115.299 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -62.21 -31.64 72.21 Favored 'General case' 0 CA--C 1.462 -2.429 0 N-CA-C 117.94 2.57 . . . . 0.0 117.94 173.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -82.26 -16.6 48.92 Favored 'General case' 0 N--CA 1.419 -1.991 0 C-N-CA 117.592 -1.643 . . . . 0.0 109.253 173.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.521 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.5 t -72.89 -45.82 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.856 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.547 ' HE3' HG21 ' A' ' 158' ' ' VAL . 35.7 ttmt -50.59 -51.67 46.24 Favored 'General case' 0 CA--C 1.464 -2.359 0 C-N-CA 125.775 1.63 . . . . 0.0 111.863 172.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -70.1 -41.13 74.43 Favored 'General case' 0 N--CA 1.406 -2.66 0 C-N-CA 125.936 1.695 . . . . 0.0 109.275 -168.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.418 ' HB3' HD11 ' A' ' 111' ' ' LEU . 22.9 t70 -74.18 -32.79 63.22 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 116.701 -2.0 . . . . 0.0 115.527 173.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.507 HD12 HG12 ' A' ' 148' ' ' VAL 0.348 0.3 OUTLIER -81.93 -26.2 34.25 Favored 'General case' 0 CA--C 1.461 -2.464 0 CA-C-O 116.409 -1.758 . . . . 0.0 115.128 -178.606 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -25.43 -29.94 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.489 1 C-N-CA 135.02 5.328 . . . . 0.0 119.202 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 5.9 mt-10 -49.24 -50.38 38.86 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 128.413 2.685 . . . . 0.0 113.993 169.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 tt -118.26 -50.62 2.45 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 126.339 1.855 . . . . 0.0 109.881 -164.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.825 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.346 . . -106.58 147.22 29.72 Favored 'General case' 0 CA--C 1.443 -3.17 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 -177.437 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.5 m -118.34 -174.54 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.529 0 C-N-CA 114.841 -2.744 . . . . 0.0 114.321 141.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.547 HG21 ' HE3' ' A' ' 149' ' ' LYS . 2.8 t -88.08 151.02 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.233 0 CA-C-N 111.762 -2.472 . . . . 0.0 105.717 168.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -81.89 -39.59 23.61 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.451 ' H ' HG12 ' A' ' 158' ' ' VAL . 1.1 t -160.69 142.0 12.04 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -171.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -103.06 90.08 2.25 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 101.751 -3.426 . . . . 0.0 101.751 169.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -101.55 -94.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.736 0 N-CA-C 108.055 -1.556 . . . . 0.0 108.055 -139.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.48 -103.07 0.31 Allowed 'General case' 0 N--CA 1.4 -2.956 0 C-N-CA 118.337 -1.345 . . . . 0.0 108.855 -136.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -156.16 156.81 34.85 Favored 'General case' 0 N--CA 1.422 -1.874 1 N-CA-C 99.565 -4.235 . . . . 0.0 99.565 -174.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.426 HG13 ' H ' ' A' ' 165' ' ' ILE . 1.3 mt -73.64 134.13 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.306 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 172.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -106.47 108.36 19.83 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 75.54 -139.4 24.6 Favored Glycine 0 CA--C 1.482 -2.006 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 -171.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -114.05 60.06 0.67 Allowed 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 113.095 -1.553 . . . . 0.0 107.79 174.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -173.14 131.19 0.48 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 10.7 ttm -121.53 162.6 20.28 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.6 mt -122.02 152.11 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 158.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.1 ttt -122.22 129.33 52.16 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 103.313 -2.847 . . . . 0.0 103.313 162.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.407 HG13 ' HG2' ' A' ' 125' ' ' LYS . 25.7 t -88.5 138.06 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -176.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.651 HD23 HD11 ' A' ' 118' ' ' LEU . 6.0 tp -118.87 90.15 3.27 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 131.104 3.762 . . . . 0.0 121.1 -177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.391 . . -104.9 165.41 13.29 Favored Pre-proline 0 CA--C 1.5 -0.975 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -71.97 141.01 35.9 Favored 'Trans proline' 0 CA--C 1.492 -1.614 0 C-N-CA 121.762 1.641 . . . . 0.0 108.412 -171.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.9 tmmt? -77.84 132.24 37.9 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 125.097 1.498 . . . . 0.0 107.593 -173.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -70.4 111.55 6.05 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.941 -174.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -78.94 111.87 15.56 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 166.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 . . . . . 0 C--O 1.26 1.652 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 -176.594 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.468 -2.178 0 CA-C-O 124.942 2.306 . . . . 0.0 107.276 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.5 mm -96.52 119.17 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.452 0 CA-C-N 108.653 -3.885 . . . . 0.0 107.057 176.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -93.62 169.07 10.61 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.498 HG22 ' HD3' ' A' ' 123' ' ' LYS . 92.2 t -101.07 115.73 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 161.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -99.62 172.52 7.23 Favored 'General case' 0 CA--C 1.476 -1.892 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 157.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -148.08 148.2 30.38 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -172.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.8 tp -131.43 161.06 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 103.733 -2.691 . . . . 0.0 103.733 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -121.88 154.25 37.34 Favored 'General case' 0 CA--C 1.487 -1.48 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.606 163.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.494 ' HB3' HG11 ' A' ' 144' ' ' VAL . 46.4 m-85 -129.62 143.5 50.85 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 170.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -121.01 167.39 13.21 Favored Pre-proline 0 N--CA 1.428 -1.543 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.468 ' HB3' HG23 ' A' ' 140' ' ' ILE . 10.5 Cg_endo -73.5 143.1 33.97 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 122.846 2.364 . . . . 0.0 107.338 170.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.55 9.73 80.91 Favored Glycine 0 CA--C 1.483 -1.947 0 O-C-N 124.16 0.912 . . . . 0.0 110.941 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.5 m -102.08 96.06 6.76 Favored 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 173.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -130.5 -146.49 0.31 Allowed 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 111.932 -2.394 . . . . 0.0 104.67 169.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.64 -69.32 0.25 Allowed 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -84.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.84 39.5 2.79 Favored Glycine 0 CA--C 1.484 -1.862 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.33 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -102.52 -39.16 7.23 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 148.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.91 -75.95 0.11 Allowed 'General case' 0 CA--C 1.478 -1.798 0 C-N-CA 126.784 2.034 . . . . 0.0 109.976 -171.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.432 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.331 0.0 OUTLIER -59.49 -12.7 6.73 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 119.967 3.321 . . . . 0.0 119.967 176.622 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.24 -43.74 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 122.126 0.965 . . . . 0.0 110.259 162.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -91.7 -1.09 57.56 Favored 'General case' 0 CA--C 1.475 -1.938 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.411 HD21 HD22 ' A' ' 152' ' ' LEU . 5.3 tt -79.05 -31.15 44.41 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 161.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.513 ' HA ' HG12 ' A' ' 115' ' ' ILE . 19.1 ttt85 -62.69 -43.0 99.92 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 118.599 -0.715 . . . . 0.0 111.276 169.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.4 m -61.69 -40.97 96.87 Favored 'General case' 0 C--N 1.378 1.819 0 C-N-CA 118.899 -1.12 . . . . 0.0 113.51 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.476 HD11 HD23 ' A' ' 174' ' ' LEU 0.282 55.8 tp -69.09 -26.97 65.2 Favored 'General case' 0 N--CA 1.402 -2.863 0 C-N-CA 126.259 1.823 . . . . 0.0 113.952 178.073 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.513 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.268 5.6 mm -60.96 -49.37 84.98 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.873 0 CA-C-N 121.061 1.755 . . . . 0.0 109.232 170.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -52.39 -48.36 65.69 Favored 'General case' 0 CA--C 1.494 -1.203 0 C-N-CA 126.662 1.985 . . . . 0.0 108.899 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -56.5 -53.85 52.67 Favored 'General case' 0 CA--C 1.483 -1.622 0 C-N-CA 125.992 1.717 . . . . 0.0 111.647 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.515 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -58.4 -39.83 80.76 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 179.243 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.23 -14.06 44.99 Favored 'General case' 0 C--N 1.364 1.212 0 C-N-CA 125.767 1.627 . . . . 0.0 111.746 -170.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -65.79 -25.06 67.08 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 123.073 0.549 . . . . 0.0 109.839 161.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.2 59.47 1.3 Allowed Glycine 0 CA--C 1.468 -2.865 0 N-CA-C 103.917 -3.673 . . . . 0.0 103.917 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -125.32 164.5 20.24 Favored 'General case' 0 CA--C 1.461 -2.475 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 171.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.498 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -102.02 121.54 42.36 Favored 'General case' 0 N--CA 1.407 -2.601 1 N-CA-C 99.869 -4.122 . . . . 0.0 99.869 179.401 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.446 ' HB1' ' CD1' ' A' ' 114' ' ' LEU . . . -111.91 115.91 29.76 Favored 'General case' 0 N--CA 1.415 -2.191 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.597 -166.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -98.3 119.68 37.39 Favored 'General case' 0 CA--C 1.491 -1.315 0 O-C-N 121.683 -0.636 . . . . 0.0 110.717 -167.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.9 mm -83.82 134.8 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.442 ' HA ' HD13 ' A' ' 171' ' ' ILE . 18.6 m -116.64 115.38 25.58 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 165.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.78 HD21 ' HA2' ' A' ' 141' ' ' GLY . 18.4 tp -82.4 148.49 28.19 Favored 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 167.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -150.58 103.82 3.15 Favored 'General case' 0 N--CA 1.405 -2.708 1 N-CA-C 98.44 -4.652 . . . . 0.0 98.44 -174.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.702 ' CZ ' HD13 ' A' ' 165' ' ' ILE 0.294 77.6 m-85 -74.41 97.69 3.12 Favored 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 127.345 2.258 . . . . 0.0 109.227 -175.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -107.78 28.96 7.68 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 125.036 1.335 . . . . 0.0 110.008 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.19 -46.38 7.03 Favored Glycine 0 CA--C 1.473 -2.581 1 N-CA-C 102.471 -4.252 . . . . 0.0 102.471 161.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 57.26 42.45 25.23 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 109.734 -3.233 . . . . 0.0 112.248 168.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -82.15 -62.17 1.7 Allowed 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 102.246 -3.242 . . . . 0.0 102.246 159.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 25.7 mmt -121.91 -98.25 0.44 Allowed 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.521 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.412 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . 169.58 108.2 0.01 OUTLIER 'General case' 0 N--CA 1.418 -2.048 1 N-CA-C 98.299 -4.704 . . . . 0.0 98.299 -165.802 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.63 ' CD2' HD12 ' A' ' 140' ' ' ILE . 6.0 m-70 -110.64 161.95 15.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -159.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -91.92 -10.83 38.09 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.648 170.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -77.33 -58.26 3.37 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 174.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.63 HD12 ' CD2' ' A' ' 137' ' ' HIS . 91.3 mt -54.91 -49.32 71.41 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 C-N-CA 126.934 2.094 . . . . 0.0 111.774 -178.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.78 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -77.0 -57.99 3.56 Favored Glycine 0 CA--C 1.458 -3.515 0 C-N-CA 119.07 -1.538 . . . . 0.0 113.733 -171.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 53.0 mtm -84.54 -0.04 51.62 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 118.123 -0.942 . . . . 0.0 113.09 -166.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.303 2.8 tp10 -64.34 -69.73 0.27 Allowed 'General case' 0 CA--C 1.454 -2.741 0 C-N-CA 115.051 -2.659 . . . . 0.0 115.012 143.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.494 HG11 ' HB3' ' A' ' 98' ' ' PHE . 39.7 t -59.98 -66.9 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.455 -2.707 0 O-C-N 126.261 2.226 . . . . 0.0 110.884 -161.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.452 HD11 HD22 ' A' ' 128' ' ' LEU . 73.4 mt -46.07 -55.06 7.45 Favored 'General case' 0 CA--C 1.483 -1.631 0 C-N-CA 128.421 2.688 . . . . 0.0 114.278 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.7 -30.01 69.68 Favored 'General case' 0 CA--C 1.469 -2.151 0 N-CA-C 118.609 2.818 . . . . 0.0 118.609 172.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -82.24 -15.35 53.37 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 119.41 -0.329 . . . . 0.0 110.486 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.463 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.9 t -77.37 -42.47 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.666 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 175.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.481 ' HB2' HG21 ' A' ' 158' ' ' VAL 0.254 31.8 ttmt -53.91 -52.04 61.83 Favored 'General case' 0 CA--C 1.462 -2.409 0 C-N-CA 124.943 1.297 . . . . 0.0 111.014 171.659 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -71.88 -38.75 69.95 Favored 'General case' 0 N--CA 1.407 -2.608 0 C-N-CA 125.674 1.59 . . . . 0.0 109.18 -169.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -74.53 -24.84 59.03 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 116.802 -1.959 . . . . 0.0 114.647 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 156' ' ' ALA 0.267 0.1 OUTLIER -78.92 -37.06 40.78 Favored 'General case' 0 CA--C 1.477 -1.833 0 CA-C-O 116.26 -1.829 . . . . 0.0 111.958 177.259 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 156' ' ' ALA . 3.9 tt0 -27.63 -29.89 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.488 1 C-N-CA 135.8 5.64 . . . . 0.0 119.642 -167.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 7.4 mt-10 -51.51 -47.69 63.19 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 128.789 2.836 . . . . 0.0 114.202 170.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -120.24 -51.88 2.19 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 128.167 2.587 . . . . 0.0 105.47 -159.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.875 ' HB1' HD11 ' A' ' 174' ' ' LEU 0.302 . . -107.43 144.62 34.09 Favored 'General case' 0 CA--C 1.452 -2.806 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.303 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.3 m -122.71 164.72 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.762 0 C-N-CA 115.286 -2.565 . . . . 0.0 117.604 141.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 5.8 t -81.82 149.37 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.257 0 CA-C-N 110.067 -3.242 . . . . 0.0 105.968 -174.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.76 -38.9 27.81 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -173.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -162.65 144.82 10.64 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -173.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -104.28 88.7 2.17 Favored Pre-proline 0 N--CA 1.424 -1.74 0 N-CA-C 100.64 -3.837 . . . . 0.0 100.64 165.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -94.67 -93.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.657 0 N-CA-C 108.687 -1.313 . . . . 0.0 108.687 -137.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.465 ' HB ' ' H ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -102.4 -104.91 0.27 Allowed 'General case' 0 N--CA 1.4 -2.974 0 C-N-CA 117.997 -1.481 . . . . 0.0 107.464 -139.244 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.465 ' H ' ' HB ' ' A' ' 163' ' ' THR . 41.1 ttmt -157.02 150.76 24.53 Favored 'General case' 0 N--CA 1.42 -1.942 1 N-CA-C 97.63 -4.952 . . . . 0.0 97.63 176.487 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.702 HD13 ' CZ ' ' A' ' 130' ' ' PHE . 4.0 mt -74.21 133.7 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.285 0 CA-C-O 122.567 1.175 . . . . 0.0 108.61 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -113.98 116.22 28.87 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.74 -149.6 36.75 Favored Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -172.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -105.26 40.3 1.56 Allowed 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 125.393 1.477 . . . . 0.0 109.792 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -171.41 122.15 0.53 Allowed 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.798 -167.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 39.4 ttm -118.49 123.89 46.25 Favored 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 124.008 0.923 . . . . 0.0 108.815 -174.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 127' ' ' THR . 15.5 mm -83.72 130.05 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 O-C-N 120.968 -1.082 . . . . 0.0 108.282 168.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.41 ' HB3' HD22 ' A' ' 145' ' ' LEU . 3.2 ttp -110.87 124.31 51.81 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 160.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 43.5 t -88.46 136.51 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.875 HD11 ' HB1' ' A' ' 156' ' ' ALA . 0.5 OUTLIER -124.77 150.31 46.41 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 101.673 -3.455 . . . . 0.0 101.673 -178.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.337 . . -142.26 -179.32 0.94 Allowed Pre-proline 0 CA--C 1.488 -1.42 0 CA-C-O 117.824 -1.084 . . . . 0.0 109.458 -173.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.434 ' HA ' HD21 ' A' ' 118' ' ' LEU . 82.2 Cg_exo -64.93 143.4 79.23 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 122.82 2.347 . . . . 0.0 110.111 165.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -79.7 158.2 27.02 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 165.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -62.36 129.24 39.82 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 123.709 0.803 . . . . 0.0 109.38 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 96.6 mttt 61.17 69.92 0.64 Allowed 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 126.408 1.883 . . . . 0.0 109.827 -169.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 . . . . . 0 C--O 1.259 1.587 0 C-N-CA 127.269 2.227 . . . . 0.0 112.183 179.527 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.482 -1.643 0 CA-C-O 122.073 0.939 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.4 mm -86.85 121.66 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-N 112.964 -1.925 . . . . 0.0 106.549 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -110.74 158.81 18.23 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 -161.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.62 113.61 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.813 0 C-N-CA 118.641 -1.224 . . . . 0.0 108.028 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -107.76 177.42 4.83 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 155.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -139.14 155.8 47.6 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.482 -172.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 tp -133.85 161.37 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 102.936 -2.987 . . . . 0.0 102.936 166.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -118.16 159.36 23.42 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 118.845 0.748 . . . . 0.0 110.175 165.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.654 ' HB3' HG11 ' A' ' 144' ' ' VAL . 25.8 m-85 -138.51 114.01 9.68 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 167.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -93.2 170.66 8.37 Favored Pre-proline 0 N--CA 1.433 -1.286 0 C-N-CA 124.586 1.154 . . . . 0.0 107.911 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -73.84 137.99 25.4 Favored 'Trans proline' 0 N--CA 1.43 -2.238 0 N-CA-C 105.354 -2.595 . . . . 0.0 105.354 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.55 8.0 66.31 Favored Glycine 0 CA--C 1.483 -1.923 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 78.8 m -100.73 89.85 4.03 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 167.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -124.59 -173.61 2.83 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 112.481 -2.145 . . . . 0.0 105.984 173.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -52.97 -43.79 66.65 Favored 'General case' 0 CA--C 1.481 -1.704 0 C-N-CA 126.682 1.993 . . . . 0.0 114.406 -128.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.43 -5.47 79.11 Favored Glycine 0 N--CA 1.417 -2.624 0 N-CA-C 116.332 1.293 . . . . 0.0 116.332 -170.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -98.25 -30.14 12.79 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 124.826 1.251 . . . . 0.0 107.857 168.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -86.78 -71.08 0.57 Allowed 'General case' 0 CA--C 1.469 -2.154 0 CA-C-N 112.351 -2.204 . . . . 0.0 111.235 -157.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.471 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.323 0.0 OUTLIER -58.94 -14.97 10.7 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 118.844 2.905 . . . . 0.0 118.844 174.057 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.03 -45.71 98.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 C-N-CA 124.711 1.205 . . . . 0.0 110.328 161.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -92.84 5.15 52.29 Favored 'General case' 0 CA--C 1.485 -1.541 0 O-C-N 120.137 -1.602 . . . . 0.0 115.269 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -83.45 -32.42 26.05 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 163.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.451 ' HA ' HG12 ' A' ' 115' ' ' ILE . 14.9 ttp180 -60.33 -45.62 92.77 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 125.158 1.383 . . . . 0.0 110.122 169.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.5 t -62.0 -40.38 95.45 Favored 'General case' 0 C--N 1.374 1.66 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.5 tp -67.42 -33.4 75.08 Favored 'General case' 0 N--CA 1.401 -2.88 0 C-N-CA 125.069 1.348 . . . . 0.0 113.844 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.255 8.5 mm -54.16 -50.75 53.12 Favored 'Isoleucine or valine' 0 C--N 1.373 1.626 0 CA-C-N 119.155 0.889 . . . . 0.0 108.865 170.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -50.01 -45.22 51.64 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 128.172 2.589 . . . . 0.0 112.464 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -55.94 -54.23 47.23 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 172.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.598 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -68.51 -22.35 64.53 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -76.27 -31.4 58.26 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 126.188 1.795 . . . . 0.0 111.175 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.1 -23.93 63.13 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 168.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.28 72.89 1.24 Allowed Glycine 0 CA--C 1.466 -2.977 0 N-CA-C 104.778 -3.329 . . . . 0.0 104.778 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -129.14 170.91 12.95 Favored 'General case' 0 CA--C 1.449 -2.941 1 N-CA-C 97.749 -4.908 . . . . 0.0 97.749 169.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -104.72 113.48 27.1 Favored 'General case' 0 N--CA 1.393 -3.314 1 N-CA-C 96.395 -5.409 . . . . 0.0 96.395 171.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.99 154.34 25.75 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.406 ' HG2' HG13 ' A' ' 173' ' ' VAL 0.279 78.9 mttt -118.68 137.53 53.25 Favored 'General case' 0 CA--C 1.469 -2.145 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 164.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.5 mm -83.18 128.92 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.37 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.8 m -110.78 122.84 48.84 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 169.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.542 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.2 OUTLIER -87.01 155.37 20.19 Favored 'General case' 0 CA--C 1.469 -2.163 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 170.225 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -151.57 89.69 1.51 Allowed 'General case' 0 N--CA 1.405 -2.694 0 N-CA-C 101.042 -3.688 . . . . 0.0 101.042 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.628 ' CE2' HD13 ' A' ' 165' ' ' ILE . 95.8 m-85 -78.35 163.18 25.9 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 112.237 -2.256 . . . . 0.0 109.394 -171.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -113.2 32.84 5.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 170.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -114.12 -13.08 10.3 Favored Glycine 0 CA--C 1.47 -2.747 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.5 mtm-85 70.98 -146.33 0.07 Allowed 'General case' 0 CA--C 1.491 -1.321 0 O-C-N 125.604 1.414 . . . . 0.0 109.793 170.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -48.72 107.37 0.13 Allowed 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 127.812 2.445 . . . . 0.0 112.6 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 1.3 mtp 49.37 77.88 0.1 Allowed 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 127.187 2.195 . . . . 0.0 111.546 -169.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.35 -163.35 0.5 Allowed 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 122.706 1.241 . . . . 0.0 113.608 -173.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -32.51 153.18 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 131.176 3.79 . . . . 0.0 117.701 159.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -124.06 -2.83 8.13 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 170.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -83.81 -55.05 4.46 Favored 'General case' 0 CA--C 1.481 -1.702 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.2 mt -83.01 110.66 18.28 Favored 'Isoleucine or valine' 1 N--CA 1.376 -4.163 1 N-CA-C 95.296 -5.816 . . . . 0.0 95.296 166.289 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.542 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . 147.88 -71.01 0.33 Allowed Glycine 1 N--CA 1.381 -4.999 2 C-N-CA 134.887 5.994 . . . . 0.0 108.273 165.293 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.4 mtm -94.86 20.07 9.32 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -169.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -50.68 25.45 Favored 'General case' 0 CA--C 1.454 -2.726 0 C-N-CA 116.4 -2.12 . . . . 0.0 113.939 137.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.654 HG11 ' HB3' ' A' ' 98' ' ' PHE . 15.0 t -68.14 -67.72 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.429 -3.696 0 O-C-N 126.469 2.356 . . . . 0.0 106.669 -159.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.13 -55.93 3.05 Favored 'General case' 0 CA--C 1.459 -2.546 0 C-N-CA 129.336 3.055 . . . . 0.0 111.843 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -57.51 -37.96 73.83 Favored 'General case' 0 CA--C 1.469 -2.157 0 C-N-CA 125.924 1.689 . . . . 0.0 114.509 178.645 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -81.82 -14.83 55.8 Favored 'General case' 0 N--CA 1.421 -1.925 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.747 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.4 t -75.25 -47.77 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.764 0 CA-C-O 116.082 -1.913 . . . . 0.0 106.55 176.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.608 ' HB2' HG21 ' A' ' 158' ' ' VAL . 3.5 ttmt -53.06 -51.87 60.37 Favored 'General case' 0 CA--C 1.46 -2.482 0 CA-C-O 117.248 -1.358 . . . . 0.0 110.02 171.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.41 -36.53 81.46 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 119.01 0.823 . . . . 0.0 110.268 -168.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.29 -43.97 66.09 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 116.519 -2.072 . . . . 0.0 116.414 168.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.275 0.2 OUTLIER -82.74 -18.17 41.68 Favored 'General case' 0 CA--C 1.468 -2.176 0 N-CA-C 118.064 2.616 . . . . 0.0 118.064 -172.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -25.64 -31.52 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.154 1 C-N-CA 133.571 4.748 . . . . 0.0 118.321 170.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.4 mt-10 -53.11 -50.32 64.7 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 127.998 2.519 . . . . 0.0 114.459 173.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 tt -112.4 -51.76 2.82 Favored 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 125.97 1.708 . . . . 0.0 110.633 -169.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.598 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.308 . . -104.46 144.46 31.63 Favored 'General case' 0 CA--C 1.452 -2.821 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.572 -174.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 177' ' ' LYS . 5.5 m -128.84 159.78 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.484 0 N-CA-C 120.196 3.406 . . . . 0.0 120.196 148.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 149' ' ' LYS . 2.4 t -83.2 150.07 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.257 0 CA-C-N 110.108 -3.224 . . . . 0.0 105.841 -173.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -81.54 -39.75 24.18 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 -174.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.4 t -159.78 157.74 29.89 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -169.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -116.32 103.52 52.88 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 175.005 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 38.0 Cg_endo -145.99 -120.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.422 1 C-N-CA 111.733 -5.045 . . . . 0.0 106.351 -136.557 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.447 ' HB ' ' H ' ' A' ' 164' ' ' LYS . 0.2 OUTLIER -80.32 -84.41 0.1 Allowed 'General case' 0 N--CA 1.408 -2.553 0 C-N-CA 116.581 -2.048 . . . . 0.0 110.521 -84.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.447 ' H ' ' HB ' ' A' ' 163' ' ' THR . 14.5 ptpt -156.19 152.68 28.13 Favored 'General case' 0 N--CA 1.419 -2.009 1 N-CA-C 99.586 -4.227 . . . . 0.0 99.586 175.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.628 HD13 ' CE2' ' A' ' 130' ' ' PHE . 3.3 mt -81.46 127.66 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -120.49 103.52 9.24 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 111.351 -2.659 . . . . 0.0 104.728 -171.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.26 -139.47 24.11 Favored Glycine 0 CA--C 1.481 -2.073 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 -168.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -97.4 29.83 3.09 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.395 -1.402 . . . . 0.0 112.104 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.322 28.5 mt-30 -167.08 145.46 4.99 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 118.378 0.536 . . . . 0.0 112.371 -157.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 41.9 ttm -129.98 121.11 25.9 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 121.275 0.559 . . . . 0.0 110.519 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.7 mm -83.02 128.99 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 O-C-N 120.895 -1.128 . . . . 0.0 109.205 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.408 ' SD ' ' CE1' ' A' ' 161' ' ' PHE . 1.2 ttp -108.48 140.61 41.56 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 156.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.406 HG13 ' HG2' ' A' ' 125' ' ' LYS . 11.1 t -106.17 135.79 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 C-N-CA 119.171 -1.011 . . . . 0.0 109.299 -173.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.558 HD13 HG22 ' A' ' 158' ' ' VAL . 6.1 tp -118.81 96.66 5.35 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 121.626 3.935 . . . . 0.0 121.626 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.271 . . -98.84 168.43 9.75 Favored Pre-proline 0 CA--C 1.499 -0.987 0 N-CA-C 115.899 1.815 . . . . 0.0 115.899 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -75.7 135.6 18.02 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 N-CA-C 105.039 -2.716 . . . . 0.0 105.039 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.427 ' HB3' HG13 ' A' ' 157' ' ' VAL . 58.2 pttt -80.72 163.06 23.82 Favored 'General case' 0 CA--C 1.49 -1.349 0 C-N-CA 118.365 -1.334 . . . . 0.0 113.905 -175.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -84.42 122.66 29.27 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 166.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -67.84 126.87 30.79 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 . . . . . 0 C--O 1.259 1.589 0 CA-C-O 117.787 -1.101 . . . . 0.0 108.545 -179.668 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.469 -2.136 0 CA-C-O 124.836 2.255 . . . . 0.0 107.568 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.4 mm -86.0 120.55 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.496 0 CA-C-N 108.526 -3.943 . . . . 0.0 107.046 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -98.98 164.67 12.09 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -166.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.8 t -97.84 120.34 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -102.5 168.5 9.25 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 152.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -136.12 153.27 51.35 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 tp -135.57 160.93 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 167.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -117.27 155.73 28.99 Favored 'General case' 0 CA--C 1.484 -1.564 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.831 165.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.55 ' HB3' HG11 ' A' ' 144' ' ' VAL . 5.4 m-85 -139.44 139.29 37.03 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -104.77 175.2 2.27 Favored Pre-proline 0 N--CA 1.434 -1.253 0 CA-C-O 118.804 -0.617 . . . . 0.0 109.403 -172.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.99 136.52 61.66 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 C-N-CA 123.518 2.812 . . . . 0.0 111.383 171.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 26.88 95.58 0.01 OUTLIER Glycine 0 CA--C 1.468 -2.851 0 C-N-CA 130.628 3.966 . . . . 0.0 114.463 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.99 -157.24 0.59 Allowed 'General case' 0 N--CA 1.397 -3.116 0 CA-C-N 111.4 -2.4 . . . . 0.0 106.264 -169.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 107' ' ' TYR 0.443 0.7 OUTLIER -144.47 167.0 23.53 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 110.637 -2.983 . . . . 0.0 110.781 -142.973 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -68.8 -76.53 0.09 Allowed 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -107.02 47.06 1.08 Allowed Glycine 0 CA--C 1.478 -2.259 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.619 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.422 ' H ' ' HB3' ' A' ' 103' ' ' ASP . 24.1 t70 -104.97 -42.32 5.36 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 144.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.522 ' HB3' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER -82.51 -64.02 1.26 Allowed 'General case' 0 CA--C 1.483 -1.609 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.138 -163.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.336 0.0 OUTLIER -61.44 -12.02 12.88 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 119.649 3.203 . . . . 0.0 119.649 176.738 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.84 -44.69 99.73 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-O 122.649 1.214 . . . . 0.0 110.06 161.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -91.46 0.55 57.49 Favored 'General case' 0 CA--C 1.477 -1.842 0 O-C-N 120.454 -1.404 . . . . 0.0 114.568 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.3 tt -81.66 -28.76 33.43 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 162.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.494 ' HA ' HG12 ' A' ' 115' ' ' ILE . 40.7 ttt180 -62.08 -42.78 99.56 Favored 'General case' 0 C--N 1.361 1.096 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.874 166.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.4 m -58.88 -43.6 90.96 Favored 'General case' 0 C--N 1.38 1.9 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 173.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.261 83.5 mt -64.75 -29.2 70.17 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 116.585 2.069 . . . . 0.0 116.585 175.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.254 10.1 mm -58.32 -51.44 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.899 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.085 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -50.08 -46.88 53.78 Favored 'General case' 0 CA--C 1.49 -1.329 0 O-C-N 126.025 2.078 . . . . 0.0 109.713 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -59.76 -56.05 26.65 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.221 1.008 . . . . 0.0 112.848 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -69.71 -27.66 65.18 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 125.737 1.615 . . . . 0.0 115.321 -177.597 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -82.8 -17.34 44.43 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 124.113 0.965 . . . . 0.0 111.81 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -71.44 -29.64 65.12 Favored 'General case' 0 C--N 1.362 1.137 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 162.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.02 65.27 1.13 Allowed Glycine 0 CA--C 1.474 -2.483 0 N-CA-C 105.558 -3.017 . . . . 0.0 105.558 -172.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -125.82 173.34 9.15 Favored 'General case' 0 CA--C 1.456 -2.654 1 N-CA-C 98.069 -4.789 . . . . 0.0 98.069 169.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.12 122.49 47.39 Favored 'General case' 0 N--CA 1.4 -2.974 1 N-CA-C 96.983 -5.191 . . . . 0.0 96.983 170.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.98 160.11 21.1 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 115.453 -2.499 . . . . 0.0 105.708 169.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -133.26 119.3 19.62 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 171.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.585 HD11 HD22 ' A' ' 174' ' ' LEU . 7.8 mm -85.23 134.65 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.704 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.1 m -122.89 127.97 49.7 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.481 HD21 ' HA2' ' A' ' 141' ' ' GLY 0.377 0.3 OUTLIER -80.47 153.35 28.24 Favored 'General case' 0 CA--C 1.454 -2.739 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 169.365 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 33.4 ttt-85 -148.34 91.77 1.95 Allowed 'General case' 0 N--CA 1.399 -3.024 1 N-CA-C 98.556 -4.609 . . . . 0.0 98.556 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -65.56 141.38 58.46 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 110.598 -3.001 . . . . 0.0 109.139 -172.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.0 ttm105 -110.92 25.56 11.65 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -80.39 -47.49 6.86 Favored Glycine 0 CA--C 1.475 -2.418 1 N-CA-C 102.85 -4.1 . . . . 0.0 102.85 156.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 65.03 30.87 11.53 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 129.835 3.254 . . . . 0.0 112.088 169.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 176.75 -42.2 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.514 1 N-CA-C 100.188 -4.004 . . . . 0.0 100.188 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 67.7 mtm -79.12 -25.33 42.97 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.094 -174.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 4.48 115.76 0.0 OUTLIER 'General case' 0 C--N 1.37 1.468 1 C-N-CA 131.85 4.06 . . . . 0.0 117.871 176.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.532 ' HB2' ' H ' ' A' ' 140' ' ' ILE . 0.5 OUTLIER -111.36 167.33 10.38 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -161.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -94.21 -4.33 49.18 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 121.566 0.698 . . . . 0.0 109.73 169.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -82.83 -54.42 5.12 Favored 'General case' 0 CA--C 1.476 -1.868 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.532 ' H ' ' HB2' ' A' ' 137' ' ' HIS . 82.8 mt -56.31 -47.5 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.125 0 C-N-CA 126.51 1.924 . . . . 0.0 110.753 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.481 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -72.85 -63.55 2.82 Favored Glycine 0 N--CA 1.414 -2.809 0 O-C-N 123.814 0.696 . . . . 0.0 112.404 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 71.5 mtm -96.84 24.75 5.83 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -163.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -62.3 1.49 Allowed 'General case' 0 CA--C 1.453 -2.756 0 C-N-CA 116.171 -2.212 . . . . 0.0 115.545 129.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.55 HG11 ' HB3' ' A' ' 98' ' ' PHE . 25.7 t -61.94 -64.03 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.45 -2.899 0 O-C-N 126.435 2.335 . . . . 0.0 109.183 -161.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' A' ' 172' ' ' MET . 72.9 mt -43.45 -55.53 4.12 Favored 'General case' 0 CA--C 1.48 -1.725 0 C-N-CA 127.686 2.395 . . . . 0.0 114.086 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -57.62 -37.6 73.56 Favored 'General case' 0 CA--C 1.476 -1.879 0 C-N-CA 126.484 1.914 . . . . 0.0 114.298 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.419 ' HA ' ' HB2' ' A' ' 150' ' ' ASP . 15.9 ttp180 -80.2 -15.29 57.36 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 118.845 0.748 . . . . 0.0 111.38 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.8 t -74.2 -47.07 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.724 0 CA-C-O 116.459 -1.734 . . . . 0.0 106.732 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.607 ' HE3' HG21 ' A' ' 158' ' ' VAL . 10.7 ttmt -55.41 -50.78 68.87 Favored 'General case' 0 CA--C 1.461 -2.452 0 CA-C-O 116.776 -1.583 . . . . 0.0 110.011 172.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.419 ' HB2' ' HA ' ' A' ' 147' ' ' ARG . 69.0 m-20 -66.84 -36.45 82.36 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 119.733 1.151 . . . . 0.0 110.105 -168.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.09 -48.44 57.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 116.662 -2.015 . . . . 0.0 115.843 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.465 HD13 HD21 ' A' ' 174' ' ' LEU 0.283 0.2 OUTLIER -82.62 -14.38 54.86 Favored 'General case' 0 CA--C 1.468 -2.198 0 N-CA-C 118.147 2.647 . . . . 0.0 118.147 -172.297 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -25.4 -30.23 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.263 1 C-N-CA 133.815 4.846 . . . . 0.0 118.358 168.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.3 mt-10 -51.36 -54.37 27.09 Favored 'General case' 0 CA--C 1.488 -1.428 0 C-N-CA 127.478 2.311 . . . . 0.0 113.828 170.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.3 tt -113.52 -53.7 2.67 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.38 -1.736 . . . . 0.0 110.491 -168.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.519 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.301 . . -92.65 148.22 22.24 Favored 'General case' 0 CA--C 1.455 -2.698 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -177.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.486 ' HB ' ' H ' ' A' ' 158' ' ' VAL . 15.2 m -118.58 -164.04 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.452 -2.821 0 C-N-CA 114.305 -2.958 . . . . 0.0 111.155 141.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.607 HG21 ' HE3' ' A' ' 149' ' ' LYS 0.277 2.9 t -111.93 163.01 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.394 0 C-N-CA 129.649 3.18 . . . . 0.0 107.364 -177.319 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -84.09 -43.97 14.53 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 172.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.584 ' H ' HG12 ' A' ' 158' ' ' VAL . 0.9 OUTLIER -157.29 147.62 21.01 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.557 -167.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.5 99.62 38.07 Favored Pre-proline 0 N--CA 1.416 -2.15 0 N-CA-C 103.136 -2.912 . . . . 0.0 103.136 165.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -100.35 -111.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.41 -3.382 0 N-CA-C 101.795 -3.963 . . . . 0.0 101.795 -163.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 179.44 -46.53 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.575 0 N-CA-C 102.785 -3.043 . . . . 0.0 102.785 -144.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -83.26 102.91 12.25 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 122.681 1.229 . . . . 0.0 113.043 -146.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.1 mt -80.07 131.03 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.119 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 166.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -125.26 98.81 5.79 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 -175.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.15 -139.07 17.27 Favored Glycine 0 CA--C 1.483 -1.939 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 -169.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.01 38.87 1.74 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.136 1.774 . . . . 0.0 109.637 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -169.68 139.22 1.97 Allowed 'General case' 0 C--N 1.359 0.988 0 O-C-N 121.383 -0.823 . . . . 0.0 111.835 -168.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 31.2 ttm -123.36 121.86 36.85 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -170.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.46 HG21 HD13 ' A' ' 171' ' ' ILE . 1.4 mt -87.69 142.69 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 C-N-CA 117.755 -1.578 . . . . 0.0 110.758 173.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.458 ' HB3' HD22 ' A' ' 145' ' ' LEU . 3.3 tmm? -111.72 126.84 55.47 Favored 'General case' 0 CA--C 1.476 -1.894 0 N-CA-C 101.421 -3.548 . . . . 0.0 101.421 153.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.2 t -91.72 124.93 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 118.052 -1.459 . . . . 0.0 108.45 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.585 HD22 HD11 ' A' ' 126' ' ' ILE . 14.5 tp -104.45 84.43 2.19 Favored 'General case' 0 C--N 1.349 0.556 0 N-CA-C 121.324 3.824 . . . . 0.0 121.324 -174.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.438 . . -108.08 155.66 39.7 Favored Pre-proline 0 C--N 1.359 0.993 0 N-CA-C 119.279 3.066 . . . . 0.0 119.279 -173.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.25 139.39 45.84 Favored 'Trans proline' 0 CA--C 1.491 -1.653 0 C-N-CA 123.398 2.732 . . . . 0.0 111.545 -160.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -79.63 144.29 33.93 Favored 'General case' 0 CA--C 1.49 -1.343 0 O-C-N 125.053 1.471 . . . . 0.0 107.614 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -66.69 113.08 4.55 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.591 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -76.92 127.53 32.89 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 175.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 . . . . . 0 C--O 1.26 1.63 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.243 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.469 -2.167 0 CA-C-O 124.734 2.207 . . . . 0.0 107.404 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.9 mm -88.92 116.37 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 108.732 -3.849 . . . . 0.0 107.295 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -107.06 158.79 16.79 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -167.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.463 HG22 ' HD2' ' A' ' 123' ' ' LYS . 72.3 t -90.18 112.43 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -104.58 177.08 4.95 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 157.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -140.01 156.29 46.69 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 117.778 0.263 . . . . 0.0 111.265 -170.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 tp -139.51 168.64 18.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 164.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -118.23 155.61 30.24 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 118.833 0.742 . . . . 0.0 111.178 162.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.548 ' HD2' HG21 ' A' ' 126' ' ' ILE . 19.2 m-85 -124.55 153.49 42.04 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 168.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -131.17 166.57 26.75 Favored Pre-proline 0 N--CA 1.437 -1.101 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.828 -170.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.522 ' HG3' ' H ' ' A' ' 131' ' ' ARG . 22.1 Cg_endo -78.29 140.22 17.28 Favored 'Trans proline' 0 CA--C 1.49 -1.689 0 C-N-CA 124.092 3.195 . . . . 0.0 108.31 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.65 13.72 83.19 Favored Glycine 0 CA--C 1.484 -1.872 0 O-C-N 124.14 0.9 . . . . 0.0 112.0 173.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.2 m -103.5 98.74 8.58 Favored 'General case' 0 N--CA 1.408 -2.546 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -126.69 -138.09 0.26 Allowed 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 110.889 -2.869 . . . . 0.0 103.636 166.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.52 -81.56 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -86.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.13 43.73 1.73 Allowed Glycine 0 CA--C 1.485 -1.785 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.554 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -103.89 -39.38 6.64 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 150.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.23 -71.69 0.29 Allowed 'General case' 0 CA--C 1.479 -1.76 0 C-N-CA 126.556 1.942 . . . . 0.0 109.112 -171.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.461 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.368 0.0 OUTLIER -57.49 -15.42 6.97 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 119.8 3.259 . . . . 0.0 119.8 175.11 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.97 -43.89 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-O 122.014 0.911 . . . . 0.0 110.699 163.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -91.96 2.78 56.33 Favored 'General case' 0 CA--C 1.477 -1.858 0 O-C-N 120.495 -1.378 . . . . 0.0 114.367 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 151' ' ' ASP . 5.9 tt -81.82 -31.96 31.47 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 163.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.438 ' HA ' HG12 ' A' ' 115' ' ' ILE . 50.4 ttt180 -62.64 -42.36 99.55 Favored 'General case' 0 C--N 1.361 1.095 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.696 168.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.7 m -60.18 -38.0 81.91 Favored 'General case' 0 C--N 1.377 1.798 0 C-N-CA 118.632 -1.227 . . . . 0.0 113.728 172.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.469 HD22 ' HB3' ' A' ' 124' ' ' ALA . 72.2 mt -65.24 -33.74 76.71 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 175.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 112' ' ' ARG . 4.7 mm -58.62 -46.11 90.34 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.391 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -49.64 -48.78 49.02 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 128.14 2.576 . . . . 0.0 111.835 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -58.97 -50.05 75.56 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.739 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -70.56 -21.77 62.66 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 124.853 1.261 . . . . 0.0 114.119 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -71.29 -37.7 71.84 Favored 'General case' 0 CA--C 1.491 -1.327 0 C-N-CA 126.75 2.02 . . . . 0.0 109.694 173.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -66.82 -28.22 68.19 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-O 120.732 0.301 . . . . 0.0 110.61 170.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.53 71.47 1.29 Allowed Glycine 0 CA--C 1.473 -2.579 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 -175.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -134.79 174.45 10.56 Favored 'General case' 0 N--CA 1.414 -2.229 1 N-CA-C 99.97 -4.085 . . . . 0.0 99.97 170.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HD2' HG22 ' A' ' 93' ' ' VAL 0.333 13.9 mtmt -88.5 147.47 24.63 Favored 'General case' 0 CA--C 1.459 -2.554 0 N-CA-C 100.918 -3.734 . . . . 0.0 100.918 159.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.469 ' HB3' HD22 ' A' ' 114' ' ' LEU . . . -116.18 123.2 47.21 Favored 'General case' 0 CA--C 1.457 -2.623 0 C-N-CA 115.331 -2.548 . . . . 0.0 106.091 160.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -99.75 117.67 34.59 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -168.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.548 HG21 ' HD2' ' A' ' 98' ' ' PHE . 3.6 mm -85.29 125.92 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.445 ' HA ' HD13 ' A' ' 171' ' ' ILE . 17.3 m -97.79 117.22 31.61 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 159.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.767 HD13 ' CZ ' ' A' ' 130' ' ' PHE . 0.5 OUTLIER -76.46 148.5 37.2 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 166.328 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.518 ' H ' HD23 ' A' ' 128' ' ' LEU . 24.4 ttt180 -151.14 92.61 1.82 Allowed 'General case' 0 N--CA 1.402 -2.837 1 N-CA-C 97.009 -5.182 . . . . 0.0 97.009 -167.618 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.767 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 90.5 m-85 -76.0 134.27 40.18 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 101.423 -3.547 . . . . 0.0 101.423 174.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.522 ' H ' ' HG3' ' A' ' 100' ' ' PRO . 0.6 OUTLIER -88.58 84.58 6.75 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 103.336 -2.839 . . . . 0.0 103.336 168.81 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.441 ' H ' ' HE ' ' A' ' 168' ' ' ARG . . . -172.06 -130.88 1.29 Allowed Glycine 0 N--CA 1.42 -2.423 0 C-N-CA 116.352 -2.832 . . . . 0.0 112.642 -148.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 64.86 44.99 3.4 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 112.408 -1.896 . . . . 0.0 106.166 -148.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.432 ' H ' ' H ' ' A' ' 136' ' ' ALA . 12.9 pt-20 178.44 -26.21 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 100.592 -3.855 . . . . 0.0 100.592 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 25.6 mmt -113.88 -2.49 13.6 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 169.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.432 ' H ' ' H ' ' A' ' 134' ' ' GLU . . . -77.77 102.12 7.02 Favored 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 121.67 -0.644 . . . . 0.0 109.43 165.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.556 ' HB2' ' H ' ' A' ' 140' ' ' ILE . 21.6 m170 -108.02 -128.86 0.28 Allowed 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.901 0.858 . . . . 0.0 111.352 -173.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.446 ' H ' ' H ' ' A' ' 139' ' ' GLN . 15.6 pt20 -149.35 0.45 0.51 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 103.024 -2.954 . . . . 0.0 103.024 158.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.446 ' H ' ' H ' ' A' ' 138' ' ' GLN . 64.8 mm-40 -86.32 -51.81 6.01 Favored 'General case' 0 CA--C 1.476 -1.894 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.556 ' H ' ' HB2' ' A' ' 137' ' ' HIS . 16.6 mt -90.8 98.9 8.87 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.623 1 N-CA-C 94.153 -6.24 . . . . 0.0 94.153 169.684 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.404 ' HA2' ' CD1' ' A' ' 128' ' ' LEU . . . 157.7 -89.67 0.11 Allowed Glycine 0 N--CA 1.412 -2.943 1 CA-C-N 107.883 -4.235 . . . . 0.0 108.857 -174.147 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.541 ' HG2' ' CE1' ' A' ' 161' ' ' PHE 0.254 75.0 mtp -90.09 5.16 47.96 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 128.779 2.832 . . . . 0.0 113.876 -168.394 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.251 2.3 tp10 -75.48 -45.67 37.06 Favored 'General case' 0 CA--C 1.433 -3.529 0 C-N-CA 116.111 -2.236 . . . . 0.0 111.823 151.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 98' ' ' PHE . 38.5 t -68.51 -74.9 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.444 -3.113 0 O-C-N 126.693 2.495 . . . . 0.0 107.539 -161.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.579 ' CD2' HD12 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -51.46 -47.4 63.12 Favored 'General case' 0 CA--C 1.481 -1.675 0 C-N-CA 129.908 3.283 . . . . 0.0 112.102 -177.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.253 1.5 t30 -64.98 -32.31 73.97 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -81.39 -15.58 54.78 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.363 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.48 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.7 t -74.78 -46.42 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.885 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.47 ' CE ' ' HB ' ' A' ' 158' ' ' VAL 0.303 19.7 ttmt -51.27 -48.48 62.19 Favored 'General case' 0 CA--C 1.472 -2.051 0 C-N-CA 126.781 2.032 . . . . 0.0 113.424 172.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.89 -39.65 61.36 Favored 'General case' 0 N--CA 1.408 -2.554 0 C-N-CA 127.238 2.215 . . . . 0.0 109.577 -171.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.413 ' HB3' HD11 ' A' ' 111' ' ' LEU . 14.2 t70 -75.24 -25.06 57.8 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 116.623 -2.031 . . . . 0.0 115.0 170.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.415 HD11 ' HA ' ' A' ' 115' ' ' ILE 0.307 0.2 OUTLIER -79.44 -31.55 42.56 Favored 'General case' 0 CA--C 1.466 -2.252 0 CA-C-O 116.152 -1.88 . . . . 0.0 112.223 178.192 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -30.57 -17.88 0.0 OUTLIER 'General case' 0 C--N 1.371 1.526 1 C-N-CA 135.237 5.415 . . . . 0.0 120.336 -175.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 4.4 mt-10 -53.58 -58.41 7.28 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 126.379 1.872 . . . . 0.0 111.378 163.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.58 -54.09 2.73 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 126.002 1.721 . . . . 0.0 109.286 -172.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.739 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.307 . . -110.67 140.16 45.28 Favored 'General case' 0 CA--C 1.459 -2.557 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.652 -164.344 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.8 m -126.73 166.87 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.527 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 144.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 174' ' ' LEU 0.305 70.2 t -74.54 146.83 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.874 0 CA-C-N 111.121 -2.763 . . . . 0.0 107.349 176.137 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.46 -41.42 16.62 Favored 'General case' 0 CA--C 1.473 -2.016 0 CA-C-N 110.895 -2.866 . . . . 0.0 105.695 -170.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -160.18 140.15 11.41 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 -169.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.541 ' CE1' ' HG2' ' A' ' 142' ' ' MET . 1.8 t80 -102.48 91.96 3.02 Favored Pre-proline 0 N--CA 1.425 -1.689 0 N-CA-C 100.373 -3.936 . . . . 0.0 100.373 170.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -96.34 -82.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.632 0 CA-C-N 121.66 1.628 . . . . 0.0 108.823 -139.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.429 ' HB ' ' H ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -103.5 -105.03 0.29 Allowed 'General case' 0 N--CA 1.399 -2.987 0 C-N-CA 117.684 -1.607 . . . . 0.0 109.012 -138.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.429 ' H ' ' HB ' ' A' ' 163' ' ' THR . 62.7 tttm -155.7 161.5 40.73 Favored 'General case' 0 N--CA 1.422 -1.84 1 N-CA-C 96.302 -5.444 . . . . 0.0 96.302 -177.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.603 HD13 ' CE2' ' A' ' 130' ' ' PHE . 2.7 mt -74.78 126.93 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.125 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 169.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -113.7 106.38 14.43 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 111.908 -2.406 . . . . 0.0 104.8 -176.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.41 -141.89 27.37 Favored Glycine 0 CA--C 1.484 -1.852 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -171.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.441 ' HE ' ' H ' ' A' ' 132' ' ' GLY . 63.6 mtp180 -101.68 36.03 2.16 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 113.288 -1.456 . . . . 0.0 110.189 -176.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.264 18.3 mt-30 -167.03 137.26 3.02 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 118.89 0.768 . . . . 0.0 111.406 -169.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 46.6 ttm -124.41 119.12 28.29 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 127' ' ' THR . 16.0 mm -81.9 136.57 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 O-C-N 120.624 -1.297 . . . . 0.0 108.299 171.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.448 ' HG2' HG13 ' A' ' 158' ' ' VAL . 6.5 tmm? -124.23 133.8 53.42 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 102.78 -3.045 . . . . 0.0 102.78 156.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.58 135.29 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 106.833 -1.544 . . . . 0.0 106.833 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -115.69 141.81 47.58 Favored 'General case' 0 C--N 1.362 1.142 1 N-CA-C 99.577 -4.231 . . . . 0.0 99.577 -179.74 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.353 . . -147.71 -179.97 1.06 Allowed Pre-proline 0 CA--C 1.494 -1.211 0 CA-C-N 120.024 1.283 . . . . 0.0 112.517 -168.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -68.91 137.69 38.63 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 121.109 1.206 . . . . 0.0 109.673 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -81.42 138.68 35.54 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -80.69 141.23 35.09 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.207 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? 60.23 59.9 2.2 Favored 'General case' 0 CA--C 1.495 -1.162 0 C-N-CA 126.634 1.974 . . . . 0.0 110.031 -173.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? . . . . . 0 C--O 1.26 1.643 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 178.517 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.469 -2.151 0 CA-C-O 124.948 2.308 . . . . 0.0 107.385 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.7 mm -97.12 119.69 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.36 0 CA-C-N 108.669 -3.878 . . . . 0.0 107.841 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -94.07 169.51 10.21 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.533 HG22 ' HD3' ' A' ' 123' ' ' LYS . 88.1 t -102.49 118.12 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 163.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -103.19 175.12 5.58 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 159.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -145.97 153.33 40.67 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 tp -134.38 164.0 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -119.5 153.13 35.8 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.349 161.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.516 ' HB3' HG11 ' A' ' 144' ' ' VAL . 40.1 m-85 -127.85 164.01 23.16 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 171.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.12 176.8 1.49 Allowed Pre-proline 0 N--CA 1.419 -2.019 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -170.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.441 ' HG3' ' H ' ' A' ' 131' ' ' ARG . 83.3 Cg_exo -58.51 144.09 97.33 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 125.267 3.978 . . . . 0.0 111.931 164.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -13.69 101.5 0.01 OUTLIER Glycine 0 CA--C 1.469 -2.84 1 C-N-CA 131.039 4.161 . . . . 0.0 114.996 -173.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.12 -153.82 0.5 Allowed 'General case' 0 N--CA 1.399 -2.988 0 CA-C-N 111.163 -2.519 . . . . 0.0 108.408 -152.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' A' ' 107' ' ' TYR 0.434 0.7 OUTLIER -121.87 166.88 13.73 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-N 109.996 -3.275 . . . . 0.0 111.703 -152.964 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.38 -74.31 0.13 Allowed 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -107.04 46.22 1.2 Allowed Glycine 0 CA--C 1.476 -2.385 0 C-N-CA 119.983 -1.103 . . . . 0.0 112.912 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -106.34 -41.17 5.39 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 145.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.523 ' HB3' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER -84.92 -65.11 1.05 Allowed 'General case' 0 CA--C 1.481 -1.704 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.519 -164.669 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.461 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.324 0.0 OUTLIER -62.29 -9.37 7.81 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 178.051 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 64.7 t -60.67 -46.9 95.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 122.359 1.076 . . . . 0.0 109.864 158.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -90.83 -3.21 57.56 Favored 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.443 HD23 HD11 ' A' ' 115' ' ' ILE . 4.5 tt -77.44 -32.16 54.35 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 162.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.471 ' HA ' HG12 ' A' ' 115' ' ' ILE . 41.7 ttt180 -61.94 -42.41 99.07 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.041 169.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.5 m -59.56 -43.61 93.51 Favored 'General case' 0 C--N 1.38 1.902 0 C-N-CA 118.44 -1.304 . . . . 0.0 113.975 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.538 ' O ' HD12 ' A' ' 118' ' ' LEU 0.263 47.4 mt -64.03 -30.56 71.63 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 175.3 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.265 4.0 mm -61.98 -47.73 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.92 0 CA-C-N 119.936 1.243 . . . . 0.0 108.699 177.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -54.0 -43.16 69.82 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 125.765 1.915 . . . . 0.0 110.214 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -59.72 -51.65 68.87 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.78 0.832 . . . . 0.0 112.542 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 156' ' ' ALA . 1.8 mt -71.98 -19.57 61.86 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 126.466 1.906 . . . . 0.0 114.452 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -73.14 -35.4 66.5 Favored 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 125.978 1.711 . . . . 0.0 110.122 171.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -68.25 -23.79 64.83 Favored 'General case' 0 C--N 1.36 1.063 0 C-N-CA 122.575 0.35 . . . . 0.0 110.144 168.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.63 69.31 1.38 Allowed Glycine 0 CA--C 1.466 -2.99 0 N-CA-C 104.762 -3.335 . . . . 0.0 104.762 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -123.38 165.11 17.57 Favored 'General case' 0 CA--C 1.458 -2.573 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.533 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -101.66 107.36 18.58 Favored 'General case' 0 N--CA 1.404 -2.735 1 N-CA-C 98.762 -4.533 . . . . 0.0 98.762 178.123 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.71 122.38 41.87 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -174.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -95.77 122.1 38.2 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -173.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.9 mm -83.57 131.65 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.451 ' HA ' HD13 ' A' ' 171' ' ' ILE . 23.4 m -116.7 116.54 27.72 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 167.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.876 HD21 ' HA2' ' A' ' 141' ' ' GLY . 17.5 tp -77.95 151.69 33.56 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 169.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -150.23 96.75 2.46 Favored 'General case' 0 N--CA 1.407 -2.611 1 N-CA-C 100.054 -4.054 . . . . 0.0 100.054 -175.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.535 ' HB3' ' H ' ' A' ' 132' ' ' GLY 0.267 68.4 m-85 -73.04 153.41 40.88 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 111.739 -2.482 . . . . 0.0 109.72 -179.324 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.441 ' H ' ' HG3' ' A' ' 100' ' ' PRO . 23.9 mmm180 -117.93 29.43 7.82 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 163.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.535 ' H ' ' HB3' ' A' ' 130' ' ' PHE . . . -82.74 -122.52 0.75 Allowed Glycine 0 CA--C 1.483 -1.913 0 C-N-CA 125.594 1.569 . . . . 0.0 111.5 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -92.23 -160.23 0.72 Allowed 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 112.804 -1.698 . . . . 0.0 108.613 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -67.36 -92.15 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 166.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 51.9 mtt -77.74 110.83 12.93 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 161.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.39 -146.41 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -157.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.61 ' CD2' HD12 ' A' ' 140' ' ' ILE . 15.0 m-70 -76.62 -71.48 0.39 Allowed 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -162.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 74.29 27.37 1.48 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 126.666 1.986 . . . . 0.0 108.014 -160.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -126.97 -51.3 1.44 Allowed 'General case' 0 CA--C 1.475 -1.934 0 N-CA-C 101.164 -3.643 . . . . 0.0 101.164 169.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.61 HD12 ' CD2' ' A' ' 137' ' ' HIS 0.252 53.1 mt -54.32 -42.27 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-N 112.863 -1.971 . . . . 0.0 110.022 165.36 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.876 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -72.49 -60.05 4.22 Favored Glycine 0 N--CA 1.408 -3.181 0 N-CA-C 115.241 0.856 . . . . 0.0 115.241 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 7.6 ptt? -87.4 0.89 54.82 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 118.569 -0.729 . . . . 0.0 112.932 -160.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.255 0.6 OUTLIER -59.4 -60.81 3.26 Favored 'General case' 0 CA--C 1.461 -2.466 0 C-N-CA 114.94 -2.704 . . . . 0.0 114.987 146.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' A' ' 98' ' ' PHE . 34.0 t -64.7 -64.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.927 0 O-C-N 125.956 2.035 . . . . 0.0 109.433 -164.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.435 HD11 HD22 ' A' ' 128' ' ' LEU . 49.4 mt -44.88 -54.31 6.59 Favored 'General case' 0 CA--C 1.488 -1.405 0 C-N-CA 128.242 2.617 . . . . 0.0 113.891 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.8 t30 -63.6 -30.93 71.97 Favored 'General case' 0 CA--C 1.465 -2.304 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 174.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -80.82 -14.86 57.67 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.354 173.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.449 HG21 ' CE2' ' A' ' 98' ' ' PHE . 2.0 t -76.59 -45.29 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.802 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 174.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.493 ' HB2' HG21 ' A' ' 158' ' ' VAL . 33.6 ttmt -54.42 -51.33 65.26 Favored 'General case' 0 CA--C 1.462 -2.417 0 CA-C-O 117.368 -1.301 . . . . 0.0 111.238 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.13 -40.09 75.05 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 125.477 1.511 . . . . 0.0 108.857 -169.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.421 ' HB3' HD11 ' A' ' 111' ' ' LEU . 24.3 t70 -74.94 -23.2 58.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 116.366 -2.134 . . . . 0.0 115.206 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.413 HD22 HD21 ' A' ' 111' ' ' LEU 0.271 0.1 OUTLIER -81.85 -36.32 28.41 Favored 'General case' 0 CA--C 1.476 -1.872 0 CA-C-O 116.939 -1.505 . . . . 0.0 111.86 179.035 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -27.91 -32.3 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.664 1 C-N-CA 135.614 5.566 . . . . 0.0 119.142 -168.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 6.3 mt-10 -51.2 -47.2 62.31 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 128.914 2.886 . . . . 0.0 114.126 172.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.424 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 3.1 tm? -116.84 -51.61 2.56 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 128.384 2.673 . . . . 0.0 107.258 -161.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.315 . . -114.41 143.6 44.66 Favored 'General case' 0 CA--C 1.462 -2.421 0 CA-C-O 117.788 -1.101 . . . . 0.0 109.815 -175.27 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.5 m -129.54 164.47 32.04 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.125 0 N-CA-C 120.717 3.599 . . . . 0.0 120.717 148.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.4 t -80.49 147.73 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.957 0 CA-C-N 110.877 -2.874 . . . . 0.0 108.207 -176.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -82.37 -39.4 22.8 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.426 -1.715 . . . . 0.0 106.419 -172.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -151.6 142.36 22.84 Favored 'General case' 0 CA--C 1.464 -2.346 0 N-CA-C 104.805 -2.295 . . . . 0.0 104.805 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -105.42 98.25 16.36 Favored Pre-proline 0 N--CA 1.42 -1.969 0 N-CA-C 100.757 -3.794 . . . . 0.0 100.757 163.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -98.09 -113.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.411 -3.336 0 N-CA-C 101.735 -3.986 . . . . 0.0 101.735 -168.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -174.63 -48.45 0.01 OUTLIER 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 -146.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -86.88 102.77 14.65 Favored 'General case' 0 CA--C 1.486 -1.482 0 CA-C-O 121.792 0.806 . . . . 0.0 112.952 -145.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.422 HD13 ' CZ ' ' A' ' 130' ' ' PHE . 4.9 mt -85.43 134.51 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.069 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 173.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -129.1 112.28 13.82 Favored 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.48 -150.36 34.81 Favored Glycine 0 CA--C 1.484 -1.887 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 -167.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -98.92 46.91 0.98 Allowed 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.964 1.306 . . . . 0.0 108.17 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.269 41.5 mt-30 -165.62 134.46 3.24 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 121.905 -0.497 . . . . 0.0 109.91 -170.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.469 ' H ' ' HB3' ' A' ' 128' ' ' LEU . 23.8 ttm -122.96 122.78 39.39 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -176.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 127' ' ' THR . 19.3 mm -82.81 124.79 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 171.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.1 ttp -108.42 130.39 55.23 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 103.166 -2.901 . . . . 0.0 103.166 160.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 32.8 t -96.43 137.49 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 118.873 -1.131 . . . . 0.0 108.42 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.795 HD11 ' HB1' ' A' ' 156' ' ' ALA . 1.1 tp -128.88 144.32 51.14 Favored 'General case' 0 C--N 1.362 1.149 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 -174.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.361 . . -148.5 175.02 2.96 Favored Pre-proline 0 CA--C 1.493 -1.241 0 CA-C-O 117.501 -1.238 . . . . 0.0 110.216 -169.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -73.53 144.92 36.8 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 CA-C-N 121.621 1.614 . . . . 0.0 108.022 -177.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -79.94 132.99 36.17 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -78.55 100.28 6.86 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.852 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -91.17 84.34 5.66 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 . . . . . 0 C--O 1.26 1.646 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -176.167 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.467 -2.238 0 CA-C-O 124.775 2.226 . . . . 0.0 107.667 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.8 mm -86.85 116.23 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 108.621 -3.899 . . . . 0.0 107.09 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -101.07 162.9 12.56 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -170.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.3 t -92.3 115.21 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.558 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -108.46 178.97 4.33 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.569 154.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -142.53 157.07 45.12 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 -171.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 tp -140.31 166.75 19.34 Favored 'Isoleucine or valine' 0 C--N 1.356 0.848 0 N-CA-C 102.544 -3.132 . . . . 0.0 102.544 164.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -116.17 158.69 22.87 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-N 118.943 0.792 . . . . 0.0 111.021 166.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.587 ' HB3' HG11 ' A' ' 144' ' ' VAL . 2.4 m-85 -149.46 99.84 2.94 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -87.42 173.53 6.41 Favored Pre-proline 0 N--CA 1.436 -1.175 0 C-N-CA 125.573 1.549 . . . . 0.0 109.541 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.466 ' HG3' ' H ' ' A' ' 131' ' ' ARG . 16.4 Cg_endo -72.02 132.68 20.15 Favored 'Trans proline' 0 N--CA 1.433 -2.06 0 N-CA-C 105.135 -2.679 . . . . 0.0 105.135 163.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.69 4.64 60.43 Favored Glycine 0 CA--C 1.484 -1.878 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.407 HG22 ' HB2' ' A' ' 107' ' ' TYR . 60.6 m -103.71 89.62 3.39 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 164.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -127.39 -171.82 2.51 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 112.816 -1.993 . . . . 0.0 105.885 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.57 -41.52 69.92 Favored 'General case' 0 CA--C 1.481 -1.709 0 C-N-CA 125.987 1.715 . . . . 0.0 114.54 -127.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.18 -5.06 80.64 Favored Glycine 0 N--CA 1.419 -2.497 0 N-CA-C 116.478 1.351 . . . . 0.0 116.478 -171.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -100.21 -29.17 12.62 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 124.947 1.299 . . . . 0.0 108.019 168.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.407 ' HB2' HG22 ' A' ' 102' ' ' THR . 1.1 t80 -88.81 -69.93 0.68 Allowed 'General case' 0 CA--C 1.473 -1.992 0 CA-C-N 112.611 -2.086 . . . . 0.0 111.316 -158.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.485 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.35 0.0 OUTLIER -56.02 -18.56 9.79 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 118.783 2.883 . . . . 0.0 118.783 172.504 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.59 -49.65 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 CA-C-O 122.391 1.091 . . . . 0.0 110.091 163.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -91.54 9.08 33.54 Favored 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 7.1 tt -85.03 -32.67 22.78 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 163.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.468 ' HA ' HG12 ' A' ' 115' ' ' ILE . 55.2 ttt180 -62.27 -42.89 99.73 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 118.807 -0.616 . . . . 0.0 110.928 167.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 t -54.46 -45.88 73.21 Favored 'General case' 0 C--N 1.379 1.862 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 171.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 118' ' ' LEU . 46.4 mt -63.35 -34.36 77.55 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 117.608 2.447 . . . . 0.0 117.608 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.468 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.9 mm -55.99 -48.57 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 O-C-N 124.3 1.0 . . . . 0.0 108.899 173.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -51.6 -45.62 63.26 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 126.033 1.733 . . . . 0.0 113.402 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -57.49 -50.58 72.58 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' A' ' 156' ' ' ALA . 1.8 mt -72.61 -21.18 61.16 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 125.304 1.442 . . . . 0.0 113.902 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -75.13 -33.22 61.53 Favored 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 125.671 1.588 . . . . 0.0 110.391 173.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -68.91 -26.31 65.03 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 167.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.46 78.24 1.22 Allowed Glycine 0 CA--C 1.47 -2.778 0 N-CA-C 106.338 -2.705 . . . . 0.0 106.338 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -134.31 168.3 19.14 Favored 'General case' 0 CA--C 1.465 -2.318 1 N-CA-C 99.902 -4.111 . . . . 0.0 99.902 168.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.317 0.0 OUTLIER -88.29 121.14 30.35 Favored 'General case' 0 CA--C 1.457 -2.631 1 N-CA-C 99.719 -4.178 . . . . 0.0 99.719 156.903 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.53 123.38 33.58 Favored 'General case' 0 N--CA 1.41 -2.443 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 166.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.459 ' HG2' HG13 ' A' ' 173' ' ' VAL . 36.2 mtmt -102.18 125.27 48.83 Favored 'General case' 0 CA--C 1.469 -2.149 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -175.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.421 HD12 HD11 ' A' ' 114' ' ' LEU . 6.3 mm -86.16 125.29 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.43 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.2 m -103.31 121.62 43.11 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.704 HD23 HD11 ' A' ' 145' ' ' LEU 0.313 0.2 OUTLIER -81.0 150.53 28.86 Favored 'General case' 0 CA--C 1.456 -2.655 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 166.597 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -147.25 89.23 1.77 Allowed 'General case' 0 N--CA 1.402 -2.838 1 N-CA-C 98.645 -4.576 . . . . 0.0 98.645 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -71.83 143.42 49.46 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-N 111.259 -2.7 . . . . 0.0 109.877 -166.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.466 ' H ' ' HG3' ' A' ' 100' ' ' PRO . 23.6 mmm180 -96.14 84.92 3.88 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 102.46 -3.163 . . . . 0.0 102.46 157.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -172.3 -142.97 3.94 Favored Glycine 0 N--CA 1.424 -2.11 0 C-N-CA 118.581 -1.771 . . . . 0.0 109.128 -160.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.513 ' H ' ' HB2' ' A' ' 136' ' ' ALA . 20.2 ttt180 -136.3 -167.94 2.15 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -165.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 135' ' ' MET . 4.3 pt-20 -51.3 -69.84 0.1 Allowed 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 127.095 2.158 . . . . 0.0 110.171 173.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.435 ' H ' ' HG3' ' A' ' 134' ' ' GLU . 9.2 ptt? -98.97 106.2 18.43 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 103.9 -2.629 . . . . 0.0 103.9 155.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.513 ' HB2' ' H ' ' A' ' 133' ' ' ARG . . . -73.64 -53.65 9.95 Favored 'General case' 0 CA--C 1.473 -2.013 0 CA-C-O 124.764 2.221 . . . . 0.0 111.287 -176.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.621 ' CE1' HD11 ' A' ' 165' ' ' ILE . 56.8 p-80 -115.15 169.05 9.4 Favored 'General case' 0 N--CA 1.417 -2.109 1 CA-C-N 108.205 -4.089 . . . . 0.0 114.538 -148.017 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -128.4 -2.67 5.56 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 140.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -106.76 -56.94 2.12 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 113.372 -1.74 . . . . 0.0 112.121 -166.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 74.7 mt -58.42 -52.11 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 C-N-CA 127.169 2.187 . . . . 0.0 111.424 -171.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.81 -65.19 2.18 Favored Glycine 0 N--CA 1.419 -2.458 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 75.0 mtm -93.04 11.75 26.48 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -159.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -72.75 -53.38 11.77 Favored 'General case' 0 CA--C 1.444 -3.1 0 C-N-CA 117.155 -1.818 . . . . 0.0 113.153 143.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.587 HG11 ' HB3' ' A' ' 98' ' ' PHE . 31.2 t -67.71 -66.94 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.446 -3.019 0 O-C-N 126.539 2.399 . . . . 0.0 107.681 -160.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.704 HD11 HD23 ' A' ' 128' ' ' LEU . 97.3 mt -46.97 -49.7 20.28 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 128.563 2.745 . . . . 0.0 115.387 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -59.34 -38.96 81.69 Favored 'General case' 0 CA--C 1.477 -1.833 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 172.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -80.65 -14.75 57.89 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.614 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.447 HG23 ' HA ' ' A' ' 145' ' ' LEU . 1.8 t -76.53 -47.91 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.69 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.288 12.7 ttmt -55.0 -43.46 73.61 Favored 'General case' 0 CA--C 1.466 -2.286 0 C-N-CA 126.015 1.726 . . . . 0.0 113.128 172.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -40.11 65.3 Favored 'General case' 0 N--CA 1.41 -2.452 0 C-N-CA 124.162 0.985 . . . . 0.0 109.446 -174.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -73.93 -26.3 60.43 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 116.579 -2.049 . . . . 0.0 115.569 170.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.271 0.2 OUTLIER -80.9 -32.42 34.79 Favored 'General case' 0 CA--C 1.47 -2.101 0 CA-C-O 116.749 -1.596 . . . . 0.0 112.223 -178.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -28.8 -23.52 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.69 1 C-N-CA 135.528 5.531 . . . . 0.0 119.987 -174.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -53.33 -56.75 14.16 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 126.557 1.943 . . . . 0.0 111.989 167.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.3 tt -107.94 -52.25 2.79 Favored 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 126.557 1.943 . . . . 0.0 108.529 -167.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.62 ' CB ' HD11 ' A' ' 174' ' ' LEU 0.294 . . -110.5 138.37 46.98 Favored 'General case' 0 CA--C 1.467 -2.241 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.505 -173.295 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 177' ' ' LYS . 29.7 m -128.84 165.12 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.496 0 N-CA-C 119.445 3.128 . . . . 0.0 119.445 147.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 160' ' ' SER . 3.9 t -76.96 153.02 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.135 0 CA-C-N 111.562 -2.563 . . . . 0.0 108.401 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.06 -39.91 25.0 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.753 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.548 ' H ' HG12 ' A' ' 158' ' ' VAL . 0.9 OUTLIER -150.38 137.2 19.17 Favored 'General case' 0 CA--C 1.469 -2.171 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 -173.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -114.23 98.55 48.81 Favored Pre-proline 0 CA--C 1.486 -1.517 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 177.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -135.36 -117.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.42 -2.832 0 C-N-CA 114.09 -3.473 . . . . 0.0 103.918 -152.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -169.13 -38.15 0.02 OUTLIER 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -128.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -85.53 92.58 8.56 Favored 'General case' 0 CA--C 1.489 -1.378 0 CA-C-O 121.254 0.549 . . . . 0.0 111.334 -159.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.621 HD11 ' CE1' ' A' ' 137' ' ' HIS . 0.8 OUTLIER -83.96 137.22 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.244 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 174.178 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -106.06 94.31 5.1 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.43 -134.37 14.09 Favored Glycine 0 CA--C 1.481 -2.069 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -170.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.04 48.32 0.84 Allowed 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 125.914 1.685 . . . . 0.0 107.304 178.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.417 ' H ' HG22 ' A' ' 165' ' ' ILE . 36.6 tt0 -168.27 116.34 0.72 Allowed 'General case' 0 C--N 1.353 0.722 0 O-C-N 121.909 -0.495 . . . . 0.0 110.46 -170.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 28.8 ttp -115.8 118.86 34.2 Favored 'General case' 0 C--N 1.369 1.444 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -165.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.4 mm -84.03 124.46 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 O-C-N 120.633 -1.292 . . . . 0.0 108.964 170.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.598 ' HB2' HD13 ' A' ' 145' ' ' LEU . 1.9 tmm? -99.44 133.0 44.39 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 102.141 -3.281 . . . . 0.0 102.141 156.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.459 HG13 ' HG2' ' A' ' 125' ' ' LYS . 24.7 t -99.94 116.22 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 118.239 -1.384 . . . . 0.0 110.013 -177.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.62 HD11 ' CB ' ' A' ' 156' ' ' ALA . 1.1 tp -106.57 107.62 18.73 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 -167.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.265 . . -99.57 179.54 1.02 Allowed Pre-proline 0 CA--C 1.486 -1.481 0 C-N-CA 124.746 1.218 . . . . 0.0 113.169 -176.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -70.55 153.76 65.1 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 N-CA-C 106.483 -2.161 . . . . 0.0 106.483 170.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.579 ' HA ' HG22 ' A' ' 157' ' ' VAL . 33.2 ttmt -73.4 120.86 19.59 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 123.026 1.393 . . . . 0.0 110.125 -175.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -70.51 -174.08 0.82 Allowed 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 129.217 3.007 . . . . 0.0 113.227 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -62.36 104.7 0.52 Allowed 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.233 1.413 . . . . 0.0 109.941 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 . . . . . 0 C--O 1.26 1.628 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 176.658 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.468 -2.206 0 CA-C-O 124.724 2.202 . . . . 0.0 107.555 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.4 mm -87.29 114.8 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 108.62 -3.9 . . . . 0.0 107.376 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -100.66 176.19 5.4 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -170.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.4 t -105.17 125.12 60.29 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.485 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 167.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -106.8 174.9 5.69 Favored 'General case' 0 CA--C 1.464 -2.339 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 155.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -149.28 147.05 27.9 Favored 'General case' 0 N--CA 1.422 -1.851 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.084 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tp -129.21 162.42 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -122.22 152.78 39.64 Favored 'General case' 0 CA--C 1.488 -1.44 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.979 162.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.526 ' HB3' HG11 ' A' ' 144' ' ' VAL . 45.2 m-85 -130.82 146.73 52.34 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 172.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.32 169.8 6.18 Favored Pre-proline 0 N--CA 1.435 -1.181 0 C-N-CA 123.644 0.777 . . . . 0.0 109.08 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -58.36 138.13 84.2 Favored 'Trans proline' 0 N--CA 1.436 -1.883 1 C-N-CA 125.506 4.138 . . . . 0.0 110.933 167.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.16 -125.1 20.97 Favored Glycine 0 CA--C 1.479 -2.196 0 N-CA-C 106.786 -2.526 . . . . 0.0 106.786 -173.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.7 m 55.7 106.58 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.759 0 C-N-CA 129.492 3.117 . . . . 0.0 112.958 173.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -125.17 -131.04 0.25 Allowed 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 105.026 -2.212 . . . . 0.0 105.026 171.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -55.58 -80.05 0.02 OUTLIER 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -89.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.51 45.5 1.35 Allowed Glycine 0 CA--C 1.484 -1.902 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.671 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -101.95 -42.73 6.01 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 146.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -73.79 -75.59 0.15 Allowed 'General case' 0 CA--C 1.48 -1.714 0 CA-C-N 113.189 -1.823 . . . . 0.0 108.678 -169.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.431 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.341 0.0 OUTLIER -58.66 -12.31 4.04 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 120.389 3.477 . . . . 0.0 120.389 178.427 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 66.3 t -61.75 -45.42 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 CA-C-O 122.59 1.186 . . . . 0.0 110.041 161.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -91.77 -0.83 57.56 Favored 'General case' 0 CA--C 1.472 -2.037 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.491 HD12 HG13 ' A' ' 148' ' ' VAL . 5.8 tt -78.17 -32.0 49.94 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 161.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.457 ' HA ' HG12 ' A' ' 115' ' ' ILE . 48.4 ttt180 -63.52 -43.13 98.06 Favored 'General case' 0 C--N 1.361 1.077 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.242 170.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.8 m -63.92 -37.28 86.82 Favored 'General case' 0 C--N 1.377 1.788 0 C-N-CA 118.648 -1.221 . . . . 0.0 113.405 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.493 HD11 HD23 ' A' ' 174' ' ' LEU 0.296 60.5 tp -70.38 -28.96 65.5 Favored 'General case' 0 N--CA 1.401 -2.91 0 C-N-CA 125.196 1.398 . . . . 0.0 113.782 176.611 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 112' ' ' ARG . 9.7 mm -58.57 -50.59 78.44 Favored 'Isoleucine or valine' 0 C--N 1.371 1.507 0 CA-C-N 120.982 1.719 . . . . 0.0 110.033 170.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -52.28 -44.11 64.79 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 127.697 2.399 . . . . 0.0 110.668 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -59.44 -50.03 75.51 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 125.868 1.667 . . . . 0.0 113.04 176.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.444 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -60.46 -34.6 74.25 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 175.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -72.1 -32.12 66.7 Favored 'General case' 0 CA--C 1.487 -1.468 0 C-N-CA 127.745 2.418 . . . . 0.0 110.913 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -64.81 -20.83 66.6 Favored 'General case' 0 C--N 1.36 1.023 0 C-N-CA 123.117 0.567 . . . . 0.0 111.444 171.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 89.17 59.51 1.56 Allowed Glycine 0 CA--C 1.466 -2.987 0 N-CA-C 104.65 -3.38 . . . . 0.0 104.65 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -123.21 167.73 13.35 Favored 'General case' 0 CA--C 1.455 -2.701 0 N-CA-C 102.121 -3.289 . . . . 0.0 102.121 171.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -94.22 132.32 38.9 Favored 'General case' 0 CA--C 1.449 -2.942 0 N-CA-C 100.602 -3.851 . . . . 0.0 100.602 162.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.422 ' HB1' HD12 ' A' ' 114' ' ' LEU . . . -108.22 115.71 30.63 Favored 'General case' 0 N--CA 1.4 -2.942 0 C-N-CA 117.378 -1.729 . . . . 0.0 106.593 -173.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -97.26 122.39 40.23 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.543 0.687 . . . . 0.0 109.275 -163.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.6 mm -84.16 133.78 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.961 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.9 m -112.97 117.12 31.19 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 165.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.849 HD21 ' HA2' ' A' ' 141' ' ' GLY . 10.4 tp -79.61 153.17 29.61 Favored 'General case' 0 CA--C 1.474 -1.97 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 167.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -152.88 94.12 1.83 Allowed 'General case' 0 N--CA 1.4 -2.938 0 N-CA-C 101.335 -3.579 . . . . 0.0 101.335 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.545 ' CZ ' HD23 ' A' ' 128' ' ' LEU 0.311 94.2 m-85 -71.55 173.46 7.97 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 126.909 2.084 . . . . 0.0 109.837 178.283 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.8 tpt85 -98.84 79.88 2.45 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 104.616 -2.365 . . . . 0.0 104.616 148.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -112.2 -101.65 2.57 Favored Glycine 0 CA--C 1.472 -2.64 0 CA-C-O 122.899 1.277 . . . . 0.0 110.249 -167.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.499 ' H ' ' HA ' ' A' ' 168' ' ' ARG . 19.8 tpp180 77.8 70.61 0.05 Allowed 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 110.808 -2.696 . . . . 0.0 109.237 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -169.34 -139.09 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.189 1 N-CA-C 98.927 -4.472 . . . . 0.0 98.927 167.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -99.48 103.57 15.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 100.774 -3.787 . . . . 0.0 100.774 143.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.62 -149.13 0.11 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -160.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.537 ' CG ' HD12 ' A' ' 140' ' ' ILE . 15.9 m80 -39.19 130.36 1.62 Allowed 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 130.368 3.467 . . . . 0.0 114.533 166.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -116.34 10.48 14.75 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -90.54 -53.11 4.57 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.537 HD12 ' CG ' ' A' ' 137' ' ' HIS . 51.9 mt -52.75 -41.53 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 C-N-CA 127.971 2.509 . . . . 0.0 111.361 174.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.849 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -70.58 -60.42 4.68 Favored Glycine 0 CA--C 1.458 -3.53 0 O-C-N 123.951 0.782 . . . . 0.0 113.958 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.424 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 5.1 ptt? -85.78 -1.52 57.31 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -159.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.271 2.0 tp10 -61.44 -60.67 3.36 Favored 'General case' 0 CA--C 1.454 -2.747 0 C-N-CA 114.412 -2.915 . . . . 0.0 115.394 146.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 98' ' ' PHE . 23.1 t -66.26 -65.87 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.91 0 O-C-N 125.978 2.049 . . . . 0.0 108.7 -162.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.521 HD11 HD22 ' A' ' 128' ' ' LEU . 32.0 mt -44.85 -54.17 6.7 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 129.131 2.972 . . . . 0.0 114.316 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 142' ' ' MET . 2.0 t-20 -66.16 -28.34 68.71 Favored 'General case' 0 CA--C 1.468 -2.179 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 174.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -80.35 -15.34 57.09 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.222 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.491 HG13 HD12 ' A' ' 111' ' ' LEU . 1.9 t -76.08 -44.47 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.78 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.448 ' HE3' HG21 ' A' ' 158' ' ' VAL 0.262 34.9 ttmt -52.98 -48.76 67.19 Favored 'General case' 0 CA--C 1.47 -2.105 0 C-N-CA 125.435 1.494 . . . . 0.0 112.435 171.326 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.1 -38.39 66.38 Favored 'General case' 0 N--CA 1.409 -2.508 0 C-N-CA 125.853 1.661 . . . . 0.0 109.605 -171.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.53 -25.72 54.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 116.462 -2.095 . . . . 0.0 115.201 170.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 156' ' ' ALA 0.298 0.1 OUTLIER -77.31 -30.84 54.29 Favored 'General case' 0 CA--C 1.473 -1.992 0 CA-C-O 116.525 -1.703 . . . . 0.0 113.451 176.069 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -29.44 -20.13 0.0 OUTLIER 'General case' 0 C--N 1.366 1.302 1 C-N-CA 134.91 5.284 . . . . 0.0 120.224 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.2 mt-10 -56.29 -62.15 1.91 Allowed 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 127.187 2.195 . . . . 0.0 111.178 167.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.13 -56.01 2.78 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 125.542 1.537 . . . . 0.0 109.048 -174.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.466 ' CB ' HD11 ' A' ' 174' ' ' LEU 0.269 . . -98.48 146.66 25.53 Favored 'General case' 0 CA--C 1.449 -2.934 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.877 -165.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.2 m -121.59 172.2 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.454 -2.723 0 C-N-CA 114.626 -2.83 . . . . 0.0 116.384 134.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 3.8 t -82.31 153.4 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.831 0 CA-C-N 111.784 -2.462 . . . . 0.0 107.157 -177.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -81.59 -41.22 21.86 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 -173.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.4 t -157.29 143.15 17.61 Favored 'General case' 0 CA--C 1.46 -2.499 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -104.46 94.38 7.0 Favored Pre-proline 0 N--CA 1.423 -1.806 0 N-CA-C 100.996 -3.705 . . . . 0.0 100.996 167.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -102.05 -110.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.412 -3.294 0 N-CA-C 103.273 -3.395 . . . . 0.0 103.273 -155.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -170.62 -40.82 0.02 OUTLIER 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -139.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -86.61 79.03 9.04 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -147.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.1 mt -84.16 124.08 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.091 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 168.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -123.34 101.79 7.56 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 111.752 -2.476 . . . . 0.0 105.519 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 86.27 -144.36 19.94 Favored Glycine 0 CA--C 1.483 -1.937 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -172.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.499 ' HA ' ' H ' ' A' ' 133' ' ' ARG . 15.4 ptm180 -97.1 41.15 1.12 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.145 1.378 . . . . 0.0 109.418 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -170.72 141.18 1.79 Allowed 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 121.76 -0.587 . . . . 0.0 111.999 -172.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.471 ' H ' ' HB3' ' A' ' 128' ' ' LEU . 48.5 ttm -122.11 122.86 40.21 Favored 'General case' 0 CA--C 1.481 -1.678 0 C-N-CA 123.547 0.739 . . . . 0.0 109.405 -176.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.2 mm -81.99 122.7 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 166.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 3.9 ttp -106.55 129.53 54.48 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 101.582 -3.488 . . . . 0.0 101.582 161.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.5 t -94.48 137.33 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -117.81 150.22 39.51 Favored 'General case' 0 C--N 1.357 0.898 1 N-CA-C 99.516 -4.253 . . . . 0.0 99.516 -179.987 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.26 . . -140.75 -178.92 0.89 Allowed Pre-proline 0 N--CA 1.432 -1.341 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.681 -170.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.416 ' HA ' HD21 ' A' ' 118' ' ' LEU . 75.8 Cg_exo -69.85 147.45 62.31 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 C-N-CA 122.395 2.063 . . . . 0.0 109.055 165.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -80.07 141.83 35.46 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 171.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -76.5 95.89 3.97 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 168.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -81.24 110.27 16.55 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 . . . . . 0 C--O 1.26 1.649 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -178.359 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 CA--C 1.472 -2.035 0 CA-C-O 124.906 2.288 . . . . 0.0 107.694 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.2 mm -93.16 124.79 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.503 0 CA-C-N 108.73 -3.85 . . . . 0.0 107.194 176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -92.59 168.09 11.48 Favored 'General case' 0 CA--C 1.48 -1.749 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.498 HG22 ' HE2' ' A' ' 123' ' ' LYS . 46.4 t -105.99 121.82 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.874 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 162.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -101.51 175.94 5.4 Favored 'General case' 0 CA--C 1.468 -2.2 0 C-N-CA 116.427 -2.109 . . . . 0.0 105.715 166.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -143.08 152.67 42.11 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 tp -135.03 163.03 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 103.028 -2.953 . . . . 0.0 103.028 167.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -115.13 153.33 30.98 Favored 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.567 162.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.515 ' HB3' HG11 ' A' ' 144' ' ' VAL . 32.6 m-85 -125.42 131.33 52.94 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 169.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -93.84 169.43 10.03 Favored Pre-proline 0 N--CA 1.433 -1.304 0 C-N-CA 124.258 1.023 . . . . 0.0 109.254 -175.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.2 139.5 42.31 Favored 'Trans proline' 0 CA--C 1.489 -1.726 0 C-N-CA 124.417 3.411 . . . . 0.0 107.502 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.3 -122.51 8.79 Favored Glycine 0 CA--C 1.482 -1.971 0 N-CA-C 106.33 -2.708 . . . . 0.0 106.33 -166.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.0 m 55.78 103.74 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.923 0 C-N-CA 129.904 3.282 . . . . 0.0 112.887 177.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -121.94 -167.79 1.6 Allowed 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.142 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -27.06 -59.3 0.09 Allowed 'General case' 0 CA--C 1.482 -1.657 1 C-N-CA 131.873 4.069 . . . . 0.0 115.283 -146.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -17.28 -74.6 0.01 OUTLIER Glycine 0 CA--C 1.459 -3.463 1 C-N-CA 133.173 5.178 . . . . 0.0 118.098 168.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . 0.363 53.9 m-20 -89.7 -33.94 16.42 Favored 'General case' 0 N--CA 1.4 -2.957 0 CA-C-N 109.869 -3.165 . . . . 0.0 109.766 -174.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.58 -72.1 0.33 Allowed 'General case' 0 CA--C 1.484 -1.595 0 CA-C-N 112.747 -2.024 . . . . 0.0 109.799 -161.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.444 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.293 0.0 OUTLIER -63.52 -7.68 7.58 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 119.843 3.275 . . . . 0.0 119.843 178.122 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.67 -42.95 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 C-N-CA 124.015 0.926 . . . . 0.0 110.025 160.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.0 mmtt -92.74 -5.06 52.04 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.2 tt -75.69 -35.02 60.44 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 163.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.459 ' HA ' HG12 ' A' ' 115' ' ' ILE . 7.4 ttm180 -59.31 -43.65 92.61 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 125.541 1.536 . . . . 0.0 111.318 169.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.8 t -56.79 -46.59 81.46 Favored 'General case' 0 C--N 1.377 1.791 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.267 71.0 mt -67.56 -28.12 67.51 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 176.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.7 mm -59.78 -49.5 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.709 0 CA-C-N 119.696 1.134 . . . . 0.0 108.83 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -51.57 -44.58 62.79 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 127.26 2.224 . . . . 0.0 110.1 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -63.65 -52.77 59.27 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.686 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -67.91 -29.48 68.58 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 125.605 1.562 . . . . 0.0 114.699 -178.584 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.62 -29.53 51.84 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 124.03 0.932 . . . . 0.0 110.842 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -82.84 -1.2 51.29 Favored 'General case' 0 C--N 1.362 1.139 0 CA-C-O 120.602 0.239 . . . . 0.0 110.829 170.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.05 70.16 1.32 Allowed Glycine 0 CA--C 1.473 -2.59 0 C-N-CA 126.242 1.877 . . . . 0.0 109.552 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -128.04 163.64 24.13 Favored 'General case' 0 CA--C 1.449 -2.92 0 N-CA-C 100.786 -3.783 . . . . 0.0 100.786 169.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.498 ' HE2' HG22 ' A' ' 93' ' ' VAL . 1.6 tmmm? -98.33 106.03 18.26 Favored 'General case' 0 N--CA 1.399 -3.019 1 N-CA-C 97.706 -4.924 . . . . 0.0 97.706 172.864 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.08 155.25 21.59 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -133.47 129.95 37.91 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 119.844 -1.785 . . . . 0.0 106.552 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.8 mm -82.74 137.98 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.576 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.1 m -117.14 127.51 54.2 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 167.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.663 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.1 OUTLIER -85.83 153.56 22.17 Favored 'General case' 0 CA--C 1.462 -2.441 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 166.426 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.439 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 56.9 ttt180 -151.36 91.41 1.67 Allowed 'General case' 0 N--CA 1.394 -3.231 1 N-CA-C 98.715 -4.55 . . . . 0.0 98.715 -175.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.56 ' CE2' HD13 ' A' ' 165' ' ' ILE 0.253 97.6 m-85 -74.35 164.62 26.39 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 111.438 -2.619 . . . . 0.0 105.903 179.475 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -78.9 99.5 6.81 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 161.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.24 126.58 41.81 Favored Glycine 0 CA--C 1.478 -2.219 0 N-CA-C 117.936 1.935 . . . . 0.0 117.936 -149.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . 0.32 11.8 ptp85 57.89 24.51 11.0 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 129.188 2.995 . . . . 0.0 116.043 171.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.94 -26.76 3.4 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 101.874 -3.38 . . . . 0.0 101.874 163.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 25.3 mmt -129.5 5.44 5.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.667 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.47 ' HA ' ' CG ' ' A' ' 130' ' ' PHE . . . -76.48 90.57 3.29 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-N 120.373 1.442 . . . . 0.0 112.267 167.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.15 164.88 19.95 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -98.37 15.36 24.93 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -89.03 -49.72 6.6 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 166.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.29 68.1 mt -66.45 -37.32 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 0 C-N-CA 128.369 2.668 . . . . 0.0 108.281 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.663 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -78.34 -66.6 1.72 Allowed Glycine 0 N--CA 1.408 -3.193 0 CA-C-N 114.372 -1.285 . . . . 0.0 113.574 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 43.0 mtt -95.03 24.21 5.04 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -164.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -71.14 -55.7 7.63 Favored 'General case' 0 CA--C 1.456 -2.652 0 C-N-CA 116.521 -2.072 . . . . 0.0 114.644 133.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 98' ' ' PHE . 19.4 t -64.16 -66.25 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.443 -3.172 0 O-C-N 126.174 2.171 . . . . 0.0 107.834 -163.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 172' ' ' MET . 71.1 mt -44.61 -55.03 5.53 Favored 'General case' 0 CA--C 1.478 -1.824 0 O-C-N 126.543 2.402 . . . . 0.0 114.108 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.36 -36.79 74.01 Favored 'General case' 0 CA--C 1.473 -2.017 0 C-N-CA 127.229 2.212 . . . . 0.0 114.062 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.407 ' HA ' ' HB2' ' A' ' 150' ' ' ASP . 18.5 ttp180 -81.71 -14.98 55.84 Favored 'General case' 0 N--CA 1.418 -2.027 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.882 175.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.472 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.4 t -75.24 -43.64 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.74 0 CA-C-O 116.374 -1.774 . . . . 0.0 107.355 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.517 ' HB2' HG21 ' A' ' 158' ' ' VAL . 14.6 ttmt -53.49 -52.88 58.14 Favored 'General case' 0 CA--C 1.463 -2.394 0 CA-C-O 116.861 -1.542 . . . . 0.0 109.884 169.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.407 ' HB2' ' HA ' ' A' ' 147' ' ' ARG . 66.8 m-20 -67.52 -39.43 85.08 Favored 'General case' 0 N--CA 1.41 -2.47 0 C-N-CA 124.22 1.008 . . . . 0.0 109.359 -166.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -75.05 -26.84 59.71 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 116.447 -2.101 . . . . 0.0 116.075 171.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.281 0.1 OUTLIER -81.1 -33.28 33.42 Favored 'General case' 0 CA--C 1.479 -1.757 0 CA-C-O 117.107 -1.425 . . . . 0.0 113.605 -178.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -28.5 -29.94 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.478 1 C-N-CA 135.555 5.542 . . . . 0.0 118.85 -173.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.9 -53.32 54.22 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 127.509 2.324 . . . . 0.0 113.204 173.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.17 -53.53 2.67 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.624 -165.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.686 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.308 . . -96.81 153.08 18.09 Favored 'General case' 0 CA--C 1.447 -2.998 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 -177.703 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.417 ' HB ' ' H ' ' A' ' 158' ' ' VAL . 20.3 m -116.39 -164.14 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.905 0 C-N-CA 113.69 -3.204 . . . . 0.0 112.343 138.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 160' ' ' SER 0.28 3.3 t -108.35 162.93 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.559 0 C-N-CA 128.326 2.65 . . . . 0.0 106.009 177.239 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.44 -42.49 18.47 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.548 ' H ' HG12 ' A' ' 158' ' ' VAL . 1.2 t -162.02 154.2 19.34 Favored 'General case' 0 CA--C 1.479 -1.777 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.581 -166.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.88 87.26 3.57 Favored Pre-proline 0 N--CA 1.42 -1.939 0 N-CA-C 103.366 -2.827 . . . . 0.0 103.366 168.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -95.89 -79.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.412 0 N-CA-C 109.529 -0.989 . . . . 0.0 109.529 -136.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.99 -158.01 0.59 Allowed 'General case' 1 N--CA 1.376 -4.159 0 CA-C-O 125.928 2.775 . . . . 0.0 112.071 -141.32 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -142.31 132.98 25.4 Favored 'General case' 0 N--CA 1.423 -1.796 2 N-CA-C 98.745 -4.539 . . . . 0.0 98.745 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.56 HD13 ' CE2' ' A' ' 130' ' ' PHE . 3.5 mt -70.44 132.13 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 CA-C-O 123.212 1.482 . . . . 0.0 110.086 -166.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -125.94 122.71 36.77 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.58 -155.11 39.04 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -172.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -103.84 27.48 7.52 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.992 -1.104 . . . . 0.0 112.398 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.439 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.285 30.3 mt-30 -172.73 147.63 1.79 Allowed 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -159.285 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.406 ' O ' ' HB2' ' A' ' 128' ' ' LEU . 58.7 ttp -142.86 117.22 9.62 Favored 'General case' 0 C--N 1.364 1.196 0 CA-C-O 121.756 0.789 . . . . 0.0 111.703 -174.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.9 mm -80.16 138.44 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 O-C-N 120.105 -1.622 . . . . 0.0 109.816 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.455 ' SD ' HG13 ' A' ' 158' ' ' VAL . 3.3 tmm? -113.85 135.24 54.18 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 154.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.85 127.86 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.612 HD13 ' CD1' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -112.13 73.76 0.83 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 117.241 2.312 . . . . 0.0 117.241 -166.801 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.432 . . -105.46 156.6 36.1 Favored Pre-proline 0 C--N 1.355 0.815 0 N-CA-C 120.024 3.342 . . . . 0.0 120.024 -167.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -67.45 142.12 58.38 Favored 'Trans proline' 0 CA--C 1.492 -1.62 0 C-N-CA 123.258 2.639 . . . . 0.0 111.276 -161.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -77.7 133.41 38.34 Favored 'General case' 0 CA--C 1.49 -1.357 0 O-C-N 125.029 1.456 . . . . 0.0 107.907 -174.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -60.26 126.18 26.52 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 125.939 1.696 . . . . 0.0 110.718 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -77.66 146.93 35.78 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.379 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 . . . . . 0 C--O 1.261 1.696 0 CA-C-O 117.494 -1.241 . . . . 0.0 108.352 177.927 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.467 -2.223 0 CA-C-O 124.93 2.3 . . . . 0.0 107.384 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.7 mm -97.36 119.25 45.15 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 CA-C-N 108.765 -3.834 . . . . 0.0 107.102 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -95.31 170.95 9.02 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.577 HG22 ' HD3' ' A' ' 123' ' ' LYS . 95.0 t -99.69 120.88 49.67 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 161.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -103.68 172.31 6.87 Favored 'General case' 0 CA--C 1.472 -2.04 0 C-N-CA 116.924 -1.911 . . . . 0.0 106.896 155.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -145.09 148.24 33.43 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tp -128.28 162.24 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 174.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -119.74 153.68 35.3 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.702 163.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.556 ' HB3' HG11 ' A' ' 144' ' ' VAL . 41.7 m-85 -127.12 141.73 51.69 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 168.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -113.04 166.08 11.83 Favored Pre-proline 0 N--CA 1.423 -1.788 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 173.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.493 ' HB3' HG23 ' A' ' 140' ' ' ILE . 2.1 Cg_endo -66.8 138.08 47.56 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 C-N-CA 123.924 3.083 . . . . 0.0 108.312 165.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.91 14.59 74.84 Favored Glycine 0 CA--C 1.482 -1.974 0 O-C-N 124.143 0.902 . . . . 0.0 111.919 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.4 m -104.92 99.72 9.35 Favored 'General case' 0 CA--C 1.466 -2.25 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 173.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.35 -142.35 0.27 Allowed 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 112.005 -2.362 . . . . 0.0 105.023 168.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -59.95 -76.6 0.05 OUTLIER 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -84.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.62 41.97 2.02 Favored Glycine 0 CA--C 1.485 -1.842 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.099 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -103.28 -38.98 7.01 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 149.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -70.74 -72.53 0.2 Allowed 'General case' 0 CA--C 1.477 -1.847 0 C-N-CA 126.574 1.949 . . . . 0.0 109.313 -172.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.418 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.35 0.0 OUTLIER -58.47 -15.19 9.97 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 119.816 3.265 . . . . 0.0 119.816 175.881 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.87 -38.69 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 C-N-CA 123.966 0.906 . . . . 0.0 111.229 164.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -92.82 -1.37 56.83 Favored 'General case' 0 CA--C 1.476 -1.875 0 O-C-N 120.159 -1.588 . . . . 0.0 114.708 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 151' ' ' ASP . 5.7 tt -79.53 -31.62 42.11 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 163.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.457 ' HA ' HG12 ' A' ' 115' ' ' ILE . 3.3 tpp180 -60.36 -46.09 91.16 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 125.123 1.369 . . . . 0.0 110.772 168.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.8 t -59.81 -44.55 93.93 Favored 'General case' 0 C--N 1.375 1.697 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.651 HD11 HD12 ' A' ' 174' ' ' LEU 0.303 61.4 tp -67.9 -29.79 68.98 Favored 'General case' 0 N--CA 1.407 -2.595 0 C-N-CA 127.321 2.248 . . . . 0.0 113.562 178.421 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.273 9.4 mm -57.78 -51.41 70.61 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.872 0 CA-C-N 120.941 1.7 . . . . 0.0 108.686 170.808 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.6 tpt85 -54.75 -39.95 68.82 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 126.703 2.001 . . . . 0.0 111.042 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -63.04 -50.64 69.86 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 124.229 1.012 . . . . 0.0 112.263 176.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.545 ' CD1' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -59.1 -37.27 76.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 176.709 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -75.26 -35.73 61.33 Favored 'General case' 0 CA--C 1.487 -1.462 0 C-N-CA 128.931 2.892 . . . . 0.0 109.907 -169.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.55 6.08 11.36 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 123.605 0.762 . . . . 0.0 111.472 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.18 64.11 2.16 Favored Glycine 0 CA--C 1.467 -2.932 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 174.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -128.52 165.17 21.24 Favored 'General case' 0 CA--C 1.448 -2.945 0 N-CA-C 102.306 -3.22 . . . . 0.0 102.306 169.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.577 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -99.93 115.62 30.08 Favored 'General case' 0 N--CA 1.395 -3.211 1 N-CA-C 97.952 -4.832 . . . . 0.0 97.952 173.162 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -87.69 160.5 18.08 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.477 ' HD3' HD12 ' A' ' 171' ' ' ILE . 35.7 ttmt -136.56 131.3 33.65 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 168.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.457 HD11 ' HG ' ' A' ' 174' ' ' LEU . 10.0 mm -83.19 135.24 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 171.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.472 ' HA ' HD13 ' A' ' 171' ' ' ILE . 17.3 m -113.57 115.65 28.29 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 163.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.801 HD21 ' HA2' ' A' ' 141' ' ' GLY . 17.1 tp -84.93 150.06 25.21 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 168.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -153.8 103.05 2.57 Favored 'General case' 0 N--CA 1.406 -2.674 1 N-CA-C 99.834 -4.136 . . . . 0.0 99.834 -170.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.599 ' CZ ' HD23 ' A' ' 128' ' ' LEU 0.347 81.9 m-85 -83.15 86.48 7.01 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 126.535 1.934 . . . . 0.0 109.297 -171.957 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -123.71 30.55 6.16 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -97.19 -34.88 5.47 Favored Glycine 0 CA--C 1.466 -3.022 0 N-CA-C 104.714 -3.354 . . . . 0.0 104.714 171.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -144.54 123.41 12.7 Favored 'General case' 0 CA--C 1.475 -1.928 1 N-CA-C 99.699 -4.186 . . . . 0.0 99.699 165.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.61 -16.02 54.48 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -161.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 35.1 tpp -71.68 -103.28 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 123.15 0.58 . . . . 0.0 111.394 174.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.54 ' HB1' HD13 ' A' ' 165' ' ' ILE . . . 173.55 110.41 0.02 OUTLIER 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -157.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -119.96 149.25 42.43 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 121.252 0.549 . . . . 0.0 111.455 -178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -82.24 -13.09 57.59 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 121.272 0.558 . . . . 0.0 109.894 173.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -84.29 -53.6 5.37 Favored 'General case' 0 CA--C 1.481 -1.691 0 C-N-CA 125.862 1.665 . . . . 0.0 108.667 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.493 HG23 ' HB3' ' A' ' 100' ' ' PRO . 70.8 mt -51.98 -44.7 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 C-N-CA 126.548 1.939 . . . . 0.0 110.877 176.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.801 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -70.62 -60.72 4.49 Favored Glycine 0 CA--C 1.456 -3.607 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.961 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 4.3 ptt? -85.57 -1.15 56.81 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -157.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.257 0.5 OUTLIER -61.76 -63.54 1.23 Allowed 'General case' 0 CA--C 1.46 -2.484 0 C-N-CA 115.035 -2.666 . . . . 0.0 115.694 147.393 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.556 HG11 ' HB3' ' A' ' 98' ' ' PHE . 35.8 t -62.77 -67.5 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.448 -2.944 0 O-C-N 126.021 2.076 . . . . 0.0 109.007 -166.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.464 HD11 HD22 ' A' ' 128' ' ' LEU . 34.4 mt -43.49 -55.32 4.28 Favored 'General case' 0 CA--C 1.482 -1.666 0 C-N-CA 128.858 2.863 . . . . 0.0 114.564 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 142' ' ' MET . 2.3 t30 -63.23 -30.41 71.56 Favored 'General case' 0 CA--C 1.467 -2.229 0 N-CA-C 117.689 2.478 . . . . 0.0 117.689 174.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -81.15 -14.57 57.52 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.612 172.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.7 t -76.79 -44.14 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.787 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 175.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.514 ' HE3' HG21 ' A' ' 158' ' ' VAL 0.256 33.9 ttmt -52.84 -49.95 64.72 Favored 'General case' 0 CA--C 1.467 -2.219 0 C-N-CA 125.631 1.573 . . . . 0.0 112.033 171.02 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -37.69 64.41 Favored 'General case' 0 N--CA 1.409 -2.521 0 C-N-CA 125.506 1.522 . . . . 0.0 109.456 -169.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.405 ' HB3' HD11 ' A' ' 111' ' ' LEU . 17.8 t70 -75.33 -25.63 57.98 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 116.372 -2.131 . . . . 0.0 114.993 169.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 156' ' ' ALA 0.308 0.1 OUTLIER -78.41 -32.42 48.71 Favored 'General case' 0 CA--C 1.472 -2.05 0 CA-C-O 116.792 -1.575 . . . . 0.0 112.614 178.392 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -29.58 -22.26 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.403 1 C-N-CA 135.237 5.415 . . . . 0.0 119.884 -174.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -56.4 -61.71 2.22 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.94 2.096 . . . . 0.0 110.974 168.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.69 -55.64 2.94 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 113.877 -1.511 . . . . 0.0 107.973 -171.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.478 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.255 . . -98.25 150.87 21.07 Favored 'General case' 0 CA--C 1.443 -3.136 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.565 -166.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.53 173.25 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.662 0 C-N-CA 114.11 -3.036 . . . . 0.0 116.113 130.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.514 HG21 ' HE3' ' A' ' 149' ' ' LYS 0.3 3.1 t -81.2 151.6 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.104 0 CA-C-N 110.133 -3.212 . . . . 0.0 104.911 173.764 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -81.71 -38.47 25.74 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -174.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.39 136.73 14.92 Favored 'General case' 0 N--CA 1.408 -2.54 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -177.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.63 123.49 56.0 Favored Pre-proline 0 N--CA 1.417 -2.1 1 N-CA-C 97.632 -4.951 . . . . 0.0 97.632 156.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -74.29 -85.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.267 1 N-CA-C 101.111 -4.227 . . . . 0.0 101.111 167.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 176.6 -55.49 0.01 OUTLIER 'General case' 0 N--CA 1.394 -3.257 1 N-CA-C 94.583 -6.08 . . . . 0.0 94.583 172.598 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -129.85 176.11 8.31 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.585 -161.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.651 ' H ' HD12 ' A' ' 165' ' ' ILE . 0.6 OUTLIER -93.61 150.93 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 C-N-CA 126.108 1.763 . . . . 0.0 109.819 -172.085 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -115.25 84.74 2.14 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 160.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.72 -162.5 24.68 Favored Glycine 0 C--N 1.353 1.527 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 -170.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.405 ' HA ' ' HB2' ' A' ' 136' ' ' ALA . 81.7 mtp180 -114.86 32.84 5.74 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.223 1.009 . . . . 0.0 111.341 -173.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.6 ' H ' HG21 ' A' ' 165' ' ' ILE . 39.4 tt0 173.5 115.17 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 -158.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.413 ' HA ' HG23 ' A' ' 165' ' ' ILE . 11.3 ttm -107.63 119.08 38.43 Favored 'General case' 0 CA--C 1.472 -2.036 0 CA-C-O 121.201 0.524 . . . . 0.0 111.838 -166.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.477 HD12 ' HD3' ' A' ' 125' ' ' LYS . 22.6 mm -83.27 122.1 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 167.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.4 ttp -105.81 127.47 53.12 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 102.448 -3.167 . . . . 0.0 102.448 162.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.2 t -91.62 140.29 16.33 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 C-N-CA 118.336 -1.345 . . . . 0.0 109.093 -174.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.651 HD12 HD11 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -124.65 75.75 1.44 Allowed 'General case' 0 C--N 1.366 1.288 0 N-CA-C 120.334 3.457 . . . . 0.0 120.334 -169.467 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.256 . . -85.31 -176.2 0.74 Allowed Pre-proline 0 CA--C 1.502 -0.872 0 O-C-N 119.374 -2.079 . . . . 0.0 115.357 -169.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.472 ' HA ' HD21 ' A' ' 118' ' ' LEU . 79.9 Cg_exo -65.55 153.77 76.7 Favored 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 122.292 1.994 . . . . 0.0 109.969 160.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -77.25 126.32 30.75 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 170.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -60.53 137.78 58.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.325 1.45 . . . . 0.0 111.899 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 28.1 tptp 59.28 83.23 0.13 Allowed 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 126.134 1.773 . . . . 0.0 108.709 -166.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 . . . . . 0 C--O 1.259 1.575 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.952 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.468 -2.187 0 CA-C-O 124.81 2.243 . . . . 0.0 107.436 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.5 mm -88.25 114.97 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 108.513 -3.949 . . . . 0.0 106.927 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -98.98 167.27 10.84 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -168.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.58 HG22 ' HE3' ' A' ' 123' ' ' LYS . 79.3 t -99.31 120.65 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.431 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 170.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -104.22 173.16 6.42 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 154.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -142.62 154.65 44.58 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -176.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.701 HG21 HD21 ' A' ' 114' ' ' LEU . 3.9 tp -138.7 167.28 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 170.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -119.84 156.25 31.04 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.214 161.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.515 ' HB3' HG11 ' A' ' 144' ' ' VAL . 29.4 m-85 -130.52 160.54 33.82 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 170.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -103.04 174.28 2.92 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 125.213 1.405 . . . . 0.0 108.611 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.432 ' HB3' HG23 ' A' ' 140' ' ' ILE . 86.5 Cg_exo -58.47 146.48 90.33 Favored 'Trans proline' 0 N--CA 1.438 -1.78 1 C-N-CA 125.354 4.036 . . . . 0.0 111.001 158.103 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -9.04 102.65 0.01 OUTLIER Glycine 0 CA--C 1.474 -2.499 1 C-N-CA 131.017 4.151 . . . . 0.0 115.241 -174.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.16 -152.14 0.42 Allowed 'General case' 0 N--CA 1.403 -2.804 0 CA-C-N 111.015 -2.592 . . . . 0.0 108.812 -150.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 107' ' ' TYR 0.451 0.7 OUTLIER -123.77 164.32 19.39 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 109.947 -3.297 . . . . 0.0 110.822 -154.469 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -69.51 -79.24 0.06 Allowed 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -106.77 46.26 1.19 Allowed Glycine 0 CA--C 1.477 -2.295 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.109 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -103.13 -41.82 5.97 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 143.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.506 ' HB3' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER -80.22 -65.44 1.01 Allowed 'General case' 0 CA--C 1.481 -1.673 0 O-C-N 124.29 0.994 . . . . 0.0 109.567 -165.389 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.444 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.337 0.0 OUTLIER -62.26 -9.6 8.38 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 120.472 3.508 . . . . 0.0 120.472 178.878 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.53 -44.2 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-O 122.684 1.23 . . . . 0.0 109.72 160.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.623 ' O ' HD22 ' A' ' 114' ' ' LEU . 22.1 mmtp -89.19 -6.87 56.58 Favored 'General case' 0 CA--C 1.469 -2.149 0 O-C-N 120.395 -1.441 . . . . 0.0 114.727 177.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 2.7 tt -72.34 -35.26 68.52 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 162.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.48 ' HA ' HG12 ' A' ' 115' ' ' ILE . 2.4 tpt180 -56.99 -40.68 77.0 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.484 1.114 . . . . 0.0 111.222 168.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.7 t -59.56 -47.69 84.55 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.701 HD21 HG21 ' A' ' 96' ' ' ILE 0.306 1.4 mm? -67.4 -25.55 66.0 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 175.63 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.271 3.0 mm -62.24 -47.74 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.767 0 CA-C-N 120.53 1.514 . . . . 0.0 107.993 177.759 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -52.53 -47.03 66.95 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 127.766 2.426 . . . . 0.0 109.751 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -61.24 -51.88 67.1 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.531 1.132 . . . . 0.0 113.028 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.805 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -71.49 -21.25 61.96 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 126.998 2.119 . . . . 0.0 113.75 -178.711 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -68.86 -41.74 78.01 Favored 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 126.94 2.096 . . . . 0.0 109.245 171.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.78 -26.68 67.81 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 123.037 0.535 . . . . 0.0 110.785 173.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.34 68.01 1.47 Allowed Glycine 0 CA--C 1.469 -2.802 0 N-CA-C 104.477 -3.449 . . . . 0.0 104.477 -171.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -120.59 164.26 16.75 Favored 'General case' 0 CA--C 1.447 -2.995 1 N-CA-C 97.985 -4.82 . . . . 0.0 97.985 168.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.628 ' HD3' HG12 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -101.19 114.88 29.24 Favored 'General case' 0 N--CA 1.393 -3.276 1 N-CA-C 97.175 -5.12 . . . . 0.0 97.175 170.551 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.508 ' CB ' HD12 ' A' ' 114' ' ' LEU . . . -84.07 160.44 20.95 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 173.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -135.38 128.66 32.03 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.9 mm -82.04 135.44 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.436 ' HA ' HD13 ' A' ' 171' ' ' ILE . 15.1 m -109.84 118.29 36.09 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 163.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.843 HD21 ' HA2' ' A' ' 141' ' ' GLY . 11.0 tp -81.07 149.53 29.18 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 168.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.413 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 28.4 ttm180 -150.76 95.76 2.26 Favored 'General case' 0 N--CA 1.398 -3.026 1 N-CA-C 97.007 -5.183 . . . . 0.0 97.007 -175.915 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.556 ' CZ ' HD13 ' A' ' 165' ' ' ILE . 95.4 m-85 -66.54 121.6 15.72 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 111.262 -2.699 . . . . 0.0 104.748 174.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -77.37 105.67 8.64 Favored 'General case' 0 CA--C 1.482 -1.659 1 N-CA-C 100.082 -4.044 . . . . 0.0 100.082 164.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.28 115.58 7.24 Favored Glycine 0 CA--C 1.473 -2.557 0 O-C-N 124.909 1.381 . . . . 0.0 112.799 -154.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -74.74 -85.92 0.04 OUTLIER 'General case' 0 CA--C 1.477 -1.86 0 CA-C-N 112.496 -1.852 . . . . 0.0 107.743 173.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -68.57 -65.45 0.7 Allowed 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 158.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.445 ' H ' ' H ' ' A' ' 136' ' ' ALA . 17.2 ttt -165.71 -33.72 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 174.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.445 ' H ' ' H ' ' A' ' 135' ' ' MET . . . 172.49 109.48 0.01 OUTLIER 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -152.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.59 ' CD2' HD12 ' A' ' 140' ' ' ILE . 5.8 m170 -119.08 156.99 28.73 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-O 120.763 0.316 . . . . 0.0 110.404 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -95.53 22.32 7.19 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 121.485 -0.759 . . . . 0.0 109.164 168.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -104.37 -49.83 3.48 Favored 'General case' 0 CA--C 1.476 -1.894 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 168.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.59 HD12 ' CD2' ' A' ' 137' ' ' HIS . 69.4 mt -56.28 -44.5 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.087 0 C-N-CA 127.41 2.284 . . . . 0.0 110.092 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.843 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -72.74 -56.67 5.82 Favored Glycine 0 CA--C 1.459 -3.455 0 CA-C-O 118.744 -1.031 . . . . 0.0 113.438 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.403 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 5.6 ptt? -84.85 0.0 52.45 Favored 'General case' 0 N--CA 1.41 -2.438 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -161.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.261 2.8 tp10 -61.19 -61.12 2.79 Favored 'General case' 0 CA--C 1.461 -2.456 0 C-N-CA 114.879 -2.728 . . . . 0.0 115.308 147.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 98' ' ' PHE . 22.0 t -65.96 -65.2 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.938 0 O-C-N 125.651 1.844 . . . . 0.0 109.293 -163.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.536 HD11 HD22 ' A' ' 128' ' ' LEU . 26.4 mt -45.79 -55.74 6.21 Favored 'General case' 0 N--CA 1.427 -1.619 0 C-N-CA 129.315 3.046 . . . . 0.0 114.431 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 142' ' ' MET 0.261 2.4 t30 -62.81 -31.01 71.92 Favored 'General case' 0 CA--C 1.47 -2.133 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 173.174 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -79.5 -15.72 57.26 Favored 'General case' 0 N--CA 1.421 -1.91 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.193 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.514 HG12 HD12 ' A' ' 152' ' ' LEU . 1.6 t -72.33 -50.24 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.823 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 175.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.456 ' HE3' ' CG2' ' A' ' 158' ' ' VAL 0.261 31.4 ttmt -50.1 -50.96 46.68 Favored 'General case' 0 CA--C 1.466 -2.255 0 C-N-CA 125.682 1.593 . . . . 0.0 112.69 173.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.08 -39.59 68.88 Favored 'General case' 0 N--CA 1.407 -2.604 0 C-N-CA 126.216 1.807 . . . . 0.0 109.451 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -76.22 -27.46 56.83 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 115.716 -2.393 . . . . 0.0 115.198 172.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.514 HD12 HG12 ' A' ' 148' ' ' VAL 0.346 0.4 OUTLIER -81.23 -29.54 34.43 Favored 'General case' 0 CA--C 1.458 -2.595 0 CA-C-O 116.137 -1.887 . . . . 0.0 114.474 179.347 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -26.03 -26.54 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.683 1 C-N-CA 136.065 5.746 . . . . 0.0 119.756 -173.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -51.94 -55.45 20.24 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 126.58 1.952 . . . . 0.0 112.742 166.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.421 ' HG ' ' CG2' ' A' ' 115' ' ' ILE 0.3 1.2 mm? -94.73 -58.82 2.07 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 128.048 2.539 . . . . 0.0 107.191 -169.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.805 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.298 . . -109.28 151.32 26.71 Favored 'General case' 0 CA--C 1.446 -3.055 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.974 -161.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.59 176.53 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.543 0 C-N-CA 115.216 -2.594 . . . . 0.0 116.65 140.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.456 ' CG2' ' HE3' ' A' ' 149' ' ' LYS . 3.4 t -84.96 150.29 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 168.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -80.64 -37.76 30.4 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.402 ' H ' HG12 ' A' ' 158' ' ' VAL . 3.3 t -159.84 144.04 14.68 Favored 'General case' 0 CA--C 1.461 -2.477 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -174.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -100.28 90.81 1.48 Allowed Pre-proline 0 N--CA 1.426 -1.627 0 N-CA-C 101.979 -3.341 . . . . 0.0 101.979 170.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -98.39 -82.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.446 0 CA-C-N 120.717 1.292 . . . . 0.0 109.406 -137.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.23 -162.29 0.94 Allowed 'General case' 1 N--CA 1.375 -4.223 0 CA-C-O 126.05 2.833 . . . . 0.0 112.658 -137.727 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -122.79 124.69 43.89 Favored 'General case' 0 N--CA 1.423 -1.789 2 CA-C-N 107.031 -4.622 . . . . 0.0 99.737 171.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.556 HD13 ' CZ ' ' A' ' 130' ' ' PHE . 3.2 mt -73.44 132.96 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 CA-C-O 122.752 1.263 . . . . 0.0 109.854 -172.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -115.41 128.85 56.34 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 172.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.31 -156.22 46.61 Favored Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -108.62 43.3 1.26 Allowed 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 124.326 1.051 . . . . 0.0 109.589 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.413 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.302 39.4 mt-30 -167.03 137.79 3.12 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -174.723 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 59.6 ttp -134.61 117.96 16.7 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 120.883 0.373 . . . . 0.0 110.165 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.436 HD13 ' HA ' ' A' ' 127' ' ' THR . 11.2 mm -77.95 133.3 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 145' ' ' LEU . 2.8 ttt -119.69 131.3 55.38 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 165.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.628 HG12 ' HD3' ' A' ' 123' ' ' LYS . 1.6 t -100.21 143.01 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -171.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.551 HD13 HD11 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -130.59 70.51 1.45 Allowed 'General case' 0 C--N 1.364 1.23 0 N-CA-C 119.469 3.137 . . . . 0.0 119.469 -161.64 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 123' ' ' LYS 0.284 . . -92.31 173.75 4.83 Favored Pre-proline 0 C--N 1.358 0.962 0 N-CA-C 119.416 3.117 . . . . 0.0 119.416 -171.084 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -70.46 142.03 43.85 Favored 'Trans proline' 0 N--CA 1.443 -1.493 0 CA-C-N 120.591 1.247 . . . . 0.0 110.842 -175.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -81.62 129.83 34.83 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 175.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -86.38 101.36 13.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.479 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -76.11 123.65 26.15 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 C--O 1.26 1.623 0 C-N-CA 124.749 1.219 . . . . 0.0 109.408 179.324 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 CA--C 1.483 -1.606 0 CA-C-O 122.34 1.067 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.9 mm -92.04 127.11 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-N 113.013 -1.903 . . . . 0.0 107.066 176.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -94.16 167.42 11.57 Favored 'General case' 0 CA--C 1.48 -1.743 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -174.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.581 HG22 ' HD3' ' A' ' 123' ' ' LYS . 86.4 t -98.69 117.16 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.712 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 157.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -106.66 170.66 7.8 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 155.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -137.85 157.22 46.87 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -167.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.21 159.27 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 N-CA-C 102.329 -3.212 . . . . 0.0 102.329 174.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -117.85 157.45 26.6 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 118.937 0.79 . . . . 0.0 111.587 166.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.614 ' HB3' HG11 ' A' ' 144' ' ' VAL . 28.5 m-85 -139.89 90.94 2.43 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 172.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -84.31 170.49 13.66 Favored Pre-proline 0 N--CA 1.436 -1.153 0 C-N-CA 123.849 0.86 . . . . 0.0 108.937 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -74.72 145.3 32.41 Favored 'Trans proline' 0 N--CA 1.436 -1.88 0 C-N-CA 122.218 1.945 . . . . 0.0 107.309 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.64 8.64 63.65 Favored Glycine 0 CA--C 1.483 -1.925 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 m -108.27 94.45 5.07 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 170.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -124.7 -168.49 1.82 Allowed 'General case' 0 N--CA 1.411 -2.404 0 CA-C-N 112.79 -2.004 . . . . 0.0 106.933 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -50.69 -48.7 58.58 Favored 'General case' 0 CA--C 1.479 -1.759 0 C-N-CA 127.514 2.326 . . . . 0.0 113.659 -128.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.41 0.18 77.4 Favored Glycine 0 N--CA 1.42 -2.395 0 N-CA-C 116.035 1.174 . . . . 0.0 116.035 -169.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -101.45 -29.42 12.02 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -86.57 -70.43 0.61 Allowed 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 113.265 -1.789 . . . . 0.0 110.261 -158.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.422 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.326 0.0 OUTLIER -59.01 -14.06 8.35 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 119.004 2.964 . . . . 0.0 119.004 173.604 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.24 -45.75 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 122.096 0.95 . . . . 0.0 110.225 161.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -91.36 4.37 52.57 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.417 HD12 HG13 ' A' ' 148' ' ' VAL . 6.0 tt -83.51 -30.63 26.98 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 162.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.498 ' HA ' HG12 ' A' ' 115' ' ' ILE . 25.1 ttt85 -62.51 -42.42 99.5 Favored 'General case' 0 C--N 1.361 1.082 0 CA-C-O 118.686 -0.674 . . . . 0.0 110.664 167.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.25 65.7 m -55.1 -44.97 75.41 Favored 'General case' 0 C--N 1.379 1.866 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 169.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.607 HD11 HD12 ' A' ' 126' ' ' ILE . 13.7 mt -65.08 -29.53 70.41 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.2 mm -61.04 -45.51 98.42 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.378 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -52.7 43.54 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.542 1.537 . . . . 0.0 111.302 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -57.34 -46.32 83.41 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.423 HD11 ' HA ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -54.48 -44.53 72.72 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 127.802 2.441 . . . . 0.0 112.848 172.682 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -79.54 -20.09 47.94 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 126.555 1.942 . . . . 0.0 112.416 -174.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -68.11 -21.59 64.94 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.139 0.576 . . . . 0.0 110.745 170.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.73 51.4 3.64 Favored Glycine 0 CA--C 1.474 -2.474 0 N-CA-C 105.804 -2.918 . . . . 0.0 105.804 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -126.78 165.97 18.29 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.581 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -96.53 119.82 35.72 Favored 'General case' 0 N--CA 1.409 -2.5 1 N-CA-C 99.795 -4.15 . . . . 0.0 99.795 178.562 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -91.98 144.04 25.86 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 103.176 -2.898 . . . . 0.0 103.176 -172.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.432 ' HD3' HD12 ' A' ' 171' ' ' ILE . 22.4 ttmm -118.72 125.05 48.81 Favored 'General case' 0 CA--C 1.479 -1.785 0 O-C-N 117.893 -3.004 . . . . 0.0 106.314 173.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.7 HD11 HD22 ' A' ' 174' ' ' LEU . 4.2 mm -86.34 131.99 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 173.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.485 ' HA ' HD13 ' A' ' 171' ' ' ILE . 32.8 m -121.76 123.92 42.97 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 173.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.485 HD23 HD11 ' A' ' 145' ' ' LEU 0.362 0.4 OUTLIER -76.58 150.16 36.53 Favored 'General case' 0 CA--C 1.468 -2.188 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 164.787 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.513 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 56.6 ttt180 -145.15 88.96 1.91 Allowed 'General case' 0 N--CA 1.399 -3.008 1 N-CA-C 99.735 -4.172 . . . . 0.0 99.735 177.549 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.59 ' HB3' ' CE1' ' A' ' 137' ' ' HIS 0.25 70.1 m-85 -63.11 144.44 56.9 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 110.986 -2.824 . . . . 0.0 109.144 -177.69 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -119.49 29.16 7.76 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 133' ' ' ARG . . . -124.46 -17.17 2.97 Favored Glycine 0 CA--C 1.482 -1.991 0 N-CA-C 105.878 -2.889 . . . . 0.0 105.878 169.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.403 ' HA ' ' HE1' ' A' ' 137' ' ' HIS . 21.0 ptt180 1.18 79.37 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.071 1 C-N-CA 133.306 4.642 . . . . 0.0 118.169 177.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -141.5 21.54 2.19 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 169.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 58.3 mtt 55.48 72.11 0.5 Allowed 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 125.416 1.486 . . . . 0.0 107.292 -156.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.705 ' HB3' ' CD2' ' A' ' 137' ' ' HIS . . . -89.01 -38.25 14.56 Favored 'General case' 0 CA--C 1.473 -1.996 0 CA-C-O 125.214 2.435 . . . . 0.0 109.709 -169.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.705 ' CD2' ' HB3' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -106.4 159.44 16.14 Favored 'General case' 0 N--CA 1.413 -2.312 1 CA-C-N 107.531 -4.395 . . . . 0.0 111.019 -148.139 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -138.73 0.84 2.05 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 102.536 -3.135 . . . . 0.0 102.536 142.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -90.47 -50.92 5.68 Favored 'General case' 0 CA--C 1.477 -1.85 0 CA-C-N 113.808 -1.542 . . . . 0.0 108.838 -167.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.486 HD12 ' HD2' ' A' ' 137' ' ' HIS 0.399 57.5 mt -52.83 -38.92 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 126.945 2.098 . . . . 0.0 112.329 174.254 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.47 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -71.4 -64.9 2.59 Favored Glycine 0 N--CA 1.418 -2.513 0 CA-C-O 119.474 -0.626 . . . . 0.0 112.676 173.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.569 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 7.4 ptt? -87.1 -5.85 58.88 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -153.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.02 -48.46 78.67 Favored 'General case' 0 CA--C 1.457 -2.615 0 C-N-CA 116.496 -2.081 . . . . 0.0 113.837 156.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.614 HG11 ' HB3' ' A' ' 98' ' ' PHE . 21.4 t -69.39 -67.77 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.444 -3.133 0 O-C-N 126.023 2.077 . . . . 0.0 106.936 -167.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.58 HD13 ' HB2' ' A' ' 172' ' ' MET . 42.7 mt -43.0 -54.15 4.42 Favored 'General case' 0 CA--C 1.476 -1.898 0 C-N-CA 128.495 2.718 . . . . 0.0 115.679 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.569 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.5 t-20 -63.87 -31.91 73.25 Favored 'General case' 0 CA--C 1.461 -2.474 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 175.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.3 ttp180 -81.81 -14.51 56.25 Favored 'General case' 0 N--CA 1.419 -2.013 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.014 172.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.8 t -76.27 -46.6 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.81 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 176.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.544 ' HE3' HG21 ' A' ' 158' ' ' VAL . 31.4 ttmt -51.9 -51.21 58.52 Favored 'General case' 0 CA--C 1.461 -2.453 0 C-N-CA 125.239 1.416 . . . . 0.0 111.003 172.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.81 -35.85 67.43 Favored 'General case' 0 N--CA 1.409 -2.513 0 C-N-CA 124.612 1.165 . . . . 0.0 110.529 -168.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -72.84 -39.41 66.57 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 116.291 -2.164 . . . . 0.0 114.941 170.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.303 0.2 OUTLIER -80.87 -19.56 44.18 Favored 'General case' 0 CA--C 1.464 -2.341 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -178.293 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -27.11 -25.07 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.363 1 C-N-CA 134.586 5.154 . . . . 0.0 119.064 174.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.2 mt-10 -54.24 -57.77 9.92 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 126.903 2.081 . . . . 0.0 113.361 167.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.38 -51.39 2.88 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 113.498 -1.683 . . . . 0.0 108.525 -164.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.423 ' HA ' HD11 ' A' ' 118' ' ' LEU 0.321 . . -91.65 146.13 24.03 Favored 'General case' 0 CA--C 1.455 -2.685 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 177.689 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.4 m -121.12 171.6 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.457 -2.615 0 C-N-CA 114.265 -2.974 . . . . 0.0 116.307 126.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.544 HG21 ' HE3' ' A' ' 149' ' ' LYS 0.298 3.2 t -81.8 155.11 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 C-N-CA 130.524 3.53 . . . . 0.0 107.313 179.391 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -82.15 -42.45 19.05 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.03 141.31 18.58 Favored 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -174.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -98.22 109.73 53.33 Favored Pre-proline 0 N--CA 1.417 -2.077 1 N-CA-C 98.766 -4.531 . . . . 0.0 98.766 158.128 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -86.4 -100.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.536 0 N-CA-C 102.886 -3.544 . . . . 0.0 102.886 -169.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -162.84 -62.9 0.04 OUTLIER 'General case' 0 N--CA 1.405 -2.71 0 N-CA-C 103.402 -2.814 . . . . 0.0 103.402 -160.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -151.56 162.92 40.15 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 122.81 1.29 . . . . 0.0 110.768 -161.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.9 mt -53.01 142.96 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 1 C-N-CA 132.234 4.213 . . . . 0.0 111.933 172.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -131.09 96.8 4.13 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 89.83 -143.8 17.33 Favored Glycine 0 CA--C 1.486 -1.729 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -171.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -97.42 27.29 4.32 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 125.327 1.451 . . . . 0.0 112.298 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.279 57.8 mt-30 -171.99 142.26 1.44 Allowed 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 -157.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.41 ' HB3' ' HB2' ' A' ' 128' ' ' LEU . 21.6 ttm -104.57 158.35 16.55 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 102.45 -3.167 . . . . 0.0 102.45 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 127' ' ' THR . 32.7 mm -118.43 131.53 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.157 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 159.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.58 ' HB2' HD13 ' A' ' 145' ' ' LEU . 2.5 ttp -108.12 128.4 54.65 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 153.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 37.0 t -91.47 130.39 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 C-N-CA 118.17 -1.412 . . . . 0.0 108.597 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.7 HD22 HD11 ' A' ' 126' ' ' ILE . 13.1 tp -101.82 144.07 30.94 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 130.213 3.405 . . . . 0.0 116.915 174.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.261 . . -143.08 -179.3 0.93 Allowed Pre-proline 0 CA--C 1.483 -1.599 0 O-C-N 119.255 -2.153 . . . . 0.0 108.991 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -65.24 145.24 83.5 Favored 'Trans proline' 0 N--CA 1.436 -1.877 0 C-N-CA 123.025 2.483 . . . . 0.0 109.197 158.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -76.91 143.4 39.61 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 165.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -69.81 105.19 2.69 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 170.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.03 77.53 1.84 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 . . . . . 0 C--O 1.26 1.61 0 C-N-CA 125.226 1.411 . . . . 0.0 110.038 -176.186 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 CA--C 1.481 -1.687 0 CA-C-O 122.128 0.966 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.6 mm -90.3 117.54 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 113.183 -1.826 . . . . 0.0 108.685 176.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -89.93 169.89 10.85 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.503 HG22 ' HD3' ' A' ' 123' ' ' LYS . 54.5 t -102.65 119.47 51.06 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.789 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 161.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -115.19 178.59 4.23 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 160.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -141.7 158.98 43.15 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -171.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.1 tp -134.37 164.74 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 168.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -120.24 154.62 34.65 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.113 162.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.599 ' HB3' HG11 ' A' ' 144' ' ' VAL . 37.9 m-85 -128.9 136.66 50.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 102.922 -2.992 . . . . 0.0 102.922 167.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -114.33 174.22 2.46 Favored Pre-proline 0 N--CA 1.432 -1.344 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -72.88 135.72 23.91 Favored 'Trans proline' 0 N--CA 1.432 -2.093 0 N-CA-C 105.472 -2.549 . . . . 0.0 105.472 163.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.32 10.2 64.23 Favored Glycine 0 CA--C 1.484 -1.893 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 88.2 m -100.51 90.13 4.18 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 169.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -125.02 -171.9 2.46 Favored 'General case' 0 N--CA 1.41 -2.441 0 CA-C-N 112.122 -2.308 . . . . 0.0 106.523 172.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -48.14 -49.96 30.43 Favored 'General case' 0 CA--C 1.48 -1.731 0 C-N-CA 128.155 2.582 . . . . 0.0 113.793 -131.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.84 1.1 77.62 Favored Glycine 0 N--CA 1.418 -2.523 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -168.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -100.51 -30.15 11.96 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 125.08 1.352 . . . . 0.0 108.044 166.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.19 -72.79 0.5 Allowed 'General case' 0 CA--C 1.47 -2.105 0 CA-C-N 112.283 -2.235 . . . . 0.0 111.036 -157.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.457 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.312 0.0 OUTLIER -60.18 -13.45 12.34 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 118.808 2.892 . . . . 0.0 118.808 174.435 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 94.9 t -60.47 -48.74 87.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 C-N-CA 124.209 1.004 . . . . 0.0 109.997 160.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -91.72 7.41 41.83 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 5.3 tt -86.21 -31.14 21.89 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 163.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.461 ' HA ' HG12 ' A' ' 115' ' ' ILE . 56.9 ttt-85 -62.25 -43.8 97.99 Favored 'General case' 0 C--N 1.363 1.158 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.021 167.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.1 m -60.14 -42.37 94.71 Favored 'General case' 0 C--N 1.378 1.838 0 C-N-CA 118.181 -1.408 . . . . 0.0 113.175 174.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.52 HD11 HD12 ' A' ' 126' ' ' ILE . 9.9 mt -62.48 -30.77 71.5 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 175.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.6 mm -58.33 -51.58 69.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.733 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 25.9 tpt85 -50.38 -45.96 55.69 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 126.716 2.007 . . . . 0.0 112.745 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -61.22 -54.54 42.96 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -57.56 -39.46 76.74 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 177.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -78.43 -29.91 47.32 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 128.703 2.801 . . . . 0.0 110.252 -169.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.92 7.47 8.82 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 123.067 0.547 . . . . 0.0 111.406 173.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.09 61.13 2.57 Favored Glycine 0 CA--C 1.467 -2.937 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 173.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -131.88 168.57 17.63 Favored 'General case' 0 CA--C 1.448 -2.971 0 N-CA-C 101.194 -3.632 . . . . 0.0 101.194 170.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.503 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -108.25 116.71 32.48 Favored 'General case' 0 N--CA 1.39 -3.472 1 N-CA-C 98.091 -4.781 . . . . 0.0 98.091 173.373 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -82.72 158.22 22.97 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 102.586 -3.116 . . . . 0.0 102.586 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.306 33.2 mtmm -126.29 144.49 50.78 Favored 'General case' 0 CA--C 1.481 -1.677 0 O-C-N 118.795 -2.441 . . . . 0.0 105.47 155.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.52 HD12 HD11 ' A' ' 114' ' ' LEU . 6.4 mm -86.62 137.37 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 167.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.9 m -117.17 123.78 47.52 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 166.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 170' ' ' MET 0.258 0.2 OUTLIER -80.18 153.78 28.4 Favored 'General case' 0 CA--C 1.467 -2.213 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 166.573 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -148.21 94.79 2.37 Favored 'General case' 0 N--CA 1.404 -2.756 1 N-CA-C 99.51 -4.255 . . . . 0.0 99.51 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -77.15 175.79 9.32 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.116 -170.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -66.27 108.49 2.33 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 152.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.86 121.67 10.94 Favored Glycine 0 CA--C 1.479 -2.161 0 CA-C-O 122.214 0.897 . . . . 0.0 114.599 -155.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -129.32 172.8 11.12 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -61.89 -73.6 0.1 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.107 0.963 . . . . 0.0 110.539 176.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 14.2 tpt -104.3 102.08 11.78 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 103.36 -2.83 . . . . 0.0 103.36 166.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.99 -171.66 3.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -171.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.512 ' CG ' HD12 ' A' ' 140' ' ' ILE . 21.0 m80 -35.34 121.54 0.58 Allowed 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 130.397 3.479 . . . . 0.0 114.898 165.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -98.12 -0.81 43.68 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -87.79 -51.9 5.6 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -175.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.512 HD12 ' CG ' ' A' ' 137' ' ' HIS 0.253 68.4 mt -52.9 -41.12 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 C-N-CA 127.306 2.242 . . . . 0.0 111.67 173.16 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -70.11 -64.5 2.87 Favored Glycine 0 N--CA 1.416 -2.657 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.556 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 7.1 ptt? -84.78 -5.66 59.33 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -155.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.32 -53.72 48.33 Favored 'General case' 0 CA--C 1.459 -2.529 0 C-N-CA 115.925 -2.31 . . . . 0.0 114.126 154.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.599 HG11 ' HB3' ' A' ' 98' ' ' PHE . 21.8 t -66.11 -67.05 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.443 -3.144 0 O-C-N 126.028 2.08 . . . . 0.0 107.499 -167.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.438 HD22 ' HB3' ' A' ' 172' ' ' MET . 23.9 mt -41.08 -56.63 2.27 Favored 'General case' 0 CA--C 1.476 -1.877 0 C-N-CA 128.977 2.911 . . . . 0.0 115.15 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.4 t-20 -63.31 -31.41 72.55 Favored 'General case' 0 CA--C 1.466 -2.285 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 175.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -82.69 -13.68 55.96 Favored 'General case' 0 N--CA 1.419 -2.012 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.868 173.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.7 t -76.31 -46.96 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 177.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.531 ' HE3' HG21 ' A' ' 158' ' ' VAL 0.251 35.3 ttmt -51.21 -49.83 60.27 Favored 'General case' 0 CA--C 1.464 -2.357 0 C-N-CA 125.642 1.577 . . . . 0.0 111.991 172.65 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -37.39 64.93 Favored 'General case' 0 N--CA 1.408 -2.57 0 C-N-CA 125.276 1.43 . . . . 0.0 109.978 -169.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -72.22 -38.21 69.02 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 116.412 -2.115 . . . . 0.0 114.923 171.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.423 HD13 HD11 ' A' ' 174' ' ' LEU 0.296 0.2 OUTLIER -81.84 -20.68 38.49 Favored 'General case' 0 CA--C 1.461 -2.443 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -178.318 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -25.87 -28.2 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.305 1 C-N-CA 134.305 5.042 . . . . 0.0 119.142 175.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 5.2 mt-10 -50.88 -54.05 27.23 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 128.101 2.56 . . . . 0.0 113.747 168.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.1 tt -113.22 -51.0 2.84 Favored 'General case' 0 N--CA 1.42 -1.932 0 C-N-CA 126.163 1.785 . . . . 0.0 108.611 -167.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.534 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.343 . . -104.7 142.0 35.46 Favored 'General case' 0 CA--C 1.449 -2.937 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.822 -177.707 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.5 m -120.04 171.76 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.65 0 CA-C-O 125.117 2.389 . . . . 0.0 116.022 140.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.531 HG21 ' HE3' ' A' ' 149' ' ' LYS 0.289 2.7 t -81.82 152.86 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 109.917 -3.311 . . . . 0.0 106.336 177.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -83.33 -39.2 21.06 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -176.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.76 140.95 18.51 Favored 'General case' 0 CA--C 1.468 -2.193 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -174.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -103.94 106.37 52.63 Favored Pre-proline 0 N--CA 1.422 -1.845 0 N-CA-C 101.259 -3.608 . . . . 0.0 101.259 164.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -102.95 -110.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.413 -3.233 1 N-CA-C 101.209 -4.189 . . . . 0.0 101.209 -174.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 179.66 -47.68 0.01 OUTLIER 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 101.657 -3.46 . . . . 0.0 101.657 -146.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -83.76 112.79 20.4 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-O 121.964 0.887 . . . . 0.0 111.915 -148.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -76.85 129.1 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 102.494 -3.15 . . . . 0.0 102.494 170.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -120.37 100.43 7.15 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.21 -145.71 23.38 Favored Glycine 0 CA--C 1.484 -1.859 0 N-CA-C 107.306 -2.318 . . . . 0.0 107.306 -168.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -99.85 36.71 1.75 Allowed 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 125.158 1.383 . . . . 0.0 110.472 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.314 19.8 mt-30 -170.61 141.48 1.89 Allowed 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 124.663 1.185 . . . . 0.0 108.024 -157.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.406 ' HB3' ' HB2' ' A' ' 128' ' ' LEU . 4.6 ttm -116.14 112.99 22.49 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-N 119.805 1.184 . . . . 0.0 109.878 -175.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.9 mm -80.92 123.57 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 O-C-N 121.06 -1.025 . . . . 0.0 108.646 170.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.438 ' HB3' HD22 ' A' ' 145' ' ' LEU . 2.9 ttt -107.49 131.24 54.52 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 159.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 39.1 t -93.09 140.86 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.017 -173.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -126.92 81.1 1.99 Allowed 'General case' 0 C--N 1.364 1.208 0 N-CA-C 118.988 2.958 . . . . 0.0 118.988 -169.055 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.276 . . -85.94 178.73 2.16 Favored Pre-proline 0 CA--C 1.499 -0.993 0 O-C-N 119.644 -1.91 . . . . 0.0 115.998 -171.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.442 ' HA ' HD21 ' A' ' 118' ' ' LEU . 84.4 Cg_exo -62.06 142.97 94.29 Favored 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 122.849 2.366 . . . . 0.0 109.786 159.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -78.14 131.38 37.2 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -74.95 104.41 5.54 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 171.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -78.2 121.33 24.22 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 . . . . . 0 C--O 1.259 1.588 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -177.931 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.472 -2.05 0 CA-C-O 124.947 2.308 . . . . 0.0 107.489 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.54 123.75 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 CA-C-N 108.448 -3.978 . . . . 0.0 106.785 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -97.48 163.83 12.7 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 -166.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.575 HG22 ' HE3' ' A' ' 123' ' ' LYS . 76.3 t -100.78 119.99 49.67 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.588 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -104.85 172.44 6.79 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 155.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -143.78 154.23 43.22 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -175.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 tp -138.71 165.26 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 103.918 -2.623 . . . . 0.0 103.918 171.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -117.13 155.04 30.0 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-N 118.744 0.702 . . . . 0.0 110.903 163.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.57 ' HB3' HG11 ' A' ' 144' ' ' VAL . 26.7 m-85 -128.9 145.47 51.21 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 170.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -100.23 166.52 12.52 Favored Pre-proline 0 N--CA 1.438 -1.046 0 C-N-CA 126.341 1.856 . . . . 0.0 106.719 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.471 ' HB3' HG23 ' A' ' 140' ' ' ILE . 62.6 Cg_exo -56.09 139.14 84.86 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 C-N-CA 124.751 3.634 . . . . 0.0 113.399 169.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 3.82 98.17 0.0 OUTLIER Glycine 0 CA--C 1.468 -2.898 1 C-N-CA 131.989 4.614 . . . . 0.0 114.816 -173.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.57 -154.99 0.49 Allowed 'General case' 0 N--CA 1.397 -3.122 0 CA-C-N 111.104 -2.548 . . . . 0.0 108.731 -154.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 107' ' ' TYR 0.435 0.7 OUTLIER -125.56 166.55 16.49 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-N 109.734 -3.394 . . . . 0.0 111.372 -149.631 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.67 -75.02 0.12 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -107.14 45.79 1.26 Allowed Glycine 0 CA--C 1.476 -2.395 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.742 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -105.19 -42.7 5.21 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 144.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.549 ' HB3' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER -84.66 -63.82 1.27 Allowed 'General case' 0 CA--C 1.481 -1.708 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.678 -161.758 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.467 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.325 0.0 OUTLIER -61.87 -11.89 15.05 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 119.64 3.2 . . . . 0.0 119.64 177.392 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.5 t -60.96 -48.05 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-O 122.37 1.081 . . . . 0.0 109.552 160.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -91.41 -1.65 57.52 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tt -78.5 -33.42 48.1 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 162.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.451 ' HA ' HG12 ' A' ' 115' ' ' ILE . 46.7 ttt-85 -61.91 -40.57 95.91 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 117.672 -1.156 . . . . 0.0 110.997 169.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.6 m -57.43 -46.17 83.84 Favored 'General case' 0 C--N 1.38 1.913 0 C-N-CA 119.001 -1.08 . . . . 0.0 113.84 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.268 84.4 mt -65.49 -30.87 71.69 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.9 mm -58.75 -49.7 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.676 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -55.85 -39.55 71.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 126.801 2.041 . . . . 0.0 111.32 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -62.45 -51.7 66.46 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 123.581 0.752 . . . . 0.0 112.081 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.737 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -66.83 -23.09 66.0 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 126.232 1.813 . . . . 0.0 114.978 177.331 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -69.98 -38.2 75.96 Favored 'General case' 0 CA--C 1.491 -1.306 0 C-N-CA 126.216 1.806 . . . . 0.0 109.875 172.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -66.63 -26.08 66.9 Favored 'General case' 0 C--N 1.361 1.083 0 O-C-N 123.28 0.363 . . . . 0.0 110.893 171.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.41 65.36 1.52 Allowed Glycine 0 CA--C 1.471 -2.702 0 N-CA-C 104.743 -3.343 . . . . 0.0 104.743 -172.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -121.52 164.72 16.76 Favored 'General case' 0 CA--C 1.449 -2.929 1 N-CA-C 98.79 -4.522 . . . . 0.0 98.79 170.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.575 ' HE3' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -101.5 117.6 35.26 Favored 'General case' 0 N--CA 1.396 -3.173 1 N-CA-C 97.538 -4.986 . . . . 0.0 97.538 169.106 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.63 160.6 20.37 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 172.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -134.42 131.43 38.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 169.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.1 mm -82.93 135.87 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.416 ' HA ' HD13 ' A' ' 171' ' ' ILE . 16.4 m -113.19 119.23 37.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 165.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.739 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.2 OUTLIER -84.73 153.75 22.86 Favored 'General case' 0 CA--C 1.474 -1.963 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 167.532 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.493 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 24.8 ttm-85 -151.62 103.05 2.92 Favored 'General case' 0 N--CA 1.395 -3.183 1 N-CA-C 96.504 -5.369 . . . . 0.0 96.504 -173.804 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.451 ' CE1' HD22 ' A' ' 128' ' ' LEU . 60.2 m-85 -72.48 176.69 5.17 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 112.537 -2.119 . . . . 0.0 109.987 -174.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -73.4 -18.12 61.19 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-O 122.895 1.331 . . . . 0.0 113.939 -169.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 173.39 -5.76 0.03 OUTLIER Glycine 0 CA--C 1.472 -2.602 0 N-CA-C 106.657 -2.577 . . . . 0.0 106.657 165.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 55.92 52.44 10.64 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 112.738 -1.731 . . . . 0.0 106.937 -147.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -87.68 -51.8 5.68 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 172.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 59.3 ttm -90.36 -64.99 1.06 Allowed 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 170.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.428 ' HB3' HG13 ' A' ' 140' ' ' ILE . . . -165.74 -138.24 0.03 OUTLIER 'General case' 0 CA--C 1.481 -1.698 0 CA-C-O 122.579 1.18 . . . . 0.0 112.529 -157.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.571 ' CG ' HD12 ' A' ' 165' ' ' ILE . 7.0 m170 166.33 -76.86 0.0 OUTLIER 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 110.84 -2.891 . . . . 0.0 113.018 -106.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -95.56 -25.52 16.15 Favored 'General case' 0 CA--C 1.475 -1.931 0 CA-C-O 122.274 1.035 . . . . 0.0 111.46 -161.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -81.48 -52.71 6.96 Favored 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.471 HG23 ' HB3' ' A' ' 100' ' ' PRO . 5.8 mt -53.57 -50.2 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.24 0 C-N-CA 128.834 2.853 . . . . 0.0 111.602 -177.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.739 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -79.94 -53.47 4.23 Favored Glycine 0 CA--C 1.458 -3.498 0 O-C-N 124.876 1.36 . . . . 0.0 110.517 -168.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 71.1 mtm -85.74 3.1 42.79 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -166.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.261 2.2 tp10 -62.42 -64.82 0.81 Allowed 'General case' 0 CA--C 1.466 -2.26 0 C-N-CA 115.199 -2.6 . . . . 0.0 115.876 141.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.57 HG11 ' HB3' ' A' ' 98' ' ' PHE . 16.1 t -62.59 -65.29 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.447 -2.994 0 O-C-N 125.907 2.005 . . . . 0.0 109.264 -162.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.3 mt -42.4 -53.99 4.0 Favored 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 129.435 3.094 . . . . 0.0 114.641 176.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -61.83 -35.89 79.58 Favored 'General case' 0 CA--C 1.466 -2.254 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -80.15 -14.71 58.26 Favored 'General case' 0 N--CA 1.419 -2.01 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.486 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.444 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.9 t -76.72 -46.46 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.725 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.422 ' HE3' ' CG2' ' A' ' 158' ' ' VAL 0.271 31.4 ttmt -53.73 -48.31 69.75 Favored 'General case' 0 CA--C 1.467 -2.241 0 C-N-CA 126.007 1.723 . . . . 0.0 112.587 173.382 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -39.33 66.75 Favored 'General case' 0 N--CA 1.407 -2.596 0 C-N-CA 125.476 1.51 . . . . 0.0 108.77 -171.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -75.07 -22.95 58.0 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 115.637 -2.425 . . . . 0.0 115.63 170.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.407 HD23 HG12 ' A' ' 148' ' ' VAL 0.313 0.2 OUTLIER -83.26 -31.12 27.12 Favored 'General case' 0 CA--C 1.473 -1.999 0 CA-C-O 116.887 -1.53 . . . . 0.0 112.827 -179.649 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -29.11 -26.48 0.0 OUTLIER 'General case' 0 C--N 1.367 1.346 1 C-N-CA 134.93 5.292 . . . . 0.0 119.346 -175.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 5.7 mt-10 -50.86 -53.28 33.69 Favored 'General case' 0 CA--C 1.491 -1.297 0 C-N-CA 128.642 2.777 . . . . 0.0 112.611 170.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . 0.251 0.2 OUTLIER -111.31 -53.53 2.69 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 113.701 -1.591 . . . . 0.0 108.593 -169.59 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.737 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.318 . . -105.65 154.33 20.58 Favored 'General case' 0 CA--C 1.444 -3.112 0 CA-C-N 113.732 -1.576 . . . . 0.0 107.756 -166.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.58 178.58 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.506 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 139.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.43 HG22 HD23 ' A' ' 174' ' ' LEU . 2.7 t -83.8 151.74 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.996 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 166.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -80.29 -38.59 30.47 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 6.8 t -123.02 -175.96 3.3 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -175.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -131.84 94.51 24.79 Favored Pre-proline 0 N--CA 1.419 -1.992 0 N-CA-C 102.343 -3.206 . . . . 0.0 102.343 144.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -77.46 -48.54 0.11 Allowed 'Trans proline' 0 CA--C 1.489 -1.726 0 CA-C-N 121.3 1.5 . . . . 0.0 113.152 -139.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . 0.254 1.3 m 5.84 51.32 0.0 OUTLIER 'General case' 0 N--CA 1.421 -1.911 1 C-N-CA 135.439 5.496 . . . . 0.0 119.648 -158.422 . . . . . . . . 3 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -114.01 74.64 0.88 Allowed 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 109.781 -3.372 . . . . 0.0 103.337 158.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.571 HD12 ' CG ' ' A' ' 137' ' ' HIS . 8.3 mt -68.06 138.14 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 C-N-CA 125.05 1.34 . . . . 0.0 109.324 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -111.24 104.92 13.45 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 113.194 -1.821 . . . . 0.0 107.035 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.64 -147.61 29.75 Favored Glycine 0 CA--C 1.485 -1.806 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 -175.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -102.18 38.8 1.59 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.734 1.614 . . . . 0.0 110.202 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.493 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.257 26.0 mt-30 -169.78 132.99 1.2 Allowed 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -170.081 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -120.78 115.17 22.77 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -173.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 127' ' ' THR . 16.1 mm -79.07 123.86 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 167.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.412 ' HG3' ' CG1' ' A' ' 158' ' ' VAL . 2.4 ttt -107.21 136.89 46.28 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 163.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.97 134.88 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 118.176 -1.409 . . . . 0.0 108.782 -172.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.576 HD13 HD11 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -122.71 69.27 0.98 Allowed 'General case' 0 C--N 1.356 0.883 0 N-CA-C 119.782 3.253 . . . . 0.0 119.782 -164.709 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.312 . . -89.59 172.71 6.83 Favored Pre-proline 0 C--N 1.356 0.85 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 -172.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -72.04 139.44 32.84 Favored 'Trans proline' 0 CA--C 1.493 -1.545 0 N-CA-C 107.905 -1.613 . . . . 0.0 107.905 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -81.06 168.01 19.12 Favored 'General case' 0 N--CA 1.433 -1.315 0 O-C-N 124.126 0.892 . . . . 0.0 111.521 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.18 111.52 2.99 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 125.324 1.449 . . . . 0.0 110.31 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -75.2 116.58 16.09 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 171.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 . . . . . 0 C--O 1.261 1.678 0 CA-C-O 117.001 -1.476 . . . . 0.0 108.679 -171.955 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.469 -2.139 0 CA-C-O 124.983 2.325 . . . . 0.0 107.549 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.9 mm -94.86 124.44 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 CA-C-N 108.658 -3.883 . . . . 0.0 107.061 176.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -94.61 167.84 11.22 Favored 'General case' 0 CA--C 1.48 -1.724 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -174.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.559 HG22 ' HE2' ' A' ' 123' ' ' LYS . 55.2 t -96.42 123.75 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 160.1 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -103.28 172.42 6.82 Favored 'General case' 0 CA--C 1.468 -2.187 0 C-N-CA 116.105 -2.238 . . . . 0.0 105.985 160.616 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -144.29 148.34 34.7 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 tp -131.83 160.65 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 102.372 -3.196 . . . . 0.0 102.372 172.056 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -113.86 154.15 27.97 Favored 'General case' 0 CA--C 1.484 -1.566 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.207 164.131 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.547 ' HB3' HG11 ' A' ' 144' ' ' VAL . 4.7 m-85 -137.13 130.29 30.95 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.419 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -86.94 179.57 1.73 Allowed Pre-proline 0 N--CA 1.422 -1.839 0 C-N-CA 124.013 0.925 . . . . 0.0 110.648 179.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.417 ' HG3' ' H ' ' A' ' 131' ' ' ARG . 76.2 Cg_exo -56.73 146.64 76.24 Favored 'Trans proline' 0 N--CA 1.441 -1.597 1 C-N-CA 125.612 4.208 . . . . 0.0 113.826 173.272 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -13.37 103.29 0.01 OUTLIER Glycine 0 CA--C 1.472 -2.645 1 C-N-CA 131.263 4.268 . . . . 0.0 115.04 -173.456 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.13 -152.41 0.48 Allowed 'General case' 0 N--CA 1.402 -2.855 0 CA-C-N 111.032 -2.584 . . . . 0.0 108.151 -153.344 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.563 ' O ' ' HB3' ' A' ' 107' ' ' TYR 0.426 0.7 OUTLIER -124.39 166.31 16.18 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 110.042 -3.254 . . . . 0.0 111.134 -153.183 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.64 -73.4 0.16 Allowed 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -105.19 46.54 1.16 Allowed Glycine 0 CA--C 1.477 -2.295 0 C-N-CA 119.95 -1.119 . . . . 0.0 113.264 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -106.91 -42.47 4.91 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 145.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.563 ' HB3' ' O ' ' A' ' 103' ' ' ASP . 0.5 OUTLIER -88.91 -60.73 1.88 Allowed 'General case' 0 CA--C 1.479 -1.765 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.772 -161.265 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.346 0.0 OUTLIER -61.43 -12.74 15.78 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 119.281 3.067 . . . . 0.0 119.281 174.638 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.61 -47.81 91.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-O 122.201 1.001 . . . . 0.0 109.613 160.026 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -90.81 3.57 54.07 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 178.5 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.441 HD12 HG13 ' A' ' 148' ' ' VAL . 5.6 tt -82.61 -30.55 29.41 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 162.708 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.458 ' HA ' HG12 ' A' ' 115' ' ' ILE . 59.0 ttt-85 -62.3 -41.98 98.97 Favored 'General case' 0 C--N 1.361 1.105 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.731 166.399 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 t -57.0 -45.38 83.07 Favored 'General case' 0 C--N 1.378 1.807 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 175.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.336 29.3 mt -66.98 -29.0 68.73 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 175.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.273 7.1 mm -61.67 -48.42 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.882 0 CA-C-N 120.049 1.295 . . . . 0.0 108.064 174.624 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -54.2 -43.85 71.11 Favored 'General case' 0 CA--C 1.479 -1.759 0 C-N-CA 126.929 2.092 . . . . 0.0 110.026 -178.166 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -63.28 -48.73 76.88 Favored 'General case' 0 CA--C 1.487 -1.45 0 O-C-N 124.385 1.053 . . . . 0.0 112.636 177.15 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.533 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -61.49 -44.13 97.64 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -178.455 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -85.61 -17.8 35.12 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 126.813 2.045 . . . . 0.0 112.02 -169.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -81.71 -0.95 45.15 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 167.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.74 64.23 1.5 Allowed Glycine 0 CA--C 1.47 -2.74 0 C-N-CA 125.939 1.733 . . . . 0.0 108.947 171.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -134.92 165.96 24.1 Favored 'General case' 0 CA--C 1.445 -3.073 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 171.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.559 ' HE2' HG22 ' A' ' 93' ' ' VAL . 2.6 tmmm? -102.56 117.34 34.48 Favored 'General case' 0 N--CA 1.394 -3.232 1 N-CA-C 95.804 -5.628 . . . . 0.0 95.804 178.367 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.09 162.37 16.81 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -144.53 130.25 19.14 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 119.188 -2.195 . . . . 0.0 106.663 170.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.4 mm -84.02 136.39 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 174.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.479 ' HA ' HD13 ' A' ' 171' ' ' ILE . 20.1 m -108.52 119.92 40.93 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 161.098 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.772 HD12 HD11 ' A' ' 145' ' ' LEU 0.281 0.3 OUTLIER -71.84 147.49 47.12 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.394 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 53.1 ttm-85 -149.22 96.24 2.5 Favored 'General case' 0 N--CA 1.405 -2.717 1 N-CA-C 99.165 -4.383 . . . . 0.0 99.165 -178.533 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.416 ' CZ ' HD13 ' A' ' 165' ' ' ILE . 76.6 m-85 -70.47 146.09 50.52 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 111.787 -2.46 . . . . 0.0 109.417 -177.428 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.417 ' H ' ' HG3' ' A' ' 100' ' ' PRO . 93.7 mtt180 -120.3 25.84 9.58 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 168.35 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.45 -115.05 0.11 Allowed Glycine 0 CA--C 1.478 -2.228 0 C-N-CA 126.351 1.929 . . . . 0.0 110.451 178.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -114.36 -165.74 1.04 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 112.601 -1.799 . . . . 0.0 107.891 177.01 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -58.8 -89.05 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 125.912 1.685 . . . . 0.0 111.261 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 26.1 ttt -77.38 104.63 8.01 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 103.612 -2.736 . . . . 0.0 103.612 162.471 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.406 ' HB1' ' H ' ' A' ' 137' ' ' HIS . . . -80.69 -158.25 0.19 Allowed 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -158.227 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.452 ' CG ' HD12 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -96.58 140.19 31.56 Favored 'General case' 0 CA--C 1.476 -1.866 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.849 -170.479 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -88.31 1.2 55.09 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 121.325 0.583 . . . . 0.0 110.316 174.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -83.49 -50.62 8.1 Favored 'General case' 0 CA--C 1.481 -1.685 0 C-N-CA 126.667 1.987 . . . . 0.0 107.29 174.324 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.452 HD12 ' CG ' ' A' ' 137' ' ' HIS 0.256 59.4 mt -53.79 -42.41 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 C-N-CA 127.476 2.31 . . . . 0.0 111.061 177.474 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.529 ' CA ' HD11 ' A' ' 128' ' ' LEU . . . -74.33 -54.98 5.86 Favored Glycine 0 N--CA 1.412 -2.962 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.16 -178.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.477 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 6.3 ptt? -85.68 -0.53 55.41 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -163.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.26 2.2 tp10 -60.46 -57.97 10.49 Favored 'General case' 0 CA--C 1.453 -2.776 0 C-N-CA 114.687 -2.805 . . . . 0.0 114.805 147.486 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 98' ' ' PHE . 17.1 t -67.15 -64.82 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.448 -2.956 0 O-C-N 126.118 2.136 . . . . 0.0 108.981 -161.401 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.772 HD11 HD12 ' A' ' 128' ' ' LEU . 51.2 mt -47.32 -52.43 16.44 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 128.227 2.611 . . . . 0.0 115.286 178.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 142' ' ' MET 0.265 1.7 t30 -63.44 -30.73 71.81 Favored 'General case' 0 CA--C 1.479 -1.761 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 174.175 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -80.61 -15.88 55.5 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.858 173.342 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 98' ' ' PHE . 2.0 t -75.58 -43.95 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.614 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.444 ' HB2' HG21 ' A' ' 158' ' ' VAL 0.283 23.2 ttmt -52.52 -49.53 64.63 Favored 'General case' 0 CA--C 1.47 -2.133 0 C-N-CA 126.222 1.809 . . . . 0.0 113.391 173.669 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -73.24 -41.45 63.7 Favored 'General case' 0 N--CA 1.404 -2.745 0 C-N-CA 127.78 2.432 . . . . 0.0 108.545 -172.216 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -75.04 -24.5 58.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 116.474 -2.09 . . . . 0.0 114.813 172.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 156' ' ' ALA 0.308 0.1 OUTLIER -81.93 -31.41 31.33 Favored 'General case' 0 CA--C 1.47 -2.13 0 CA-C-O 116.063 -1.922 . . . . 0.0 112.339 178.172 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -28.45 -26.92 0.0 OUTLIER 'General case' 0 C--N 1.37 1.461 1 C-N-CA 134.745 5.218 . . . . 0.0 119.651 -173.33 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -48.24 -50.06 30.98 Favored 'General case' 0 CA--C 1.49 -1.349 0 C-N-CA 129.151 2.98 . . . . 0.0 113.458 167.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.35 -48.35 1.84 Allowed 'General case' 0 N--CA 1.416 -2.155 0 C-N-CA 126.057 1.743 . . . . 0.0 109.293 -164.682 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.533 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.347 . . -107.14 151.24 25.66 Favored 'General case' 0 CA--C 1.449 -2.934 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.536 -177.364 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.04 175.37 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.545 0 C-N-CA 115.803 -2.359 . . . . 0.0 116.304 136.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.476 HG13 ' HG2' ' A' ' 172' ' ' MET 0.372 74.8 t -76.98 147.88 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.25 0 CA-C-N 110.935 -2.848 . . . . 0.0 105.04 168.931 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -84.1 -39.5 19.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -172.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.8 t -160.06 142.41 13.24 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 113.73 -1.577 . . . . 0.0 106.898 -171.196 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -102.46 90.03 1.99 Allowed Pre-proline 0 N--CA 1.432 -1.373 0 N-CA-C 101.539 -3.504 . . . . 0.0 101.539 171.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -104.44 -87.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.472 0 CA-C-N 120.853 1.34 . . . . 0.0 108.707 -138.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.92 -158.14 0.65 Allowed 'General case' 1 N--CA 1.376 -4.16 0 CA-C-O 125.583 2.611 . . . . 0.0 111.01 -143.923 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -107.29 144.21 34.44 Favored 'General case' 0 N--CA 1.424 -1.748 1 CA-C-N 108.083 -4.144 . . . . 0.0 103.395 174.215 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.416 HD13 ' CZ ' ' A' ' 130' ' ' PHE . 9.1 mt -74.15 135.17 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 176.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -116.95 110.82 18.78 Favored 'General case' 0 CA--C 1.481 -1.703 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 177.182 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 75.79 -149.23 37.79 Favored Glycine 0 CA--C 1.483 -1.939 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 -171.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -99.73 39.91 1.28 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 125.35 1.46 . . . . 0.0 109.718 -176.283 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -170.11 139.36 1.8 Allowed 'General case' 0 CA--C 1.494 -1.177 0 O-C-N 121.351 -0.843 . . . . 0.0 110.515 -175.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 13.3 ttm -124.33 168.64 12.73 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 -178.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 127' ' ' THR . 23.5 mm -112.69 141.07 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.937 0 C-N-CA 126.183 1.793 . . . . 0.0 108.022 163.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.576 ' HB2' HD13 ' A' ' 145' ' ' LEU . 5.1 tmm? -116.22 131.89 56.82 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 103.05 -2.944 . . . . 0.0 103.05 151.507 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.5 t -89.21 134.05 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.248 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -116.91 74.08 0.89 Allowed 'General case' 0 C--N 1.357 0.92 0 N-CA-C 117.946 2.573 . . . . 0.0 117.946 -170.627 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -86.53 -178.3 1.1 Allowed Pre-proline 0 CA--C 1.509 -0.615 0 N-CA-C 117.965 2.579 . . . . 0.0 117.965 -170.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.415 ' HA ' HD21 ' A' ' 118' ' ' LEU . 85.4 Cg_exo -66.59 144.65 73.38 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 122.498 2.132 . . . . 0.0 109.44 160.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -78.72 146.89 33.66 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-O 122.063 0.935 . . . . 0.0 111.785 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -106.14 63.66 0.66 Allowed 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.035 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -79.43 116.97 19.98 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 C--O 1.261 1.702 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 177.013 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.483 -1.633 0 CA-C-O 122.28 1.038 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.1 mm -86.47 117.4 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 CA-C-N 112.811 -1.995 . . . . 0.0 106.855 177.624 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -97.18 169.96 9.44 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -170.122 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 82.9 t -103.89 121.85 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.525 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 168.396 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.407 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 26.4 mmmt -104.05 174.76 5.73 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 155.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -143.95 151.29 39.58 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 -178.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 tp -132.04 161.84 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 171.163 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -116.65 151.7 35.75 Favored 'General case' 0 CA--C 1.482 -1.662 0 C-N-CA 118.739 -1.184 . . . . 0.0 110.825 160.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.609 ' HB3' HG11 ' A' ' 144' ' ' VAL . 36.7 m-85 -124.33 133.03 53.57 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 168.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.57 ' HE ' ' H ' ' A' ' 99' ' ' ARG . 0.3 OUTLIER -98.39 169.1 8.82 Favored Pre-proline 0 N--CA 1.427 -1.589 0 C-N-CA 124.58 1.152 . . . . 0.0 108.41 -173.959 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -63.24 139.81 74.03 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 123.535 2.823 . . . . 0.0 111.321 171.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.43 -125.77 21.19 Favored Glycine 0 CA--C 1.479 -2.206 0 N-CA-C 106.746 -2.541 . . . . 0.0 106.746 -171.518 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.6 m 57.76 107.8 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.744 0 C-N-CA 129.437 3.095 . . . . 0.0 113.108 173.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -127.39 -131.83 0.23 Allowed 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 170.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -55.24 -81.79 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -86.228 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.08 49.84 0.93 Allowed Glycine 0 CA--C 1.482 -1.989 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.749 179.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -105.96 -40.96 5.52 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 147.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.2 -73.49 0.19 Allowed 'General case' 0 CA--C 1.482 -1.65 0 C-N-CA 126.659 1.984 . . . . 0.0 108.455 -174.103 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.449 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.333 0.0 OUTLIER -59.75 -11.14 4.6 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 120.65 3.574 . . . . 0.0 120.65 176.159 . . . . . . . . 4 4 . 1 . 022 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.42 -39.86 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-O 122.005 0.907 . . . . 0.0 110.421 160.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -93.18 -1.95 55.76 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 176.104 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 tt -79.13 -31.32 44.07 Favored 'General case' 0 N--CA 1.417 -2.083 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 162.253 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.499 ' HA ' HG12 ' A' ' 115' ' ' ILE . 7.4 ttm-85 -60.11 -44.65 94.7 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 124.806 1.242 . . . . 0.0 111.298 169.186 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.3 t -60.14 -41.76 93.38 Favored 'General case' 0 C--N 1.371 1.515 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 76.0 mt -65.29 -29.79 70.58 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 173.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.252 5.3 mm -60.61 -48.92 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 CA-C-N 119.751 1.16 . . . . 0.0 108.361 176.836 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -51.19 -45.02 61.69 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 127.274 2.229 . . . . 0.0 110.146 178.456 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.407 ' CD2' ' HB2' ' A' ' 94' ' ' LYS . 12.2 m-30 -61.75 -49.93 74.44 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -179.275 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.695 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -72.5 -20.32 61.38 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.268 1.427 . . . . 0.0 114.298 179.248 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.73 -33.75 64.48 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 125.333 1.453 . . . . 0.0 110.677 172.397 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -67.62 -27.98 67.36 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 169.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.52 67.85 1.38 Allowed Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 105.213 -3.155 . . . . 0.0 105.213 -173.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -123.67 169.27 11.66 Favored 'General case' 0 CA--C 1.452 -2.797 1 N-CA-C 97.852 -4.87 . . . . 0.0 97.852 169.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.81 134.76 39.69 Favored 'General case' 0 CA--C 1.455 -2.704 1 N-CA-C 98.169 -4.752 . . . . 0.0 98.169 157.475 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.24 161.2 21.57 Favored 'General case' 0 N--CA 1.418 -2.037 0 C-N-CA 115.032 -2.667 . . . . 0.0 105.37 160.171 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -111.78 136.24 51.31 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 159.525 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.562 HD11 HD22 ' A' ' 174' ' ' LEU . 4.9 mm -82.47 128.64 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 165.215 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.3 m -111.99 120.31 41.46 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 169.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.717 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.1 OUTLIER -82.42 153.89 25.46 Favored 'General case' 0 CA--C 1.464 -2.341 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 167.162 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.496 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 67.5 ttt180 -148.94 95.39 2.4 Favored 'General case' 0 N--CA 1.393 -3.318 1 N-CA-C 95.736 -5.653 . . . . 0.0 95.736 -176.861 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.487 ' CE1' HD22 ' A' ' 128' ' ' LEU . 97.4 m-85 -74.06 116.77 15.08 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 102.347 -3.205 . . . . 0.0 102.347 175.043 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -87.93 91.12 8.65 Favored 'General case' 0 CA--C 1.484 -1.588 0 N-CA-C 101.216 -3.624 . . . . 0.0 101.216 172.611 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -62.13 120.64 22.81 Favored Glycine 0 CA--C 1.468 -2.847 0 O-C-N 125.694 1.871 . . . . 0.0 113.947 -140.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -73.51 -72.2 0.27 Allowed 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 113.07 -1.565 . . . . 0.0 107.806 172.166 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.408 ' H ' ' CE1' ' A' ' 137' ' ' HIS . 35.2 tt0 -72.46 -78.73 0.08 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 110.912 -2.858 . . . . 0.0 104.474 159.642 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.441 ' H ' ' H ' ' A' ' 136' ' ' ALA . 17.2 ptt? -173.27 -19.67 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.714 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.441 ' H ' ' H ' ' A' ' 135' ' ' MET . . . 175.42 114.75 0.02 OUTLIER 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 -156.094 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.502 ' HB3' ' H ' ' A' ' 139' ' ' GLN . 68.0 m80 -126.59 149.11 49.64 Favored 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -163.286 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -107.32 26.65 9.94 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 163.604 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.502 ' H ' ' HB3' ' A' ' 137' ' ' HIS . 7.3 mt-30 -125.87 -57.0 1.45 Allowed 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -177.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 137' ' ' HIS 0.271 74.8 mt -56.58 -38.67 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.974 0 C-N-CA 127.987 2.515 . . . . 0.0 109.518 171.767 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.717 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -74.33 -60.59 3.47 Favored Glycine 0 N--CA 1.405 -3.41 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.872 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.448 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 4.9 ptt? -89.61 5.61 44.9 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -160.365 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -62.56 -58.45 7.53 Favored 'General case' 0 CA--C 1.46 -2.504 0 C-N-CA 114.907 -2.717 . . . . 0.0 114.595 143.624 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.609 HG11 ' HB3' ' A' ' 98' ' ' PHE . 15.2 t -68.11 -63.06 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.442 -3.194 0 O-C-N 126.096 2.123 . . . . 0.0 107.335 -160.631 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 145' ' ' LEU . 17.7 mt -41.05 -60.15 1.29 Allowed 'General case' 0 CA--C 1.464 -2.344 0 C-N-CA 128.351 2.66 . . . . 0.0 113.454 176.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.3 t-20 -55.72 -37.8 68.9 Favored 'General case' 0 CA--C 1.464 -2.333 0 C-N-CA 125.996 1.718 . . . . 0.0 115.327 177.161 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.5 ttt85 -81.01 -14.04 58.29 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 119.861 -0.735 . . . . 0.0 111.914 175.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.8 t -75.36 -46.72 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.747 0 CA-C-O 116.037 -1.935 . . . . 0.0 106.495 176.006 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.629 ' HB2' HG21 ' A' ' 158' ' ' VAL . 1.2 ttpp -54.65 -57.03 13.07 Favored 'General case' 0 CA--C 1.459 -2.523 0 CA-C-O 116.244 -1.836 . . . . 0.0 108.22 171.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -34.58 78.22 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 120.116 1.325 . . . . 0.0 111.26 -166.587 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.6 -39.47 62.16 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 168.631 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.329 0.2 OUTLIER -80.61 -24.29 39.19 Favored 'General case' 0 CA--C 1.47 -2.109 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -176.82 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -26.07 -31.06 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.812 1 C-N-CA 136.5 5.92 . . . . 0.0 118.357 -177.882 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -52.35 -52.92 50.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.734 2.014 . . . . 0.0 114.298 170.638 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.423 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 3.2 tm? -107.52 -55.86 2.29 Favored 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 128.5 2.72 . . . . 0.0 108.434 -160.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.695 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.279 . . -102.0 154.88 18.56 Favored 'General case' 0 CA--C 1.449 -2.935 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 -176.1 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 18.7 m -118.66 -179.05 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.458 -2.594 0 C-N-CA 113.661 -3.216 . . . . 0.0 115.494 139.401 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.629 HG21 ' HB2' ' A' ' 149' ' ' LYS . 3.3 t -94.89 149.92 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.989 0 N-CA-C 104.94 -2.245 . . . . 0.0 104.94 166.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -82.28 -41.9 19.54 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 -176.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -153.43 148.23 26.43 Favored 'General case' 0 CA--C 1.47 -2.12 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -172.921 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.438 ' CZ ' ' HA ' ' A' ' 146' ' ' ASN . 0.2 OUTLIER -107.41 104.7 53.6 Favored Pre-proline 0 CA--C 1.46 -2.512 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 171.495 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 1.6 Cg_endo -103.82 -128.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.408 -3.536 1 N-CA-C 100.76 -4.361 . . . . 0.0 100.76 -156.179 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 179.68 -48.74 0.01 OUTLIER 'General case' 0 N--CA 1.411 -2.389 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 -137.294 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -88.63 97.09 10.92 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-O 121.387 0.613 . . . . 0.0 111.375 -153.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.41 HG21 ' HB1' ' A' ' 136' ' ' ALA . 1.9 mt -89.0 135.13 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 175.213 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -121.02 109.62 15.27 Favored 'General case' 0 CA--C 1.481 -1.694 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.2 -141.72 26.35 Favored Glycine 0 CA--C 1.482 -2.002 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 -170.207 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -104.83 45.14 0.98 Allowed 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 113.243 -1.479 . . . . 0.0 109.385 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.496 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.314 60.1 mt-30 -167.31 136.68 2.77 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -173.693 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.4 ttp -125.32 118.66 26.42 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 118.561 0.618 . . . . 0.0 111.395 -173.461 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.7 mm -80.38 124.93 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 CA-C-O 122.47 1.128 . . . . 0.0 108.534 169.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.9 ttt -105.95 136.98 44.64 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 159.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.0 t -102.32 134.28 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 117.682 -1.607 . . . . 0.0 109.123 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.562 HD22 HD11 ' A' ' 126' ' ' ILE . 11.7 tp -112.38 86.78 2.42 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 121.338 3.829 . . . . 0.0 121.338 -177.68 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.388 . . -107.77 155.54 39.65 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -178.614 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -70.2 150.6 65.77 Favored 'Trans proline' 0 CA--C 1.486 -1.877 0 C-N-CA 122.885 2.39 . . . . 0.0 109.378 -163.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -76.78 120.33 21.79 Favored 'General case' 0 N--CA 1.433 -1.323 0 O-C-N 124.853 1.346 . . . . 0.0 108.21 -175.456 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -85.54 104.07 14.97 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 171.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -75.85 133.13 40.68 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 . . . . . 0 C--O 1.261 1.685 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.913 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.47 -2.105 0 CA-C-O 125.001 2.334 . . . . 0.0 107.391 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.6 mm -85.3 124.52 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 1 CA-C-N 108.215 -4.084 . . . . 0.0 106.319 178.727 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -97.29 162.71 13.21 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 -167.069 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.474 HG22 ' HE3' ' A' ' 123' ' ' LYS . 83.1 t -101.94 121.83 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.66 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 174.524 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -107.15 -178.23 3.58 Favored 'General case' 0 CA--C 1.472 -2.029 0 C-N-CA 117.373 -1.731 . . . . 0.0 107.535 162.472 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -150.03 150.12 31.32 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.058 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 tp -132.82 161.6 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 173.414 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -122.1 153.75 38.27 Favored 'General case' 0 CA--C 1.485 -1.535 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.071 164.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.59 ' HB3' HG11 ' A' ' 144' ' ' VAL . 40.6 m-85 -134.07 136.76 44.18 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.557 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.6 ttt85 -110.71 160.99 26.64 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-O 117.612 -1.185 . . . . 0.0 108.817 -173.713 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.411 ' HB3' HG23 ' A' ' 140' ' ' ILE . 39.1 Cg_exo -63.6 137.22 58.22 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 124.81 3.673 . . . . 0.0 110.608 177.062 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 51.65 57.33 12.5 Favored Glycine 0 CA--C 1.473 -2.567 0 C-N-CA 126.511 2.005 . . . . 0.0 112.005 173.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 84.3 m -129.64 107.21 9.27 Favored 'General case' 0 CA--C 1.463 -2.37 0 N-CA-C 102.708 -3.071 . . . . 0.0 102.708 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -124.68 -137.38 0.28 Allowed 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 171.25 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.02 -78.02 0.03 OUTLIER 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -86.511 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.45 42.96 1.8 Allowed Glycine 0 CA--C 1.483 -1.963 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.488 -177.644 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -101.48 -41.55 6.59 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 147.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.8 -74.06 0.18 Allowed 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 126.525 1.93 . . . . 0.0 109.12 -169.615 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.433 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.326 0.0 OUTLIER -59.64 -11.27 4.62 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 120.335 3.457 . . . . 0.0 120.335 177.175 . . . . . . . . 4 4 . 1 . 023 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.12 -40.57 89.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 122.094 0.949 . . . . 0.0 110.296 161.387 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -92.87 -4.28 53.16 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 176.359 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.5 tt -75.84 -33.27 60.03 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 161.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.476 ' HA ' HG12 ' A' ' 115' ' ' ILE . 16.2 ttp180 -60.4 -44.93 95.22 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 125.175 1.39 . . . . 0.0 111.146 170.651 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 t -62.46 -42.63 99.61 Favored 'General case' 0 C--N 1.375 1.687 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 118' ' ' LEU 0.327 51.2 tp -68.69 -30.38 69.03 Favored 'General case' 0 N--CA 1.402 -2.835 0 C-N-CA 125.706 1.602 . . . . 0.0 113.519 177.707 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.283 8.9 mm -56.3 -52.03 56.59 Favored 'Isoleucine or valine' 0 C--N 1.378 1.833 0 CA-C-N 120.94 1.7 . . . . 0.0 109.402 171.099 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -53.47 -40.16 65.08 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 128.386 2.674 . . . . 0.0 110.559 -177.396 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -61.01 -54.16 48.39 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 124.393 1.077 . . . . 0.0 112.043 175.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.677 HD13 ' HB2' ' A' ' 156' ' ' ALA . 1.3 mt -67.76 -21.08 65.28 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -72.52 -36.21 68.29 Favored 'General case' 0 CA--C 1.491 -1.317 0 C-N-CA 126.043 1.737 . . . . 0.0 110.25 172.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -67.16 -22.2 65.77 Favored 'General case' 0 C--N 1.36 1.031 0 O-C-N 123.185 0.303 . . . . 0.0 111.214 169.303 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.83 68.1 1.42 Allowed Glycine 0 CA--C 1.469 -2.839 0 N-CA-C 104.81 -3.316 . . . . 0.0 104.81 -174.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -123.28 163.4 20.78 Favored 'General case' 0 CA--C 1.448 -2.971 0 N-CA-C 100.641 -3.837 . . . . 0.0 100.641 171.019 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.639 ' HD3' HG12 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -105.45 106.27 16.69 Favored 'General case' 0 N--CA 1.399 -3.007 1 N-CA-C 99.101 -4.407 . . . . 0.0 99.101 173.892 . . . . . . . . 4 4 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -97.77 128.54 44.48 Favored 'General case' 0 N--CA 1.411 -2.39 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.561 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -96.07 129.88 43.24 Favored 'General case' 0 CA--C 1.474 -1.969 0 CA-C-O 121.621 0.724 . . . . 0.0 109.325 -176.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.6 mm -82.9 132.92 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 171.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.526 ' HA ' HD13 ' A' ' 171' ' ' ILE . 21.8 m -113.82 120.81 42.05 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 167.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.656 HD12 HD11 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -74.2 145.65 43.98 Favored 'General case' 0 CA--C 1.474 -1.962 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 165.808 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.448 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 52.3 ttp180 -147.48 94.96 2.45 Favored 'General case' 0 N--CA 1.4 -2.93 1 N-CA-C 98.591 -4.596 . . . . 0.0 98.591 -178.739 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 136' ' ' ALA . 77.1 m-85 -67.46 164.03 19.66 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 111.267 -2.697 . . . . 0.0 108.009 178.563 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 49.7 tpt85 -81.24 82.42 7.13 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 158.685 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.447 ' H ' ' HE ' ' A' ' 168' ' ' ARG . . . -82.84 111.91 3.44 Favored Glycine 0 CA--C 1.455 -3.673 0 C-N-CA 118.473 -1.822 . . . . 0.0 112.94 -139.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.452 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 23.1 tpt85 -165.45 -133.97 0.02 OUTLIER 'General case' 0 CA--C 1.485 -1.53 0 CA-C-N 112.443 -1.879 . . . . 0.0 107.365 -168.08 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.452 ' H ' ' HG3' ' A' ' 133' ' ' ARG . 46.0 mm-40 -86.56 17.92 3.61 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 125.758 1.623 . . . . 0.0 108.855 156.001 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -120.31 27.44 8.6 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 161.041 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 130' ' ' PHE . . . -113.3 98.11 6.9 Favored 'General case' 0 CA--C 1.484 -1.594 0 C-N-CA 124.788 1.235 . . . . 0.0 108.557 163.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.404 ' HB3' ' H ' ' A' ' 139' ' ' GLN . 14.0 m-70 -129.15 171.47 12.38 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.154 -172.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -85.94 8.82 18.87 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 121.84 -0.538 . . . . 0.0 110.8 166.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.404 ' H ' ' HB3' ' A' ' 137' ' ' HIS . 42.8 mt-30 -97.23 -47.34 5.78 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 173.866 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.411 HG23 ' HB3' ' A' ' 100' ' ' PRO 0.323 63.1 mt -65.07 -35.58 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 C-N-CA 127.65 2.38 . . . . 0.0 109.335 -177.615 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.576 ' CA ' HD11 ' A' ' 128' ' ' LEU . . . -74.15 -61.14 3.32 Favored Glycine 0 N--CA 1.409 -3.112 0 CA-C-N 114.911 -1.041 . . . . 0.0 114.134 171.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.496 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 6.7 ptt? -85.43 -2.59 58.28 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -158.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.61 -53.23 59.96 Favored 'General case' 0 CA--C 1.455 -2.688 0 C-N-CA 114.807 -2.757 . . . . 0.0 114.461 150.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.59 HG11 ' HB3' ' A' ' 98' ' ' PHE . 12.7 t -69.77 -65.33 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.447 -2.998 0 O-C-N 126.011 2.069 . . . . 0.0 107.765 -164.055 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.656 HD11 HD12 ' A' ' 128' ' ' LEU . 14.5 mt -44.07 -55.07 4.98 Favored 'General case' 0 CA--C 1.481 -1.674 0 C-N-CA 128.757 2.823 . . . . 0.0 115.675 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.6 t-20 -63.76 -30.95 71.99 Favored 'General case' 0 CA--C 1.462 -2.404 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 174.234 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -81.44 -15.16 55.95 Favored 'General case' 0 N--CA 1.419 -1.993 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.853 172.387 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.466 HG21 ' CE2' ' A' ' 98' ' ' PHE . 2.0 t -74.71 -47.13 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.819 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 176.137 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.478 ' HE3' HG21 ' A' ' 158' ' ' VAL . 35.2 ttmt -51.61 -53.95 32.96 Favored 'General case' 0 CA--C 1.459 -2.558 0 C-N-CA 125.47 1.508 . . . . 0.0 110.642 172.85 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.19 -35.99 71.77 Favored 'General case' 0 N--CA 1.411 -2.415 0 C-N-CA 125.241 1.416 . . . . 0.0 110.172 -167.149 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -71.59 -34.98 70.38 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 115.872 -2.331 . . . . 0.0 114.885 170.25 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 115' ' ' ILE 0.262 0.2 OUTLIER -81.31 -26.26 35.81 Favored 'General case' 0 CA--C 1.463 -2.372 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -178.178 . . . . . . . . 4 4 . 1 . 023 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -28.62 -21.61 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.511 1 C-N-CA 135.896 5.679 . . . . 0.0 119.292 178.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -53.99 -58.45 7.27 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 125.753 1.621 . . . . 0.0 112.733 164.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 tt -111.45 -43.57 3.66 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 127.338 2.255 . . . . 0.0 109.666 -159.21 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.854 ' HB1' HD11 ' A' ' 174' ' ' LEU 0.303 . . -115.59 142.14 47.13 Favored 'General case' 0 CA--C 1.464 -2.357 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.809 179.554 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.3 m -130.02 164.83 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.021 0 N-CA-C 121.776 3.991 . . . . 0.0 121.776 147.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.7 t -79.81 149.27 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.973 0 CA-C-N 111.06 -2.791 . . . . 0.0 107.944 -174.021 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.76 -38.87 25.0 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 113.033 -1.894 . . . . 0.0 106.079 -172.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.2 t -162.57 150.01 13.69 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -171.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 2.4 t80 -108.19 103.36 50.12 Favored Pre-proline 0 N--CA 1.427 -1.589 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 173.142 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 83.5 Cg_endo -132.91 -106.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 115.016 -2.856 . . . . 0.0 108.137 -142.262 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.0 -94.36 0.13 Allowed 'General case' 0 N--CA 1.406 -2.635 0 C-N-CA 117.355 -1.738 . . . . 0.0 113.093 -109.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -153.11 132.56 12.9 Favored 'General case' 0 CA--C 1.476 -1.872 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 -169.223 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.0 mt -76.22 131.1 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 N-CA-C 103.987 -2.598 . . . . 0.0 103.987 166.67 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -133.55 113.62 12.65 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 102.589 -3.115 . . . . 0.0 102.589 -178.153 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.29 -141.02 24.44 Favored Glycine 0 CA--C 1.483 -1.947 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -168.677 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.447 ' HE ' ' H ' ' A' ' 132' ' ' GLY . 67.4 mtp180 -101.04 33.72 2.75 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 113.073 -1.564 . . . . 0.0 110.897 -174.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.448 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.291 58.2 mt-30 -171.22 141.22 1.58 Allowed 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.511 -162.347 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 15.9 ttm -118.7 170.75 8.71 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 172.365 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.526 HD13 ' HA ' ' A' ' 127' ' ' THR . 28.2 mm -117.74 142.25 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 C-N-CA 126.727 2.011 . . . . 0.0 108.232 161.553 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.7 ttt -124.33 133.81 53.35 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 102.988 -2.967 . . . . 0.0 102.988 157.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.639 HG12 ' HD3' ' A' ' 123' ' ' LYS . 1.6 t -100.75 139.75 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.021 -171.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.854 HD11 ' HB1' ' A' ' 156' ' ' ALA . 1.4 tp -131.54 130.59 42.49 Favored 'General case' 0 C--N 1.365 1.263 0 CA-C-N 121.688 2.04 . . . . 0.0 106.625 -172.418 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.299 . . -129.56 178.26 1.78 Allowed Pre-proline 0 CA--C 1.49 -1.329 0 C-N-CA 125.819 1.648 . . . . 0.0 111.819 -173.106 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -71.35 158.24 54.84 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 CA-C-N 120.925 1.366 . . . . 0.0 111.036 -177.49 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -76.65 118.81 19.66 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 174.36 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -78.21 117.34 19.39 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 165.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -59.54 118.74 6.41 Favored 'General case' 0 CA--C 1.496 -1.126 0 C-N-CA 124.92 1.288 . . . . 0.0 112.148 -168.309 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 . . . . . 0 C--O 1.259 1.583 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.339 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 CA--C 1.48 -1.719 0 CA-C-O 122.166 0.984 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.1 mm -89.57 114.04 26.89 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 CA-C-N 113.104 -1.862 . . . . 0.0 106.311 171.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -107.38 164.09 12.49 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -163.143 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.532 HG22 ' HE2' ' A' ' 123' ' ' LYS . 69.2 t -88.88 117.32 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.903 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 162.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -110.29 169.75 8.53 Favored 'General case' 0 CA--C 1.483 -1.601 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 151.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -136.37 157.95 45.59 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.812 -163.164 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 tp -131.58 163.67 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 165.469 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -119.57 154.42 33.93 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 119.479 -0.888 . . . . 0.0 112.321 162.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.628 ' HB3' HG11 ' A' ' 144' ' ' VAL . 45.9 m-85 -129.09 147.31 50.93 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 169.571 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -114.91 170.78 5.1 Favored Pre-proline 0 N--CA 1.431 -1.401 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.449 ' HB3' HG23 ' A' ' 140' ' ' ILE . 5.8 Cg_endo -70.36 152.22 66.08 Favored 'Trans proline' 0 CA--C 1.487 -1.845 0 C-N-CA 123.463 2.776 . . . . 0.0 109.147 172.087 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.22 -127.53 17.82 Favored Glycine 0 CA--C 1.479 -2.203 0 N-CA-C 105.293 -3.123 . . . . 0.0 105.293 -168.006 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.2 m 49.26 100.6 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.731 0 C-N-CA 129.867 3.267 . . . . 0.0 112.38 178.42 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -117.52 -157.54 0.67 Allowed 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.48 -176.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -62.04 -43.78 98.1 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -121.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -104.6 60.55 0.42 Allowed Glycine 0 N--CA 1.42 -2.399 0 CA-C-O 123.951 1.862 . . . . 0.0 111.473 -171.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -169.76 -41.0 0.02 OUTLIER 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 130.308 3.443 . . . . 0.0 103.76 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -86.61 -71.62 0.54 Allowed 'General case' 0 CA--C 1.482 -1.649 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.798 -166.691 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.506 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.311 0.0 OUTLIER -61.08 -14.76 26.21 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 118.872 2.916 . . . . 0.0 118.872 172.414 . . . . . . . . 4 4 . 1 . 024 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.17 -41.71 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.982 0.913 . . . . 0.0 109.791 162.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -93.15 6.76 46.86 Favored 'General case' 0 CA--C 1.486 -1.513 0 O-C-N 120.376 -1.452 . . . . 0.0 114.905 175.602 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.8 tt -85.8 -31.32 22.39 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 162.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.428 ' HA ' HG12 ' A' ' 115' ' ' ILE . 14.3 ttp180 -60.47 -45.36 94.0 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.654 1.182 . . . . 0.0 109.843 168.061 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 t -58.89 -43.07 90.91 Favored 'General case' 0 C--N 1.375 1.705 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 173.375 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.432 HD11 HD12 ' A' ' 126' ' ' ILE . 10.3 mt -60.95 -33.1 72.66 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 175.493 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.434 ' CG2' ' HG ' ' A' ' 155' ' ' LEU . 3.1 mm -61.06 -46.79 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 177.285 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -53.09 22.39 Favored 'General case' 0 CA--C 1.497 -1.07 0 O-C-N 125.985 2.053 . . . . 0.0 110.923 178.146 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -58.41 -46.37 86.56 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 178.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.533 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -62.06 -36.64 82.22 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 176.119 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -79.19 -21.54 46.21 Favored 'General case' 0 CA--C 1.487 -1.469 0 C-N-CA 127.671 2.388 . . . . 0.0 112.638 -173.558 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -71.56 -15.15 62.27 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 169.22 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.61 65.5 1.5 Allowed Glycine 0 CA--C 1.462 -3.252 0 N-CA-C 104.469 -3.452 . . . . 0.0 104.469 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -133.14 173.69 11.17 Favored 'General case' 0 CA--C 1.447 -3.012 1 N-CA-C 97.724 -4.917 . . . . 0.0 97.724 170.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.532 ' HE2' HG22 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -90.01 135.02 33.9 Favored 'General case' 0 N--CA 1.399 -2.978 1 N-CA-C 97.898 -4.853 . . . . 0.0 97.898 158.611 . . . . . . . . 4 4 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -79.09 156.74 28.19 Favored 'General case' 0 N--CA 1.405 -2.677 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 156.231 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -140.06 133.13 29.52 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 101.121 -3.659 . . . . 0.0 101.121 169.719 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.475 HD11 HD12 ' A' ' 174' ' ' LEU . 8.5 mm -83.83 134.56 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.112 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -178.358 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.6 m -116.28 121.53 42.29 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 168.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.32 154.18 33.09 Favored 'General case' 0 CA--C 1.47 -2.103 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 166.778 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.558 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 35.2 ttp85 -146.07 96.67 2.83 Favored 'General case' 0 N--CA 1.397 -3.1 1 N-CA-C 96.073 -5.529 . . . . 0.0 96.073 -179.482 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -70.31 126.0 28.39 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 111.88 -2.418 . . . . 0.0 106.212 178.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -77.22 108.06 10.06 Favored 'General case' 0 CA--C 1.479 -1.753 1 N-CA-C 99.779 -4.156 . . . . 0.0 99.779 160.016 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.47 118.11 6.52 Favored Glycine 0 CA--C 1.467 -2.963 0 O-C-N 124.865 1.353 . . . . 0.0 112.303 -157.412 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -117.61 19.4 13.91 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-N 112.73 -1.735 . . . . 0.0 108.919 169.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 179.15 -11.96 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 101.355 -3.572 . . . . 0.0 101.355 -176.446 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 54.7 mtt 80.23 -5.51 1.8 Allowed 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 129.272 3.029 . . . . 0.0 111.894 -170.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.459 ' HB1' HD12 ' A' ' 165' ' ' ILE . . . -179.42 112.66 0.05 Allowed 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.548 -161.265 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.65 ' CG ' HD13 ' A' ' 140' ' ' ILE . 1.7 m-70 -131.49 154.84 48.34 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.142 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -108.84 46.1 0.99 Allowed 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 160.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -130.51 -54.25 1.09 Allowed 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 103.579 -2.749 . . . . 0.0 103.579 172.559 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.65 HD13 ' CG ' ' A' ' 137' ' ' HIS . 1.7 mp -50.46 -52.54 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.772 0 C-N-CA 127.23 2.212 . . . . 0.0 109.424 167.295 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -68.12 -59.78 6.11 Favored Glycine 0 N--CA 1.416 -2.677 0 O-C-N 124.222 0.951 . . . . 0.0 111.439 -176.418 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.482 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 6.8 ptm -90.88 6.36 44.83 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -161.121 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.09 -56.02 15.4 Favored 'General case' 0 CA--C 1.455 -2.703 0 C-N-CA 115.875 -2.33 . . . . 0.0 113.559 146.224 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.628 HG11 ' HB3' ' A' ' 98' ' ' PHE . 24.3 t -67.89 -66.46 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.44 -3.251 0 O-C-N 126.498 2.374 . . . . 0.0 107.39 -164.477 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.8 mt -39.27 -57.04 1.42 Allowed 'General case' 0 CA--C 1.467 -2.224 0 C-N-CA 128.138 2.575 . . . . 0.0 114.018 178.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 161' ' ' PHE . 1.2 t-20 -52.99 -45.05 67.68 Favored 'General case' 0 CA--C 1.47 -2.132 0 C-N-CA 126.607 1.963 . . . . 0.0 115.911 175.454 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -83.27 -12.86 56.3 Favored 'General case' 0 N--CA 1.424 -1.768 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.41 179.331 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 144' ' ' VAL . 2.1 t -76.27 -40.0 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.697 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 177.367 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.41 -52.16 62.72 Favored 'General case' 0 CA--C 1.449 -2.934 0 CA-C-O 117.332 -1.318 . . . . 0.0 113.108 176.696 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -60.15 -39.1 85.17 Favored 'General case' 0 N--CA 1.404 -2.747 0 C-N-CA 127.097 2.159 . . . . 0.0 108.836 -178.13 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.458 ' HB3' HD11 ' A' ' 111' ' ' LEU . 21.1 t70 -75.52 -28.55 59.16 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 117.403 2.371 . . . . 0.0 117.403 169.462 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.629 ' HG ' ' HB3' ' A' ' 156' ' ' ALA 0.269 0.0 OUTLIER -75.53 -37.12 60.27 Favored 'General case' 0 CA--C 1.477 -1.841 0 CA-C-N 120.185 1.357 . . . . 0.0 112.79 179.258 . . . . . . . . 4 4 . 1 . 024 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -27.66 -32.61 0.0 OUTLIER 'General case' 0 CA--C 1.474 -1.946 1 C-N-CA 137.071 6.148 . . . . 0.0 119.079 -164.653 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 4.7 mt-10 -52.43 -51.3 59.86 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 127.37 2.268 . . . . 0.0 113.153 172.299 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.434 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 2.7 tm? -109.4 -47.81 3.34 Favored 'General case' 0 N--CA 1.42 -1.953 0 C-N-CA 128.716 2.806 . . . . 0.0 107.472 -161.171 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.629 ' HB3' ' HG ' ' A' ' 152' ' ' LEU 0.327 . . -119.64 140.59 50.37 Favored 'General case' 0 CA--C 1.457 -2.606 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.372 -176.765 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.2 m -126.32 -176.36 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.47 -2.111 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 155.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.35 166.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.58 0 C-N-CA 126.619 1.968 . . . . 0.0 110.159 -165.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -85.87 -41.65 14.8 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 154.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -164.59 146.24 8.27 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.997 -171.742 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.495 ' CZ ' ' HA ' ' A' ' 146' ' ' ASN . 0.2 OUTLIER -100.29 117.4 63.15 Favored Pre-proline 0 CA--C 1.462 -2.408 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 170.404 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 50.8 Cg_endo -133.12 -128.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.409 -3.448 1 N-CA-C 101.553 -4.056 . . . . 0.0 101.553 -158.957 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -178.18 -42.1 0.01 OUTLIER 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 -120.383 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -85.63 88.18 7.5 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 121.667 0.746 . . . . 0.0 111.483 -158.592 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.459 HD12 ' HB1' ' A' ' 136' ' ' ALA . 1.7 mt -84.01 129.57 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 172.666 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -125.32 102.82 7.61 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 -173.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.45 -139.74 21.25 Favored Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 -171.45 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -101.44 39.42 1.43 Allowed 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 112.831 -1.685 . . . . 0.0 109.538 -176.419 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.558 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.337 59.0 mt-30 -172.1 133.12 0.68 Allowed 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 121.866 -0.522 . . . . 0.0 110.301 -162.415 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 22.4 ttp -115.32 115.53 26.78 Favored 'General case' 0 CA--C 1.481 -1.692 0 CA-C-O 121.472 0.654 . . . . 0.0 111.679 -171.706 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.0 mm -81.72 126.88 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.367 0 CA-C-O 122.123 0.964 . . . . 0.0 108.76 172.41 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.435 ' SD ' ' CZ ' ' A' ' 161' ' ' PHE . 3.2 ttt -112.65 142.96 44.63 Favored 'General case' 0 CA--C 1.476 -1.875 0 N-CA-C 103.167 -2.901 . . . . 0.0 103.167 155.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.6 t -98.87 153.37 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 118.589 -1.244 . . . . 0.0 107.696 -175.258 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.475 HD12 HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -134.92 81.75 1.92 Allowed 'General case' 0 C--N 1.36 1.053 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -174.836 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.278 . . -83.34 174.4 6.05 Favored Pre-proline 0 CA--C 1.505 -0.787 0 O-C-N 119.637 -1.914 . . . . 0.0 115.038 -175.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -68.33 135.93 35.55 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.363 2.042 . . . . 0.0 108.996 165.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -80.08 163.19 24.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 124.037 0.836 . . . . 0.0 110.864 171.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -74.06 107.12 6.07 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.075 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -67.87 105.89 2.12 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 124.701 1.2 . . . . 0.0 110.358 -173.015 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 C--O 1.26 1.635 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -179.389 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 . . . . . 0 CA--C 1.481 -1.676 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.642 HG22 ' HD3' ' A' ' 123' ' ' LYS . 70.2 t -102.04 114.32 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.665 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 161.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -108.94 -179.83 3.97 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 156.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -143.82 158.42 43.69 Favored 'General case' 0 N--CA 1.433 -1.309 0 O-C-N 123.462 0.476 . . . . 0.0 110.544 -169.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.9 tp -135.35 162.23 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 166.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -120.91 157.26 30.25 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 118.863 0.756 . . . . 0.0 111.396 165.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.627 ' HB3' HG11 ' A' ' 144' ' ' VAL . 39.8 m-85 -136.92 100.32 4.27 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 173.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 . . . . . 0 N--CA 1.434 -1.274 0 C-N-CA 124.124 0.97 . . . . 0.0 109.086 178.862 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.0 t70 . . . . . 0 N--CA 1.424 -1.757 0 CA-C-O 122.758 1.266 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -73.95 -71.17 0.34 Allowed 'General case' 0 CA--C 1.474 -1.977 0 CA-C-N 111.572 -2.558 . . . . 0.0 113.082 -161.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.33 0.0 OUTLIER -60.63 -14.11 18.47 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 119.639 3.2 . . . . 0.0 119.639 175.693 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 87.5 t -60.65 -47.82 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.18 0.99 . . . . 0.0 109.444 161.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -91.94 7.66 41.09 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 6.0 tt -84.08 -32.78 24.6 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 162.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.481 ' HA ' HG12 ' A' ' 115' ' ' ILE . 58.3 ttt-85 -61.87 -42.79 99.48 Favored 'General case' 0 C--N 1.363 1.189 0 CA-C-O 118.739 -0.648 . . . . 0.0 110.677 168.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.6 t -61.56 -41.31 97.19 Favored 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.512 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.46 HD11 HD23 ' A' ' 174' ' ' LEU . 65.0 tp -70.08 -29.29 66.24 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-O 117.088 -1.434 . . . . 0.0 113.541 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.481 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.269 10.0 mm -55.47 -53.08 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.957 0 CA-C-N 120.293 1.406 . . . . 0.0 107.569 170.014 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -47.29 -48.9 24.71 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 128.649 2.78 . . . . 0.0 111.776 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -56.81 -55.71 30.83 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.561 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -54.94 -36.17 64.99 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 174.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -89.1 -14.9 35.21 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 128.929 2.892 . . . . 0.0 110.341 -166.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -67.57 -24.94 65.57 Favored 'General case' 0 C--N 1.36 1.023 0 C-N-CA 122.981 0.512 . . . . 0.0 109.706 161.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 93.42 57.52 1.35 Allowed Glycine 0 CA--C 1.472 -2.655 0 N-CA-C 104.542 -3.423 . . . . 0.0 104.542 -174.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -126.53 167.73 15.23 Favored 'General case' 0 CA--C 1.462 -2.408 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.642 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -101.54 115.61 30.91 Favored 'General case' 0 N--CA 1.407 -2.597 1 N-CA-C 99.762 -4.162 . . . . 0.0 99.762 176.689 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.77 115.7 31.11 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.065 -1.425 . . . . 0.0 107.751 -168.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -97.44 121.58 39.51 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -171.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.1 mm -84.04 134.22 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.486 ' HA ' HD13 ' A' ' 171' ' ' ILE . 25.7 m -119.62 124.06 45.4 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 173.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.662 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.1 OUTLIER -88.02 155.84 19.61 Favored 'General case' 0 CA--C 1.467 -2.236 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 167.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.478 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 22.2 ttt85 -152.07 91.52 1.62 Allowed 'General case' 0 N--CA 1.397 -3.115 1 N-CA-C 99.221 -4.363 . . . . 0.0 99.221 -174.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.498 ' CE1' HD22 ' A' ' 128' ' ' LEU . 92.0 m-85 . . . . . 0 N--CA 1.422 -1.854 0 CA-C-N 112.437 -2.165 . . . . 0.0 108.755 -173.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 82.1 mt . . . . . 0 CA--C 1.468 -2.188 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.662 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -79.59 -60.95 2.38 Favored Glycine 0 N--CA 1.41 -3.099 0 C-N-CA 118.867 -1.635 . . . . 0.0 111.926 -170.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 72.4 mtm -89.51 0.08 57.14 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -161.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -67.77 -50.37 57.47 Favored 'General case' 0 CA--C 1.457 -2.614 0 C-N-CA 116.096 -2.242 . . . . 0.0 113.295 151.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.627 HG11 ' HB3' ' A' ' 98' ' ' PHE . 21.8 t -67.81 -69.22 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.443 -3.168 0 O-C-N 125.946 2.028 . . . . 0.0 108.15 -166.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' A' ' 172' ' ' MET . 27.8 mt -42.22 -53.31 4.12 Favored 'General case' 0 CA--C 1.476 -1.887 0 C-N-CA 128.929 2.891 . . . . 0.0 115.119 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -62.9 -36.16 82.43 Favored 'General case' 0 CA--C 1.46 -2.508 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -81.76 -14.15 56.82 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.603 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.6 t -77.68 -46.2 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.768 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.455 ' HB2' HG21 ' A' ' 158' ' ' VAL . 29.7 ttmt -51.93 -50.62 60.79 Favored 'General case' 0 CA--C 1.463 -2.401 0 C-N-CA 125.583 1.553 . . . . 0.0 111.003 171.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.64 -36.62 70.76 Favored 'General case' 0 N--CA 1.411 -2.404 0 C-N-CA 124.447 1.099 . . . . 0.0 110.187 -169.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -72.69 -40.09 66.5 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 116.305 -2.158 . . . . 0.0 115.299 170.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.289 0.2 OUTLIER -80.2 -19.97 45.78 Favored 'General case' 0 CA--C 1.464 -2.352 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -177.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -26.38 -27.04 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.443 1 C-N-CA 134.457 5.103 . . . . 0.0 118.901 173.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -55.28 -59.04 5.35 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 127.045 2.138 . . . . 0.0 112.902 169.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.42 -52.1 3.19 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 125.842 1.657 . . . . 0.0 107.805 -167.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.929 ' HB1' HD11 ' A' ' 174' ' ' LEU 0.281 . . -100.28 141.44 33.12 Favored 'General case' 0 CA--C 1.459 -2.546 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.882 -178.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.5 m -123.93 164.25 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.421 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 139.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.5 t -84.08 153.46 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.104 0 CA-C-N 110.021 -3.263 . . . . 0.0 108.478 -172.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -82.32 -41.25 20.32 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.3 t -152.45 151.17 30.44 Favored 'General case' 0 CA--C 1.468 -2.174 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 N--CA 1.424 -1.768 0 N-CA-C 101.199 -3.63 . . . . 0.0 101.199 164.771 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.478 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.3 38.0 mt-30 . . . . . 0 CA--C 1.504 -0.79 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 51.8 ttp -134.93 118.73 17.2 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 119.155 0.889 . . . . 0.0 111.671 -173.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 127' ' ' THR . 22.0 mm -82.49 123.94 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 O-C-N 121.31 -0.869 . . . . 0.0 108.666 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.403 ' HB3' HD22 ' A' ' 145' ' ' LEU . 2.9 ttt -101.07 130.29 47.07 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 159.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.16 134.87 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -173.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.929 HD11 ' HB1' ' A' ' 156' ' ' ALA . 1.1 tp -129.19 143.73 50.96 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 -174.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.32 . . -131.98 178.36 1.79 Allowed Pre-proline 0 CA--C 1.488 -1.424 0 C-N-CA 123.813 0.845 . . . . 0.0 110.065 -174.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.523 ' HA ' HD21 ' A' ' 118' ' ' LEU . 78.0 Cg_exo -62.73 148.23 93.66 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 122.932 2.421 . . . . 0.0 109.059 160.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt . . . . . 0 CA--C 1.492 -1.273 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 174.54 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 . . . . . 0 CA--C 1.481 -1.706 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.509 HG22 ' HE3' ' A' ' 123' ' ' LYS . 82.0 t -103.03 124.77 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -108.38 171.74 7.24 Favored 'General case' 0 CA--C 1.479 -1.784 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 154.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -144.43 146.65 32.6 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 tp -124.97 160.07 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.085 0 N-CA-C 103.169 -2.9 . . . . 0.0 103.169 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -119.22 154.12 33.89 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 119.414 -0.915 . . . . 0.0 110.447 162.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.588 ' HB3' HG11 ' A' ' 144' ' ' VAL . 34.1 m-85 -134.03 110.83 9.91 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 . . . . . 0 N--CA 1.429 -1.486 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.187 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.4 t70 . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.91 -73.71 0.13 Allowed 'General case' 0 CA--C 1.477 -1.86 0 C-N-CA 127.209 2.203 . . . . 0.0 110.371 -173.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.487 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.275 0.0 OUTLIER -65.49 -9.02 22.32 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 119.394 3.109 . . . . 0.0 119.394 -179.321 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.84 -42.79 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 122.169 0.985 . . . . 0.0 110.793 161.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -91.67 -1.53 57.4 Favored 'General case' 0 CA--C 1.477 -1.831 0 O-C-N 120.352 -1.468 . . . . 0.0 114.686 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.5 tt -76.79 -31.98 57.36 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 161.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.536 ' HA ' HG12 ' A' ' 115' ' ' ILE . 31.4 ttt180 -62.47 -45.03 94.88 Favored 'General case' 0 C--N 1.363 1.19 0 C-N-CA 123.812 0.845 . . . . 0.0 111.482 170.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.1 m -61.77 -42.31 98.83 Favored 'General case' 0 C--N 1.377 1.796 0 C-N-CA 118.666 -1.214 . . . . 0.0 113.761 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.653 HD11 HD12 ' A' ' 174' ' ' LEU 0.323 52.4 tp -68.0 -27.92 66.98 Favored 'General case' 0 N--CA 1.406 -2.644 0 C-N-CA 126.73 2.012 . . . . 0.0 113.67 177.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.289 9.4 mm -57.33 -52.87 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.901 0 CA-C-N 121.036 1.744 . . . . 0.0 108.217 170.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -53.78 -42.64 68.5 Favored 'General case' 0 CA--C 1.492 -1.262 0 O-C-N 125.816 1.947 . . . . 0.0 110.402 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -58.21 -54.11 50.66 Favored 'General case' 0 CA--C 1.481 -1.701 0 C-N-CA 125.343 1.457 . . . . 0.0 112.639 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.552 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -61.16 -33.07 72.84 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 177.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -73.58 -31.56 63.66 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 129.116 2.966 . . . . 0.0 109.798 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -64.67 -19.75 65.9 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 124.213 1.005 . . . . 0.0 111.679 171.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.53 54.79 2.72 Favored Glycine 0 CA--C 1.469 -2.825 0 N-CA-C 103.995 -3.642 . . . . 0.0 103.995 -174.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -120.42 163.52 17.77 Favored 'General case' 0 CA--C 1.447 -2.984 1 N-CA-C 99.82 -4.141 . . . . 0.0 99.82 170.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.509 ' HE3' HG22 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -101.04 116.13 32.12 Favored 'General case' 0 N--CA 1.393 -3.285 1 N-CA-C 98.644 -4.576 . . . . 0.0 98.644 171.526 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.52 156.71 25.12 Favored 'General case' 0 N--CA 1.407 -2.585 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 173.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.314 27.4 mtpp -131.44 138.76 49.19 Favored 'General case' 0 CA--C 1.487 -1.458 0 O-C-N 118.688 -2.507 . . . . 0.0 104.248 163.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.9 mm -85.43 136.77 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 27.5 m -117.51 130.11 56.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 169.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.643 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.1 OUTLIER -92.19 160.09 15.34 Favored 'General case' 0 CA--C 1.468 -2.189 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 167.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.413 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 56.1 ttt180 -152.48 96.26 2.13 Favored 'General case' 0 N--CA 1.402 -2.843 1 N-CA-C 99.036 -4.431 . . . . 0.0 99.036 -174.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.503 ' CE1' HD22 ' A' ' 128' ' ' LEU . 96.8 m-85 . . . . . 0 CA--C 1.485 -1.551 0 CA-C-N 113.068 -1.878 . . . . 0.0 106.438 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 89.5 mt . . . . . 0 CA--C 1.477 -1.843 0 CA-C-O 119.997 -0.049 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.643 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -78.94 -57.85 3.14 Favored Glycine 0 N--CA 1.407 -3.245 0 C-N-CA 119.355 -1.403 . . . . 0.0 112.505 -167.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 58.4 mtm -93.92 18.24 10.84 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -170.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.86 -61.25 1.96 Allowed 'General case' 0 CA--C 1.456 -2.657 0 C-N-CA 115.138 -2.625 . . . . 0.0 114.573 133.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.588 HG11 ' HB3' ' A' ' 98' ' ' PHE . 23.7 t -64.07 -66.14 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.444 -3.111 0 O-C-N 126.213 2.196 . . . . 0.0 109.064 -160.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.1 mt -43.58 -55.81 4.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 127.811 2.444 . . . . 0.0 114.003 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -53.62 -43.12 68.41 Favored 'General case' 0 CA--C 1.485 -1.522 0 C-N-CA 126.791 2.036 . . . . 0.0 114.159 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -82.48 -14.26 55.33 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 144' ' ' VAL . 2.5 t -72.93 -44.57 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.597 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.448 ' CE ' HG22 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -60.22 -53.94 51.74 Favored 'General case' 0 CA--C 1.45 -2.888 0 O-C-N 125.126 1.516 . . . . 0.0 112.722 179.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.88 -38.68 82.91 Favored 'General case' 0 N--CA 1.403 -2.791 0 C-N-CA 127.686 2.394 . . . . 0.0 109.241 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.412 ' HB3' HD11 ' A' ' 111' ' ' LEU . 25.4 t70 -71.01 -40.48 71.79 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 116.065 -2.254 . . . . 0.0 116.901 168.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.483 HD13 HD11 ' A' ' 174' ' ' LEU 0.277 0.2 OUTLIER -80.2 -22.89 41.39 Favored 'General case' 0 CA--C 1.463 -2.384 0 N-CA-C 117.263 2.319 . . . . 0.0 117.263 -175.285 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -27.51 -27.96 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.44 1 C-N-CA 135.376 5.47 . . . . 0.0 118.483 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 3.4 mt-10 -50.77 -53.52 31.06 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 127.353 2.261 . . . . 0.0 112.842 168.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -53.56 2.99 Favored 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 126.102 1.761 . . . . 0.0 110.309 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.552 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.299 . . -110.32 136.54 49.34 Favored 'General case' 0 CA--C 1.452 -2.821 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -163.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.433 HG22 ' HA ' ' A' ' 177' ' ' LYS . 12.1 m -126.16 -179.57 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.407 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 161.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.448 HG22 ' CE ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -85.71 163.41 2.67 Favored 'Isoleucine or valine' 1 N--CA 1.377 -4.091 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.54 -166.312 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -84.5 -41.72 16.25 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 156.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.422 ' H ' HG12 ' A' ' 158' ' ' VAL 0.269 0.4 OUTLIER -169.85 150.87 4.0 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.921 -169.106 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.426 -1.649 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 167.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.413 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.267 32.3 mt-30 . . . . . 0 CA--C 1.51 -0.562 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 56.1 ttp -141.29 116.29 9.86 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-O 122.079 0.942 . . . . 0.0 112.063 -173.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 8.7 mm -80.35 135.95 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.841 0 O-C-N 120.944 -1.098 . . . . 0.0 109.005 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -108.53 131.42 54.85 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 151.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.47 135.81 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.653 HD12 HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -120.82 81.98 1.85 Allowed 'General case' 0 C--N 1.356 0.884 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -170.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -87.03 179.01 1.92 Allowed Pre-proline 0 CA--C 1.509 -0.599 0 O-C-N 118.407 -2.683 . . . . 0.0 117.128 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.503 ' HA ' HD21 ' A' ' 118' ' ' LEU . 68.0 Cg_exo -64.35 137.69 56.97 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 122.702 2.268 . . . . 0.0 111.966 169.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.433 ' HA ' HG22 ' A' ' 157' ' ' VAL . 33.9 ttpt . . . . . 0 CA--C 1.487 -1.455 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 168.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 . . . . . 0 CA--C 1.481 -1.697 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.44 117.48 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.744 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -112.24 173.99 6.1 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 153.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -139.5 159.25 42.59 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 123.34 0.4 . . . . 0.0 109.951 -165.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 tp -137.03 162.8 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 165.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -121.35 153.27 37.98 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.675 0.75 . . . . 0.0 112.225 164.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.595 ' HB3' HG11 ' A' ' 144' ' ' VAL . 43.7 m-85 -130.27 135.04 47.68 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 170.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.444 ' HD3' HH21 ' A' ' 129' ' ' ARG . 22.1 mtm-85 . . . . . 0 N--CA 1.434 -1.249 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 -176.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 47.1 t0 . . . . . 0 N--CA 1.427 -1.589 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.7 -73.29 0.45 Allowed 'General case' 0 CA--C 1.475 -1.904 0 CA-C-N 112.316 -2.22 . . . . 0.0 110.868 -156.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.5 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.331 0.0 OUTLIER -58.13 -15.85 11.11 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 119.038 2.977 . . . . 0.0 119.038 174.66 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.67 -48.94 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-O 122.488 1.137 . . . . 0.0 110.233 162.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -91.72 8.07 38.73 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.7 tt -84.29 -32.23 24.49 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 161.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.467 ' HA ' HG12 ' A' ' 115' ' ' ILE . 57.4 ttt180 -62.84 -44.2 96.77 Favored 'General case' 0 C--N 1.363 1.157 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.636 168.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 69.3 m -60.08 -40.38 89.34 Favored 'General case' 0 C--N 1.378 1.824 0 C-N-CA 118.464 -1.295 . . . . 0.0 113.532 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.588 HD11 HD12 ' A' ' 126' ' ' ILE . 5.9 mt -61.02 -33.68 73.65 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.3 mm -58.52 -48.86 84.24 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.648 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -49.82 -51.26 41.16 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 125.814 1.946 . . . . 0.0 112.255 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -54.75 -50.38 68.56 Favored 'General case' 0 CA--C 1.476 -1.874 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.621 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -61.73 -43.24 99.23 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 178.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.3 -12.63 56.46 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 125.723 1.609 . . . . 0.0 112.358 -171.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.18 -12.7 60.97 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 124.112 0.965 . . . . 0.0 109.759 166.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.82 60.73 1.57 Allowed Glycine 0 CA--C 1.467 -2.908 0 N-CA-C 106.45 -2.66 . . . . 0.0 106.45 175.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -135.93 175.49 9.55 Favored 'General case' 0 CA--C 1.462 -2.42 0 N-CA-C 102.301 -3.222 . . . . 0.0 102.301 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.299 21.0 mtpt -89.21 148.05 23.82 Favored 'General case' 0 N--CA 1.405 -2.682 1 N-CA-C 100.046 -4.057 . . . . 0.0 100.046 165.35 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.469 ' HB1' ' CD2' ' A' ' 114' ' ' LEU . . . -117.26 115.41 25.23 Favored 'General case' 0 N--CA 1.407 -2.585 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 173.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -100.63 116.56 32.84 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.588 HD12 HD11 ' A' ' 114' ' ' LEU . 6.9 mm -85.73 132.23 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 28.1 m -119.65 127.92 53.36 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.429 ' CB ' ' H ' ' A' ' 170' ' ' MET 0.26 0.2 OUTLIER -79.91 154.88 28.03 Favored 'General case' 0 CA--C 1.469 -2.148 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 167.54 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.485 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 47.0 ttp180 -145.18 91.19 2.11 Favored 'General case' 0 N--CA 1.404 -2.759 1 N-CA-C 100.154 -4.017 . . . . 0.0 100.154 178.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 . . . . . 0 N--CA 1.429 -1.502 0 CA-C-N 111.84 -2.437 . . . . 0.0 110.301 -170.92 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.424 -1.762 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.38 -69.37 1.4 Allowed Glycine 0 N--CA 1.412 -2.918 0 O-C-N 124.094 0.871 . . . . 0.0 111.747 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 55.0 mtm -96.56 23.57 6.76 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -163.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -72.92 -55.86 6.0 Favored 'General case' 0 CA--C 1.452 -2.824 0 C-N-CA 116.355 -2.138 . . . . 0.0 113.072 135.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 98' ' ' PHE . 38.9 t -64.69 -67.28 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.445 -3.063 0 O-C-N 126.512 2.382 . . . . 0.0 108.526 -163.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.0 mt -42.02 -54.98 3.34 Favored 'General case' 0 CA--C 1.475 -1.942 0 C-N-CA 127.662 2.385 . . . . 0.0 113.768 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -54.48 -44.76 72.92 Favored 'General case' 0 CA--C 1.484 -1.559 0 C-N-CA 126.619 1.967 . . . . 0.0 114.031 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -83.26 -12.29 56.9 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 118.386 0.539 . . . . 0.0 112.102 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 144' ' ' VAL . 2.3 t -73.87 -44.46 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.683 ' NZ ' HD13 ' A' ' 174' ' ' LEU . 0.8 OUTLIER -61.12 -53.76 53.01 Favored 'General case' 0 CA--C 1.451 -2.859 0 O-C-N 125.366 1.666 . . . . 0.0 112.341 179.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -61.9 -36.75 82.25 Favored 'General case' 0 N--CA 1.403 -2.784 0 C-N-CA 126.807 2.043 . . . . 0.0 109.716 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.426 ' HB3' HD11 ' A' ' 111' ' ' LEU . 24.9 t70 -72.87 -34.1 66.5 Favored 'General case' 0 C--N 1.358 0.948 0 C-N-CA 115.955 -2.298 . . . . 0.0 116.469 169.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.31 0.2 OUTLIER -81.31 -27.91 34.83 Favored 'General case' 0 CA--C 1.464 -2.331 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -176.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -28.42 -25.78 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.531 1 C-N-CA 136.116 5.766 . . . . 0.0 118.885 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 5.4 mt-10 -48.71 -50.44 33.47 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 127.65 2.38 . . . . 0.0 113.234 166.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 tt -114.66 -48.57 2.85 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 126.282 1.833 . . . . 0.0 108.895 -170.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 1.046 ' HB1' HD11 ' A' ' 174' ' ' LEU 0.284 . . -110.82 131.02 55.41 Favored 'General case' 0 CA--C 1.463 -2.398 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -170.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 177' ' ' LYS . 4.2 m -128.12 175.33 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.029 0 N-CA-C 119.929 3.307 . . . . 0.0 119.929 162.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -83.14 162.49 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.388 0 C-N-CA 126.309 1.844 . . . . 0.0 111.054 -159.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.61 -44.19 12.83 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 159.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.491 ' H ' HG12 ' A' ' 158' ' ' VAL 0.265 0.9 OUTLIER -167.92 145.81 4.43 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.621 -171.51 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.478 -1.817 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 172.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.485 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.281 20.2 mt-30 . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 118.585 -0.721 . . . . 0.0 111.014 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.429 ' H ' ' CB ' ' A' ' 128' ' ' LEU . 32.5 ttp -118.43 117.54 29.31 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 119.743 1.156 . . . . 0.0 113.841 -169.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.7 mm -84.37 127.16 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.356 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.51 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -105.53 130.3 53.62 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 101.339 -3.578 . . . . 0.0 101.339 150.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.3 t -91.93 136.32 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 1.046 HD11 ' HB1' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -122.25 147.64 45.97 Favored 'General case' 0 N--CA 1.439 -0.988 1 N-CA-C 99.177 -4.379 . . . . 0.0 99.177 -176.997 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.431 ' H ' HD12 ' A' ' 174' ' ' LEU 0.351 . . -137.19 179.87 1.24 Allowed Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 125.61 1.564 . . . . 0.0 109.426 -173.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.463 ' HA ' HD21 ' A' ' 118' ' ' LEU . 84.2 Cg_exo -63.75 138.16 62.4 Favored 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 122.681 2.254 . . . . 0.0 110.176 167.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.494 ' HA ' HG22 ' A' ' 157' ' ' VAL . 36.6 ttpt . . . . . 0 CA--C 1.488 -1.424 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 165.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 . . . . . 0 CA--C 1.48 -1.73 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.555 HG22 ' HE2' ' A' ' 123' ' ' LYS . 69.0 t -88.49 114.26 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.793 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 174.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -109.9 179.84 4.0 Favored 'General case' 0 CA--C 1.472 -2.057 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 160.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -146.68 158.01 43.82 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.585 -168.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 tp -135.59 163.25 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 169.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -116.46 154.2 30.76 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-O 121.522 0.677 . . . . 0.0 111.496 162.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.663 ' HB3' HG11 ' A' ' 144' ' ' VAL . 40.9 m-85 -130.52 131.4 45.06 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 102.866 -3.012 . . . . 0.0 102.866 166.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 . . . . . 0 N--CA 1.431 -1.376 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -179.452 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . 0.328 52.6 m-20 . . . . . 0 N--CA 1.404 -2.726 0 CA-C-O 122.204 1.002 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -72.83 -72.58 0.24 Allowed 'General case' 0 CA--C 1.479 -1.775 0 CA-C-N 112.579 -2.101 . . . . 0.0 111.138 -163.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.419 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.34 0.0 OUTLIER -58.5 -14.67 8.5 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 119.548 3.166 . . . . 0.0 119.548 176.77 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.08 -45.86 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 C-N-CA 124.092 0.957 . . . . 0.0 110.183 163.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -91.8 4.95 51.67 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 151' ' ' ASP . 6.1 tt -82.97 -32.52 27.03 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 162.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.451 ' HA ' HG12 ' A' ' 115' ' ' ILE . 57.5 ttt180 -63.05 -42.74 99.79 Favored 'General case' 0 C--N 1.362 1.122 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.73 168.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.8 m -59.71 -40.93 89.6 Favored 'General case' 0 C--N 1.377 1.799 0 C-N-CA 118.509 -1.276 . . . . 0.0 113.36 173.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.572 HD11 HD12 ' A' ' 126' ' ' ILE . 7.6 mt -62.6 -32.84 73.91 Favored 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 175.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.0 mm -59.21 -46.67 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.533 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 174.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.57 -47.88 66.54 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 126.04 1.736 . . . . 0.0 113.079 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -54.93 -49.7 70.67 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.455 HD21 ' HA ' ' A' ' 176' ' ' PRO . 0.1 OUTLIER -60.7 -37.28 81.13 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 177.283 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -80.09 -20.82 44.23 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 128.26 2.624 . . . . 0.0 112.46 -173.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -71.97 -15.83 62.07 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 168.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.42 69.58 1.33 Allowed Glycine 0 CA--C 1.463 -3.174 0 N-CA-C 104.182 -3.567 . . . . 0.0 104.182 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -143.62 177.77 8.25 Favored 'General case' 0 CA--C 1.459 -2.529 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 171.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.555 ' HE2' HG22 ' A' ' 93' ' ' VAL . 4.0 tmmm? -116.94 114.08 23.33 Favored 'General case' 0 N--CA 1.393 -3.3 1 N-CA-C 96.929 -5.212 . . . . 0.0 96.929 -170.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -103.42 111.54 24.02 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.361 -1.335 . . . . 0.0 108.237 -162.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -97.6 122.85 41.16 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -164.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.572 HD12 HD11 ' A' ' 114' ' ' LEU . 6.3 mm -85.49 133.46 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.2 m -119.57 123.13 43.17 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . 0.266 0.2 OUTLIER -80.05 150.91 30.18 Favored 'General case' 0 CA--C 1.471 -2.065 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 166.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -145.75 95.39 2.64 Favored 'General case' 0 N--CA 1.403 -2.798 1 N-CA-C 98.712 -4.551 . . . . 0.0 98.712 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 . . . . . 0 N--CA 1.426 -1.665 0 CA-C-N 112.01 -2.359 . . . . 0.0 110.476 -172.107 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.8 mt . . . . . 0 N--CA 1.424 -1.759 0 N-CA-C 111.448 0.166 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.46 -58.83 4.06 Favored Glycine 0 N--CA 1.415 -2.729 0 O-C-N 123.695 0.622 . . . . 0.0 112.07 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 22.4 mtm -92.85 2.96 56.49 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 113.502 0.926 . . . . 0.0 113.502 -160.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.252 1.2 tm-20 -54.74 -71.65 0.08 Allowed 'General case' 0 CA--C 1.449 -2.913 0 C-N-CA 115.083 -2.647 . . . . 0.0 114.767 138.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.663 HG11 ' HB3' ' A' ' 98' ' ' PHE . 39.2 t -56.51 -67.6 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.441 -3.216 0 O-C-N 127.411 2.944 . . . . 0.0 108.973 -161.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.569 HD22 ' HB3' ' A' ' 172' ' ' MET . 62.2 mt -39.09 -53.78 1.79 Allowed 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 128.399 2.68 . . . . 0.0 115.213 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.409 ' HA ' ' CE2' ' A' ' 161' ' ' PHE . 1.7 t-20 -62.82 -36.71 84.09 Favored 'General case' 0 CA--C 1.46 -2.5 0 N-CA-C 117.591 2.441 . . . . 0.0 117.591 175.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -81.09 -14.46 57.73 Favored 'General case' 0 N--CA 1.417 -2.097 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.233 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.5 t -77.58 -43.11 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.48 ' HB2' HG21 ' A' ' 158' ' ' VAL . 30.5 ttmt -52.93 -51.09 62.55 Favored 'General case' 0 CA--C 1.464 -2.364 0 CA-C-O 117.024 -1.465 . . . . 0.0 110.8 169.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.75 -38.2 73.48 Favored 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 124.27 1.028 . . . . 0.0 110.071 -168.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.429 ' HB3' HD11 ' A' ' 111' ' ' LEU . 9.9 t70 -75.65 -28.78 58.88 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 116.673 -2.011 . . . . 0.0 115.414 171.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 156' ' ' ALA 0.286 0.1 OUTLIER -76.39 -33.02 58.88 Favored 'General case' 0 CA--C 1.475 -1.931 0 CA-C-O 116.827 -1.559 . . . . 0.0 113.084 178.107 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -28.26 -26.94 0.0 OUTLIER 'General case' 0 CA--C 1.483 -1.623 1 C-N-CA 135.468 5.507 . . . . 0.0 119.525 -172.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.417 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.7 mt-10 -57.63 -59.0 5.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.155 2.182 . . . . 0.0 112.246 171.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.08 -52.18 3.48 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.39 -1.732 . . . . 0.0 108.186 -167.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.541 ' CB ' HD11 ' A' ' 174' ' ' LEU 0.284 . . -98.85 147.53 24.84 Favored 'General case' 0 CA--C 1.459 -2.533 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.773 -178.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.43 171.41 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.765 0 C-N-CA 114.794 -2.762 . . . . 0.0 116.405 134.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.7 t -82.37 155.88 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.979 0 C-N-CA 128.948 2.899 . . . . 0.0 109.798 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -82.16 -42.93 18.39 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 113.7 -1.591 . . . . 0.0 106.885 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.7 t -152.87 144.97 23.81 Favored 'General case' 0 CA--C 1.464 -2.328 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.409 ' CE2' ' HA ' ' A' ' 146' ' ' ASN . 2.7 t80 . . . . . 0 N--CA 1.421 -1.918 0 N-CA-C 101.087 -3.671 . . . . 0.0 101.087 163.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.251 20.4 mt-30 . . . . . 0 CA--C 1.506 -0.718 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.7 ttp -113.6 113.59 25.28 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 118.742 0.701 . . . . 0.0 110.326 -172.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.1 mm -82.17 124.98 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 O-C-N 121.227 -0.921 . . . . 0.0 108.756 170.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.569 ' HB3' HD22 ' A' ' 145' ' ' LEU . 4.2 ttp -106.92 135.44 48.47 Favored 'General case' 0 CA--C 1.471 -2.081 0 N-CA-C 101.783 -3.414 . . . . 0.0 101.783 156.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 t -98.1 132.94 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 C-N-CA 116.486 -2.085 . . . . 0.0 106.894 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.541 HD11 ' CB ' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -116.47 148.33 40.86 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 100.255 -3.98 . . . . 0.0 100.255 -177.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -142.06 -173.96 0.39 Allowed Pre-proline 0 N--CA 1.431 -1.401 0 CA-C-O 117.009 -1.472 . . . . 0.0 110.242 -172.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.455 ' HA ' HD21 ' A' ' 118' ' ' LEU . 71.3 Cg_exo -68.88 153.67 72.34 Favored 'Trans proline' 0 N--CA 1.437 -1.823 0 C-N-CA 122.564 2.176 . . . . 0.0 108.817 165.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt . . . . . 0 CA--C 1.488 -1.427 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 169.706 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 . . . . . 0 CA--C 1.484 -1.582 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.471 HG22 ' HE3' ' A' ' 123' ' ' LYS . 99.3 t -103.22 120.67 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.627 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 172.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -104.34 171.81 7.14 Favored 'General case' 0 CA--C 1.482 -1.661 0 C-N-CA 117.863 -1.535 . . . . 0.0 107.203 152.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -144.46 154.73 43.23 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.52 165.23 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 171.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -111.32 153.71 25.57 Favored 'General case' 0 CA--C 1.487 -1.456 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.113 166.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.593 ' HB3' HG11 ' A' ' 144' ' ' VAL . 3.1 m-85 -140.24 98.9 3.53 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 172.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 . . . . . 0 N--CA 1.435 -1.193 0 C-N-CA 125.376 1.471 . . . . 0.0 110.013 -173.703 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . 0.263 0.9 OUTLIER . . . . . 0 N--CA 1.404 -2.728 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -87.14 -72.18 0.52 Allowed 'General case' 0 CA--C 1.477 -1.833 0 CA-C-N 113.953 -1.476 . . . . 0.0 109.787 -158.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.453 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.35 0.0 OUTLIER -55.61 -15.36 2.85 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 120.018 3.34 . . . . 0.0 120.018 173.905 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.4 t -61.54 -46.82 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 123.397 1.57 . . . . 0.0 110.373 163.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -89.25 -18.5 26.91 Favored 'General case' 0 CA--C 1.468 -2.207 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.415 ' CB ' ' HA ' ' A' ' 108' ' ' GLN . 2.0 tt -56.23 -38.26 70.83 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.094 154.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.549 ' HA ' HG12 ' A' ' 115' ' ' ILE . 42.3 ttt-85 -60.02 -42.93 95.42 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-N 119.193 0.906 . . . . 0.0 111.756 169.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.0 t -56.78 -45.87 81.87 Favored 'General case' 0 C--N 1.376 1.756 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.272 72.2 mt -67.7 -24.83 65.44 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.549 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.284 7.2 mm -60.74 -51.09 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.437 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 172.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.37 -43.72 68.03 Favored 'General case' 0 N--CA 1.426 -1.63 0 O-C-N 126.196 2.185 . . . . 0.0 109.898 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -60.51 -53.8 53.2 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.682 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -69.49 -21.01 63.72 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 126.926 2.091 . . . . 0.0 114.649 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -73.26 -37.1 66.42 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 127.188 2.195 . . . . 0.0 108.625 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -66.51 -26.98 67.42 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 123.14 0.576 . . . . 0.0 110.669 170.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.45 65.05 1.47 Allowed Glycine 0 CA--C 1.471 -2.662 0 N-CA-C 104.717 -3.353 . . . . 0.0 104.717 -171.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -119.97 166.41 13.38 Favored 'General case' 0 CA--C 1.451 -2.848 1 N-CA-C 97.775 -4.898 . . . . 0.0 97.775 169.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.471 ' HE3' HG22 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -106.63 116.97 32.85 Favored 'General case' 0 N--CA 1.395 -3.202 1 N-CA-C 97.365 -5.05 . . . . 0.0 97.365 171.018 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.27 159.09 21.02 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.416 ' HA ' ' H ' ' A' ' 174' ' ' LEU 0.258 44.8 mtmt -128.08 133.54 49.06 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 163.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.421 HG12 ' SD ' ' A' ' 172' ' ' MET . 6.9 mm -86.3 129.96 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.3 m -100.38 126.16 46.72 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 168.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.614 HD23 HD11 ' A' ' 145' ' ' LEU 0.278 0.3 OUTLIER -80.28 152.1 29.2 Favored 'General case' 0 CA--C 1.462 -2.412 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 164.724 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.517 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 42.3 ttt180 -149.42 96.42 2.5 Favored 'General case' 0 N--CA 1.395 -3.216 1 N-CA-C 96.853 -5.24 . . . . 0.0 96.853 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 . . . . . 0 N--CA 1.427 -1.578 0 CA-C-N 112.227 -2.26 . . . . 0.0 111.542 -172.943 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 67.5 mt . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.47 -61.4 3.9 Favored Glycine 0 N--CA 1.417 -2.627 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.513 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 8.4 ptm -87.51 -3.2 59.0 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -156.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -53.37 57.46 Favored 'General case' 0 CA--C 1.452 -2.813 0 C-N-CA 115.391 -2.524 . . . . 0.0 114.095 152.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.593 HG11 ' HB3' ' A' ' 98' ' ' PHE . 20.1 t -69.62 -64.33 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.445 -3.071 0 O-C-N 126.308 2.255 . . . . 0.0 107.859 -162.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.754 HD13 ' HB2' ' A' ' 172' ' ' MET . 90.2 mt -47.13 -52.98 13.99 Favored 'General case' 0 CA--C 1.477 -1.831 0 C-N-CA 128.274 2.63 . . . . 0.0 114.789 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 142' ' ' MET 0.258 1.5 t30 -62.9 -30.86 71.86 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 174.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -82.83 -14.31 54.58 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.385 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.441 HG12 HD12 ' A' ' 152' ' ' LEU . 2.1 t -76.23 -46.67 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.628 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 177.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.449 ' HE3' ' CG2' ' A' ' 158' ' ' VAL 0.265 25.2 ttmt -49.51 -53.68 22.06 Favored 'General case' 0 CA--C 1.458 -2.56 0 C-N-CA 125.895 1.678 . . . . 0.0 111.539 173.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -37.2 63.69 Favored 'General case' 0 N--CA 1.408 -2.56 0 C-N-CA 126.469 1.907 . . . . 0.0 109.985 -167.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.79 -31.62 66.79 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 116.339 -2.144 . . . . 0.0 114.678 171.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.441 HD12 HG12 ' A' ' 148' ' ' VAL 0.296 0.2 OUTLIER -83.51 -27.48 29.34 Favored 'General case' 0 CA--C 1.46 -2.51 0 CA-C-O 115.702 -2.094 . . . . 0.0 115.326 179.892 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -28.07 -22.31 0.0 OUTLIER 'General case' 0 CA--C 1.483 -1.624 1 C-N-CA 136.163 5.785 . . . . 0.0 119.786 -174.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -50.16 -49.58 51.72 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 126.342 1.857 . . . . 0.0 115.042 162.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -121.6 -52.77 2.01 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 128.06 2.544 . . . . 0.0 107.23 -157.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.682 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.362 . . -112.1 148.16 34.54 Favored 'General case' 0 CA--C 1.452 -2.791 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -176.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -119.93 -178.27 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.459 -2.528 0 C-N-CA 116.128 -2.229 . . . . 0.0 115.672 147.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 160' ' ' SER . 6.0 t -86.64 148.63 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 165.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -82.39 -39.54 22.56 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.532 ' H ' HG12 ' A' ' 158' ' ' VAL . 0.9 OUTLIER -150.61 131.0 13.74 Favored 'General case' 0 CA--C 1.465 -2.316 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -174.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.0 t80 . . . . . 0 N--CA 1.424 -1.755 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 172.001 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.517 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.317 25.6 mt-30 . . . . . 0 N--CA 1.443 -0.781 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.635 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 38.1 ttp -123.0 117.27 25.09 Favored 'General case' 0 C--N 1.364 1.214 0 CA-C-N 118.802 0.728 . . . . 0.0 112.633 -172.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.7 mm -82.19 123.84 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 O-C-N 120.555 -1.341 . . . . 0.0 109.058 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.754 ' HB2' HD13 ' A' ' 145' ' ' LEU . 2.8 tmm? -100.47 128.57 46.49 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 157.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.22 122.94 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.404 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.553 HD13 ' CD1' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -105.2 69.12 0.84 Allowed 'General case' 0 C--N 1.354 0.765 0 C-N-CA 127.654 2.382 . . . . 0.0 117.281 -170.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.335 . . -91.48 172.59 6.37 Favored Pre-proline 0 C--N 1.359 0.99 0 N-CA-C 119.604 3.187 . . . . 0.0 119.604 -171.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -68.85 140.08 45.24 Favored 'Trans proline' 0 CA--C 1.491 -1.661 0 CA-C-N 120.912 1.362 . . . . 0.0 110.922 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp . . . . . 0 CA--C 1.483 -1.597 0 O-C-N 125.0 1.438 . . . . 0.0 107.263 176.772 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 . . . . . 0 CA--C 1.479 -1.755 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.465 HG22 ' HE2' ' A' ' 123' ' ' LYS . 75.3 t -90.2 120.62 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.801 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 161.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -112.09 166.54 11.15 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 150.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -133.94 155.72 49.42 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.002 -164.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 tp -135.72 162.82 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 101.881 -3.377 . . . . 0.0 101.881 166.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -111.15 157.78 19.65 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 119.413 1.006 . . . . 0.0 109.612 163.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.67 ' HB3' HG11 ' A' ' 144' ' ' VAL . 17.1 m-85 -125.74 135.15 51.73 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 166.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mpm_? . . . . . 0 N--CA 1.424 -1.735 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.359 -167.914 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 N--CA 1.425 -1.677 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.9 -71.78 0.31 Allowed 'General case' 0 CA--C 1.481 -1.693 0 C-N-CA 126.265 1.826 . . . . 0.0 109.475 -170.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.325 0.0 OUTLIER -59.32 -15.48 16.36 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 119.487 3.144 . . . . 0.0 119.487 173.517 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.66 -43.56 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 121.556 0.693 . . . . 0.0 109.937 162.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -92.39 7.38 43.21 Favored 'General case' 0 CA--C 1.485 -1.556 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 6.2 tt -85.13 -31.5 23.26 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 104.038 -2.579 . . . . 0.0 104.038 161.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.495 ' HA ' HG12 ' A' ' 115' ' ' ILE . 31.7 ttt180 -62.97 -43.2 99.45 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 122.88 0.472 . . . . 0.0 110.969 168.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.2 t -56.51 -45.26 81.15 Favored 'General case' 0 C--N 1.376 1.732 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.66 -30.23 71.37 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.495 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.8 mm -58.54 -48.49 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.521 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 173.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.1 tpt85 -52.37 -50.29 62.7 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 125.466 1.729 . . . . 0.0 112.391 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -57.58 -44.97 85.75 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.53 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -65.57 -35.39 80.7 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 176.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -77.69 -20.87 52.92 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 127.821 2.448 . . . . 0.0 112.417 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -67.87 -19.91 65.07 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 123.658 0.783 . . . . 0.0 109.422 169.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.45 61.59 1.7 Allowed Glycine 0 CA--C 1.46 -3.357 0 N-CA-C 103.561 -3.816 . . . . 0.0 103.561 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -134.19 175.45 9.49 Favored 'General case' 0 CA--C 1.446 -3.043 1 N-CA-C 99.003 -4.443 . . . . 0.0 99.003 173.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HE2' HG22 ' A' ' 93' ' ' VAL 0.263 17.8 mtpt -89.12 140.19 29.71 Favored 'General case' 0 N--CA 1.396 -3.167 1 N-CA-C 97.55 -4.981 . . . . 0.0 97.55 163.622 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.582 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -84.49 160.34 20.56 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 155.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -142.33 125.87 16.79 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 102.673 -3.084 . . . . 0.0 102.673 167.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.556 HG21 ' HD2' ' A' ' 98' ' ' PHE . 4.0 mm -86.14 122.72 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.41 ' HA ' HD13 ' A' ' 171' ' ' ILE . 11.9 m -92.66 123.0 35.63 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 163.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.803 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.2 OUTLIER -84.11 152.05 24.55 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 165.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.444 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 28.0 ttm180 -152.56 91.5 1.58 Allowed 'General case' 0 N--CA 1.393 -3.281 1 N-CA-C 98.752 -4.536 . . . . 0.0 98.752 -172.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.476 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 93.9 m-85 . . . . . 0 N--CA 1.417 -2.075 0 CA-C-N 112.638 -2.074 . . . . 0.0 107.128 -175.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 66.8 mt . . . . . 0 N--CA 1.421 -1.9 0 CA-C-O 119.822 -0.132 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.803 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -76.57 -59.82 3.17 Favored Glycine 0 CA--C 1.466 -2.982 0 C-N-CA 119.059 -1.543 . . . . 0.0 113.122 -172.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 60.5 mtm -88.02 -0.07 56.58 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -166.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -68.16 -47.7 67.31 Favored 'General case' 0 CA--C 1.457 -2.632 0 C-N-CA 114.73 -2.788 . . . . 0.0 113.33 151.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.67 HG11 ' HB3' ' A' ' 98' ' ' PHE . 31.9 t -70.1 -68.98 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.436 -3.426 0 O-C-N 125.67 1.856 . . . . 0.0 107.343 -163.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.537 HD21 HD12 ' A' ' 128' ' ' LEU . 1.3 mp -48.79 -50.54 33.69 Favored 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 129.217 3.007 . . . . 0.0 113.259 -175.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -61.03 -37.01 81.07 Favored 'General case' 0 CA--C 1.471 -2.061 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -81.02 -14.22 58.11 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.512 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.7 t -76.14 -49.1 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.645 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.281 11.9 ttmt -51.95 -45.84 64.53 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 126.394 1.878 . . . . 0.0 113.096 171.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.57 -36.48 63.07 Favored 'General case' 0 N--CA 1.409 -2.492 0 C-N-CA 124.347 1.059 . . . . 0.0 110.024 -171.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -72.94 -39.72 66.0 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 116.473 -2.091 . . . . 0.0 115.178 169.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.47 HD13 HD11 ' A' ' 174' ' ' LEU 0.306 0.2 OUTLIER -79.61 -20.24 47.32 Favored 'General case' 0 CA--C 1.46 -2.514 0 CA-C-O 116.357 -1.782 . . . . 0.0 115.759 -177.271 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -26.24 -23.79 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.493 1 C-N-CA 135.042 5.337 . . . . 0.0 119.55 175.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 6.0 mt-10 -51.69 -56.54 13.1 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 126.993 2.117 . . . . 0.0 113.21 165.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.3 tt -116.38 -47.42 2.74 Favored 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 126.455 1.902 . . . . 0.0 109.291 -162.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.53 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.352 . . -110.14 143.45 40.21 Favored 'General case' 0 CA--C 1.448 -2.954 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.043 -179.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.8 m -120.46 171.98 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.483 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 140.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.522 HG22 HD23 ' A' ' 174' ' ' LEU . 4.0 t -81.46 151.54 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.931 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 172.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -80.92 -38.35 28.02 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 125.581 1.552 . . . . 0.0 107.005 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.478 ' H ' HG12 ' A' ' 158' ' ' VAL . 5.4 t -118.44 -176.32 3.05 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 145' ' ' LEU . 10.7 t80 . . . . . 0 N--CA 1.42 -1.959 0 N-CA-C 101.111 -3.663 . . . . 0.0 101.111 139.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.444 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.291 36.4 mt-30 . . . . . 0 CA--C 1.495 -1.165 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 60.7 ttp -146.47 120.85 9.63 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 118.933 0.788 . . . . 0.0 110.765 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 127' ' ' THR . 14.4 mm -79.64 126.89 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 O-C-N 120.786 -1.196 . . . . 0.0 108.627 173.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.404 ' SD ' HG11 ' A' ' 158' ' ' VAL . 4.7 ttp -105.5 135.24 47.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 160.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.58 126.39 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 118.299 -1.36 . . . . 0.0 109.68 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.582 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 0.1 OUTLIER -110.78 80.32 1.29 Allowed 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 -168.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.279 . . -85.82 174.91 5.0 Favored Pre-proline 0 CA--C 1.498 -1.032 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -169.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -64.15 141.48 76.34 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 C-N-CA 123.243 2.629 . . . . 0.0 108.263 160.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? . . . . . 0 N--CA 1.431 -1.395 0 O-C-N 124.216 0.947 . . . . 0.0 110.856 -177.857 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 . . . . . 0 N--CA 1.431 -1.411 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.9 t -96.67 115.7 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.792 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 160.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -107.35 175.45 5.49 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 152.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -135.17 155.34 50.85 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 tp -134.66 162.79 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 102.573 -3.121 . . . . 0.0 102.573 164.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -112.31 159.96 18.14 Favored 'General case' 0 CA--C 1.487 -1.465 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.195 161.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.551 ' HB3' HG11 ' A' ' 144' ' ' VAL . 10.8 m-85 -129.31 149.23 51.19 Favored 'General case' 0 CA--C 1.475 -1.924 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 166.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.417 -2.109 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.845 -171.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 N--CA 1.423 -1.818 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -74.92 -72.73 0.28 Allowed 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 125.902 1.681 . . . . 0.0 108.677 -171.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.439 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.328 0.0 OUTLIER -58.57 -12.42 4.04 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 120.417 3.488 . . . . 0.0 120.417 178.494 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.56 -41.82 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 C-N-CA 124.197 0.999 . . . . 0.0 110.184 161.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -92.58 -0.09 57.36 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.418 HD11 ' HB3' ' A' ' 151' ' ' ASP . 5.6 tt -77.52 -35.1 53.75 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 162.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.435 ' HA ' HG12 ' A' ' 115' ' ' ILE . 9.3 ttp180 -60.87 -44.74 96.64 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 125.093 1.357 . . . . 0.0 110.67 171.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.4 m -59.64 -42.18 92.16 Favored 'General case' 0 C--N 1.378 1.831 0 C-N-CA 118.755 -1.178 . . . . 0.0 113.396 174.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.49 HD11 HD12 ' A' ' 126' ' ' ILE . 40.5 mt -62.2 -33.58 74.82 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 176.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.2 mm -55.43 -50.52 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 O-C-N 124.433 1.083 . . . . 0.0 108.37 173.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.9 tpt85 -51.71 -45.73 63.67 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 126.207 1.803 . . . . 0.0 112.783 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -58.08 -51.72 68.54 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.825 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -72.21 -19.61 61.7 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -73.45 -34.51 65.44 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 125.257 1.423 . . . . 0.0 110.294 173.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -67.89 -27.84 67.0 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 169.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.56 61.73 1.68 Allowed Glycine 0 CA--C 1.471 -2.678 0 N-CA-C 105.73 -2.948 . . . . 0.0 105.73 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -122.44 170.55 9.85 Favored 'General case' 0 CA--C 1.461 -2.467 1 N-CA-C 98.541 -4.614 . . . . 0.0 98.541 171.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -105.58 122.94 47.06 Favored 'General case' 0 N--CA 1.401 -2.879 1 N-CA-C 97.079 -5.156 . . . . 0.0 97.079 171.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.03 155.32 22.78 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 114.897 -2.721 . . . . 0.0 103.807 167.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.407 ' HG2' HG13 ' A' ' 173' ' ' VAL . 87.4 mttt -115.71 127.35 55.07 Favored 'General case' 0 CA--C 1.476 -1.899 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 165.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.635 HD11 HD22 ' A' ' 174' ' ' LEU . 3.2 mm -86.65 116.03 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 176.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.3 m -98.13 119.01 36.03 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 172.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.719 HD12 HD11 ' A' ' 145' ' ' LEU 0.287 0.3 OUTLIER -79.95 145.49 32.57 Favored 'General case' 0 CA--C 1.466 -2.263 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 167.844 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -150.46 89.17 1.54 Allowed 'General case' 0 N--CA 1.401 -2.895 1 N-CA-C 96.192 -5.484 . . . . 0.0 96.192 -172.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.548 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 56.0 m-85 . . . . . 0 N--CA 1.417 -2.097 0 N-CA-C 101.37 -3.567 . . . . 0.0 101.37 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.293 89.2 mt . . . . . 0 N--CA 1.407 -2.608 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.566 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -80.85 -58.61 2.62 Favored Glycine 0 N--CA 1.417 -2.61 0 CA-C-N 114.438 -1.255 . . . . 0.0 113.986 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.4 mtm -89.25 1.4 55.76 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -163.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -55.53 -67.71 0.26 Allowed 'General case' 0 CA--C 1.445 -3.063 0 C-N-CA 115.391 -2.524 . . . . 0.0 114.284 140.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 98' ' ' PHE . 22.6 t -59.69 -66.63 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.438 -3.346 0 O-C-N 127.269 2.856 . . . . 0.0 108.336 -158.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.719 HD11 HD12 ' A' ' 128' ' ' LEU . 22.6 mt -45.99 -55.2 7.15 Favored 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 129.0 2.92 . . . . 0.0 115.299 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -62.21 -31.64 72.21 Favored 'General case' 0 CA--C 1.462 -2.429 0 N-CA-C 117.94 2.57 . . . . 0.0 117.94 173.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -82.26 -16.6 48.92 Favored 'General case' 0 N--CA 1.419 -1.991 0 C-N-CA 117.592 -1.643 . . . . 0.0 109.253 173.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.521 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.5 t -72.89 -45.82 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.856 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.547 ' HE3' HG21 ' A' ' 158' ' ' VAL . 35.7 ttmt -50.59 -51.67 46.24 Favored 'General case' 0 CA--C 1.464 -2.359 0 C-N-CA 125.775 1.63 . . . . 0.0 111.863 172.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -70.1 -41.13 74.43 Favored 'General case' 0 N--CA 1.406 -2.66 0 C-N-CA 125.936 1.695 . . . . 0.0 109.275 -168.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.418 ' HB3' HD11 ' A' ' 111' ' ' LEU . 22.9 t70 -74.18 -32.79 63.22 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 116.701 -2.0 . . . . 0.0 115.527 173.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.507 HD12 HG12 ' A' ' 148' ' ' VAL 0.348 0.3 OUTLIER -81.93 -26.2 34.25 Favored 'General case' 0 CA--C 1.461 -2.464 0 CA-C-O 116.409 -1.758 . . . . 0.0 115.128 -178.606 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -25.43 -29.94 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.489 1 C-N-CA 135.02 5.328 . . . . 0.0 119.202 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 5.9 mt-10 -49.24 -50.38 38.86 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 128.413 2.685 . . . . 0.0 113.993 169.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 tt -118.26 -50.62 2.45 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 126.339 1.855 . . . . 0.0 109.881 -164.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.825 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.346 . . -106.58 147.22 29.72 Favored 'General case' 0 CA--C 1.443 -3.17 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 -177.437 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.5 m -118.34 -174.54 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.529 0 C-N-CA 114.841 -2.744 . . . . 0.0 114.321 141.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.547 HG21 ' HE3' ' A' ' 149' ' ' LYS . 2.8 t -88.08 151.02 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.233 0 CA-C-N 111.762 -2.472 . . . . 0.0 105.717 168.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -81.89 -39.59 23.61 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.451 ' H ' HG12 ' A' ' 158' ' ' VAL . 1.1 t -160.69 142.0 12.04 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -171.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.426 -1.632 0 N-CA-C 101.751 -3.426 . . . . 0.0 101.751 169.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 . . . . . 0 N--CA 1.443 -0.777 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 10.7 ttm -121.53 162.6 20.28 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.6 mt -122.02 152.11 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 158.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.1 ttt -122.22 129.33 52.16 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 103.313 -2.847 . . . . 0.0 103.313 162.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.407 HG13 ' HG2' ' A' ' 125' ' ' LYS . 25.7 t -88.5 138.06 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -176.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.651 HD23 HD11 ' A' ' 118' ' ' LEU . 6.0 tp -118.87 90.15 3.27 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 131.104 3.762 . . . . 0.0 121.1 -177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.391 . . -104.9 165.41 13.29 Favored Pre-proline 0 CA--C 1.5 -0.975 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -71.97 141.01 35.9 Favored 'Trans proline' 0 CA--C 1.492 -1.614 0 C-N-CA 121.762 1.641 . . . . 0.0 108.412 -171.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.9 tmmt? . . . . . 0 CA--C 1.488 -1.432 0 O-C-N 125.097 1.498 . . . . 0.0 107.593 -173.136 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 . . . . . 0 CA--C 1.481 -1.7 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.498 HG22 ' HD3' ' A' ' 123' ' ' LYS . 92.2 t -101.07 115.73 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 161.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -99.62 172.52 7.23 Favored 'General case' 0 CA--C 1.476 -1.892 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 157.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -148.08 148.2 30.38 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -172.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.8 tp -131.43 161.06 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 103.733 -2.691 . . . . 0.0 103.733 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -121.88 154.25 37.34 Favored 'General case' 0 CA--C 1.487 -1.48 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.606 163.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.494 ' HB3' HG11 ' A' ' 144' ' ' VAL . 46.4 m-85 -129.62 143.5 50.85 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 170.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 . . . . . 0 N--CA 1.428 -1.543 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 174.273 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 N--CA 1.427 -1.616 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.91 -75.95 0.11 Allowed 'General case' 0 CA--C 1.478 -1.798 0 C-N-CA 126.784 2.034 . . . . 0.0 109.976 -171.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.432 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.331 0.0 OUTLIER -59.49 -12.7 6.73 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 119.967 3.321 . . . . 0.0 119.967 176.622 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.24 -43.74 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 122.126 0.965 . . . . 0.0 110.259 162.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -91.7 -1.09 57.56 Favored 'General case' 0 CA--C 1.475 -1.938 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.411 HD21 HD22 ' A' ' 152' ' ' LEU . 5.3 tt -79.05 -31.15 44.41 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 161.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.513 ' HA ' HG12 ' A' ' 115' ' ' ILE . 19.1 ttt85 -62.69 -43.0 99.92 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 118.599 -0.715 . . . . 0.0 111.276 169.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.4 m -61.69 -40.97 96.87 Favored 'General case' 0 C--N 1.378 1.819 0 C-N-CA 118.899 -1.12 . . . . 0.0 113.51 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.476 HD11 HD23 ' A' ' 174' ' ' LEU 0.282 55.8 tp -69.09 -26.97 65.2 Favored 'General case' 0 N--CA 1.402 -2.863 0 C-N-CA 126.259 1.823 . . . . 0.0 113.952 178.073 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.513 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.268 5.6 mm -60.96 -49.37 84.98 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.873 0 CA-C-N 121.061 1.755 . . . . 0.0 109.232 170.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -52.39 -48.36 65.69 Favored 'General case' 0 CA--C 1.494 -1.203 0 C-N-CA 126.662 1.985 . . . . 0.0 108.899 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -56.5 -53.85 52.67 Favored 'General case' 0 CA--C 1.483 -1.622 0 C-N-CA 125.992 1.717 . . . . 0.0 111.647 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.515 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -58.4 -39.83 80.76 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 179.243 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.23 -14.06 44.99 Favored 'General case' 0 C--N 1.364 1.212 0 C-N-CA 125.767 1.627 . . . . 0.0 111.746 -170.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -65.79 -25.06 67.08 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 123.073 0.549 . . . . 0.0 109.839 161.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.2 59.47 1.3 Allowed Glycine 0 CA--C 1.468 -2.865 0 N-CA-C 103.917 -3.673 . . . . 0.0 103.917 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -125.32 164.5 20.24 Favored 'General case' 0 CA--C 1.461 -2.475 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 171.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.498 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -102.02 121.54 42.36 Favored 'General case' 0 N--CA 1.407 -2.601 1 N-CA-C 99.869 -4.122 . . . . 0.0 99.869 179.401 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.446 ' HB1' ' CD1' ' A' ' 114' ' ' LEU . . . -111.91 115.91 29.76 Favored 'General case' 0 N--CA 1.415 -2.191 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.597 -166.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -98.3 119.68 37.39 Favored 'General case' 0 CA--C 1.491 -1.315 0 O-C-N 121.683 -0.636 . . . . 0.0 110.717 -167.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.9 mm -83.82 134.8 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.442 ' HA ' HD13 ' A' ' 171' ' ' ILE . 18.6 m -116.64 115.38 25.58 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 165.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.78 HD21 ' HA2' ' A' ' 141' ' ' GLY . 18.4 tp -82.4 148.49 28.19 Favored 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 167.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -150.58 103.82 3.15 Favored 'General case' 0 N--CA 1.405 -2.708 1 N-CA-C 98.44 -4.652 . . . . 0.0 98.44 -174.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.572 ' CZ ' HD23 ' A' ' 128' ' ' LEU 0.294 77.6 m-85 . . . . . 0 CA--C 1.491 -1.321 0 C-N-CA 127.345 2.258 . . . . 0.0 109.227 -175.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 91.3 mt . . . . . 0 CA--C 1.478 -1.8 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.78 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -77.0 -57.99 3.56 Favored Glycine 0 CA--C 1.458 -3.515 0 C-N-CA 119.07 -1.538 . . . . 0.0 113.733 -171.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 53.0 mtm -84.54 -0.04 51.62 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 118.123 -0.942 . . . . 0.0 113.09 -166.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.303 2.8 tp10 -64.34 -69.73 0.27 Allowed 'General case' 0 CA--C 1.454 -2.741 0 C-N-CA 115.051 -2.659 . . . . 0.0 115.012 143.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.494 HG11 ' HB3' ' A' ' 98' ' ' PHE . 39.7 t -59.98 -66.9 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.455 -2.707 0 O-C-N 126.261 2.226 . . . . 0.0 110.884 -161.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.452 HD11 HD22 ' A' ' 128' ' ' LEU . 73.4 mt -46.07 -55.06 7.45 Favored 'General case' 0 CA--C 1.483 -1.631 0 C-N-CA 128.421 2.688 . . . . 0.0 114.278 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -60.7 -30.01 69.68 Favored 'General case' 0 CA--C 1.469 -2.151 0 N-CA-C 118.609 2.818 . . . . 0.0 118.609 172.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -82.24 -15.35 53.37 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 119.41 -0.329 . . . . 0.0 110.486 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.463 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.9 t -77.37 -42.47 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.666 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 175.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.481 ' HB2' HG21 ' A' ' 158' ' ' VAL 0.254 31.8 ttmt -53.91 -52.04 61.83 Favored 'General case' 0 CA--C 1.462 -2.409 0 C-N-CA 124.943 1.297 . . . . 0.0 111.014 171.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -71.88 -38.75 69.95 Favored 'General case' 0 N--CA 1.407 -2.608 0 C-N-CA 125.674 1.59 . . . . 0.0 109.18 -169.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -74.53 -24.84 59.03 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 116.802 -1.959 . . . . 0.0 114.647 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 156' ' ' ALA 0.267 0.1 OUTLIER -78.92 -37.06 40.78 Favored 'General case' 0 CA--C 1.477 -1.833 0 CA-C-O 116.26 -1.829 . . . . 0.0 111.958 177.259 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 156' ' ' ALA . 3.9 tt0 -27.63 -29.89 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.488 1 C-N-CA 135.8 5.64 . . . . 0.0 119.642 -167.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 7.4 mt-10 -51.51 -47.69 63.19 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 128.789 2.836 . . . . 0.0 114.202 170.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -120.24 -51.88 2.19 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 128.167 2.587 . . . . 0.0 105.47 -159.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.875 ' HB1' HD11 ' A' ' 174' ' ' LEU 0.302 . . -107.43 144.62 34.09 Favored 'General case' 0 CA--C 1.452 -2.806 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.303 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.3 m -122.71 164.72 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.762 0 C-N-CA 115.286 -2.565 . . . . 0.0 117.604 141.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 5.8 t -81.82 149.37 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.257 0 CA-C-N 110.067 -3.242 . . . . 0.0 105.968 -174.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.76 -38.9 27.81 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -173.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -162.65 144.82 10.64 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -173.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.424 -1.74 0 N-CA-C 100.64 -3.837 . . . . 0.0 100.64 165.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.444 -0.74 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 39.4 ttm -118.49 123.89 46.25 Favored 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 124.008 0.923 . . . . 0.0 108.815 -174.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 127' ' ' THR . 15.5 mm -83.72 130.05 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 O-C-N 120.968 -1.082 . . . . 0.0 108.282 168.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.41 ' HB3' HD22 ' A' ' 145' ' ' LEU . 3.2 ttp -110.87 124.31 51.81 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 160.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 43.5 t -88.46 136.51 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.875 HD11 ' HB1' ' A' ' 156' ' ' ALA . 0.5 OUTLIER -124.77 150.31 46.41 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 101.673 -3.455 . . . . 0.0 101.673 -178.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.337 . . -142.26 -179.32 0.94 Allowed Pre-proline 0 CA--C 1.488 -1.42 0 CA-C-O 117.824 -1.084 . . . . 0.0 109.458 -173.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.434 ' HA ' HD21 ' A' ' 118' ' ' LEU . 82.2 Cg_exo -64.93 143.4 79.23 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 122.82 2.347 . . . . 0.0 110.111 165.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp . . . . . 0 N--CA 1.434 -1.226 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 165.855 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 . . . . . 0 CA--C 1.478 -1.807 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.62 113.61 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.813 0 C-N-CA 118.641 -1.224 . . . . 0.0 108.028 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -107.76 177.42 4.83 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 155.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -139.14 155.8 47.6 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.482 -172.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 tp -133.85 161.37 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 102.936 -2.987 . . . . 0.0 102.936 166.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -118.16 159.36 23.42 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 118.845 0.748 . . . . 0.0 110.175 165.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.654 ' HB3' HG11 ' A' ' 144' ' ' VAL . 25.8 m-85 -138.51 114.01 9.68 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 167.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.433 -1.286 0 C-N-CA 124.586 1.154 . . . . 0.0 107.911 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 N--CA 1.425 -1.686 0 CA-C-O 122.648 1.214 . . . . 0.0 107.857 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -86.78 -71.08 0.57 Allowed 'General case' 0 CA--C 1.469 -2.154 0 CA-C-N 112.351 -2.204 . . . . 0.0 111.235 -157.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.471 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.323 0.0 OUTLIER -58.94 -14.97 10.7 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 118.844 2.905 . . . . 0.0 118.844 174.057 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.03 -45.71 98.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 C-N-CA 124.711 1.205 . . . . 0.0 110.328 161.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -92.84 5.15 52.29 Favored 'General case' 0 CA--C 1.485 -1.541 0 O-C-N 120.137 -1.602 . . . . 0.0 115.269 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -83.45 -32.42 26.05 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 163.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.451 ' HA ' HG12 ' A' ' 115' ' ' ILE . 14.9 ttp180 -60.33 -45.62 92.77 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 125.158 1.383 . . . . 0.0 110.122 169.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.5 t -62.0 -40.38 95.45 Favored 'General case' 0 C--N 1.374 1.66 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.5 tp -67.42 -33.4 75.08 Favored 'General case' 0 N--CA 1.401 -2.88 0 C-N-CA 125.069 1.348 . . . . 0.0 113.844 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.255 8.5 mm -54.16 -50.75 53.12 Favored 'Isoleucine or valine' 0 C--N 1.373 1.626 0 CA-C-N 119.155 0.889 . . . . 0.0 108.865 170.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -50.01 -45.22 51.64 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 128.172 2.589 . . . . 0.0 112.464 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -55.94 -54.23 47.23 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 172.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.598 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -68.51 -22.35 64.53 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -76.27 -31.4 58.26 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 126.188 1.795 . . . . 0.0 111.175 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.1 -23.93 63.13 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 168.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.28 72.89 1.24 Allowed Glycine 0 CA--C 1.466 -2.977 0 N-CA-C 104.778 -3.329 . . . . 0.0 104.778 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -129.14 170.91 12.95 Favored 'General case' 0 CA--C 1.449 -2.941 1 N-CA-C 97.749 -4.908 . . . . 0.0 97.749 169.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -104.72 113.48 27.1 Favored 'General case' 0 N--CA 1.393 -3.314 1 N-CA-C 96.395 -5.409 . . . . 0.0 96.395 171.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.99 154.34 25.75 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.406 ' HG2' HG13 ' A' ' 173' ' ' VAL 0.279 78.9 mttt -118.68 137.53 53.25 Favored 'General case' 0 CA--C 1.469 -2.145 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 164.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.5 mm -83.18 128.92 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.37 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.8 m -110.78 122.84 48.84 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 169.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.542 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.2 OUTLIER -87.01 155.37 20.19 Favored 'General case' 0 CA--C 1.469 -2.163 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 170.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -151.57 89.69 1.51 Allowed 'General case' 0 N--CA 1.405 -2.694 0 N-CA-C 101.042 -3.688 . . . . 0.0 101.042 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.488 ' CE1' HD22 ' A' ' 128' ' ' LEU . 95.8 m-85 . . . . . 0 N--CA 1.425 -1.707 0 CA-C-N 112.237 -2.256 . . . . 0.0 109.394 -171.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.2 mt . . . . . 1 N--CA 1.376 -4.163 1 N-CA-C 95.296 -5.816 . . . . 0.0 95.296 . . . . . . . . . 2 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.542 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . 147.88 -71.01 0.33 Allowed Glycine 1 N--CA 1.381 -4.999 2 C-N-CA 134.887 5.994 . . . . 0.0 108.273 165.293 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.4 mtm -94.86 20.07 9.32 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -169.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -50.68 25.45 Favored 'General case' 0 CA--C 1.454 -2.726 0 C-N-CA 116.4 -2.12 . . . . 0.0 113.939 137.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.654 HG11 ' HB3' ' A' ' 98' ' ' PHE . 15.0 t -68.14 -67.72 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.429 -3.696 0 O-C-N 126.469 2.356 . . . . 0.0 106.669 -159.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.13 -55.93 3.05 Favored 'General case' 0 CA--C 1.459 -2.546 0 C-N-CA 129.336 3.055 . . . . 0.0 111.843 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -57.51 -37.96 73.83 Favored 'General case' 0 CA--C 1.469 -2.157 0 C-N-CA 125.924 1.689 . . . . 0.0 114.509 178.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -81.82 -14.83 55.8 Favored 'General case' 0 N--CA 1.421 -1.925 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.747 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.4 t -75.25 -47.77 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.764 0 CA-C-O 116.082 -1.913 . . . . 0.0 106.55 176.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.608 ' HB2' HG21 ' A' ' 158' ' ' VAL . 3.5 ttmt -53.06 -51.87 60.37 Favored 'General case' 0 CA--C 1.46 -2.482 0 CA-C-O 117.248 -1.358 . . . . 0.0 110.02 171.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.41 -36.53 81.46 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 119.01 0.823 . . . . 0.0 110.268 -168.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.29 -43.97 66.09 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 116.519 -2.072 . . . . 0.0 116.414 168.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.275 0.2 OUTLIER -82.74 -18.17 41.68 Favored 'General case' 0 CA--C 1.468 -2.176 0 N-CA-C 118.064 2.616 . . . . 0.0 118.064 -172.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -25.64 -31.52 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.154 1 C-N-CA 133.571 4.748 . . . . 0.0 118.321 170.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.4 mt-10 -53.11 -50.32 64.7 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 127.998 2.519 . . . . 0.0 114.459 173.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 tt -112.4 -51.76 2.82 Favored 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 125.97 1.708 . . . . 0.0 110.633 -169.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.598 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.308 . . -104.46 144.46 31.63 Favored 'General case' 0 CA--C 1.452 -2.821 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.572 -174.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 177' ' ' LYS . 5.5 m -128.84 159.78 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.484 0 N-CA-C 120.196 3.406 . . . . 0.0 120.196 148.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 149' ' ' LYS . 2.4 t -83.2 150.07 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.257 0 CA-C-N 110.108 -3.224 . . . . 0.0 105.841 -173.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -81.54 -39.75 24.18 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 -174.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.4 t -159.78 157.74 29.89 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -169.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 146' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.423 -1.819 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.322 28.5 mt-30 . . . . . 0 CA--C 1.504 -0.817 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 41.9 ttm -129.98 121.11 25.9 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 121.275 0.559 . . . . 0.0 110.519 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.7 mm -83.02 128.99 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 O-C-N 120.895 -1.128 . . . . 0.0 109.205 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.408 ' SD ' ' CE1' ' A' ' 161' ' ' PHE . 1.2 ttp -108.48 140.61 41.56 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 156.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.406 HG13 ' HG2' ' A' ' 125' ' ' LYS . 11.1 t -106.17 135.79 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 C-N-CA 119.171 -1.011 . . . . 0.0 109.299 -173.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.558 HD13 HG22 ' A' ' 158' ' ' VAL . 6.1 tp -118.81 96.66 5.35 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 121.626 3.935 . . . . 0.0 121.626 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.271 . . -98.84 168.43 9.75 Favored Pre-proline 0 CA--C 1.499 -0.987 0 N-CA-C 115.899 1.815 . . . . 0.0 115.899 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -75.7 135.6 18.02 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 N-CA-C 105.039 -2.716 . . . . 0.0 105.039 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.427 ' HB3' HG13 ' A' ' 157' ' ' VAL . 58.2 pttt . . . . . 0 CA--C 1.49 -1.349 0 C-N-CA 118.365 -1.334 . . . . 0.0 113.905 -175.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 . . . . . 0 CA--C 1.482 -1.667 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.8 t -97.84 120.34 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -102.5 168.5 9.25 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 152.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -136.12 153.27 51.35 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 tp -135.57 160.93 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 167.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -117.27 155.73 28.99 Favored 'General case' 0 CA--C 1.484 -1.564 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.831 165.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.55 ' HB3' HG11 ' A' ' 144' ' ' VAL . 5.4 m-85 -139.44 139.29 37.03 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 . . . . . 0 N--CA 1.434 -1.253 0 CA-C-O 118.804 -0.617 . . . . 0.0 109.403 -172.01 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 N--CA 1.423 -1.811 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.413 ' HD1' ' CE1' ' A' ' 98' ' ' PHE . 0.6 OUTLIER -82.51 -64.02 1.26 Allowed 'General case' 0 CA--C 1.483 -1.609 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.138 -163.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.336 0.0 OUTLIER -61.44 -12.02 12.88 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 119.649 3.203 . . . . 0.0 119.649 176.738 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.84 -44.69 99.73 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-O 122.649 1.214 . . . . 0.0 110.06 161.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -91.46 0.55 57.49 Favored 'General case' 0 CA--C 1.477 -1.842 0 O-C-N 120.454 -1.404 . . . . 0.0 114.568 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.3 tt -81.66 -28.76 33.43 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 162.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.494 ' HA ' HG12 ' A' ' 115' ' ' ILE . 40.7 ttt180 -62.08 -42.78 99.56 Favored 'General case' 0 C--N 1.361 1.096 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.874 166.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.4 m -58.88 -43.6 90.96 Favored 'General case' 0 C--N 1.38 1.9 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 173.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.261 83.5 mt -64.75 -29.2 70.17 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 116.585 2.069 . . . . 0.0 116.585 175.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.254 10.1 mm -58.32 -51.44 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.899 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.085 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -50.08 -46.88 53.78 Favored 'General case' 0 CA--C 1.49 -1.329 0 O-C-N 126.025 2.078 . . . . 0.0 109.713 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -59.76 -56.05 26.65 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.221 1.008 . . . . 0.0 112.848 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -69.71 -27.66 65.18 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 125.737 1.615 . . . . 0.0 115.321 -177.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -82.8 -17.34 44.43 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 124.113 0.965 . . . . 0.0 111.81 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -71.44 -29.64 65.12 Favored 'General case' 0 C--N 1.362 1.137 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 162.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.02 65.27 1.13 Allowed Glycine 0 CA--C 1.474 -2.483 0 N-CA-C 105.558 -3.017 . . . . 0.0 105.558 -172.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -125.82 173.34 9.15 Favored 'General case' 0 CA--C 1.456 -2.654 1 N-CA-C 98.069 -4.789 . . . . 0.0 98.069 169.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.12 122.49 47.39 Favored 'General case' 0 N--CA 1.4 -2.974 1 N-CA-C 96.983 -5.191 . . . . 0.0 96.983 170.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.98 160.11 21.1 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 115.453 -2.499 . . . . 0.0 105.708 169.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -133.26 119.3 19.62 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 171.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.585 HD11 HD22 ' A' ' 174' ' ' LEU . 7.8 mm -85.23 134.65 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.704 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.1 m -122.89 127.97 49.7 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.481 HD21 ' HA2' ' A' ' 141' ' ' GLY 0.377 0.3 OUTLIER -80.47 153.35 28.24 Favored 'General case' 0 CA--C 1.454 -2.739 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 169.365 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 33.4 ttt-85 -148.34 91.77 1.95 Allowed 'General case' 0 N--CA 1.399 -3.024 1 N-CA-C 98.556 -4.609 . . . . 0.0 98.556 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 . . . . . 0 N--CA 1.423 -1.82 0 CA-C-N 110.598 -3.001 . . . . 0.0 109.139 -172.882 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.416 -2.125 0 N-CA-C 110.753 -0.091 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.481 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -72.85 -63.55 2.82 Favored Glycine 0 N--CA 1.414 -2.809 0 O-C-N 123.814 0.696 . . . . 0.0 112.404 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 71.5 mtm -96.84 24.75 5.83 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -163.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -62.3 1.49 Allowed 'General case' 0 CA--C 1.453 -2.756 0 C-N-CA 116.171 -2.212 . . . . 0.0 115.545 129.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.55 HG11 ' HB3' ' A' ' 98' ' ' PHE . 25.7 t -61.94 -64.03 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.45 -2.899 0 O-C-N 126.435 2.335 . . . . 0.0 109.183 -161.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' A' ' 172' ' ' MET . 72.9 mt -43.45 -55.53 4.12 Favored 'General case' 0 CA--C 1.48 -1.725 0 C-N-CA 127.686 2.395 . . . . 0.0 114.086 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -57.62 -37.6 73.56 Favored 'General case' 0 CA--C 1.476 -1.879 0 C-N-CA 126.484 1.914 . . . . 0.0 114.298 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.419 ' HA ' ' HB2' ' A' ' 150' ' ' ASP . 15.9 ttp180 -80.2 -15.29 57.36 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 118.845 0.748 . . . . 0.0 111.38 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.8 t -74.2 -47.07 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.724 0 CA-C-O 116.459 -1.734 . . . . 0.0 106.732 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.607 ' HE3' HG21 ' A' ' 158' ' ' VAL . 10.7 ttmt -55.41 -50.78 68.87 Favored 'General case' 0 CA--C 1.461 -2.452 0 CA-C-O 116.776 -1.583 . . . . 0.0 110.011 172.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.419 ' HB2' ' HA ' ' A' ' 147' ' ' ARG . 69.0 m-20 -66.84 -36.45 82.36 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 119.733 1.151 . . . . 0.0 110.105 -168.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.09 -48.44 57.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 116.662 -2.015 . . . . 0.0 115.843 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.465 HD13 HD21 ' A' ' 174' ' ' LEU 0.283 0.2 OUTLIER -82.62 -14.38 54.86 Favored 'General case' 0 CA--C 1.468 -2.198 0 N-CA-C 118.147 2.647 . . . . 0.0 118.147 -172.297 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -25.4 -30.23 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.263 1 C-N-CA 133.815 4.846 . . . . 0.0 118.358 168.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.3 mt-10 -51.36 -54.37 27.09 Favored 'General case' 0 CA--C 1.488 -1.428 0 C-N-CA 127.478 2.311 . . . . 0.0 113.828 170.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.3 tt -113.52 -53.7 2.67 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.38 -1.736 . . . . 0.0 110.491 -168.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.519 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.301 . . -92.65 148.22 22.24 Favored 'General case' 0 CA--C 1.455 -2.698 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -177.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.486 ' HB ' ' H ' ' A' ' 158' ' ' VAL . 15.2 m -118.58 -164.04 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.452 -2.821 0 C-N-CA 114.305 -2.958 . . . . 0.0 111.155 141.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.607 HG21 ' HE3' ' A' ' 149' ' ' LYS 0.277 2.9 t -111.93 163.01 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.394 0 C-N-CA 129.649 3.18 . . . . 0.0 107.364 -177.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -84.09 -43.97 14.53 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 172.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.584 ' H ' HG12 ' A' ' 158' ' ' VAL . 0.9 OUTLIER -157.29 147.62 21.01 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.557 -167.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.416 -2.15 0 N-CA-C 103.136 -2.912 . . . . 0.0 103.136 165.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.508 -0.671 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 31.2 ttm -123.36 121.86 36.85 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -170.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.46 HG21 HD13 ' A' ' 171' ' ' ILE . 1.4 mt -87.69 142.69 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 C-N-CA 117.755 -1.578 . . . . 0.0 110.758 173.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.458 ' HB3' HD22 ' A' ' 145' ' ' LEU . 3.3 tmm? -111.72 126.84 55.47 Favored 'General case' 0 CA--C 1.476 -1.894 0 N-CA-C 101.421 -3.548 . . . . 0.0 101.421 153.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.2 t -91.72 124.93 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 118.052 -1.459 . . . . 0.0 108.45 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.585 HD22 HD11 ' A' ' 126' ' ' ILE . 14.5 tp -104.45 84.43 2.19 Favored 'General case' 0 C--N 1.349 0.556 0 N-CA-C 121.324 3.824 . . . . 0.0 121.324 -174.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.438 . . -108.08 155.66 39.7 Favored Pre-proline 0 C--N 1.359 0.993 0 N-CA-C 119.279 3.066 . . . . 0.0 119.279 -173.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.25 139.39 45.84 Favored 'Trans proline' 0 CA--C 1.491 -1.653 0 C-N-CA 123.398 2.732 . . . . 0.0 111.545 -160.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp . . . . . 0 CA--C 1.49 -1.343 0 O-C-N 125.053 1.471 . . . . 0.0 107.614 -178.777 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 . . . . . 0 CA--C 1.484 -1.571 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.463 HG22 ' HD2' ' A' ' 123' ' ' LYS . 72.3 t -90.18 112.43 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -104.58 177.08 4.95 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 157.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -140.01 156.29 46.69 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 117.778 0.263 . . . . 0.0 111.265 -170.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 tp -139.51 168.64 18.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 164.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -118.23 155.61 30.24 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 118.833 0.742 . . . . 0.0 111.178 162.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.548 ' HD2' HG21 ' A' ' 126' ' ' ILE . 19.2 m-85 -124.55 153.49 42.04 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 168.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 . . . . . 0 N--CA 1.437 -1.101 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.828 -170.501 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 N--CA 1.424 -1.731 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.23 -71.69 0.29 Allowed 'General case' 0 CA--C 1.479 -1.76 0 C-N-CA 126.556 1.942 . . . . 0.0 109.112 -171.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.461 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.368 0.0 OUTLIER -57.49 -15.42 6.97 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 119.8 3.259 . . . . 0.0 119.8 175.11 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.97 -43.89 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-O 122.014 0.911 . . . . 0.0 110.699 163.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -91.96 2.78 56.33 Favored 'General case' 0 CA--C 1.477 -1.858 0 O-C-N 120.495 -1.378 . . . . 0.0 114.367 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 151' ' ' ASP . 5.9 tt -81.82 -31.96 31.47 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 163.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.438 ' HA ' HG12 ' A' ' 115' ' ' ILE . 50.4 ttt180 -62.64 -42.36 99.55 Favored 'General case' 0 C--N 1.361 1.095 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.696 168.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.7 m -60.18 -38.0 81.91 Favored 'General case' 0 C--N 1.377 1.798 0 C-N-CA 118.632 -1.227 . . . . 0.0 113.728 172.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.469 HD22 ' HB3' ' A' ' 124' ' ' ALA . 72.2 mt -65.24 -33.74 76.71 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 175.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 112' ' ' ARG . 4.7 mm -58.62 -46.11 90.34 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.391 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -49.64 -48.78 49.02 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 128.14 2.576 . . . . 0.0 111.835 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -58.97 -50.05 75.56 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.739 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -70.56 -21.77 62.66 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 124.853 1.261 . . . . 0.0 114.119 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -71.29 -37.7 71.84 Favored 'General case' 0 CA--C 1.491 -1.327 0 C-N-CA 126.75 2.02 . . . . 0.0 109.694 173.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -66.82 -28.22 68.19 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-O 120.732 0.301 . . . . 0.0 110.61 170.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.53 71.47 1.29 Allowed Glycine 0 CA--C 1.473 -2.579 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 -175.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -134.79 174.45 10.56 Favored 'General case' 0 N--CA 1.414 -2.229 1 N-CA-C 99.97 -4.085 . . . . 0.0 99.97 170.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HD2' HG22 ' A' ' 93' ' ' VAL 0.333 13.9 mtmt -88.5 147.47 24.63 Favored 'General case' 0 CA--C 1.459 -2.554 0 N-CA-C 100.918 -3.734 . . . . 0.0 100.918 159.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.469 ' HB3' HD22 ' A' ' 114' ' ' LEU . . . -116.18 123.2 47.21 Favored 'General case' 0 CA--C 1.457 -2.623 0 C-N-CA 115.331 -2.548 . . . . 0.0 106.091 160.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -99.75 117.67 34.59 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -168.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.548 HG21 ' HD2' ' A' ' 98' ' ' PHE . 3.6 mm -85.29 125.92 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.445 ' HA ' HD13 ' A' ' 171' ' ' ILE . 17.3 m -97.79 117.22 31.61 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 159.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.767 HD13 ' CZ ' ' A' ' 130' ' ' PHE . 0.5 OUTLIER -76.46 148.5 37.2 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 166.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.518 ' H ' HD23 ' A' ' 128' ' ' LEU . 24.4 ttt180 -151.14 92.61 1.82 Allowed 'General case' 0 N--CA 1.402 -2.837 1 N-CA-C 97.009 -5.182 . . . . 0.0 97.009 -167.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.767 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 90.5 m-85 . . . . . 0 N--CA 1.418 -2.031 0 N-CA-C 101.423 -3.547 . . . . 0.0 101.423 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.411 HG22 ' CD1' ' A' ' 130' ' ' PHE . 16.6 mt . . . . . 1 N--CA 1.367 -4.623 1 N-CA-C 94.153 -6.24 . . . . 0.0 94.153 . . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.404 ' HA2' ' CD1' ' A' ' 128' ' ' LEU . . . 157.7 -89.67 0.11 Allowed Glycine 0 N--CA 1.412 -2.943 1 CA-C-N 107.883 -4.235 . . . . 0.0 108.857 -174.147 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.541 ' HG2' ' CE1' ' A' ' 161' ' ' PHE 0.254 75.0 mtp -90.09 5.16 47.96 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 128.779 2.832 . . . . 0.0 113.876 -168.394 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.251 2.3 tp10 -75.48 -45.67 37.06 Favored 'General case' 0 CA--C 1.433 -3.529 0 C-N-CA 116.111 -2.236 . . . . 0.0 111.823 151.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 98' ' ' PHE . 38.5 t -68.51 -74.9 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.444 -3.113 0 O-C-N 126.693 2.495 . . . . 0.0 107.539 -161.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.579 ' CD2' HD12 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -51.46 -47.4 63.12 Favored 'General case' 0 CA--C 1.481 -1.675 0 C-N-CA 129.908 3.283 . . . . 0.0 112.102 -177.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.253 1.5 t30 -64.98 -32.31 73.97 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -81.39 -15.58 54.78 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.363 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.48 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.7 t -74.78 -46.42 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.885 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.47 ' CE ' ' HB ' ' A' ' 158' ' ' VAL 0.303 19.7 ttmt -51.27 -48.48 62.19 Favored 'General case' 0 CA--C 1.472 -2.051 0 C-N-CA 126.781 2.032 . . . . 0.0 113.424 172.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.89 -39.65 61.36 Favored 'General case' 0 N--CA 1.408 -2.554 0 C-N-CA 127.238 2.215 . . . . 0.0 109.577 -171.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.413 ' HB3' HD11 ' A' ' 111' ' ' LEU . 14.2 t70 -75.24 -25.06 57.8 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 116.623 -2.031 . . . . 0.0 115.0 170.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.415 HD11 ' HA ' ' A' ' 115' ' ' ILE 0.307 0.2 OUTLIER -79.44 -31.55 42.56 Favored 'General case' 0 CA--C 1.466 -2.252 0 CA-C-O 116.152 -1.88 . . . . 0.0 112.223 178.192 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -30.57 -17.88 0.0 OUTLIER 'General case' 0 C--N 1.371 1.526 1 C-N-CA 135.237 5.415 . . . . 0.0 120.336 -175.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 4.4 mt-10 -53.58 -58.41 7.28 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 126.379 1.872 . . . . 0.0 111.378 163.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.58 -54.09 2.73 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 126.002 1.721 . . . . 0.0 109.286 -172.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.739 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.307 . . -110.67 140.16 45.28 Favored 'General case' 0 CA--C 1.459 -2.557 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.652 -164.344 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.8 m -126.73 166.87 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.527 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 144.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 174' ' ' LEU 0.305 70.2 t -74.54 146.83 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.874 0 CA-C-N 111.121 -2.763 . . . . 0.0 107.349 176.137 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.46 -41.42 16.62 Favored 'General case' 0 CA--C 1.473 -2.016 0 CA-C-N 110.895 -2.866 . . . . 0.0 105.695 -170.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -160.18 140.15 11.41 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 -169.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.541 ' CE1' ' HG2' ' A' ' 142' ' ' MET . 1.8 t80 . . . . . 0 N--CA 1.425 -1.689 0 N-CA-C 100.373 -3.936 . . . . 0.0 100.373 170.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.264 18.3 mt-30 . . . . . 0 CA--C 1.506 -0.749 0 CA-C-O 119.78 -0.152 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 46.6 ttm -124.41 119.12 28.29 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 127' ' ' THR . 16.0 mm -81.9 136.57 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 O-C-N 120.624 -1.297 . . . . 0.0 108.299 171.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.448 ' HG2' HG13 ' A' ' 158' ' ' VAL . 6.5 tmm? -124.23 133.8 53.42 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 102.78 -3.045 . . . . 0.0 102.78 156.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.58 135.29 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 106.833 -1.544 . . . . 0.0 106.833 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -115.69 141.81 47.58 Favored 'General case' 0 C--N 1.362 1.142 1 N-CA-C 99.577 -4.231 . . . . 0.0 99.577 -179.74 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.353 . . -147.71 -179.97 1.06 Allowed Pre-proline 0 CA--C 1.494 -1.211 0 CA-C-N 120.024 1.283 . . . . 0.0 112.517 -168.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -68.91 137.69 38.63 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 121.109 1.206 . . . . 0.0 109.673 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp . . . . . 0 CA--C 1.488 -1.43 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.439 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 . . . . . 0 CA--C 1.483 -1.607 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.533 HG22 ' HD3' ' A' ' 123' ' ' LYS . 88.1 t -102.49 118.12 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 163.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -103.19 175.12 5.58 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 159.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -145.97 153.33 40.67 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 tp -134.38 164.0 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -119.5 153.13 35.8 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.349 161.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.516 ' HB3' HG11 ' A' ' 144' ' ' VAL . 40.1 m-85 -127.85 164.01 23.16 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 171.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.419 -2.019 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -170.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 CA--C 1.475 -1.916 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -84.92 -65.11 1.05 Allowed 'General case' 0 CA--C 1.481 -1.704 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.519 -164.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.461 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.324 0.0 OUTLIER -62.29 -9.37 7.81 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 178.051 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 64.7 t -60.67 -46.9 95.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 122.359 1.076 . . . . 0.0 109.864 158.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -90.83 -3.21 57.56 Favored 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.443 HD23 HD11 ' A' ' 115' ' ' ILE . 4.5 tt -77.44 -32.16 54.35 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 162.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.471 ' HA ' HG12 ' A' ' 115' ' ' ILE . 41.7 ttt180 -61.94 -42.41 99.07 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.041 169.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.5 m -59.56 -43.61 93.51 Favored 'General case' 0 C--N 1.38 1.902 0 C-N-CA 118.44 -1.304 . . . . 0.0 113.975 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.538 ' O ' HD12 ' A' ' 118' ' ' LEU 0.263 47.4 mt -64.03 -30.56 71.63 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 175.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.265 4.0 mm -61.98 -47.73 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.92 0 CA-C-N 119.936 1.243 . . . . 0.0 108.699 177.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -54.0 -43.16 69.82 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 125.765 1.915 . . . . 0.0 110.214 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -59.72 -51.65 68.87 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.78 0.832 . . . . 0.0 112.542 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 156' ' ' ALA . 1.8 mt -71.98 -19.57 61.86 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 126.466 1.906 . . . . 0.0 114.452 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -73.14 -35.4 66.5 Favored 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 125.978 1.711 . . . . 0.0 110.122 171.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -68.25 -23.79 64.83 Favored 'General case' 0 C--N 1.36 1.063 0 C-N-CA 122.575 0.35 . . . . 0.0 110.144 168.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.63 69.31 1.38 Allowed Glycine 0 CA--C 1.466 -2.99 0 N-CA-C 104.762 -3.335 . . . . 0.0 104.762 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -123.38 165.11 17.57 Favored 'General case' 0 CA--C 1.458 -2.573 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.533 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -101.66 107.36 18.58 Favored 'General case' 0 N--CA 1.404 -2.735 1 N-CA-C 98.762 -4.533 . . . . 0.0 98.762 178.123 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.71 122.38 41.87 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -174.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -95.77 122.1 38.2 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -173.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.9 mm -83.57 131.65 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.451 ' HA ' HD13 ' A' ' 171' ' ' ILE . 23.4 m -116.7 116.54 27.72 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 167.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.876 HD21 ' HA2' ' A' ' 141' ' ' GLY . 17.5 tp -77.95 151.69 33.56 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 169.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -150.23 96.75 2.46 Favored 'General case' 0 N--CA 1.407 -2.611 1 N-CA-C 100.054 -4.054 . . . . 0.0 100.054 -175.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.527 ' CE2' HD23 ' A' ' 128' ' ' LEU 0.267 68.4 m-85 . . . . . 0 N--CA 1.428 -1.559 0 CA-C-N 111.739 -2.482 . . . . 0.0 109.72 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.252 53.1 mt . . . . . 0 N--CA 1.424 -1.743 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.876 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -72.49 -60.05 4.22 Favored Glycine 0 N--CA 1.408 -3.181 0 N-CA-C 115.241 0.856 . . . . 0.0 115.241 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 7.6 ptt? -87.4 0.89 54.82 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 118.569 -0.729 . . . . 0.0 112.932 -160.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.255 0.6 OUTLIER -59.4 -60.81 3.26 Favored 'General case' 0 CA--C 1.461 -2.466 0 C-N-CA 114.94 -2.704 . . . . 0.0 114.987 146.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' A' ' 98' ' ' PHE . 34.0 t -64.7 -64.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.927 0 O-C-N 125.956 2.035 . . . . 0.0 109.433 -164.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.435 HD11 HD22 ' A' ' 128' ' ' LEU . 49.4 mt -44.88 -54.31 6.59 Favored 'General case' 0 CA--C 1.488 -1.405 0 C-N-CA 128.242 2.617 . . . . 0.0 113.891 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.8 t30 -63.6 -30.93 71.97 Favored 'General case' 0 CA--C 1.465 -2.304 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 174.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -80.82 -14.86 57.67 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.354 173.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.449 HG21 ' CE2' ' A' ' 98' ' ' PHE . 2.0 t -76.59 -45.29 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.802 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 174.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.493 ' HB2' HG21 ' A' ' 158' ' ' VAL . 33.6 ttmt -54.42 -51.33 65.26 Favored 'General case' 0 CA--C 1.462 -2.417 0 CA-C-O 117.368 -1.301 . . . . 0.0 111.238 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.13 -40.09 75.05 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 125.477 1.511 . . . . 0.0 108.857 -169.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.421 ' HB3' HD11 ' A' ' 111' ' ' LEU . 24.3 t70 -74.94 -23.2 58.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 116.366 -2.134 . . . . 0.0 115.206 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.413 HD22 HD21 ' A' ' 111' ' ' LEU 0.271 0.1 OUTLIER -81.85 -36.32 28.41 Favored 'General case' 0 CA--C 1.476 -1.872 0 CA-C-O 116.939 -1.505 . . . . 0.0 111.86 179.035 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -27.91 -32.3 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.664 1 C-N-CA 135.614 5.566 . . . . 0.0 119.142 -168.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 6.3 mt-10 -51.2 -47.2 62.31 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 128.914 2.886 . . . . 0.0 114.126 172.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.424 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 3.1 tm? -116.84 -51.61 2.56 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 128.384 2.673 . . . . 0.0 107.258 -161.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.315 . . -114.41 143.6 44.66 Favored 'General case' 0 CA--C 1.462 -2.421 0 CA-C-O 117.788 -1.101 . . . . 0.0 109.815 -175.27 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.5 m -129.54 164.47 32.04 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.125 0 N-CA-C 120.717 3.599 . . . . 0.0 120.717 148.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.4 t -80.49 147.73 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.957 0 CA-C-N 110.877 -2.874 . . . . 0.0 108.207 -176.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -82.37 -39.4 22.8 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.426 -1.715 . . . . 0.0 106.419 -172.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -151.6 142.36 22.84 Favored 'General case' 0 CA--C 1.464 -2.346 0 N-CA-C 104.805 -2.295 . . . . 0.0 104.805 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.6 t80 . . . . . 0 N--CA 1.42 -1.969 0 N-CA-C 100.757 -3.794 . . . . 0.0 100.757 163.807 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.269 29.9 mt-30 . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.469 ' H ' ' HB3' ' A' ' 128' ' ' LEU . 23.8 ttm -122.96 122.78 39.39 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -176.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 127' ' ' THR . 19.3 mm -82.81 124.79 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 171.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.1 ttp -108.42 130.39 55.23 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 103.166 -2.901 . . . . 0.0 103.166 160.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 32.8 t -96.43 137.49 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 118.873 -1.131 . . . . 0.0 108.42 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.795 HD11 ' HB1' ' A' ' 156' ' ' ALA . 1.1 tp -128.88 144.32 51.14 Favored 'General case' 0 C--N 1.362 1.149 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 -174.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.361 . . -148.5 175.02 2.96 Favored Pre-proline 0 CA--C 1.493 -1.241 0 CA-C-O 117.501 -1.238 . . . . 0.0 110.216 -169.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -73.53 144.92 36.8 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 CA-C-N 121.621 1.614 . . . . 0.0 108.022 -177.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt . . . . . 0 CA--C 1.487 -1.473 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 176.265 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 . . . . . 0 CA--C 1.486 -1.511 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.3 t -92.3 115.21 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.558 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -108.46 178.97 4.33 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.569 154.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -142.53 157.07 45.12 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 -171.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 tp -140.31 166.75 19.34 Favored 'Isoleucine or valine' 0 C--N 1.356 0.848 0 N-CA-C 102.544 -3.132 . . . . 0.0 102.544 164.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -116.17 158.69 22.87 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-N 118.943 0.792 . . . . 0.0 111.021 166.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.587 ' HB3' HG11 ' A' ' 144' ' ' VAL . 2.4 m-85 -149.46 99.84 2.94 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 . . . . . 0 N--CA 1.436 -1.175 0 C-N-CA 125.573 1.549 . . . . 0.0 109.541 -177.053 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 . . . . . 0 N--CA 1.425 -1.681 0 CA-C-O 122.569 1.176 . . . . 0.0 108.019 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -88.81 -69.93 0.68 Allowed 'General case' 0 CA--C 1.473 -1.992 0 CA-C-N 112.611 -2.086 . . . . 0.0 111.316 -158.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.485 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.35 0.0 OUTLIER -56.02 -18.56 9.79 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 118.783 2.883 . . . . 0.0 118.783 172.504 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.59 -49.65 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 CA-C-O 122.391 1.091 . . . . 0.0 110.091 163.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -91.54 9.08 33.54 Favored 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 7.1 tt -85.03 -32.67 22.78 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 163.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.468 ' HA ' HG12 ' A' ' 115' ' ' ILE . 55.2 ttt180 -62.27 -42.89 99.73 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 118.807 -0.616 . . . . 0.0 110.928 167.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 t -54.46 -45.88 73.21 Favored 'General case' 0 C--N 1.379 1.862 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 171.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 118' ' ' LEU . 46.4 mt -63.35 -34.36 77.55 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 117.608 2.447 . . . . 0.0 117.608 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.468 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.9 mm -55.99 -48.57 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 O-C-N 124.3 1.0 . . . . 0.0 108.899 173.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -51.6 -45.62 63.26 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 126.033 1.733 . . . . 0.0 113.402 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -57.49 -50.58 72.58 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' A' ' 156' ' ' ALA . 1.8 mt -72.61 -21.18 61.16 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 125.304 1.442 . . . . 0.0 113.902 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -75.13 -33.22 61.53 Favored 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 125.671 1.588 . . . . 0.0 110.391 173.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -68.91 -26.31 65.03 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 167.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.46 78.24 1.22 Allowed Glycine 0 CA--C 1.47 -2.778 0 N-CA-C 106.338 -2.705 . . . . 0.0 106.338 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -134.31 168.3 19.14 Favored 'General case' 0 CA--C 1.465 -2.318 1 N-CA-C 99.902 -4.111 . . . . 0.0 99.902 168.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.317 0.0 OUTLIER -88.29 121.14 30.35 Favored 'General case' 0 CA--C 1.457 -2.631 1 N-CA-C 99.719 -4.178 . . . . 0.0 99.719 156.903 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.53 123.38 33.58 Favored 'General case' 0 N--CA 1.41 -2.443 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 166.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.459 ' HG2' HG13 ' A' ' 173' ' ' VAL . 36.2 mtmt -102.18 125.27 48.83 Favored 'General case' 0 CA--C 1.469 -2.149 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -175.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.421 HD12 HD11 ' A' ' 114' ' ' LEU . 6.3 mm -86.16 125.29 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.43 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.2 m -103.31 121.62 43.11 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.704 HD23 HD11 ' A' ' 145' ' ' LEU 0.313 0.2 OUTLIER -81.0 150.53 28.86 Favored 'General case' 0 CA--C 1.456 -2.655 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 166.597 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -147.25 89.23 1.77 Allowed 'General case' 0 N--CA 1.402 -2.838 1 N-CA-C 98.645 -4.576 . . . . 0.0 98.645 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 . . . . . 0 CA--C 1.487 -1.457 0 CA-C-N 111.259 -2.7 . . . . 0.0 109.877 -166.655 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.426 -1.632 0 N-CA-C 111.424 0.157 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.81 -65.19 2.18 Favored Glycine 0 N--CA 1.419 -2.458 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 75.0 mtm -93.04 11.75 26.48 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -159.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -72.75 -53.38 11.77 Favored 'General case' 0 CA--C 1.444 -3.1 0 C-N-CA 117.155 -1.818 . . . . 0.0 113.153 143.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.587 HG11 ' HB3' ' A' ' 98' ' ' PHE . 31.2 t -67.71 -66.94 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.446 -3.019 0 O-C-N 126.539 2.399 . . . . 0.0 107.681 -160.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.704 HD11 HD23 ' A' ' 128' ' ' LEU . 97.3 mt -46.97 -49.7 20.28 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 128.563 2.745 . . . . 0.0 115.387 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -59.34 -38.96 81.69 Favored 'General case' 0 CA--C 1.477 -1.833 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 172.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -80.65 -14.75 57.89 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.614 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.447 HG23 ' HA ' ' A' ' 145' ' ' LEU . 1.8 t -76.53 -47.91 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.69 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.288 12.7 ttmt -55.0 -43.46 73.61 Favored 'General case' 0 CA--C 1.466 -2.286 0 C-N-CA 126.015 1.726 . . . . 0.0 113.128 172.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -40.11 65.3 Favored 'General case' 0 N--CA 1.41 -2.452 0 C-N-CA 124.162 0.985 . . . . 0.0 109.446 -174.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -73.93 -26.3 60.43 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 116.579 -2.049 . . . . 0.0 115.569 170.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.271 0.2 OUTLIER -80.9 -32.42 34.79 Favored 'General case' 0 CA--C 1.47 -2.101 0 CA-C-O 116.749 -1.596 . . . . 0.0 112.223 -178.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -28.8 -23.52 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.69 1 C-N-CA 135.528 5.531 . . . . 0.0 119.987 -174.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -53.33 -56.75 14.16 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 126.557 1.943 . . . . 0.0 111.989 167.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.3 tt -107.94 -52.25 2.79 Favored 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 126.557 1.943 . . . . 0.0 108.529 -167.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.62 ' CB ' HD11 ' A' ' 174' ' ' LEU 0.294 . . -110.5 138.37 46.98 Favored 'General case' 0 CA--C 1.467 -2.241 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.505 -173.295 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 177' ' ' LYS . 29.7 m -128.84 165.12 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.496 0 N-CA-C 119.445 3.128 . . . . 0.0 119.445 147.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 160' ' ' SER . 3.9 t -76.96 153.02 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.135 0 CA-C-N 111.562 -2.563 . . . . 0.0 108.401 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.06 -39.91 25.0 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.753 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.548 ' H ' HG12 ' A' ' 158' ' ' VAL . 0.9 OUTLIER -150.38 137.2 19.17 Favored 'General case' 0 CA--C 1.469 -2.171 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 -173.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.7 t80 . . . . . 0 CA--C 1.486 -1.517 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 177.171 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 N--CA 1.446 -0.668 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 28.8 ttp -115.8 118.86 34.2 Favored 'General case' 0 C--N 1.369 1.444 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -165.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.4 mm -84.03 124.46 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 O-C-N 120.633 -1.292 . . . . 0.0 108.964 170.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.598 ' HB2' HD13 ' A' ' 145' ' ' LEU . 1.9 tmm? -99.44 133.0 44.39 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 102.141 -3.281 . . . . 0.0 102.141 156.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.459 HG13 ' HG2' ' A' ' 125' ' ' LYS . 24.7 t -99.94 116.22 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 118.239 -1.384 . . . . 0.0 110.013 -177.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.62 HD11 ' CB ' ' A' ' 156' ' ' ALA . 1.1 tp -106.57 107.62 18.73 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 -167.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.265 . . -99.57 179.54 1.02 Allowed Pre-proline 0 CA--C 1.486 -1.481 0 C-N-CA 124.746 1.218 . . . . 0.0 113.169 -176.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -70.55 153.76 65.1 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 N-CA-C 106.483 -2.161 . . . . 0.0 106.483 170.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.579 ' HA ' HG22 ' A' ' 157' ' ' VAL . 33.2 ttmt . . . . . 0 N--CA 1.431 -1.383 0 CA-C-O 123.026 1.393 . . . . 0.0 110.125 -175.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 . . . . . 0 CA--C 1.484 -1.566 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.4 t -105.17 125.12 60.29 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.485 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 167.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -106.8 174.9 5.69 Favored 'General case' 0 CA--C 1.464 -2.339 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 155.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -149.28 147.05 27.9 Favored 'General case' 0 N--CA 1.422 -1.851 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.084 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tp -129.21 162.42 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -122.22 152.78 39.64 Favored 'General case' 0 CA--C 1.488 -1.44 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.979 162.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.526 ' HB3' HG11 ' A' ' 144' ' ' VAL . 45.2 m-85 -130.82 146.73 52.34 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 172.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.435 -1.181 0 C-N-CA 123.644 0.777 . . . . 0.0 109.08 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 N--CA 1.424 -1.736 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -73.79 -75.59 0.15 Allowed 'General case' 0 CA--C 1.48 -1.714 0 CA-C-N 113.189 -1.823 . . . . 0.0 108.678 -169.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.431 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.341 0.0 OUTLIER -58.66 -12.31 4.04 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 120.389 3.477 . . . . 0.0 120.389 178.427 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 66.3 t -61.75 -45.42 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 CA-C-O 122.59 1.186 . . . . 0.0 110.041 161.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -91.77 -0.83 57.56 Favored 'General case' 0 CA--C 1.472 -2.037 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.491 HD12 HG13 ' A' ' 148' ' ' VAL . 5.8 tt -78.17 -32.0 49.94 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 161.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.457 ' HA ' HG12 ' A' ' 115' ' ' ILE . 48.4 ttt180 -63.52 -43.13 98.06 Favored 'General case' 0 C--N 1.361 1.077 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.242 170.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.8 m -63.92 -37.28 86.82 Favored 'General case' 0 C--N 1.377 1.788 0 C-N-CA 118.648 -1.221 . . . . 0.0 113.405 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.493 HD11 HD23 ' A' ' 174' ' ' LEU 0.296 60.5 tp -70.38 -28.96 65.5 Favored 'General case' 0 N--CA 1.401 -2.91 0 C-N-CA 125.196 1.398 . . . . 0.0 113.782 176.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 112' ' ' ARG . 9.7 mm -58.57 -50.59 78.44 Favored 'Isoleucine or valine' 0 C--N 1.371 1.507 0 CA-C-N 120.982 1.719 . . . . 0.0 110.033 170.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -52.28 -44.11 64.79 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 127.697 2.399 . . . . 0.0 110.668 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -59.44 -50.03 75.51 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 125.868 1.667 . . . . 0.0 113.04 176.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.444 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -60.46 -34.6 74.25 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 175.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -72.1 -32.12 66.7 Favored 'General case' 0 CA--C 1.487 -1.468 0 C-N-CA 127.745 2.418 . . . . 0.0 110.913 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -64.81 -20.83 66.6 Favored 'General case' 0 C--N 1.36 1.023 0 C-N-CA 123.117 0.567 . . . . 0.0 111.444 171.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 89.17 59.51 1.56 Allowed Glycine 0 CA--C 1.466 -2.987 0 N-CA-C 104.65 -3.38 . . . . 0.0 104.65 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -123.21 167.73 13.35 Favored 'General case' 0 CA--C 1.455 -2.701 0 N-CA-C 102.121 -3.289 . . . . 0.0 102.121 171.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -94.22 132.32 38.9 Favored 'General case' 0 CA--C 1.449 -2.942 0 N-CA-C 100.602 -3.851 . . . . 0.0 100.602 162.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.422 ' HB1' HD12 ' A' ' 114' ' ' LEU . . . -108.22 115.71 30.63 Favored 'General case' 0 N--CA 1.4 -2.942 0 C-N-CA 117.378 -1.729 . . . . 0.0 106.593 -173.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -97.26 122.39 40.23 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.543 0.687 . . . . 0.0 109.275 -163.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.6 mm -84.16 133.78 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.961 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.9 m -112.97 117.12 31.19 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 165.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.849 HD21 ' HA2' ' A' ' 141' ' ' GLY . 10.4 tp -79.61 153.17 29.61 Favored 'General case' 0 CA--C 1.474 -1.97 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 167.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -152.88 94.12 1.83 Allowed 'General case' 0 N--CA 1.4 -2.938 0 N-CA-C 101.335 -3.579 . . . . 0.0 101.335 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.545 ' CZ ' HD23 ' A' ' 128' ' ' LEU 0.311 94.2 m-85 . . . . . 0 N--CA 1.429 -1.521 0 C-N-CA 126.909 2.084 . . . . 0.0 109.837 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 51.9 mt . . . . . 0 N--CA 1.423 -1.798 0 CA-C-O 120.43 0.157 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.849 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -70.58 -60.42 4.68 Favored Glycine 0 CA--C 1.458 -3.53 0 O-C-N 123.951 0.782 . . . . 0.0 113.958 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.424 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 5.1 ptt? -85.78 -1.52 57.31 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -159.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.271 2.0 tp10 -61.44 -60.67 3.36 Favored 'General case' 0 CA--C 1.454 -2.747 0 C-N-CA 114.412 -2.915 . . . . 0.0 115.394 146.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 98' ' ' PHE . 23.1 t -66.26 -65.87 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.91 0 O-C-N 125.978 2.049 . . . . 0.0 108.7 -162.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.521 HD11 HD22 ' A' ' 128' ' ' LEU . 32.0 mt -44.85 -54.17 6.7 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 129.131 2.972 . . . . 0.0 114.316 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 142' ' ' MET . 2.0 t-20 -66.16 -28.34 68.71 Favored 'General case' 0 CA--C 1.468 -2.179 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 174.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -80.35 -15.34 57.09 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.222 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.491 HG13 HD12 ' A' ' 111' ' ' LEU . 1.9 t -76.08 -44.47 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.78 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.448 ' HE3' HG21 ' A' ' 158' ' ' VAL 0.262 34.9 ttmt -52.98 -48.76 67.19 Favored 'General case' 0 CA--C 1.47 -2.105 0 C-N-CA 125.435 1.494 . . . . 0.0 112.435 171.326 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.1 -38.39 66.38 Favored 'General case' 0 N--CA 1.409 -2.508 0 C-N-CA 125.853 1.661 . . . . 0.0 109.605 -171.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.53 -25.72 54.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 116.462 -2.095 . . . . 0.0 115.201 170.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 156' ' ' ALA 0.298 0.1 OUTLIER -77.31 -30.84 54.29 Favored 'General case' 0 CA--C 1.473 -1.992 0 CA-C-O 116.525 -1.703 . . . . 0.0 113.451 176.069 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -29.44 -20.13 0.0 OUTLIER 'General case' 0 C--N 1.366 1.302 1 C-N-CA 134.91 5.284 . . . . 0.0 120.224 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.2 mt-10 -56.29 -62.15 1.91 Allowed 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 127.187 2.195 . . . . 0.0 111.178 167.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.13 -56.01 2.78 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 125.542 1.537 . . . . 0.0 109.048 -174.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.466 ' CB ' HD11 ' A' ' 174' ' ' LEU 0.269 . . -98.48 146.66 25.53 Favored 'General case' 0 CA--C 1.449 -2.934 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.877 -165.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.2 m -121.59 172.2 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.454 -2.723 0 C-N-CA 114.626 -2.83 . . . . 0.0 116.384 134.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 3.8 t -82.31 153.4 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.831 0 CA-C-N 111.784 -2.462 . . . . 0.0 107.157 -177.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -81.59 -41.22 21.86 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 -173.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.4 t -157.29 143.15 17.61 Favored 'General case' 0 CA--C 1.46 -2.499 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.0 t80 . . . . . 0 N--CA 1.423 -1.806 0 N-CA-C 100.996 -3.705 . . . . 0.0 100.996 167.158 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.503 -0.844 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.471 ' H ' ' HB3' ' A' ' 128' ' ' LEU . 48.5 ttm -122.11 122.86 40.21 Favored 'General case' 0 CA--C 1.481 -1.678 0 C-N-CA 123.547 0.739 . . . . 0.0 109.405 -176.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.2 mm -81.99 122.7 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 166.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 3.9 ttp -106.55 129.53 54.48 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 101.582 -3.488 . . . . 0.0 101.582 161.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.5 t -94.48 137.33 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -117.81 150.22 39.51 Favored 'General case' 0 C--N 1.357 0.898 1 N-CA-C 99.516 -4.253 . . . . 0.0 99.516 -179.987 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.26 . . -140.75 -178.92 0.89 Allowed Pre-proline 0 N--CA 1.432 -1.341 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.681 -170.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.416 ' HA ' HD21 ' A' ' 118' ' ' LEU . 75.8 Cg_exo -69.85 147.45 62.31 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 C-N-CA 122.395 2.063 . . . . 0.0 109.055 165.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt . . . . . 0 CA--C 1.491 -1.297 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 171.147 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 . . . . . 0 CA--C 1.48 -1.749 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.498 HG22 ' HE2' ' A' ' 123' ' ' LYS . 46.4 t -105.99 121.82 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.874 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 162.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -101.51 175.94 5.4 Favored 'General case' 0 CA--C 1.468 -2.2 0 C-N-CA 116.427 -2.109 . . . . 0.0 105.715 166.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -143.08 152.67 42.11 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 tp -135.03 163.03 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 103.028 -2.953 . . . . 0.0 103.028 167.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -115.13 153.33 30.98 Favored 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.567 162.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.515 ' HB3' HG11 ' A' ' 144' ' ' VAL . 32.6 m-85 -125.42 131.33 52.94 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 169.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 . . . . . 0 N--CA 1.433 -1.304 0 C-N-CA 124.258 1.023 . . . . 0.0 109.254 -175.421 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . 0.363 53.9 m-20 . . . . . 0 N--CA 1.4 -2.957 0 CA-C-O 121.644 0.735 . . . . 0.0 109.766 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.58 -72.1 0.33 Allowed 'General case' 0 CA--C 1.484 -1.595 0 CA-C-N 112.747 -2.024 . . . . 0.0 109.799 -161.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.444 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.293 0.0 OUTLIER -63.52 -7.68 7.58 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 119.843 3.275 . . . . 0.0 119.843 178.122 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.67 -42.95 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 C-N-CA 124.015 0.926 . . . . 0.0 110.025 160.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.0 mmtt -92.74 -5.06 52.04 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.2 tt -75.69 -35.02 60.44 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 163.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.459 ' HA ' HG12 ' A' ' 115' ' ' ILE . 7.4 ttm180 -59.31 -43.65 92.61 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 125.541 1.536 . . . . 0.0 111.318 169.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.8 t -56.79 -46.59 81.46 Favored 'General case' 0 C--N 1.377 1.791 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.267 71.0 mt -67.56 -28.12 67.51 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 176.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.7 mm -59.78 -49.5 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.709 0 CA-C-N 119.696 1.134 . . . . 0.0 108.83 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -51.57 -44.58 62.79 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 127.26 2.224 . . . . 0.0 110.1 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -63.65 -52.77 59.27 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.686 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -67.91 -29.48 68.58 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 125.605 1.562 . . . . 0.0 114.699 -178.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.62 -29.53 51.84 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 124.03 0.932 . . . . 0.0 110.842 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -82.84 -1.2 51.29 Favored 'General case' 0 C--N 1.362 1.139 0 CA-C-O 120.602 0.239 . . . . 0.0 110.829 170.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.05 70.16 1.32 Allowed Glycine 0 CA--C 1.473 -2.59 0 C-N-CA 126.242 1.877 . . . . 0.0 109.552 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -128.04 163.64 24.13 Favored 'General case' 0 CA--C 1.449 -2.92 0 N-CA-C 100.786 -3.783 . . . . 0.0 100.786 169.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.498 ' HE2' HG22 ' A' ' 93' ' ' VAL . 1.6 tmmm? -98.33 106.03 18.26 Favored 'General case' 0 N--CA 1.399 -3.019 1 N-CA-C 97.706 -4.924 . . . . 0.0 97.706 172.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.08 155.25 21.59 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -133.47 129.95 37.91 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 119.844 -1.785 . . . . 0.0 106.552 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.8 mm -82.74 137.98 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.576 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.1 m -117.14 127.51 54.2 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 167.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.663 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.1 OUTLIER -85.83 153.56 22.17 Favored 'General case' 0 CA--C 1.462 -2.441 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 166.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.439 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 56.9 ttt180 -151.36 91.41 1.67 Allowed 'General case' 0 N--CA 1.394 -3.231 1 N-CA-C 98.715 -4.55 . . . . 0.0 98.715 -175.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.552 ' CE1' HD22 ' A' ' 128' ' ' LEU 0.253 97.6 m-85 . . . . . 0 N--CA 1.428 -1.554 0 CA-C-N 111.438 -2.619 . . . . 0.0 105.903 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.29 68.1 mt . . . . . 0 N--CA 1.406 -2.639 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.663 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -78.34 -66.6 1.72 Allowed Glycine 0 N--CA 1.408 -3.193 0 CA-C-N 114.372 -1.285 . . . . 0.0 113.574 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 43.0 mtt -95.03 24.21 5.04 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -164.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -71.14 -55.7 7.63 Favored 'General case' 0 CA--C 1.456 -2.652 0 C-N-CA 116.521 -2.072 . . . . 0.0 114.644 133.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 98' ' ' PHE . 19.4 t -64.16 -66.25 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.443 -3.172 0 O-C-N 126.174 2.171 . . . . 0.0 107.834 -163.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 172' ' ' MET . 71.1 mt -44.61 -55.03 5.53 Favored 'General case' 0 CA--C 1.478 -1.824 0 O-C-N 126.543 2.402 . . . . 0.0 114.108 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.36 -36.79 74.01 Favored 'General case' 0 CA--C 1.473 -2.017 0 C-N-CA 127.229 2.212 . . . . 0.0 114.062 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.407 ' HA ' ' HB2' ' A' ' 150' ' ' ASP . 18.5 ttp180 -81.71 -14.98 55.84 Favored 'General case' 0 N--CA 1.418 -2.027 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.882 175.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.472 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.4 t -75.24 -43.64 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.74 0 CA-C-O 116.374 -1.774 . . . . 0.0 107.355 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.517 ' HB2' HG21 ' A' ' 158' ' ' VAL . 14.6 ttmt -53.49 -52.88 58.14 Favored 'General case' 0 CA--C 1.463 -2.394 0 CA-C-O 116.861 -1.542 . . . . 0.0 109.884 169.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.407 ' HB2' ' HA ' ' A' ' 147' ' ' ARG . 66.8 m-20 -67.52 -39.43 85.08 Favored 'General case' 0 N--CA 1.41 -2.47 0 C-N-CA 124.22 1.008 . . . . 0.0 109.359 -166.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -75.05 -26.84 59.71 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 116.447 -2.101 . . . . 0.0 116.075 171.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.281 0.1 OUTLIER -81.1 -33.28 33.42 Favored 'General case' 0 CA--C 1.479 -1.757 0 CA-C-O 117.107 -1.425 . . . . 0.0 113.605 -178.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -28.5 -29.94 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.478 1 C-N-CA 135.555 5.542 . . . . 0.0 118.85 -173.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.9 -53.32 54.22 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 127.509 2.324 . . . . 0.0 113.204 173.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.17 -53.53 2.67 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.624 -165.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.686 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.308 . . -96.81 153.08 18.09 Favored 'General case' 0 CA--C 1.447 -2.998 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 -177.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.417 ' HB ' ' H ' ' A' ' 158' ' ' VAL . 20.3 m -116.39 -164.14 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.905 0 C-N-CA 113.69 -3.204 . . . . 0.0 112.343 138.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 160' ' ' SER 0.28 3.3 t -108.35 162.93 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.559 0 C-N-CA 128.326 2.65 . . . . 0.0 106.009 177.239 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.44 -42.49 18.47 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.548 ' H ' HG12 ' A' ' 158' ' ' VAL . 1.2 t -162.02 154.2 19.34 Favored 'General case' 0 CA--C 1.479 -1.777 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.581 -166.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.42 -1.939 0 N-CA-C 103.366 -2.827 . . . . 0.0 103.366 168.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.439 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.285 30.3 mt-30 . . . . . 0 CA--C 1.507 -0.702 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.406 ' O ' ' HB2' ' A' ' 128' ' ' LEU . 58.7 ttp -142.86 117.22 9.62 Favored 'General case' 0 C--N 1.364 1.196 0 CA-C-O 121.756 0.789 . . . . 0.0 111.703 -174.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.9 mm -80.16 138.44 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 O-C-N 120.105 -1.622 . . . . 0.0 109.816 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.455 ' SD ' HG13 ' A' ' 158' ' ' VAL . 3.3 tmm? -113.85 135.24 54.18 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 154.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.85 127.86 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.612 HD13 ' CD1' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -112.13 73.76 0.83 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 117.241 2.312 . . . . 0.0 117.241 -166.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.432 . . -105.46 156.6 36.1 Favored Pre-proline 0 C--N 1.355 0.815 0 N-CA-C 120.024 3.342 . . . . 0.0 120.024 -167.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -67.45 142.12 58.38 Favored 'Trans proline' 0 CA--C 1.492 -1.62 0 C-N-CA 123.258 2.639 . . . . 0.0 111.276 -161.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt . . . . . 0 CA--C 1.49 -1.357 0 O-C-N 125.029 1.456 . . . . 0.0 107.907 -174.974 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 . . . . . 0 CA--C 1.482 -1.664 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.577 HG22 ' HD3' ' A' ' 123' ' ' LYS . 95.0 t -99.69 120.88 49.67 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 161.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -103.68 172.31 6.87 Favored 'General case' 0 CA--C 1.472 -2.04 0 C-N-CA 116.924 -1.911 . . . . 0.0 106.896 155.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -145.09 148.24 33.43 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tp -128.28 162.24 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 174.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -119.74 153.68 35.3 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.702 163.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.556 ' HB3' HG11 ' A' ' 144' ' ' VAL . 41.7 m-85 -127.12 141.73 51.69 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 168.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 . . . . . 0 N--CA 1.423 -1.788 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 173.177 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.2 t70 . . . . . 0 N--CA 1.425 -1.684 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -70.74 -72.53 0.2 Allowed 'General case' 0 CA--C 1.477 -1.847 0 C-N-CA 126.574 1.949 . . . . 0.0 109.313 -172.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.418 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.35 0.0 OUTLIER -58.47 -15.19 9.97 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 119.816 3.265 . . . . 0.0 119.816 175.881 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.87 -38.69 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 C-N-CA 123.966 0.906 . . . . 0.0 111.229 164.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -92.82 -1.37 56.83 Favored 'General case' 0 CA--C 1.476 -1.875 0 O-C-N 120.159 -1.588 . . . . 0.0 114.708 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 151' ' ' ASP . 5.7 tt -79.53 -31.62 42.11 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 163.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.457 ' HA ' HG12 ' A' ' 115' ' ' ILE . 3.3 tpp180 -60.36 -46.09 91.16 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 125.123 1.369 . . . . 0.0 110.772 168.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.8 t -59.81 -44.55 93.93 Favored 'General case' 0 C--N 1.375 1.697 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.651 HD11 HD12 ' A' ' 174' ' ' LEU 0.303 61.4 tp -67.9 -29.79 68.98 Favored 'General case' 0 N--CA 1.407 -2.595 0 C-N-CA 127.321 2.248 . . . . 0.0 113.562 178.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.273 9.4 mm -57.78 -51.41 70.61 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.872 0 CA-C-N 120.941 1.7 . . . . 0.0 108.686 170.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.6 tpt85 -54.75 -39.95 68.82 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 126.703 2.001 . . . . 0.0 111.042 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -63.04 -50.64 69.86 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 124.229 1.012 . . . . 0.0 112.263 176.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.545 ' CD1' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -59.1 -37.27 76.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 176.709 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -75.26 -35.73 61.33 Favored 'General case' 0 CA--C 1.487 -1.462 0 C-N-CA 128.931 2.892 . . . . 0.0 109.907 -169.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.55 6.08 11.36 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 123.605 0.762 . . . . 0.0 111.472 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.18 64.11 2.16 Favored Glycine 0 CA--C 1.467 -2.932 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 174.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -128.52 165.17 21.24 Favored 'General case' 0 CA--C 1.448 -2.945 0 N-CA-C 102.306 -3.22 . . . . 0.0 102.306 169.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.577 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -99.93 115.62 30.08 Favored 'General case' 0 N--CA 1.395 -3.211 1 N-CA-C 97.952 -4.832 . . . . 0.0 97.952 173.162 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -87.69 160.5 18.08 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.477 ' HD3' HD12 ' A' ' 171' ' ' ILE . 35.7 ttmt -136.56 131.3 33.65 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 168.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.457 HD11 ' HG ' ' A' ' 174' ' ' LEU . 10.0 mm -83.19 135.24 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 171.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.472 ' HA ' HD13 ' A' ' 171' ' ' ILE . 17.3 m -113.57 115.65 28.29 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 163.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.801 HD21 ' HA2' ' A' ' 141' ' ' GLY . 17.1 tp -84.93 150.06 25.21 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 168.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -153.8 103.05 2.57 Favored 'General case' 0 N--CA 1.406 -2.674 1 N-CA-C 99.834 -4.136 . . . . 0.0 99.834 -170.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.599 ' CZ ' HD23 ' A' ' 128' ' ' LEU 0.347 81.9 m-85 . . . . . 0 CA--C 1.488 -1.434 0 C-N-CA 126.535 1.934 . . . . 0.0 109.297 -171.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 70.8 mt . . . . . 0 N--CA 1.428 -1.53 0 N-CA-C 110.877 -0.046 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.801 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -70.62 -60.72 4.49 Favored Glycine 0 CA--C 1.456 -3.607 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.961 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 4.3 ptt? -85.57 -1.15 56.81 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -157.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.257 0.5 OUTLIER -61.76 -63.54 1.23 Allowed 'General case' 0 CA--C 1.46 -2.484 0 C-N-CA 115.035 -2.666 . . . . 0.0 115.694 147.393 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.556 HG11 ' HB3' ' A' ' 98' ' ' PHE . 35.8 t -62.77 -67.5 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.448 -2.944 0 O-C-N 126.021 2.076 . . . . 0.0 109.007 -166.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.464 HD11 HD22 ' A' ' 128' ' ' LEU . 34.4 mt -43.49 -55.32 4.28 Favored 'General case' 0 CA--C 1.482 -1.666 0 C-N-CA 128.858 2.863 . . . . 0.0 114.564 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 142' ' ' MET . 2.3 t30 -63.23 -30.41 71.56 Favored 'General case' 0 CA--C 1.467 -2.229 0 N-CA-C 117.689 2.478 . . . . 0.0 117.689 174.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -81.15 -14.57 57.52 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.612 172.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.7 t -76.79 -44.14 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.787 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 175.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.514 ' HE3' HG21 ' A' ' 158' ' ' VAL 0.256 33.9 ttmt -52.84 -49.95 64.72 Favored 'General case' 0 CA--C 1.467 -2.219 0 C-N-CA 125.631 1.573 . . . . 0.0 112.033 171.02 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -37.69 64.41 Favored 'General case' 0 N--CA 1.409 -2.521 0 C-N-CA 125.506 1.522 . . . . 0.0 109.456 -169.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.405 ' HB3' HD11 ' A' ' 111' ' ' LEU . 17.8 t70 -75.33 -25.63 57.98 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 116.372 -2.131 . . . . 0.0 114.993 169.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 156' ' ' ALA 0.308 0.1 OUTLIER -78.41 -32.42 48.71 Favored 'General case' 0 CA--C 1.472 -2.05 0 CA-C-O 116.792 -1.575 . . . . 0.0 112.614 178.392 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -29.58 -22.26 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.403 1 C-N-CA 135.237 5.415 . . . . 0.0 119.884 -174.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -56.4 -61.71 2.22 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.94 2.096 . . . . 0.0 110.974 168.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.69 -55.64 2.94 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 113.877 -1.511 . . . . 0.0 107.973 -171.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.478 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.255 . . -98.25 150.87 21.07 Favored 'General case' 0 CA--C 1.443 -3.136 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.565 -166.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.53 173.25 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.662 0 C-N-CA 114.11 -3.036 . . . . 0.0 116.113 130.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.514 HG21 ' HE3' ' A' ' 149' ' ' LYS 0.3 3.1 t -81.2 151.6 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.104 0 CA-C-N 110.133 -3.212 . . . . 0.0 104.911 173.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -81.71 -38.47 25.74 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -174.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.39 136.73 14.92 Favored 'General case' 0 N--CA 1.408 -2.54 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -177.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 N--CA 1.417 -2.1 1 N-CA-C 97.632 -4.951 . . . . 0.0 97.632 156.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 11.3 ttm -107.63 119.08 38.43 Favored 'General case' 0 CA--C 1.472 -2.036 0 CA-C-O 121.201 0.524 . . . . 0.0 111.838 -166.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.477 HD12 ' HD3' ' A' ' 125' ' ' LYS . 22.6 mm -83.27 122.1 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 167.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.4 ttp -105.81 127.47 53.12 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 102.448 -3.167 . . . . 0.0 102.448 162.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.2 t -91.62 140.29 16.33 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 C-N-CA 118.336 -1.345 . . . . 0.0 109.093 -174.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.651 HD12 HD11 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -124.65 75.75 1.44 Allowed 'General case' 0 C--N 1.366 1.288 0 N-CA-C 120.334 3.457 . . . . 0.0 120.334 -169.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.256 . . -85.31 -176.2 0.74 Allowed Pre-proline 0 CA--C 1.502 -0.872 0 O-C-N 119.374 -2.079 . . . . 0.0 115.357 -169.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.472 ' HA ' HD21 ' A' ' 118' ' ' LEU . 79.9 Cg_exo -65.55 153.77 76.7 Favored 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 122.292 1.994 . . . . 0.0 109.969 160.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm . . . . . 0 CA--C 1.489 -1.373 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 170.405 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 . . . . . 0 CA--C 1.483 -1.627 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.58 HG22 ' HE3' ' A' ' 123' ' ' LYS . 79.3 t -99.31 120.65 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.431 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 170.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -104.22 173.16 6.42 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 154.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -142.62 154.65 44.58 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -176.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.701 HG21 HD21 ' A' ' 114' ' ' LEU . 3.9 tp -138.7 167.28 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 170.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -119.84 156.25 31.04 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.214 161.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.515 ' HB3' HG11 ' A' ' 144' ' ' VAL . 29.4 m-85 -130.52 160.54 33.82 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 170.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 . . . . . 0 N--CA 1.43 -1.438 0 C-N-CA 125.213 1.405 . . . . 0.0 108.611 -179.07 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.2 t70 . . . . . 0 N--CA 1.422 -1.836 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -80.22 -65.44 1.01 Allowed 'General case' 0 CA--C 1.481 -1.673 0 O-C-N 124.29 0.994 . . . . 0.0 109.567 -165.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.444 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.337 0.0 OUTLIER -62.26 -9.6 8.38 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 120.472 3.508 . . . . 0.0 120.472 178.878 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.53 -44.2 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-O 122.684 1.23 . . . . 0.0 109.72 160.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.623 ' O ' HD22 ' A' ' 114' ' ' LEU . 22.1 mmtp -89.19 -6.87 56.58 Favored 'General case' 0 CA--C 1.469 -2.149 0 O-C-N 120.395 -1.441 . . . . 0.0 114.727 177.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 2.7 tt -72.34 -35.26 68.52 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 162.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.48 ' HA ' HG12 ' A' ' 115' ' ' ILE . 2.4 tpt180 -56.99 -40.68 77.0 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.484 1.114 . . . . 0.0 111.222 168.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.7 t -59.56 -47.69 84.55 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.701 HD21 HG21 ' A' ' 96' ' ' ILE 0.306 1.4 mm? -67.4 -25.55 66.0 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 175.63 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.271 3.0 mm -62.24 -47.74 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.767 0 CA-C-N 120.53 1.514 . . . . 0.0 107.993 177.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -52.53 -47.03 66.95 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 127.766 2.426 . . . . 0.0 109.751 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -61.24 -51.88 67.1 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.531 1.132 . . . . 0.0 113.028 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.805 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -71.49 -21.25 61.96 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 126.998 2.119 . . . . 0.0 113.75 -178.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -68.86 -41.74 78.01 Favored 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 126.94 2.096 . . . . 0.0 109.245 171.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.78 -26.68 67.81 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 123.037 0.535 . . . . 0.0 110.785 173.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.34 68.01 1.47 Allowed Glycine 0 CA--C 1.469 -2.802 0 N-CA-C 104.477 -3.449 . . . . 0.0 104.477 -171.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -120.59 164.26 16.75 Favored 'General case' 0 CA--C 1.447 -2.995 1 N-CA-C 97.985 -4.82 . . . . 0.0 97.985 168.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.628 ' HD3' HG12 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -101.19 114.88 29.24 Favored 'General case' 0 N--CA 1.393 -3.276 1 N-CA-C 97.175 -5.12 . . . . 0.0 97.175 170.551 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.508 ' CB ' HD12 ' A' ' 114' ' ' LEU . . . -84.07 160.44 20.95 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 173.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -135.38 128.66 32.03 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.9 mm -82.04 135.44 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.436 ' HA ' HD13 ' A' ' 171' ' ' ILE . 15.1 m -109.84 118.29 36.09 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 163.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.843 HD21 ' HA2' ' A' ' 141' ' ' GLY . 11.0 tp -81.07 149.53 29.18 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 168.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.413 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 28.4 ttm180 -150.76 95.76 2.26 Favored 'General case' 0 N--CA 1.398 -3.026 1 N-CA-C 97.007 -5.183 . . . . 0.0 97.007 -175.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.516 ' CZ ' HD23 ' A' ' 128' ' ' LEU . 95.4 m-85 . . . . . 0 N--CA 1.421 -1.883 0 CA-C-N 111.262 -2.699 . . . . 0.0 104.748 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 69.4 mt . . . . . 0 N--CA 1.417 -2.087 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.843 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -72.74 -56.67 5.82 Favored Glycine 0 CA--C 1.459 -3.455 0 CA-C-O 118.744 -1.031 . . . . 0.0 113.438 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.403 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 5.6 ptt? -84.85 0.0 52.45 Favored 'General case' 0 N--CA 1.41 -2.438 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -161.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.261 2.8 tp10 -61.19 -61.12 2.79 Favored 'General case' 0 CA--C 1.461 -2.456 0 C-N-CA 114.879 -2.728 . . . . 0.0 115.308 147.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 98' ' ' PHE . 22.0 t -65.96 -65.2 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.938 0 O-C-N 125.651 1.844 . . . . 0.0 109.293 -163.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.536 HD11 HD22 ' A' ' 128' ' ' LEU . 26.4 mt -45.79 -55.74 6.21 Favored 'General case' 0 N--CA 1.427 -1.619 0 C-N-CA 129.315 3.046 . . . . 0.0 114.431 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 142' ' ' MET 0.261 2.4 t30 -62.81 -31.01 71.92 Favored 'General case' 0 CA--C 1.47 -2.133 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 173.174 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -79.5 -15.72 57.26 Favored 'General case' 0 N--CA 1.421 -1.91 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.193 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.514 HG12 HD12 ' A' ' 152' ' ' LEU . 1.6 t -72.33 -50.24 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.823 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 175.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.456 ' HE3' ' CG2' ' A' ' 158' ' ' VAL 0.261 31.4 ttmt -50.1 -50.96 46.68 Favored 'General case' 0 CA--C 1.466 -2.255 0 C-N-CA 125.682 1.593 . . . . 0.0 112.69 173.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.08 -39.59 68.88 Favored 'General case' 0 N--CA 1.407 -2.604 0 C-N-CA 126.216 1.807 . . . . 0.0 109.451 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -76.22 -27.46 56.83 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 115.716 -2.393 . . . . 0.0 115.198 172.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.514 HD12 HG12 ' A' ' 148' ' ' VAL 0.346 0.4 OUTLIER -81.23 -29.54 34.43 Favored 'General case' 0 CA--C 1.458 -2.595 0 CA-C-O 116.137 -1.887 . . . . 0.0 114.474 179.347 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -26.03 -26.54 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.683 1 C-N-CA 136.065 5.746 . . . . 0.0 119.756 -173.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -51.94 -55.45 20.24 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 126.58 1.952 . . . . 0.0 112.742 166.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.421 ' HG ' ' CG2' ' A' ' 115' ' ' ILE 0.3 1.2 mm? -94.73 -58.82 2.07 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 128.048 2.539 . . . . 0.0 107.191 -169.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.805 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.298 . . -109.28 151.32 26.71 Favored 'General case' 0 CA--C 1.446 -3.055 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.974 -161.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.59 176.53 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.543 0 C-N-CA 115.216 -2.594 . . . . 0.0 116.65 140.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.456 ' CG2' ' HE3' ' A' ' 149' ' ' LYS . 3.4 t -84.96 150.29 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 168.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -80.64 -37.76 30.4 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.402 ' H ' HG12 ' A' ' 158' ' ' VAL . 3.3 t -159.84 144.04 14.68 Favored 'General case' 0 CA--C 1.461 -2.477 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -174.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.3 t80 . . . . . 0 N--CA 1.426 -1.627 0 N-CA-C 101.979 -3.341 . . . . 0.0 101.979 170.243 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.413 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.302 32.1 mt-30 . . . . . 0 CA--C 1.498 -1.055 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 59.6 ttp -134.61 117.96 16.7 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 120.883 0.373 . . . . 0.0 110.165 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.436 HD13 ' HA ' ' A' ' 127' ' ' THR . 11.2 mm -77.95 133.3 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 145' ' ' LEU . 2.8 ttt -119.69 131.3 55.38 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 165.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.628 HG12 ' HD3' ' A' ' 123' ' ' LYS . 1.6 t -100.21 143.01 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -171.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.551 HD13 HD11 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -130.59 70.51 1.45 Allowed 'General case' 0 C--N 1.364 1.23 0 N-CA-C 119.469 3.137 . . . . 0.0 119.469 -161.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 123' ' ' LYS 0.284 . . -92.31 173.75 4.83 Favored Pre-proline 0 C--N 1.358 0.962 0 N-CA-C 119.416 3.117 . . . . 0.0 119.416 -171.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -70.46 142.03 43.85 Favored 'Trans proline' 0 N--CA 1.443 -1.493 0 CA-C-N 120.591 1.247 . . . . 0.0 110.842 -175.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp . . . . . 0 CA--C 1.485 -1.55 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 175.551 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 . . . . . 0 CA--C 1.48 -1.743 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.581 HG22 ' HD3' ' A' ' 123' ' ' LYS . 86.4 t -98.69 117.16 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.712 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 157.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -106.66 170.66 7.8 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 155.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -137.85 157.22 46.87 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -167.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.21 159.27 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 N-CA-C 102.329 -3.212 . . . . 0.0 102.329 174.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -117.85 157.45 26.6 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 118.937 0.79 . . . . 0.0 111.587 166.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.614 ' HB3' HG11 ' A' ' 144' ' ' VAL . 28.5 m-85 -139.89 90.94 2.43 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 172.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 . . . . . 0 N--CA 1.436 -1.153 0 C-N-CA 123.849 0.86 . . . . 0.0 108.937 -179.34 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 t70 . . . . . 0 N--CA 1.424 -1.768 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -86.57 -70.43 0.61 Allowed 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 113.265 -1.789 . . . . 0.0 110.261 -158.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.422 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.326 0.0 OUTLIER -59.01 -14.06 8.35 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 119.004 2.964 . . . . 0.0 119.004 173.604 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.24 -45.75 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 122.096 0.95 . . . . 0.0 110.225 161.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -91.36 4.37 52.57 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.417 HD12 HG13 ' A' ' 148' ' ' VAL . 6.0 tt -83.51 -30.63 26.98 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 162.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.498 ' HA ' HG12 ' A' ' 115' ' ' ILE . 25.1 ttt85 -62.51 -42.42 99.5 Favored 'General case' 0 C--N 1.361 1.082 0 CA-C-O 118.686 -0.674 . . . . 0.0 110.664 167.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.25 65.7 m -55.1 -44.97 75.41 Favored 'General case' 0 C--N 1.379 1.866 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 169.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.607 HD11 HD12 ' A' ' 126' ' ' ILE . 13.7 mt -65.08 -29.53 70.41 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.2 mm -61.04 -45.51 98.42 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.378 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -52.7 43.54 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.542 1.537 . . . . 0.0 111.302 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -57.34 -46.32 83.41 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.423 HD11 ' HA ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -54.48 -44.53 72.72 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 127.802 2.441 . . . . 0.0 112.848 172.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -79.54 -20.09 47.94 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 126.555 1.942 . . . . 0.0 112.416 -174.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -68.11 -21.59 64.94 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.139 0.576 . . . . 0.0 110.745 170.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.73 51.4 3.64 Favored Glycine 0 CA--C 1.474 -2.474 0 N-CA-C 105.804 -2.918 . . . . 0.0 105.804 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -126.78 165.97 18.29 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.581 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -96.53 119.82 35.72 Favored 'General case' 0 N--CA 1.409 -2.5 1 N-CA-C 99.795 -4.15 . . . . 0.0 99.795 178.562 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -91.98 144.04 25.86 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 103.176 -2.898 . . . . 0.0 103.176 -172.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.432 ' HD3' HD12 ' A' ' 171' ' ' ILE . 22.4 ttmm -118.72 125.05 48.81 Favored 'General case' 0 CA--C 1.479 -1.785 0 O-C-N 117.893 -3.004 . . . . 0.0 106.314 173.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.7 HD11 HD22 ' A' ' 174' ' ' LEU . 4.2 mm -86.34 131.99 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 173.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.485 ' HA ' HD13 ' A' ' 171' ' ' ILE . 32.8 m -121.76 123.92 42.97 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 173.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.485 HD23 HD11 ' A' ' 145' ' ' LEU 0.362 0.4 OUTLIER -76.58 150.16 36.53 Favored 'General case' 0 CA--C 1.468 -2.188 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 164.787 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.513 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 56.6 ttt180 -145.15 88.96 1.91 Allowed 'General case' 0 N--CA 1.399 -3.008 1 N-CA-C 99.735 -4.172 . . . . 0.0 99.735 177.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . 0.25 70.1 m-85 . . . . . 0 N--CA 1.428 -1.559 0 CA-C-N 110.986 -2.824 . . . . 0.0 109.144 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.399 57.5 mt . . . . . 0 N--CA 1.429 -1.499 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.47 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -71.4 -64.9 2.59 Favored Glycine 0 N--CA 1.418 -2.513 0 CA-C-O 119.474 -0.626 . . . . 0.0 112.676 173.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.569 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 7.4 ptt? -87.1 -5.85 58.88 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -153.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.02 -48.46 78.67 Favored 'General case' 0 CA--C 1.457 -2.615 0 C-N-CA 116.496 -2.081 . . . . 0.0 113.837 156.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.614 HG11 ' HB3' ' A' ' 98' ' ' PHE . 21.4 t -69.39 -67.77 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.444 -3.133 0 O-C-N 126.023 2.077 . . . . 0.0 106.936 -167.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.58 HD13 ' HB2' ' A' ' 172' ' ' MET . 42.7 mt -43.0 -54.15 4.42 Favored 'General case' 0 CA--C 1.476 -1.898 0 C-N-CA 128.495 2.718 . . . . 0.0 115.679 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.569 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.5 t-20 -63.87 -31.91 73.25 Favored 'General case' 0 CA--C 1.461 -2.474 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 175.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.3 ttp180 -81.81 -14.51 56.25 Favored 'General case' 0 N--CA 1.419 -2.013 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.014 172.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.8 t -76.27 -46.6 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.81 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 176.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.544 ' HE3' HG21 ' A' ' 158' ' ' VAL . 31.4 ttmt -51.9 -51.21 58.52 Favored 'General case' 0 CA--C 1.461 -2.453 0 C-N-CA 125.239 1.416 . . . . 0.0 111.003 172.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.81 -35.85 67.43 Favored 'General case' 0 N--CA 1.409 -2.513 0 C-N-CA 124.612 1.165 . . . . 0.0 110.529 -168.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -72.84 -39.41 66.57 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 116.291 -2.164 . . . . 0.0 114.941 170.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.303 0.2 OUTLIER -80.87 -19.56 44.18 Favored 'General case' 0 CA--C 1.464 -2.341 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -178.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -27.11 -25.07 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.363 1 C-N-CA 134.586 5.154 . . . . 0.0 119.064 174.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.2 mt-10 -54.24 -57.77 9.92 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 126.903 2.081 . . . . 0.0 113.361 167.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.38 -51.39 2.88 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 113.498 -1.683 . . . . 0.0 108.525 -164.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.423 ' HA ' HD11 ' A' ' 118' ' ' LEU 0.321 . . -91.65 146.13 24.03 Favored 'General case' 0 CA--C 1.455 -2.685 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 177.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.4 m -121.12 171.6 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.457 -2.615 0 C-N-CA 114.265 -2.974 . . . . 0.0 116.307 126.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.544 HG21 ' HE3' ' A' ' 149' ' ' LYS 0.298 3.2 t -81.8 155.11 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 C-N-CA 130.524 3.53 . . . . 0.0 107.313 179.391 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -82.15 -42.45 19.05 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.03 141.31 18.58 Favored 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -174.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.417 -2.077 1 N-CA-C 98.766 -4.531 . . . . 0.0 98.766 158.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.279 15.5 mt-30 . . . . . 0 CA--C 1.492 -1.257 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.41 ' HB3' ' HB2' ' A' ' 128' ' ' LEU . 21.6 ttm -104.57 158.35 16.55 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 102.45 -3.167 . . . . 0.0 102.45 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 127' ' ' THR . 32.7 mm -118.43 131.53 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.157 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 159.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.58 ' HB2' HD13 ' A' ' 145' ' ' LEU . 2.5 ttp -108.12 128.4 54.65 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 153.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 37.0 t -91.47 130.39 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 C-N-CA 118.17 -1.412 . . . . 0.0 108.597 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.7 HD22 HD11 ' A' ' 126' ' ' ILE . 13.1 tp -101.82 144.07 30.94 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 130.213 3.405 . . . . 0.0 116.915 174.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.261 . . -143.08 -179.3 0.93 Allowed Pre-proline 0 CA--C 1.483 -1.599 0 O-C-N 119.255 -2.153 . . . . 0.0 108.991 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -65.24 145.24 83.5 Favored 'Trans proline' 0 N--CA 1.436 -1.877 0 C-N-CA 123.025 2.483 . . . . 0.0 109.197 158.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt . . . . . 0 CA--C 1.492 -1.28 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 165.928 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 N--CA 1.429 -1.485 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.503 HG22 ' HD3' ' A' ' 123' ' ' LYS . 54.5 t -102.65 119.47 51.06 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.789 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 161.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -115.19 178.59 4.23 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 160.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -141.7 158.98 43.15 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -171.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.1 tp -134.37 164.74 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 168.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -120.24 154.62 34.65 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.113 162.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.599 ' HB3' HG11 ' A' ' 144' ' ' VAL . 37.9 m-85 -128.9 136.66 50.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 102.922 -2.992 . . . . 0.0 102.922 167.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 . . . . . 0 N--CA 1.432 -1.344 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -177.663 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.5 t70 . . . . . 0 N--CA 1.427 -1.616 0 CA-C-O 122.681 1.229 . . . . 0.0 108.044 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.19 -72.79 0.5 Allowed 'General case' 0 CA--C 1.47 -2.105 0 CA-C-N 112.283 -2.235 . . . . 0.0 111.036 -157.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.457 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.312 0.0 OUTLIER -60.18 -13.45 12.34 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 118.808 2.892 . . . . 0.0 118.808 174.435 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 94.9 t -60.47 -48.74 87.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 C-N-CA 124.209 1.004 . . . . 0.0 109.997 160.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -91.72 7.41 41.83 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 5.3 tt -86.21 -31.14 21.89 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 163.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.461 ' HA ' HG12 ' A' ' 115' ' ' ILE . 56.9 ttt-85 -62.25 -43.8 97.99 Favored 'General case' 0 C--N 1.363 1.158 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.021 167.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.1 m -60.14 -42.37 94.71 Favored 'General case' 0 C--N 1.378 1.838 0 C-N-CA 118.181 -1.408 . . . . 0.0 113.175 174.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.52 HD11 HD12 ' A' ' 126' ' ' ILE . 9.9 mt -62.48 -30.77 71.5 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 175.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.6 mm -58.33 -51.58 69.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.733 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 25.9 tpt85 -50.38 -45.96 55.69 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 126.716 2.007 . . . . 0.0 112.745 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -61.22 -54.54 42.96 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -57.56 -39.46 76.74 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 177.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -78.43 -29.91 47.32 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 128.703 2.801 . . . . 0.0 110.252 -169.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.92 7.47 8.82 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 123.067 0.547 . . . . 0.0 111.406 173.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.09 61.13 2.57 Favored Glycine 0 CA--C 1.467 -2.937 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 173.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -131.88 168.57 17.63 Favored 'General case' 0 CA--C 1.448 -2.971 0 N-CA-C 101.194 -3.632 . . . . 0.0 101.194 170.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.503 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -108.25 116.71 32.48 Favored 'General case' 0 N--CA 1.39 -3.472 1 N-CA-C 98.091 -4.781 . . . . 0.0 98.091 173.373 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -82.72 158.22 22.97 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 102.586 -3.116 . . . . 0.0 102.586 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.306 33.2 mtmm -126.29 144.49 50.78 Favored 'General case' 0 CA--C 1.481 -1.677 0 O-C-N 118.795 -2.441 . . . . 0.0 105.47 155.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.52 HD12 HD11 ' A' ' 114' ' ' LEU . 6.4 mm -86.62 137.37 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 167.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.9 m -117.17 123.78 47.52 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 166.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 170' ' ' MET 0.258 0.2 OUTLIER -80.18 153.78 28.4 Favored 'General case' 0 CA--C 1.467 -2.213 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 166.573 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -148.21 94.79 2.37 Favored 'General case' 0 N--CA 1.404 -2.756 1 N-CA-C 99.51 -4.255 . . . . 0.0 99.51 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 . . . . . 0 N--CA 1.424 -1.759 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.116 -170.84 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.253 68.4 mt . . . . . 0 CA--C 1.489 -1.37 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -70.11 -64.5 2.87 Favored Glycine 0 N--CA 1.416 -2.657 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.556 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 7.1 ptt? -84.78 -5.66 59.33 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -155.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.32 -53.72 48.33 Favored 'General case' 0 CA--C 1.459 -2.529 0 C-N-CA 115.925 -2.31 . . . . 0.0 114.126 154.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.599 HG11 ' HB3' ' A' ' 98' ' ' PHE . 21.8 t -66.11 -67.05 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.443 -3.144 0 O-C-N 126.028 2.08 . . . . 0.0 107.499 -167.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.438 HD22 ' HB3' ' A' ' 172' ' ' MET . 23.9 mt -41.08 -56.63 2.27 Favored 'General case' 0 CA--C 1.476 -1.877 0 C-N-CA 128.977 2.911 . . . . 0.0 115.15 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.4 t-20 -63.31 -31.41 72.55 Favored 'General case' 0 CA--C 1.466 -2.285 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 175.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -82.69 -13.68 55.96 Favored 'General case' 0 N--CA 1.419 -2.012 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.868 173.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.7 t -76.31 -46.96 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 177.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.531 ' HE3' HG21 ' A' ' 158' ' ' VAL 0.251 35.3 ttmt -51.21 -49.83 60.27 Favored 'General case' 0 CA--C 1.464 -2.357 0 C-N-CA 125.642 1.577 . . . . 0.0 111.991 172.65 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -37.39 64.93 Favored 'General case' 0 N--CA 1.408 -2.57 0 C-N-CA 125.276 1.43 . . . . 0.0 109.978 -169.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -72.22 -38.21 69.02 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 116.412 -2.115 . . . . 0.0 114.923 171.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.423 HD13 HD11 ' A' ' 174' ' ' LEU 0.296 0.2 OUTLIER -81.84 -20.68 38.49 Favored 'General case' 0 CA--C 1.461 -2.443 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -178.318 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -25.87 -28.2 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.305 1 C-N-CA 134.305 5.042 . . . . 0.0 119.142 175.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 5.2 mt-10 -50.88 -54.05 27.23 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 128.101 2.56 . . . . 0.0 113.747 168.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.1 tt -113.22 -51.0 2.84 Favored 'General case' 0 N--CA 1.42 -1.932 0 C-N-CA 126.163 1.785 . . . . 0.0 108.611 -167.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.534 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.343 . . -104.7 142.0 35.46 Favored 'General case' 0 CA--C 1.449 -2.937 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.822 -177.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.5 m -120.04 171.76 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.65 0 CA-C-O 125.117 2.389 . . . . 0.0 116.022 140.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.531 HG21 ' HE3' ' A' ' 149' ' ' LYS 0.289 2.7 t -81.82 152.86 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 109.917 -3.311 . . . . 0.0 106.336 177.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -83.33 -39.2 21.06 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -176.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.76 140.95 18.51 Favored 'General case' 0 CA--C 1.468 -2.193 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -174.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.6 t80 . . . . . 0 N--CA 1.422 -1.845 0 N-CA-C 101.259 -3.608 . . . . 0.0 101.259 164.492 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.314 19.8 mt-30 . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.406 ' HB3' ' HB2' ' A' ' 128' ' ' LEU . 4.6 ttm -116.14 112.99 22.49 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-N 119.805 1.184 . . . . 0.0 109.878 -175.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.9 mm -80.92 123.57 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 O-C-N 121.06 -1.025 . . . . 0.0 108.646 170.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.438 ' HB3' HD22 ' A' ' 145' ' ' LEU . 2.9 ttt -107.49 131.24 54.52 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 159.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 39.1 t -93.09 140.86 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.017 -173.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -126.92 81.1 1.99 Allowed 'General case' 0 C--N 1.364 1.208 0 N-CA-C 118.988 2.958 . . . . 0.0 118.988 -169.055 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.276 . . -85.94 178.73 2.16 Favored Pre-proline 0 CA--C 1.499 -0.993 0 O-C-N 119.644 -1.91 . . . . 0.0 115.998 -171.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.442 ' HA ' HD21 ' A' ' 118' ' ' LEU . 84.4 Cg_exo -62.06 142.97 94.29 Favored 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 122.849 2.366 . . . . 0.0 109.786 159.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.968 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 . . . . . 0 CA--C 1.482 -1.655 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.575 HG22 ' HE3' ' A' ' 123' ' ' LYS . 76.3 t -100.78 119.99 49.67 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.588 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -104.85 172.44 6.79 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 155.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -143.78 154.23 43.22 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -175.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 tp -138.71 165.26 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 103.918 -2.623 . . . . 0.0 103.918 171.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -117.13 155.04 30.0 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-N 118.744 0.702 . . . . 0.0 110.903 163.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.57 ' HB3' HG11 ' A' ' 144' ' ' VAL . 26.7 m-85 -128.9 145.47 51.21 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 170.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 . . . . . 0 N--CA 1.438 -1.046 0 C-N-CA 126.341 1.856 . . . . 0.0 106.719 -176.5 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.6 t70 . . . . . 0 N--CA 1.423 -1.825 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.425 ' HD1' ' CE1' ' A' ' 98' ' ' PHE . 0.6 OUTLIER -84.66 -63.82 1.27 Allowed 'General case' 0 CA--C 1.481 -1.708 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.678 -161.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.467 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.325 0.0 OUTLIER -61.87 -11.89 15.05 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 119.64 3.2 . . . . 0.0 119.64 177.392 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.5 t -60.96 -48.05 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-O 122.37 1.081 . . . . 0.0 109.552 160.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -91.41 -1.65 57.52 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tt -78.5 -33.42 48.1 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 162.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.451 ' HA ' HG12 ' A' ' 115' ' ' ILE . 46.7 ttt-85 -61.91 -40.57 95.91 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 117.672 -1.156 . . . . 0.0 110.997 169.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.6 m -57.43 -46.17 83.84 Favored 'General case' 0 C--N 1.38 1.913 0 C-N-CA 119.001 -1.08 . . . . 0.0 113.84 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.268 84.4 mt -65.49 -30.87 71.69 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.9 mm -58.75 -49.7 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.676 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -55.85 -39.55 71.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 126.801 2.041 . . . . 0.0 111.32 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -62.45 -51.7 66.46 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 123.581 0.752 . . . . 0.0 112.081 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.737 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -66.83 -23.09 66.0 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 126.232 1.813 . . . . 0.0 114.978 177.331 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -69.98 -38.2 75.96 Favored 'General case' 0 CA--C 1.491 -1.306 0 C-N-CA 126.216 1.806 . . . . 0.0 109.875 172.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -66.63 -26.08 66.9 Favored 'General case' 0 C--N 1.361 1.083 0 O-C-N 123.28 0.363 . . . . 0.0 110.893 171.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.41 65.36 1.52 Allowed Glycine 0 CA--C 1.471 -2.702 0 N-CA-C 104.743 -3.343 . . . . 0.0 104.743 -172.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -121.52 164.72 16.76 Favored 'General case' 0 CA--C 1.449 -2.929 1 N-CA-C 98.79 -4.522 . . . . 0.0 98.79 170.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.575 ' HE3' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -101.5 117.6 35.26 Favored 'General case' 0 N--CA 1.396 -3.173 1 N-CA-C 97.538 -4.986 . . . . 0.0 97.538 169.106 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.63 160.6 20.37 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 172.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -134.42 131.43 38.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 169.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.1 mm -82.93 135.87 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.416 ' HA ' HD13 ' A' ' 171' ' ' ILE . 16.4 m -113.19 119.23 37.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 165.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.739 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.2 OUTLIER -84.73 153.75 22.86 Favored 'General case' 0 CA--C 1.474 -1.963 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 167.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.493 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 24.8 ttm-85 -151.62 103.05 2.92 Favored 'General case' 0 N--CA 1.395 -3.183 1 N-CA-C 96.504 -5.369 . . . . 0.0 96.504 -173.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.451 ' CE1' HD22 ' A' ' 128' ' ' LEU . 60.2 m-85 . . . . . 0 N--CA 1.431 -1.391 0 CA-C-N 112.537 -2.119 . . . . 0.0 109.987 -174.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.8 mt . . . . . 0 CA--C 1.467 -2.24 0 CA-C-O 120.803 0.335 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.739 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -79.94 -53.47 4.23 Favored Glycine 0 CA--C 1.458 -3.498 0 O-C-N 124.876 1.36 . . . . 0.0 110.517 -168.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 71.1 mtm -85.74 3.1 42.79 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -166.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.261 2.2 tp10 -62.42 -64.82 0.81 Allowed 'General case' 0 CA--C 1.466 -2.26 0 C-N-CA 115.199 -2.6 . . . . 0.0 115.876 141.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.57 HG11 ' HB3' ' A' ' 98' ' ' PHE . 16.1 t -62.59 -65.29 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.447 -2.994 0 O-C-N 125.907 2.005 . . . . 0.0 109.264 -162.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.3 mt -42.4 -53.99 4.0 Favored 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 129.435 3.094 . . . . 0.0 114.641 176.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -61.83 -35.89 79.58 Favored 'General case' 0 CA--C 1.466 -2.254 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -80.15 -14.71 58.26 Favored 'General case' 0 N--CA 1.419 -2.01 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.486 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.444 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.9 t -76.72 -46.46 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.725 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.422 ' HE3' ' CG2' ' A' ' 158' ' ' VAL 0.271 31.4 ttmt -53.73 -48.31 69.75 Favored 'General case' 0 CA--C 1.467 -2.241 0 C-N-CA 126.007 1.723 . . . . 0.0 112.587 173.382 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -39.33 66.75 Favored 'General case' 0 N--CA 1.407 -2.596 0 C-N-CA 125.476 1.51 . . . . 0.0 108.77 -171.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -75.07 -22.95 58.0 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 115.637 -2.425 . . . . 0.0 115.63 170.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.407 HD23 HG12 ' A' ' 148' ' ' VAL 0.313 0.2 OUTLIER -83.26 -31.12 27.12 Favored 'General case' 0 CA--C 1.473 -1.999 0 CA-C-O 116.887 -1.53 . . . . 0.0 112.827 -179.649 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -29.11 -26.48 0.0 OUTLIER 'General case' 0 C--N 1.367 1.346 1 C-N-CA 134.93 5.292 . . . . 0.0 119.346 -175.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 5.7 mt-10 -50.86 -53.28 33.69 Favored 'General case' 0 CA--C 1.491 -1.297 0 C-N-CA 128.642 2.777 . . . . 0.0 112.611 170.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . 0.251 0.2 OUTLIER -111.31 -53.53 2.69 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 113.701 -1.591 . . . . 0.0 108.593 -169.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.737 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.318 . . -105.65 154.33 20.58 Favored 'General case' 0 CA--C 1.444 -3.112 0 CA-C-N 113.732 -1.576 . . . . 0.0 107.756 -166.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.58 178.58 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.506 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 139.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.43 HG22 HD23 ' A' ' 174' ' ' LEU . 2.7 t -83.8 151.74 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.996 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 166.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -80.29 -38.59 30.47 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 6.8 t -123.02 -175.96 3.3 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -175.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 8.8 t80 . . . . . 0 N--CA 1.419 -1.992 0 N-CA-C 102.343 -3.206 . . . . 0.0 102.343 144.131 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.493 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.257 26.0 mt-30 . . . . . 0 CA--C 1.499 -1.013 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -120.78 115.17 22.77 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -173.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 127' ' ' THR . 16.1 mm -79.07 123.86 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 167.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.412 ' HG3' ' CG1' ' A' ' 158' ' ' VAL . 2.4 ttt -107.21 136.89 46.28 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 163.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.97 134.88 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 118.176 -1.409 . . . . 0.0 108.782 -172.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.576 HD13 HD11 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -122.71 69.27 0.98 Allowed 'General case' 0 C--N 1.356 0.883 0 N-CA-C 119.782 3.253 . . . . 0.0 119.782 -164.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.312 . . -89.59 172.71 6.83 Favored Pre-proline 0 C--N 1.356 0.85 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 -172.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -72.04 139.44 32.84 Favored 'Trans proline' 0 CA--C 1.493 -1.545 0 N-CA-C 107.905 -1.613 . . . . 0.0 107.905 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.1 pttp . . . . . 0 N--CA 1.433 -1.315 0 O-C-N 124.126 0.892 . . . . 0.0 111.521 -179.264 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 . . . . . 0 CA--C 1.48 -1.724 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.559 HG22 ' HE2' ' A' ' 123' ' ' LYS . 55.2 t -96.42 123.75 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 160.1 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -103.28 172.42 6.82 Favored 'General case' 0 CA--C 1.468 -2.187 0 C-N-CA 116.105 -2.238 . . . . 0.0 105.985 160.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -144.29 148.34 34.7 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 tp -131.83 160.65 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 102.372 -3.196 . . . . 0.0 102.372 172.056 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -113.86 154.15 27.97 Favored 'General case' 0 CA--C 1.484 -1.566 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.207 164.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.547 ' HB3' HG11 ' A' ' 144' ' ' VAL . 4.7 m-85 -137.13 130.29 30.95 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 . . . . . 0 N--CA 1.422 -1.839 0 C-N-CA 124.013 0.925 . . . . 0.0 110.648 179.234 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 t70 . . . . . 0 CA--C 1.477 -1.845 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -88.91 -60.73 1.88 Allowed 'General case' 0 CA--C 1.479 -1.765 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.772 -161.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.346 0.0 OUTLIER -61.43 -12.74 15.78 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 119.281 3.067 . . . . 0.0 119.281 174.638 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.61 -47.81 91.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-O 122.201 1.001 . . . . 0.0 109.613 160.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -90.81 3.57 54.07 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 178.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.441 HD12 HG13 ' A' ' 148' ' ' VAL . 5.6 tt -82.61 -30.55 29.41 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 162.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.458 ' HA ' HG12 ' A' ' 115' ' ' ILE . 59.0 ttt-85 -62.3 -41.98 98.97 Favored 'General case' 0 C--N 1.361 1.105 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.731 166.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 t -57.0 -45.38 83.07 Favored 'General case' 0 C--N 1.378 1.807 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 175.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.336 29.3 mt -66.98 -29.0 68.73 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 175.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.273 7.1 mm -61.67 -48.42 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.882 0 CA-C-N 120.049 1.295 . . . . 0.0 108.064 174.624 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -54.2 -43.85 71.11 Favored 'General case' 0 CA--C 1.479 -1.759 0 C-N-CA 126.929 2.092 . . . . 0.0 110.026 -178.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -63.28 -48.73 76.88 Favored 'General case' 0 CA--C 1.487 -1.45 0 O-C-N 124.385 1.053 . . . . 0.0 112.636 177.15 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.533 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -61.49 -44.13 97.64 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -178.455 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -85.61 -17.8 35.12 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 126.813 2.045 . . . . 0.0 112.02 -169.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -81.71 -0.95 45.15 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 167.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.74 64.23 1.5 Allowed Glycine 0 CA--C 1.47 -2.74 0 C-N-CA 125.939 1.733 . . . . 0.0 108.947 171.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -134.92 165.96 24.1 Favored 'General case' 0 CA--C 1.445 -3.073 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 171.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.559 ' HE2' HG22 ' A' ' 93' ' ' VAL . 2.6 tmmm? -102.56 117.34 34.48 Favored 'General case' 0 N--CA 1.394 -3.232 1 N-CA-C 95.804 -5.628 . . . . 0.0 95.804 178.367 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.09 162.37 16.81 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -144.53 130.25 19.14 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 119.188 -2.195 . . . . 0.0 106.663 170.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.4 mm -84.02 136.39 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 174.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.479 ' HA ' HD13 ' A' ' 171' ' ' ILE . 20.1 m -108.52 119.92 40.93 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 161.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.772 HD12 HD11 ' A' ' 145' ' ' LEU 0.281 0.3 OUTLIER -71.84 147.49 47.12 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.394 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 53.1 ttm-85 -149.22 96.24 2.5 Favored 'General case' 0 N--CA 1.405 -2.717 1 N-CA-C 99.165 -4.383 . . . . 0.0 99.165 -178.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.413 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 76.6 m-85 . . . . . 0 N--CA 1.422 -1.826 0 CA-C-N 111.787 -2.46 . . . . 0.0 109.417 -177.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.256 59.4 mt . . . . . 0 N--CA 1.423 -1.821 0 CA-C-O 120.578 0.228 . . . . 0.0 111.061 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.529 ' CA ' HD11 ' A' ' 128' ' ' LEU . . . -74.33 -54.98 5.86 Favored Glycine 0 N--CA 1.412 -2.962 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.16 -178.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.477 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 6.3 ptt? -85.68 -0.53 55.41 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -163.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.26 2.2 tp10 -60.46 -57.97 10.49 Favored 'General case' 0 CA--C 1.453 -2.776 0 C-N-CA 114.687 -2.805 . . . . 0.0 114.805 147.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 98' ' ' PHE . 17.1 t -67.15 -64.82 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.448 -2.956 0 O-C-N 126.118 2.136 . . . . 0.0 108.981 -161.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.772 HD11 HD12 ' A' ' 128' ' ' LEU . 51.2 mt -47.32 -52.43 16.44 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 128.227 2.611 . . . . 0.0 115.286 178.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 142' ' ' MET 0.265 1.7 t30 -63.44 -30.73 71.81 Favored 'General case' 0 CA--C 1.479 -1.761 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 174.175 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -80.61 -15.88 55.5 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.858 173.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 98' ' ' PHE . 2.0 t -75.58 -43.95 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.614 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.444 ' HB2' HG21 ' A' ' 158' ' ' VAL 0.283 23.2 ttmt -52.52 -49.53 64.63 Favored 'General case' 0 CA--C 1.47 -2.133 0 C-N-CA 126.222 1.809 . . . . 0.0 113.391 173.669 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -73.24 -41.45 63.7 Favored 'General case' 0 N--CA 1.404 -2.745 0 C-N-CA 127.78 2.432 . . . . 0.0 108.545 -172.216 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -75.04 -24.5 58.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 116.474 -2.09 . . . . 0.0 114.813 172.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 156' ' ' ALA 0.308 0.1 OUTLIER -81.93 -31.41 31.33 Favored 'General case' 0 CA--C 1.47 -2.13 0 CA-C-O 116.063 -1.922 . . . . 0.0 112.339 178.172 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -28.45 -26.92 0.0 OUTLIER 'General case' 0 C--N 1.37 1.461 1 C-N-CA 134.745 5.218 . . . . 0.0 119.651 -173.33 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -48.24 -50.06 30.98 Favored 'General case' 0 CA--C 1.49 -1.349 0 C-N-CA 129.151 2.98 . . . . 0.0 113.458 167.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.35 -48.35 1.84 Allowed 'General case' 0 N--CA 1.416 -2.155 0 C-N-CA 126.057 1.743 . . . . 0.0 109.293 -164.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.533 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.347 . . -107.14 151.24 25.66 Favored 'General case' 0 CA--C 1.449 -2.934 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.536 -177.364 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.04 175.37 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.545 0 C-N-CA 115.803 -2.359 . . . . 0.0 116.304 136.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.476 HG13 ' HG2' ' A' ' 172' ' ' MET 0.372 74.8 t -76.98 147.88 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.25 0 CA-C-N 110.935 -2.848 . . . . 0.0 105.04 168.931 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -84.1 -39.5 19.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -172.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.8 t -160.06 142.41 13.24 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 113.73 -1.577 . . . . 0.0 106.898 -171.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.9 t80 . . . . . 0 N--CA 1.432 -1.373 0 N-CA-C 101.539 -3.504 . . . . 0.0 101.539 171.872 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.494 -1.177 0 CA-C-O 121.355 0.597 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 13.3 ttm -124.33 168.64 12.73 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 -178.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 127' ' ' THR . 23.5 mm -112.69 141.07 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.937 0 C-N-CA 126.183 1.793 . . . . 0.0 108.022 163.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.576 ' HB2' HD13 ' A' ' 145' ' ' LEU . 5.1 tmm? -116.22 131.89 56.82 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 103.05 -2.944 . . . . 0.0 103.05 151.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.5 t -89.21 134.05 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -116.91 74.08 0.89 Allowed 'General case' 0 C--N 1.357 0.92 0 N-CA-C 117.946 2.573 . . . . 0.0 117.946 -170.627 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -86.53 -178.3 1.1 Allowed Pre-proline 0 CA--C 1.509 -0.615 0 N-CA-C 117.965 2.579 . . . . 0.0 117.965 -170.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.415 ' HA ' HD21 ' A' ' 118' ' ' LEU . 85.4 Cg_exo -66.59 144.65 73.38 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 122.498 2.132 . . . . 0.0 109.44 160.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.5 pttp . . . . . 0 N--CA 1.428 -1.525 0 CA-C-O 122.063 0.935 . . . . 0.0 111.785 179.894 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 . . . . . 0 N--CA 1.427 -1.606 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 82.9 t -103.89 121.85 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.525 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 168.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.407 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 26.4 mmmt -104.05 174.76 5.73 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 155.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -143.95 151.29 39.58 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 -178.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 tp -132.04 161.84 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 171.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -116.65 151.7 35.75 Favored 'General case' 0 CA--C 1.482 -1.662 0 C-N-CA 118.739 -1.184 . . . . 0.0 110.825 160.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.609 ' HB3' HG11 ' A' ' 144' ' ' VAL . 36.7 m-85 -124.33 133.03 53.57 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 168.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.57 ' H ' ' HE ' ' A' ' 99' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.427 -1.589 0 C-N-CA 124.58 1.152 . . . . 0.0 108.41 -173.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.0 t70 . . . . . 0 N--CA 1.424 -1.736 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.2 -73.49 0.19 Allowed 'General case' 0 CA--C 1.482 -1.65 0 C-N-CA 126.659 1.984 . . . . 0.0 108.455 -174.103 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.449 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.333 0.0 OUTLIER -59.75 -11.14 4.6 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 120.65 3.574 . . . . 0.0 120.65 176.159 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.42 -39.86 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-O 122.005 0.907 . . . . 0.0 110.421 160.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -93.18 -1.95 55.76 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 176.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 tt -79.13 -31.32 44.07 Favored 'General case' 0 N--CA 1.417 -2.083 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 162.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.499 ' HA ' HG12 ' A' ' 115' ' ' ILE . 7.4 ttm-85 -60.11 -44.65 94.7 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 124.806 1.242 . . . . 0.0 111.298 169.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.3 t -60.14 -41.76 93.38 Favored 'General case' 0 C--N 1.371 1.515 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 76.0 mt -65.29 -29.79 70.58 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 173.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.252 5.3 mm -60.61 -48.92 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 CA-C-N 119.751 1.16 . . . . 0.0 108.361 176.836 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -51.19 -45.02 61.69 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 127.274 2.229 . . . . 0.0 110.146 178.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.407 ' CD2' ' HB2' ' A' ' 94' ' ' LYS . 12.2 m-30 -61.75 -49.93 74.44 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -179.275 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.695 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -72.5 -20.32 61.38 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.268 1.427 . . . . 0.0 114.298 179.248 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.73 -33.75 64.48 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 125.333 1.453 . . . . 0.0 110.677 172.397 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -67.62 -27.98 67.36 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 169.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.52 67.85 1.38 Allowed Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 105.213 -3.155 . . . . 0.0 105.213 -173.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -123.67 169.27 11.66 Favored 'General case' 0 CA--C 1.452 -2.797 1 N-CA-C 97.852 -4.87 . . . . 0.0 97.852 169.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.81 134.76 39.69 Favored 'General case' 0 CA--C 1.455 -2.704 1 N-CA-C 98.169 -4.752 . . . . 0.0 98.169 157.475 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.24 161.2 21.57 Favored 'General case' 0 N--CA 1.418 -2.037 0 C-N-CA 115.032 -2.667 . . . . 0.0 105.37 160.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -111.78 136.24 51.31 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 159.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.562 HD11 HD22 ' A' ' 174' ' ' LEU . 4.9 mm -82.47 128.64 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 165.215 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.3 m -111.99 120.31 41.46 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 169.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.717 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.1 OUTLIER -82.42 153.89 25.46 Favored 'General case' 0 CA--C 1.464 -2.341 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 167.162 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.496 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 67.5 ttt180 -148.94 95.39 2.4 Favored 'General case' 0 N--CA 1.393 -3.318 1 N-CA-C 95.736 -5.653 . . . . 0.0 95.736 -176.861 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.487 ' CE1' HD22 ' A' ' 128' ' ' LEU . 97.4 m-85 . . . . . 0 N--CA 1.413 -2.285 0 N-CA-C 102.347 -3.205 . . . . 0.0 102.347 175.043 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.271 74.8 mt . . . . . 0 CA--C 1.474 -1.974 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.717 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -74.33 -60.59 3.47 Favored Glycine 0 N--CA 1.405 -3.41 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.872 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.448 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 4.9 ptt? -89.61 5.61 44.9 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -160.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -62.56 -58.45 7.53 Favored 'General case' 0 CA--C 1.46 -2.504 0 C-N-CA 114.907 -2.717 . . . . 0.0 114.595 143.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.609 HG11 ' HB3' ' A' ' 98' ' ' PHE . 15.2 t -68.11 -63.06 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.442 -3.194 0 O-C-N 126.096 2.123 . . . . 0.0 107.335 -160.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 145' ' ' LEU . 17.7 mt -41.05 -60.15 1.29 Allowed 'General case' 0 CA--C 1.464 -2.344 0 C-N-CA 128.351 2.66 . . . . 0.0 113.454 176.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.3 t-20 -55.72 -37.8 68.9 Favored 'General case' 0 CA--C 1.464 -2.333 0 C-N-CA 125.996 1.718 . . . . 0.0 115.327 177.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.5 ttt85 -81.01 -14.04 58.29 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 119.861 -0.735 . . . . 0.0 111.914 175.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.8 t -75.36 -46.72 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.747 0 CA-C-O 116.037 -1.935 . . . . 0.0 106.495 176.006 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.629 ' HB2' HG21 ' A' ' 158' ' ' VAL . 1.2 ttpp -54.65 -57.03 13.07 Favored 'General case' 0 CA--C 1.459 -2.523 0 CA-C-O 116.244 -1.836 . . . . 0.0 108.22 171.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -34.58 78.22 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 120.116 1.325 . . . . 0.0 111.26 -166.587 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.6 -39.47 62.16 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 168.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.329 0.2 OUTLIER -80.61 -24.29 39.19 Favored 'General case' 0 CA--C 1.47 -2.109 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -176.82 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -26.07 -31.06 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.812 1 C-N-CA 136.5 5.92 . . . . 0.0 118.357 -177.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -52.35 -52.92 50.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.734 2.014 . . . . 0.0 114.298 170.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.423 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 3.2 tm? -107.52 -55.86 2.29 Favored 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 128.5 2.72 . . . . 0.0 108.434 -160.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.695 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.279 . . -102.0 154.88 18.56 Favored 'General case' 0 CA--C 1.449 -2.935 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 -176.1 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 18.7 m -118.66 -179.05 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.458 -2.594 0 C-N-CA 113.661 -3.216 . . . . 0.0 115.494 139.401 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.629 HG21 ' HB2' ' A' ' 149' ' ' LYS . 3.3 t -94.89 149.92 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.989 0 N-CA-C 104.94 -2.245 . . . . 0.0 104.94 166.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -82.28 -41.9 19.54 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 -176.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -153.43 148.23 26.43 Favored 'General case' 0 CA--C 1.47 -2.12 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -172.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.438 ' CZ ' ' HA ' ' A' ' 146' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.46 -2.512 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 171.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.496 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.314 19.7 mt-30 . . . . . 0 CA--C 1.503 -0.863 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.4 ttp -125.32 118.66 26.42 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 118.561 0.618 . . . . 0.0 111.395 -173.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.7 mm -80.38 124.93 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 CA-C-O 122.47 1.128 . . . . 0.0 108.534 169.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.9 ttt -105.95 136.98 44.64 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 159.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.0 t -102.32 134.28 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 117.682 -1.607 . . . . 0.0 109.123 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.562 HD22 HD11 ' A' ' 126' ' ' ILE . 11.7 tp -112.38 86.78 2.42 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 121.338 3.829 . . . . 0.0 121.338 -177.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.388 . . -107.77 155.54 39.65 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -178.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -70.2 150.6 65.77 Favored 'Trans proline' 0 CA--C 1.486 -1.877 0 C-N-CA 122.885 2.39 . . . . 0.0 109.378 -163.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt . . . . . 0 N--CA 1.433 -1.323 0 O-C-N 124.853 1.346 . . . . 0.0 108.21 -175.456 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 . . . . . 0 CA--C 1.48 -1.726 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.474 HG22 ' HE3' ' A' ' 123' ' ' LYS . 83.1 t -101.94 121.83 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.66 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 174.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -107.15 -178.23 3.58 Favored 'General case' 0 CA--C 1.472 -2.029 0 C-N-CA 117.373 -1.731 . . . . 0.0 107.535 162.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -150.03 150.12 31.32 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.058 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 tp -132.82 161.6 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 173.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -122.1 153.75 38.27 Favored 'General case' 0 CA--C 1.485 -1.535 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.071 164.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.59 ' HB3' HG11 ' A' ' 144' ' ' VAL . 40.6 m-85 -134.07 136.76 44.18 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.6 ttt85 . . . . . 0 N--CA 1.433 -1.276 0 CA-C-O 117.612 -1.185 . . . . 0.0 108.817 -173.713 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 N--CA 1.425 -1.712 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.8 -74.06 0.18 Allowed 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 126.525 1.93 . . . . 0.0 109.12 -169.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.433 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.326 0.0 OUTLIER -59.64 -11.27 4.62 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 120.335 3.457 . . . . 0.0 120.335 177.175 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.12 -40.57 89.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 122.094 0.949 . . . . 0.0 110.296 161.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -92.87 -4.28 53.16 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 176.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.5 tt -75.84 -33.27 60.03 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 161.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.476 ' HA ' HG12 ' A' ' 115' ' ' ILE . 16.2 ttp180 -60.4 -44.93 95.22 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 125.175 1.39 . . . . 0.0 111.146 170.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 t -62.46 -42.63 99.61 Favored 'General case' 0 C--N 1.375 1.687 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 118' ' ' LEU 0.327 51.2 tp -68.69 -30.38 69.03 Favored 'General case' 0 N--CA 1.402 -2.835 0 C-N-CA 125.706 1.602 . . . . 0.0 113.519 177.707 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.283 8.9 mm -56.3 -52.03 56.59 Favored 'Isoleucine or valine' 0 C--N 1.378 1.833 0 CA-C-N 120.94 1.7 . . . . 0.0 109.402 171.099 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -53.47 -40.16 65.08 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 128.386 2.674 . . . . 0.0 110.559 -177.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -61.01 -54.16 48.39 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 124.393 1.077 . . . . 0.0 112.043 175.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.677 HD13 ' HB2' ' A' ' 156' ' ' ALA . 1.3 mt -67.76 -21.08 65.28 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -72.52 -36.21 68.29 Favored 'General case' 0 CA--C 1.491 -1.317 0 C-N-CA 126.043 1.737 . . . . 0.0 110.25 172.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -67.16 -22.2 65.77 Favored 'General case' 0 C--N 1.36 1.031 0 O-C-N 123.185 0.303 . . . . 0.0 111.214 169.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.83 68.1 1.42 Allowed Glycine 0 CA--C 1.469 -2.839 0 N-CA-C 104.81 -3.316 . . . . 0.0 104.81 -174.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -123.28 163.4 20.78 Favored 'General case' 0 CA--C 1.448 -2.971 0 N-CA-C 100.641 -3.837 . . . . 0.0 100.641 171.019 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.639 ' HD3' HG12 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -105.45 106.27 16.69 Favored 'General case' 0 N--CA 1.399 -3.007 1 N-CA-C 99.101 -4.407 . . . . 0.0 99.101 173.892 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -97.77 128.54 44.48 Favored 'General case' 0 N--CA 1.411 -2.39 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.561 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -96.07 129.88 43.24 Favored 'General case' 0 CA--C 1.474 -1.969 0 CA-C-O 121.621 0.724 . . . . 0.0 109.325 -176.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.6 mm -82.9 132.92 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 171.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.526 ' HA ' HD13 ' A' ' 171' ' ' ILE . 21.8 m -113.82 120.81 42.05 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 167.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.656 HD12 HD11 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -74.2 145.65 43.98 Favored 'General case' 0 CA--C 1.474 -1.962 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 165.808 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.448 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 52.3 ttp180 -147.48 94.96 2.45 Favored 'General case' 0 N--CA 1.4 -2.93 1 N-CA-C 98.591 -4.596 . . . . 0.0 98.591 -178.739 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 . . . . . 0 N--CA 1.427 -1.596 0 CA-C-N 111.267 -2.697 . . . . 0.0 108.009 178.563 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.323 63.1 mt . . . . . 0 N--CA 1.415 -2.179 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.576 ' CA ' HD11 ' A' ' 128' ' ' LEU . . . -74.15 -61.14 3.32 Favored Glycine 0 N--CA 1.409 -3.112 0 CA-C-N 114.911 -1.041 . . . . 0.0 114.134 171.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.496 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 6.7 ptt? -85.43 -2.59 58.28 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -158.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.61 -53.23 59.96 Favored 'General case' 0 CA--C 1.455 -2.688 0 C-N-CA 114.807 -2.757 . . . . 0.0 114.461 150.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.59 HG11 ' HB3' ' A' ' 98' ' ' PHE . 12.7 t -69.77 -65.33 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.447 -2.998 0 O-C-N 126.011 2.069 . . . . 0.0 107.765 -164.055 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.656 HD11 HD12 ' A' ' 128' ' ' LEU . 14.5 mt -44.07 -55.07 4.98 Favored 'General case' 0 CA--C 1.481 -1.674 0 C-N-CA 128.757 2.823 . . . . 0.0 115.675 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.6 t-20 -63.76 -30.95 71.99 Favored 'General case' 0 CA--C 1.462 -2.404 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 174.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -81.44 -15.16 55.95 Favored 'General case' 0 N--CA 1.419 -1.993 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.853 172.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.466 HG21 ' CE2' ' A' ' 98' ' ' PHE . 2.0 t -74.71 -47.13 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.819 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 176.137 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.478 ' HE3' HG21 ' A' ' 158' ' ' VAL . 35.2 ttmt -51.61 -53.95 32.96 Favored 'General case' 0 CA--C 1.459 -2.558 0 C-N-CA 125.47 1.508 . . . . 0.0 110.642 172.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.19 -35.99 71.77 Favored 'General case' 0 N--CA 1.411 -2.415 0 C-N-CA 125.241 1.416 . . . . 0.0 110.172 -167.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -71.59 -34.98 70.38 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 115.872 -2.331 . . . . 0.0 114.885 170.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 115' ' ' ILE 0.262 0.2 OUTLIER -81.31 -26.26 35.81 Favored 'General case' 0 CA--C 1.463 -2.372 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -178.178 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -28.62 -21.61 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.511 1 C-N-CA 135.896 5.679 . . . . 0.0 119.292 178.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -53.99 -58.45 7.27 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 125.753 1.621 . . . . 0.0 112.733 164.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 tt -111.45 -43.57 3.66 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 127.338 2.255 . . . . 0.0 109.666 -159.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.854 ' HB1' HD11 ' A' ' 174' ' ' LEU 0.303 . . -115.59 142.14 47.13 Favored 'General case' 0 CA--C 1.464 -2.357 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.809 179.554 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.3 m -130.02 164.83 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.021 0 N-CA-C 121.776 3.991 . . . . 0.0 121.776 147.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.7 t -79.81 149.27 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.973 0 CA-C-N 111.06 -2.791 . . . . 0.0 107.944 -174.021 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.76 -38.87 25.0 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 113.033 -1.894 . . . . 0.0 106.079 -172.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.2 t -162.57 150.01 13.69 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -171.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.4 t80 . . . . . 0 N--CA 1.427 -1.589 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 173.142 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.448 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.291 17.7 mt-30 . . . . . 0 CA--C 1.496 -1.12 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 15.9 ttm -118.7 170.75 8.71 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 172.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.526 HD13 ' HA ' ' A' ' 127' ' ' THR . 28.2 mm -117.74 142.25 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 C-N-CA 126.727 2.011 . . . . 0.0 108.232 161.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.7 ttt -124.33 133.81 53.35 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 102.988 -2.967 . . . . 0.0 102.988 157.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.639 HG12 ' HD3' ' A' ' 123' ' ' LYS . 1.6 t -100.75 139.75 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.021 -171.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.854 HD11 ' HB1' ' A' ' 156' ' ' ALA . 1.4 tp -131.54 130.59 42.49 Favored 'General case' 0 C--N 1.365 1.263 0 CA-C-N 121.688 2.04 . . . . 0.0 106.625 -172.418 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.299 . . -129.56 178.26 1.78 Allowed Pre-proline 0 CA--C 1.49 -1.329 0 C-N-CA 125.819 1.648 . . . . 0.0 111.819 -173.106 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -71.35 158.24 54.84 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 CA-C-N 120.925 1.366 . . . . 0.0 111.036 -177.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? . . . . . 0 CA--C 1.491 -1.302 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 174.36 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 . . . . . 0 CA--C 1.475 -1.916 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.532 HG22 ' HE2' ' A' ' 123' ' ' LYS . 69.2 t -88.88 117.32 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.903 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 162.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -110.29 169.75 8.53 Favored 'General case' 0 CA--C 1.483 -1.601 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 151.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -136.37 157.95 45.59 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.812 -163.164 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 tp -131.58 163.67 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 165.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -119.57 154.42 33.93 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 119.479 -0.888 . . . . 0.0 112.321 162.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.628 ' HB3' HG11 ' A' ' 144' ' ' VAL . 45.9 m-85 -129.09 147.31 50.93 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 169.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 . . . . . 0 N--CA 1.431 -1.401 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.877 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.8 t70 . . . . . 0 N--CA 1.414 -2.229 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -86.61 -71.62 0.54 Allowed 'General case' 0 CA--C 1.482 -1.649 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.798 -166.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.506 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.311 0.0 OUTLIER -61.08 -14.76 26.21 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 118.872 2.916 . . . . 0.0 118.872 172.414 . . . . . . . . 4 4 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.17 -41.71 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.982 0.913 . . . . 0.0 109.791 162.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -93.15 6.76 46.86 Favored 'General case' 0 CA--C 1.486 -1.513 0 O-C-N 120.376 -1.452 . . . . 0.0 114.905 175.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.8 tt -85.8 -31.32 22.39 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 162.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.428 ' HA ' HG12 ' A' ' 115' ' ' ILE . 14.3 ttp180 -60.47 -45.36 94.0 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.654 1.182 . . . . 0.0 109.843 168.061 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 t -58.89 -43.07 90.91 Favored 'General case' 0 C--N 1.375 1.705 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 173.375 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.432 HD11 HD12 ' A' ' 126' ' ' ILE . 10.3 mt -60.95 -33.1 72.66 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 175.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.434 ' CG2' ' HG ' ' A' ' 155' ' ' LEU . 3.1 mm -61.06 -46.79 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 177.285 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -53.09 22.39 Favored 'General case' 0 CA--C 1.497 -1.07 0 O-C-N 125.985 2.053 . . . . 0.0 110.923 178.146 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -58.41 -46.37 86.56 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 178.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.533 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -62.06 -36.64 82.22 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 176.119 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -79.19 -21.54 46.21 Favored 'General case' 0 CA--C 1.487 -1.469 0 C-N-CA 127.671 2.388 . . . . 0.0 112.638 -173.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -71.56 -15.15 62.27 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 169.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.61 65.5 1.5 Allowed Glycine 0 CA--C 1.462 -3.252 0 N-CA-C 104.469 -3.452 . . . . 0.0 104.469 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -133.14 173.69 11.17 Favored 'General case' 0 CA--C 1.447 -3.012 1 N-CA-C 97.724 -4.917 . . . . 0.0 97.724 170.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.532 ' HE2' HG22 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -90.01 135.02 33.9 Favored 'General case' 0 N--CA 1.399 -2.978 1 N-CA-C 97.898 -4.853 . . . . 0.0 97.898 158.611 . . . . . . . . 4 4 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -79.09 156.74 28.19 Favored 'General case' 0 N--CA 1.405 -2.677 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 156.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -140.06 133.13 29.52 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 101.121 -3.659 . . . . 0.0 101.121 169.719 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.475 HD11 HD12 ' A' ' 174' ' ' LEU . 8.5 mm -83.83 134.56 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.112 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -178.358 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.6 m -116.28 121.53 42.29 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 168.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.32 154.18 33.09 Favored 'General case' 0 CA--C 1.47 -2.103 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 166.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.558 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 35.2 ttp85 -146.07 96.67 2.83 Favored 'General case' 0 N--CA 1.397 -3.1 1 N-CA-C 96.073 -5.529 . . . . 0.0 96.073 -179.482 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 . . . . . 0 N--CA 1.419 -2.022 0 CA-C-N 111.88 -2.418 . . . . 0.0 106.212 178.101 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.424 -1.772 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -68.12 -59.78 6.11 Favored Glycine 0 N--CA 1.416 -2.677 0 O-C-N 124.222 0.951 . . . . 0.0 111.439 -176.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.482 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 6.8 ptm -90.88 6.36 44.83 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -161.121 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.09 -56.02 15.4 Favored 'General case' 0 CA--C 1.455 -2.703 0 C-N-CA 115.875 -2.33 . . . . 0.0 113.559 146.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.628 HG11 ' HB3' ' A' ' 98' ' ' PHE . 24.3 t -67.89 -66.46 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.44 -3.251 0 O-C-N 126.498 2.374 . . . . 0.0 107.39 -164.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.8 mt -39.27 -57.04 1.42 Allowed 'General case' 0 CA--C 1.467 -2.224 0 C-N-CA 128.138 2.575 . . . . 0.0 114.018 178.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 161' ' ' PHE . 1.2 t-20 -52.99 -45.05 67.68 Favored 'General case' 0 CA--C 1.47 -2.132 0 C-N-CA 126.607 1.963 . . . . 0.0 115.911 175.454 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -83.27 -12.86 56.3 Favored 'General case' 0 N--CA 1.424 -1.768 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.41 179.331 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 144' ' ' VAL . 2.1 t -76.27 -40.0 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.697 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 177.367 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.41 -52.16 62.72 Favored 'General case' 0 CA--C 1.449 -2.934 0 CA-C-O 117.332 -1.318 . . . . 0.0 113.108 176.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -60.15 -39.1 85.17 Favored 'General case' 0 N--CA 1.404 -2.747 0 C-N-CA 127.097 2.159 . . . . 0.0 108.836 -178.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.458 ' HB3' HD11 ' A' ' 111' ' ' LEU . 21.1 t70 -75.52 -28.55 59.16 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 117.403 2.371 . . . . 0.0 117.403 169.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.629 ' HG ' ' HB3' ' A' ' 156' ' ' ALA 0.269 0.0 OUTLIER -75.53 -37.12 60.27 Favored 'General case' 0 CA--C 1.477 -1.841 0 CA-C-N 120.185 1.357 . . . . 0.0 112.79 179.258 . . . . . . . . 4 4 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -27.66 -32.61 0.0 OUTLIER 'General case' 0 CA--C 1.474 -1.946 1 C-N-CA 137.071 6.148 . . . . 0.0 119.079 -164.653 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 4.7 mt-10 -52.43 -51.3 59.86 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 127.37 2.268 . . . . 0.0 113.153 172.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.434 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 2.7 tm? -109.4 -47.81 3.34 Favored 'General case' 0 N--CA 1.42 -1.953 0 C-N-CA 128.716 2.806 . . . . 0.0 107.472 -161.171 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.629 ' HB3' ' HG ' ' A' ' 152' ' ' LEU 0.327 . . -119.64 140.59 50.37 Favored 'General case' 0 CA--C 1.457 -2.606 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.372 -176.765 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.2 m -126.32 -176.36 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.47 -2.111 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 155.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.35 166.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.58 0 C-N-CA 126.619 1.968 . . . . 0.0 110.159 -165.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -85.87 -41.65 14.8 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 154.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -164.59 146.24 8.27 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.997 -171.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.495 ' CZ ' ' HA ' ' A' ' 146' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.462 -2.408 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 170.404 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.558 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.337 18.7 mt-30 . . . . . 0 CA--C 1.502 -0.866 0 CA-C-O 119.059 -0.496 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 22.4 ttp -115.32 115.53 26.78 Favored 'General case' 0 CA--C 1.481 -1.692 0 CA-C-O 121.472 0.654 . . . . 0.0 111.679 -171.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.0 mm -81.72 126.88 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.367 0 CA-C-O 122.123 0.964 . . . . 0.0 108.76 172.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.435 ' SD ' ' CZ ' ' A' ' 161' ' ' PHE . 3.2 ttt -112.65 142.96 44.63 Favored 'General case' 0 CA--C 1.476 -1.875 0 N-CA-C 103.167 -2.901 . . . . 0.0 103.167 155.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.6 t -98.87 153.37 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 118.589 -1.244 . . . . 0.0 107.696 -175.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.475 HD12 HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -134.92 81.75 1.92 Allowed 'General case' 0 C--N 1.36 1.053 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -174.836 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.278 . . -83.34 174.4 6.05 Favored Pre-proline 0 CA--C 1.505 -0.787 0 O-C-N 119.637 -1.914 . . . . 0.0 115.038 -175.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -68.33 135.93 35.55 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.363 2.042 . . . . 0.0 108.996 165.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt . . . . . 0 N--CA 1.43 -1.466 0 O-C-N 124.037 0.836 . . . . 0.0 110.864 171.851 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.8 m . . . . . 0 CA--C 1.482 -1.656 0 CA-C-O 122.241 1.019 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.7 mm -92.2 126.57 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 113.141 -1.845 . . . . 0.0 108.176 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -95.95 167.89 10.96 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.642 HG22 ' HD3' ' A' ' 123' ' ' LYS . 70.2 t -102.04 114.32 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.665 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 161.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -108.94 -179.83 3.97 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 156.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -143.82 158.42 43.69 Favored 'General case' 0 N--CA 1.433 -1.309 0 O-C-N 123.462 0.476 . . . . 0.0 110.544 -169.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.9 tp -135.35 162.23 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 166.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -120.91 157.26 30.25 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 118.863 0.756 . . . . 0.0 111.396 165.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.627 ' HB3' HG11 ' A' ' 144' ' ' VAL . 39.8 m-85 -136.92 100.32 4.27 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 173.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -85.45 171.31 10.97 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 124.124 0.97 . . . . 0.0 109.086 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.443 ' HG3' ' H ' ' A' ' 131' ' ' ARG . 9.2 Cg_endo -74.5 140.89 27.52 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 N-CA-C 106.202 -2.268 . . . . 0.0 106.202 174.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.36 9.9 59.91 Favored Glycine 0 CA--C 1.483 -1.952 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 95.6 m -106.04 92.79 4.3 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 170.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -128.71 174.88 9.04 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-N 112.692 -2.049 . . . . 0.0 108.993 172.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -27.32 -56.21 0.09 Allowed 'General case' 0 CA--C 1.486 -1.485 1 C-N-CA 132.399 4.28 . . . . 0.0 116.097 -145.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -21.26 -75.1 0.01 OUTLIER Glycine 0 CA--C 1.472 -2.625 1 C-N-CA 130.745 4.021 . . . . 0.0 118.539 163.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -81.58 -33.07 31.81 Favored 'General case' 0 N--CA 1.424 -1.757 0 C-N-CA 128.931 2.893 . . . . 0.0 109.357 -175.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -73.95 -71.17 0.34 Allowed 'General case' 0 CA--C 1.474 -1.977 0 CA-C-N 111.572 -2.558 . . . . 0.0 113.082 -161.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.33 0.0 OUTLIER -60.63 -14.11 18.47 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 119.639 3.2 . . . . 0.0 119.639 175.693 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 87.5 t -60.65 -47.82 91.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.18 0.99 . . . . 0.0 109.444 161.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -91.94 7.66 41.09 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 6.0 tt -84.08 -32.78 24.6 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 162.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.481 ' HA ' HG12 ' A' ' 115' ' ' ILE . 58.3 ttt-85 -61.87 -42.79 99.48 Favored 'General case' 0 C--N 1.363 1.189 0 CA-C-O 118.739 -0.648 . . . . 0.0 110.677 168.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.6 t -61.56 -41.31 97.19 Favored 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.512 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.46 HD11 HD23 ' A' ' 174' ' ' LEU . 65.0 tp -70.08 -29.29 66.24 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-O 117.088 -1.434 . . . . 0.0 113.541 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.481 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.269 10.0 mm -55.47 -53.08 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.957 0 CA-C-N 120.293 1.406 . . . . 0.0 107.569 170.014 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -47.29 -48.9 24.71 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 128.649 2.78 . . . . 0.0 111.776 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -56.81 -55.71 30.83 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.561 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -54.94 -36.17 64.99 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 174.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -89.1 -14.9 35.21 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 128.929 2.892 . . . . 0.0 110.341 -166.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -67.57 -24.94 65.57 Favored 'General case' 0 C--N 1.36 1.023 0 C-N-CA 122.981 0.512 . . . . 0.0 109.706 161.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 93.42 57.52 1.35 Allowed Glycine 0 CA--C 1.472 -2.655 0 N-CA-C 104.542 -3.423 . . . . 0.0 104.542 -174.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -126.53 167.73 15.23 Favored 'General case' 0 CA--C 1.462 -2.408 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.642 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -101.54 115.61 30.91 Favored 'General case' 0 N--CA 1.407 -2.597 1 N-CA-C 99.762 -4.162 . . . . 0.0 99.762 176.689 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.77 115.7 31.11 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.065 -1.425 . . . . 0.0 107.751 -168.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -97.44 121.58 39.51 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -171.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.1 mm -84.04 134.22 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.486 ' HA ' HD13 ' A' ' 171' ' ' ILE . 25.7 m -119.62 124.06 45.4 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 173.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.662 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.1 OUTLIER -88.02 155.84 19.61 Favored 'General case' 0 CA--C 1.467 -2.236 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 167.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.478 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 22.2 ttt85 -152.07 91.52 1.62 Allowed 'General case' 0 N--CA 1.397 -3.115 1 N-CA-C 99.221 -4.363 . . . . 0.0 99.221 -174.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.498 ' CE1' HD22 ' A' ' 128' ' ' LEU . 92.0 m-85 -76.1 151.41 37.05 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 112.437 -2.165 . . . . 0.0 108.755 -173.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.443 ' H ' ' HG3' ' A' ' 100' ' ' PRO . 4.9 tmt_? -82.66 92.63 7.2 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 101.675 -3.454 . . . . 0.0 101.675 153.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 176.07 -150.21 10.5 Favored Glycine 0 N--CA 1.423 -2.204 0 C-N-CA 116.067 -2.968 . . . . 0.0 112.118 -162.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.5 mtm105 -150.82 -164.24 1.97 Allowed 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -158.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -67.69 -29.41 68.67 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 126.562 1.945 . . . . 0.0 111.496 176.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 28.5 ttt -126.32 93.4 3.79 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 102.936 -2.987 . . . . 0.0 102.936 155.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.07 -57.02 6.78 Favored 'General case' 0 CA--C 1.469 -2.17 0 CA-C-O 124.729 2.204 . . . . 0.0 110.865 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.516 ' HB2' ' H ' ' A' ' 139' ' ' GLN . 14.6 p80 -118.37 172.11 7.68 Favored 'General case' 0 N--CA 1.416 -2.167 1 CA-C-N 108.174 -4.103 . . . . 0.0 112.226 -155.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -134.21 4.58 3.47 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 104.257 -2.498 . . . . 0.0 104.257 149.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.516 ' H ' ' HB2' ' A' ' 137' ' ' HIS . 12.3 mt-30 -120.84 -57.41 1.89 Allowed 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.116 -166.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.491 ' H ' ' HB2' ' A' ' 137' ' ' HIS . 82.1 mt -52.4 -48.27 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.188 0 C-N-CA 128.963 2.905 . . . . 0.0 111.476 -169.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.662 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -79.59 -60.95 2.38 Favored Glycine 0 N--CA 1.41 -3.099 0 C-N-CA 118.867 -1.635 . . . . 0.0 111.926 -170.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 72.4 mtm -89.51 0.08 57.14 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -161.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -67.77 -50.37 57.47 Favored 'General case' 0 CA--C 1.457 -2.614 0 C-N-CA 116.096 -2.242 . . . . 0.0 113.295 151.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.627 HG11 ' HB3' ' A' ' 98' ' ' PHE . 21.8 t -67.81 -69.22 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.443 -3.168 0 O-C-N 125.946 2.028 . . . . 0.0 108.15 -166.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' A' ' 172' ' ' MET . 27.8 mt -42.22 -53.31 4.12 Favored 'General case' 0 CA--C 1.476 -1.887 0 C-N-CA 128.929 2.891 . . . . 0.0 115.119 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -62.9 -36.16 82.43 Favored 'General case' 0 CA--C 1.46 -2.508 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -81.76 -14.15 56.82 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.603 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.6 t -77.68 -46.2 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.768 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.455 ' HB2' HG21 ' A' ' 158' ' ' VAL . 29.7 ttmt -51.93 -50.62 60.79 Favored 'General case' 0 CA--C 1.463 -2.401 0 C-N-CA 125.583 1.553 . . . . 0.0 111.003 171.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.64 -36.62 70.76 Favored 'General case' 0 N--CA 1.411 -2.404 0 C-N-CA 124.447 1.099 . . . . 0.0 110.187 -169.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -72.69 -40.09 66.5 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 116.305 -2.158 . . . . 0.0 115.299 170.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.289 0.2 OUTLIER -80.2 -19.97 45.78 Favored 'General case' 0 CA--C 1.464 -2.352 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -177.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -26.38 -27.04 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.443 1 C-N-CA 134.457 5.103 . . . . 0.0 118.901 173.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -55.28 -59.04 5.35 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 127.045 2.138 . . . . 0.0 112.902 169.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.42 -52.1 3.19 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 125.842 1.657 . . . . 0.0 107.805 -167.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.929 ' HB1' HD11 ' A' ' 174' ' ' LEU 0.281 . . -100.28 141.44 33.12 Favored 'General case' 0 CA--C 1.459 -2.546 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.882 -178.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.5 m -123.93 164.25 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.421 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 139.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.5 t -84.08 153.46 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.104 0 CA-C-N 110.021 -3.263 . . . . 0.0 108.478 -172.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -82.32 -41.25 20.32 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.3 t -152.45 151.17 30.44 Favored 'General case' 0 CA--C 1.468 -2.174 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -99.89 104.4 28.32 Favored Pre-proline 0 N--CA 1.424 -1.768 0 N-CA-C 101.199 -3.63 . . . . 0.0 101.199 164.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -74.19 -44.81 0.4 Allowed 'Trans proline' 0 CA--C 1.485 -1.954 0 C-N-CA 124.074 3.182 . . . . 0.0 111.241 -148.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.427 ' HA ' ' SD ' ' A' ' 170' ' ' MET 0.283 1.9 m 8.22 50.41 0.0 OUTLIER 'General case' 0 N--CA 1.412 -2.339 1 C-N-CA 136.185 5.794 . . . . 0.0 118.764 -156.918 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.32 105.16 7.94 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 111.33 -2.668 . . . . 0.0 106.022 163.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.402 HG23 ' HB2' ' A' ' 170' ' ' MET . 0.6 OUTLIER -81.79 141.58 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -119.35 105.89 11.75 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.77 -152.28 31.61 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -173.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -95.54 33.83 1.56 Allowed 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 125.25 1.42 . . . . 0.0 111.23 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.478 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.3 38.0 mt-30 -165.78 144.85 6.19 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 124.338 1.055 . . . . 0.0 108.221 -167.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.427 ' SD ' ' HA ' ' A' ' 163' ' ' THR . 51.8 ttp -134.93 118.73 17.2 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 119.155 0.889 . . . . 0.0 111.671 -173.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 127' ' ' THR . 22.0 mm -82.49 123.94 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 O-C-N 121.31 -0.869 . . . . 0.0 108.666 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.403 ' HB3' HD22 ' A' ' 145' ' ' LEU . 2.9 ttt -101.07 130.29 47.07 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 159.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.16 134.87 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -173.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.929 HD11 ' HB1' ' A' ' 156' ' ' ALA . 1.1 tp -129.19 143.73 50.96 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 -174.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.32 . . -131.98 178.36 1.79 Allowed Pre-proline 0 CA--C 1.488 -1.424 0 C-N-CA 123.813 0.845 . . . . 0.0 110.065 -174.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.523 ' HA ' HD21 ' A' ' 118' ' ' LEU . 78.0 Cg_exo -62.73 148.23 93.66 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 122.932 2.421 . . . . 0.0 109.059 160.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -74.0 125.28 27.91 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -77.03 126.91 31.74 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 113.277 -1.783 . . . . 0.0 109.726 -167.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -72.43 126.98 31.16 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 . . . . . 0 C--O 1.26 1.642 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.889 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 CA--C 1.482 -1.635 0 CA-C-O 122.204 1.002 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.4 mm -84.89 122.23 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.497 0 CA-C-N 112.842 -1.981 . . . . 0.0 106.289 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -96.72 167.05 11.35 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 -167.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.509 HG22 ' HE3' ' A' ' 123' ' ' LYS . 82.0 t -103.03 124.77 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -108.38 171.74 7.24 Favored 'General case' 0 CA--C 1.479 -1.784 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 154.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -144.43 146.65 32.6 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 tp -124.97 160.07 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.085 0 N-CA-C 103.169 -2.9 . . . . 0.0 103.169 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -119.22 154.12 33.89 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 119.414 -0.915 . . . . 0.0 110.447 162.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.588 ' HB3' HG11 ' A' ' 144' ' ' VAL . 34.1 m-85 -134.03 110.83 9.91 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -89.16 165.45 26.4 Favored Pre-proline 0 N--CA 1.429 -1.486 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.443 ' HB3' HG23 ' A' ' 140' ' ' ILE . 10.1 Cg_endo -70.84 138.46 34.43 Favored 'Trans proline' 0 N--CA 1.437 -1.847 0 C-N-CA 123.377 2.718 . . . . 0.0 106.479 167.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.04 7.8 67.65 Favored Glycine 0 CA--C 1.482 -2.028 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.6 m -101.21 91.4 4.5 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 169.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -133.85 -150.55 0.41 Allowed 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 170.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -61.2 -66.62 0.51 Allowed 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 118.76 0.709 . . . . 0.0 109.188 -85.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -104.75 33.53 6.5 Favored Glycine 0 CA--C 1.486 -1.778 0 CA-C-N 118.676 0.671 . . . . 0.0 112.854 -177.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.19 -38.02 9.47 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 152.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.91 -73.71 0.13 Allowed 'General case' 0 CA--C 1.477 -1.86 0 C-N-CA 127.209 2.203 . . . . 0.0 110.371 -173.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.487 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.275 0.0 OUTLIER -65.49 -9.02 22.32 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 119.394 3.109 . . . . 0.0 119.394 -179.321 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.84 -42.79 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 122.169 0.985 . . . . 0.0 110.793 161.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -91.67 -1.53 57.4 Favored 'General case' 0 CA--C 1.477 -1.831 0 O-C-N 120.352 -1.468 . . . . 0.0 114.686 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.5 tt -76.79 -31.98 57.36 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 161.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.536 ' HA ' HG12 ' A' ' 115' ' ' ILE . 31.4 ttt180 -62.47 -45.03 94.88 Favored 'General case' 0 C--N 1.363 1.19 0 C-N-CA 123.812 0.845 . . . . 0.0 111.482 170.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.1 m -61.77 -42.31 98.83 Favored 'General case' 0 C--N 1.377 1.796 0 C-N-CA 118.666 -1.214 . . . . 0.0 113.761 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.653 HD11 HD12 ' A' ' 174' ' ' LEU 0.323 52.4 tp -68.0 -27.92 66.98 Favored 'General case' 0 N--CA 1.406 -2.644 0 C-N-CA 126.73 2.012 . . . . 0.0 113.67 177.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.289 9.4 mm -57.33 -52.87 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.901 0 CA-C-N 121.036 1.744 . . . . 0.0 108.217 170.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -53.78 -42.64 68.5 Favored 'General case' 0 CA--C 1.492 -1.262 0 O-C-N 125.816 1.947 . . . . 0.0 110.402 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -58.21 -54.11 50.66 Favored 'General case' 0 CA--C 1.481 -1.701 0 C-N-CA 125.343 1.457 . . . . 0.0 112.639 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.552 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -61.16 -33.07 72.84 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 177.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -73.58 -31.56 63.66 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 129.116 2.966 . . . . 0.0 109.798 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -64.67 -19.75 65.9 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 124.213 1.005 . . . . 0.0 111.679 171.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.53 54.79 2.72 Favored Glycine 0 CA--C 1.469 -2.825 0 N-CA-C 103.995 -3.642 . . . . 0.0 103.995 -174.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -120.42 163.52 17.77 Favored 'General case' 0 CA--C 1.447 -2.984 1 N-CA-C 99.82 -4.141 . . . . 0.0 99.82 170.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.509 ' HE3' HG22 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -101.04 116.13 32.12 Favored 'General case' 0 N--CA 1.393 -3.285 1 N-CA-C 98.644 -4.576 . . . . 0.0 98.644 171.526 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.52 156.71 25.12 Favored 'General case' 0 N--CA 1.407 -2.585 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 173.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.314 27.4 mtpp -131.44 138.76 49.19 Favored 'General case' 0 CA--C 1.487 -1.458 0 O-C-N 118.688 -2.507 . . . . 0.0 104.248 163.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.9 mm -85.43 136.77 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 27.5 m -117.51 130.11 56.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 169.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.643 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.1 OUTLIER -92.19 160.09 15.34 Favored 'General case' 0 CA--C 1.468 -2.189 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 167.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.413 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 56.1 ttt180 -152.48 96.26 2.13 Favored 'General case' 0 N--CA 1.402 -2.843 1 N-CA-C 99.036 -4.431 . . . . 0.0 99.036 -174.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.667 ' CE2' HD13 ' A' ' 165' ' ' ILE . 96.8 m-85 -80.49 103.96 10.7 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 113.068 -1.878 . . . . 0.0 106.438 -175.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -133.54 21.13 3.94 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.67 -50.08 4.85 Favored Glycine 0 CA--C 1.46 -3.375 0 N-CA-C 105.113 -3.195 . . . . 0.0 105.113 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -122.33 153.53 38.85 Favored 'General case' 0 CA--C 1.481 -1.71 0 N-CA-C 100.603 -3.851 . . . . 0.0 100.603 161.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -54.92 -42.4 72.17 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 125.001 1.321 . . . . 0.0 111.901 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 9.7 ptm -61.81 -100.57 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.528 ' HB1' HD12 ' A' ' 165' ' ' ILE . . . 171.27 112.3 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -145.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.438 ' CD2' HD12 ' A' ' 140' ' ' ILE . 10.2 m-70 -130.38 147.9 52.14 Favored 'General case' 0 CA--C 1.477 -1.829 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.91 173.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.12 9.03 43.45 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -79.36 -55.39 5.1 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 103.831 -2.655 . . . . 0.0 103.831 163.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.443 HG23 ' HB3' ' A' ' 100' ' ' PRO . 89.5 mt -52.2 -48.96 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.843 0 C-N-CA 126.405 1.882 . . . . 0.0 111.011 175.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.643 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -78.94 -57.85 3.14 Favored Glycine 0 N--CA 1.407 -3.245 0 C-N-CA 119.355 -1.403 . . . . 0.0 112.505 -167.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 58.4 mtm -93.92 18.24 10.84 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -170.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.86 -61.25 1.96 Allowed 'General case' 0 CA--C 1.456 -2.657 0 C-N-CA 115.138 -2.625 . . . . 0.0 114.573 133.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.588 HG11 ' HB3' ' A' ' 98' ' ' PHE . 23.7 t -64.07 -66.14 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.444 -3.111 0 O-C-N 126.213 2.196 . . . . 0.0 109.064 -160.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.1 mt -43.58 -55.81 4.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 127.811 2.444 . . . . 0.0 114.003 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -53.62 -43.12 68.41 Favored 'General case' 0 CA--C 1.485 -1.522 0 C-N-CA 126.791 2.036 . . . . 0.0 114.159 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -82.48 -14.26 55.33 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 144' ' ' VAL . 2.5 t -72.93 -44.57 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.597 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.448 ' CE ' HG22 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -60.22 -53.94 51.74 Favored 'General case' 0 CA--C 1.45 -2.888 0 O-C-N 125.126 1.516 . . . . 0.0 112.722 179.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.88 -38.68 82.91 Favored 'General case' 0 N--CA 1.403 -2.791 0 C-N-CA 127.686 2.394 . . . . 0.0 109.241 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.412 ' HB3' HD11 ' A' ' 111' ' ' LEU . 25.4 t70 -71.01 -40.48 71.79 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 116.065 -2.254 . . . . 0.0 116.901 168.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.483 HD13 HD11 ' A' ' 174' ' ' LEU 0.277 0.2 OUTLIER -80.2 -22.89 41.39 Favored 'General case' 0 CA--C 1.463 -2.384 0 N-CA-C 117.263 2.319 . . . . 0.0 117.263 -175.285 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -27.51 -27.96 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.44 1 C-N-CA 135.376 5.47 . . . . 0.0 118.483 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 3.4 mt-10 -50.77 -53.52 31.06 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 127.353 2.261 . . . . 0.0 112.842 168.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -53.56 2.99 Favored 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 126.102 1.761 . . . . 0.0 110.309 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.552 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.299 . . -110.32 136.54 49.34 Favored 'General case' 0 CA--C 1.452 -2.821 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -163.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.433 HG22 ' HA ' ' A' ' 177' ' ' LYS . 12.1 m -126.16 -179.57 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.407 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 161.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.448 HG22 ' CE ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -85.71 163.41 2.67 Favored 'Isoleucine or valine' 1 N--CA 1.377 -4.091 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.54 -166.312 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -84.5 -41.72 16.25 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 156.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.422 ' H ' HG12 ' A' ' 158' ' ' VAL 0.269 0.4 OUTLIER -169.85 150.87 4.0 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.921 -169.106 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.37 91.68 2.78 Favored Pre-proline 0 N--CA 1.426 -1.649 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 167.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -83.79 -91.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.216 0 O-C-N 123.318 1.167 . . . . 0.0 110.156 -130.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.739 HG22 ' H ' ' A' ' 164' ' ' LYS 0.389 1.1 m -132.49 -104.58 0.26 Allowed 'General case' 0 N--CA 1.408 -2.537 0 N-CA-C 102.979 -2.971 . . . . 0.0 102.979 -144.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.739 ' H ' HG22 ' A' ' 163' ' ' THR . 18.1 ptpt -153.81 170.48 20.87 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 102.577 -3.12 . . . . 0.0 102.577 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.667 HD13 ' CE2' ' A' ' 130' ' ' PHE . 2.7 mt -79.7 137.11 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 CA-C-O 122.621 1.201 . . . . 0.0 108.33 -175.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -124.78 109.39 13.03 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.98 -147.68 30.8 Favored Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -170.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 81.4 mtt85 -104.66 36.16 2.52 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.935 -1.132 . . . . 0.0 110.487 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.413 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.267 32.3 mt-30 -169.32 145.11 3.24 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -166.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 56.1 ttp -141.29 116.29 9.86 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-O 122.079 0.942 . . . . 0.0 112.063 -173.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 8.7 mm -80.35 135.95 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.841 0 O-C-N 120.944 -1.098 . . . . 0.0 109.005 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -108.53 131.42 54.85 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 151.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.47 135.81 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.653 HD12 HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -120.82 81.98 1.85 Allowed 'General case' 0 C--N 1.356 0.884 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -170.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -87.03 179.01 1.92 Allowed Pre-proline 0 CA--C 1.509 -0.599 0 O-C-N 118.407 -2.683 . . . . 0.0 117.128 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.503 ' HA ' HD21 ' A' ' 118' ' ' LEU . 68.0 Cg_exo -64.35 137.69 56.97 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 122.702 2.268 . . . . 0.0 111.966 169.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.433 ' HA ' HG22 ' A' ' 157' ' ' VAL . 33.9 ttpt -81.14 135.97 35.84 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 168.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.32 107.44 17.33 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 172.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -71.63 120.68 17.56 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 . . . . . 0 C--O 1.26 1.642 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.707 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 CA--C 1.483 -1.613 0 CA-C-O 121.762 0.792 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.417 HG22 ' HG3' ' A' ' 123' ' ' LYS . 33.2 mm -86.64 121.4 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 C-N-CA 126.537 1.935 . . . . 0.0 107.657 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -113.5 161.88 16.82 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -160.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.44 117.48 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.744 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -112.24 173.99 6.1 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 153.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -139.5 159.25 42.59 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 123.34 0.4 . . . . 0.0 109.951 -165.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 tp -137.03 162.8 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 165.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -121.35 153.27 37.98 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.675 0.75 . . . . 0.0 112.225 164.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.595 ' HB3' HG11 ' A' ' 144' ' ' VAL . 43.7 m-85 -130.27 135.04 47.68 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 170.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.444 ' HD3' HH21 ' A' ' 129' ' ' ARG . 22.1 mtm-85 -113.84 171.88 4.03 Favored Pre-proline 0 N--CA 1.434 -1.249 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -73.74 136.67 23.6 Favored 'Trans proline' 0 N--CA 1.433 -2.067 0 N-CA-C 105.158 -2.67 . . . . 0.0 105.158 162.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.38 9.18 62.0 Favored Glycine 0 CA--C 1.483 -1.96 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.2 m -104.16 89.91 3.42 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -121.96 -175.63 3.15 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 112.325 -2.216 . . . . 0.0 106.249 172.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -51.18 -42.1 60.63 Favored 'General case' 0 CA--C 1.481 -1.685 0 C-N-CA 127.116 2.167 . . . . 0.0 115.103 -132.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.7 -6.52 80.0 Favored Glycine 0 N--CA 1.417 -2.621 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 -170.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -98.16 -30.8 12.44 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 125.42 1.488 . . . . 0.0 107.349 167.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.7 -73.29 0.45 Allowed 'General case' 0 CA--C 1.475 -1.904 0 CA-C-N 112.316 -2.22 . . . . 0.0 110.868 -156.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.5 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.331 0.0 OUTLIER -58.13 -15.85 11.11 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 119.038 2.977 . . . . 0.0 119.038 174.66 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.67 -48.94 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-O 122.488 1.137 . . . . 0.0 110.233 162.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -91.72 8.07 38.73 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.7 tt -84.29 -32.23 24.49 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 161.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.467 ' HA ' HG12 ' A' ' 115' ' ' ILE . 57.4 ttt180 -62.84 -44.2 96.77 Favored 'General case' 0 C--N 1.363 1.157 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.636 168.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 69.3 m -60.08 -40.38 89.34 Favored 'General case' 0 C--N 1.378 1.824 0 C-N-CA 118.464 -1.295 . . . . 0.0 113.532 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.588 HD11 HD12 ' A' ' 126' ' ' ILE . 5.9 mt -61.02 -33.68 73.65 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.3 mm -58.52 -48.86 84.24 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.648 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -49.82 -51.26 41.16 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 125.814 1.946 . . . . 0.0 112.255 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -54.75 -50.38 68.56 Favored 'General case' 0 CA--C 1.476 -1.874 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.621 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -61.73 -43.24 99.23 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 178.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.3 -12.63 56.46 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 125.723 1.609 . . . . 0.0 112.358 -171.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.18 -12.7 60.97 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 124.112 0.965 . . . . 0.0 109.759 166.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.82 60.73 1.57 Allowed Glycine 0 CA--C 1.467 -2.908 0 N-CA-C 106.45 -2.66 . . . . 0.0 106.45 175.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -135.93 175.49 9.55 Favored 'General case' 0 CA--C 1.462 -2.42 0 N-CA-C 102.301 -3.222 . . . . 0.0 102.301 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.417 ' HG3' HG22 ' A' ' 91' ' ' ILE 0.299 21.0 mtpt -89.21 148.05 23.82 Favored 'General case' 0 N--CA 1.405 -2.682 1 N-CA-C 100.046 -4.057 . . . . 0.0 100.046 165.35 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.469 ' HB1' ' CD2' ' A' ' 114' ' ' LEU . . . -117.26 115.41 25.23 Favored 'General case' 0 N--CA 1.407 -2.585 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 173.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -100.63 116.56 32.84 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.588 HD12 HD11 ' A' ' 114' ' ' LEU . 6.9 mm -85.73 132.23 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 28.1 m -119.65 127.92 53.36 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.429 ' CB ' ' H ' ' A' ' 170' ' ' MET 0.26 0.2 OUTLIER -79.91 154.88 28.03 Favored 'General case' 0 CA--C 1.469 -2.148 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 167.54 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.485 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 47.0 ttp180 -145.18 91.19 2.11 Favored 'General case' 0 N--CA 1.404 -2.759 1 N-CA-C 100.154 -4.017 . . . . 0.0 100.154 178.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -75.48 153.37 37.58 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 111.84 -2.437 . . . . 0.0 110.301 -170.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -116.88 19.77 14.22 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 170.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.0 -25.01 13.57 Favored Glycine 0 CA--C 1.482 -2.019 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 61.04 -179.85 0.11 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 129.796 3.238 . . . . 0.0 115.814 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 3.83 99.05 0.01 OUTLIER 'General case' 0 C--N 1.363 1.191 1 C-N-CA 132.907 4.483 . . . . 0.0 116.915 -169.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 37.3 tpp 55.58 73.71 0.41 Allowed 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 126.872 2.069 . . . . 0.0 107.955 -172.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.443 ' HB1' ' H ' ' A' ' 137' ' ' HIS . . . -81.27 -143.52 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 123.576 1.655 . . . . 0.0 115.159 -164.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.619 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 74.6 m-70 -87.79 155.84 19.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.271 2.628 . . . . 0.0 115.604 -168.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -120.21 7.08 10.73 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 169.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -89.28 -56.57 3.21 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.619 ' HB ' ' HB2' ' A' ' 137' ' ' HIS . 93.6 mt -59.47 -43.83 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 C-N-CA 127.586 2.354 . . . . 0.0 110.41 177.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.38 -69.37 1.4 Allowed Glycine 0 N--CA 1.412 -2.918 0 O-C-N 124.094 0.871 . . . . 0.0 111.747 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 55.0 mtm -96.56 23.57 6.76 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -163.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -72.92 -55.86 6.0 Favored 'General case' 0 CA--C 1.452 -2.824 0 C-N-CA 116.355 -2.138 . . . . 0.0 113.072 135.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 98' ' ' PHE . 38.9 t -64.69 -67.28 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.445 -3.063 0 O-C-N 126.512 2.382 . . . . 0.0 108.526 -163.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.0 mt -42.02 -54.98 3.34 Favored 'General case' 0 CA--C 1.475 -1.942 0 C-N-CA 127.662 2.385 . . . . 0.0 113.768 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -54.48 -44.76 72.92 Favored 'General case' 0 CA--C 1.484 -1.559 0 C-N-CA 126.619 1.967 . . . . 0.0 114.031 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -83.26 -12.29 56.9 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 118.386 0.539 . . . . 0.0 112.102 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 144' ' ' VAL . 2.3 t -73.87 -44.46 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.683 ' NZ ' HD13 ' A' ' 174' ' ' LEU . 0.8 OUTLIER -61.12 -53.76 53.01 Favored 'General case' 0 CA--C 1.451 -2.859 0 O-C-N 125.366 1.666 . . . . 0.0 112.341 179.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -61.9 -36.75 82.25 Favored 'General case' 0 N--CA 1.403 -2.784 0 C-N-CA 126.807 2.043 . . . . 0.0 109.716 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.426 ' HB3' HD11 ' A' ' 111' ' ' LEU . 24.9 t70 -72.87 -34.1 66.5 Favored 'General case' 0 C--N 1.358 0.948 0 C-N-CA 115.955 -2.298 . . . . 0.0 116.469 169.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.31 0.2 OUTLIER -81.31 -27.91 34.83 Favored 'General case' 0 CA--C 1.464 -2.331 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -176.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -28.42 -25.78 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.531 1 C-N-CA 136.116 5.766 . . . . 0.0 118.885 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 5.4 mt-10 -48.71 -50.44 33.47 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 127.65 2.38 . . . . 0.0 113.234 166.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 tt -114.66 -48.57 2.85 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 126.282 1.833 . . . . 0.0 108.895 -170.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 1.046 ' HB1' HD11 ' A' ' 174' ' ' LEU 0.284 . . -110.82 131.02 55.41 Favored 'General case' 0 CA--C 1.463 -2.398 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -170.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 177' ' ' LYS . 4.2 m -128.12 175.33 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.029 0 N-CA-C 119.929 3.307 . . . . 0.0 119.929 162.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -83.14 162.49 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.388 0 C-N-CA 126.309 1.844 . . . . 0.0 111.054 -159.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.61 -44.19 12.83 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 159.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.491 ' H ' HG12 ' A' ' 158' ' ' VAL 0.265 0.9 OUTLIER -167.92 145.81 4.43 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.621 -171.51 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -105.74 111.21 64.69 Favored Pre-proline 0 CA--C 1.478 -1.817 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 172.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 73.0 Cg_endo -133.2 -119.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.419 -2.895 0 N-CA-C 103.235 -3.41 . . . . 0.0 103.235 -157.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -170.4 -40.92 0.02 OUTLIER 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 -128.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -85.94 97.57 10.31 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-O 121.256 0.55 . . . . 0.0 110.704 -155.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.03 129.0 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 169.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -108.51 94.58 5.13 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 111.694 -2.503 . . . . 0.0 105.712 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.56 -127.41 8.3 Favored Glycine 0 CA--C 1.479 -2.178 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -108.9 44.83 1.09 Allowed 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 112.473 -1.863 . . . . 0.0 109.865 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.485 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.281 20.2 mt-30 -162.25 130.6 4.1 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-O 118.585 -0.721 . . . . 0.0 111.014 -175.52 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.429 ' H ' ' CB ' ' A' ' 128' ' ' LEU . 32.5 ttp -118.43 117.54 29.31 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 119.743 1.156 . . . . 0.0 113.841 -169.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.7 mm -84.37 127.16 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.356 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.51 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -105.53 130.3 53.62 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 101.339 -3.578 . . . . 0.0 101.339 150.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.3 t -91.93 136.32 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 1.046 HD11 ' HB1' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -122.25 147.64 45.97 Favored 'General case' 0 N--CA 1.439 -0.988 1 N-CA-C 99.177 -4.379 . . . . 0.0 99.177 -176.997 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.431 ' H ' HD12 ' A' ' 174' ' ' LEU 0.351 . . -137.19 179.87 1.24 Allowed Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 125.61 1.564 . . . . 0.0 109.426 -173.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.463 ' HA ' HD21 ' A' ' 118' ' ' LEU . 84.2 Cg_exo -63.75 138.16 62.4 Favored 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 122.681 2.254 . . . . 0.0 110.176 167.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.494 ' HA ' HG22 ' A' ' 157' ' ' VAL . 36.6 ttpt -78.35 141.36 38.47 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 165.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.49 102.85 1.2 Allowed 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 125.412 1.485 . . . . 0.0 110.007 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -81.96 125.49 30.83 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 . . . . . 0 C--O 1.259 1.589 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 179.78 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 CA--C 1.478 -1.793 0 CA-C-O 122.868 1.318 . . . . 0.0 111.445 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -93.12 149.36 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.035 0 N-CA-C 102.095 -3.298 . . . . 0.0 102.095 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -97.91 163.04 12.95 Favored 'General case' 0 CA--C 1.48 -1.73 0 C-N-CA 118.088 -1.445 . . . . 0.0 109.053 -167.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.555 HG22 ' HE2' ' A' ' 123' ' ' LYS . 69.0 t -88.49 114.26 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.793 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 174.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -109.9 179.84 4.0 Favored 'General case' 0 CA--C 1.472 -2.057 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 160.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -146.68 158.01 43.82 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.585 -168.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 tp -135.59 163.25 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 169.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -116.46 154.2 30.76 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-O 121.522 0.677 . . . . 0.0 111.496 162.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.663 ' HB3' HG11 ' A' ' 144' ' ' VAL . 40.9 m-85 -130.52 131.4 45.06 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 102.866 -3.012 . . . . 0.0 102.866 166.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -113.33 171.0 4.7 Favored Pre-proline 0 N--CA 1.431 -1.376 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -74.02 140.83 28.93 Favored 'Trans proline' 0 N--CA 1.432 -2.121 0 N-CA-C 105.377 -2.586 . . . . 0.0 105.377 165.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.42 6.07 68.82 Favored Glycine 0 CA--C 1.485 -1.843 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.9 m -108.21 92.51 4.09 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 168.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -126.46 175.36 7.94 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 112.996 -1.911 . . . . 0.0 107.014 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -24.0 -57.16 0.04 OUTLIER 'General case' 0 CA--C 1.487 -1.472 1 C-N-CA 132.507 4.323 . . . . 0.0 116.223 -149.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -21.81 -77.01 0.01 OUTLIER Glycine 0 CA--C 1.47 -2.764 1 C-N-CA 131.148 4.213 . . . . 0.0 117.903 165.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . 0.328 52.6 m-20 -81.24 -32.4 33.38 Favored 'General case' 0 N--CA 1.404 -2.726 0 C-N-CA 131.052 3.741 . . . . 0.0 110.806 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -72.83 -72.58 0.24 Allowed 'General case' 0 CA--C 1.479 -1.775 0 CA-C-N 112.579 -2.101 . . . . 0.0 111.138 -163.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.419 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.34 0.0 OUTLIER -58.5 -14.67 8.5 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 119.548 3.166 . . . . 0.0 119.548 176.77 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.08 -45.86 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 C-N-CA 124.092 0.957 . . . . 0.0 110.183 163.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -91.8 4.95 51.67 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 151' ' ' ASP . 6.1 tt -82.97 -32.52 27.03 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 162.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.451 ' HA ' HG12 ' A' ' 115' ' ' ILE . 57.5 ttt180 -63.05 -42.74 99.79 Favored 'General case' 0 C--N 1.362 1.122 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.73 168.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.8 m -59.71 -40.93 89.6 Favored 'General case' 0 C--N 1.377 1.799 0 C-N-CA 118.509 -1.276 . . . . 0.0 113.36 173.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.572 HD11 HD12 ' A' ' 126' ' ' ILE . 7.6 mt -62.6 -32.84 73.91 Favored 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 175.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.0 mm -59.21 -46.67 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.533 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 174.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.57 -47.88 66.54 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 126.04 1.736 . . . . 0.0 113.079 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -54.93 -49.7 70.67 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.455 HD21 ' HA ' ' A' ' 176' ' ' PRO . 0.1 OUTLIER -60.7 -37.28 81.13 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 177.283 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -80.09 -20.82 44.23 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 128.26 2.624 . . . . 0.0 112.46 -173.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -71.97 -15.83 62.07 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 168.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.42 69.58 1.33 Allowed Glycine 0 CA--C 1.463 -3.174 0 N-CA-C 104.182 -3.567 . . . . 0.0 104.182 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -143.62 177.77 8.25 Favored 'General case' 0 CA--C 1.459 -2.529 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 171.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.555 ' HE2' HG22 ' A' ' 93' ' ' VAL . 4.0 tmmm? -116.94 114.08 23.33 Favored 'General case' 0 N--CA 1.393 -3.3 1 N-CA-C 96.929 -5.212 . . . . 0.0 96.929 -170.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -103.42 111.54 24.02 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.361 -1.335 . . . . 0.0 108.237 -162.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -97.6 122.85 41.16 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -164.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.572 HD12 HD11 ' A' ' 114' ' ' LEU . 6.3 mm -85.49 133.46 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.2 m -119.57 123.13 43.17 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . 0.266 0.2 OUTLIER -80.05 150.91 30.18 Favored 'General case' 0 CA--C 1.471 -2.065 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 166.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -145.75 95.39 2.64 Favored 'General case' 0 N--CA 1.403 -2.798 1 N-CA-C 98.712 -4.551 . . . . 0.0 98.712 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -72.75 157.5 37.39 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 112.01 -2.359 . . . . 0.0 110.476 -172.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.6 ttp-105 -129.2 28.05 5.3 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -128.09 -5.0 5.36 Favored Glycine 0 CA--C 1.483 -1.961 0 N-CA-C 105.99 -2.844 . . . . 0.0 105.99 172.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -29.74 101.7 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 130.797 3.639 . . . . 0.0 119.005 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -114.88 -110.18 0.36 Allowed 'General case' 0 N--CA 1.432 -1.338 1 N-CA-C 99.95 -4.093 . . . . 0.0 99.95 148.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 96.6 mtp -85.06 111.85 20.11 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 101.714 -3.439 . . . . 0.0 101.714 148.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.414 ' HB1' ' H ' ' A' ' 137' ' ' HIS . . . -80.65 -151.29 0.08 Allowed 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 117.155 2.28 . . . . 0.0 117.155 -157.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.59 ' HB2' ' HB ' ' A' ' 140' ' ' ILE . 63.7 m-70 -97.33 143.55 27.97 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 127.037 2.135 . . . . 0.0 113.717 -166.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -107.19 8.14 29.85 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 169.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -83.57 -59.98 2.27 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 171.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' A' ' 137' ' ' HIS . 76.8 mt -54.56 -48.09 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 C-N-CA 128.434 2.694 . . . . 0.0 111.448 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.46 -58.83 4.06 Favored Glycine 0 N--CA 1.415 -2.729 0 O-C-N 123.695 0.622 . . . . 0.0 112.07 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 22.4 mtm -92.85 2.96 56.49 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 113.502 0.926 . . . . 0.0 113.502 -160.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.252 1.2 tm-20 -54.74 -71.65 0.08 Allowed 'General case' 0 CA--C 1.449 -2.913 0 C-N-CA 115.083 -2.647 . . . . 0.0 114.767 138.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.663 HG11 ' HB3' ' A' ' 98' ' ' PHE . 39.2 t -56.51 -67.6 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.441 -3.216 0 O-C-N 127.411 2.944 . . . . 0.0 108.973 -161.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.569 HD22 ' HB3' ' A' ' 172' ' ' MET . 62.2 mt -39.09 -53.78 1.79 Allowed 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 128.399 2.68 . . . . 0.0 115.213 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.409 ' HA ' ' CE2' ' A' ' 161' ' ' PHE . 1.7 t-20 -62.82 -36.71 84.09 Favored 'General case' 0 CA--C 1.46 -2.5 0 N-CA-C 117.591 2.441 . . . . 0.0 117.591 175.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -81.09 -14.46 57.73 Favored 'General case' 0 N--CA 1.417 -2.097 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.233 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.5 t -77.58 -43.11 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.48 ' HB2' HG21 ' A' ' 158' ' ' VAL . 30.5 ttmt -52.93 -51.09 62.55 Favored 'General case' 0 CA--C 1.464 -2.364 0 CA-C-O 117.024 -1.465 . . . . 0.0 110.8 169.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.75 -38.2 73.48 Favored 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 124.27 1.028 . . . . 0.0 110.071 -168.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.429 ' HB3' HD11 ' A' ' 111' ' ' LEU . 9.9 t70 -75.65 -28.78 58.88 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 116.673 -2.011 . . . . 0.0 115.414 171.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 156' ' ' ALA 0.286 0.1 OUTLIER -76.39 -33.02 58.88 Favored 'General case' 0 CA--C 1.475 -1.931 0 CA-C-O 116.827 -1.559 . . . . 0.0 113.084 178.107 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -28.26 -26.94 0.0 OUTLIER 'General case' 0 CA--C 1.483 -1.623 1 C-N-CA 135.468 5.507 . . . . 0.0 119.525 -172.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.417 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.7 mt-10 -57.63 -59.0 5.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.155 2.182 . . . . 0.0 112.246 171.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.08 -52.18 3.48 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.39 -1.732 . . . . 0.0 108.186 -167.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.541 ' CB ' HD11 ' A' ' 174' ' ' LEU 0.284 . . -98.85 147.53 24.84 Favored 'General case' 0 CA--C 1.459 -2.533 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.773 -178.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.43 171.41 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.765 0 C-N-CA 114.794 -2.762 . . . . 0.0 116.405 134.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.7 t -82.37 155.88 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.979 0 C-N-CA 128.948 2.899 . . . . 0.0 109.798 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -82.16 -42.93 18.39 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 113.7 -1.591 . . . . 0.0 106.885 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.7 t -152.87 144.97 23.81 Favored 'General case' 0 CA--C 1.464 -2.328 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.409 ' CE2' ' HA ' ' A' ' 146' ' ' ASN . 2.7 t80 -107.69 111.83 62.41 Favored Pre-proline 0 N--CA 1.421 -1.918 0 N-CA-C 101.087 -3.671 . . . . 0.0 101.087 163.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -107.44 -116.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.412 -3.312 1 N-CA-C 100.622 -4.415 . . . . 0.0 100.622 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 175.28 -48.47 0.01 OUTLIER 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 100.387 -3.931 . . . . 0.0 100.387 -140.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -85.26 115.6 23.13 Favored 'General case' 0 CA--C 1.487 -1.458 0 CA-C-O 123.052 1.406 . . . . 0.0 111.705 -155.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.4 mt -82.41 143.43 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 CA-C-N 113.022 -1.899 . . . . 0.0 107.258 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -104.85 84.28 2.12 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 176.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.93 -129.34 9.14 Favored Glycine 0 CA--C 1.482 -2.008 0 CA-C-O 122.94 1.3 . . . . 0.0 110.857 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -94.43 25.18 4.03 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 126.722 2.009 . . . . 0.0 114.155 -172.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.251 20.4 mt-30 -172.13 130.93 0.62 Allowed 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -165.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.7 ttp -113.6 113.59 25.28 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 118.742 0.701 . . . . 0.0 110.326 -172.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.1 mm -82.17 124.98 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 O-C-N 121.227 -0.921 . . . . 0.0 108.756 170.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.569 ' HB3' HD22 ' A' ' 145' ' ' LEU . 4.2 ttp -106.92 135.44 48.47 Favored 'General case' 0 CA--C 1.471 -2.081 0 N-CA-C 101.783 -3.414 . . . . 0.0 101.783 156.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 t -98.1 132.94 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 C-N-CA 116.486 -2.085 . . . . 0.0 106.894 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.541 HD11 ' CB ' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -116.47 148.33 40.86 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 100.255 -3.98 . . . . 0.0 100.255 -177.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -142.06 -173.96 0.39 Allowed Pre-proline 0 N--CA 1.431 -1.401 0 CA-C-O 117.009 -1.472 . . . . 0.0 110.242 -172.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.455 ' HA ' HD21 ' A' ' 118' ' ' LEU . 71.3 Cg_exo -68.88 153.67 72.34 Favored 'Trans proline' 0 N--CA 1.437 -1.823 0 C-N-CA 122.564 2.176 . . . . 0.0 108.817 165.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -77.55 113.94 15.88 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 169.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -100.96 79.63 2.05 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -75.48 117.06 16.85 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 . . . . . 0 C--O 1.261 1.664 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -178.691 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 CA--C 1.479 -1.766 0 CA-C-O 122.174 0.988 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.4 mm -86.27 116.97 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 CA-C-N 112.874 -1.967 . . . . 0.0 106.808 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -95.08 164.82 12.71 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -170.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.471 HG22 ' HE3' ' A' ' 123' ' ' LYS . 99.3 t -103.22 120.67 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.627 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 172.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -104.34 171.81 7.14 Favored 'General case' 0 CA--C 1.482 -1.661 0 C-N-CA 117.863 -1.535 . . . . 0.0 107.203 152.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -144.46 154.73 43.23 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.52 165.23 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 171.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -111.32 153.71 25.57 Favored 'General case' 0 CA--C 1.487 -1.456 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.113 166.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.593 ' HB3' HG11 ' A' ' 144' ' ' VAL . 3.1 m-85 -140.24 98.9 3.53 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 172.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -87.71 172.97 7.02 Favored Pre-proline 0 N--CA 1.435 -1.193 0 C-N-CA 125.376 1.471 . . . . 0.0 110.013 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.74 135.53 26.07 Favored 'Trans proline' 0 N--CA 1.433 -2.078 0 N-CA-C 105.596 -2.501 . . . . 0.0 105.596 168.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.61 13.89 60.6 Favored Glycine 0 CA--C 1.483 -1.952 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 106' ' ' ASP . 38.1 m -107.54 88.45 2.74 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 168.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.256 0.6 OUTLIER -111.42 -179.5 3.73 Favored 'General case' 1 N--CA 1.373 -4.317 0 C-N-CA 128.867 2.867 . . . . 0.0 109.998 176.553 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -51.04 -40.21 57.74 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 127.747 2.419 . . . . 0.0 114.689 -138.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.83 -17.55 69.99 Favored Glycine 0 N--CA 1.414 -2.793 0 N-CA-C 117.169 1.628 . . . . 0.0 117.169 -171.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.406 ' HB3' HG23 ' A' ' 102' ' ' THR 0.263 0.9 OUTLIER -93.86 -27.29 16.5 Favored 'General case' 0 N--CA 1.404 -2.728 0 C-N-CA 126.169 1.788 . . . . 0.0 108.376 169.556 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -87.14 -72.18 0.52 Allowed 'General case' 0 CA--C 1.477 -1.833 0 CA-C-N 113.953 -1.476 . . . . 0.0 109.787 -158.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.453 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.35 0.0 OUTLIER -55.61 -15.36 2.85 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 120.018 3.34 . . . . 0.0 120.018 173.905 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.4 t -61.54 -46.82 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 123.397 1.57 . . . . 0.0 110.373 163.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -89.25 -18.5 26.91 Favored 'General case' 0 CA--C 1.468 -2.207 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.415 ' CB ' ' HA ' ' A' ' 108' ' ' GLN . 2.0 tt -56.23 -38.26 70.83 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.094 154.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.549 ' HA ' HG12 ' A' ' 115' ' ' ILE . 42.3 ttt-85 -60.02 -42.93 95.42 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-N 119.193 0.906 . . . . 0.0 111.756 169.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.0 t -56.78 -45.87 81.87 Favored 'General case' 0 C--N 1.376 1.756 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.272 72.2 mt -67.7 -24.83 65.44 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.549 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.284 7.2 mm -60.74 -51.09 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.437 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 172.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.37 -43.72 68.03 Favored 'General case' 0 N--CA 1.426 -1.63 0 O-C-N 126.196 2.185 . . . . 0.0 109.898 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -60.51 -53.8 53.2 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.682 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -69.49 -21.01 63.72 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 126.926 2.091 . . . . 0.0 114.649 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -73.26 -37.1 66.42 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 127.188 2.195 . . . . 0.0 108.625 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -66.51 -26.98 67.42 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 123.14 0.576 . . . . 0.0 110.669 170.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.45 65.05 1.47 Allowed Glycine 0 CA--C 1.471 -2.662 0 N-CA-C 104.717 -3.353 . . . . 0.0 104.717 -171.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -119.97 166.41 13.38 Favored 'General case' 0 CA--C 1.451 -2.848 1 N-CA-C 97.775 -4.898 . . . . 0.0 97.775 169.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.471 ' HE3' HG22 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -106.63 116.97 32.85 Favored 'General case' 0 N--CA 1.395 -3.202 1 N-CA-C 97.365 -5.05 . . . . 0.0 97.365 171.018 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.27 159.09 21.02 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.416 ' HA ' ' H ' ' A' ' 174' ' ' LEU 0.258 44.8 mtmt -128.08 133.54 49.06 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 163.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.421 HG12 ' SD ' ' A' ' 172' ' ' MET . 6.9 mm -86.3 129.96 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.3 m -100.38 126.16 46.72 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 168.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.614 HD23 HD11 ' A' ' 145' ' ' LEU 0.278 0.3 OUTLIER -80.28 152.1 29.2 Favored 'General case' 0 CA--C 1.462 -2.412 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 164.724 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.517 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 42.3 ttt180 -149.42 96.42 2.5 Favored 'General case' 0 N--CA 1.395 -3.216 1 N-CA-C 96.853 -5.24 . . . . 0.0 96.853 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -71.5 -175.35 1.28 Allowed 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 112.227 -2.26 . . . . 0.0 111.542 -172.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -57.54 -76.75 0.03 OUTLIER 'General case' 0 CA--C 1.481 -1.693 0 CA-C-O 123.552 1.644 . . . . 0.0 107.537 166.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 171.26 138.64 2.57 Favored Glycine 0 CA--C 1.474 -2.502 0 CA-C-N 111.686 -2.507 . . . . 0.0 109.395 148.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -149.84 177.54 9.73 Favored 'General case' 0 CA--C 1.496 -1.131 0 C-N-CA 118.204 -1.398 . . . . 0.0 107.409 158.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.81 -60.0 3.05 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 123.516 0.726 . . . . 0.0 109.464 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 94.9 mmm -109.68 105.29 14.49 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 102.837 -3.023 . . . . 0.0 102.837 159.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.18 172.71 3.61 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.465 ' CG ' HD12 ' A' ' 140' ' ' ILE . 13.0 m-70 -22.05 120.31 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 129.581 3.153 . . . . 0.0 114.316 147.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -106.47 7.27 30.88 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -89.61 -51.3 5.6 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.465 HD12 ' CG ' ' A' ' 137' ' ' HIS . 67.5 mt -52.62 -41.82 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.624 2.37 . . . . 0.0 111.709 173.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.47 -61.4 3.9 Favored Glycine 0 N--CA 1.417 -2.627 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.513 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 8.4 ptm -87.51 -3.2 59.0 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -156.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -53.37 57.46 Favored 'General case' 0 CA--C 1.452 -2.813 0 C-N-CA 115.391 -2.524 . . . . 0.0 114.095 152.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.593 HG11 ' HB3' ' A' ' 98' ' ' PHE . 20.1 t -69.62 -64.33 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.445 -3.071 0 O-C-N 126.308 2.255 . . . . 0.0 107.859 -162.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.754 HD13 ' HB2' ' A' ' 172' ' ' MET . 90.2 mt -47.13 -52.98 13.99 Favored 'General case' 0 CA--C 1.477 -1.831 0 C-N-CA 128.274 2.63 . . . . 0.0 114.789 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 142' ' ' MET 0.258 1.5 t30 -62.9 -30.86 71.86 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 174.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -82.83 -14.31 54.58 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.385 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.441 HG12 HD12 ' A' ' 152' ' ' LEU . 2.1 t -76.23 -46.67 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.628 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 177.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.449 ' HE3' ' CG2' ' A' ' 158' ' ' VAL 0.265 25.2 ttmt -49.51 -53.68 22.06 Favored 'General case' 0 CA--C 1.458 -2.56 0 C-N-CA 125.895 1.678 . . . . 0.0 111.539 173.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.31 -37.2 63.69 Favored 'General case' 0 N--CA 1.408 -2.56 0 C-N-CA 126.469 1.907 . . . . 0.0 109.985 -167.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.79 -31.62 66.79 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 116.339 -2.144 . . . . 0.0 114.678 171.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.441 HD12 HG12 ' A' ' 148' ' ' VAL 0.296 0.2 OUTLIER -83.51 -27.48 29.34 Favored 'General case' 0 CA--C 1.46 -2.51 0 CA-C-O 115.702 -2.094 . . . . 0.0 115.326 179.892 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -28.07 -22.31 0.0 OUTLIER 'General case' 0 CA--C 1.483 -1.624 1 C-N-CA 136.163 5.785 . . . . 0.0 119.786 -174.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -50.16 -49.58 51.72 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 126.342 1.857 . . . . 0.0 115.042 162.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -121.6 -52.77 2.01 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 128.06 2.544 . . . . 0.0 107.23 -157.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.682 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.362 . . -112.1 148.16 34.54 Favored 'General case' 0 CA--C 1.452 -2.791 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -176.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -119.93 -178.27 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.459 -2.528 0 C-N-CA 116.128 -2.229 . . . . 0.0 115.672 147.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 160' ' ' SER . 6.0 t -86.64 148.63 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 165.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -82.39 -39.54 22.56 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.532 ' H ' HG12 ' A' ' 158' ' ' VAL . 0.9 OUTLIER -150.61 131.0 13.74 Favored 'General case' 0 CA--C 1.465 -2.316 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -174.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -106.67 117.81 55.95 Favored Pre-proline 0 N--CA 1.424 -1.755 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -132.69 -118.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.413 -3.208 1 N-CA-C 101.054 -4.248 . . . . 0.0 101.054 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -174.22 -44.2 0.01 OUTLIER 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 -133.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -85.61 103.81 14.77 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-O 122.26 1.029 . . . . 0.0 110.866 -159.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.6 mt -81.78 142.02 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.254 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -119.31 100.61 7.42 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.74 -143.89 27.18 Favored Glycine 0 CA--C 1.482 -1.969 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -173.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 43.0 ptt85 -96.46 38.14 1.22 Allowed 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 125.673 1.589 . . . . 0.0 110.707 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.517 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.317 25.6 mt-30 -166.72 135.5 2.85 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.229 0.612 . . . . 0.0 110.635 -172.358 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 38.1 ttp -123.0 117.27 25.09 Favored 'General case' 0 C--N 1.364 1.214 0 CA-C-N 118.802 0.728 . . . . 0.0 112.633 -172.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.7 mm -82.19 123.84 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 O-C-N 120.555 -1.341 . . . . 0.0 109.058 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.754 ' HB2' HD13 ' A' ' 145' ' ' LEU . 2.8 tmm? -100.47 128.57 46.49 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 157.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.22 122.94 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.404 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.553 HD13 ' CD1' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -105.2 69.12 0.84 Allowed 'General case' 0 C--N 1.354 0.765 0 C-N-CA 127.654 2.382 . . . . 0.0 117.281 -170.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.335 . . -91.48 172.59 6.37 Favored Pre-proline 0 C--N 1.359 0.99 0 N-CA-C 119.604 3.187 . . . . 0.0 119.604 -171.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -68.85 140.08 45.24 Favored 'Trans proline' 0 CA--C 1.491 -1.661 0 CA-C-N 120.912 1.362 . . . . 0.0 110.922 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -79.95 135.27 36.36 Favored 'General case' 0 CA--C 1.483 -1.597 0 O-C-N 125.0 1.438 . . . . 0.0 107.263 176.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -72.66 118.43 15.57 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 113.969 -1.468 . . . . 0.0 107.142 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -70.68 134.7 47.75 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.559 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 . . . . . 0 C--O 1.26 1.638 0 CA-C-O 117.79 -1.1 . . . . 0.0 108.657 -178.449 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.47 -2.124 0 CA-C-O 124.631 2.157 . . . . 0.0 107.684 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.0 mm -87.34 121.0 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 CA-C-N 108.67 -3.877 . . . . 0.0 107.801 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -111.04 164.99 12.25 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -162.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.465 HG22 ' HE2' ' A' ' 123' ' ' LYS . 75.3 t -90.2 120.62 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.801 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 161.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -112.09 166.54 11.15 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 150.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -133.94 155.72 49.42 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.002 -164.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 tp -135.72 162.82 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 101.881 -3.377 . . . . 0.0 101.881 166.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -111.15 157.78 19.65 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 119.413 1.006 . . . . 0.0 109.612 163.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.67 ' HB3' HG11 ' A' ' 144' ' ' VAL . 17.1 m-85 -125.74 135.15 51.73 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 166.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mpm_? -104.7 167.79 9.39 Favored Pre-proline 0 N--CA 1.424 -1.735 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.359 -167.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.496 ' HA ' HG23 ' A' ' 140' ' ' ILE . 21.8 Cg_exo -57.72 138.16 84.73 Favored 'Trans proline' 0 CA--C 1.483 -2.052 0 C-N-CA 125.115 3.876 . . . . 0.0 112.841 169.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.42 -119.32 9.23 Favored Glycine 0 CA--C 1.479 -2.182 0 N-CA-C 106.803 -2.519 . . . . 0.0 106.803 -170.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.5 m 52.34 103.82 0.01 OUTLIER 'General case' 0 CA--C 1.481 -1.674 0 C-N-CA 130.212 3.405 . . . . 0.0 114.038 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -131.39 -139.44 0.21 Allowed 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 103.668 -2.715 . . . . 0.0 103.668 170.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.06 -72.76 0.12 Allowed 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -84.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.39 44.54 1.53 Allowed Glycine 0 CA--C 1.485 -1.841 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.606 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -106.18 -39.49 5.94 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 147.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.9 -71.78 0.31 Allowed 'General case' 0 CA--C 1.481 -1.693 0 C-N-CA 126.265 1.826 . . . . 0.0 109.475 -170.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.325 0.0 OUTLIER -59.32 -15.48 16.36 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 119.487 3.144 . . . . 0.0 119.487 173.517 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.66 -43.56 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 121.556 0.693 . . . . 0.0 109.937 162.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -92.39 7.38 43.21 Favored 'General case' 0 CA--C 1.485 -1.556 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 6.2 tt -85.13 -31.5 23.26 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 104.038 -2.579 . . . . 0.0 104.038 161.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.495 ' HA ' HG12 ' A' ' 115' ' ' ILE . 31.7 ttt180 -62.97 -43.2 99.45 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 122.88 0.472 . . . . 0.0 110.969 168.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.2 t -56.51 -45.26 81.15 Favored 'General case' 0 C--N 1.376 1.732 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.66 -30.23 71.37 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.495 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.8 mm -58.54 -48.49 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.521 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 173.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.1 tpt85 -52.37 -50.29 62.7 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 125.466 1.729 . . . . 0.0 112.391 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -57.58 -44.97 85.75 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.53 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -65.57 -35.39 80.7 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 176.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -77.69 -20.87 52.92 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 127.821 2.448 . . . . 0.0 112.417 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -67.87 -19.91 65.07 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 123.658 0.783 . . . . 0.0 109.422 169.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.45 61.59 1.7 Allowed Glycine 0 CA--C 1.46 -3.357 0 N-CA-C 103.561 -3.816 . . . . 0.0 103.561 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -134.19 175.45 9.49 Favored 'General case' 0 CA--C 1.446 -3.043 1 N-CA-C 99.003 -4.443 . . . . 0.0 99.003 173.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HE2' HG22 ' A' ' 93' ' ' VAL 0.263 17.8 mtpt -89.12 140.19 29.71 Favored 'General case' 0 N--CA 1.396 -3.167 1 N-CA-C 97.55 -4.981 . . . . 0.0 97.55 163.622 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.582 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -84.49 160.34 20.56 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 155.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -142.33 125.87 16.79 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 102.673 -3.084 . . . . 0.0 102.673 167.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.556 HG21 ' HD2' ' A' ' 98' ' ' PHE . 4.0 mm -86.14 122.72 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.41 ' HA ' HD13 ' A' ' 171' ' ' ILE . 11.9 m -92.66 123.0 35.63 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 163.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.803 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.2 OUTLIER -84.11 152.05 24.55 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 165.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.444 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 28.0 ttm180 -152.56 91.5 1.58 Allowed 'General case' 0 N--CA 1.393 -3.281 1 N-CA-C 98.752 -4.536 . . . . 0.0 98.752 -172.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.476 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 93.9 m-85 -79.6 158.09 27.18 Favored 'General case' 0 N--CA 1.417 -2.075 0 CA-C-N 112.638 -2.074 . . . . 0.0 107.128 -175.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -89.77 80.99 6.44 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 104.06 -2.571 . . . . 0.0 104.06 155.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.67 -144.31 7.91 Favored Glycine 0 CA--C 1.478 -2.259 0 C-N-CA 120.07 -1.062 . . . . 0.0 114.237 -143.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.492 ' H ' ' HB2' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -144.34 -168.13 2.81 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -170.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -66.06 -55.68 15.36 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 124.334 1.054 . . . . 0.0 110.464 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 35.3 mtt -111.93 113.61 26.03 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 102.437 -3.172 . . . . 0.0 102.437 153.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.492 ' HB2' ' H ' ' A' ' 133' ' ' ARG . . . -76.8 178.14 7.07 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -172.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.442 ' HB3' ' H ' ' A' ' 139' ' ' GLN . 98.5 m-70 0.43 -95.75 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.359 1 C-N-CA 131.754 4.022 . . . . 0.0 120.127 172.17 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 73.9 13.96 4.1 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 127.131 2.173 . . . . 0.0 110.278 -165.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.442 ' H ' ' HB3' ' A' ' 137' ' ' HIS . 20.8 mt-30 -106.71 -55.65 2.3 Favored 'General case' 0 CA--C 1.48 -1.733 0 N-CA-C 101.118 -3.66 . . . . 0.0 101.118 171.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.496 HG23 ' HA ' ' A' ' 100' ' ' PRO . 66.8 mt -54.17 -42.43 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 C-N-CA 127.344 2.258 . . . . 0.0 110.908 167.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.803 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -76.57 -59.82 3.17 Favored Glycine 0 CA--C 1.466 -2.982 0 C-N-CA 119.059 -1.543 . . . . 0.0 113.122 -172.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 60.5 mtm -88.02 -0.07 56.58 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -166.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -68.16 -47.7 67.31 Favored 'General case' 0 CA--C 1.457 -2.632 0 C-N-CA 114.73 -2.788 . . . . 0.0 113.33 151.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.67 HG11 ' HB3' ' A' ' 98' ' ' PHE . 31.9 t -70.1 -68.98 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.436 -3.426 0 O-C-N 125.67 1.856 . . . . 0.0 107.343 -163.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.537 HD21 HD12 ' A' ' 128' ' ' LEU . 1.3 mp -48.79 -50.54 33.69 Favored 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 129.217 3.007 . . . . 0.0 113.259 -175.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -61.03 -37.01 81.07 Favored 'General case' 0 CA--C 1.471 -2.061 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -81.02 -14.22 58.11 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.512 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.7 t -76.14 -49.1 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.645 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.281 11.9 ttmt -51.95 -45.84 64.53 Favored 'General case' 0 CA--C 1.464 -2.33 0 C-N-CA 126.394 1.878 . . . . 0.0 113.096 171.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.57 -36.48 63.07 Favored 'General case' 0 N--CA 1.409 -2.492 0 C-N-CA 124.347 1.059 . . . . 0.0 110.024 -171.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -72.94 -39.72 66.0 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 116.473 -2.091 . . . . 0.0 115.178 169.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.47 HD13 HD11 ' A' ' 174' ' ' LEU 0.306 0.2 OUTLIER -79.61 -20.24 47.32 Favored 'General case' 0 CA--C 1.46 -2.514 0 CA-C-O 116.357 -1.782 . . . . 0.0 115.759 -177.271 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -26.24 -23.79 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.493 1 C-N-CA 135.042 5.337 . . . . 0.0 119.55 175.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 6.0 mt-10 -51.69 -56.54 13.1 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 126.993 2.117 . . . . 0.0 113.21 165.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.3 tt -116.38 -47.42 2.74 Favored 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 126.455 1.902 . . . . 0.0 109.291 -162.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.53 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.352 . . -110.14 143.45 40.21 Favored 'General case' 0 CA--C 1.448 -2.954 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.043 -179.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.8 m -120.46 171.98 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.483 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 140.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.522 HG22 HD23 ' A' ' 174' ' ' LEU . 4.0 t -81.46 151.54 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.931 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 172.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -80.92 -38.35 28.02 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 125.581 1.552 . . . . 0.0 107.005 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.478 ' H ' HG12 ' A' ' 158' ' ' VAL . 5.4 t -118.44 -176.32 3.05 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 145' ' ' LEU . 10.7 t80 -130.73 101.82 16.77 Favored Pre-proline 0 N--CA 1.42 -1.959 0 N-CA-C 101.111 -3.663 . . . . 0.0 101.111 139.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -75.5 -38.41 1.41 Allowed 'Trans proline' 0 CA--C 1.485 -1.941 0 C-N-CA 122.301 2.001 . . . . 0.0 112.458 -145.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . 0.318 2.4 m 9.66 48.78 0.0 OUTLIER 'General case' 0 N--CA 1.416 -2.165 1 C-N-CA 135.684 5.593 . . . . 0.0 118.713 -160.142 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -123.09 97.85 5.62 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 111.423 -2.626 . . . . 0.0 105.096 164.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -75.28 139.48 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -112.01 85.41 2.14 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.916 -1.493 . . . . 0.0 107.694 -175.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.66 -140.54 20.39 Favored Glycine 0 CA--C 1.485 -1.819 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.1 ttp85 -92.74 28.25 2.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 125.412 1.485 . . . . 0.0 111.214 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.444 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.291 36.4 mt-30 -169.04 155.13 6.47 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -167.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 60.7 ttp -146.47 120.85 9.63 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 118.933 0.788 . . . . 0.0 110.765 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 127' ' ' THR . 14.4 mm -79.64 126.89 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 O-C-N 120.786 -1.196 . . . . 0.0 108.627 173.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.404 ' SD ' HG11 ' A' ' 158' ' ' VAL . 4.7 ttp -105.5 135.24 47.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 160.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.58 126.39 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 C-N-CA 118.299 -1.36 . . . . 0.0 109.68 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.582 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 0.1 OUTLIER -110.78 80.32 1.29 Allowed 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 -168.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.279 . . -85.82 174.91 5.0 Favored Pre-proline 0 CA--C 1.498 -1.032 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -169.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -64.15 141.48 76.34 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 C-N-CA 123.243 2.629 . . . . 0.0 108.263 160.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -76.88 153.83 34.36 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 124.216 0.947 . . . . 0.0 110.856 -177.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -68.76 115.27 7.91 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 170.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -76.49 105.84 7.78 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 . . . . . 0 C--O 1.261 1.672 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -176.659 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.469 -2.135 0 CA-C-O 124.7 2.191 . . . . 0.0 107.645 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.1 mm -91.18 130.85 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 CA-C-N 108.703 -3.862 . . . . 0.0 108.908 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -89.64 162.79 15.44 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.9 t -96.67 115.7 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.792 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 160.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -107.35 175.45 5.49 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 152.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -135.17 155.34 50.85 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 tp -134.66 162.79 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 102.573 -3.121 . . . . 0.0 102.573 164.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -112.31 159.96 18.14 Favored 'General case' 0 CA--C 1.487 -1.465 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.195 161.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.551 ' HB3' HG11 ' A' ' 144' ' ' VAL . 10.8 m-85 -129.31 149.23 51.19 Favored 'General case' 0 CA--C 1.475 -1.924 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 166.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.89 157.81 40.8 Favored Pre-proline 0 N--CA 1.417 -2.109 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.845 -171.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.558 ' HG3' ' H ' ' A' ' 131' ' ' ARG . 18.2 Cg_endo -67.28 124.65 12.37 Favored 'Trans proline' 0 N--CA 1.44 -1.652 1 C-N-CA 125.475 4.117 . . . . 0.0 108.314 168.47 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 26.01 98.24 0.01 OUTLIER Glycine 0 CA--C 1.478 -2.229 0 C-N-CA 130.559 3.933 . . . . 0.0 115.214 -176.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.0 m -163.63 119.08 1.64 Allowed 'General case' 0 CA--C 1.472 -2.047 0 N-CA-C 101.928 -3.36 . . . . 0.0 101.928 -165.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -117.41 -130.5 0.3 Allowed 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -58.16 -81.35 0.02 OUTLIER 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -90.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.33 43.24 1.8 Allowed Glycine 0 CA--C 1.482 -1.987 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.851 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -104.26 -41.0 5.91 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 150.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -74.92 -72.73 0.28 Allowed 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 125.902 1.681 . . . . 0.0 108.677 -171.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.439 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.328 0.0 OUTLIER -58.57 -12.42 4.04 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 120.417 3.488 . . . . 0.0 120.417 178.494 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.56 -41.82 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 C-N-CA 124.197 0.999 . . . . 0.0 110.184 161.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -92.58 -0.09 57.36 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.418 HD11 ' HB3' ' A' ' 151' ' ' ASP . 5.6 tt -77.52 -35.1 53.75 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 162.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.435 ' HA ' HG12 ' A' ' 115' ' ' ILE . 9.3 ttp180 -60.87 -44.74 96.64 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 125.093 1.357 . . . . 0.0 110.67 171.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.4 m -59.64 -42.18 92.16 Favored 'General case' 0 C--N 1.378 1.831 0 C-N-CA 118.755 -1.178 . . . . 0.0 113.396 174.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.49 HD11 HD12 ' A' ' 126' ' ' ILE . 40.5 mt -62.2 -33.58 74.82 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 176.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.2 mm -55.43 -50.52 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 O-C-N 124.433 1.083 . . . . 0.0 108.37 173.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.9 tpt85 -51.71 -45.73 63.67 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 126.207 1.803 . . . . 0.0 112.783 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -58.08 -51.72 68.54 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.825 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -72.21 -19.61 61.7 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -73.45 -34.51 65.44 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 125.257 1.423 . . . . 0.0 110.294 173.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -67.89 -27.84 67.0 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 169.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.56 61.73 1.68 Allowed Glycine 0 CA--C 1.471 -2.678 0 N-CA-C 105.73 -2.948 . . . . 0.0 105.73 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -122.44 170.55 9.85 Favored 'General case' 0 CA--C 1.461 -2.467 1 N-CA-C 98.541 -4.614 . . . . 0.0 98.541 171.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -105.58 122.94 47.06 Favored 'General case' 0 N--CA 1.401 -2.879 1 N-CA-C 97.079 -5.156 . . . . 0.0 97.079 171.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.03 155.32 22.78 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 114.897 -2.721 . . . . 0.0 103.807 167.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.407 ' HG2' HG13 ' A' ' 173' ' ' VAL . 87.4 mttt -115.71 127.35 55.07 Favored 'General case' 0 CA--C 1.476 -1.899 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 165.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.635 HD11 HD22 ' A' ' 174' ' ' LEU . 3.2 mm -86.65 116.03 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 176.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.3 m -98.13 119.01 36.03 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 172.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.719 HD12 HD11 ' A' ' 145' ' ' LEU 0.287 0.3 OUTLIER -79.95 145.49 32.57 Favored 'General case' 0 CA--C 1.466 -2.263 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 167.844 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -150.46 89.17 1.54 Allowed 'General case' 0 N--CA 1.401 -2.895 1 N-CA-C 96.192 -5.484 . . . . 0.0 96.192 -172.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.548 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 56.0 m-85 -76.3 113.83 14.3 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 101.37 -3.567 . . . . 0.0 101.37 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.558 ' H ' ' HG3' ' A' ' 100' ' ' PRO . 84.2 mtm180 -76.99 -61.71 1.89 Allowed 'General case' 0 CA--C 1.467 -2.246 0 CA-C-O 124.856 2.265 . . . . 0.0 105.346 -176.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 174.82 117.99 0.5 Allowed Glycine 0 CA--C 1.46 -3.345 0 CA-C-N 108.809 -3.814 . . . . 0.0 104.549 148.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.424 ' HB3' HD13 ' A' ' 140' ' ' ILE . 74.3 ttt-85 -85.75 -64.32 1.17 Allowed 'General case' 0 CA--C 1.472 -2.041 0 CA-C-O 123.763 1.744 . . . . 0.0 106.349 170.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -120.82 26.11 9.29 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 110.48 -3.054 . . . . 0.0 106.219 168.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 58.9 mtt 78.33 -173.27 0.07 Allowed 'General case' 0 C--N 1.36 1.027 0 C-N-CA 127.384 2.274 . . . . 0.0 107.355 -159.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.26 114.7 9.59 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -121.65 170.14 10.01 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 171.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -96.1 20.98 9.39 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 123.953 0.901 . . . . 0.0 108.929 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -99.22 -46.81 5.42 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 167.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.424 HD13 ' HB3' ' A' ' 133' ' ' ARG 0.293 89.2 mt -67.28 -38.67 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.608 0 C-N-CA 129.104 2.961 . . . . 0.0 107.484 -174.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.566 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -80.85 -58.61 2.62 Favored Glycine 0 N--CA 1.417 -2.61 0 CA-C-N 114.438 -1.255 . . . . 0.0 113.986 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.4 mtm -89.25 1.4 55.76 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -163.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -55.53 -67.71 0.26 Allowed 'General case' 0 CA--C 1.445 -3.063 0 C-N-CA 115.391 -2.524 . . . . 0.0 114.284 140.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 98' ' ' PHE . 22.6 t -59.69 -66.63 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.438 -3.346 0 O-C-N 127.269 2.856 . . . . 0.0 108.336 -158.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.719 HD11 HD12 ' A' ' 128' ' ' LEU . 22.6 mt -45.99 -55.2 7.15 Favored 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 129.0 2.92 . . . . 0.0 115.299 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -62.21 -31.64 72.21 Favored 'General case' 0 CA--C 1.462 -2.429 0 N-CA-C 117.94 2.57 . . . . 0.0 117.94 173.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -82.26 -16.6 48.92 Favored 'General case' 0 N--CA 1.419 -1.991 0 C-N-CA 117.592 -1.643 . . . . 0.0 109.253 173.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.521 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.5 t -72.89 -45.82 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.856 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.547 ' HE3' HG21 ' A' ' 158' ' ' VAL . 35.7 ttmt -50.59 -51.67 46.24 Favored 'General case' 0 CA--C 1.464 -2.359 0 C-N-CA 125.775 1.63 . . . . 0.0 111.863 172.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -70.1 -41.13 74.43 Favored 'General case' 0 N--CA 1.406 -2.66 0 C-N-CA 125.936 1.695 . . . . 0.0 109.275 -168.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.418 ' HB3' HD11 ' A' ' 111' ' ' LEU . 22.9 t70 -74.18 -32.79 63.22 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 116.701 -2.0 . . . . 0.0 115.527 173.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.507 HD12 HG12 ' A' ' 148' ' ' VAL 0.348 0.3 OUTLIER -81.93 -26.2 34.25 Favored 'General case' 0 CA--C 1.461 -2.464 0 CA-C-O 116.409 -1.758 . . . . 0.0 115.128 -178.606 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -25.43 -29.94 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.489 1 C-N-CA 135.02 5.328 . . . . 0.0 119.202 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 5.9 mt-10 -49.24 -50.38 38.86 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 128.413 2.685 . . . . 0.0 113.993 169.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 tt -118.26 -50.62 2.45 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 126.339 1.855 . . . . 0.0 109.881 -164.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.825 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.346 . . -106.58 147.22 29.72 Favored 'General case' 0 CA--C 1.443 -3.17 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 -177.437 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.5 m -118.34 -174.54 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.529 0 C-N-CA 114.841 -2.744 . . . . 0.0 114.321 141.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.547 HG21 ' HE3' ' A' ' 149' ' ' LYS . 2.8 t -88.08 151.02 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.233 0 CA-C-N 111.762 -2.472 . . . . 0.0 105.717 168.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -81.89 -39.59 23.61 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.451 ' H ' HG12 ' A' ' 158' ' ' VAL . 1.1 t -160.69 142.0 12.04 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -171.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -103.06 90.08 2.25 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 101.751 -3.426 . . . . 0.0 101.751 169.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -101.55 -94.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.736 0 N-CA-C 108.055 -1.556 . . . . 0.0 108.055 -139.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.48 -103.07 0.31 Allowed 'General case' 0 N--CA 1.4 -2.956 0 C-N-CA 118.337 -1.345 . . . . 0.0 108.855 -136.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -156.16 156.81 34.85 Favored 'General case' 0 N--CA 1.422 -1.874 1 N-CA-C 99.565 -4.235 . . . . 0.0 99.565 -174.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.426 HG13 ' H ' ' A' ' 165' ' ' ILE . 1.3 mt -73.64 134.13 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.306 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 172.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -106.47 108.36 19.83 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 75.54 -139.4 24.6 Favored Glycine 0 CA--C 1.482 -2.006 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 -171.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -114.05 60.06 0.67 Allowed 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 113.095 -1.553 . . . . 0.0 107.79 174.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -173.14 131.19 0.48 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 10.7 ttm -121.53 162.6 20.28 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.6 mt -122.02 152.11 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 158.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.1 ttt -122.22 129.33 52.16 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 103.313 -2.847 . . . . 0.0 103.313 162.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.407 HG13 ' HG2' ' A' ' 125' ' ' LYS . 25.7 t -88.5 138.06 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -176.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.651 HD23 HD11 ' A' ' 118' ' ' LEU . 6.0 tp -118.87 90.15 3.27 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 131.104 3.762 . . . . 0.0 121.1 -177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.391 . . -104.9 165.41 13.29 Favored Pre-proline 0 CA--C 1.5 -0.975 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -71.97 141.01 35.9 Favored 'Trans proline' 0 CA--C 1.492 -1.614 0 C-N-CA 121.762 1.641 . . . . 0.0 108.412 -171.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.9 tmmt? -77.84 132.24 37.9 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 125.097 1.498 . . . . 0.0 107.593 -173.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -70.4 111.55 6.05 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.941 -174.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -78.94 111.87 15.56 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 166.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 . . . . . 0 C--O 1.26 1.652 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 -176.594 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.468 -2.178 0 CA-C-O 124.942 2.306 . . . . 0.0 107.276 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.5 mm -96.52 119.17 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.452 0 CA-C-N 108.653 -3.885 . . . . 0.0 107.057 176.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -93.62 169.07 10.61 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.498 HG22 ' HD3' ' A' ' 123' ' ' LYS . 92.2 t -101.07 115.73 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 161.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -99.62 172.52 7.23 Favored 'General case' 0 CA--C 1.476 -1.892 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 157.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -148.08 148.2 30.38 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -172.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.8 tp -131.43 161.06 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 103.733 -2.691 . . . . 0.0 103.733 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -121.88 154.25 37.34 Favored 'General case' 0 CA--C 1.487 -1.48 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.606 163.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.494 ' HB3' HG11 ' A' ' 144' ' ' VAL . 46.4 m-85 -129.62 143.5 50.85 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 170.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -121.01 167.39 13.21 Favored Pre-proline 0 N--CA 1.428 -1.543 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.468 ' HB3' HG23 ' A' ' 140' ' ' ILE . 10.5 Cg_endo -73.5 143.1 33.97 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 122.846 2.364 . . . . 0.0 107.338 170.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.55 9.73 80.91 Favored Glycine 0 CA--C 1.483 -1.947 0 O-C-N 124.16 0.912 . . . . 0.0 110.941 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.5 m -102.08 96.06 6.76 Favored 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 173.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -130.5 -146.49 0.31 Allowed 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 111.932 -2.394 . . . . 0.0 104.67 169.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.64 -69.32 0.25 Allowed 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -84.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.84 39.5 2.79 Favored Glycine 0 CA--C 1.484 -1.862 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.33 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -102.52 -39.16 7.23 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 148.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.91 -75.95 0.11 Allowed 'General case' 0 CA--C 1.478 -1.798 0 C-N-CA 126.784 2.034 . . . . 0.0 109.976 -171.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.432 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.331 0.0 OUTLIER -59.49 -12.7 6.73 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 119.967 3.321 . . . . 0.0 119.967 176.622 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.24 -43.74 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 122.126 0.965 . . . . 0.0 110.259 162.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -91.7 -1.09 57.56 Favored 'General case' 0 CA--C 1.475 -1.938 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.411 HD21 HD22 ' A' ' 152' ' ' LEU . 5.3 tt -79.05 -31.15 44.41 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 161.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.513 ' HA ' HG12 ' A' ' 115' ' ' ILE . 19.1 ttt85 -62.69 -43.0 99.92 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 118.599 -0.715 . . . . 0.0 111.276 169.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.4 m -61.69 -40.97 96.87 Favored 'General case' 0 C--N 1.378 1.819 0 C-N-CA 118.899 -1.12 . . . . 0.0 113.51 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.476 HD11 HD23 ' A' ' 174' ' ' LEU 0.282 55.8 tp -69.09 -26.97 65.2 Favored 'General case' 0 N--CA 1.402 -2.863 0 C-N-CA 126.259 1.823 . . . . 0.0 113.952 178.073 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.513 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.268 5.6 mm -60.96 -49.37 84.98 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.873 0 CA-C-N 121.061 1.755 . . . . 0.0 109.232 170.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -52.39 -48.36 65.69 Favored 'General case' 0 CA--C 1.494 -1.203 0 C-N-CA 126.662 1.985 . . . . 0.0 108.899 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -56.5 -53.85 52.67 Favored 'General case' 0 CA--C 1.483 -1.622 0 C-N-CA 125.992 1.717 . . . . 0.0 111.647 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.515 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -58.4 -39.83 80.76 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 179.243 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.23 -14.06 44.99 Favored 'General case' 0 C--N 1.364 1.212 0 C-N-CA 125.767 1.627 . . . . 0.0 111.746 -170.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -65.79 -25.06 67.08 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 123.073 0.549 . . . . 0.0 109.839 161.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.2 59.47 1.3 Allowed Glycine 0 CA--C 1.468 -2.865 0 N-CA-C 103.917 -3.673 . . . . 0.0 103.917 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -125.32 164.5 20.24 Favored 'General case' 0 CA--C 1.461 -2.475 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 171.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.498 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -102.02 121.54 42.36 Favored 'General case' 0 N--CA 1.407 -2.601 1 N-CA-C 99.869 -4.122 . . . . 0.0 99.869 179.401 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.446 ' HB1' ' CD1' ' A' ' 114' ' ' LEU . . . -111.91 115.91 29.76 Favored 'General case' 0 N--CA 1.415 -2.191 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.597 -166.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -98.3 119.68 37.39 Favored 'General case' 0 CA--C 1.491 -1.315 0 O-C-N 121.683 -0.636 . . . . 0.0 110.717 -167.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.9 mm -83.82 134.8 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.442 ' HA ' HD13 ' A' ' 171' ' ' ILE . 18.6 m -116.64 115.38 25.58 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 165.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.78 HD21 ' HA2' ' A' ' 141' ' ' GLY . 18.4 tp -82.4 148.49 28.19 Favored 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 167.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -150.58 103.82 3.15 Favored 'General case' 0 N--CA 1.405 -2.708 1 N-CA-C 98.44 -4.652 . . . . 0.0 98.44 -174.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.702 ' CZ ' HD13 ' A' ' 165' ' ' ILE 0.294 77.6 m-85 -74.41 97.69 3.12 Favored 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 127.345 2.258 . . . . 0.0 109.227 -175.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -107.78 28.96 7.68 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 125.036 1.335 . . . . 0.0 110.008 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.19 -46.38 7.03 Favored Glycine 0 CA--C 1.473 -2.581 1 N-CA-C 102.471 -4.252 . . . . 0.0 102.471 161.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 57.26 42.45 25.23 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 109.734 -3.233 . . . . 0.0 112.248 168.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -82.15 -62.17 1.7 Allowed 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 102.246 -3.242 . . . . 0.0 102.246 159.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 25.7 mmt -121.91 -98.25 0.44 Allowed 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.521 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.412 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . 169.58 108.2 0.01 OUTLIER 'General case' 0 N--CA 1.418 -2.048 1 N-CA-C 98.299 -4.704 . . . . 0.0 98.299 -165.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.63 ' CD2' HD12 ' A' ' 140' ' ' ILE . 6.0 m-70 -110.64 161.95 15.22 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -159.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -91.92 -10.83 38.09 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.648 170.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -77.33 -58.26 3.37 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 174.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.63 HD12 ' CD2' ' A' ' 137' ' ' HIS . 91.3 mt -54.91 -49.32 71.41 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 C-N-CA 126.934 2.094 . . . . 0.0 111.774 -178.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.78 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -77.0 -57.99 3.56 Favored Glycine 0 CA--C 1.458 -3.515 0 C-N-CA 119.07 -1.538 . . . . 0.0 113.733 -171.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 53.0 mtm -84.54 -0.04 51.62 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 118.123 -0.942 . . . . 0.0 113.09 -166.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.303 2.8 tp10 -64.34 -69.73 0.27 Allowed 'General case' 0 CA--C 1.454 -2.741 0 C-N-CA 115.051 -2.659 . . . . 0.0 115.012 143.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.494 HG11 ' HB3' ' A' ' 98' ' ' PHE . 39.7 t -59.98 -66.9 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.455 -2.707 0 O-C-N 126.261 2.226 . . . . 0.0 110.884 -161.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.452 HD11 HD22 ' A' ' 128' ' ' LEU . 73.4 mt -46.07 -55.06 7.45 Favored 'General case' 0 CA--C 1.483 -1.631 0 C-N-CA 128.421 2.688 . . . . 0.0 114.278 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -60.7 -30.01 69.68 Favored 'General case' 0 CA--C 1.469 -2.151 0 N-CA-C 118.609 2.818 . . . . 0.0 118.609 172.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -82.24 -15.35 53.37 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 119.41 -0.329 . . . . 0.0 110.486 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.463 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.9 t -77.37 -42.47 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.666 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 175.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.481 ' HB2' HG21 ' A' ' 158' ' ' VAL 0.254 31.8 ttmt -53.91 -52.04 61.83 Favored 'General case' 0 CA--C 1.462 -2.409 0 C-N-CA 124.943 1.297 . . . . 0.0 111.014 171.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -71.88 -38.75 69.95 Favored 'General case' 0 N--CA 1.407 -2.608 0 C-N-CA 125.674 1.59 . . . . 0.0 109.18 -169.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -74.53 -24.84 59.03 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 116.802 -1.959 . . . . 0.0 114.647 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 156' ' ' ALA 0.267 0.1 OUTLIER -78.92 -37.06 40.78 Favored 'General case' 0 CA--C 1.477 -1.833 0 CA-C-O 116.26 -1.829 . . . . 0.0 111.958 177.259 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 156' ' ' ALA . 3.9 tt0 -27.63 -29.89 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.488 1 C-N-CA 135.8 5.64 . . . . 0.0 119.642 -167.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 7.4 mt-10 -51.51 -47.69 63.19 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 128.789 2.836 . . . . 0.0 114.202 170.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -120.24 -51.88 2.19 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 128.167 2.587 . . . . 0.0 105.47 -159.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.875 ' HB1' HD11 ' A' ' 174' ' ' LEU 0.302 . . -107.43 144.62 34.09 Favored 'General case' 0 CA--C 1.452 -2.806 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.303 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.3 m -122.71 164.72 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.762 0 C-N-CA 115.286 -2.565 . . . . 0.0 117.604 141.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 5.8 t -81.82 149.37 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.257 0 CA-C-N 110.067 -3.242 . . . . 0.0 105.968 -174.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.76 -38.9 27.81 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -173.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -162.65 144.82 10.64 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -173.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -104.28 88.7 2.17 Favored Pre-proline 0 N--CA 1.424 -1.74 0 N-CA-C 100.64 -3.837 . . . . 0.0 100.64 165.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -94.67 -93.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.657 0 N-CA-C 108.687 -1.313 . . . . 0.0 108.687 -137.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.465 ' HB ' ' H ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -102.4 -104.91 0.27 Allowed 'General case' 0 N--CA 1.4 -2.974 0 C-N-CA 117.997 -1.481 . . . . 0.0 107.464 -139.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.465 ' H ' ' HB ' ' A' ' 163' ' ' THR . 41.1 ttmt -157.02 150.76 24.53 Favored 'General case' 0 N--CA 1.42 -1.942 1 N-CA-C 97.63 -4.952 . . . . 0.0 97.63 176.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.702 HD13 ' CZ ' ' A' ' 130' ' ' PHE . 4.0 mt -74.21 133.7 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.285 0 CA-C-O 122.567 1.175 . . . . 0.0 108.61 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -113.98 116.22 28.87 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.74 -149.6 36.75 Favored Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -172.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -105.26 40.3 1.56 Allowed 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 125.393 1.477 . . . . 0.0 109.792 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -171.41 122.15 0.53 Allowed 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.798 -167.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 39.4 ttm -118.49 123.89 46.25 Favored 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 124.008 0.923 . . . . 0.0 108.815 -174.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 127' ' ' THR . 15.5 mm -83.72 130.05 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 O-C-N 120.968 -1.082 . . . . 0.0 108.282 168.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.41 ' HB3' HD22 ' A' ' 145' ' ' LEU . 3.2 ttp -110.87 124.31 51.81 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 160.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 43.5 t -88.46 136.51 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.875 HD11 ' HB1' ' A' ' 156' ' ' ALA . 0.5 OUTLIER -124.77 150.31 46.41 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 101.673 -3.455 . . . . 0.0 101.673 -178.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.337 . . -142.26 -179.32 0.94 Allowed Pre-proline 0 CA--C 1.488 -1.42 0 CA-C-O 117.824 -1.084 . . . . 0.0 109.458 -173.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.434 ' HA ' HD21 ' A' ' 118' ' ' LEU . 82.2 Cg_exo -64.93 143.4 79.23 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 122.82 2.347 . . . . 0.0 110.111 165.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -79.7 158.2 27.02 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 165.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -62.36 129.24 39.82 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 123.709 0.803 . . . . 0.0 109.38 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 96.6 mttt 61.17 69.92 0.64 Allowed 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 126.408 1.883 . . . . 0.0 109.827 -169.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 . . . . . 0 C--O 1.259 1.587 0 C-N-CA 127.269 2.227 . . . . 0.0 112.183 179.527 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.482 -1.643 0 CA-C-O 122.073 0.939 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.4 mm -86.85 121.66 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-N 112.964 -1.925 . . . . 0.0 106.549 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -110.74 158.81 18.23 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 -161.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.62 113.61 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.813 0 C-N-CA 118.641 -1.224 . . . . 0.0 108.028 170.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -107.76 177.42 4.83 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 155.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -139.14 155.8 47.6 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.482 -172.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.2 tp -133.85 161.37 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 102.936 -2.987 . . . . 0.0 102.936 166.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -118.16 159.36 23.42 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 118.845 0.748 . . . . 0.0 110.175 165.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.654 ' HB3' HG11 ' A' ' 144' ' ' VAL . 25.8 m-85 -138.51 114.01 9.68 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 167.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -93.2 170.66 8.37 Favored Pre-proline 0 N--CA 1.433 -1.286 0 C-N-CA 124.586 1.154 . . . . 0.0 107.911 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -73.84 137.99 25.4 Favored 'Trans proline' 0 N--CA 1.43 -2.238 0 N-CA-C 105.354 -2.595 . . . . 0.0 105.354 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.55 8.0 66.31 Favored Glycine 0 CA--C 1.483 -1.923 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 78.8 m -100.73 89.85 4.03 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 167.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -124.59 -173.61 2.83 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 112.481 -2.145 . . . . 0.0 105.984 173.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -52.97 -43.79 66.65 Favored 'General case' 0 CA--C 1.481 -1.704 0 C-N-CA 126.682 1.993 . . . . 0.0 114.406 -128.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.43 -5.47 79.11 Favored Glycine 0 N--CA 1.417 -2.624 0 N-CA-C 116.332 1.293 . . . . 0.0 116.332 -170.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -98.25 -30.14 12.79 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 124.826 1.251 . . . . 0.0 107.857 168.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -86.78 -71.08 0.57 Allowed 'General case' 0 CA--C 1.469 -2.154 0 CA-C-N 112.351 -2.204 . . . . 0.0 111.235 -157.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.471 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.323 0.0 OUTLIER -58.94 -14.97 10.7 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 118.844 2.905 . . . . 0.0 118.844 174.057 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.03 -45.71 98.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 C-N-CA 124.711 1.205 . . . . 0.0 110.328 161.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -92.84 5.15 52.29 Favored 'General case' 0 CA--C 1.485 -1.541 0 O-C-N 120.137 -1.602 . . . . 0.0 115.269 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -83.45 -32.42 26.05 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 163.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.451 ' HA ' HG12 ' A' ' 115' ' ' ILE . 14.9 ttp180 -60.33 -45.62 92.77 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 125.158 1.383 . . . . 0.0 110.122 169.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.5 t -62.0 -40.38 95.45 Favored 'General case' 0 C--N 1.374 1.66 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.5 tp -67.42 -33.4 75.08 Favored 'General case' 0 N--CA 1.401 -2.88 0 C-N-CA 125.069 1.348 . . . . 0.0 113.844 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.255 8.5 mm -54.16 -50.75 53.12 Favored 'Isoleucine or valine' 0 C--N 1.373 1.626 0 CA-C-N 119.155 0.889 . . . . 0.0 108.865 170.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -50.01 -45.22 51.64 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 128.172 2.589 . . . . 0.0 112.464 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -55.94 -54.23 47.23 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 172.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.598 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -68.51 -22.35 64.53 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -76.27 -31.4 58.26 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 126.188 1.795 . . . . 0.0 111.175 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.1 -23.93 63.13 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 168.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.28 72.89 1.24 Allowed Glycine 0 CA--C 1.466 -2.977 0 N-CA-C 104.778 -3.329 . . . . 0.0 104.778 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -129.14 170.91 12.95 Favored 'General case' 0 CA--C 1.449 -2.941 1 N-CA-C 97.749 -4.908 . . . . 0.0 97.749 169.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -104.72 113.48 27.1 Favored 'General case' 0 N--CA 1.393 -3.314 1 N-CA-C 96.395 -5.409 . . . . 0.0 96.395 171.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.99 154.34 25.75 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.406 ' HG2' HG13 ' A' ' 173' ' ' VAL 0.279 78.9 mttt -118.68 137.53 53.25 Favored 'General case' 0 CA--C 1.469 -2.145 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 164.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.5 mm -83.18 128.92 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.37 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.8 m -110.78 122.84 48.84 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 169.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.542 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.2 OUTLIER -87.01 155.37 20.19 Favored 'General case' 0 CA--C 1.469 -2.163 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 170.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -151.57 89.69 1.51 Allowed 'General case' 0 N--CA 1.405 -2.694 0 N-CA-C 101.042 -3.688 . . . . 0.0 101.042 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.628 ' CE2' HD13 ' A' ' 165' ' ' ILE . 95.8 m-85 -78.35 163.18 25.9 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 112.237 -2.256 . . . . 0.0 109.394 -171.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -113.2 32.84 5.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 170.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -114.12 -13.08 10.3 Favored Glycine 0 CA--C 1.47 -2.747 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.5 mtm-85 70.98 -146.33 0.07 Allowed 'General case' 0 CA--C 1.491 -1.321 0 O-C-N 125.604 1.414 . . . . 0.0 109.793 170.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -48.72 107.37 0.13 Allowed 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 127.812 2.445 . . . . 0.0 112.6 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 1.3 mtp 49.37 77.88 0.1 Allowed 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 127.187 2.195 . . . . 0.0 111.546 -169.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.35 -163.35 0.5 Allowed 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 122.706 1.241 . . . . 0.0 113.608 -173.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -32.51 153.18 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 131.176 3.79 . . . . 0.0 117.701 159.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -124.06 -2.83 8.13 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 170.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -83.81 -55.05 4.46 Favored 'General case' 0 CA--C 1.481 -1.702 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.2 mt -83.01 110.66 18.28 Favored 'Isoleucine or valine' 1 N--CA 1.376 -4.163 1 N-CA-C 95.296 -5.816 . . . . 0.0 95.296 166.289 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.542 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . 147.88 -71.01 0.33 Allowed Glycine 1 N--CA 1.381 -4.999 2 C-N-CA 134.887 5.994 . . . . 0.0 108.273 165.293 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.4 mtm -94.86 20.07 9.32 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -169.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -50.68 25.45 Favored 'General case' 0 CA--C 1.454 -2.726 0 C-N-CA 116.4 -2.12 . . . . 0.0 113.939 137.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.654 HG11 ' HB3' ' A' ' 98' ' ' PHE . 15.0 t -68.14 -67.72 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.429 -3.696 0 O-C-N 126.469 2.356 . . . . 0.0 106.669 -159.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.13 -55.93 3.05 Favored 'General case' 0 CA--C 1.459 -2.546 0 C-N-CA 129.336 3.055 . . . . 0.0 111.843 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -57.51 -37.96 73.83 Favored 'General case' 0 CA--C 1.469 -2.157 0 C-N-CA 125.924 1.689 . . . . 0.0 114.509 178.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -81.82 -14.83 55.8 Favored 'General case' 0 N--CA 1.421 -1.925 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.747 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.4 t -75.25 -47.77 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.764 0 CA-C-O 116.082 -1.913 . . . . 0.0 106.55 176.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.608 ' HB2' HG21 ' A' ' 158' ' ' VAL . 3.5 ttmt -53.06 -51.87 60.37 Favored 'General case' 0 CA--C 1.46 -2.482 0 CA-C-O 117.248 -1.358 . . . . 0.0 110.02 171.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.41 -36.53 81.46 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 119.01 0.823 . . . . 0.0 110.268 -168.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.29 -43.97 66.09 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 116.519 -2.072 . . . . 0.0 116.414 168.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.275 0.2 OUTLIER -82.74 -18.17 41.68 Favored 'General case' 0 CA--C 1.468 -2.176 0 N-CA-C 118.064 2.616 . . . . 0.0 118.064 -172.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -25.64 -31.52 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.154 1 C-N-CA 133.571 4.748 . . . . 0.0 118.321 170.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.4 mt-10 -53.11 -50.32 64.7 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 127.998 2.519 . . . . 0.0 114.459 173.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 tt -112.4 -51.76 2.82 Favored 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 125.97 1.708 . . . . 0.0 110.633 -169.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.598 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.308 . . -104.46 144.46 31.63 Favored 'General case' 0 CA--C 1.452 -2.821 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.572 -174.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 177' ' ' LYS . 5.5 m -128.84 159.78 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.484 0 N-CA-C 120.196 3.406 . . . . 0.0 120.196 148.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 149' ' ' LYS . 2.4 t -83.2 150.07 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.257 0 CA-C-N 110.108 -3.224 . . . . 0.0 105.841 -173.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -81.54 -39.75 24.18 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 -174.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.4 t -159.78 157.74 29.89 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -169.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -116.32 103.52 52.88 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 175.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 38.0 Cg_endo -145.99 -120.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.422 1 C-N-CA 111.733 -5.045 . . . . 0.0 106.351 -136.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.447 ' HB ' ' H ' ' A' ' 164' ' ' LYS . 0.2 OUTLIER -80.32 -84.41 0.1 Allowed 'General case' 0 N--CA 1.408 -2.553 0 C-N-CA 116.581 -2.048 . . . . 0.0 110.521 -84.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.447 ' H ' ' HB ' ' A' ' 163' ' ' THR . 14.5 ptpt -156.19 152.68 28.13 Favored 'General case' 0 N--CA 1.419 -2.009 1 N-CA-C 99.586 -4.227 . . . . 0.0 99.586 175.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.628 HD13 ' CE2' ' A' ' 130' ' ' PHE . 3.3 mt -81.46 127.66 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 175.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -120.49 103.52 9.24 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 111.351 -2.659 . . . . 0.0 104.728 -171.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.26 -139.47 24.11 Favored Glycine 0 CA--C 1.481 -2.073 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 -168.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -97.4 29.83 3.09 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.395 -1.402 . . . . 0.0 112.104 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.322 28.5 mt-30 -167.08 145.46 4.99 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 118.378 0.536 . . . . 0.0 112.371 -157.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 41.9 ttm -129.98 121.11 25.9 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 121.275 0.559 . . . . 0.0 110.519 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.7 mm -83.02 128.99 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 O-C-N 120.895 -1.128 . . . . 0.0 109.205 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.408 ' SD ' ' CE1' ' A' ' 161' ' ' PHE . 1.2 ttp -108.48 140.61 41.56 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 156.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.406 HG13 ' HG2' ' A' ' 125' ' ' LYS . 11.1 t -106.17 135.79 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 C-N-CA 119.171 -1.011 . . . . 0.0 109.299 -173.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.558 HD13 HG22 ' A' ' 158' ' ' VAL . 6.1 tp -118.81 96.66 5.35 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 121.626 3.935 . . . . 0.0 121.626 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.271 . . -98.84 168.43 9.75 Favored Pre-proline 0 CA--C 1.499 -0.987 0 N-CA-C 115.899 1.815 . . . . 0.0 115.899 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -75.7 135.6 18.02 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 N-CA-C 105.039 -2.716 . . . . 0.0 105.039 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.427 ' HB3' HG13 ' A' ' 157' ' ' VAL . 58.2 pttt -80.72 163.06 23.82 Favored 'General case' 0 CA--C 1.49 -1.349 0 C-N-CA 118.365 -1.334 . . . . 0.0 113.905 -175.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -84.42 122.66 29.27 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 166.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -67.84 126.87 30.79 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 . . . . . 0 C--O 1.259 1.589 0 CA-C-O 117.787 -1.101 . . . . 0.0 108.545 -179.668 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.469 -2.136 0 CA-C-O 124.836 2.255 . . . . 0.0 107.568 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.4 mm -86.0 120.55 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.496 0 CA-C-N 108.526 -3.943 . . . . 0.0 107.046 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -98.98 164.67 12.09 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -166.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.8 t -97.84 120.34 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -102.5 168.5 9.25 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 152.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -136.12 153.27 51.35 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 tp -135.57 160.93 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 167.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -117.27 155.73 28.99 Favored 'General case' 0 CA--C 1.484 -1.564 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.831 165.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.55 ' HB3' HG11 ' A' ' 144' ' ' VAL . 5.4 m-85 -139.44 139.29 37.03 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -104.77 175.2 2.27 Favored Pre-proline 0 N--CA 1.434 -1.253 0 CA-C-O 118.804 -0.617 . . . . 0.0 109.403 -172.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.99 136.52 61.66 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 C-N-CA 123.518 2.812 . . . . 0.0 111.383 171.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 26.88 95.58 0.01 OUTLIER Glycine 0 CA--C 1.468 -2.851 0 C-N-CA 130.628 3.966 . . . . 0.0 114.463 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.99 -157.24 0.59 Allowed 'General case' 0 N--CA 1.397 -3.116 0 CA-C-N 111.4 -2.4 . . . . 0.0 106.264 -169.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 107' ' ' TYR 0.443 0.7 OUTLIER -144.47 167.0 23.53 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 110.637 -2.983 . . . . 0.0 110.781 -142.973 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -68.8 -76.53 0.09 Allowed 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -107.02 47.06 1.08 Allowed Glycine 0 CA--C 1.478 -2.259 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.619 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.422 ' H ' ' HB3' ' A' ' 103' ' ' ASP . 24.1 t70 -104.97 -42.32 5.36 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 144.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.522 ' HB3' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER -82.51 -64.02 1.26 Allowed 'General case' 0 CA--C 1.483 -1.609 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.138 -163.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.336 0.0 OUTLIER -61.44 -12.02 12.88 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 119.649 3.203 . . . . 0.0 119.649 176.738 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.84 -44.69 99.73 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-O 122.649 1.214 . . . . 0.0 110.06 161.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -91.46 0.55 57.49 Favored 'General case' 0 CA--C 1.477 -1.842 0 O-C-N 120.454 -1.404 . . . . 0.0 114.568 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.3 tt -81.66 -28.76 33.43 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 162.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.494 ' HA ' HG12 ' A' ' 115' ' ' ILE . 40.7 ttt180 -62.08 -42.78 99.56 Favored 'General case' 0 C--N 1.361 1.096 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.874 166.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.4 m -58.88 -43.6 90.96 Favored 'General case' 0 C--N 1.38 1.9 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 173.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.261 83.5 mt -64.75 -29.2 70.17 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 116.585 2.069 . . . . 0.0 116.585 175.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.254 10.1 mm -58.32 -51.44 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.899 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.085 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -50.08 -46.88 53.78 Favored 'General case' 0 CA--C 1.49 -1.329 0 O-C-N 126.025 2.078 . . . . 0.0 109.713 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -59.76 -56.05 26.65 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.221 1.008 . . . . 0.0 112.848 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -69.71 -27.66 65.18 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 125.737 1.615 . . . . 0.0 115.321 -177.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -82.8 -17.34 44.43 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 124.113 0.965 . . . . 0.0 111.81 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -71.44 -29.64 65.12 Favored 'General case' 0 C--N 1.362 1.137 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 162.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.02 65.27 1.13 Allowed Glycine 0 CA--C 1.474 -2.483 0 N-CA-C 105.558 -3.017 . . . . 0.0 105.558 -172.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -125.82 173.34 9.15 Favored 'General case' 0 CA--C 1.456 -2.654 1 N-CA-C 98.069 -4.789 . . . . 0.0 98.069 169.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.12 122.49 47.39 Favored 'General case' 0 N--CA 1.4 -2.974 1 N-CA-C 96.983 -5.191 . . . . 0.0 96.983 170.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.98 160.11 21.1 Favored 'General case' 0 N--CA 1.42 -1.958 0 C-N-CA 115.453 -2.499 . . . . 0.0 105.708 169.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -133.26 119.3 19.62 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 171.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.585 HD11 HD22 ' A' ' 174' ' ' LEU . 7.8 mm -85.23 134.65 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.704 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.1 m -122.89 127.97 49.7 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.481 HD21 ' HA2' ' A' ' 141' ' ' GLY 0.377 0.3 OUTLIER -80.47 153.35 28.24 Favored 'General case' 0 CA--C 1.454 -2.739 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 169.365 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 33.4 ttt-85 -148.34 91.77 1.95 Allowed 'General case' 0 N--CA 1.399 -3.024 1 N-CA-C 98.556 -4.609 . . . . 0.0 98.556 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -65.56 141.38 58.46 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 110.598 -3.001 . . . . 0.0 109.139 -172.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.0 ttm105 -110.92 25.56 11.65 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -80.39 -47.49 6.86 Favored Glycine 0 CA--C 1.475 -2.418 1 N-CA-C 102.85 -4.1 . . . . 0.0 102.85 156.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 65.03 30.87 11.53 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 129.835 3.254 . . . . 0.0 112.088 169.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 176.75 -42.2 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.514 1 N-CA-C 100.188 -4.004 . . . . 0.0 100.188 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 67.7 mtm -79.12 -25.33 42.97 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.094 -174.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 4.48 115.76 0.0 OUTLIER 'General case' 0 C--N 1.37 1.468 1 C-N-CA 131.85 4.06 . . . . 0.0 117.871 176.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.589 ' CD2' HD12 ' A' ' 140' ' ' ILE . 4.0 m170 -111.36 167.33 10.38 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -161.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -94.21 -4.33 49.18 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 121.566 0.698 . . . . 0.0 109.73 169.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -82.83 -54.42 5.12 Favored 'General case' 0 CA--C 1.476 -1.868 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.589 HD12 ' CD2' ' A' ' 137' ' ' HIS . 82.8 mt -56.31 -47.5 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.125 0 C-N-CA 126.51 1.924 . . . . 0.0 110.753 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.481 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -72.85 -63.55 2.82 Favored Glycine 0 N--CA 1.414 -2.809 0 O-C-N 123.814 0.696 . . . . 0.0 112.404 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 71.5 mtm -96.84 24.75 5.83 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -163.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -62.3 1.49 Allowed 'General case' 0 CA--C 1.453 -2.756 0 C-N-CA 116.171 -2.212 . . . . 0.0 115.545 129.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.55 HG11 ' HB3' ' A' ' 98' ' ' PHE . 25.7 t -61.94 -64.03 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.45 -2.899 0 O-C-N 126.435 2.335 . . . . 0.0 109.183 -161.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' A' ' 172' ' ' MET . 72.9 mt -43.45 -55.53 4.12 Favored 'General case' 0 CA--C 1.48 -1.725 0 C-N-CA 127.686 2.395 . . . . 0.0 114.086 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -57.62 -37.6 73.56 Favored 'General case' 0 CA--C 1.476 -1.879 0 C-N-CA 126.484 1.914 . . . . 0.0 114.298 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.419 ' HA ' ' HB2' ' A' ' 150' ' ' ASP . 15.9 ttp180 -80.2 -15.29 57.36 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 118.845 0.748 . . . . 0.0 111.38 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.8 t -74.2 -47.07 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.724 0 CA-C-O 116.459 -1.734 . . . . 0.0 106.732 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.607 ' HE3' HG21 ' A' ' 158' ' ' VAL . 10.7 ttmt -55.41 -50.78 68.87 Favored 'General case' 0 CA--C 1.461 -2.452 0 CA-C-O 116.776 -1.583 . . . . 0.0 110.011 172.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.419 ' HB2' ' HA ' ' A' ' 147' ' ' ARG . 69.0 m-20 -66.84 -36.45 82.36 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 119.733 1.151 . . . . 0.0 110.105 -168.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.09 -48.44 57.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 116.662 -2.015 . . . . 0.0 115.843 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.465 HD13 HD21 ' A' ' 174' ' ' LEU 0.283 0.2 OUTLIER -82.62 -14.38 54.86 Favored 'General case' 0 CA--C 1.468 -2.198 0 N-CA-C 118.147 2.647 . . . . 0.0 118.147 -172.297 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -25.4 -30.23 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.263 1 C-N-CA 133.815 4.846 . . . . 0.0 118.358 168.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.3 mt-10 -51.36 -54.37 27.09 Favored 'General case' 0 CA--C 1.488 -1.428 0 C-N-CA 127.478 2.311 . . . . 0.0 113.828 170.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.3 tt -113.52 -53.7 2.67 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.38 -1.736 . . . . 0.0 110.491 -168.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.519 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.301 . . -92.65 148.22 22.24 Favored 'General case' 0 CA--C 1.455 -2.698 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -177.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.486 ' HB ' ' H ' ' A' ' 158' ' ' VAL . 15.2 m -118.58 -164.04 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.452 -2.821 0 C-N-CA 114.305 -2.958 . . . . 0.0 111.155 141.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.607 HG21 ' HE3' ' A' ' 149' ' ' LYS 0.277 2.9 t -111.93 163.01 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.394 0 C-N-CA 129.649 3.18 . . . . 0.0 107.364 -177.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -84.09 -43.97 14.53 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 172.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.584 ' H ' HG12 ' A' ' 158' ' ' VAL . 0.9 OUTLIER -157.29 147.62 21.01 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.557 -167.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.5 99.62 38.07 Favored Pre-proline 0 N--CA 1.416 -2.15 0 N-CA-C 103.136 -2.912 . . . . 0.0 103.136 165.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -100.35 -111.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.41 -3.382 0 N-CA-C 101.795 -3.963 . . . . 0.0 101.795 -163.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 179.44 -46.53 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.575 0 N-CA-C 102.785 -3.043 . . . . 0.0 102.785 -144.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -83.26 102.91 12.25 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 122.681 1.229 . . . . 0.0 113.043 -146.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.1 mt -80.07 131.03 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.119 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 166.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -125.26 98.81 5.79 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 -175.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.15 -139.07 17.27 Favored Glycine 0 CA--C 1.483 -1.939 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 -169.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.01 38.87 1.74 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.136 1.774 . . . . 0.0 109.637 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -169.68 139.22 1.97 Allowed 'General case' 0 C--N 1.359 0.988 0 O-C-N 121.383 -0.823 . . . . 0.0 111.835 -168.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 31.2 ttm -123.36 121.86 36.85 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -170.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.46 HG21 HD13 ' A' ' 171' ' ' ILE . 1.4 mt -87.69 142.69 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 C-N-CA 117.755 -1.578 . . . . 0.0 110.758 173.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.458 ' HB3' HD22 ' A' ' 145' ' ' LEU . 3.3 tmm? -111.72 126.84 55.47 Favored 'General case' 0 CA--C 1.476 -1.894 0 N-CA-C 101.421 -3.548 . . . . 0.0 101.421 153.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.2 t -91.72 124.93 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 118.052 -1.459 . . . . 0.0 108.45 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.585 HD22 HD11 ' A' ' 126' ' ' ILE . 14.5 tp -104.45 84.43 2.19 Favored 'General case' 0 C--N 1.349 0.556 0 N-CA-C 121.324 3.824 . . . . 0.0 121.324 -174.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.438 . . -108.08 155.66 39.7 Favored Pre-proline 0 C--N 1.359 0.993 0 N-CA-C 119.279 3.066 . . . . 0.0 119.279 -173.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -68.25 139.39 45.84 Favored 'Trans proline' 0 CA--C 1.491 -1.653 0 C-N-CA 123.398 2.732 . . . . 0.0 111.545 -160.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -79.63 144.29 33.93 Favored 'General case' 0 CA--C 1.49 -1.343 0 O-C-N 125.053 1.471 . . . . 0.0 107.614 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -66.69 113.08 4.55 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.591 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -76.92 127.53 32.89 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 175.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 . . . . . 0 C--O 1.26 1.63 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.243 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.469 -2.167 0 CA-C-O 124.734 2.207 . . . . 0.0 107.404 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.9 mm -88.92 116.37 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 108.732 -3.849 . . . . 0.0 107.295 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -107.06 158.79 16.79 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -167.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.463 HG22 ' HD2' ' A' ' 123' ' ' LYS . 72.3 t -90.18 112.43 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -104.58 177.08 4.95 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 157.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -140.01 156.29 46.69 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 117.778 0.263 . . . . 0.0 111.265 -170.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 tp -139.51 168.64 18.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 164.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -118.23 155.61 30.24 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 118.833 0.742 . . . . 0.0 111.178 162.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.548 ' HD2' HG21 ' A' ' 126' ' ' ILE . 19.2 m-85 -124.55 153.49 42.04 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 168.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -131.17 166.57 26.75 Favored Pre-proline 0 N--CA 1.437 -1.101 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.828 -170.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.522 ' HG3' ' H ' ' A' ' 131' ' ' ARG . 22.1 Cg_endo -78.29 140.22 17.28 Favored 'Trans proline' 0 CA--C 1.49 -1.689 0 C-N-CA 124.092 3.195 . . . . 0.0 108.31 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.65 13.72 83.19 Favored Glycine 0 CA--C 1.484 -1.872 0 O-C-N 124.14 0.9 . . . . 0.0 112.0 173.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.2 m -103.5 98.74 8.58 Favored 'General case' 0 N--CA 1.408 -2.546 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -126.69 -138.09 0.26 Allowed 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 110.889 -2.869 . . . . 0.0 103.636 166.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.52 -81.56 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -86.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.13 43.73 1.73 Allowed Glycine 0 CA--C 1.485 -1.785 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.554 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -103.89 -39.38 6.64 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 150.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.23 -71.69 0.29 Allowed 'General case' 0 CA--C 1.479 -1.76 0 C-N-CA 126.556 1.942 . . . . 0.0 109.112 -171.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.461 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.368 0.0 OUTLIER -57.49 -15.42 6.97 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 119.8 3.259 . . . . 0.0 119.8 175.11 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.97 -43.89 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-O 122.014 0.911 . . . . 0.0 110.699 163.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -91.96 2.78 56.33 Favored 'General case' 0 CA--C 1.477 -1.858 0 O-C-N 120.495 -1.378 . . . . 0.0 114.367 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 151' ' ' ASP . 5.9 tt -81.82 -31.96 31.47 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 163.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.438 ' HA ' HG12 ' A' ' 115' ' ' ILE . 50.4 ttt180 -62.64 -42.36 99.55 Favored 'General case' 0 C--N 1.361 1.095 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.696 168.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.7 m -60.18 -38.0 81.91 Favored 'General case' 0 C--N 1.377 1.798 0 C-N-CA 118.632 -1.227 . . . . 0.0 113.728 172.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.469 HD22 ' HB3' ' A' ' 124' ' ' ALA . 72.2 mt -65.24 -33.74 76.71 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 175.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 112' ' ' ARG . 4.7 mm -58.62 -46.11 90.34 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.391 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -49.64 -48.78 49.02 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 128.14 2.576 . . . . 0.0 111.835 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -58.97 -50.05 75.56 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.739 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -70.56 -21.77 62.66 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 124.853 1.261 . . . . 0.0 114.119 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -71.29 -37.7 71.84 Favored 'General case' 0 CA--C 1.491 -1.327 0 C-N-CA 126.75 2.02 . . . . 0.0 109.694 173.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -66.82 -28.22 68.19 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-O 120.732 0.301 . . . . 0.0 110.61 170.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.53 71.47 1.29 Allowed Glycine 0 CA--C 1.473 -2.579 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 -175.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -134.79 174.45 10.56 Favored 'General case' 0 N--CA 1.414 -2.229 1 N-CA-C 99.97 -4.085 . . . . 0.0 99.97 170.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HD2' HG22 ' A' ' 93' ' ' VAL 0.333 13.9 mtmt -88.5 147.47 24.63 Favored 'General case' 0 CA--C 1.459 -2.554 0 N-CA-C 100.918 -3.734 . . . . 0.0 100.918 159.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.469 ' HB3' HD22 ' A' ' 114' ' ' LEU . . . -116.18 123.2 47.21 Favored 'General case' 0 CA--C 1.457 -2.623 0 C-N-CA 115.331 -2.548 . . . . 0.0 106.091 160.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -99.75 117.67 34.59 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -168.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.548 HG21 ' HD2' ' A' ' 98' ' ' PHE . 3.6 mm -85.29 125.92 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.445 ' HA ' HD13 ' A' ' 171' ' ' ILE . 17.3 m -97.79 117.22 31.61 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 159.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.767 HD13 ' CZ ' ' A' ' 130' ' ' PHE . 0.5 OUTLIER -76.46 148.5 37.2 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 166.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.518 ' H ' HD23 ' A' ' 128' ' ' LEU . 24.4 ttt180 -151.14 92.61 1.82 Allowed 'General case' 0 N--CA 1.402 -2.837 1 N-CA-C 97.009 -5.182 . . . . 0.0 97.009 -167.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.767 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 90.5 m-85 -76.0 134.27 40.18 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 101.423 -3.547 . . . . 0.0 101.423 174.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.522 ' H ' ' HG3' ' A' ' 100' ' ' PRO . 0.6 OUTLIER -88.58 84.58 6.75 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 103.336 -2.839 . . . . 0.0 103.336 168.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.441 ' H ' ' HE ' ' A' ' 168' ' ' ARG . . . -172.06 -130.88 1.29 Allowed Glycine 0 N--CA 1.42 -2.423 0 C-N-CA 116.352 -2.832 . . . . 0.0 112.642 -148.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 64.86 44.99 3.4 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 112.408 -1.896 . . . . 0.0 106.166 -148.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.432 ' H ' ' H ' ' A' ' 136' ' ' ALA . 12.9 pt-20 178.44 -26.21 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 100.592 -3.855 . . . . 0.0 100.592 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 25.6 mmt -113.88 -2.49 13.6 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 169.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.432 ' H ' ' H ' ' A' ' 134' ' ' GLU . . . -77.77 102.12 7.02 Favored 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 121.67 -0.644 . . . . 0.0 109.43 165.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.556 ' HB2' ' H ' ' A' ' 140' ' ' ILE . 21.6 m170 -108.02 -128.86 0.28 Allowed 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.901 0.858 . . . . 0.0 111.352 -173.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.446 ' H ' ' H ' ' A' ' 139' ' ' GLN . 15.6 pt20 -149.35 0.45 0.51 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 103.024 -2.954 . . . . 0.0 103.024 158.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.446 ' H ' ' H ' ' A' ' 138' ' ' GLN . 64.8 mm-40 -86.32 -51.81 6.01 Favored 'General case' 0 CA--C 1.476 -1.894 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.556 ' H ' ' HB2' ' A' ' 137' ' ' HIS . 16.6 mt -90.8 98.9 8.87 Favored 'Isoleucine or valine' 1 N--CA 1.367 -4.623 1 N-CA-C 94.153 -6.24 . . . . 0.0 94.153 169.684 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.404 ' HA2' ' CD1' ' A' ' 128' ' ' LEU . . . 157.7 -89.67 0.11 Allowed Glycine 0 N--CA 1.412 -2.943 1 CA-C-N 107.883 -4.235 . . . . 0.0 108.857 -174.147 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.541 ' HG2' ' CE1' ' A' ' 161' ' ' PHE 0.254 75.0 mtp -90.09 5.16 47.96 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 128.779 2.832 . . . . 0.0 113.876 -168.394 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.251 2.3 tp10 -75.48 -45.67 37.06 Favored 'General case' 0 CA--C 1.433 -3.529 0 C-N-CA 116.111 -2.236 . . . . 0.0 111.823 151.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 98' ' ' PHE . 38.5 t -68.51 -74.9 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.444 -3.113 0 O-C-N 126.693 2.495 . . . . 0.0 107.539 -161.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.579 ' CD2' HD12 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -51.46 -47.4 63.12 Favored 'General case' 0 CA--C 1.481 -1.675 0 C-N-CA 129.908 3.283 . . . . 0.0 112.102 -177.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.253 1.5 t30 -64.98 -32.31 73.97 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -81.39 -15.58 54.78 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.363 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.48 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.7 t -74.78 -46.42 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.885 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.47 ' CE ' ' HB ' ' A' ' 158' ' ' VAL 0.303 19.7 ttmt -51.27 -48.48 62.19 Favored 'General case' 0 CA--C 1.472 -2.051 0 C-N-CA 126.781 2.032 . . . . 0.0 113.424 172.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.89 -39.65 61.36 Favored 'General case' 0 N--CA 1.408 -2.554 0 C-N-CA 127.238 2.215 . . . . 0.0 109.577 -171.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.413 ' HB3' HD11 ' A' ' 111' ' ' LEU . 14.2 t70 -75.24 -25.06 57.8 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 116.623 -2.031 . . . . 0.0 115.0 170.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.415 HD11 ' HA ' ' A' ' 115' ' ' ILE 0.307 0.2 OUTLIER -79.44 -31.55 42.56 Favored 'General case' 0 CA--C 1.466 -2.252 0 CA-C-O 116.152 -1.88 . . . . 0.0 112.223 178.192 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -30.57 -17.88 0.0 OUTLIER 'General case' 0 C--N 1.371 1.526 1 C-N-CA 135.237 5.415 . . . . 0.0 120.336 -175.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 4.4 mt-10 -53.58 -58.41 7.28 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 126.379 1.872 . . . . 0.0 111.378 163.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.58 -54.09 2.73 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 126.002 1.721 . . . . 0.0 109.286 -172.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.739 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.307 . . -110.67 140.16 45.28 Favored 'General case' 0 CA--C 1.459 -2.557 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.652 -164.344 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.8 m -126.73 166.87 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.527 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 144.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 174' ' ' LEU 0.305 70.2 t -74.54 146.83 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.874 0 CA-C-N 111.121 -2.763 . . . . 0.0 107.349 176.137 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.46 -41.42 16.62 Favored 'General case' 0 CA--C 1.473 -2.016 0 CA-C-N 110.895 -2.866 . . . . 0.0 105.695 -170.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -160.18 140.15 11.41 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 -169.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.541 ' CE1' ' HG2' ' A' ' 142' ' ' MET . 1.8 t80 -102.48 91.96 3.02 Favored Pre-proline 0 N--CA 1.425 -1.689 0 N-CA-C 100.373 -3.936 . . . . 0.0 100.373 170.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -96.34 -82.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.632 0 CA-C-N 121.66 1.628 . . . . 0.0 108.823 -139.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.429 ' HB ' ' H ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -103.5 -105.03 0.29 Allowed 'General case' 0 N--CA 1.399 -2.987 0 C-N-CA 117.684 -1.607 . . . . 0.0 109.012 -138.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.429 ' H ' ' HB ' ' A' ' 163' ' ' THR . 62.7 tttm -155.7 161.5 40.73 Favored 'General case' 0 N--CA 1.422 -1.84 1 N-CA-C 96.302 -5.444 . . . . 0.0 96.302 -177.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.603 HD13 ' CE2' ' A' ' 130' ' ' PHE . 2.7 mt -74.78 126.93 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.125 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 169.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -113.7 106.38 14.43 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 111.908 -2.406 . . . . 0.0 104.8 -176.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.41 -141.89 27.37 Favored Glycine 0 CA--C 1.484 -1.852 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -171.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.441 ' HE ' ' H ' ' A' ' 132' ' ' GLY . 63.6 mtp180 -101.68 36.03 2.16 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 113.288 -1.456 . . . . 0.0 110.189 -176.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.264 18.3 mt-30 -167.03 137.26 3.02 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 118.89 0.768 . . . . 0.0 111.406 -169.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 46.6 ttm -124.41 119.12 28.29 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 127' ' ' THR . 16.0 mm -81.9 136.57 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 O-C-N 120.624 -1.297 . . . . 0.0 108.299 171.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.448 ' HG2' HG13 ' A' ' 158' ' ' VAL . 6.5 tmm? -124.23 133.8 53.42 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 102.78 -3.045 . . . . 0.0 102.78 156.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.58 135.29 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 106.833 -1.544 . . . . 0.0 106.833 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -115.69 141.81 47.58 Favored 'General case' 0 C--N 1.362 1.142 1 N-CA-C 99.577 -4.231 . . . . 0.0 99.577 -179.74 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.353 . . -147.71 -179.97 1.06 Allowed Pre-proline 0 CA--C 1.494 -1.211 0 CA-C-N 120.024 1.283 . . . . 0.0 112.517 -168.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -68.91 137.69 38.63 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 121.109 1.206 . . . . 0.0 109.673 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -81.42 138.68 35.54 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -80.69 141.23 35.09 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.207 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? 60.23 59.9 2.2 Favored 'General case' 0 CA--C 1.495 -1.162 0 C-N-CA 126.634 1.974 . . . . 0.0 110.031 -173.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? . . . . . 0 C--O 1.26 1.643 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 178.517 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.469 -2.151 0 CA-C-O 124.948 2.308 . . . . 0.0 107.385 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.7 mm -97.12 119.69 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.36 0 CA-C-N 108.669 -3.878 . . . . 0.0 107.841 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -94.07 169.51 10.21 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.533 HG22 ' HD3' ' A' ' 123' ' ' LYS . 88.1 t -102.49 118.12 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 163.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -103.19 175.12 5.58 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 159.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -145.97 153.33 40.67 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 tp -134.38 164.0 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -119.5 153.13 35.8 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.349 161.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.516 ' HB3' HG11 ' A' ' 144' ' ' VAL . 40.1 m-85 -127.85 164.01 23.16 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 171.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.12 176.8 1.49 Allowed Pre-proline 0 N--CA 1.419 -2.019 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -170.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.441 ' HG3' ' H ' ' A' ' 131' ' ' ARG . 83.3 Cg_exo -58.51 144.09 97.33 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 125.267 3.978 . . . . 0.0 111.931 164.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -13.69 101.5 0.01 OUTLIER Glycine 0 CA--C 1.469 -2.84 1 C-N-CA 131.039 4.161 . . . . 0.0 114.996 -173.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.12 -153.82 0.5 Allowed 'General case' 0 N--CA 1.399 -2.988 0 CA-C-N 111.163 -2.519 . . . . 0.0 108.408 -152.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' A' ' 107' ' ' TYR 0.434 0.7 OUTLIER -121.87 166.88 13.73 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-N 109.996 -3.275 . . . . 0.0 111.703 -152.964 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.38 -74.31 0.13 Allowed 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -107.04 46.22 1.2 Allowed Glycine 0 CA--C 1.476 -2.385 0 C-N-CA 119.983 -1.103 . . . . 0.0 112.912 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -106.34 -41.17 5.39 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 145.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.523 ' HB3' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER -84.92 -65.11 1.05 Allowed 'General case' 0 CA--C 1.481 -1.704 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.519 -164.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.461 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.324 0.0 OUTLIER -62.29 -9.37 7.81 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 178.051 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 64.7 t -60.67 -46.9 95.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 122.359 1.076 . . . . 0.0 109.864 158.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -90.83 -3.21 57.56 Favored 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.443 HD23 HD11 ' A' ' 115' ' ' ILE . 4.5 tt -77.44 -32.16 54.35 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 162.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.471 ' HA ' HG12 ' A' ' 115' ' ' ILE . 41.7 ttt180 -61.94 -42.41 99.07 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.041 169.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.5 m -59.56 -43.61 93.51 Favored 'General case' 0 C--N 1.38 1.902 0 C-N-CA 118.44 -1.304 . . . . 0.0 113.975 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.538 ' O ' HD12 ' A' ' 118' ' ' LEU 0.263 47.4 mt -64.03 -30.56 71.63 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 175.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.265 4.0 mm -61.98 -47.73 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.92 0 CA-C-N 119.936 1.243 . . . . 0.0 108.699 177.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -54.0 -43.16 69.82 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 125.765 1.915 . . . . 0.0 110.214 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -59.72 -51.65 68.87 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.78 0.832 . . . . 0.0 112.542 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 156' ' ' ALA . 1.8 mt -71.98 -19.57 61.86 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 126.466 1.906 . . . . 0.0 114.452 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -73.14 -35.4 66.5 Favored 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 125.978 1.711 . . . . 0.0 110.122 171.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -68.25 -23.79 64.83 Favored 'General case' 0 C--N 1.36 1.063 0 C-N-CA 122.575 0.35 . . . . 0.0 110.144 168.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.63 69.31 1.38 Allowed Glycine 0 CA--C 1.466 -2.99 0 N-CA-C 104.762 -3.335 . . . . 0.0 104.762 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -123.38 165.11 17.57 Favored 'General case' 0 CA--C 1.458 -2.573 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.533 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -101.66 107.36 18.58 Favored 'General case' 0 N--CA 1.404 -2.735 1 N-CA-C 98.762 -4.533 . . . . 0.0 98.762 178.123 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.71 122.38 41.87 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -174.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -95.77 122.1 38.2 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -173.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.9 mm -83.57 131.65 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.451 ' HA ' HD13 ' A' ' 171' ' ' ILE . 23.4 m -116.7 116.54 27.72 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 167.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.876 HD21 ' HA2' ' A' ' 141' ' ' GLY . 17.5 tp -77.95 151.69 33.56 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 169.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -150.23 96.75 2.46 Favored 'General case' 0 N--CA 1.407 -2.611 1 N-CA-C 100.054 -4.054 . . . . 0.0 100.054 -175.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.535 ' HB3' ' H ' ' A' ' 132' ' ' GLY 0.267 68.4 m-85 -73.04 153.41 40.88 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 111.739 -2.482 . . . . 0.0 109.72 -179.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.441 ' H ' ' HG3' ' A' ' 100' ' ' PRO . 23.9 mmm180 -117.93 29.43 7.82 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 163.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.535 ' H ' ' HB3' ' A' ' 130' ' ' PHE . . . -82.74 -122.52 0.75 Allowed Glycine 0 CA--C 1.483 -1.913 0 C-N-CA 125.594 1.569 . . . . 0.0 111.5 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -92.23 -160.23 0.72 Allowed 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 112.804 -1.698 . . . . 0.0 108.613 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -67.36 -92.15 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 166.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 51.9 mtt -77.74 110.83 12.93 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 161.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.39 -146.41 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -157.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.61 ' CD2' HD12 ' A' ' 140' ' ' ILE . 15.0 m-70 -76.62 -71.48 0.39 Allowed 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -162.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 74.29 27.37 1.48 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 126.666 1.986 . . . . 0.0 108.014 -160.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -126.97 -51.3 1.44 Allowed 'General case' 0 CA--C 1.475 -1.934 0 N-CA-C 101.164 -3.643 . . . . 0.0 101.164 169.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.61 HD12 ' CD2' ' A' ' 137' ' ' HIS 0.252 53.1 mt -54.32 -42.27 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-N 112.863 -1.971 . . . . 0.0 110.022 165.36 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.876 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -72.49 -60.05 4.22 Favored Glycine 0 N--CA 1.408 -3.181 0 N-CA-C 115.241 0.856 . . . . 0.0 115.241 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 7.6 ptt? -87.4 0.89 54.82 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 118.569 -0.729 . . . . 0.0 112.932 -160.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.255 0.6 OUTLIER -59.4 -60.81 3.26 Favored 'General case' 0 CA--C 1.461 -2.466 0 C-N-CA 114.94 -2.704 . . . . 0.0 114.987 146.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' A' ' 98' ' ' PHE . 34.0 t -64.7 -64.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.927 0 O-C-N 125.956 2.035 . . . . 0.0 109.433 -164.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.435 HD11 HD22 ' A' ' 128' ' ' LEU . 49.4 mt -44.88 -54.31 6.59 Favored 'General case' 0 CA--C 1.488 -1.405 0 C-N-CA 128.242 2.617 . . . . 0.0 113.891 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.8 t30 -63.6 -30.93 71.97 Favored 'General case' 0 CA--C 1.465 -2.304 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 174.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -80.82 -14.86 57.67 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.354 173.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.449 HG21 ' CE2' ' A' ' 98' ' ' PHE . 2.0 t -76.59 -45.29 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.802 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 174.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.493 ' HB2' HG21 ' A' ' 158' ' ' VAL . 33.6 ttmt -54.42 -51.33 65.26 Favored 'General case' 0 CA--C 1.462 -2.417 0 CA-C-O 117.368 -1.301 . . . . 0.0 111.238 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.13 -40.09 75.05 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 125.477 1.511 . . . . 0.0 108.857 -169.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.421 ' HB3' HD11 ' A' ' 111' ' ' LEU . 24.3 t70 -74.94 -23.2 58.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 116.366 -2.134 . . . . 0.0 115.206 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.413 HD22 HD21 ' A' ' 111' ' ' LEU 0.271 0.1 OUTLIER -81.85 -36.32 28.41 Favored 'General case' 0 CA--C 1.476 -1.872 0 CA-C-O 116.939 -1.505 . . . . 0.0 111.86 179.035 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -27.91 -32.3 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.664 1 C-N-CA 135.614 5.566 . . . . 0.0 119.142 -168.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 6.3 mt-10 -51.2 -47.2 62.31 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 128.914 2.886 . . . . 0.0 114.126 172.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.424 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 3.1 tm? -116.84 -51.61 2.56 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 128.384 2.673 . . . . 0.0 107.258 -161.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.315 . . -114.41 143.6 44.66 Favored 'General case' 0 CA--C 1.462 -2.421 0 CA-C-O 117.788 -1.101 . . . . 0.0 109.815 -175.27 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.5 m -129.54 164.47 32.04 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.125 0 N-CA-C 120.717 3.599 . . . . 0.0 120.717 148.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.4 t -80.49 147.73 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.957 0 CA-C-N 110.877 -2.874 . . . . 0.0 108.207 -176.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -82.37 -39.4 22.8 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.426 -1.715 . . . . 0.0 106.419 -172.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -151.6 142.36 22.84 Favored 'General case' 0 CA--C 1.464 -2.346 0 N-CA-C 104.805 -2.295 . . . . 0.0 104.805 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -105.42 98.25 16.36 Favored Pre-proline 0 N--CA 1.42 -1.969 0 N-CA-C 100.757 -3.794 . . . . 0.0 100.757 163.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -98.09 -113.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.411 -3.336 0 N-CA-C 101.735 -3.986 . . . . 0.0 101.735 -168.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -174.63 -48.45 0.01 OUTLIER 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 -146.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -86.88 102.77 14.65 Favored 'General case' 0 CA--C 1.486 -1.482 0 CA-C-O 121.792 0.806 . . . . 0.0 112.952 -145.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.422 HD13 ' CZ ' ' A' ' 130' ' ' PHE . 4.9 mt -85.43 134.51 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.069 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 173.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -129.1 112.28 13.82 Favored 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.48 -150.36 34.81 Favored Glycine 0 CA--C 1.484 -1.887 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 -167.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -98.92 46.91 0.98 Allowed 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.964 1.306 . . . . 0.0 108.17 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.269 29.9 mt-30 -165.62 134.46 3.24 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 121.905 -0.497 . . . . 0.0 109.91 -170.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.469 ' H ' ' HB3' ' A' ' 128' ' ' LEU . 23.8 ttm -122.96 122.78 39.39 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -176.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 127' ' ' THR . 19.3 mm -82.81 124.79 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 171.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.1 ttp -108.42 130.39 55.23 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 103.166 -2.901 . . . . 0.0 103.166 160.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 32.8 t -96.43 137.49 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 118.873 -1.131 . . . . 0.0 108.42 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.795 HD11 ' HB1' ' A' ' 156' ' ' ALA . 1.1 tp -128.88 144.32 51.14 Favored 'General case' 0 C--N 1.362 1.149 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 -174.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.361 . . -148.5 175.02 2.96 Favored Pre-proline 0 CA--C 1.493 -1.241 0 CA-C-O 117.501 -1.238 . . . . 0.0 110.216 -169.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -73.53 144.92 36.8 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 CA-C-N 121.621 1.614 . . . . 0.0 108.022 -177.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -79.94 132.99 36.17 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -78.55 100.28 6.86 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.852 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -91.17 84.34 5.66 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 . . . . . 0 C--O 1.26 1.646 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -176.167 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.467 -2.238 0 CA-C-O 124.775 2.226 . . . . 0.0 107.667 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.8 mm -86.85 116.23 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 108.621 -3.899 . . . . 0.0 107.09 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -101.07 162.9 12.56 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -170.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.3 t -92.3 115.21 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.558 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -108.46 178.97 4.33 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.569 154.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -142.53 157.07 45.12 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 -171.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 tp -140.31 166.75 19.34 Favored 'Isoleucine or valine' 0 C--N 1.356 0.848 0 N-CA-C 102.544 -3.132 . . . . 0.0 102.544 164.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -116.17 158.69 22.87 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-N 118.943 0.792 . . . . 0.0 111.021 166.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.587 ' HB3' HG11 ' A' ' 144' ' ' VAL . 2.4 m-85 -149.46 99.84 2.94 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -87.42 173.53 6.41 Favored Pre-proline 0 N--CA 1.436 -1.175 0 C-N-CA 125.573 1.549 . . . . 0.0 109.541 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.466 ' HG3' ' H ' ' A' ' 131' ' ' ARG . 16.4 Cg_endo -72.02 132.68 20.15 Favored 'Trans proline' 0 N--CA 1.433 -2.06 0 N-CA-C 105.135 -2.679 . . . . 0.0 105.135 163.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.69 4.64 60.43 Favored Glycine 0 CA--C 1.484 -1.878 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.407 HG22 ' HB2' ' A' ' 107' ' ' TYR . 60.6 m -103.71 89.62 3.39 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 164.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -127.39 -171.82 2.51 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 112.816 -1.993 . . . . 0.0 105.885 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.57 -41.52 69.92 Favored 'General case' 0 CA--C 1.481 -1.709 0 C-N-CA 125.987 1.715 . . . . 0.0 114.54 -127.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.18 -5.06 80.64 Favored Glycine 0 N--CA 1.419 -2.497 0 N-CA-C 116.478 1.351 . . . . 0.0 116.478 -171.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -100.21 -29.17 12.62 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 124.947 1.299 . . . . 0.0 108.019 168.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.407 ' HB2' HG22 ' A' ' 102' ' ' THR . 1.1 t80 -88.81 -69.93 0.68 Allowed 'General case' 0 CA--C 1.473 -1.992 0 CA-C-N 112.611 -2.086 . . . . 0.0 111.316 -158.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.485 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.35 0.0 OUTLIER -56.02 -18.56 9.79 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 118.783 2.883 . . . . 0.0 118.783 172.504 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.59 -49.65 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 CA-C-O 122.391 1.091 . . . . 0.0 110.091 163.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -91.54 9.08 33.54 Favored 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 7.1 tt -85.03 -32.67 22.78 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 163.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.468 ' HA ' HG12 ' A' ' 115' ' ' ILE . 55.2 ttt180 -62.27 -42.89 99.73 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 118.807 -0.616 . . . . 0.0 110.928 167.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 t -54.46 -45.88 73.21 Favored 'General case' 0 C--N 1.379 1.862 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 171.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 118' ' ' LEU . 46.4 mt -63.35 -34.36 77.55 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 117.608 2.447 . . . . 0.0 117.608 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.468 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.9 mm -55.99 -48.57 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 O-C-N 124.3 1.0 . . . . 0.0 108.899 173.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -51.6 -45.62 63.26 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 126.033 1.733 . . . . 0.0 113.402 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -57.49 -50.58 72.58 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' A' ' 156' ' ' ALA . 1.8 mt -72.61 -21.18 61.16 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 125.304 1.442 . . . . 0.0 113.902 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -75.13 -33.22 61.53 Favored 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 125.671 1.588 . . . . 0.0 110.391 173.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -68.91 -26.31 65.03 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 167.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.46 78.24 1.22 Allowed Glycine 0 CA--C 1.47 -2.778 0 N-CA-C 106.338 -2.705 . . . . 0.0 106.338 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -134.31 168.3 19.14 Favored 'General case' 0 CA--C 1.465 -2.318 1 N-CA-C 99.902 -4.111 . . . . 0.0 99.902 168.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.317 0.0 OUTLIER -88.29 121.14 30.35 Favored 'General case' 0 CA--C 1.457 -2.631 1 N-CA-C 99.719 -4.178 . . . . 0.0 99.719 156.903 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.53 123.38 33.58 Favored 'General case' 0 N--CA 1.41 -2.443 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 166.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.459 ' HG2' HG13 ' A' ' 173' ' ' VAL . 36.2 mtmt -102.18 125.27 48.83 Favored 'General case' 0 CA--C 1.469 -2.149 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -175.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.421 HD12 HD11 ' A' ' 114' ' ' LEU . 6.3 mm -86.16 125.29 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.43 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.2 m -103.31 121.62 43.11 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.704 HD23 HD11 ' A' ' 145' ' ' LEU 0.313 0.2 OUTLIER -81.0 150.53 28.86 Favored 'General case' 0 CA--C 1.456 -2.655 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 166.597 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -147.25 89.23 1.77 Allowed 'General case' 0 N--CA 1.402 -2.838 1 N-CA-C 98.645 -4.576 . . . . 0.0 98.645 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.439 ' CE1' ' CD2' ' A' ' 137' ' ' HIS . 74.5 m-85 -71.83 143.42 49.46 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-N 111.259 -2.7 . . . . 0.0 109.877 -166.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.466 ' H ' ' HG3' ' A' ' 100' ' ' PRO . 23.6 mmm180 -96.14 84.92 3.88 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 102.46 -3.163 . . . . 0.0 102.46 157.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -172.3 -142.97 3.94 Favored Glycine 0 N--CA 1.424 -2.11 0 C-N-CA 118.581 -1.771 . . . . 0.0 109.128 -160.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.513 ' H ' ' HB2' ' A' ' 136' ' ' ALA . 20.2 ttt180 -136.3 -167.94 2.15 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -165.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 135' ' ' MET . 4.3 pt-20 -51.3 -69.84 0.1 Allowed 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 127.095 2.158 . . . . 0.0 110.171 173.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.435 ' H ' ' HG3' ' A' ' 134' ' ' GLU . 9.2 ptt? -98.97 106.2 18.43 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 103.9 -2.629 . . . . 0.0 103.9 155.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.513 ' HB2' ' H ' ' A' ' 133' ' ' ARG . . . -73.64 -53.65 9.95 Favored 'General case' 0 CA--C 1.473 -2.013 0 CA-C-O 124.764 2.221 . . . . 0.0 111.287 -176.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.439 ' CD2' ' CE1' ' A' ' 130' ' ' PHE . 17.9 p80 -115.15 169.05 9.4 Favored 'General case' 0 N--CA 1.417 -2.109 1 CA-C-N 108.205 -4.089 . . . . 0.0 114.538 -148.017 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -128.4 -2.67 5.56 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 140.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -106.76 -56.94 2.12 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 113.372 -1.74 . . . . 0.0 112.121 -166.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 74.7 mt -58.42 -52.11 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 C-N-CA 127.169 2.187 . . . . 0.0 111.424 -171.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.81 -65.19 2.18 Favored Glycine 0 N--CA 1.419 -2.458 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 75.0 mtm -93.04 11.75 26.48 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -159.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -72.75 -53.38 11.77 Favored 'General case' 0 CA--C 1.444 -3.1 0 C-N-CA 117.155 -1.818 . . . . 0.0 113.153 143.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.587 HG11 ' HB3' ' A' ' 98' ' ' PHE . 31.2 t -67.71 -66.94 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.446 -3.019 0 O-C-N 126.539 2.399 . . . . 0.0 107.681 -160.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.704 HD11 HD23 ' A' ' 128' ' ' LEU . 97.3 mt -46.97 -49.7 20.28 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 128.563 2.745 . . . . 0.0 115.387 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -59.34 -38.96 81.69 Favored 'General case' 0 CA--C 1.477 -1.833 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 172.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -80.65 -14.75 57.89 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.614 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.447 HG23 ' HA ' ' A' ' 145' ' ' LEU . 1.8 t -76.53 -47.91 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.69 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.288 12.7 ttmt -55.0 -43.46 73.61 Favored 'General case' 0 CA--C 1.466 -2.286 0 C-N-CA 126.015 1.726 . . . . 0.0 113.128 172.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -40.11 65.3 Favored 'General case' 0 N--CA 1.41 -2.452 0 C-N-CA 124.162 0.985 . . . . 0.0 109.446 -174.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -73.93 -26.3 60.43 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 116.579 -2.049 . . . . 0.0 115.569 170.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.271 0.2 OUTLIER -80.9 -32.42 34.79 Favored 'General case' 0 CA--C 1.47 -2.101 0 CA-C-O 116.749 -1.596 . . . . 0.0 112.223 -178.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -28.8 -23.52 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.69 1 C-N-CA 135.528 5.531 . . . . 0.0 119.987 -174.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -53.33 -56.75 14.16 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 126.557 1.943 . . . . 0.0 111.989 167.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.3 tt -107.94 -52.25 2.79 Favored 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 126.557 1.943 . . . . 0.0 108.529 -167.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.62 ' CB ' HD11 ' A' ' 174' ' ' LEU 0.294 . . -110.5 138.37 46.98 Favored 'General case' 0 CA--C 1.467 -2.241 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.505 -173.295 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 177' ' ' LYS . 29.7 m -128.84 165.12 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.496 0 N-CA-C 119.445 3.128 . . . . 0.0 119.445 147.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 160' ' ' SER . 3.9 t -76.96 153.02 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.135 0 CA-C-N 111.562 -2.563 . . . . 0.0 108.401 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.06 -39.91 25.0 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.753 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.548 ' H ' HG12 ' A' ' 158' ' ' VAL . 0.9 OUTLIER -150.38 137.2 19.17 Favored 'General case' 0 CA--C 1.469 -2.171 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 -173.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -114.23 98.55 48.81 Favored Pre-proline 0 CA--C 1.486 -1.517 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 177.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -135.36 -117.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.42 -2.832 0 C-N-CA 114.09 -3.473 . . . . 0.0 103.918 -152.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -169.13 -38.15 0.02 OUTLIER 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -128.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -85.53 92.58 8.56 Favored 'General case' 0 CA--C 1.489 -1.378 0 CA-C-O 121.254 0.549 . . . . 0.0 111.334 -159.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.417 HD11 ' NE2' ' A' ' 137' ' ' HIS . 0.8 OUTLIER -83.96 137.22 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.244 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 174.178 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -106.06 94.31 5.1 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.43 -134.37 14.09 Favored Glycine 0 CA--C 1.481 -2.069 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -170.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.04 48.32 0.84 Allowed 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 125.914 1.685 . . . . 0.0 107.304 178.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.417 ' H ' HG22 ' A' ' 165' ' ' ILE . 36.6 tt0 -168.27 116.34 0.72 Allowed 'General case' 0 C--N 1.353 0.722 0 O-C-N 121.909 -0.495 . . . . 0.0 110.46 -170.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 28.8 ttp -115.8 118.86 34.2 Favored 'General case' 0 C--N 1.369 1.444 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -165.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.4 mm -84.03 124.46 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 O-C-N 120.633 -1.292 . . . . 0.0 108.964 170.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.598 ' HB2' HD13 ' A' ' 145' ' ' LEU . 1.9 tmm? -99.44 133.0 44.39 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 102.141 -3.281 . . . . 0.0 102.141 156.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.459 HG13 ' HG2' ' A' ' 125' ' ' LYS . 24.7 t -99.94 116.22 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 118.239 -1.384 . . . . 0.0 110.013 -177.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.62 HD11 ' CB ' ' A' ' 156' ' ' ALA . 1.1 tp -106.57 107.62 18.73 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 -167.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.265 . . -99.57 179.54 1.02 Allowed Pre-proline 0 CA--C 1.486 -1.481 0 C-N-CA 124.746 1.218 . . . . 0.0 113.169 -176.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -70.55 153.76 65.1 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 N-CA-C 106.483 -2.161 . . . . 0.0 106.483 170.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.579 ' HA ' HG22 ' A' ' 157' ' ' VAL . 33.2 ttmt -73.4 120.86 19.59 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 123.026 1.393 . . . . 0.0 110.125 -175.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -70.51 -174.08 0.82 Allowed 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 129.217 3.007 . . . . 0.0 113.227 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -62.36 104.7 0.52 Allowed 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.233 1.413 . . . . 0.0 109.941 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 . . . . . 0 C--O 1.26 1.628 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 176.658 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.468 -2.206 0 CA-C-O 124.724 2.202 . . . . 0.0 107.555 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.4 mm -87.29 114.8 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 108.62 -3.9 . . . . 0.0 107.376 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -100.66 176.19 5.4 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -170.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.4 t -105.17 125.12 60.29 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.485 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 167.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -106.8 174.9 5.69 Favored 'General case' 0 CA--C 1.464 -2.339 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 155.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -149.28 147.05 27.9 Favored 'General case' 0 N--CA 1.422 -1.851 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.084 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tp -129.21 162.42 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -122.22 152.78 39.64 Favored 'General case' 0 CA--C 1.488 -1.44 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.979 162.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.526 ' HB3' HG11 ' A' ' 144' ' ' VAL . 45.2 m-85 -130.82 146.73 52.34 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 172.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.32 169.8 6.18 Favored Pre-proline 0 N--CA 1.435 -1.181 0 C-N-CA 123.644 0.777 . . . . 0.0 109.08 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -58.36 138.13 84.2 Favored 'Trans proline' 0 N--CA 1.436 -1.883 1 C-N-CA 125.506 4.138 . . . . 0.0 110.933 167.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.16 -125.1 20.97 Favored Glycine 0 CA--C 1.479 -2.196 0 N-CA-C 106.786 -2.526 . . . . 0.0 106.786 -173.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.7 m 55.7 106.58 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.759 0 C-N-CA 129.492 3.117 . . . . 0.0 112.958 173.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -125.17 -131.04 0.25 Allowed 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 105.026 -2.212 . . . . 0.0 105.026 171.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -55.58 -80.05 0.02 OUTLIER 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -89.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.51 45.5 1.35 Allowed Glycine 0 CA--C 1.484 -1.902 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.671 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -101.95 -42.73 6.01 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 146.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -73.79 -75.59 0.15 Allowed 'General case' 0 CA--C 1.48 -1.714 0 CA-C-N 113.189 -1.823 . . . . 0.0 108.678 -169.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.431 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.341 0.0 OUTLIER -58.66 -12.31 4.04 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 120.389 3.477 . . . . 0.0 120.389 178.427 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 66.3 t -61.75 -45.42 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 CA-C-O 122.59 1.186 . . . . 0.0 110.041 161.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -91.77 -0.83 57.56 Favored 'General case' 0 CA--C 1.472 -2.037 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.491 HD12 HG13 ' A' ' 148' ' ' VAL . 5.8 tt -78.17 -32.0 49.94 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 161.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.457 ' HA ' HG12 ' A' ' 115' ' ' ILE . 48.4 ttt180 -63.52 -43.13 98.06 Favored 'General case' 0 C--N 1.361 1.077 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.242 170.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.8 m -63.92 -37.28 86.82 Favored 'General case' 0 C--N 1.377 1.788 0 C-N-CA 118.648 -1.221 . . . . 0.0 113.405 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.493 HD11 HD23 ' A' ' 174' ' ' LEU 0.296 60.5 tp -70.38 -28.96 65.5 Favored 'General case' 0 N--CA 1.401 -2.91 0 C-N-CA 125.196 1.398 . . . . 0.0 113.782 176.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 112' ' ' ARG . 9.7 mm -58.57 -50.59 78.44 Favored 'Isoleucine or valine' 0 C--N 1.371 1.507 0 CA-C-N 120.982 1.719 . . . . 0.0 110.033 170.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -52.28 -44.11 64.79 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 127.697 2.399 . . . . 0.0 110.668 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -59.44 -50.03 75.51 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 125.868 1.667 . . . . 0.0 113.04 176.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.444 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -60.46 -34.6 74.25 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 175.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -72.1 -32.12 66.7 Favored 'General case' 0 CA--C 1.487 -1.468 0 C-N-CA 127.745 2.418 . . . . 0.0 110.913 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -64.81 -20.83 66.6 Favored 'General case' 0 C--N 1.36 1.023 0 C-N-CA 123.117 0.567 . . . . 0.0 111.444 171.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 89.17 59.51 1.56 Allowed Glycine 0 CA--C 1.466 -2.987 0 N-CA-C 104.65 -3.38 . . . . 0.0 104.65 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -123.21 167.73 13.35 Favored 'General case' 0 CA--C 1.455 -2.701 0 N-CA-C 102.121 -3.289 . . . . 0.0 102.121 171.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -94.22 132.32 38.9 Favored 'General case' 0 CA--C 1.449 -2.942 0 N-CA-C 100.602 -3.851 . . . . 0.0 100.602 162.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.422 ' HB1' HD12 ' A' ' 114' ' ' LEU . . . -108.22 115.71 30.63 Favored 'General case' 0 N--CA 1.4 -2.942 0 C-N-CA 117.378 -1.729 . . . . 0.0 106.593 -173.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -97.26 122.39 40.23 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.543 0.687 . . . . 0.0 109.275 -163.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.6 mm -84.16 133.78 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.961 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.9 m -112.97 117.12 31.19 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 165.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.849 HD21 ' HA2' ' A' ' 141' ' ' GLY . 10.4 tp -79.61 153.17 29.61 Favored 'General case' 0 CA--C 1.474 -1.97 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 167.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -152.88 94.12 1.83 Allowed 'General case' 0 N--CA 1.4 -2.938 0 N-CA-C 101.335 -3.579 . . . . 0.0 101.335 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.545 ' CZ ' HD23 ' A' ' 128' ' ' LEU 0.311 94.2 m-85 -71.55 173.46 7.97 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 126.909 2.084 . . . . 0.0 109.837 178.283 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.8 tpt85 -98.84 79.88 2.45 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 104.616 -2.365 . . . . 0.0 104.616 148.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -112.2 -101.65 2.57 Favored Glycine 0 CA--C 1.472 -2.64 0 CA-C-O 122.899 1.277 . . . . 0.0 110.249 -167.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.499 ' H ' ' HA ' ' A' ' 168' ' ' ARG . 19.8 tpp180 77.8 70.61 0.05 Allowed 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 110.808 -2.696 . . . . 0.0 109.237 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -169.34 -139.09 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.189 1 N-CA-C 98.927 -4.472 . . . . 0.0 98.927 167.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -99.48 103.57 15.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 100.774 -3.787 . . . . 0.0 100.774 143.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.521 ' HB1' ' CD2' ' A' ' 137' ' ' HIS . . . -84.62 -149.13 0.11 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -160.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.537 ' CG ' HD12 ' A' ' 140' ' ' ILE . 32.0 m-70 -39.19 130.36 1.62 Allowed 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 130.368 3.467 . . . . 0.0 114.533 166.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -116.34 10.48 14.75 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -90.54 -53.11 4.57 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.537 HD12 ' CG ' ' A' ' 137' ' ' HIS . 51.9 mt -52.75 -41.53 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 C-N-CA 127.971 2.509 . . . . 0.0 111.361 174.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.849 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -70.58 -60.42 4.68 Favored Glycine 0 CA--C 1.458 -3.53 0 O-C-N 123.951 0.782 . . . . 0.0 113.958 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.424 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 5.1 ptt? -85.78 -1.52 57.31 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -159.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.271 2.0 tp10 -61.44 -60.67 3.36 Favored 'General case' 0 CA--C 1.454 -2.747 0 C-N-CA 114.412 -2.915 . . . . 0.0 115.394 146.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 98' ' ' PHE . 23.1 t -66.26 -65.87 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.91 0 O-C-N 125.978 2.049 . . . . 0.0 108.7 -162.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.521 HD11 HD22 ' A' ' 128' ' ' LEU . 32.0 mt -44.85 -54.17 6.7 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 129.131 2.972 . . . . 0.0 114.316 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 142' ' ' MET . 2.0 t-20 -66.16 -28.34 68.71 Favored 'General case' 0 CA--C 1.468 -2.179 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 174.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -80.35 -15.34 57.09 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.222 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.491 HG13 HD12 ' A' ' 111' ' ' LEU . 1.9 t -76.08 -44.47 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.78 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.448 ' HE3' HG21 ' A' ' 158' ' ' VAL 0.262 34.9 ttmt -52.98 -48.76 67.19 Favored 'General case' 0 CA--C 1.47 -2.105 0 C-N-CA 125.435 1.494 . . . . 0.0 112.435 171.326 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.1 -38.39 66.38 Favored 'General case' 0 N--CA 1.409 -2.508 0 C-N-CA 125.853 1.661 . . . . 0.0 109.605 -171.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.53 -25.72 54.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 116.462 -2.095 . . . . 0.0 115.201 170.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 156' ' ' ALA 0.298 0.1 OUTLIER -77.31 -30.84 54.29 Favored 'General case' 0 CA--C 1.473 -1.992 0 CA-C-O 116.525 -1.703 . . . . 0.0 113.451 176.069 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -29.44 -20.13 0.0 OUTLIER 'General case' 0 C--N 1.366 1.302 1 C-N-CA 134.91 5.284 . . . . 0.0 120.224 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.2 mt-10 -56.29 -62.15 1.91 Allowed 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 127.187 2.195 . . . . 0.0 111.178 167.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.13 -56.01 2.78 Favored 'General case' 0 N--CA 1.424 -1.758 0 C-N-CA 125.542 1.537 . . . . 0.0 109.048 -174.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.466 ' CB ' HD11 ' A' ' 174' ' ' LEU 0.269 . . -98.48 146.66 25.53 Favored 'General case' 0 CA--C 1.449 -2.934 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.877 -165.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.2 m -121.59 172.2 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.454 -2.723 0 C-N-CA 114.626 -2.83 . . . . 0.0 116.384 134.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 3.8 t -82.31 153.4 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.831 0 CA-C-N 111.784 -2.462 . . . . 0.0 107.157 -177.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -81.59 -41.22 21.86 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 -173.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.4 t -157.29 143.15 17.61 Favored 'General case' 0 CA--C 1.46 -2.499 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -104.46 94.38 7.0 Favored Pre-proline 0 N--CA 1.423 -1.806 0 N-CA-C 100.996 -3.705 . . . . 0.0 100.996 167.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -102.05 -110.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.412 -3.294 0 N-CA-C 103.273 -3.395 . . . . 0.0 103.273 -155.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -170.62 -40.82 0.02 OUTLIER 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -139.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -86.61 79.03 9.04 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -147.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.1 mt -84.16 124.08 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.091 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 168.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -123.34 101.79 7.56 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 111.752 -2.476 . . . . 0.0 105.519 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 86.27 -144.36 19.94 Favored Glycine 0 CA--C 1.483 -1.937 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -172.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.499 ' HA ' ' H ' ' A' ' 133' ' ' ARG . 15.4 ptm180 -97.1 41.15 1.12 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.145 1.378 . . . . 0.0 109.418 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -170.72 141.18 1.79 Allowed 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 121.76 -0.587 . . . . 0.0 111.999 -172.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.471 ' H ' ' HB3' ' A' ' 128' ' ' LEU . 48.5 ttm -122.11 122.86 40.21 Favored 'General case' 0 CA--C 1.481 -1.678 0 C-N-CA 123.547 0.739 . . . . 0.0 109.405 -176.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.2 mm -81.99 122.7 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 166.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 3.9 ttp -106.55 129.53 54.48 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 101.582 -3.488 . . . . 0.0 101.582 161.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.5 t -94.48 137.33 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -117.81 150.22 39.51 Favored 'General case' 0 C--N 1.357 0.898 1 N-CA-C 99.516 -4.253 . . . . 0.0 99.516 -179.987 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.26 . . -140.75 -178.92 0.89 Allowed Pre-proline 0 N--CA 1.432 -1.341 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.681 -170.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.416 ' HA ' HD21 ' A' ' 118' ' ' LEU . 75.8 Cg_exo -69.85 147.45 62.31 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 C-N-CA 122.395 2.063 . . . . 0.0 109.055 165.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -80.07 141.83 35.46 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 171.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -76.5 95.89 3.97 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 168.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -81.24 110.27 16.55 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 . . . . . 0 C--O 1.26 1.649 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -178.359 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 CA--C 1.472 -2.035 0 CA-C-O 124.906 2.288 . . . . 0.0 107.694 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.2 mm -93.16 124.79 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.503 0 CA-C-N 108.73 -3.85 . . . . 0.0 107.194 176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -92.59 168.09 11.48 Favored 'General case' 0 CA--C 1.48 -1.749 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.498 HG22 ' HE2' ' A' ' 123' ' ' LYS . 46.4 t -105.99 121.82 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.874 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 162.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -101.51 175.94 5.4 Favored 'General case' 0 CA--C 1.468 -2.2 0 C-N-CA 116.427 -2.109 . . . . 0.0 105.715 166.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -143.08 152.67 42.11 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 tp -135.03 163.03 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 103.028 -2.953 . . . . 0.0 103.028 167.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -115.13 153.33 30.98 Favored 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.567 162.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.515 ' HB3' HG11 ' A' ' 144' ' ' VAL . 32.6 m-85 -125.42 131.33 52.94 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 169.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -93.84 169.43 10.03 Favored Pre-proline 0 N--CA 1.433 -1.304 0 C-N-CA 124.258 1.023 . . . . 0.0 109.254 -175.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.2 139.5 42.31 Favored 'Trans proline' 0 CA--C 1.489 -1.726 0 C-N-CA 124.417 3.411 . . . . 0.0 107.502 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.3 -122.51 8.79 Favored Glycine 0 CA--C 1.482 -1.971 0 N-CA-C 106.33 -2.708 . . . . 0.0 106.33 -166.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.0 m 55.78 103.74 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.923 0 C-N-CA 129.904 3.282 . . . . 0.0 112.887 177.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -121.94 -167.79 1.6 Allowed 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.142 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -27.06 -59.3 0.09 Allowed 'General case' 0 CA--C 1.482 -1.657 1 C-N-CA 131.873 4.069 . . . . 0.0 115.283 -146.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -17.28 -74.6 0.01 OUTLIER Glycine 0 CA--C 1.459 -3.463 1 C-N-CA 133.173 5.178 . . . . 0.0 118.098 168.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . 0.363 53.9 m-20 -89.7 -33.94 16.42 Favored 'General case' 0 N--CA 1.4 -2.957 0 CA-C-N 109.869 -3.165 . . . . 0.0 109.766 -174.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.58 -72.1 0.33 Allowed 'General case' 0 CA--C 1.484 -1.595 0 CA-C-N 112.747 -2.024 . . . . 0.0 109.799 -161.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.444 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.293 0.0 OUTLIER -63.52 -7.68 7.58 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 119.843 3.275 . . . . 0.0 119.843 178.122 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.67 -42.95 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 C-N-CA 124.015 0.926 . . . . 0.0 110.025 160.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.0 mmtt -92.74 -5.06 52.04 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.2 tt -75.69 -35.02 60.44 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 163.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.459 ' HA ' HG12 ' A' ' 115' ' ' ILE . 7.4 ttm180 -59.31 -43.65 92.61 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 125.541 1.536 . . . . 0.0 111.318 169.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.8 t -56.79 -46.59 81.46 Favored 'General case' 0 C--N 1.377 1.791 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.267 71.0 mt -67.56 -28.12 67.51 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 176.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.7 mm -59.78 -49.5 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.709 0 CA-C-N 119.696 1.134 . . . . 0.0 108.83 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -51.57 -44.58 62.79 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 127.26 2.224 . . . . 0.0 110.1 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -63.65 -52.77 59.27 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.686 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -67.91 -29.48 68.58 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 125.605 1.562 . . . . 0.0 114.699 -178.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.62 -29.53 51.84 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 124.03 0.932 . . . . 0.0 110.842 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -82.84 -1.2 51.29 Favored 'General case' 0 C--N 1.362 1.139 0 CA-C-O 120.602 0.239 . . . . 0.0 110.829 170.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.05 70.16 1.32 Allowed Glycine 0 CA--C 1.473 -2.59 0 C-N-CA 126.242 1.877 . . . . 0.0 109.552 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -128.04 163.64 24.13 Favored 'General case' 0 CA--C 1.449 -2.92 0 N-CA-C 100.786 -3.783 . . . . 0.0 100.786 169.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.498 ' HE2' HG22 ' A' ' 93' ' ' VAL . 1.6 tmmm? -98.33 106.03 18.26 Favored 'General case' 0 N--CA 1.399 -3.019 1 N-CA-C 97.706 -4.924 . . . . 0.0 97.706 172.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.08 155.25 21.59 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -133.47 129.95 37.91 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 119.844 -1.785 . . . . 0.0 106.552 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.8 mm -82.74 137.98 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.576 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.1 m -117.14 127.51 54.2 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 167.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.663 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.1 OUTLIER -85.83 153.56 22.17 Favored 'General case' 0 CA--C 1.462 -2.441 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 166.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.439 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 56.9 ttt180 -151.36 91.41 1.67 Allowed 'General case' 0 N--CA 1.394 -3.231 1 N-CA-C 98.715 -4.55 . . . . 0.0 98.715 -175.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.56 ' CE2' HD13 ' A' ' 165' ' ' ILE 0.253 97.6 m-85 -74.35 164.62 26.39 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 111.438 -2.619 . . . . 0.0 105.903 179.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -78.9 99.5 6.81 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 161.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.24 126.58 41.81 Favored Glycine 0 CA--C 1.478 -2.219 0 N-CA-C 117.936 1.935 . . . . 0.0 117.936 -149.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . 0.32 11.8 ptp85 57.89 24.51 11.0 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 129.188 2.995 . . . . 0.0 116.043 171.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.94 -26.76 3.4 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 101.874 -3.38 . . . . 0.0 101.874 163.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 25.3 mmt -129.5 5.44 5.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.667 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.47 ' HA ' ' CG ' ' A' ' 130' ' ' PHE . . . -76.48 90.57 3.29 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-N 120.373 1.442 . . . . 0.0 112.267 167.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -126.15 164.88 19.95 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -98.37 15.36 24.93 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -89.03 -49.72 6.6 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 166.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . 0.29 68.1 mt -66.45 -37.32 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 0 C-N-CA 128.369 2.668 . . . . 0.0 108.281 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.663 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -78.34 -66.6 1.72 Allowed Glycine 0 N--CA 1.408 -3.193 0 CA-C-N 114.372 -1.285 . . . . 0.0 113.574 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 43.0 mtt -95.03 24.21 5.04 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -164.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -71.14 -55.7 7.63 Favored 'General case' 0 CA--C 1.456 -2.652 0 C-N-CA 116.521 -2.072 . . . . 0.0 114.644 133.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 98' ' ' PHE . 19.4 t -64.16 -66.25 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.443 -3.172 0 O-C-N 126.174 2.171 . . . . 0.0 107.834 -163.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 172' ' ' MET . 71.1 mt -44.61 -55.03 5.53 Favored 'General case' 0 CA--C 1.478 -1.824 0 O-C-N 126.543 2.402 . . . . 0.0 114.108 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.36 -36.79 74.01 Favored 'General case' 0 CA--C 1.473 -2.017 0 C-N-CA 127.229 2.212 . . . . 0.0 114.062 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.407 ' HA ' ' HB2' ' A' ' 150' ' ' ASP . 18.5 ttp180 -81.71 -14.98 55.84 Favored 'General case' 0 N--CA 1.418 -2.027 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.882 175.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.472 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.4 t -75.24 -43.64 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.74 0 CA-C-O 116.374 -1.774 . . . . 0.0 107.355 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.517 ' HB2' HG21 ' A' ' 158' ' ' VAL . 14.6 ttmt -53.49 -52.88 58.14 Favored 'General case' 0 CA--C 1.463 -2.394 0 CA-C-O 116.861 -1.542 . . . . 0.0 109.884 169.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.407 ' HB2' ' HA ' ' A' ' 147' ' ' ARG . 66.8 m-20 -67.52 -39.43 85.08 Favored 'General case' 0 N--CA 1.41 -2.47 0 C-N-CA 124.22 1.008 . . . . 0.0 109.359 -166.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -75.05 -26.84 59.71 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 116.447 -2.101 . . . . 0.0 116.075 171.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.281 0.1 OUTLIER -81.1 -33.28 33.42 Favored 'General case' 0 CA--C 1.479 -1.757 0 CA-C-O 117.107 -1.425 . . . . 0.0 113.605 -178.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -28.5 -29.94 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.478 1 C-N-CA 135.555 5.542 . . . . 0.0 118.85 -173.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.9 -53.32 54.22 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 127.509 2.324 . . . . 0.0 113.204 173.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.17 -53.53 2.67 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 112.926 -1.943 . . . . 0.0 109.624 -165.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.686 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.308 . . -96.81 153.08 18.09 Favored 'General case' 0 CA--C 1.447 -2.998 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 -177.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.417 ' HB ' ' H ' ' A' ' 158' ' ' VAL . 20.3 m -116.39 -164.14 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.905 0 C-N-CA 113.69 -3.204 . . . . 0.0 112.343 138.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 160' ' ' SER 0.28 3.3 t -108.35 162.93 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.559 0 C-N-CA 128.326 2.65 . . . . 0.0 106.009 177.239 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.44 -42.49 18.47 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.548 ' H ' HG12 ' A' ' 158' ' ' VAL . 1.2 t -162.02 154.2 19.34 Favored 'General case' 0 CA--C 1.479 -1.777 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.581 -166.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.88 87.26 3.57 Favored Pre-proline 0 N--CA 1.42 -1.939 0 N-CA-C 103.366 -2.827 . . . . 0.0 103.366 168.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -95.89 -79.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.412 0 N-CA-C 109.529 -0.989 . . . . 0.0 109.529 -136.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.99 -158.01 0.59 Allowed 'General case' 1 N--CA 1.376 -4.159 0 CA-C-O 125.928 2.775 . . . . 0.0 112.071 -141.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -142.31 132.98 25.4 Favored 'General case' 0 N--CA 1.423 -1.796 2 N-CA-C 98.745 -4.539 . . . . 0.0 98.745 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.56 HD13 ' CE2' ' A' ' 130' ' ' PHE . 3.5 mt -70.44 132.13 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 CA-C-O 123.212 1.482 . . . . 0.0 110.086 -166.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -125.94 122.71 36.77 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.58 -155.11 39.04 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -172.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -103.84 27.48 7.52 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.992 -1.104 . . . . 0.0 112.398 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.439 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.285 30.3 mt-30 -172.73 147.63 1.79 Allowed 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -159.285 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.406 ' O ' ' HB2' ' A' ' 128' ' ' LEU . 58.7 ttp -142.86 117.22 9.62 Favored 'General case' 0 C--N 1.364 1.196 0 CA-C-O 121.756 0.789 . . . . 0.0 111.703 -174.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.9 mm -80.16 138.44 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 O-C-N 120.105 -1.622 . . . . 0.0 109.816 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.455 ' SD ' HG13 ' A' ' 158' ' ' VAL . 3.3 tmm? -113.85 135.24 54.18 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 154.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.85 127.86 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.612 HD13 ' CD1' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -112.13 73.76 0.83 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 117.241 2.312 . . . . 0.0 117.241 -166.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.432 . . -105.46 156.6 36.1 Favored Pre-proline 0 C--N 1.355 0.815 0 N-CA-C 120.024 3.342 . . . . 0.0 120.024 -167.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -67.45 142.12 58.38 Favored 'Trans proline' 0 CA--C 1.492 -1.62 0 C-N-CA 123.258 2.639 . . . . 0.0 111.276 -161.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -77.7 133.41 38.34 Favored 'General case' 0 CA--C 1.49 -1.357 0 O-C-N 125.029 1.456 . . . . 0.0 107.907 -174.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -60.26 126.18 26.52 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 125.939 1.696 . . . . 0.0 110.718 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -77.66 146.93 35.78 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.379 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 . . . . . 0 C--O 1.261 1.696 0 CA-C-O 117.494 -1.241 . . . . 0.0 108.352 177.927 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.467 -2.223 0 CA-C-O 124.93 2.3 . . . . 0.0 107.384 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.7 mm -97.36 119.25 45.15 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 CA-C-N 108.765 -3.834 . . . . 0.0 107.102 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -95.31 170.95 9.02 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.577 HG22 ' HD3' ' A' ' 123' ' ' LYS . 95.0 t -99.69 120.88 49.67 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 161.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -103.68 172.31 6.87 Favored 'General case' 0 CA--C 1.472 -2.04 0 C-N-CA 116.924 -1.911 . . . . 0.0 106.896 155.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -145.09 148.24 33.43 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tp -128.28 162.24 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 174.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -119.74 153.68 35.3 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.702 163.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.556 ' HB3' HG11 ' A' ' 144' ' ' VAL . 41.7 m-85 -127.12 141.73 51.69 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 168.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -113.04 166.08 11.83 Favored Pre-proline 0 N--CA 1.423 -1.788 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 173.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.493 ' HB3' HG23 ' A' ' 140' ' ' ILE . 2.1 Cg_endo -66.8 138.08 47.56 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 C-N-CA 123.924 3.083 . . . . 0.0 108.312 165.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.91 14.59 74.84 Favored Glycine 0 CA--C 1.482 -1.974 0 O-C-N 124.143 0.902 . . . . 0.0 111.919 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.4 m -104.92 99.72 9.35 Favored 'General case' 0 CA--C 1.466 -2.25 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 173.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.35 -142.35 0.27 Allowed 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 112.005 -2.362 . . . . 0.0 105.023 168.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -59.95 -76.6 0.05 OUTLIER 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -84.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.62 41.97 2.02 Favored Glycine 0 CA--C 1.485 -1.842 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.099 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -103.28 -38.98 7.01 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 149.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -70.74 -72.53 0.2 Allowed 'General case' 0 CA--C 1.477 -1.847 0 C-N-CA 126.574 1.949 . . . . 0.0 109.313 -172.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.418 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.35 0.0 OUTLIER -58.47 -15.19 9.97 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 119.816 3.265 . . . . 0.0 119.816 175.881 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.87 -38.69 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 C-N-CA 123.966 0.906 . . . . 0.0 111.229 164.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -92.82 -1.37 56.83 Favored 'General case' 0 CA--C 1.476 -1.875 0 O-C-N 120.159 -1.588 . . . . 0.0 114.708 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 151' ' ' ASP . 5.7 tt -79.53 -31.62 42.11 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 163.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.457 ' HA ' HG12 ' A' ' 115' ' ' ILE . 3.3 tpp180 -60.36 -46.09 91.16 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 125.123 1.369 . . . . 0.0 110.772 168.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.8 t -59.81 -44.55 93.93 Favored 'General case' 0 C--N 1.375 1.697 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.651 HD11 HD12 ' A' ' 174' ' ' LEU 0.303 61.4 tp -67.9 -29.79 68.98 Favored 'General case' 0 N--CA 1.407 -2.595 0 C-N-CA 127.321 2.248 . . . . 0.0 113.562 178.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.273 9.4 mm -57.78 -51.41 70.61 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.872 0 CA-C-N 120.941 1.7 . . . . 0.0 108.686 170.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.6 tpt85 -54.75 -39.95 68.82 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 126.703 2.001 . . . . 0.0 111.042 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -63.04 -50.64 69.86 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 124.229 1.012 . . . . 0.0 112.263 176.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.545 ' CD1' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -59.1 -37.27 76.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 176.709 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -75.26 -35.73 61.33 Favored 'General case' 0 CA--C 1.487 -1.462 0 C-N-CA 128.931 2.892 . . . . 0.0 109.907 -169.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.55 6.08 11.36 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 123.605 0.762 . . . . 0.0 111.472 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.18 64.11 2.16 Favored Glycine 0 CA--C 1.467 -2.932 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 174.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -128.52 165.17 21.24 Favored 'General case' 0 CA--C 1.448 -2.945 0 N-CA-C 102.306 -3.22 . . . . 0.0 102.306 169.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.577 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -99.93 115.62 30.08 Favored 'General case' 0 N--CA 1.395 -3.211 1 N-CA-C 97.952 -4.832 . . . . 0.0 97.952 173.162 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -87.69 160.5 18.08 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.477 ' HD3' HD12 ' A' ' 171' ' ' ILE . 35.7 ttmt -136.56 131.3 33.65 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 168.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.457 HD11 ' HG ' ' A' ' 174' ' ' LEU . 10.0 mm -83.19 135.24 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 171.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.472 ' HA ' HD13 ' A' ' 171' ' ' ILE . 17.3 m -113.57 115.65 28.29 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 163.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.801 HD21 ' HA2' ' A' ' 141' ' ' GLY . 17.1 tp -84.93 150.06 25.21 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 168.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -153.8 103.05 2.57 Favored 'General case' 0 N--CA 1.406 -2.674 1 N-CA-C 99.834 -4.136 . . . . 0.0 99.834 -170.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.599 ' CZ ' HD23 ' A' ' 128' ' ' LEU 0.347 81.9 m-85 -83.15 86.48 7.01 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 126.535 1.934 . . . . 0.0 109.297 -171.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -123.71 30.55 6.16 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -97.19 -34.88 5.47 Favored Glycine 0 CA--C 1.466 -3.022 0 N-CA-C 104.714 -3.354 . . . . 0.0 104.714 171.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.454 HH11 ' CE1' ' A' ' 137' ' ' HIS . 42.3 ttm180 -144.54 123.41 12.7 Favored 'General case' 0 CA--C 1.475 -1.928 1 N-CA-C 99.699 -4.186 . . . . 0.0 99.699 165.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.61 -16.02 54.48 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -161.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 35.1 tpp -71.68 -103.28 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 123.15 0.58 . . . . 0.0 111.394 174.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.54 ' HB1' HD13 ' A' ' 165' ' ' ILE . . . 173.55 110.41 0.02 OUTLIER 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -157.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.504 ' CD2' HD12 ' A' ' 140' ' ' ILE . 15.5 m-70 -119.96 149.25 42.43 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 121.252 0.549 . . . . 0.0 111.455 -178.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -82.24 -13.09 57.59 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 121.272 0.558 . . . . 0.0 109.894 173.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -84.29 -53.6 5.37 Favored 'General case' 0 CA--C 1.481 -1.691 0 C-N-CA 125.862 1.665 . . . . 0.0 108.667 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.504 HD12 ' CD2' ' A' ' 137' ' ' HIS . 70.8 mt -51.98 -44.7 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 C-N-CA 126.548 1.939 . . . . 0.0 110.877 176.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.801 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -70.62 -60.72 4.49 Favored Glycine 0 CA--C 1.456 -3.607 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.961 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 4.3 ptt? -85.57 -1.15 56.81 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -157.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.257 0.5 OUTLIER -61.76 -63.54 1.23 Allowed 'General case' 0 CA--C 1.46 -2.484 0 C-N-CA 115.035 -2.666 . . . . 0.0 115.694 147.393 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.556 HG11 ' HB3' ' A' ' 98' ' ' PHE . 35.8 t -62.77 -67.5 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.448 -2.944 0 O-C-N 126.021 2.076 . . . . 0.0 109.007 -166.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.464 HD11 HD22 ' A' ' 128' ' ' LEU . 34.4 mt -43.49 -55.32 4.28 Favored 'General case' 0 CA--C 1.482 -1.666 0 C-N-CA 128.858 2.863 . . . . 0.0 114.564 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 142' ' ' MET . 2.3 t30 -63.23 -30.41 71.56 Favored 'General case' 0 CA--C 1.467 -2.229 0 N-CA-C 117.689 2.478 . . . . 0.0 117.689 174.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -81.15 -14.57 57.52 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.612 172.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.7 t -76.79 -44.14 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.787 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 175.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.514 ' HE3' HG21 ' A' ' 158' ' ' VAL 0.256 33.9 ttmt -52.84 -49.95 64.72 Favored 'General case' 0 CA--C 1.467 -2.219 0 C-N-CA 125.631 1.573 . . . . 0.0 112.033 171.02 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -37.69 64.41 Favored 'General case' 0 N--CA 1.409 -2.521 0 C-N-CA 125.506 1.522 . . . . 0.0 109.456 -169.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.405 ' HB3' HD11 ' A' ' 111' ' ' LEU . 17.8 t70 -75.33 -25.63 57.98 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 116.372 -2.131 . . . . 0.0 114.993 169.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 156' ' ' ALA 0.308 0.1 OUTLIER -78.41 -32.42 48.71 Favored 'General case' 0 CA--C 1.472 -2.05 0 CA-C-O 116.792 -1.575 . . . . 0.0 112.614 178.392 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -29.58 -22.26 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.403 1 C-N-CA 135.237 5.415 . . . . 0.0 119.884 -174.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -56.4 -61.71 2.22 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.94 2.096 . . . . 0.0 110.974 168.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.69 -55.64 2.94 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 113.877 -1.511 . . . . 0.0 107.973 -171.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.478 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.255 . . -98.25 150.87 21.07 Favored 'General case' 0 CA--C 1.443 -3.136 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.565 -166.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.53 173.25 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.662 0 C-N-CA 114.11 -3.036 . . . . 0.0 116.113 130.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.514 HG21 ' HE3' ' A' ' 149' ' ' LYS 0.3 3.1 t -81.2 151.6 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.104 0 CA-C-N 110.133 -3.212 . . . . 0.0 104.911 173.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -81.71 -38.47 25.74 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -174.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.39 136.73 14.92 Favored 'General case' 0 N--CA 1.408 -2.54 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -177.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.63 123.49 56.0 Favored Pre-proline 0 N--CA 1.417 -2.1 1 N-CA-C 97.632 -4.951 . . . . 0.0 97.632 156.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -74.29 -85.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.267 1 N-CA-C 101.111 -4.227 . . . . 0.0 101.111 167.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 176.6 -55.49 0.01 OUTLIER 'General case' 0 N--CA 1.394 -3.257 1 N-CA-C 94.583 -6.08 . . . . 0.0 94.583 172.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -129.85 176.11 8.31 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.585 -161.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.651 ' H ' HD12 ' A' ' 165' ' ' ILE . 0.6 OUTLIER -93.61 150.93 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 C-N-CA 126.108 1.763 . . . . 0.0 109.819 -172.085 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -115.25 84.74 2.14 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 160.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.72 -162.5 24.68 Favored Glycine 0 C--N 1.353 1.527 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 -170.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.405 ' HA ' ' HB2' ' A' ' 136' ' ' ALA . 81.7 mtp180 -114.86 32.84 5.74 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.223 1.009 . . . . 0.0 111.341 -173.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.6 ' H ' HG21 ' A' ' 165' ' ' ILE . 39.4 tt0 173.5 115.17 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 -158.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.413 ' HA ' HG23 ' A' ' 165' ' ' ILE . 11.3 ttm -107.63 119.08 38.43 Favored 'General case' 0 CA--C 1.472 -2.036 0 CA-C-O 121.201 0.524 . . . . 0.0 111.838 -166.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.477 HD12 ' HD3' ' A' ' 125' ' ' LYS . 22.6 mm -83.27 122.1 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 167.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.4 ttp -105.81 127.47 53.12 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 102.448 -3.167 . . . . 0.0 102.448 162.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.2 t -91.62 140.29 16.33 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 C-N-CA 118.336 -1.345 . . . . 0.0 109.093 -174.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.651 HD12 HD11 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -124.65 75.75 1.44 Allowed 'General case' 0 C--N 1.366 1.288 0 N-CA-C 120.334 3.457 . . . . 0.0 120.334 -169.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.256 . . -85.31 -176.2 0.74 Allowed Pre-proline 0 CA--C 1.502 -0.872 0 O-C-N 119.374 -2.079 . . . . 0.0 115.357 -169.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.472 ' HA ' HD21 ' A' ' 118' ' ' LEU . 79.9 Cg_exo -65.55 153.77 76.7 Favored 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 122.292 1.994 . . . . 0.0 109.969 160.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -77.25 126.32 30.75 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 170.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -60.53 137.78 58.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.325 1.45 . . . . 0.0 111.899 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 28.1 tptp 59.28 83.23 0.13 Allowed 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 126.134 1.773 . . . . 0.0 108.709 -166.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 . . . . . 0 C--O 1.259 1.575 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.952 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.468 -2.187 0 CA-C-O 124.81 2.243 . . . . 0.0 107.436 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.5 mm -88.25 114.97 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 108.513 -3.949 . . . . 0.0 106.927 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -98.98 167.27 10.84 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -168.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.58 HG22 ' HE3' ' A' ' 123' ' ' LYS . 79.3 t -99.31 120.65 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.431 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 170.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -104.22 173.16 6.42 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 154.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -142.62 154.65 44.58 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -176.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.701 HG21 HD21 ' A' ' 114' ' ' LEU . 3.9 tp -138.7 167.28 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 170.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -119.84 156.25 31.04 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.214 161.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.515 ' HB3' HG11 ' A' ' 144' ' ' VAL . 29.4 m-85 -130.52 160.54 33.82 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 170.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -103.04 174.28 2.92 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 125.213 1.405 . . . . 0.0 108.611 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.432 ' HB3' HG23 ' A' ' 140' ' ' ILE . 86.5 Cg_exo -58.47 146.48 90.33 Favored 'Trans proline' 0 N--CA 1.438 -1.78 1 C-N-CA 125.354 4.036 . . . . 0.0 111.001 158.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -9.04 102.65 0.01 OUTLIER Glycine 0 CA--C 1.474 -2.499 1 C-N-CA 131.017 4.151 . . . . 0.0 115.241 -174.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.16 -152.14 0.42 Allowed 'General case' 0 N--CA 1.403 -2.804 0 CA-C-N 111.015 -2.592 . . . . 0.0 108.812 -150.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 107' ' ' TYR 0.451 0.7 OUTLIER -123.77 164.32 19.39 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 109.947 -3.297 . . . . 0.0 110.822 -154.469 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -69.51 -79.24 0.06 Allowed 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -106.77 46.26 1.19 Allowed Glycine 0 CA--C 1.477 -2.295 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.109 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -103.13 -41.82 5.97 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 143.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.506 ' HB3' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER -80.22 -65.44 1.01 Allowed 'General case' 0 CA--C 1.481 -1.673 0 O-C-N 124.29 0.994 . . . . 0.0 109.567 -165.389 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.444 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.337 0.0 OUTLIER -62.26 -9.6 8.38 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 120.472 3.508 . . . . 0.0 120.472 178.878 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.53 -44.2 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-O 122.684 1.23 . . . . 0.0 109.72 160.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.623 ' O ' HD22 ' A' ' 114' ' ' LEU . 22.1 mmtp -89.19 -6.87 56.58 Favored 'General case' 0 CA--C 1.469 -2.149 0 O-C-N 120.395 -1.441 . . . . 0.0 114.727 177.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 2.7 tt -72.34 -35.26 68.52 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 162.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.48 ' HA ' HG12 ' A' ' 115' ' ' ILE . 2.4 tpt180 -56.99 -40.68 77.0 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.484 1.114 . . . . 0.0 111.222 168.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.7 t -59.56 -47.69 84.55 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.701 HD21 HG21 ' A' ' 96' ' ' ILE 0.306 1.4 mm? -67.4 -25.55 66.0 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 175.63 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.271 3.0 mm -62.24 -47.74 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.767 0 CA-C-N 120.53 1.514 . . . . 0.0 107.993 177.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -52.53 -47.03 66.95 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 127.766 2.426 . . . . 0.0 109.751 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -61.24 -51.88 67.1 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.531 1.132 . . . . 0.0 113.028 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.805 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -71.49 -21.25 61.96 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 126.998 2.119 . . . . 0.0 113.75 -178.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -68.86 -41.74 78.01 Favored 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 126.94 2.096 . . . . 0.0 109.245 171.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.78 -26.68 67.81 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 123.037 0.535 . . . . 0.0 110.785 173.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.34 68.01 1.47 Allowed Glycine 0 CA--C 1.469 -2.802 0 N-CA-C 104.477 -3.449 . . . . 0.0 104.477 -171.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -120.59 164.26 16.75 Favored 'General case' 0 CA--C 1.447 -2.995 1 N-CA-C 97.985 -4.82 . . . . 0.0 97.985 168.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.628 ' HD3' HG12 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -101.19 114.88 29.24 Favored 'General case' 0 N--CA 1.393 -3.276 1 N-CA-C 97.175 -5.12 . . . . 0.0 97.175 170.551 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.508 ' CB ' HD12 ' A' ' 114' ' ' LEU . . . -84.07 160.44 20.95 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 173.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -135.38 128.66 32.03 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.9 mm -82.04 135.44 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.436 ' HA ' HD13 ' A' ' 171' ' ' ILE . 15.1 m -109.84 118.29 36.09 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 163.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.843 HD21 ' HA2' ' A' ' 141' ' ' GLY . 11.0 tp -81.07 149.53 29.18 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 168.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.413 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 28.4 ttm180 -150.76 95.76 2.26 Favored 'General case' 0 N--CA 1.398 -3.026 1 N-CA-C 97.007 -5.183 . . . . 0.0 97.007 -175.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.556 ' CZ ' HD13 ' A' ' 165' ' ' ILE . 95.4 m-85 -66.54 121.6 15.72 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 111.262 -2.699 . . . . 0.0 104.748 174.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -77.37 105.67 8.64 Favored 'General case' 0 CA--C 1.482 -1.659 1 N-CA-C 100.082 -4.044 . . . . 0.0 100.082 164.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.28 115.58 7.24 Favored Glycine 0 CA--C 1.473 -2.557 0 O-C-N 124.909 1.381 . . . . 0.0 112.799 -154.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -74.74 -85.92 0.04 OUTLIER 'General case' 0 CA--C 1.477 -1.86 0 CA-C-N 112.496 -1.852 . . . . 0.0 107.743 173.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -68.57 -65.45 0.7 Allowed 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 158.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.445 ' H ' ' H ' ' A' ' 136' ' ' ALA . 17.2 ttt -165.71 -33.72 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 174.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.445 ' H ' ' H ' ' A' ' 135' ' ' MET . . . 172.49 109.48 0.01 OUTLIER 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -152.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.59 ' CD2' HD12 ' A' ' 140' ' ' ILE . 5.8 m170 -119.08 156.99 28.73 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-O 120.763 0.316 . . . . 0.0 110.404 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -95.53 22.32 7.19 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 121.485 -0.759 . . . . 0.0 109.164 168.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -104.37 -49.83 3.48 Favored 'General case' 0 CA--C 1.476 -1.894 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 168.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.59 HD12 ' CD2' ' A' ' 137' ' ' HIS . 69.4 mt -56.28 -44.5 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.087 0 C-N-CA 127.41 2.284 . . . . 0.0 110.092 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.843 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -72.74 -56.67 5.82 Favored Glycine 0 CA--C 1.459 -3.455 0 CA-C-O 118.744 -1.031 . . . . 0.0 113.438 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.403 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 5.6 ptt? -84.85 0.0 52.45 Favored 'General case' 0 N--CA 1.41 -2.438 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -161.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.261 2.8 tp10 -61.19 -61.12 2.79 Favored 'General case' 0 CA--C 1.461 -2.456 0 C-N-CA 114.879 -2.728 . . . . 0.0 115.308 147.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 98' ' ' PHE . 22.0 t -65.96 -65.2 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.449 -2.938 0 O-C-N 125.651 1.844 . . . . 0.0 109.293 -163.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.536 HD11 HD22 ' A' ' 128' ' ' LEU . 26.4 mt -45.79 -55.74 6.21 Favored 'General case' 0 N--CA 1.427 -1.619 0 C-N-CA 129.315 3.046 . . . . 0.0 114.431 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 142' ' ' MET 0.261 2.4 t30 -62.81 -31.01 71.92 Favored 'General case' 0 CA--C 1.47 -2.133 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 173.174 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -79.5 -15.72 57.26 Favored 'General case' 0 N--CA 1.421 -1.91 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.193 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.514 HG12 HD12 ' A' ' 152' ' ' LEU . 1.6 t -72.33 -50.24 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.823 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 175.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.456 ' HE3' ' CG2' ' A' ' 158' ' ' VAL 0.261 31.4 ttmt -50.1 -50.96 46.68 Favored 'General case' 0 CA--C 1.466 -2.255 0 C-N-CA 125.682 1.593 . . . . 0.0 112.69 173.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.08 -39.59 68.88 Favored 'General case' 0 N--CA 1.407 -2.604 0 C-N-CA 126.216 1.807 . . . . 0.0 109.451 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -76.22 -27.46 56.83 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 115.716 -2.393 . . . . 0.0 115.198 172.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.514 HD12 HG12 ' A' ' 148' ' ' VAL 0.346 0.4 OUTLIER -81.23 -29.54 34.43 Favored 'General case' 0 CA--C 1.458 -2.595 0 CA-C-O 116.137 -1.887 . . . . 0.0 114.474 179.347 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -26.03 -26.54 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.683 1 C-N-CA 136.065 5.746 . . . . 0.0 119.756 -173.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -51.94 -55.45 20.24 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 126.58 1.952 . . . . 0.0 112.742 166.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.421 ' HG ' ' CG2' ' A' ' 115' ' ' ILE 0.3 1.2 mm? -94.73 -58.82 2.07 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 128.048 2.539 . . . . 0.0 107.191 -169.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.805 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.298 . . -109.28 151.32 26.71 Favored 'General case' 0 CA--C 1.446 -3.055 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.974 -161.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.59 176.53 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.543 0 C-N-CA 115.216 -2.594 . . . . 0.0 116.65 140.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.456 ' CG2' ' HE3' ' A' ' 149' ' ' LYS . 3.4 t -84.96 150.29 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 168.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -80.64 -37.76 30.4 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.402 ' H ' HG12 ' A' ' 158' ' ' VAL . 3.3 t -159.84 144.04 14.68 Favored 'General case' 0 CA--C 1.461 -2.477 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -174.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -100.28 90.81 1.48 Allowed Pre-proline 0 N--CA 1.426 -1.627 0 N-CA-C 101.979 -3.341 . . . . 0.0 101.979 170.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -98.39 -82.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.446 0 CA-C-N 120.717 1.292 . . . . 0.0 109.406 -137.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.23 -162.29 0.94 Allowed 'General case' 1 N--CA 1.375 -4.223 0 CA-C-O 126.05 2.833 . . . . 0.0 112.658 -137.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -122.79 124.69 43.89 Favored 'General case' 0 N--CA 1.423 -1.789 2 CA-C-N 107.031 -4.622 . . . . 0.0 99.737 171.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.556 HD13 ' CZ ' ' A' ' 130' ' ' PHE . 3.2 mt -73.44 132.96 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 CA-C-O 122.752 1.263 . . . . 0.0 109.854 -172.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -115.41 128.85 56.34 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 172.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.31 -156.22 46.61 Favored Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -108.62 43.3 1.26 Allowed 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 124.326 1.051 . . . . 0.0 109.589 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.413 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.302 32.1 mt-30 -167.03 137.79 3.12 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -174.723 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 59.6 ttp -134.61 117.96 16.7 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 120.883 0.373 . . . . 0.0 110.165 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.436 HD13 ' HA ' ' A' ' 127' ' ' THR . 11.2 mm -77.95 133.3 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 145' ' ' LEU . 2.8 ttt -119.69 131.3 55.38 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 165.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.628 HG12 ' HD3' ' A' ' 123' ' ' LYS . 1.6 t -100.21 143.01 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -171.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.551 HD13 HD11 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -130.59 70.51 1.45 Allowed 'General case' 0 C--N 1.364 1.23 0 N-CA-C 119.469 3.137 . . . . 0.0 119.469 -161.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 123' ' ' LYS 0.284 . . -92.31 173.75 4.83 Favored Pre-proline 0 C--N 1.358 0.962 0 N-CA-C 119.416 3.117 . . . . 0.0 119.416 -171.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -70.46 142.03 43.85 Favored 'Trans proline' 0 N--CA 1.443 -1.493 0 CA-C-N 120.591 1.247 . . . . 0.0 110.842 -175.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -81.62 129.83 34.83 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 175.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -86.38 101.36 13.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.479 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -76.11 123.65 26.15 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 C--O 1.26 1.623 0 C-N-CA 124.749 1.219 . . . . 0.0 109.408 179.324 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 CA--C 1.483 -1.606 0 CA-C-O 122.34 1.067 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.9 mm -92.04 127.11 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-N 113.013 -1.903 . . . . 0.0 107.066 176.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -94.16 167.42 11.57 Favored 'General case' 0 CA--C 1.48 -1.743 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -174.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.581 HG22 ' HD3' ' A' ' 123' ' ' LYS . 86.4 t -98.69 117.16 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.712 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 157.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -106.66 170.66 7.8 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 155.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -137.85 157.22 46.87 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -167.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.21 159.27 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 N-CA-C 102.329 -3.212 . . . . 0.0 102.329 174.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -117.85 157.45 26.6 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 118.937 0.79 . . . . 0.0 111.587 166.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.614 ' HB3' HG11 ' A' ' 144' ' ' VAL . 28.5 m-85 -139.89 90.94 2.43 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 172.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -84.31 170.49 13.66 Favored Pre-proline 0 N--CA 1.436 -1.153 0 C-N-CA 123.849 0.86 . . . . 0.0 108.937 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -74.72 145.3 32.41 Favored 'Trans proline' 0 N--CA 1.436 -1.88 0 C-N-CA 122.218 1.945 . . . . 0.0 107.309 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.64 8.64 63.65 Favored Glycine 0 CA--C 1.483 -1.925 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 m -108.27 94.45 5.07 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 170.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -124.7 -168.49 1.82 Allowed 'General case' 0 N--CA 1.411 -2.404 0 CA-C-N 112.79 -2.004 . . . . 0.0 106.933 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -50.69 -48.7 58.58 Favored 'General case' 0 CA--C 1.479 -1.759 0 C-N-CA 127.514 2.326 . . . . 0.0 113.659 -128.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.41 0.18 77.4 Favored Glycine 0 N--CA 1.42 -2.395 0 N-CA-C 116.035 1.174 . . . . 0.0 116.035 -169.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -101.45 -29.42 12.02 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -86.57 -70.43 0.61 Allowed 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 113.265 -1.789 . . . . 0.0 110.261 -158.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.422 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.326 0.0 OUTLIER -59.01 -14.06 8.35 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 119.004 2.964 . . . . 0.0 119.004 173.604 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.24 -45.75 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 122.096 0.95 . . . . 0.0 110.225 161.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -91.36 4.37 52.57 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.417 HD12 HG13 ' A' ' 148' ' ' VAL . 6.0 tt -83.51 -30.63 26.98 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 162.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.498 ' HA ' HG12 ' A' ' 115' ' ' ILE . 25.1 ttt85 -62.51 -42.42 99.5 Favored 'General case' 0 C--N 1.361 1.082 0 CA-C-O 118.686 -0.674 . . . . 0.0 110.664 167.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.25 65.7 m -55.1 -44.97 75.41 Favored 'General case' 0 C--N 1.379 1.866 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 169.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.607 HD11 HD12 ' A' ' 126' ' ' ILE . 13.7 mt -65.08 -29.53 70.41 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 112' ' ' ARG . 5.2 mm -61.04 -45.51 98.42 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.378 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -52.7 43.54 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.542 1.537 . . . . 0.0 111.302 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -57.34 -46.32 83.41 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.423 HD11 ' HA ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -54.48 -44.53 72.72 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 127.802 2.441 . . . . 0.0 112.848 172.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -79.54 -20.09 47.94 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 126.555 1.942 . . . . 0.0 112.416 -174.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -68.11 -21.59 64.94 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.139 0.576 . . . . 0.0 110.745 170.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.73 51.4 3.64 Favored Glycine 0 CA--C 1.474 -2.474 0 N-CA-C 105.804 -2.918 . . . . 0.0 105.804 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -126.78 165.97 18.29 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.581 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -96.53 119.82 35.72 Favored 'General case' 0 N--CA 1.409 -2.5 1 N-CA-C 99.795 -4.15 . . . . 0.0 99.795 178.562 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -91.98 144.04 25.86 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 103.176 -2.898 . . . . 0.0 103.176 -172.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.432 ' HD3' HD12 ' A' ' 171' ' ' ILE . 22.4 ttmm -118.72 125.05 48.81 Favored 'General case' 0 CA--C 1.479 -1.785 0 O-C-N 117.893 -3.004 . . . . 0.0 106.314 173.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.7 HD11 HD22 ' A' ' 174' ' ' LEU . 4.2 mm -86.34 131.99 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 173.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.485 ' HA ' HD13 ' A' ' 171' ' ' ILE . 32.8 m -121.76 123.92 42.97 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 173.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.485 HD23 HD11 ' A' ' 145' ' ' LEU 0.362 0.4 OUTLIER -76.58 150.16 36.53 Favored 'General case' 0 CA--C 1.468 -2.188 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 164.787 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.513 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 56.6 ttt180 -145.15 88.96 1.91 Allowed 'General case' 0 N--CA 1.399 -3.008 1 N-CA-C 99.735 -4.172 . . . . 0.0 99.735 177.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.59 ' HB3' ' CE1' ' A' ' 137' ' ' HIS 0.25 70.1 m-85 -63.11 144.44 56.9 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 110.986 -2.824 . . . . 0.0 109.144 -177.69 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -119.49 29.16 7.76 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 133' ' ' ARG . . . -124.46 -17.17 2.97 Favored Glycine 0 CA--C 1.482 -1.991 0 N-CA-C 105.878 -2.889 . . . . 0.0 105.878 169.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.403 ' HA ' ' HE1' ' A' ' 137' ' ' HIS . 21.0 ptt180 1.18 79.37 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.071 1 C-N-CA 133.306 4.642 . . . . 0.0 118.169 177.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -141.5 21.54 2.19 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 169.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 58.3 mtt 55.48 72.11 0.5 Allowed 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 125.416 1.486 . . . . 0.0 107.292 -156.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.705 ' HB3' ' CD2' ' A' ' 137' ' ' HIS . . . -89.01 -38.25 14.56 Favored 'General case' 0 CA--C 1.473 -1.996 0 CA-C-O 125.214 2.435 . . . . 0.0 109.709 -169.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.705 ' CD2' ' HB3' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -106.4 159.44 16.14 Favored 'General case' 0 N--CA 1.413 -2.312 1 CA-C-N 107.531 -4.395 . . . . 0.0 111.019 -148.139 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -138.73 0.84 2.05 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 102.536 -3.135 . . . . 0.0 102.536 142.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -90.47 -50.92 5.68 Favored 'General case' 0 CA--C 1.477 -1.85 0 CA-C-N 113.808 -1.542 . . . . 0.0 108.838 -167.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.486 HD12 ' HD2' ' A' ' 137' ' ' HIS 0.399 57.5 mt -52.83 -38.92 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 126.945 2.098 . . . . 0.0 112.329 174.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.47 ' HA2' HD21 ' A' ' 128' ' ' LEU . . . -71.4 -64.9 2.59 Favored Glycine 0 N--CA 1.418 -2.513 0 CA-C-O 119.474 -0.626 . . . . 0.0 112.676 173.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.569 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 7.4 ptt? -87.1 -5.85 58.88 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -153.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.02 -48.46 78.67 Favored 'General case' 0 CA--C 1.457 -2.615 0 C-N-CA 116.496 -2.081 . . . . 0.0 113.837 156.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.614 HG11 ' HB3' ' A' ' 98' ' ' PHE . 21.4 t -69.39 -67.77 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.444 -3.133 0 O-C-N 126.023 2.077 . . . . 0.0 106.936 -167.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.58 HD13 ' HB2' ' A' ' 172' ' ' MET . 42.7 mt -43.0 -54.15 4.42 Favored 'General case' 0 CA--C 1.476 -1.898 0 C-N-CA 128.495 2.718 . . . . 0.0 115.679 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.569 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.5 t-20 -63.87 -31.91 73.25 Favored 'General case' 0 CA--C 1.461 -2.474 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 175.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.3 ttp180 -81.81 -14.51 56.25 Favored 'General case' 0 N--CA 1.419 -2.013 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.014 172.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.8 t -76.27 -46.6 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.81 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 176.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.544 ' HE3' HG21 ' A' ' 158' ' ' VAL . 31.4 ttmt -51.9 -51.21 58.52 Favored 'General case' 0 CA--C 1.461 -2.453 0 C-N-CA 125.239 1.416 . . . . 0.0 111.003 172.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.81 -35.85 67.43 Favored 'General case' 0 N--CA 1.409 -2.513 0 C-N-CA 124.612 1.165 . . . . 0.0 110.529 -168.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -72.84 -39.41 66.57 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 116.291 -2.164 . . . . 0.0 114.941 170.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.303 0.2 OUTLIER -80.87 -19.56 44.18 Favored 'General case' 0 CA--C 1.464 -2.341 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -178.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -27.11 -25.07 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.363 1 C-N-CA 134.586 5.154 . . . . 0.0 119.064 174.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 2.2 mt-10 -54.24 -57.77 9.92 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 126.903 2.081 . . . . 0.0 113.361 167.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.38 -51.39 2.88 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 113.498 -1.683 . . . . 0.0 108.525 -164.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.423 ' HA ' HD11 ' A' ' 118' ' ' LEU 0.321 . . -91.65 146.13 24.03 Favored 'General case' 0 CA--C 1.455 -2.685 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 177.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.4 m -121.12 171.6 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.457 -2.615 0 C-N-CA 114.265 -2.974 . . . . 0.0 116.307 126.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.544 HG21 ' HE3' ' A' ' 149' ' ' LYS 0.298 3.2 t -81.8 155.11 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 C-N-CA 130.524 3.53 . . . . 0.0 107.313 179.391 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -82.15 -42.45 19.05 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.03 141.31 18.58 Favored 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -174.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -98.22 109.73 53.33 Favored Pre-proline 0 N--CA 1.417 -2.077 1 N-CA-C 98.766 -4.531 . . . . 0.0 98.766 158.128 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -86.4 -100.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.536 0 N-CA-C 102.886 -3.544 . . . . 0.0 102.886 -169.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -162.84 -62.9 0.04 OUTLIER 'General case' 0 N--CA 1.405 -2.71 0 N-CA-C 103.402 -2.814 . . . . 0.0 103.402 -160.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -151.56 162.92 40.15 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 122.81 1.29 . . . . 0.0 110.768 -161.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.9 mt -53.01 142.96 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 1 C-N-CA 132.234 4.213 . . . . 0.0 111.933 172.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -131.09 96.8 4.13 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 89.83 -143.8 17.33 Favored Glycine 0 CA--C 1.486 -1.729 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -171.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -97.42 27.29 4.32 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 125.327 1.451 . . . . 0.0 112.298 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.279 15.5 mt-30 -171.99 142.26 1.44 Allowed 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 -157.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.41 ' HB3' ' HB2' ' A' ' 128' ' ' LEU . 21.6 ttm -104.57 158.35 16.55 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 102.45 -3.167 . . . . 0.0 102.45 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 127' ' ' THR . 32.7 mm -118.43 131.53 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.157 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 159.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.58 ' HB2' HD13 ' A' ' 145' ' ' LEU . 2.5 ttp -108.12 128.4 54.65 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 153.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 37.0 t -91.47 130.39 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 C-N-CA 118.17 -1.412 . . . . 0.0 108.597 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.7 HD22 HD11 ' A' ' 126' ' ' ILE . 13.1 tp -101.82 144.07 30.94 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 130.213 3.405 . . . . 0.0 116.915 174.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.261 . . -143.08 -179.3 0.93 Allowed Pre-proline 0 CA--C 1.483 -1.599 0 O-C-N 119.255 -2.153 . . . . 0.0 108.991 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -65.24 145.24 83.5 Favored 'Trans proline' 0 N--CA 1.436 -1.877 0 C-N-CA 123.025 2.483 . . . . 0.0 109.197 158.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -76.91 143.4 39.61 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 165.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -69.81 105.19 2.69 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 170.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.03 77.53 1.84 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 . . . . . 0 C--O 1.26 1.61 0 C-N-CA 125.226 1.411 . . . . 0.0 110.038 -176.186 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 CA--C 1.481 -1.687 0 CA-C-O 122.128 0.966 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.6 mm -90.3 117.54 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 113.183 -1.826 . . . . 0.0 108.685 176.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -89.93 169.89 10.85 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.503 HG22 ' HD3' ' A' ' 123' ' ' LYS . 54.5 t -102.65 119.47 51.06 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.789 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 161.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -115.19 178.59 4.23 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 160.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -141.7 158.98 43.15 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -171.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.1 tp -134.37 164.74 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 168.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -120.24 154.62 34.65 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.113 162.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.599 ' HB3' HG11 ' A' ' 144' ' ' VAL . 37.9 m-85 -128.9 136.66 50.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 102.922 -2.992 . . . . 0.0 102.922 167.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -114.33 174.22 2.46 Favored Pre-proline 0 N--CA 1.432 -1.344 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -72.88 135.72 23.91 Favored 'Trans proline' 0 N--CA 1.432 -2.093 0 N-CA-C 105.472 -2.549 . . . . 0.0 105.472 163.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.32 10.2 64.23 Favored Glycine 0 CA--C 1.484 -1.893 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 88.2 m -100.51 90.13 4.18 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 169.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -125.02 -171.9 2.46 Favored 'General case' 0 N--CA 1.41 -2.441 0 CA-C-N 112.122 -2.308 . . . . 0.0 106.523 172.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -48.14 -49.96 30.43 Favored 'General case' 0 CA--C 1.48 -1.731 0 C-N-CA 128.155 2.582 . . . . 0.0 113.793 -131.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.84 1.1 77.62 Favored Glycine 0 N--CA 1.418 -2.523 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -168.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -100.51 -30.15 11.96 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 125.08 1.352 . . . . 0.0 108.044 166.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.19 -72.79 0.5 Allowed 'General case' 0 CA--C 1.47 -2.105 0 CA-C-N 112.283 -2.235 . . . . 0.0 111.036 -157.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.457 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.312 0.0 OUTLIER -60.18 -13.45 12.34 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 118.808 2.892 . . . . 0.0 118.808 174.435 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 94.9 t -60.47 -48.74 87.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 C-N-CA 124.209 1.004 . . . . 0.0 109.997 160.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -91.72 7.41 41.83 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 5.3 tt -86.21 -31.14 21.89 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 163.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.461 ' HA ' HG12 ' A' ' 115' ' ' ILE . 56.9 ttt-85 -62.25 -43.8 97.99 Favored 'General case' 0 C--N 1.363 1.158 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.021 167.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.1 m -60.14 -42.37 94.71 Favored 'General case' 0 C--N 1.378 1.838 0 C-N-CA 118.181 -1.408 . . . . 0.0 113.175 174.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.52 HD11 HD12 ' A' ' 126' ' ' ILE . 9.9 mt -62.48 -30.77 71.5 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 175.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.6 mm -58.33 -51.58 69.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.733 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 25.9 tpt85 -50.38 -45.96 55.69 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 126.716 2.007 . . . . 0.0 112.745 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -61.22 -54.54 42.96 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -57.56 -39.46 76.74 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 177.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -78.43 -29.91 47.32 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 128.703 2.801 . . . . 0.0 110.252 -169.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.92 7.47 8.82 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 123.067 0.547 . . . . 0.0 111.406 173.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.09 61.13 2.57 Favored Glycine 0 CA--C 1.467 -2.937 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 173.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -131.88 168.57 17.63 Favored 'General case' 0 CA--C 1.448 -2.971 0 N-CA-C 101.194 -3.632 . . . . 0.0 101.194 170.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.503 ' HD3' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -108.25 116.71 32.48 Favored 'General case' 0 N--CA 1.39 -3.472 1 N-CA-C 98.091 -4.781 . . . . 0.0 98.091 173.373 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -82.72 158.22 22.97 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 102.586 -3.116 . . . . 0.0 102.586 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.306 33.2 mtmm -126.29 144.49 50.78 Favored 'General case' 0 CA--C 1.481 -1.677 0 O-C-N 118.795 -2.441 . . . . 0.0 105.47 155.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.52 HD12 HD11 ' A' ' 114' ' ' LEU . 6.4 mm -86.62 137.37 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 167.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.9 m -117.17 123.78 47.52 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 166.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 170' ' ' MET 0.258 0.2 OUTLIER -80.18 153.78 28.4 Favored 'General case' 0 CA--C 1.467 -2.213 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 166.573 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -148.21 94.79 2.37 Favored 'General case' 0 N--CA 1.404 -2.756 1 N-CA-C 99.51 -4.255 . . . . 0.0 99.51 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -77.15 175.79 9.32 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.116 -170.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -66.27 108.49 2.33 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 152.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.86 121.67 10.94 Favored Glycine 0 CA--C 1.479 -2.161 0 CA-C-O 122.214 0.897 . . . . 0.0 114.599 -155.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -129.32 172.8 11.12 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 173.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -61.89 -73.6 0.1 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.107 0.963 . . . . 0.0 110.539 176.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 14.2 tpt -104.3 102.08 11.78 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 103.36 -2.83 . . . . 0.0 103.36 166.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.99 -171.66 3.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -171.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.512 ' CG ' HD12 ' A' ' 140' ' ' ILE . 40.1 m-70 -35.34 121.54 0.58 Allowed 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 130.397 3.479 . . . . 0.0 114.898 165.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -98.12 -0.81 43.68 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -87.79 -51.9 5.6 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -175.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.512 HD12 ' CG ' ' A' ' 137' ' ' HIS 0.253 68.4 mt -52.9 -41.12 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 C-N-CA 127.306 2.242 . . . . 0.0 111.67 173.16 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -70.11 -64.5 2.87 Favored Glycine 0 N--CA 1.416 -2.657 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.556 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 7.1 ptt? -84.78 -5.66 59.33 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -155.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.32 -53.72 48.33 Favored 'General case' 0 CA--C 1.459 -2.529 0 C-N-CA 115.925 -2.31 . . . . 0.0 114.126 154.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.599 HG11 ' HB3' ' A' ' 98' ' ' PHE . 21.8 t -66.11 -67.05 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.443 -3.144 0 O-C-N 126.028 2.08 . . . . 0.0 107.499 -167.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.438 HD22 ' HB3' ' A' ' 172' ' ' MET . 23.9 mt -41.08 -56.63 2.27 Favored 'General case' 0 CA--C 1.476 -1.877 0 C-N-CA 128.977 2.911 . . . . 0.0 115.15 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.4 t-20 -63.31 -31.41 72.55 Favored 'General case' 0 CA--C 1.466 -2.285 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 175.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -82.69 -13.68 55.96 Favored 'General case' 0 N--CA 1.419 -2.012 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.868 173.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 144' ' ' VAL . 1.7 t -76.31 -46.96 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 177.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.531 ' HE3' HG21 ' A' ' 158' ' ' VAL 0.251 35.3 ttmt -51.21 -49.83 60.27 Favored 'General case' 0 CA--C 1.464 -2.357 0 C-N-CA 125.642 1.577 . . . . 0.0 111.991 172.65 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -37.39 64.93 Favored 'General case' 0 N--CA 1.408 -2.57 0 C-N-CA 125.276 1.43 . . . . 0.0 109.978 -169.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -72.22 -38.21 69.02 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 116.412 -2.115 . . . . 0.0 114.923 171.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.423 HD13 HD11 ' A' ' 174' ' ' LEU 0.296 0.2 OUTLIER -81.84 -20.68 38.49 Favored 'General case' 0 CA--C 1.461 -2.443 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -178.318 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -25.87 -28.2 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.305 1 C-N-CA 134.305 5.042 . . . . 0.0 119.142 175.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 5.2 mt-10 -50.88 -54.05 27.23 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 128.101 2.56 . . . . 0.0 113.747 168.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.1 tt -113.22 -51.0 2.84 Favored 'General case' 0 N--CA 1.42 -1.932 0 C-N-CA 126.163 1.785 . . . . 0.0 108.611 -167.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.534 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.343 . . -104.7 142.0 35.46 Favored 'General case' 0 CA--C 1.449 -2.937 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.822 -177.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.5 m -120.04 171.76 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.65 0 CA-C-O 125.117 2.389 . . . . 0.0 116.022 140.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.531 HG21 ' HE3' ' A' ' 149' ' ' LYS 0.289 2.7 t -81.82 152.86 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 109.917 -3.311 . . . . 0.0 106.336 177.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -83.33 -39.2 21.06 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -176.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.76 140.95 18.51 Favored 'General case' 0 CA--C 1.468 -2.193 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -174.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -103.94 106.37 52.63 Favored Pre-proline 0 N--CA 1.422 -1.845 0 N-CA-C 101.259 -3.608 . . . . 0.0 101.259 164.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -102.95 -110.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.413 -3.233 1 N-CA-C 101.209 -4.189 . . . . 0.0 101.209 -174.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 179.66 -47.68 0.01 OUTLIER 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 101.657 -3.46 . . . . 0.0 101.657 -146.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -83.76 112.79 20.4 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-O 121.964 0.887 . . . . 0.0 111.915 -148.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -76.85 129.1 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 102.494 -3.15 . . . . 0.0 102.494 170.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -120.37 100.43 7.15 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.21 -145.71 23.38 Favored Glycine 0 CA--C 1.484 -1.859 0 N-CA-C 107.306 -2.318 . . . . 0.0 107.306 -168.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -99.85 36.71 1.75 Allowed 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 125.158 1.383 . . . . 0.0 110.472 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . 0.314 19.8 mt-30 -170.61 141.48 1.89 Allowed 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 124.663 1.185 . . . . 0.0 108.024 -157.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.406 ' HB3' ' HB2' ' A' ' 128' ' ' LEU . 4.6 ttm -116.14 112.99 22.49 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-N 119.805 1.184 . . . . 0.0 109.878 -175.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.9 mm -80.92 123.57 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 O-C-N 121.06 -1.025 . . . . 0.0 108.646 170.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.438 ' HB3' HD22 ' A' ' 145' ' ' LEU . 2.9 ttt -107.49 131.24 54.52 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 159.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 39.1 t -93.09 140.86 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.017 -173.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -126.92 81.1 1.99 Allowed 'General case' 0 C--N 1.364 1.208 0 N-CA-C 118.988 2.958 . . . . 0.0 118.988 -169.055 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.276 . . -85.94 178.73 2.16 Favored Pre-proline 0 CA--C 1.499 -0.993 0 O-C-N 119.644 -1.91 . . . . 0.0 115.998 -171.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.442 ' HA ' HD21 ' A' ' 118' ' ' LEU . 84.4 Cg_exo -62.06 142.97 94.29 Favored 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 122.849 2.366 . . . . 0.0 109.786 159.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -78.14 131.38 37.2 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -74.95 104.41 5.54 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 171.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -78.2 121.33 24.22 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 . . . . . 0 C--O 1.259 1.588 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -177.931 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.472 -2.05 0 CA-C-O 124.947 2.308 . . . . 0.0 107.489 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.54 123.75 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 CA-C-N 108.448 -3.978 . . . . 0.0 106.785 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -97.48 163.83 12.7 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 -166.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.575 HG22 ' HE3' ' A' ' 123' ' ' LYS . 76.3 t -100.78 119.99 49.67 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.588 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -104.85 172.44 6.79 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 155.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -143.78 154.23 43.22 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -175.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 tp -138.71 165.26 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 103.918 -2.623 . . . . 0.0 103.918 171.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -117.13 155.04 30.0 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-N 118.744 0.702 . . . . 0.0 110.903 163.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.57 ' HB3' HG11 ' A' ' 144' ' ' VAL . 26.7 m-85 -128.9 145.47 51.21 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 170.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -100.23 166.52 12.52 Favored Pre-proline 0 N--CA 1.438 -1.046 0 C-N-CA 126.341 1.856 . . . . 0.0 106.719 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.471 ' HB3' HG23 ' A' ' 140' ' ' ILE . 62.6 Cg_exo -56.09 139.14 84.86 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 C-N-CA 124.751 3.634 . . . . 0.0 113.399 169.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 3.82 98.17 0.0 OUTLIER Glycine 0 CA--C 1.468 -2.898 1 C-N-CA 131.989 4.614 . . . . 0.0 114.816 -173.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.57 -154.99 0.49 Allowed 'General case' 0 N--CA 1.397 -3.122 0 CA-C-N 111.104 -2.548 . . . . 0.0 108.731 -154.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 107' ' ' TYR 0.435 0.7 OUTLIER -125.56 166.55 16.49 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-N 109.734 -3.394 . . . . 0.0 111.372 -149.631 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.67 -75.02 0.12 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -107.14 45.79 1.26 Allowed Glycine 0 CA--C 1.476 -2.395 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.742 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -105.19 -42.7 5.21 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 144.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.549 ' HB3' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER -84.66 -63.82 1.27 Allowed 'General case' 0 CA--C 1.481 -1.708 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.678 -161.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.467 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.325 0.0 OUTLIER -61.87 -11.89 15.05 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 119.64 3.2 . . . . 0.0 119.64 177.392 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.5 t -60.96 -48.05 90.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-O 122.37 1.081 . . . . 0.0 109.552 160.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -91.41 -1.65 57.52 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tt -78.5 -33.42 48.1 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 162.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.451 ' HA ' HG12 ' A' ' 115' ' ' ILE . 46.7 ttt-85 -61.91 -40.57 95.91 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 117.672 -1.156 . . . . 0.0 110.997 169.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.6 m -57.43 -46.17 83.84 Favored 'General case' 0 C--N 1.38 1.913 0 C-N-CA 119.001 -1.08 . . . . 0.0 113.84 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.268 84.4 mt -65.49 -30.87 71.69 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 112' ' ' ARG . 6.9 mm -58.75 -49.7 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.676 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -55.85 -39.55 71.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 126.801 2.041 . . . . 0.0 111.32 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -62.45 -51.7 66.46 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 123.581 0.752 . . . . 0.0 112.081 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.737 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -66.83 -23.09 66.0 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 126.232 1.813 . . . . 0.0 114.978 177.331 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -69.98 -38.2 75.96 Favored 'General case' 0 CA--C 1.491 -1.306 0 C-N-CA 126.216 1.806 . . . . 0.0 109.875 172.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -66.63 -26.08 66.9 Favored 'General case' 0 C--N 1.361 1.083 0 O-C-N 123.28 0.363 . . . . 0.0 110.893 171.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.41 65.36 1.52 Allowed Glycine 0 CA--C 1.471 -2.702 0 N-CA-C 104.743 -3.343 . . . . 0.0 104.743 -172.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -121.52 164.72 16.76 Favored 'General case' 0 CA--C 1.449 -2.929 1 N-CA-C 98.79 -4.522 . . . . 0.0 98.79 170.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.575 ' HE3' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -101.5 117.6 35.26 Favored 'General case' 0 N--CA 1.396 -3.173 1 N-CA-C 97.538 -4.986 . . . . 0.0 97.538 169.106 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.63 160.6 20.37 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 172.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -134.42 131.43 38.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 169.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.1 mm -82.93 135.87 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.416 ' HA ' HD13 ' A' ' 171' ' ' ILE . 16.4 m -113.19 119.23 37.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 165.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.739 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.2 OUTLIER -84.73 153.75 22.86 Favored 'General case' 0 CA--C 1.474 -1.963 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 167.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.493 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 24.8 ttm-85 -151.62 103.05 2.92 Favored 'General case' 0 N--CA 1.395 -3.183 1 N-CA-C 96.504 -5.369 . . . . 0.0 96.504 -173.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.451 ' CE1' HD22 ' A' ' 128' ' ' LEU . 60.2 m-85 -72.48 176.69 5.17 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 112.537 -2.119 . . . . 0.0 109.987 -174.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -73.4 -18.12 61.19 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-O 122.895 1.331 . . . . 0.0 113.939 -169.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 173.39 -5.76 0.03 OUTLIER Glycine 0 CA--C 1.472 -2.602 0 N-CA-C 106.657 -2.577 . . . . 0.0 106.657 165.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 55.92 52.44 10.64 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 112.738 -1.731 . . . . 0.0 106.937 -147.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -87.68 -51.8 5.68 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 172.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 59.3 ttm -90.36 -64.99 1.06 Allowed 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 170.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.428 ' HB3' HG13 ' A' ' 140' ' ' ILE . . . -165.74 -138.24 0.03 OUTLIER 'General case' 0 CA--C 1.481 -1.698 0 CA-C-O 122.579 1.18 . . . . 0.0 112.529 -157.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.571 ' CG ' HD12 ' A' ' 165' ' ' ILE . 7.0 m170 166.33 -76.86 0.0 OUTLIER 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 110.84 -2.891 . . . . 0.0 113.018 -106.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -95.56 -25.52 16.15 Favored 'General case' 0 CA--C 1.475 -1.931 0 CA-C-O 122.274 1.035 . . . . 0.0 111.46 -161.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -81.48 -52.71 6.96 Favored 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.471 HG23 ' HB3' ' A' ' 100' ' ' PRO . 5.8 mt -53.57 -50.2 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.24 0 C-N-CA 128.834 2.853 . . . . 0.0 111.602 -177.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.739 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -79.94 -53.47 4.23 Favored Glycine 0 CA--C 1.458 -3.498 0 O-C-N 124.876 1.36 . . . . 0.0 110.517 -168.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 71.1 mtm -85.74 3.1 42.79 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -166.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.261 2.2 tp10 -62.42 -64.82 0.81 Allowed 'General case' 0 CA--C 1.466 -2.26 0 C-N-CA 115.199 -2.6 . . . . 0.0 115.876 141.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.57 HG11 ' HB3' ' A' ' 98' ' ' PHE . 16.1 t -62.59 -65.29 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.447 -2.994 0 O-C-N 125.907 2.005 . . . . 0.0 109.264 -162.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.3 mt -42.4 -53.99 4.0 Favored 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 129.435 3.094 . . . . 0.0 114.641 176.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -61.83 -35.89 79.58 Favored 'General case' 0 CA--C 1.466 -2.254 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -80.15 -14.71 58.26 Favored 'General case' 0 N--CA 1.419 -2.01 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.486 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.444 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.9 t -76.72 -46.46 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.725 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.422 ' HE3' ' CG2' ' A' ' 158' ' ' VAL 0.271 31.4 ttmt -53.73 -48.31 69.75 Favored 'General case' 0 CA--C 1.467 -2.241 0 C-N-CA 126.007 1.723 . . . . 0.0 112.587 173.382 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.8 -39.33 66.75 Favored 'General case' 0 N--CA 1.407 -2.596 0 C-N-CA 125.476 1.51 . . . . 0.0 108.77 -171.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -75.07 -22.95 58.0 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 115.637 -2.425 . . . . 0.0 115.63 170.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.407 HD23 HG12 ' A' ' 148' ' ' VAL 0.313 0.2 OUTLIER -83.26 -31.12 27.12 Favored 'General case' 0 CA--C 1.473 -1.999 0 CA-C-O 116.887 -1.53 . . . . 0.0 112.827 -179.649 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -29.11 -26.48 0.0 OUTLIER 'General case' 0 C--N 1.367 1.346 1 C-N-CA 134.93 5.292 . . . . 0.0 119.346 -175.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 5.7 mt-10 -50.86 -53.28 33.69 Favored 'General case' 0 CA--C 1.491 -1.297 0 C-N-CA 128.642 2.777 . . . . 0.0 112.611 170.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . 0.251 0.2 OUTLIER -111.31 -53.53 2.69 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 113.701 -1.591 . . . . 0.0 108.593 -169.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.737 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.318 . . -105.65 154.33 20.58 Favored 'General case' 0 CA--C 1.444 -3.112 0 CA-C-N 113.732 -1.576 . . . . 0.0 107.756 -166.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.58 178.58 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.506 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 139.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.43 HG22 HD23 ' A' ' 174' ' ' LEU . 2.7 t -83.8 151.74 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.996 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 166.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -80.29 -38.59 30.47 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 6.8 t -123.02 -175.96 3.3 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -175.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -131.84 94.51 24.79 Favored Pre-proline 0 N--CA 1.419 -1.992 0 N-CA-C 102.343 -3.206 . . . . 0.0 102.343 144.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -77.46 -48.54 0.11 Allowed 'Trans proline' 0 CA--C 1.489 -1.726 0 CA-C-N 121.3 1.5 . . . . 0.0 113.152 -139.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . 0.254 1.3 m 5.84 51.32 0.0 OUTLIER 'General case' 0 N--CA 1.421 -1.911 1 C-N-CA 135.439 5.496 . . . . 0.0 119.648 -158.422 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -114.01 74.64 0.88 Allowed 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 109.781 -3.372 . . . . 0.0 103.337 158.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.571 HD12 ' CG ' ' A' ' 137' ' ' HIS . 8.3 mt -68.06 138.14 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 C-N-CA 125.05 1.34 . . . . 0.0 109.324 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -111.24 104.92 13.45 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 113.194 -1.821 . . . . 0.0 107.035 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.64 -147.61 29.75 Favored Glycine 0 CA--C 1.485 -1.806 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 -175.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -102.18 38.8 1.59 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.734 1.614 . . . . 0.0 110.202 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.493 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.257 26.0 mt-30 -169.78 132.99 1.2 Allowed 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -170.081 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -120.78 115.17 22.77 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -173.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 127' ' ' THR . 16.1 mm -79.07 123.86 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 167.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.412 ' HG3' ' CG1' ' A' ' 158' ' ' VAL . 2.4 ttt -107.21 136.89 46.28 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 163.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.97 134.88 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 118.176 -1.409 . . . . 0.0 108.782 -172.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.576 HD13 HD11 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -122.71 69.27 0.98 Allowed 'General case' 0 C--N 1.356 0.883 0 N-CA-C 119.782 3.253 . . . . 0.0 119.782 -164.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.312 . . -89.59 172.71 6.83 Favored Pre-proline 0 C--N 1.356 0.85 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 -172.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -72.04 139.44 32.84 Favored 'Trans proline' 0 CA--C 1.493 -1.545 0 N-CA-C 107.905 -1.613 . . . . 0.0 107.905 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -81.06 168.01 19.12 Favored 'General case' 0 N--CA 1.433 -1.315 0 O-C-N 124.126 0.892 . . . . 0.0 111.521 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.18 111.52 2.99 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 125.324 1.449 . . . . 0.0 110.31 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -75.2 116.58 16.09 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 171.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 . . . . . 0 C--O 1.261 1.678 0 CA-C-O 117.001 -1.476 . . . . 0.0 108.679 -171.955 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.469 -2.139 0 CA-C-O 124.983 2.325 . . . . 0.0 107.549 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.9 mm -94.86 124.44 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 CA-C-N 108.658 -3.883 . . . . 0.0 107.061 176.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -94.61 167.84 11.22 Favored 'General case' 0 CA--C 1.48 -1.724 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -174.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.559 HG22 ' HE2' ' A' ' 123' ' ' LYS . 55.2 t -96.42 123.75 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 160.1 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -103.28 172.42 6.82 Favored 'General case' 0 CA--C 1.468 -2.187 0 C-N-CA 116.105 -2.238 . . . . 0.0 105.985 160.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -144.29 148.34 34.7 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 tp -131.83 160.65 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 102.372 -3.196 . . . . 0.0 102.372 172.056 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -113.86 154.15 27.97 Favored 'General case' 0 CA--C 1.484 -1.566 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.207 164.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.547 ' HB3' HG11 ' A' ' 144' ' ' VAL . 4.7 m-85 -137.13 130.29 30.95 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -86.94 179.57 1.73 Allowed Pre-proline 0 N--CA 1.422 -1.839 0 C-N-CA 124.013 0.925 . . . . 0.0 110.648 179.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.417 ' HG3' ' H ' ' A' ' 131' ' ' ARG . 76.2 Cg_exo -56.73 146.64 76.24 Favored 'Trans proline' 0 N--CA 1.441 -1.597 1 C-N-CA 125.612 4.208 . . . . 0.0 113.826 173.272 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -13.37 103.29 0.01 OUTLIER Glycine 0 CA--C 1.472 -2.645 1 C-N-CA 131.263 4.268 . . . . 0.0 115.04 -173.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.13 -152.41 0.48 Allowed 'General case' 0 N--CA 1.402 -2.855 0 CA-C-N 111.032 -2.584 . . . . 0.0 108.151 -153.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.563 ' O ' ' HB3' ' A' ' 107' ' ' TYR 0.426 0.7 OUTLIER -124.39 166.31 16.18 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 110.042 -3.254 . . . . 0.0 111.134 -153.183 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.64 -73.4 0.16 Allowed 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -105.19 46.54 1.16 Allowed Glycine 0 CA--C 1.477 -2.295 0 C-N-CA 119.95 -1.119 . . . . 0.0 113.264 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -106.91 -42.47 4.91 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 145.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.563 ' HB3' ' O ' ' A' ' 103' ' ' ASP . 0.5 OUTLIER -88.91 -60.73 1.88 Allowed 'General case' 0 CA--C 1.479 -1.765 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.772 -161.265 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.346 0.0 OUTLIER -61.43 -12.74 15.78 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 119.281 3.067 . . . . 0.0 119.281 174.638 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.61 -47.81 91.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-O 122.201 1.001 . . . . 0.0 109.613 160.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -90.81 3.57 54.07 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 178.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.441 HD12 HG13 ' A' ' 148' ' ' VAL . 5.6 tt -82.61 -30.55 29.41 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 162.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.458 ' HA ' HG12 ' A' ' 115' ' ' ILE . 59.0 ttt-85 -62.3 -41.98 98.97 Favored 'General case' 0 C--N 1.361 1.105 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.731 166.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 t -57.0 -45.38 83.07 Favored 'General case' 0 C--N 1.378 1.807 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 175.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.336 29.3 mt -66.98 -29.0 68.73 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 175.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.273 7.1 mm -61.67 -48.42 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.882 0 CA-C-N 120.049 1.295 . . . . 0.0 108.064 174.624 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -54.2 -43.85 71.11 Favored 'General case' 0 CA--C 1.479 -1.759 0 C-N-CA 126.929 2.092 . . . . 0.0 110.026 -178.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -63.28 -48.73 76.88 Favored 'General case' 0 CA--C 1.487 -1.45 0 O-C-N 124.385 1.053 . . . . 0.0 112.636 177.15 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.533 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -61.49 -44.13 97.64 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -178.455 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -85.61 -17.8 35.12 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 126.813 2.045 . . . . 0.0 112.02 -169.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -81.71 -0.95 45.15 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 167.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.74 64.23 1.5 Allowed Glycine 0 CA--C 1.47 -2.74 0 C-N-CA 125.939 1.733 . . . . 0.0 108.947 171.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -134.92 165.96 24.1 Favored 'General case' 0 CA--C 1.445 -3.073 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 171.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.559 ' HE2' HG22 ' A' ' 93' ' ' VAL . 2.6 tmmm? -102.56 117.34 34.48 Favored 'General case' 0 N--CA 1.394 -3.232 1 N-CA-C 95.804 -5.628 . . . . 0.0 95.804 178.367 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.09 162.37 16.81 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -144.53 130.25 19.14 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 119.188 -2.195 . . . . 0.0 106.663 170.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.4 mm -84.02 136.39 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 174.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.479 ' HA ' HD13 ' A' ' 171' ' ' ILE . 20.1 m -108.52 119.92 40.93 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 161.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.772 HD12 HD11 ' A' ' 145' ' ' LEU 0.281 0.3 OUTLIER -71.84 147.49 47.12 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.394 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 53.1 ttm-85 -149.22 96.24 2.5 Favored 'General case' 0 N--CA 1.405 -2.717 1 N-CA-C 99.165 -4.383 . . . . 0.0 99.165 -178.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.416 ' CZ ' HD13 ' A' ' 165' ' ' ILE . 76.6 m-85 -70.47 146.09 50.52 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 111.787 -2.46 . . . . 0.0 109.417 -177.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.417 ' H ' ' HG3' ' A' ' 100' ' ' PRO . 93.7 mtt180 -120.3 25.84 9.58 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 168.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.45 -115.05 0.11 Allowed Glycine 0 CA--C 1.478 -2.228 0 C-N-CA 126.351 1.929 . . . . 0.0 110.451 178.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -114.36 -165.74 1.04 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 112.601 -1.799 . . . . 0.0 107.891 177.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -58.8 -89.05 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 125.912 1.685 . . . . 0.0 111.261 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 26.1 ttt -77.38 104.63 8.01 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 103.612 -2.736 . . . . 0.0 103.612 162.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.406 ' HB1' ' H ' ' A' ' 137' ' ' HIS . . . -80.69 -158.25 0.19 Allowed 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -158.227 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.545 ' CD2' HD12 ' A' ' 140' ' ' ILE . 1.1 m170 -96.58 140.19 31.56 Favored 'General case' 0 CA--C 1.476 -1.866 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.849 -170.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -88.31 1.2 55.09 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 121.325 0.583 . . . . 0.0 110.316 174.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -83.49 -50.62 8.1 Favored 'General case' 0 CA--C 1.481 -1.685 0 C-N-CA 126.667 1.987 . . . . 0.0 107.29 174.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.545 HD12 ' CD2' ' A' ' 137' ' ' HIS 0.256 59.4 mt -53.79 -42.41 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 C-N-CA 127.476 2.31 . . . . 0.0 111.061 177.474 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.529 ' CA ' HD11 ' A' ' 128' ' ' LEU . . . -74.33 -54.98 5.86 Favored Glycine 0 N--CA 1.412 -2.962 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.16 -178.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.477 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 6.3 ptt? -85.68 -0.53 55.41 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -163.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . 0.26 2.2 tp10 -60.46 -57.97 10.49 Favored 'General case' 0 CA--C 1.453 -2.776 0 C-N-CA 114.687 -2.805 . . . . 0.0 114.805 147.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 98' ' ' PHE . 17.1 t -67.15 -64.82 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.448 -2.956 0 O-C-N 126.118 2.136 . . . . 0.0 108.981 -161.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.772 HD11 HD12 ' A' ' 128' ' ' LEU . 51.2 mt -47.32 -52.43 16.44 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 128.227 2.611 . . . . 0.0 115.286 178.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 142' ' ' MET 0.265 1.7 t30 -63.44 -30.73 71.81 Favored 'General case' 0 CA--C 1.479 -1.761 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 174.175 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -80.61 -15.88 55.5 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.858 173.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 98' ' ' PHE . 2.0 t -75.58 -43.95 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.614 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.444 ' HB2' HG21 ' A' ' 158' ' ' VAL 0.283 23.2 ttmt -52.52 -49.53 64.63 Favored 'General case' 0 CA--C 1.47 -2.133 0 C-N-CA 126.222 1.809 . . . . 0.0 113.391 173.669 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -73.24 -41.45 63.7 Favored 'General case' 0 N--CA 1.404 -2.745 0 C-N-CA 127.78 2.432 . . . . 0.0 108.545 -172.216 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -75.04 -24.5 58.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 116.474 -2.09 . . . . 0.0 114.813 172.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 156' ' ' ALA 0.308 0.1 OUTLIER -81.93 -31.41 31.33 Favored 'General case' 0 CA--C 1.47 -2.13 0 CA-C-O 116.063 -1.922 . . . . 0.0 112.339 178.172 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -28.45 -26.92 0.0 OUTLIER 'General case' 0 C--N 1.37 1.461 1 C-N-CA 134.745 5.218 . . . . 0.0 119.651 -173.33 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -48.24 -50.06 30.98 Favored 'General case' 0 CA--C 1.49 -1.349 0 C-N-CA 129.151 2.98 . . . . 0.0 113.458 167.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.35 -48.35 1.84 Allowed 'General case' 0 N--CA 1.416 -2.155 0 C-N-CA 126.057 1.743 . . . . 0.0 109.293 -164.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.533 ' HB2' HD22 ' A' ' 118' ' ' LEU 0.347 . . -107.14 151.24 25.66 Favored 'General case' 0 CA--C 1.449 -2.934 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.536 -177.364 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.04 175.37 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.545 0 C-N-CA 115.803 -2.359 . . . . 0.0 116.304 136.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.476 HG13 ' HG2' ' A' ' 172' ' ' MET 0.372 74.8 t -76.98 147.88 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.25 0 CA-C-N 110.935 -2.848 . . . . 0.0 105.04 168.931 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -84.1 -39.5 19.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -172.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.8 t -160.06 142.41 13.24 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 113.73 -1.577 . . . . 0.0 106.898 -171.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -102.46 90.03 1.99 Allowed Pre-proline 0 N--CA 1.432 -1.373 0 N-CA-C 101.539 -3.504 . . . . 0.0 101.539 171.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -104.44 -87.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.472 0 CA-C-N 120.853 1.34 . . . . 0.0 108.707 -138.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.92 -158.14 0.65 Allowed 'General case' 1 N--CA 1.376 -4.16 0 CA-C-O 125.583 2.611 . . . . 0.0 111.01 -143.923 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -107.29 144.21 34.44 Favored 'General case' 0 N--CA 1.424 -1.748 1 CA-C-N 108.083 -4.144 . . . . 0.0 103.395 174.215 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.416 HD13 ' CZ ' ' A' ' 130' ' ' PHE . 9.1 mt -74.15 135.17 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 176.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -116.95 110.82 18.78 Favored 'General case' 0 CA--C 1.481 -1.703 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 177.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 75.79 -149.23 37.79 Favored Glycine 0 CA--C 1.483 -1.939 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 -171.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -99.73 39.91 1.28 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 125.35 1.46 . . . . 0.0 109.718 -176.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -170.11 139.36 1.8 Allowed 'General case' 0 CA--C 1.494 -1.177 0 O-C-N 121.351 -0.843 . . . . 0.0 110.515 -175.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 13.3 ttm -124.33 168.64 12.73 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 -178.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 127' ' ' THR . 23.5 mm -112.69 141.07 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.937 0 C-N-CA 126.183 1.793 . . . . 0.0 108.022 163.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.576 ' HB2' HD13 ' A' ' 145' ' ' LEU . 5.1 tmm? -116.22 131.89 56.82 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 103.05 -2.944 . . . . 0.0 103.05 151.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.5 t -89.21 134.05 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -116.91 74.08 0.89 Allowed 'General case' 0 C--N 1.357 0.92 0 N-CA-C 117.946 2.573 . . . . 0.0 117.946 -170.627 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -86.53 -178.3 1.1 Allowed Pre-proline 0 CA--C 1.509 -0.615 0 N-CA-C 117.965 2.579 . . . . 0.0 117.965 -170.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.415 ' HA ' HD21 ' A' ' 118' ' ' LEU . 85.4 Cg_exo -66.59 144.65 73.38 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 122.498 2.132 . . . . 0.0 109.44 160.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -78.72 146.89 33.66 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-O 122.063 0.935 . . . . 0.0 111.785 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -106.14 63.66 0.66 Allowed 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.035 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -79.43 116.97 19.98 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 C--O 1.261 1.702 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 177.013 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.483 -1.633 0 CA-C-O 122.28 1.038 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.1 mm -86.47 117.4 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 CA-C-N 112.811 -1.995 . . . . 0.0 106.855 177.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -97.18 169.96 9.44 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -170.122 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 82.9 t -103.89 121.85 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.525 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 168.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.407 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 26.4 mmmt -104.05 174.76 5.73 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 155.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -143.95 151.29 39.58 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 -178.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 tp -132.04 161.84 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 171.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -116.65 151.7 35.75 Favored 'General case' 0 CA--C 1.482 -1.662 0 C-N-CA 118.739 -1.184 . . . . 0.0 110.825 160.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.609 ' HB3' HG11 ' A' ' 144' ' ' VAL . 36.7 m-85 -124.33 133.03 53.57 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 168.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.57 ' H ' ' HE ' ' A' ' 99' ' ' ARG . 0.3 OUTLIER -98.39 169.1 8.82 Favored Pre-proline 0 N--CA 1.427 -1.589 0 C-N-CA 124.58 1.152 . . . . 0.0 108.41 -173.959 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -63.24 139.81 74.03 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 123.535 2.823 . . . . 0.0 111.321 171.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.43 -125.77 21.19 Favored Glycine 0 CA--C 1.479 -2.206 0 N-CA-C 106.746 -2.541 . . . . 0.0 106.746 -171.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.6 m 57.76 107.8 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.744 0 C-N-CA 129.437 3.095 . . . . 0.0 113.108 173.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -127.39 -131.83 0.23 Allowed 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 170.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -55.24 -81.79 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -86.228 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.08 49.84 0.93 Allowed Glycine 0 CA--C 1.482 -1.989 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.749 179.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -105.96 -40.96 5.52 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 147.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.2 -73.49 0.19 Allowed 'General case' 0 CA--C 1.482 -1.65 0 C-N-CA 126.659 1.984 . . . . 0.0 108.455 -174.103 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.449 ' HG2' ' H ' ' A' ' 108' ' ' GLN 0.333 0.0 OUTLIER -59.75 -11.14 4.6 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 120.65 3.574 . . . . 0.0 120.65 176.159 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.42 -39.86 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-O 122.005 0.907 . . . . 0.0 110.421 160.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -93.18 -1.95 55.76 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 176.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 tt -79.13 -31.32 44.07 Favored 'General case' 0 N--CA 1.417 -2.083 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 162.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.499 ' HA ' HG12 ' A' ' 115' ' ' ILE . 7.4 ttm-85 -60.11 -44.65 94.7 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 124.806 1.242 . . . . 0.0 111.298 169.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.3 t -60.14 -41.76 93.38 Favored 'General case' 0 C--N 1.371 1.515 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 76.0 mt -65.29 -29.79 70.58 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 173.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.252 5.3 mm -60.61 -48.92 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 CA-C-N 119.751 1.16 . . . . 0.0 108.361 176.836 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -51.19 -45.02 61.69 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 127.274 2.229 . . . . 0.0 110.146 178.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.407 ' CD2' ' HB2' ' A' ' 94' ' ' LYS . 12.2 m-30 -61.75 -49.93 74.44 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -179.275 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.695 HD13 ' HB2' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -72.5 -20.32 61.38 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.268 1.427 . . . . 0.0 114.298 179.248 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.73 -33.75 64.48 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 125.333 1.453 . . . . 0.0 110.677 172.397 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -67.62 -27.98 67.36 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 169.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.52 67.85 1.38 Allowed Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 105.213 -3.155 . . . . 0.0 105.213 -173.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -123.67 169.27 11.66 Favored 'General case' 0 CA--C 1.452 -2.797 1 N-CA-C 97.852 -4.87 . . . . 0.0 97.852 169.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.81 134.76 39.69 Favored 'General case' 0 CA--C 1.455 -2.704 1 N-CA-C 98.169 -4.752 . . . . 0.0 98.169 157.475 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.24 161.2 21.57 Favored 'General case' 0 N--CA 1.418 -2.037 0 C-N-CA 115.032 -2.667 . . . . 0.0 105.37 160.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -111.78 136.24 51.31 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 159.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.562 HD11 HD22 ' A' ' 174' ' ' LEU . 4.9 mm -82.47 128.64 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 165.215 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.3 m -111.99 120.31 41.46 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 169.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.717 HD11 ' HA2' ' A' ' 141' ' ' GLY . 0.1 OUTLIER -82.42 153.89 25.46 Favored 'General case' 0 CA--C 1.464 -2.341 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 167.162 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.496 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 67.5 ttt180 -148.94 95.39 2.4 Favored 'General case' 0 N--CA 1.393 -3.318 1 N-CA-C 95.736 -5.653 . . . . 0.0 95.736 -176.861 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.487 ' CE1' HD22 ' A' ' 128' ' ' LEU . 97.4 m-85 -74.06 116.77 15.08 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 102.347 -3.205 . . . . 0.0 102.347 175.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -87.93 91.12 8.65 Favored 'General case' 0 CA--C 1.484 -1.588 0 N-CA-C 101.216 -3.624 . . . . 0.0 101.216 172.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -62.13 120.64 22.81 Favored Glycine 0 CA--C 1.468 -2.847 0 O-C-N 125.694 1.871 . . . . 0.0 113.947 -140.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -73.51 -72.2 0.27 Allowed 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 113.07 -1.565 . . . . 0.0 107.806 172.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.556 ' H ' ' CE1' ' A' ' 137' ' ' HIS . 35.2 tt0 -72.46 -78.73 0.08 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 110.912 -2.858 . . . . 0.0 104.474 159.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.441 ' H ' ' H ' ' A' ' 136' ' ' ALA . 17.2 ptt? -173.27 -19.67 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.441 ' H ' ' H ' ' A' ' 135' ' ' MET . . . 175.42 114.75 0.02 OUTLIER 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 -156.094 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.556 ' CE1' ' H ' ' A' ' 134' ' ' GLU . 85.5 m-70 -126.59 149.11 49.64 Favored 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -163.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -107.32 26.65 9.94 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 163.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.502 ' H ' ' HB3' ' A' ' 137' ' ' HIS . 7.3 mt-30 -125.87 -57.0 1.45 Allowed 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -177.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 137' ' ' HIS 0.271 74.8 mt -56.58 -38.67 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.974 0 C-N-CA 127.987 2.515 . . . . 0.0 109.518 171.767 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.717 ' HA2' HD11 ' A' ' 128' ' ' LEU . . . -74.33 -60.59 3.47 Favored Glycine 0 N--CA 1.405 -3.41 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.872 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.448 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 4.9 ptt? -89.61 5.61 44.9 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -160.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -62.56 -58.45 7.53 Favored 'General case' 0 CA--C 1.46 -2.504 0 C-N-CA 114.907 -2.717 . . . . 0.0 114.595 143.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.609 HG11 ' HB3' ' A' ' 98' ' ' PHE . 15.2 t -68.11 -63.06 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.442 -3.194 0 O-C-N 126.096 2.123 . . . . 0.0 107.335 -160.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 145' ' ' LEU . 17.7 mt -41.05 -60.15 1.29 Allowed 'General case' 0 CA--C 1.464 -2.344 0 C-N-CA 128.351 2.66 . . . . 0.0 113.454 176.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.3 t-20 -55.72 -37.8 68.9 Favored 'General case' 0 CA--C 1.464 -2.333 0 C-N-CA 125.996 1.718 . . . . 0.0 115.327 177.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.5 ttt85 -81.01 -14.04 58.29 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 119.861 -0.735 . . . . 0.0 111.914 175.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.8 t -75.36 -46.72 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.747 0 CA-C-O 116.037 -1.935 . . . . 0.0 106.495 176.006 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.629 ' HB2' HG21 ' A' ' 158' ' ' VAL . 1.2 ttpp -54.65 -57.03 13.07 Favored 'General case' 0 CA--C 1.459 -2.523 0 CA-C-O 116.244 -1.836 . . . . 0.0 108.22 171.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -34.58 78.22 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 120.116 1.325 . . . . 0.0 111.26 -166.587 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.6 -39.47 62.16 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 168.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.329 0.2 OUTLIER -80.61 -24.29 39.19 Favored 'General case' 0 CA--C 1.47 -2.109 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -176.82 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -26.07 -31.06 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.812 1 C-N-CA 136.5 5.92 . . . . 0.0 118.357 -177.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -52.35 -52.92 50.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.734 2.014 . . . . 0.0 114.298 170.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.423 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 3.2 tm? -107.52 -55.86 2.29 Favored 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 128.5 2.72 . . . . 0.0 108.434 -160.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.695 ' HB2' HD13 ' A' ' 118' ' ' LEU 0.279 . . -102.0 154.88 18.56 Favored 'General case' 0 CA--C 1.449 -2.935 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 -176.1 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 18.7 m -118.66 -179.05 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.458 -2.594 0 C-N-CA 113.661 -3.216 . . . . 0.0 115.494 139.401 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.629 HG21 ' HB2' ' A' ' 149' ' ' LYS . 3.3 t -94.89 149.92 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.989 0 N-CA-C 104.94 -2.245 . . . . 0.0 104.94 166.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -82.28 -41.9 19.54 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 -176.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -153.43 148.23 26.43 Favored 'General case' 0 CA--C 1.47 -2.12 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -172.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.438 ' CZ ' ' HA ' ' A' ' 146' ' ' ASN . 0.2 OUTLIER -107.41 104.7 53.6 Favored Pre-proline 0 CA--C 1.46 -2.512 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 171.495 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 1.6 Cg_endo -103.82 -128.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.408 -3.536 1 N-CA-C 100.76 -4.361 . . . . 0.0 100.76 -156.179 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 179.68 -48.74 0.01 OUTLIER 'General case' 0 N--CA 1.411 -2.389 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 -137.294 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -88.63 97.09 10.92 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-O 121.387 0.613 . . . . 0.0 111.375 -153.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.41 HG21 ' HB1' ' A' ' 136' ' ' ALA . 1.9 mt -89.0 135.13 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 175.213 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -121.02 109.62 15.27 Favored 'General case' 0 CA--C 1.481 -1.694 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.2 -141.72 26.35 Favored Glycine 0 CA--C 1.482 -2.002 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 -170.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -104.83 45.14 0.98 Allowed 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 113.243 -1.479 . . . . 0.0 109.385 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.496 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.314 19.7 mt-30 -167.31 136.68 2.77 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -173.693 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.4 ttp -125.32 118.66 26.42 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 118.561 0.618 . . . . 0.0 111.395 -173.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.7 mm -80.38 124.93 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 CA-C-O 122.47 1.128 . . . . 0.0 108.534 169.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.9 ttt -105.95 136.98 44.64 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 159.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.0 t -102.32 134.28 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 117.682 -1.607 . . . . 0.0 109.123 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.562 HD22 HD11 ' A' ' 126' ' ' ILE . 11.7 tp -112.38 86.78 2.42 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 121.338 3.829 . . . . 0.0 121.338 -177.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.388 . . -107.77 155.54 39.65 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -178.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -70.2 150.6 65.77 Favored 'Trans proline' 0 CA--C 1.486 -1.877 0 C-N-CA 122.885 2.39 . . . . 0.0 109.378 -163.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -76.78 120.33 21.79 Favored 'General case' 0 N--CA 1.433 -1.323 0 O-C-N 124.853 1.346 . . . . 0.0 108.21 -175.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -85.54 104.07 14.97 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 171.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -75.85 133.13 40.68 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 . . . . . 0 C--O 1.261 1.685 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.913 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.47 -2.105 0 CA-C-O 125.001 2.334 . . . . 0.0 107.391 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.6 mm -85.3 124.52 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 1 CA-C-N 108.215 -4.084 . . . . 0.0 106.319 178.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -97.29 162.71 13.21 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 -167.069 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.474 HG22 ' HE3' ' A' ' 123' ' ' LYS . 83.1 t -101.94 121.83 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.66 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 174.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -107.15 -178.23 3.58 Favored 'General case' 0 CA--C 1.472 -2.029 0 C-N-CA 117.373 -1.731 . . . . 0.0 107.535 162.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -150.03 150.12 31.32 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.058 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 tp -132.82 161.6 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 173.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -122.1 153.75 38.27 Favored 'General case' 0 CA--C 1.485 -1.535 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.071 164.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.59 ' HB3' HG11 ' A' ' 144' ' ' VAL . 40.6 m-85 -134.07 136.76 44.18 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.6 ttt85 -110.71 160.99 26.64 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-O 117.612 -1.185 . . . . 0.0 108.817 -173.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.411 ' HB3' HG23 ' A' ' 140' ' ' ILE . 39.1 Cg_exo -63.6 137.22 58.22 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 124.81 3.673 . . . . 0.0 110.608 177.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 51.65 57.33 12.5 Favored Glycine 0 CA--C 1.473 -2.567 0 C-N-CA 126.511 2.005 . . . . 0.0 112.005 173.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 84.3 m -129.64 107.21 9.27 Favored 'General case' 0 CA--C 1.463 -2.37 0 N-CA-C 102.708 -3.071 . . . . 0.0 102.708 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -124.68 -137.38 0.28 Allowed 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 171.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.02 -78.02 0.03 OUTLIER 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -86.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.45 42.96 1.8 Allowed Glycine 0 CA--C 1.483 -1.963 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.488 -177.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -101.48 -41.55 6.59 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 147.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.8 -74.06 0.18 Allowed 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 126.525 1.93 . . . . 0.0 109.12 -169.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.433 ' H ' ' HG2' ' A' ' 108' ' ' GLN 0.326 0.0 OUTLIER -59.64 -11.27 4.62 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 120.335 3.457 . . . . 0.0 120.335 177.175 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.12 -40.57 89.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 122.094 0.949 . . . . 0.0 110.296 161.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -92.87 -4.28 53.16 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 176.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.5 tt -75.84 -33.27 60.03 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 161.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.476 ' HA ' HG12 ' A' ' 115' ' ' ILE . 16.2 ttp180 -60.4 -44.93 95.22 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 125.175 1.39 . . . . 0.0 111.146 170.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 t -62.46 -42.63 99.61 Favored 'General case' 0 C--N 1.375 1.687 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 118' ' ' LEU 0.327 51.2 tp -68.69 -30.38 69.03 Favored 'General case' 0 N--CA 1.402 -2.835 0 C-N-CA 125.706 1.602 . . . . 0.0 113.519 177.707 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 112' ' ' ARG 0.283 8.9 mm -56.3 -52.03 56.59 Favored 'Isoleucine or valine' 0 C--N 1.378 1.833 0 CA-C-N 120.94 1.7 . . . . 0.0 109.402 171.099 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -53.47 -40.16 65.08 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 128.386 2.674 . . . . 0.0 110.559 -177.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -61.01 -54.16 48.39 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 124.393 1.077 . . . . 0.0 112.043 175.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.677 HD13 ' HB2' ' A' ' 156' ' ' ALA . 1.3 mt -67.76 -21.08 65.28 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -72.52 -36.21 68.29 Favored 'General case' 0 CA--C 1.491 -1.317 0 C-N-CA 126.043 1.737 . . . . 0.0 110.25 172.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -67.16 -22.2 65.77 Favored 'General case' 0 C--N 1.36 1.031 0 O-C-N 123.185 0.303 . . . . 0.0 111.214 169.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.83 68.1 1.42 Allowed Glycine 0 CA--C 1.469 -2.839 0 N-CA-C 104.81 -3.316 . . . . 0.0 104.81 -174.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -123.28 163.4 20.78 Favored 'General case' 0 CA--C 1.448 -2.971 0 N-CA-C 100.641 -3.837 . . . . 0.0 100.641 171.019 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.639 ' HD3' HG12 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -105.45 106.27 16.69 Favored 'General case' 0 N--CA 1.399 -3.007 1 N-CA-C 99.101 -4.407 . . . . 0.0 99.101 173.892 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -97.77 128.54 44.48 Favored 'General case' 0 N--CA 1.411 -2.39 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.561 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -96.07 129.88 43.24 Favored 'General case' 0 CA--C 1.474 -1.969 0 CA-C-O 121.621 0.724 . . . . 0.0 109.325 -176.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.6 mm -82.9 132.92 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 171.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.526 ' HA ' HD13 ' A' ' 171' ' ' ILE . 21.8 m -113.82 120.81 42.05 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 167.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.656 HD12 HD11 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -74.2 145.65 43.98 Favored 'General case' 0 CA--C 1.474 -1.962 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 165.808 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.448 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 52.3 ttp180 -147.48 94.96 2.45 Favored 'General case' 0 N--CA 1.4 -2.93 1 N-CA-C 98.591 -4.596 . . . . 0.0 98.591 -178.739 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 136' ' ' ALA . 77.1 m-85 -67.46 164.03 19.66 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 111.267 -2.697 . . . . 0.0 108.009 178.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 49.7 tpt85 -81.24 82.42 7.13 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 158.685 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.447 ' H ' ' HE ' ' A' ' 168' ' ' ARG . . . -82.84 111.91 3.44 Favored Glycine 0 CA--C 1.455 -3.673 0 C-N-CA 118.473 -1.822 . . . . 0.0 112.94 -139.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.452 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 23.1 tpt85 -165.45 -133.97 0.02 OUTLIER 'General case' 0 CA--C 1.485 -1.53 0 CA-C-N 112.443 -1.879 . . . . 0.0 107.365 -168.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.452 ' H ' ' HG3' ' A' ' 133' ' ' ARG . 46.0 mm-40 -86.56 17.92 3.61 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 125.758 1.623 . . . . 0.0 108.855 156.001 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -120.31 27.44 8.6 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 161.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 130' ' ' PHE . . . -113.3 98.11 6.9 Favored 'General case' 0 CA--C 1.484 -1.594 0 C-N-CA 124.788 1.235 . . . . 0.0 108.557 163.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.404 ' HB3' ' H ' ' A' ' 139' ' ' GLN . 14.0 m-70 -129.15 171.47 12.38 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.154 -172.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -85.94 8.82 18.87 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 121.84 -0.538 . . . . 0.0 110.8 166.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.404 ' H ' ' HB3' ' A' ' 137' ' ' HIS . 11.1 mt-30 -97.23 -47.34 5.78 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 173.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.411 HG23 ' HB3' ' A' ' 100' ' ' PRO 0.323 63.1 mt -65.07 -35.58 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 C-N-CA 127.65 2.38 . . . . 0.0 109.335 -177.615 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.576 ' CA ' HD11 ' A' ' 128' ' ' LEU . . . -74.15 -61.14 3.32 Favored Glycine 0 N--CA 1.409 -3.112 0 CA-C-N 114.911 -1.041 . . . . 0.0 114.134 171.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.496 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 6.7 ptt? -85.43 -2.59 58.28 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -158.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.61 -53.23 59.96 Favored 'General case' 0 CA--C 1.455 -2.688 0 C-N-CA 114.807 -2.757 . . . . 0.0 114.461 150.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.59 HG11 ' HB3' ' A' ' 98' ' ' PHE . 12.7 t -69.77 -65.33 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.447 -2.998 0 O-C-N 126.011 2.069 . . . . 0.0 107.765 -164.055 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.656 HD11 HD12 ' A' ' 128' ' ' LEU . 14.5 mt -44.07 -55.07 4.98 Favored 'General case' 0 CA--C 1.481 -1.674 0 C-N-CA 128.757 2.823 . . . . 0.0 115.675 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 142' ' ' MET . 1.6 t-20 -63.76 -30.95 71.99 Favored 'General case' 0 CA--C 1.462 -2.404 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 174.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -81.44 -15.16 55.95 Favored 'General case' 0 N--CA 1.419 -1.993 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.853 172.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.466 HG21 ' CE2' ' A' ' 98' ' ' PHE . 2.0 t -74.71 -47.13 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.819 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 176.137 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.478 ' HE3' HG21 ' A' ' 158' ' ' VAL . 35.2 ttmt -51.61 -53.95 32.96 Favored 'General case' 0 CA--C 1.459 -2.558 0 C-N-CA 125.47 1.508 . . . . 0.0 110.642 172.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.19 -35.99 71.77 Favored 'General case' 0 N--CA 1.411 -2.415 0 C-N-CA 125.241 1.416 . . . . 0.0 110.172 -167.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -71.59 -34.98 70.38 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 115.872 -2.331 . . . . 0.0 114.885 170.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 115' ' ' ILE 0.262 0.2 OUTLIER -81.31 -26.26 35.81 Favored 'General case' 0 CA--C 1.463 -2.372 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -178.178 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -28.62 -21.61 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.511 1 C-N-CA 135.896 5.679 . . . . 0.0 119.292 178.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -53.99 -58.45 7.27 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 125.753 1.621 . . . . 0.0 112.733 164.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 tt -111.45 -43.57 3.66 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 127.338 2.255 . . . . 0.0 109.666 -159.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.854 ' HB1' HD11 ' A' ' 174' ' ' LEU 0.303 . . -115.59 142.14 47.13 Favored 'General case' 0 CA--C 1.464 -2.357 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.809 179.554 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.3 m -130.02 164.83 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.021 0 N-CA-C 121.776 3.991 . . . . 0.0 121.776 147.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 174' ' ' LEU . 2.7 t -79.81 149.27 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.973 0 CA-C-N 111.06 -2.791 . . . . 0.0 107.944 -174.021 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.76 -38.87 25.0 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 113.033 -1.894 . . . . 0.0 106.079 -172.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.2 t -162.57 150.01 13.69 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -171.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 2.4 t80 -108.19 103.36 50.12 Favored Pre-proline 0 N--CA 1.427 -1.589 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 173.142 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 83.5 Cg_endo -132.91 -106.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 115.016 -2.856 . . . . 0.0 108.137 -142.262 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.0 -94.36 0.13 Allowed 'General case' 0 N--CA 1.406 -2.635 0 C-N-CA 117.355 -1.738 . . . . 0.0 113.093 -109.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -153.11 132.56 12.9 Favored 'General case' 0 CA--C 1.476 -1.872 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 -169.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.0 mt -76.22 131.1 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 N-CA-C 103.987 -2.598 . . . . 0.0 103.987 166.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -133.55 113.62 12.65 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 102.589 -3.115 . . . . 0.0 102.589 -178.153 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.29 -141.02 24.44 Favored Glycine 0 CA--C 1.483 -1.947 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -168.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.447 ' HE ' ' H ' ' A' ' 132' ' ' GLY . 67.4 mtp180 -101.04 33.72 2.75 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 113.073 -1.564 . . . . 0.0 110.897 -174.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.448 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.291 17.7 mt-30 -171.22 141.22 1.58 Allowed 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.511 -162.347 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 15.9 ttm -118.7 170.75 8.71 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 172.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.526 HD13 ' HA ' ' A' ' 127' ' ' THR . 28.2 mm -117.74 142.25 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 C-N-CA 126.727 2.011 . . . . 0.0 108.232 161.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.7 ttt -124.33 133.81 53.35 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 102.988 -2.967 . . . . 0.0 102.988 157.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.639 HG12 ' HD3' ' A' ' 123' ' ' LYS . 1.6 t -100.75 139.75 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.021 -171.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.854 HD11 ' HB1' ' A' ' 156' ' ' ALA . 1.4 tp -131.54 130.59 42.49 Favored 'General case' 0 C--N 1.365 1.263 0 CA-C-N 121.688 2.04 . . . . 0.0 106.625 -172.418 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.299 . . -129.56 178.26 1.78 Allowed Pre-proline 0 CA--C 1.49 -1.329 0 C-N-CA 125.819 1.648 . . . . 0.0 111.819 -173.106 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -71.35 158.24 54.84 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 CA-C-N 120.925 1.366 . . . . 0.0 111.036 -177.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -76.65 118.81 19.66 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 174.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -78.21 117.34 19.39 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 165.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -59.54 118.74 6.41 Favored 'General case' 0 CA--C 1.496 -1.126 0 C-N-CA 124.92 1.288 . . . . 0.0 112.148 -168.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 . . . . . 0 C--O 1.259 1.583 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.339 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 CA--C 1.48 -1.719 0 CA-C-O 122.166 0.984 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.1 mm -89.57 114.04 26.89 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 CA-C-N 113.104 -1.862 . . . . 0.0 106.311 171.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -107.38 164.09 12.49 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -163.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.532 HG22 ' HE2' ' A' ' 123' ' ' LYS . 69.2 t -88.88 117.32 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.903 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 162.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -110.29 169.75 8.53 Favored 'General case' 0 CA--C 1.483 -1.601 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 151.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -136.37 157.95 45.59 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.812 -163.164 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 tp -131.58 163.67 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 165.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -119.57 154.42 33.93 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 119.479 -0.888 . . . . 0.0 112.321 162.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.628 ' HB3' HG11 ' A' ' 144' ' ' VAL . 45.9 m-85 -129.09 147.31 50.93 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 169.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -114.91 170.78 5.1 Favored Pre-proline 0 N--CA 1.431 -1.401 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.449 ' HB3' HG23 ' A' ' 140' ' ' ILE . 5.8 Cg_endo -70.36 152.22 66.08 Favored 'Trans proline' 0 CA--C 1.487 -1.845 0 C-N-CA 123.463 2.776 . . . . 0.0 109.147 172.087 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.22 -127.53 17.82 Favored Glycine 0 CA--C 1.479 -2.203 0 N-CA-C 105.293 -3.123 . . . . 0.0 105.293 -168.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.2 m 49.26 100.6 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.731 0 C-N-CA 129.867 3.267 . . . . 0.0 112.38 178.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -117.52 -157.54 0.67 Allowed 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.48 -176.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -62.04 -43.78 98.1 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -121.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -104.6 60.55 0.42 Allowed Glycine 0 N--CA 1.42 -2.399 0 CA-C-O 123.951 1.862 . . . . 0.0 111.473 -171.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -169.76 -41.0 0.02 OUTLIER 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 130.308 3.443 . . . . 0.0 103.76 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -86.61 -71.62 0.54 Allowed 'General case' 0 CA--C 1.482 -1.649 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.798 -166.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.506 ' HA ' ' HB2' ' A' ' 111' ' ' LEU 0.311 0.0 OUTLIER -61.08 -14.76 26.21 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 118.872 2.916 . . . . 0.0 118.872 172.414 . . . . . . . . 4 4 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.17 -41.71 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.982 0.913 . . . . 0.0 109.791 162.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -93.15 6.76 46.86 Favored 'General case' 0 CA--C 1.486 -1.513 0 O-C-N 120.376 -1.452 . . . . 0.0 114.905 175.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.8 tt -85.8 -31.32 22.39 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 162.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.428 ' HA ' HG12 ' A' ' 115' ' ' ILE . 14.3 ttp180 -60.47 -45.36 94.0 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.654 1.182 . . . . 0.0 109.843 168.061 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 t -58.89 -43.07 90.91 Favored 'General case' 0 C--N 1.375 1.705 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 173.375 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.432 HD11 HD12 ' A' ' 126' ' ' ILE . 10.3 mt -60.95 -33.1 72.66 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 175.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.434 ' CG2' ' HG ' ' A' ' 155' ' ' LEU . 3.1 mm -61.06 -46.79 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 177.285 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -53.09 22.39 Favored 'General case' 0 CA--C 1.497 -1.07 0 O-C-N 125.985 2.053 . . . . 0.0 110.923 178.146 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -58.41 -46.37 86.56 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 178.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.533 HD22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -62.06 -36.64 82.22 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 176.119 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -79.19 -21.54 46.21 Favored 'General case' 0 CA--C 1.487 -1.469 0 C-N-CA 127.671 2.388 . . . . 0.0 112.638 -173.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -71.56 -15.15 62.27 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 169.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.61 65.5 1.5 Allowed Glycine 0 CA--C 1.462 -3.252 0 N-CA-C 104.469 -3.452 . . . . 0.0 104.469 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -133.14 173.69 11.17 Favored 'General case' 0 CA--C 1.447 -3.012 1 N-CA-C 97.724 -4.917 . . . . 0.0 97.724 170.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.532 ' HE2' HG22 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -90.01 135.02 33.9 Favored 'General case' 0 N--CA 1.399 -2.978 1 N-CA-C 97.898 -4.853 . . . . 0.0 97.898 158.611 . . . . . . . . 4 4 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 174' ' ' LEU . . . -79.09 156.74 28.19 Favored 'General case' 0 N--CA 1.405 -2.677 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 156.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -140.06 133.13 29.52 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 101.121 -3.659 . . . . 0.0 101.121 169.719 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.475 HD11 HD12 ' A' ' 174' ' ' LEU . 8.5 mm -83.83 134.56 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.112 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -178.358 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.6 m -116.28 121.53 42.29 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 168.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.32 154.18 33.09 Favored 'General case' 0 CA--C 1.47 -2.103 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 166.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.558 ' HA ' ' HG2' ' A' ' 169' ' ' GLN . 35.2 ttp85 -146.07 96.67 2.83 Favored 'General case' 0 N--CA 1.397 -3.1 1 N-CA-C 96.073 -5.529 . . . . 0.0 96.073 -179.482 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -70.31 126.0 28.39 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 111.88 -2.418 . . . . 0.0 106.212 178.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -77.22 108.06 10.06 Favored 'General case' 0 CA--C 1.479 -1.753 1 N-CA-C 99.779 -4.156 . . . . 0.0 99.779 160.016 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.47 118.11 6.52 Favored Glycine 0 CA--C 1.467 -2.963 0 O-C-N 124.865 1.353 . . . . 0.0 112.303 -157.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -117.61 19.4 13.91 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-N 112.73 -1.735 . . . . 0.0 108.919 169.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 179.15 -11.96 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 101.355 -3.572 . . . . 0.0 101.355 -176.446 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 54.7 mtt 80.23 -5.51 1.8 Allowed 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 129.272 3.029 . . . . 0.0 111.894 -170.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.459 ' HB1' HD12 ' A' ' 165' ' ' ILE . . . -179.42 112.66 0.05 Allowed 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.548 -161.265 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.65 ' CG ' HD13 ' A' ' 140' ' ' ILE . 1.7 m-70 -131.49 154.84 48.34 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.142 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -108.84 46.1 0.99 Allowed 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 160.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -130.51 -54.25 1.09 Allowed 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 103.579 -2.749 . . . . 0.0 103.579 172.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.65 HD13 ' CG ' ' A' ' 137' ' ' HIS . 1.7 mp -50.46 -52.54 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.772 0 C-N-CA 127.23 2.212 . . . . 0.0 109.424 167.295 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -68.12 -59.78 6.11 Favored Glycine 0 N--CA 1.416 -2.677 0 O-C-N 124.222 0.951 . . . . 0.0 111.439 -176.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.482 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 6.8 ptm -90.88 6.36 44.83 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -161.121 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.09 -56.02 15.4 Favored 'General case' 0 CA--C 1.455 -2.703 0 C-N-CA 115.875 -2.33 . . . . 0.0 113.559 146.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.628 HG11 ' HB3' ' A' ' 98' ' ' PHE . 24.3 t -67.89 -66.46 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.44 -3.251 0 O-C-N 126.498 2.374 . . . . 0.0 107.39 -164.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.8 mt -39.27 -57.04 1.42 Allowed 'General case' 0 CA--C 1.467 -2.224 0 C-N-CA 128.138 2.575 . . . . 0.0 114.018 178.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 161' ' ' PHE . 1.2 t-20 -52.99 -45.05 67.68 Favored 'General case' 0 CA--C 1.47 -2.132 0 C-N-CA 126.607 1.963 . . . . 0.0 115.911 175.454 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -83.27 -12.86 56.3 Favored 'General case' 0 N--CA 1.424 -1.768 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.41 179.331 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 144' ' ' VAL . 2.1 t -76.27 -40.0 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.697 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 177.367 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.41 -52.16 62.72 Favored 'General case' 0 CA--C 1.449 -2.934 0 CA-C-O 117.332 -1.318 . . . . 0.0 113.108 176.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -60.15 -39.1 85.17 Favored 'General case' 0 N--CA 1.404 -2.747 0 C-N-CA 127.097 2.159 . . . . 0.0 108.836 -178.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.458 ' HB3' HD11 ' A' ' 111' ' ' LEU . 21.1 t70 -75.52 -28.55 59.16 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 117.403 2.371 . . . . 0.0 117.403 169.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.629 ' HG ' ' HB3' ' A' ' 156' ' ' ALA 0.269 0.0 OUTLIER -75.53 -37.12 60.27 Favored 'General case' 0 CA--C 1.477 -1.841 0 CA-C-N 120.185 1.357 . . . . 0.0 112.79 179.258 . . . . . . . . 4 4 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -27.66 -32.61 0.0 OUTLIER 'General case' 0 CA--C 1.474 -1.946 1 C-N-CA 137.071 6.148 . . . . 0.0 119.079 -164.653 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 154' ' ' GLU . 4.7 mt-10 -52.43 -51.3 59.86 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 127.37 2.268 . . . . 0.0 113.153 172.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.434 ' HG ' ' CG2' ' A' ' 115' ' ' ILE . 2.7 tm? -109.4 -47.81 3.34 Favored 'General case' 0 N--CA 1.42 -1.953 0 C-N-CA 128.716 2.806 . . . . 0.0 107.472 -161.171 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.629 ' HB3' ' HG ' ' A' ' 152' ' ' LEU 0.327 . . -119.64 140.59 50.37 Favored 'General case' 0 CA--C 1.457 -2.606 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.372 -176.765 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.2 m -126.32 -176.36 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.47 -2.111 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 155.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.35 166.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.58 0 C-N-CA 126.619 1.968 . . . . 0.0 110.159 -165.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -85.87 -41.65 14.8 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 154.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 t -164.59 146.24 8.27 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.997 -171.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.495 ' CZ ' ' HA ' ' A' ' 146' ' ' ASN . 0.2 OUTLIER -100.29 117.4 63.15 Favored Pre-proline 0 CA--C 1.462 -2.408 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 170.404 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 50.8 Cg_endo -133.12 -128.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.409 -3.448 1 N-CA-C 101.553 -4.056 . . . . 0.0 101.553 -158.957 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -178.18 -42.1 0.01 OUTLIER 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 -120.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -85.63 88.18 7.5 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 121.667 0.746 . . . . 0.0 111.483 -158.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.459 HD12 ' HB1' ' A' ' 136' ' ' ALA . 1.7 mt -84.01 129.57 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 172.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -125.32 102.82 7.61 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 -173.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.45 -139.74 21.25 Favored Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 -171.45 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -101.44 39.42 1.43 Allowed 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 112.831 -1.685 . . . . 0.0 109.538 -176.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.558 ' HG2' ' HA ' ' A' ' 129' ' ' ARG 0.337 18.7 mt-30 -172.1 133.12 0.68 Allowed 'General case' 0 CA--C 1.502 -0.866 0 O-C-N 121.866 -0.522 . . . . 0.0 110.301 -162.415 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 22.4 ttp -115.32 115.53 26.78 Favored 'General case' 0 CA--C 1.481 -1.692 0 CA-C-O 121.472 0.654 . . . . 0.0 111.679 -171.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.0 mm -81.72 126.88 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.367 0 CA-C-O 122.123 0.964 . . . . 0.0 108.76 172.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.435 ' SD ' ' CZ ' ' A' ' 161' ' ' PHE . 3.2 ttt -112.65 142.96 44.63 Favored 'General case' 0 CA--C 1.476 -1.875 0 N-CA-C 103.167 -2.901 . . . . 0.0 103.167 155.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.6 t -98.87 153.37 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 118.589 -1.244 . . . . 0.0 107.696 -175.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.475 HD12 HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -134.92 81.75 1.92 Allowed 'General case' 0 C--N 1.36 1.053 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -174.836 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . 0.278 . . -83.34 174.4 6.05 Favored Pre-proline 0 CA--C 1.505 -0.787 0 O-C-N 119.637 -1.914 . . . . 0.0 115.038 -175.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -68.33 135.93 35.55 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.363 2.042 . . . . 0.0 108.996 165.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -80.08 163.19 24.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 124.037 0.836 . . . . 0.0 110.864 171.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -74.06 107.12 6.07 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -67.87 105.89 2.12 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 124.701 1.2 . . . . 0.0 110.358 -173.015 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 C--O 1.26 1.635 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -179.389 . . . . . . . . 0 0 . 1 stop_ save_